Citrus Sinensis ID: 041345

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340
Protein Sequence
MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR
Secondary Structure (PSIPRED)
cccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEccccccccHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccccccccccccccccccccccccccEEEEccccccHHHHcccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEEEccccccccccccccccccccccEEEEEEEcc
Secondary Structure Prediction (SSPRO)
cccccccEcHHHHHHHHHcccHcccccccccccEEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEccHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccHHHcEEcccccEEccccEEEEEcccccHHHHHcccEEEcccHEEHHEEEEEEEccccccccccccccHHHHHHHHHHHHccccEEHccHHHcccccHHHHHHHHHHHHHEEcccHcccccHHHEEEEccccccccccccccEEEEEccccccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
MKRDLKIFDFQTiaaatdnfspgnrlgqggfgpvykgklldgQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGcslqkgerLLVYeylpnksldffifdSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKAsnillddqmnpkisdfgmartfgmneleantnrivgthgymspeyvMNGIVSMKSDVYSFGVLVLEIISskknngcydterHLNLVGYAWQLWNEGKALELIDTtlhescspdevtRCIHVGLLcvqdkatdrptmsDVASMLtndtmalptprqpaffinissdyeepevteikleVCSVNDVTISRMEAR
Flexible Loop (DISEMBL)
MKRDLKIFDFQTiaaatdnfspgnrLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKAsnillddqmnpKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCvqdkatdrpTMSDVASMLTNDTMALPTPRQPAFFINISSDYEepevteiklevcsvndvtisrmear
Low Complexity Region (SEG)
MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR
Disordered region (IsUnstruct)
*****KIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDK**************************PAFFINISSDYEEPEVTEIKLEVCSVNDVT*******
Disordered Region (DISOPRED)
*KRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFF***********************DVTISRMEAR
Disordered Region (DISEMBL)
MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR
Disordered Region (DISPRO)
***DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINIS***************CSVNDVTISRMEA*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	340	2.2.26 [Sep-21-2011]
Q8GYA4	669	Cysteine-rich receptor-li	yes	no	0.976	0.496	0.6	1e-117
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.988	0.399	0.565	1e-115
Q9S972	847	Receptor-like serine/thre	no	no	0.991	0.397	0.580	1e-113
Q9LW83	850	G-type lectin S-receptor-	no	no	0.991	0.396	0.602	1e-113
Q39086	843	Receptor-like serine/thre	no	no	0.961	0.387	0.589	1e-113
O81906	849	G-type lectin S-receptor-	no	no	0.888	0.355	0.630	1e-112
O81905	850	Receptor-like serine/thre	no	no	0.991	0.396	0.580	1e-112
Q9LZU4	676	Cysteine-rich receptor-li	no	no	0.979	0.492	0.576	1e-111
O64793	818	G-type lectin S-receptor-	no	no	0.988	0.410	0.582	1e-111
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.988	0.394	0.576	1e-110

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  420 bits (1080), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 201/335 (60%), Positives = 253/335 (75%), Gaps = 3/335 (0%)

Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
            D++TI  ATD+F   N++GQGGFG VYKG L DG E+A+KRLSKSSGQG VEFKNE  L
Sbjct: 336 LDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVL 395

Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +AKLQH NLVRLLG  L   ER+LVYEY+PNKSLD+F+FD +KK  LDW +R+ II G+ 
Sbjct: 396 VAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVA 455

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +G+LYLH+ SRL +IHRDLKASNILLD  MNPKI+DFGMAR FG+++ E NT+RIVGT+G
Sbjct: 456 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYG 515

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           YMSPEY M+G  SMKSDVYSFGVLVLEIIS KKN+  Y T+   +LV YAW LW+ G+ L
Sbjct: 516 YMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPL 575

Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFF 307
           EL+D  + E+C  +EV RC+H+GLLCVQ+   +RPT+S +  MLT++T+ LP PRQP  F
Sbjct: 576 ELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLF 635

Query: 308 IN--ISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
               I  D  + + T   L + SV+D +I+ +  R
Sbjct: 636 FQSRIGKDPLDTDTTSKSL-LGSVDDASITDIHPR 669

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  414 bits (1064), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 191/338 (56%), Positives = 258/338 (76%), Gaps = 2/338 (0%)

Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFK 62
           ++L +F+FQ +A +TD+FS  N+LGQGGFGPVYKGKL +GQEIA+KRLS+ SGQG+ E  
Sbjct: 507 KELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELM 566

Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
           NE  +I+KLQH NLV+LLGC ++  ER+LVYEY+P KSLD ++FD  K+++LDWK RFNI
Sbjct: 567 NEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNI 626

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
           +EGI +GLLYLH+ SRL++IHRDLKASNILLD+ +NPKISDFG+AR F  NE EANT R+
Sbjct: 627 MEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRV 686

Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN 242
           VGT+GYMSPEY M G  S KSDV+S GV+ LEIIS ++N+  +  E +LNL+ YAW+LWN
Sbjct: 687 VGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWN 746

Query: 243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPR 302
           +G+A  L D  + + C   E+ +C+H+GLLCVQ+ A DRP +S+V  MLT + M+L  P+
Sbjct: 747 DGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPK 806

Query: 303 QPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           QPAF +   +   E E ++   +  S+NDV+++ +  R
Sbjct: 807 QPAFIVRRGA--SEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  409 bits (1050), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 198/341 (58%), Positives = 257/341 (75%), Gaps = 4/341 (1%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L + +++ +A AT+NFS  N+LGQGGFG VYKG LLDG+EIA+KRLSK S QG  EF N
Sbjct: 507 ELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMN 566

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E +LIAKLQH NLVRLLGC + KGE++L+YEYL N SLD  +FD ++   L+W+KRF+II
Sbjct: 567 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 626

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
            GI +GLLYLH+ SR R+IHRDLKASN+LLD  M PKISDFGMAR FG  E EANT R+V
Sbjct: 627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 686

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY M+GI SMKSDV+SFGVL+LEIIS K+N G Y++ R LNL+G+ W+ W E
Sbjct: 687 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 746

Query: 244 GKALELIDTTLHESCSPD----EVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
           GK LE++D    ++ S +    E+ RCI +GLLCVQ++A DRP MS V  ML ++T A+P
Sbjct: 747 GKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 806

Query: 300 TPRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
            P++P F +  SS   +   +  + + C+VN VT+S ++AR
Sbjct: 807 QPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  409 bits (1050), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 205/340 (60%), Positives = 260/340 (76%), Gaps = 3/340 (0%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L+IF F+++A ATD FS  N+LG+GGFGPVYKG+L+DG+E+AIKRLS +SGQG+VEFKN
Sbjct: 511 ELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKN 570

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           EA LIAKLQHTNLV+LLGC ++K E++L+YEY+PNKSLD+F+FD  +K +LDWK RF I+
Sbjct: 571 EAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIM 630

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           EGI+QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGMAR FG  E +ANT R+ 
Sbjct: 631 EGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVA 690

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC-YDTERHLNLVGYAWQLWN 242
           GT GYMSPEY   G+ S KSDV+SFGVL+LEII  +KNN   +D+E  LNL+ + W L+ 
Sbjct: 691 GTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFK 750

Query: 243 EGKALELIDTTLHESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVASMLTND-TMALPT 300
           E +  E+ID +L +S   + +V RC+ V LLCVQ  A DRP+M DV SM+  D   AL  
Sbjct: 751 ENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSL 810

Query: 301 PRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           P++PAF+        E EV   ++E  S N VTI+ MEAR
Sbjct: 811 PKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  407 bits (1046), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 195/331 (58%), Positives = 247/331 (74%), Gaps = 4/331 (1%)

Query: 14  AAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH 73
           A AT+NFS  N+LGQGGFG VYKG+LLDG+EIA+KRLSK S QG  EF NE +LIAKLQH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            NLVRLLGC + KGE++L+YEYL N SLD  +FD ++   L+W+KRF+II GI +GLLYL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H+ SR R+IHRDLKASN+LLD  M PKISDFGMAR FG  E EANT R+VGT+GYMSPEY
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEY 692

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT- 252
            M+GI SMKSDV+SFGVL+LEIIS K+N G Y++ R LNL+G+ W+ W EG  LE++D  
Sbjct: 693 AMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPI 752

Query: 253 ---TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFIN 309
              +L       E+ RCI +GLLCVQ++A DRP MS V  ML ++T A+P P++P F I 
Sbjct: 753 NIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIG 812

Query: 310 ISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
            S    +   +  + + C+VN +T+S ++AR
Sbjct: 813 RSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  405 bits (1042), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 191/303 (63%), Positives = 234/303 (77%), Gaps = 1/303 (0%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L +F    IA AT++F   N LG+GGFGPVYKG L DG+EIA+KRLS  SGQG+ EFKN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LIAKLQH NLVRLLGC  +  E++LVYEY+PNKSLDFF+FD +K+ L+DWK RF+II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           EGI +GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGMAR FG N+ EANT R+V
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY M G+ S+KSDVYSFGVL+LEI+S K+N     +E H +L+GYAW L+  
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSE-HGSLIGYAWYLYTH 751

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
           G++ EL+D  +  +CS  E  RCIHV +LCVQD A +RP M+ V  ML +DT  L  PRQ
Sbjct: 752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811

Query: 304 PAF 306
           P F
Sbjct: 812 PTF 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  403 bits (1036), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 198/341 (58%), Positives = 257/341 (75%), Gaps = 4/341 (1%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L + +F+ +A AT+NFS  N+LGQGGFG VYKGKLLDGQE+A+KRLSK+S QG  EFKN
Sbjct: 510 ELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKN 569

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E KLIA+LQH NLVRLL C +  GE++L+YEYL N SLD  +FD S+   L+W+ RF+II
Sbjct: 570 EVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDII 629

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
            GI +GLLYLH+ SR R+IHRDLKASNILLD  M PKISDFGMAR FG +E EANT ++V
Sbjct: 630 NGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVV 689

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY M+GI SMKSDV+SFGVL+LEIISSK+N G Y+++R LNL+G  W+ W E
Sbjct: 690 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKE 749

Query: 244 GKALELIDTTLHESCSP---DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
           GK LE+ID  + +S S     E+ RCI +GLLCVQ++A DRPTMS V  ML +++  +P 
Sbjct: 750 GKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQ 809

Query: 301 PRQPAFFINISSDYEEPEVTEIK-LEVCSVNDVTISRMEAR 340
           P+ P + +  S    +   ++ +  E  +VN +T+S ++AR
Sbjct: 810 PKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1

 Score =  402 bits (1034), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 247/338 (73%), Gaps = 5/338 (1%)

Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
           FDF+ I AAT+ F   N+LGQGGFG VYKG    G ++A+KRLSK+SGQG  EF NE  +
Sbjct: 339 FDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIV 398

Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +AKLQH NLVRLLG  L++ ER+LVYE++PNKSLD+FIFDS+ + LLDW +R+ II GI 
Sbjct: 399 VAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIA 458

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +G+LYLH+ SRL +IHRDLKA NILL D MN KI+DFGMAR FGM++ EANT RIVGT+G
Sbjct: 459 RGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYG 518

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY--DTERHLNLVGYAWQLWNEGK 245
           YMSPEY M G  SMKSDVYSFGVLVLEIIS KKN+  Y  D     NLV Y W+LW+ G 
Sbjct: 519 YMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGS 578

Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
            LEL+D +  ++   +EV+RCIH+ LLCVQ++A DRPTMS +  MLT  ++AL  P++P 
Sbjct: 579 PLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPG 638

Query: 306 FFINISSDYEEPEVTEIKLE---VCSVNDVTISRMEAR 340
           FF   S   +   V  + +    +CSV+D +I+ +  R
Sbjct: 639 FFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  401 bits (1030), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 198/340 (58%), Positives = 258/340 (75%), Gaps = 4/340 (1%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L+IF F+++ +ATD+FS  N+LG+GGFGPVYKGKLL+G+E+AIKRLS +SGQG+VEFKN
Sbjct: 480 ELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKN 539

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           EA LIAKLQHTNLV++LGC ++K E++L+YEY+ NKSLD+F+FD  +K +LDW  RF I+
Sbjct: 540 EAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIM 599

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           EGI+QGLLYLHKYSRL+VIHRD+KASNILLD+ MNPKISDFG+AR FG  E  ANT R+ 
Sbjct: 600 EGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVA 659

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC-YDTERHLNLVGYAWQLWN 242
           GT GYMSPEY   G+ S KSDV+SFGVL+LEII  +KNN   +D E  LNL+ + W L+ 
Sbjct: 660 GTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNLIVHVWNLFK 719

Query: 243 EGKALELIDTTLHESC-SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND-TMALPT 300
           E K  E+ID +L +S     +V RC+ V LLCVQ+ A DRP+M DV SM+  +   AL  
Sbjct: 720 ENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVVSMIYGEGNNALSL 779

Query: 301 PRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           P++PAF+      + E +V   + E  S + +TI+ +EAR
Sbjct: 780 PKEPAFYDGPRRSFPEMKVEPQEPENVSAS-ITITVLEAR 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  399 bits (1026), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 248/338 (73%), Gaps = 2/338 (0%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           D+  F+ +TI  AT NFS  N+LGQGGFGPVYKG     QEIA+KRLS+ SGQG+ EFKN
Sbjct: 516 DVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSGQGLEEFKN 575

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LIAKLQH NLVRLLG  +   E+LL+YEY+P+KSLDFFIFD    + LDWK R NII
Sbjct: 576 EVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDWKMRCNII 635

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
            GI +GLLYLH+ SRLR+IHRDLK SNILLD++MNPKISDFG+AR FG +E  ANTNR+V
Sbjct: 636 LGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETSANTNRVV 695

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY + G+ S KSDV+SFGV+V+E IS K+N G ++ E+ L+L+G+AW LW  
Sbjct: 696 GTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHAWDLWKA 755

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML-TNDTMALPTPR 302
            + +EL+D  L ESC  +   +C++VGLLCVQ+   DRPTMS+V  ML +++   LPTP+
Sbjct: 756 ERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPTPK 815

Query: 303 QPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           QPAF +           +  K E CS N++TI+  + R
Sbjct: 816 QPAFVLR-RCPSSSKASSSTKPETCSENELTITLEDGR 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	340
359482600	789	PREDICTED: G-type lectin S-receptor-like	0.985	0.424	0.710	1e-136
255550026	795	Serine/threonine-protein kinase PBS1, pu	0.985	0.421	0.682	1e-131
356556159	480	PREDICTED: G-type lectin S-receptor-like	0.976	0.691	0.673	1e-131
359482602	682	PREDICTED: G-type lectin S-receptor-like	0.985	0.491	0.661	1e-130
56561617	637	S-receptor kinase-like protein 1 [Seneci	0.982	0.524	0.646	1e-127
224056633	756	predicted protein [Populus trichocarpa]	0.988	0.444	0.648	1e-126
224056631	741	predicted protein [Populus trichocarpa]	0.985	0.452	0.660	1e-126
449491846	840	PREDICTED: LOW QUALITY PROTEIN: G-type l	0.991	0.401	0.622	1e-125
357515969	796	Serine/threonine protein kinase [Medicag	0.9	0.384	0.679	1e-125
357516049	798	Serine/threonine protein kinase [Medicag	0.9	0.383	0.676	1e-124

>gi|359482600|ref|XP_003632790.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera]

 Score =  490 bits (1262), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 240/338 (71%), Positives = 282/338 (83%), Gaps = 3/338 (0%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L++F FQ++AAAT+NFS  N+LG+GGFGPVYKGKLLDGQEIAIKRLSKSS QG+VEFKN
Sbjct: 454 ELQLFSFQSLAAATNNFSIENKLGEGGFGPVYKGKLLDGQEIAIKRLSKSSRQGLVEFKN 513

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LIAKLQH NLV+LLGC +++ E++L+YEYLPNKSLDFFIFD SKK LL+WKKR+NII
Sbjct: 514 EIALIAKLQHDNLVKLLGCCIKEEEKILIYEYLPNKSLDFFIFDPSKKNLLNWKKRYNII 573

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           EGI QGLLYLHK+SRLRVIHRDLKASNILLD++MNPKISDFGMAR FG +E EANTNR+V
Sbjct: 574 EGITQGLLYLHKFSRLRVIHRDLKASNILLDNEMNPKISDFGMARIFGQDECEANTNRVV 633

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEYVM GI S KSDV+SFGVL+LEI+SSKKN+  Y  ER LNL+GYAW+LW E
Sbjct: 634 GTYGYMSPEYVMQGIFSTKSDVFSFGVLLLEIVSSKKNHSNYHYERPLNLIGYAWELWKE 693

Query: 244 GKALELIDTTLHESCSPDEVT-RCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPR 302
           GK LEL+D TL +  S + V  RCIHVGLLCVQ+   DRPTMSDV  ML N++M L  P+
Sbjct: 694 GKELELMDQTLCDGPSSNNVVKRCIHVGLLCVQENPKDRPTMSDVVLMLANESMQLSIPK 753

Query: 303 QPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           QPAFFI      +E E+ +   E CS+N V+IS MEAR
Sbjct: 754 QPAFFIR--GIEQELEIPKRNSENCSLNIVSISVMEAR 789

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255550026|ref|XP_002516064.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544969|gb|EEF46484.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  473 bits (1218), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 230/337 (68%), Positives = 273/337 (81%), Gaps = 2/337 (0%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L IF F+ IA AT  F P N+LG+GGFGPVYKGKLLDGQEIAIKRLS+SSGQG+VEFKN
Sbjct: 461 ELHIFCFEIIAIATKYFKPENKLGEGGFGPVYKGKLLDGQEIAIKRLSRSSGQGLVEFKN 520

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           EA LIAKLQHTNLV+LLG  +   ER+LVYEY+P KSLD ++FDS KK  LDWKKRF II
Sbjct: 521 EAILIAKLQHTNLVKLLGFCVDGEERILVYEYMPKKSLDIYLFDSHKKSELDWKKRFKII 580

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           +GI QGLLYLHKYSRL+VIHRDLKASNILLDD+MNPKISDFGMAR FG+ E EANTNRIV
Sbjct: 581 DGITQGLLYLHKYSRLKVIHRDLKASNILLDDEMNPKISDFGMARIFGLKESEANTNRIV 640

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY MNG+VS K+DV+SFGVL+LEIIS +KN   + +E  +NL+GYAW LW +
Sbjct: 641 GTYGYMSPEYAMNGVVSTKTDVFSFGVLLLEIISGRKNTSFHYSECPINLIGYAWLLWKD 700

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
            + LELID  L E    ++V RCIH+GLLCVQD A DRPT+ DV SML+N+T+ L TP+Q
Sbjct: 701 NRGLELIDPKLDEFLPQNQVLRCIHIGLLCVQDHAADRPTVFDVVSMLSNETILLATPKQ 760

Query: 304 PAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           PAFF+N  +  +EP     + + CS+N V+IS MEAR
Sbjct: 761 PAFFVN--AVVQEPGEPRNRSDKCSINLVSISVMEAR 795

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356556159|ref|XP_003546394.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Glycine max]

 Score =  472 bits (1215), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 227/337 (67%), Positives = 276/337 (81%), Gaps = 5/337 (1%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           ++++F F TI  AT+NFS  N+LG+GGFGPVYKG L D QE+AIKRLSKSSGQG++EF N
Sbjct: 149 EVELFAFDTIVVATNNFSAANKLGEGGFGPVYKGNLSDQQEVAIKRLSKSSGQGLIEFTN 208

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           EAKL+AKLQHTNLV+LLG  +Q+ ER+LVYEY+ NKSLDF++FDS++K+LLDW+KR NII
Sbjct: 209 EAKLMAKLQHTNLVKLLGFCIQRDERILVYEYMSNKSLDFYLFDSARKDLLDWEKRLNII 268

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
            GI QGLLYLHKYSRL+VIHRDLKASNILLD +MN KISDFGMAR FG+   E NTNR+V
Sbjct: 269 GGIAQGLLYLHKYSRLKVIHRDLKASNILLDHEMNAKISDFGMARIFGVRVSEENTNRVV 328

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYM+PEY M G+VS+K+DV+SFGVL+LEI+SSKKNN  Y ++  LNL+GY   LWN 
Sbjct: 329 GTYGYMAPEYAMKGVVSIKTDVFSFGVLLLEILSSKKNNSRYHSDHPLNLIGY---LWNA 385

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
           G+ALELID+TL+  CS +EV RCIH+GLLCVQD+ATDRPTM D+ S L+NDT+ LP P Q
Sbjct: 386 GRALELIDSTLNGLCSQNEVFRCIHIGLLCVQDQATDRPTMVDIVSFLSNDTIQLPQPMQ 445

Query: 304 PAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           PA+FIN     EE E+   + E  S NDVTIS   AR
Sbjct: 446 PAYFIN--EVVEESELPYNQQEFHSENDVTISSTRAR 480

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482602|ref|XP_003632791.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera]

 Score =  469 bits (1208), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 223/337 (66%), Positives = 276/337 (81%), Gaps = 2/337 (0%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L++F FQ+IA AT+NFS  N+LG+GGFGPVYKG LLD QEIAIK+LS+ SGQG+ EFKN
Sbjct: 348 ELQLFSFQSIATATNNFSTENKLGEGGFGPVYKGVLLDKQEIAIKKLSRGSGQGLEEFKN 407

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LI KLQH NLVRLLGC ++  E++L+YEYLPNKSLDFF+FD  +K LLDWKKR+NII
Sbjct: 408 EILLIGKLQHNNLVRLLGCCIKGEEKILIYEYLPNKSLDFFLFDPIQKNLLDWKKRYNII 467

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           EGI QGLLYLHKYSRL+V+HRDLKASNILLD++MNPKIS FGMAR FG NE +ANT RIV
Sbjct: 468 EGIAQGLLYLHKYSRLKVVHRDLKASNILLDNEMNPKISYFGMARIFGRNESQANTKRIV 527

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY M GI SMKSDV+SFGVL+LEI+S +KN   Y  +R LNL+GYAW+LW E
Sbjct: 528 GTYGYMSPEYAMEGIFSMKSDVFSFGVLLLEIVSGRKNYSNYYYKRLLNLIGYAWELWKE 587

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
           G+ LEL+D T+ + C  + + RCIHVGLLCVQ+   DRPT+S+V SML+N++M L TP+Q
Sbjct: 588 GRILELMDQTMGDLCPKNVIRRCIHVGLLCVQENPIDRPTISEVLSMLSNESMQLSTPKQ 647

Query: 304 PAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           PAFFI  +   +E ++   + E CS+N+V+IS +EAR
Sbjct: 648 PAFFIGRT--VQESKIPTSRSENCSLNNVSISVLEAR 682

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|56561617|emb|CAG28412.1| S-receptor kinase-like protein 1 [Senecio squalidus]

 Score =  460 bits (1184), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 218/337 (64%), Positives = 265/337 (78%), Gaps = 3/337 (0%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           DL +F F +I AAT++FS  N+LGQGGFGPVYKGKL DG+EIAIKRLS++SGQG+VEFKN
Sbjct: 304 DLLLFSFSSIMAATNDFSVENKLGQGGFGPVYKGKLSDGREIAIKRLSRTSGQGLVEFKN 363

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LIAKLQHTNLVR+LGC +   E++L+YEY+PNKSLDFF+FD ++K  LDW KRFNII
Sbjct: 364 ELILIAKLQHTNLVRVLGCCIHGEEKMLIYEYMPNKSLDFFLFDENRKAELDWPKRFNII 423

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           EGI QGLLYLHKYSR+RVIHRDLKA+NILLD+ +NPKISDFGMAR F  NE EA TNR+V
Sbjct: 424 EGIAQGLLYLHKYSRMRVIHRDLKANNILLDENLNPKISDFGMARIFKENETEAMTNRVV 483

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY M G  S+KSD++SFGVL+LEI++ +KN      +R  NL+GYAW+LW +
Sbjct: 484 GTYGYMSPEYAMEGTFSIKSDIFSFGVLMLEIVTGRKNTSFVHLDRTFNLIGYAWELWQQ 543

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
           G  LEL D TL E+C   +  R +HV LLCVQ+ ATDRPT SD+ SML NDT++LPTP +
Sbjct: 544 GDTLELKDPTLGETCGIQQFLRSVHVALLCVQESATDRPTTSDMISMLLNDTISLPTPNK 603

Query: 304 PAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           PAF I      E     E K + CSVND+T++ ME R
Sbjct: 604 PAFVI---GKVESKSTDESKEKDCSVNDMTVTVMEGR 637

Source: Senecio squalidus

Species: Senecio squalidus

Genus: Senecio

Family: Asteraceae

Order: Asterales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224056633|ref|XP_002298946.1| predicted protein [Populus trichocarpa] gi|222846204|gb|EEE83751.1| predicted protein [Populus trichocarpa]

 Score =  458 bits (1179), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 225/347 (64%), Positives = 271/347 (78%), Gaps = 11/347 (3%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +LK++   TI AAT++FS  N+LGQGGFGPVYKGKL DG+E+A+KRLS++S QG+VEFKN
Sbjct: 411 NLKVYSVATIMAATNSFSAKNKLGQGGFGPVYKGKLPDGREVAVKRLSRTSRQGLVEFKN 470

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LIA LQH+NLV+LLGC ++  E++LVYEY+PNKSLD FIFD S++ELLDWKKRF II
Sbjct: 471 ELILIANLQHSNLVKLLGCCVEGEEKMLVYEYMPNKSLDSFIFDQSRRELLDWKKRFKII 530

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           E I QGLLYLHKYSRLR+IHRDLKASNILL++ ++PKISDFGMAR F +NELEANTNRIV
Sbjct: 531 EEIAQGLLYLHKYSRLRIIHRDLKASNILLNEDLSPKISDFGMARIFKINELEANTNRIV 590

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GYMSPEY M G+ S+KSD YSFGVLVLEI+S +KN G    +  LNLVGYAW+LW E
Sbjct: 591 GTYGYMSPEYAMEGVFSVKSDAYSFGVLVLEIVSGRKNRGLLQMDPPLNLVGYAWELWKE 650

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
           G   EL+D+TL +SCS D+V RCIHVGLLCV+D   DRPTMSDV SMLT+D   LP  +Q
Sbjct: 651 GNQFELVDSTLRDSCSEDQVLRCIHVGLLCVEDNVNDRPTMSDVLSMLTSDAQ-LPLLKQ 709

Query: 304 PAFFINISS----------DYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           PAF     S          + +E    E K E  S+N V++S MEAR
Sbjct: 710 PAFSCATYSTDNQSNSSHAEGKEEGKAEDKAEGNSINYVSMSTMEAR 756

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224056631|ref|XP_002298945.1| predicted protein [Populus trichocarpa] gi|222846203|gb|EEE83750.1| predicted protein [Populus trichocarpa]

 Score =  456 bits (1174), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 226/342 (66%), Positives = 271/342 (79%), Gaps = 7/342 (2%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +LK++   TI AAT++FS  N+LGQGGFGPVYKGKL DG+EIA+KRLS+SSGQG+VEFKN
Sbjct: 402 NLKVYSAATIMAATNSFSADNKLGQGGFGPVYKGKLPDGREIAVKRLSRSSGQGLVEFKN 461

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LIAKLQH NLVRLLGC +Q  E++LVYEY+PNKSLD FIFD SK+EL+DWKKRF II
Sbjct: 462 ELILIAKLQHMNLVRLLGCCIQGEEKMLVYEYMPNKSLDTFIFDQSKRELIDWKKRFEII 521

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           EGI QGLLYLHKYSR+R+IHRDLKASNILLD  +NPKISDFGMAR F +N+LE NTN+IV
Sbjct: 522 EGIAQGLLYLHKYSRVRIIHRDLKASNILLDGNLNPKISDFGMARIFKINDLEGNTNQIV 581

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE-RHLNLVGYAWQLWN 242
           GT GY+SPEY M GI S+KSDV+SFGVL+LEI+S ++  G  D + + LNLVGYAW+LW 
Sbjct: 582 GTRGYISPEYFMKGIFSVKSDVFSFGVLLLEIVSGRRIQGLLDIDGQPLNLVGYAWELWK 641

Query: 243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPR 302
            G  +EL+D  L ESCS D+V RCIHVGLLCV+D A DRP MSDV SMLT++   LP P+
Sbjct: 642 AGSPIELVDPILRESCSKDQVLRCIHVGLLCVEDNAVDRPIMSDVISMLTSEAQ-LPLPK 700

Query: 303 QPAFFINISSDYEEPEVTEI----KLEVCSVNDVTISRMEAR 340
           QPA F N  S  EE   ++       E  S+N V++S M+AR
Sbjct: 701 QPA-FSNARSIAEEKSFSKPAESGSEETGSINYVSLSTMDAR 741

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449491846|ref|XP_004159019.1| PREDICTED: LOW QUALITY PROTEIN: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Cucumis sativus]

 Score =  452 bits (1164), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 216/347 (62%), Positives = 268/347 (77%), Gaps = 10/347 (2%)

Query: 4   DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
           +L+ FDF+TI +AT+NF    +LG+GGFGPVYKG + DGQE+AIKRLSK+SGQG+VEFKN
Sbjct: 494 ELQFFDFETIVSATNNFGDECKLGKGGFGPVYKGVMTDGQEVAIKRLSKNSGQGLVEFKN 553

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  LIAKLQHTNLVRL+GC L K E+LLVYEY+PNKSLDFF+FD  KK +LDW KR ++I
Sbjct: 554 ETILIAKLQHTNLVRLIGCCLHKDEKLLVYEYMPNKSLDFFLFDLEKKLILDWXKRLHVI 613

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           +GIVQGLLYLH YSR+R+IHRDLK SNILLDD+MN KISDFGMAR F  +E EANT R+V
Sbjct: 614 QGIVQGLLYLHHYSRVRIIHRDLKVSNILLDDEMNAKISDFGMARVFKPSEHEANTGRVV 673

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT+GY+SPEY M GI S+KSDVYSFG+L+LEI++S+KN   YDTER LNL+GYAW+LW  
Sbjct: 674 GTYGYISPEYAMEGIFSIKSDVYSFGILLLEIVTSRKNYNNYDTERPLNLIGYAWELWVN 733

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
           G+  ELID+ L  S    +  RCIHV LLCVQ    DRPTM D+  M++ND   LP+P+Q
Sbjct: 734 GRGEELIDSGLCNSDQKPKALRCIHVSLLCVQQIPADRPTMLDIYFMISNDYAQLPSPKQ 793

Query: 304 PAFFINISSDYEEPEVTEIK----------LEVCSVNDVTISRMEAR 340
           PAFF+  + +  EPE+ ++           L++ S N +T+S M AR
Sbjct: 794 PAFFVAQNPNSSEPEIEDVNNELIRPVGPTLDIYSTNAMTVSVMVAR 840

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357515969|ref|XP_003628273.1| Serine/threonine protein kinase [Medicago truncatula] gi|355522295|gb|AET02749.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  452 bits (1164), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 208/306 (67%), Positives = 254/306 (83%)

Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFK 62
            D+K+F++ +I  AT NFSP N+LGQGG+GPVYKG L  GQEIA+KRLSK+SGQGIVEFK
Sbjct: 457 HDIKVFNYSSILEATMNFSPENKLGQGGYGPVYKGILPTGQEIAVKRLSKTSGQGIVEFK 516

Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
           NE  LI +LQHTNLV+LLGC + + ER+L+YEY+PNKSLDF++FDS++++ LDWKKR NI
Sbjct: 517 NEFVLICELQHTNLVQLLGCCIHQEERILIYEYMPNKSLDFYLFDSTRRKCLDWKKRLNI 576

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
           IEGI QGLLYLHKYSRL++IHRDLKASNILLD+ MNPKISDFGMAR F   E   NTNRI
Sbjct: 577 IEGISQGLLYLHKYSRLKIIHRDLKASNILLDENMNPKISDFGMARMFTQQESVVNTNRI 636

Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN 242
           VGT+GYMSPEY M GI S KSDVYSFGVL+LEII  ++NN  YD +R LNL+G+AW+LWN
Sbjct: 637 VGTYGYMSPEYAMEGICSTKSDVYSFGVLLLEIICGRRNNSFYDVDRPLNLIGHAWELWN 696

Query: 243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPR 302
           +G+ L+L+D TL+++  PDEV +CIHVGLLCV+  A +RPTMSDV SMLTN       PR
Sbjct: 697 DGEYLQLMDPTLNDTFVPDEVQKCIHVGLLCVEQYANNRPTMSDVISMLTNKYAPTTLPR 756

Query: 303 QPAFFI 308
           +PAF++
Sbjct: 757 RPAFYV 762

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357516049|ref|XP_003628313.1| Serine/threonine protein kinase [Medicago truncatula] gi|355522335|gb|AET02789.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  451 bits (1161), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 207/306 (67%), Positives = 254/306 (83%)

Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFK 62
            D+K+F+F +I  AT +FSP N+LGQGG+GPVYKG L  GQE+AIKRLSK+SGQGI+EFK
Sbjct: 460 HDIKVFNFTSILEATMDFSPENKLGQGGYGPVYKGILATGQEVAIKRLSKTSGQGIMEFK 519

Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
           NE  LI +LQH NLV+LLGC + + ER+L+Y+Y+PNKSLDF++FD +KK+LLDWKKRFN+
Sbjct: 520 NELVLICELQHINLVQLLGCCIHEEERILIYKYMPNKSLDFYLFDCTKKKLLDWKKRFNV 579

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
           IEGI QGLLYLHKYSRL++IHRDLKASNILLD+ MNPKI+DFGMAR F   E   NTNRI
Sbjct: 580 IEGISQGLLYLHKYSRLKIIHRDLKASNILLDENMNPKIADFGMARMFTQQESVVNTNRI 639

Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN 242
           VGT+GYMSPEY M G+ S KSDVYSFGVL+LEI+  +KNN  YD +R LNL+G+AW+LWN
Sbjct: 640 VGTYGYMSPEYAMEGVCSTKSDVYSFGVLLLEIVCGRKNNSFYDVDRPLNLIGHAWELWN 699

Query: 243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPR 302
           +G+ L+L+D TL+++  PDEV RCIHVGLLCV+  A DRPTMSDV SMLTN       PR
Sbjct: 700 DGEYLKLMDPTLNDTFVPDEVKRCIHVGLLCVEQYANDRPTMSDVISMLTNKYELTTIPR 759

Query: 303 QPAFFI 308
           +PAF++
Sbjct: 760 RPAFYV 765

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	340
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.991	0.396	0.602	7.1e-109
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.973	0.494	0.601	6.5e-106
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.988	0.396	0.581	1.2e-104
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.991	0.399	0.580	5.3e-104
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.991	0.396	0.583	2.3e-103
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.985	0.395	0.578	2.6e-102
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.888	0.355	0.630	3.3e-102
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.973	0.406	0.585	5.4e-102
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.979	0.492	0.576	2.7e-100
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.976	0.394	0.578	5.6e-100

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 1059 (377.8 bits), Expect = 7.1e-109, Sum P(2) = 7.1e-109
 Identities = 205/340 (60%), Positives = 260/340 (76%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             +L+IF F+++A ATD FS  N+LG+GGFGPVYKG+L+DG+E+AIKRLS +SGQG+VEFKN
Sbjct:   511 ELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKN 570

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             EA LIAKLQHTNLV+LLGC ++K E++L+YEY+PNKSLD+F+FD  +K +LDWK RF I+
Sbjct:   571 EAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIM 630

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             EGI+QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGMAR FG  E +ANT R+ 
Sbjct:   631 EGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVA 690

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY-DTERHLNLVGYAWQLWN 242
             GT GYMSPEY   G+ S KSDV+SFGVL+LEII  +KNN  + D+E  LNL+ + W L+ 
Sbjct:   691 GTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFK 750

Query:   243 EGKALELIDTTLHESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVASMLTND-TMALPT 300
             E +  E+ID +L +S   + +V RC+ V LLCVQ  A DRP+M DV SM+  D   AL  
Sbjct:   751 ENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSL 810

Query:   301 PRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
             P++PAF+        E EV   ++E  S N VTI+ MEAR
Sbjct:   811 PKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
 Identities = 201/334 (60%), Positives = 253/334 (75%)

Query:     9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLI 68
             D++TI  ATD+F   N++GQGGFG VYKG L DG E+A+KRLSKSSGQG VEFKNE  L+
Sbjct:   337 DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLV 396

Query:    69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
             AKLQH NLVRLLG  L   ER+LVYEY+PNKSLD+F+FD +KK  LDW +R+ II G+ +
Sbjct:   397 AKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVAR 456

Query:   129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
             G+LYLH+ SRL +IHRDLKASNILLD  MNPKI+DFGMAR FG+++ E NT+RIVGT+GY
Sbjct:   457 GILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGY 516

Query:   189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE 248
             MSPEY M+G  SMKSDVYSFGVLVLEIIS KKN+  Y T+   +LV YAW LW+ G+ LE
Sbjct:   517 MSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLE 576

Query:   249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFI 308
             L+D  + E+C  +EV RC+H+GLLCVQ+   +RPT+S +  MLT++T+ LP PRQP  F 
Sbjct:   577 LVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFF 636

Query:   309 N--ISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
                I  D  + + T   L + SV+D +I+ +  R
Sbjct:   637 QSRIGKDPLDTDTTSKSL-LGSVDDASITDIHPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
 Identities = 199/342 (58%), Positives = 259/342 (75%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             +L + +++ +A AT+NFS  N+LGQGGFG VYKG LLDG+EIA+KRLSK S QG  EF N
Sbjct:   507 ELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMN 566

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             E +LIAKLQH NLVRLLGC + KGE++L+YEYL N SLD  +FD ++   L+W+KRF+II
Sbjct:   567 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 626

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
              GI +GLLYLH+ SR R+IHRDLKASN+LLD  M PKISDFGMAR FG  E EANT R+V
Sbjct:   627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 686

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
             GT+GYMSPEY M+GI SMKSDV+SFGVL+LEIIS K+N G Y++ R LNL+G+ W+ W E
Sbjct:   687 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 746

Query:   244 GKALELIDTTLHESCSPD----EVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
             GK LE++D    ++ S +    E+ RCI +GLLCVQ++A DRP MS V  ML ++T A+P
Sbjct:   747 GKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 806

Query:   300 TPRQPAFFINISS-DYEEPEVTEIKLEVCSVNDVTISRMEAR 340
              P++P F +  SS + +    T+ + + C+VN VT+S ++AR
Sbjct:   807 QPKRPGFCVGRSSLEVDSSSSTQ-RDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1030 (367.6 bits), Expect = 5.3e-104, P = 5.3e-104
 Identities = 198/341 (58%), Positives = 255/341 (74%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             +L + + + +A AT+NFS  N+LGQGGFG VYKG+LLDG+EIA+KRLSK S QG  EF N
Sbjct:   503 ELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMN 562

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             E +LIAKLQH NLVRLLGC + KGE++L+YEYL N SLD  +FD ++   L+W+KRF+II
Sbjct:   563 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 622

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
              GI +GLLYLH+ SR R+IHRDLKASN+LLD  M PKISDFGMAR FG  E EANT R+V
Sbjct:   623 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 682

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
             GT+GYMSPEY M+GI SMKSDV+SFGVL+LEIIS K+N G Y++ R LNL+G+ W+ W E
Sbjct:   683 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 742

Query:   244 GKALELIDTTLHESCS---PD-EVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
             G  LE++D    +S S   P  E+ RCI +GLLCVQ++A DRP MS V  ML ++T A+P
Sbjct:   743 GNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 802

Query:   300 TPRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
              P++P F I  S    +   +  + + C+VN +T+S ++AR
Sbjct:   803 QPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
 Identities = 199/341 (58%), Positives = 256/341 (75%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             +L + +F+ +A AT+NFS  N+LGQGGFG VYKGKLLDGQE+A+KRLSK+S QG  EFKN
Sbjct:   510 ELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKN 569

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             E KLIA+LQH NLVRLL C +  GE++L+YEYL N SLD  +FD S+   L+W+ RF+II
Sbjct:   570 EVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDII 629

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
              GI +GLLYLH+ SR R+IHRDLKASNILLD  M PKISDFGMAR FG +E EANT ++V
Sbjct:   630 NGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVV 689

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
             GT+GYMSPEY M+GI SMKSDV+SFGVL+LEIISSK+N G Y+++R LNL+G  W+ W E
Sbjct:   690 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKE 749

Query:   244 GKALELIDTTLHESCSP---DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
             GK LE+ID  + +S S     E+ RCI +GLLCVQ++A DRPTMS V  ML +++  +P 
Sbjct:   750 GKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQ 809

Query:   301 PRQPAFFINISS-DYEEPEVTEIKLEVCSVNDVTISRMEAR 340
             P+ P + +  S  D +     +   E  +VN +T+S ++AR
Sbjct:   810 PKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
 Identities = 195/337 (57%), Positives = 246/337 (72%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             +LK++    I  AT NFS  N+LG+GGFGPVY G L  G+E+A+KRL ++SGQG+ EFKN
Sbjct:   514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             E  LIAKLQH NLVRLLGC + + E++LVYEY+PNKSLD F+F+  K+ LLDWKKRF+II
Sbjct:   574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             EGI +GLLYLH+ SRLRV+HRDLKASNILLD  M PKISDFGMAR FG ++ + NTNR+V
Sbjct:   634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
             GT GYMSPEY M GI S+KSDVY FGVL+LEII+ K+    +  E  LN+ GYAW+ WNE
Sbjct:   694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNE 753

Query:   244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
               A ELID  +  SCS  +V RCIH+ LLCVQD A +RP +  V  ML+ND+ +LP PR 
Sbjct:   754 DNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRP 813

Query:   304 PAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
             P   +    + E  + +E K    S+  VT++++  R
Sbjct:   814 PTLMLR-GREIESSKSSE-KDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1013 (361.7 bits), Expect = 3.3e-102, P = 3.3e-102
 Identities = 191/303 (63%), Positives = 234/303 (77%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             +L +F    IA AT++F   N LG+GGFGPVYKG L DG+EIA+KRLS  SGQG+ EFKN
Sbjct:   513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             E  LIAKLQH NLVRLLGC  +  E++LVYEY+PNKSLDFF+FD +K+ L+DWK RF+II
Sbjct:   573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             EGI +GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGMAR FG N+ EANT R+V
Sbjct:   633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
             GT+GYMSPEY M G+ S+KSDVYSFGVL+LEI+S K+N     +E H +L+GYAW L+  
Sbjct:   693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSE-HGSLIGYAWYLYTH 751

Query:   244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
             G++ EL+D  +  +CS  E  RCIHV +LCVQD A +RP M+ V  ML +DT  L  PRQ
Sbjct:   752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811

Query:   304 PAF 306
             P F
Sbjct:   812 PTF 814

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
 Identities = 198/338 (58%), Positives = 255/338 (75%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             DL IFD +TI+ ATD+FS  N LG+GGFGPVYKGKL DGQEIA+KRLS +SGQG+ EFKN
Sbjct:   484 DLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKN 543

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             E KLIAKLQH NLVRLLGC +Q  E +L+YEY+PNKSLDFFIFD  +   LDWKKR NII
Sbjct:   544 EVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNII 603

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
              G+ +G+LYLH+ SRLR+IHRDLKA N+LLD+ MNPKISDFG+A++FG ++ E++TNR+V
Sbjct:   604 NGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVV 663

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
             GT+GYM PEY ++G  S+KSDV+SFGVLVLEII+ K N G    +  LNL+G+ W++W E
Sbjct:   664 GTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVE 723

Query:   244 GKALELIDTT-LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPR 302
              + +E+ +   L E+    EV RCIHV LLCVQ K  DRPTM+ V  M  +D+ +LP P 
Sbjct:   724 DREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLPHPT 782

Query:   303 QPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
             QP FF N +     P+++   L + S N+V+I+ ++ R
Sbjct:   783 QPGFFTNRNV----PDISS-SLSLRSQNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 995 (355.3 bits), Expect = 2.7e-100, P = 2.7e-100
 Identities = 195/338 (57%), Positives = 247/338 (73%)

Query:     8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
             FDF+ I AAT+ F   N+LGQGGFG VYKG    G ++A+KRLSK+SGQG  EF NE  +
Sbjct:   339 FDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIV 398

Query:    68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
             +AKLQH NLVRLLG  L++ ER+LVYE++PNKSLD+FIFDS+ + LLDW +R+ II GI 
Sbjct:   399 VAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIA 458

Query:   128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             +G+LYLH+ SRL +IHRDLKA NILL D MN KI+DFGMAR FGM++ EANT RIVGT+G
Sbjct:   459 RGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYG 518

Query:   188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY--DTERHLNLVGYAWQLWNEGK 245
             YMSPEY M G  SMKSDVYSFGVLVLEIIS KKN+  Y  D     NLV Y W+LW+ G 
Sbjct:   519 YMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGS 578

Query:   246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              LEL+D +  ++   +EV+RCIH+ LLCVQ++A DRPTMS +  MLT  ++AL  P++P 
Sbjct:   579 PLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPG 638

Query:   306 FFINISSDYEEPEVTEIKLE---VCSVNDVTISRMEAR 340
             FF   S   +   V  + +    +CSV+D +I+ +  R
Sbjct:   639 FFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
 Identities = 196/339 (57%), Positives = 245/339 (72%)

Query:     4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN 63
             DL IF F ++A+AT +F+  N+LGQGGFG VYKG   +G+EIA+KRLS  S QG+ EFKN
Sbjct:   509 DLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKN 568

Query:    64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             E  LIAKLQH NLVRLLGC ++  E++L+YEY+PNKSLD F+FD SK+  LDW+KR+ +I
Sbjct:   569 EILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVI 628

Query:   124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
              GI +GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDFGMAR F   +  ANT R+V
Sbjct:   629 GGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVV 688

Query:   184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
             GT+GYM+PEY M GI S KSDVYSFGVL+LEI+S +KN     T+ H +L+GYAW LW++
Sbjct:   689 GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTD-HGSLIGYAWHLWSQ 747

Query:   244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
             GK  E+ID  + ++    E  RCIHVG+LC QD    RP M  V  ML + T  LP PRQ
Sbjct:   748 GKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQ 807

Query:   304 PAF--FINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
             P F  F+N S D E   +     +V SVNDVT + +  R
Sbjct:   808 PTFHSFLN-SGDIE---LNFDGHDVASVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00034402001 SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (797 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	340
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-40
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-31
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-26
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-26
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-23
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-13
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-06
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (425), Expect = 1e-50
 Identities = 71/194 (36%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+GGFG VY  +    G+++AIK + K     ++E    E +++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
             +    LV EY    SL   + ++  K  L   +   I+  I++GL YLH      +IH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 144 RDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSM 201
           RDLK  NILLD D    K++DFG+++    ++    T  IVGT  YM+PE ++  G  S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 202 KSDVYSFGVLVLEI 215
           KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  166 bits (422), Expect = 1e-49
 Identities = 93/289 (32%), Positives = 139/289 (48%), Gaps = 47/289 (16%)

Query: 24  NRLGQGGFGPVYKGKLLDGQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVR 78
            +LG+G FG VYKGKL        E+A+K L +  S +   +F  EA+++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFI------FDSSKKELLDWKKRFNIIEGIVQGLLY 132
           LLG   ++    LV EY+    L  ++      F S +K  L  K   +    I +G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG----- 187
           L      + +HRDL A N L+ + +  KISDFG++R     ++  +      T G     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE--RHLNLVGYAWQLWNE 243
           +M+PE + +GI + KSDV+SFGVL+ EI +  +    G  + E   +L           +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL----------RK 222

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
           G  L        E C PDE+   +   L C Q    DRPT S++   L 
Sbjct: 223 GYRLP-----KPEYC-PDELYELM---LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  161 bits (411), Expect = 5e-48
 Identities = 87/284 (30%), Positives = 133/284 (46%), Gaps = 45/284 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLD-----GQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 76
           G +LG+G FG VYKGKL         E+A+K L + +S Q I EF  EA+++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V+LLG   ++    +V EY+    L  ++     +  L      +    I +G+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG---YMSPEY 193
                IHRDL A N L+ + +  KISDFG++R    +  + +  R  G      +M+PE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174

Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS------SKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           +  G  + KSDV+SFGVL+ EI +         +N   +   +L            G  L
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN--EEVLEYL----------KNGYRL 222

Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                    +C P E+     + L C  +   DRPT S++  +L
Sbjct: 223 PQP-----PNC-PPEL---YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  160 bits (407), Expect = 2e-47
 Identities = 88/286 (30%), Positives = 135/286 (47%), Gaps = 48/286 (16%)

Query: 23  GNRLGQGGFGPVYKGKLLDG-----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNL 76
           G +LG+G FG VYKG L         E+A+K L +  S Q I EF  EA+++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V+LLG   ++   ++V EY+P   L  ++  +  KEL       +    I +G+ YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLE-- 120

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSP 191
                IHRDL A N L+ + +  KISDFG++R         + +      G     +M+P
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR------DLYDDDYYKVKGGKLPIRWMAP 173

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS------SKKNNGCYDTERHLNLVGYAWQLWNEGK 245
           E +  G  + KSDV+SFGVL+ EI +         +N   +   +L           +G 
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN--AEVLEYL----------KKGY 221

Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
            L         +C P E+ +   + L C  +   DRPT S++  +L
Sbjct: 222 RLPKP-----PNC-PPELYK---LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  158 bits (403), Expect = 7e-47
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           +    +LG+G FG VY  +    G+ +AIK + K   +   E    E K++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           RL      + +  LV EY     L   +    +  L + + RF  +  I+  L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
              ++HRDLK  NILLD+  + K++DFG+AR     E        VGT  YM+PE ++  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171

Query: 198 IVSMKSDVYSFGVLVLEIISSK 219
                 D++S GV++ E+++ K
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (401), Expect = 1e-46
 Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 25  RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +LG G FG VYK K    G+ +A+K L K S   +     + E +++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
               K    LV EY     L  ++   S+   L   +   I   I++GL YLH      +
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI-VS 200
           IHRDLK  NILLD+    KI+DFG+A+    +     T   VGT  YM+PE ++ G    
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177

Query: 201 MKSDVYSFGVLVLEIISSK 219
            K DV+S GV++ E+++ K
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  157 bits (399), Expect = 3e-46
 Identities = 89/288 (30%), Positives = 128/288 (44%), Gaps = 52/288 (18%)

Query: 23  GNRLGQGGFGPVYKGKLLD-----GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
           G +LG+G FG VYKG L         ++A+K L + +  +   EF  EA ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           VRLLG   Q     +V EY+P   L  F+      E L  K    +   I +G+ YL   
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE-- 119

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY-----MSP 191
                +HRDL A N L+ + +  KISDFG++R      +  +        G      M+P
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIKWMAP 173

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E + +G  + KSDV+SFGVL+ EI +             L    Y      E   LEL++
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFT-------------LGEQPYPGMSNEE--VLELLE 218

Query: 252 TTLH----ESCSPDEV----TRCIHVGLLCVQDKATDRPTMSDVASML 291
                   E+C PDE+     +C             DRPT S++   L
Sbjct: 219 DGYRLPRPENC-PDELYELMLQCWAY-------DPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  145 bits (369), Expect = 8e-42
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            ++ G  LG+G FG VY     D G+ +A+K   LS  S + +   + E ++++ LQH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 76  LVRLLGCSLQKGER-LLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIE------GIV 127
           +VR  G    + +  L ++ EY+   SL           LL    +            I+
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLS---------SLLKKFGKLPEPVIRKYTRQIL 111

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +GL YLH      ++HRD+K +NIL+D     K++DFG A+  G  E    T  + GT  
Sbjct: 112 EGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           +M+PE +        +D++S G  V+E+ + K
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  140 bits (355), Expect = 7e-40
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 25/204 (12%)

Query: 20  FSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           F    ++G+GGFG VYK +    G+E+AIK +   S +   +  NE +++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD-WKKRFN------IIEGIVQGLL 131
             G  L+K E  +V E+    SL         K+LL    +         + + +++GL 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLE 112

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YLH      +IHRD+KA+NILL      K+ DFG++            N +VGT  +M+P
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAP 166

Query: 192 EYVMNGIV-SMKSDVYSFGVLVLE 214
           E V+NG     K+D++S G+  +E
Sbjct: 167 E-VINGKPYDYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 1e-34
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 29/213 (13%)

Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 75
           N+  G+ +G+G FG VYKG  L  G  +AIK++S      + +     E  L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN---------IIEGI 126
           +V+ +G         ++ EY  N SL                K+F           +  +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL------------RQIIKKFGPFPESLVAVYVYQV 108

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
           +QGL YLH+     VIHRD+KA+NIL       K++DFG+A    +N++  +   +VGT 
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTP 163

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +M+PE +     S  SD++S G  V+E+++  
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 2e-31
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 20/200 (10%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKLIAKLQHTNLVR 78
           LG+G FG V   +  D G+  A+K L K     I++ K       E  +++++ H  +V+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK---IIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 79  LLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           L   + Q  E+L LV EY P   L   +  S +    + + RF   E IV  L YLH   
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAE-IVLALEYLH--- 110

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
            L +I+RDLK  NILLD   + K++DFG+A+         NT    GT  Y++PE ++  
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168

Query: 198 IVSMKSDVYSFGVLVLEIIS 217
                 D +S GVL+ E+++
Sbjct: 169 GYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  118 bits (298), Expect = 3e-31
 Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 23/212 (10%)

Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG+G FG VYKG+L           +AIK L ++   +   EF+ EA+L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKELLDWKKRFNIIEG 125
           LLG   ++    +++EYL +  L  F+              D + K  LD     +I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           I  G+ YL   S    +HRDL A N L+ + +  KISDFG++R     +     ++ +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M PE ++ G  + +SD++SFGV++ EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (297), Expect = 3e-31
 Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 19/198 (9%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G FG VY  +   DG+   +K   LS  S +   +  NE K++ KL H N+++    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF---NIIEGIVQ---GLLYLHKY 136
             +KG+  +V EY     L   I     K+     K F    I++  VQ    L YLH  
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKI-----KKQKKEGKPFPEEQILDWFVQLCLALKYLH-- 120

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
           SR +++HRD+K  NI L      K+ DFG+++        A T  +VGT  Y+SPE   N
Sbjct: 121 SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQN 177

Query: 197 GIVSMKSDVYSFGVLVLE 214
              + KSD++S G ++ E
Sbjct: 178 KPYNYKSDIWSLGCVLYE 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 6e-31
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 17/198 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G  +G+G FG V  G    GQ++A+K L K        F  EA ++  L+H NLV+LLG 
Sbjct: 11  GATIGKGEFGDVMLG-DYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 83  SLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
            LQ     +V EY+   SL D+    S  + ++   ++      + +G+ YL +      
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIV 199
           +HRDL A N+L+ + +  K+SDFG+A+       EA+  +  G     + +PE +     
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176

Query: 200 SMKSDVYSFGVLVLEIIS 217
           S KSDV+SFG+L+ EI S
Sbjct: 177 STKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  116 bits (294), Expect = 1e-30
 Identities = 70/228 (30%), Positives = 99/228 (43%), Gaps = 35/228 (15%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFK-----NEAKLIAKL 71
           D+F  G  +G+G F  V   K     +E AIK L K   Q I E K      E +++ +L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 72  -QHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
             H  +++L   + Q  E L  V EY PN  L  +I        LD K        I+  
Sbjct: 59  NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLA 114

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE------------- 176
           L YLH      +IHRDLK  NILLD  M+ KI+DFG A+    N                
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 177 -----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
                      VGT  Y+SPE +        SD+++ G ++ ++++ K
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 4e-30
 Identities = 90/290 (31%), Positives = 130/290 (44%), Gaps = 54/290 (18%)

Query: 24  NRLGQGGFGPVYKGKLL--DGQEI--AIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVR 78
             LG G FG V KG  L   G+E+  A+K L +     G  EF  EA ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 79  LLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSK---KELLDWKKRFNIIEGIVQGLLYLH 134
           L+G    KGE L LV E  P   L  ++    +    +L +   +      +  G+ YL 
Sbjct: 61  LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE 112

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                  +HRDL A N+LL ++   KISDFGM+R  G             T G     + 
Sbjct: 113 S---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWY 165

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +  G  S KSDV+S+GV + E  S                  Y  + + E K  E+
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFS------------------YGAKPYGEMKGAEV 207

Query: 250 IDTTLHESC----SPDEVTRCIH-VGLLCVQDKATDRPTMSDVASMLTND 294
           I   + ES      P+E  + I+ + L C + +  DRPT S++ S    D
Sbjct: 208 I--AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (294), Expect = 4e-30
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 17/213 (7%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHT- 74
           ++    +LG+G FG VY  +  D + +A+K L+K   S  + +  F  E +++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+L      +G   LV EY+   SL+  +    +K  L   +   I+  I+  L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 135 KYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFG----MNELEANTNRIVGTHGYM 189
                 +IHRD+K  NILLD D    K+ DFG+A+        + + A  +  VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 190 SPEYVM---NGIVSMKSDVYSFGVLVLEIISSK 219
           +PE ++       S  SD++S G+ + E+++  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (287), Expect = 8e-30
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)

Query: 26  LGQGGFGPVYKGKL-LDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           LGQG  G VYK +    G+  A+K++      +   +   E K +   +   +V+  G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQGLLYLHKYS 137
            ++GE  +V EY+   SL          +LL    +        I   I++GL YLH   
Sbjct: 69  YKEGEISIVLEYMDGGSLA---------DLLKKVGKIPEPVLAYIARQILKGLDYLHT-- 117

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
           +  +IHRD+K SN+L++ +   KI+DFG+++   +       N  VGT  YMSPE +   
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 198 IVSMKSDVYSFGVLVLE 214
             S  +D++S G+ +LE
Sbjct: 176 SYSYAADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (288), Expect = 9e-30
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 41/291 (14%)

Query: 24  NRLGQGGFGPVYKGK---LLDGQ--EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLV 77
            +LG+G FG V   +   L D    ++A+K L+ S   Q   +F+ E +++  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 78  RLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +  G   + G R   L+ EYLP+ SL  ++     ++ ++ K+       I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEY 193
               R IHRDL A NIL++ +   KISDFG+A+      +              Y +PE 
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS-----------SKKNNGCYDTER-HLNLVGYAWQLW 241
           +     S  SDV+SFGV + E+ +             +  G    +     L+    +L 
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL----ELL 239

Query: 242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
            EG+ L         SC PDEV     +  LC + +  DRP+ +D+  ++ 
Sbjct: 240 KEGERLPRPP-----SC-PDEV---YDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (287), Expect = 1e-29
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 27/218 (12%)

Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEA 65
           D  +     + +    ++G+G  G VYK      G+E+AIK  RL K + + I+   NE 
Sbjct: 10  DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEI 66

Query: 66  KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW-KKRFN--- 121
            ++   +H N+V      L   E  +V EY+   SL          +++     R N   
Sbjct: 67  LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQ 117

Query: 122 ---IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN 178
              +   ++QGL YLH      VIHRD+K+ NILL    + K++DFG A    + + ++ 
Sbjct: 118 IAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ--LTKEKSK 172

Query: 179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
            N +VGT  +M+PE +       K D++S G++ +E+ 
Sbjct: 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  112 bits (283), Expect = 3e-29
 Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 17/216 (7%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGKL--LDG----QEIAIKRL-SKSSGQGIVEFKNEAKLI 68
             D+ +    LG G FG VY+G     DG     ++A+K L    S Q   +F  EA ++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIE 124
           +K  H N+VRL+G S ++  R ++ E +    L  F+ ++     +   L  K       
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMARTFGMNELEANTNR 181
            + +G  YL +      IHRD+ A N LL         KI+DFGMAR            R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +    +M PE  ++GI + K+DV+SFGVL+ EI S
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 3e-29
 Identities = 69/199 (34%), Positives = 103/199 (51%), Gaps = 18/199 (9%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG-CS 83
           +LG G FG V+ G      ++A+K L K        F  EA+++ KL+H  LV+L   CS
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 84  LQKGERL-LVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
             + E + +V EY+   SL DF      KK  L   +  ++   I +G+ YL        
Sbjct: 72  --EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNY 124

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNGI 198
           IHRDL A NIL+ + +  KI+DFG+AR    +E  A      G      + +PE    G 
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGR 180

Query: 199 VSMKSDVYSFGVLVLEIIS 217
            ++KSDV+SFG+L+ EI++
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  112 bits (282), Expect = 4e-29
 Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 9/194 (4%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LG G FG V+ G      ++AIK L K        F  EA L+ +LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF       K  L   K  ++   I +G+ ++    R   IH
Sbjct: 72  QE-PIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 184

Query: 204 DVYSFGVLVLEIIS 217
           DV+SFG+L+ EI++
Sbjct: 185 DVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 6e-28
 Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 33/275 (12%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++G+G FG VYKG L    E+A+K  R +        +F  EA+++ +  H N+V+L+G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGV 60

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
            +QK    +V E +P        F   KK  L  KK   +      G+ YL   S+   I
Sbjct: 61  CVQKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--SK-NCI 115

Query: 143 HRDLKASNILLDDQMNPKISDFGMART--FGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           HRDL A N L+ +    KISDFGM+R    G+  +     +I     + +PE +  G  +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYT 173

Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC-- 258
            +SDV+S+G+L+ E  S    +  Y                +  +  E I++        
Sbjct: 174 SESDVWSYGILLWETFS--LGDTPYPG-------------MSNQQTRERIESGYRMPAPQ 218

Query: 259 -SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             P+E+ R +   L C      +RP+ S++ + L 
Sbjct: 219 LCPEEIYRLM---LQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 2e-27
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 32/208 (15%)

Query: 26  LGQGGFGPVYKGKLL-DGQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  + +G+     +AIK L + +  +   E  +EA ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 80  LGCSLQKGERL-LVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLH 134
           LG  L    ++ L+ + +P   L  ++ +       + LL+W  +      I +G+ YL 
Sbjct: 75  LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
           +    R++HRDL A N+L+    + KI+DFG+A+      L+ +        G     +M
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-----LDVDEKEYHAEGGKVPIKWM 178

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + E +++ I + KSDV+S+GV V E+++
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (266), Expect = 6e-27
 Identities = 68/202 (33%), Positives = 109/202 (53%), Gaps = 15/202 (7%)

Query: 24  NRLGQGGFGPVYKG-KLLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           N++G+G FG V+K  +  D +  A+K+  LSK + +   E  +EA+++AKL  + ++R  
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD---WKKRFNIIEGIVQGLLYLHKYS 137
              L KG+  +V EY  N  L   +     + L +   W+        I+ GL +LH   
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAHLHSK- 120

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
             +++HRD+K+ N+ LD   N KI D G+A+    N   ANT  IVGT  Y+SPE   + 
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDK 176

Query: 198 IVSMKSDVYSFGVLVLEIISSK 219
             + KSDV++ GV++ E  + K
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  106 bits (266), Expect = 6e-27
 Identities = 84/270 (31%), Positives = 134/270 (49%), Gaps = 27/270 (10%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LG G FG V+ G   +  ++A+K L K     +  F  EA L+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           ++    ++ EY+   SL DF   D   K LL   K  +    I +G+ Y+ + +    IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YIH 126

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+N+L+ + +  KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKS 185

Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD 261
           DV+SFG+L+ EI++  K    G  +++    L          G  +  +     E+C PD
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL--------QRGYRMPRM-----ENC-PD 231

Query: 262 EVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           E+   +     C ++KA +RPT   + S+L
Sbjct: 232 ELYDIMK---TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (264), Expect = 1e-26
 Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 13/198 (6%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G G FG V+ G  L+ +++AIK + +       +F  EA+++ KL H  LV+L G   +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    LV+E++ +  L  ++   +++     +    +   + +G+ YL   +   VIHRD
Sbjct: 71  RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125

Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNGIVSMK 202
           L A N L+ +    K+SDFGM R    ++  ++T    GT     + SPE       S K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSK 181

Query: 203 SDVYSFGVLVLEIISSKK 220
           SDV+SFGVL+ E+ S  K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 1e-26
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 62/287 (21%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V+ GK     ++AIK + + +     +F  EAK++ KL H NLV+L G   +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    +V EY+ N  L  ++ +   K   +W    ++   + + + YL        IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNGIVSMK 202
           L A N L+ +    K+SDFG+AR    ++  ++     GT     +  PE       S K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181

Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
           SDV+SFGVL+                         W++++EGK         +E  S  E
Sbjct: 182 SDVWSFGVLM-------------------------WEVFSEGK-------MPYERFSNSE 209

Query: 263 VTRCIHVGL-----------------LCVQDKATDRPTMSDVASMLT 292
           V   +  G                   C  +K  DRP    + S LT
Sbjct: 210 VVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  105 bits (263), Expect = 2e-26
 Identities = 70/217 (32%), Positives = 110/217 (50%), Gaps = 32/217 (14%)

Query: 23  GNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQG---------IVEFKNEAKLIAKLQ 72
           G  +G G FG VY G     G+ +A+K++   S            +     E  L+ +LQ
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF------NIIEGI 126
           H N+V+ LG SL      +  EY+P  S+           LL+    F      N +  I
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQI 115

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA--NTNR--I 182
           ++GL YLH  +R  +IHRD+K +NIL+D++   KISDFG+++    N L    N  R  +
Sbjct: 116 LKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
            G+  +M+PE V     + K+D++S G LV+E+++ K
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  104 bits (262), Expect = 3e-26
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 20/211 (9%)

Query: 24  NRLGQGGFGPVYKGKLLD-------GQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN 75
           N LG G FG VY+G   D          +A+K L K ++ Q   EF  EA L++   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE----LLDWKKRFNIIEGIVQGLL 131
           +V+LLG  L    + ++ E +    L  ++ D+  +     LL  K+  +I   + +G +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP-----KISDFGMARTFGMNELEANTNRIVGTH 186
           YL    ++  IHRDL A N L+ ++        KI DFG+AR    ++        +   
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +M+PE +++G  + +SDV+SFGVL+ EI++
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  105 bits (262), Expect = 3e-26
 Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 48/291 (16%)

Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG+  FG VYKG L         Q +AIK L  K+ G    EFK+EA + ++LQH N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKELLDWKKRFNIIEG 125
           LLG   ++    +++ Y  +  L  F+              D + K  L+     +I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           I  G+ +L   S   V+H+DL   N+L+ D++N KISD G+ R        A+  +++G 
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV----YAADYYKLMGN 185

Query: 186 H----GYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLW 241
                 +MSPE +M G  S+ SD++S+GV++ E+ S      C          GY+ Q  
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC----------GYSNQ-- 233

Query: 242 NEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
                +E+I       C PD+    ++  +L C  +  + RP   D+ S L
Sbjct: 234 ---DVIEMIRNRQVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  104 bits (261), Expect = 5e-26
 Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 35/290 (12%)

Query: 19  NFSPGNRLGQGGFGPVYKGKL----LDGQE--IAIKRLSKSSGQGI-VEFKNEAKLIAKL 71
           N      LG+G FG V+  K      +G E  + +K L K+  + +  EF+ E  +  KL
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL------LDWKKRFNIIEG 125
            H N+VRLLG   +     ++ EY     L  F+  +  K+       L  K++  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           I  G+ +L   S  R +HRDL A N L+  Q   K+S   +++    +E     N ++  
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK--NNGCYDTERHLNLVGYAWQLWNE 243
             +++PE V     S KSDV+SFGVL+ E+ +  +    G  D E  LN +         
Sbjct: 183 R-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRLQ-------A 233

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           GK LEL    + E C P  + + +     C      DRP+ S++ S L  
Sbjct: 234 GK-LEL---PVPEGC-PSRLYKLM---TRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 5e-26
 Identities = 63/199 (31%), Positives = 108/199 (54%), Gaps = 14/199 (7%)

Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V +G+L L G++   +AIK L + SS +  ++F  EA ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    +++ EY+ N SLD F+            +   ++ GI  G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN--RIVGTHGYMSPEYVMNGI 198
            +HRDL A NIL++  +  K+SDFG++R    +E    T   +I     + +PE +    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184

Query: 199 VSMKSDVYSFGVLVLEIIS 217
            +  SDV+SFG+++ E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  103 bits (258), Expect = 1e-25
 Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 25/213 (11%)

Query: 26  LGQGGFGPVYKGKL-LDGQE----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+  FG +YKG L L G +    +AIK L   ++ Q   EF+ EA L+A+L H N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIF--------------DSSKKELLDWKKRFNIIEG 125
           LG   Q+    +++EYL    L  F+               D + K  LD     +I   
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-TFGMNELEANTNRIVG 184
           I  G+ YL  +     +H+DL A NIL+ +Q++ KISD G++R  +  +        ++ 
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
              +M PE +M G  S  SD++SFGV++ EI S
Sbjct: 190 IR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 77/296 (26%), Positives = 124/296 (41%), Gaps = 56/296 (18%)

Query: 26  LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVR 78
           LG+G FG V+ G+   L    +   +A+K L +++     + F+ EA+L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 79  LLGCSLQKGERLLVYEYLPNKSLD-----------FFIFDSSKKELLDWKKRFNIIEGIV 127
             G   +    ++V+EY+ +  L+           F     S    L   +   I   I 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G++YL   +    +HRDL   N L+   +  KI DFGM+R     ++       VG H 
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGGHT 184

Query: 188 -----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW-QLW 241
                +M PE +M    + +SDV+SFGV++ EI +  K                 W  L 
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ---------------PWYGLS 229

Query: 242 NEGKALELIDTTLH----ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           NE + +E I          +C P EV     + L C +     R  + D+   L  
Sbjct: 230 NE-EVIECITQGRLLQRPRTC-PSEVY---DIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  101 bits (254), Expect = 3e-25
 Identities = 81/274 (29%), Positives = 131/274 (47%), Gaps = 43/274 (15%)

Query: 23  GNRLGQGGFGPVYKG-KLLDGQEIAIKRLS-----KSSGQGIVEFKNEAKLIAKLQHTNL 76
           G  LG G FG VY+G  L DG   A+K +S     ++  + + + + E  L++KLQH N+
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 77  VRLLGCSLQKGERLLVY-EYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           V+ LG + ++ + L ++ E +P  SL   +  + S  + ++           I+ GL YL
Sbjct: 65  VQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIR-----LYTRQILLGLEYL 118

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR---TFGMNELEANTNRIVGTHGYMS 190
           H   R   +HRD+K +NIL+D     K++DFGMA+    F             G+  +M+
Sbjct: 119 H--DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF------AKSFKGSPYWMA 169

Query: 191 PEYVM-NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           PE +   G   + +D++S G  VLE+ + K      +        G A  ++  G++ EL
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVA-AVFKIGRSKEL 220

Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT 283
                H S   DE    I   L C+Q   + RPT
Sbjct: 221 PPIPDHLS---DEAKDFI---LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  101 bits (254), Expect = 4e-25
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG+G +G VYK    + GQ +AIK +     + + E   E  ++ +     +V+  G   
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 85  QKGERLLVYEYLPNKS-LDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           +  +  +V EY    S  D  I   + K L   ++   I+   ++GL YLH     + IH
Sbjct: 69  KNTDLWIVMEYCGAGSVSD--IMKITNKTL-TEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+KA NILL+++   K++DFG++    + +  A  N ++GT  +M+PE +     + K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180

Query: 204 DVYSFGVLVLEIISSK 219
           D++S G+  +E+   K
Sbjct: 181 DIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 9e-25
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 41/216 (18%)

Query: 24  NRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSG-QGI-VEFKNEAKLIAKLQHTNLVRLL 80
            ++G+G +G VYK +    G+ +A+K++   +  +G  +    E KL+ KL+H N+VRL 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 81  G--CSLQKGERLLVYEYLP--------NKSLDF------FIFDSSKKELLDWKKRFNIIE 124
               S  KG   +V+EY+         +  + F             K+LL          
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM----KQLL---------- 110

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
              +GL YLH      ++HRD+K SNIL+++    K++DFG+AR +        TNR++ 
Sbjct: 111 ---EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163

Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSK 219
           T  Y  PE ++       + D++S G ++ E+   K
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (249), Expect = 1e-24
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 44/279 (15%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG+G FG V+KG L D   +A+K   +   Q + ++F +EA+++ +  H N+V+L+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
           Q+    +V E +P    DF  F   KK+ L  K+          G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 145 DLKASNILLDDQMNPKISDFGMAR--------TFGMNELEANTNRIVGTHGYMSPEYVMN 196
           DL A N L+ +    KISDFGM+R        + G+ ++            + +PE +  
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK---------WTAPEALNY 168

Query: 197 GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE 256
           G  S +SDV+S+G+L+ E  S             L +  Y   + N+ +A E ++     
Sbjct: 169 GRYSSESDVWSYGILLWETFS-------------LGVCPYP-GMTNQ-QAREQVEKGYRM 213

Query: 257 SCS---PDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
           SC    PD+V +   V   C   K  +RP  S++   L 
Sbjct: 214 SCPQKCPDDVYK---VMQRCWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 1e-24
 Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 17/210 (8%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKR-----LSKSSGQGIVEFKNEAKLIAKLQ 72
           N+  G  LGQG FG VY    +D G+E+A+K+      S  + + +   + E +L+  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 73  HTNLVRLLGCSLQKGERLLVY-EYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           H  +V+  GC L+  E L ++ EY+P  S+ D      +  E +  K    I+EG+    
Sbjct: 63  HERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV---- 117

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV-GTHGYM 189
            YLH      ++HRD+K +NIL D   N K+ DFG ++            + V GT  +M
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           SPE +       K+DV+S G  V+E+++ K
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 12/196 (6%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LG G FG V++G   +   +A+K L K       +F  EA+++ KL+H  L++L     
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
            +    +V E +   SL  ++   + + L    +  ++   +  G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNGIVSM 201
           DL A N+L+ +    K++DFG+AR    +  EA      G      + +PE  +    S+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183

Query: 202 KSDVYSFGVLVLEIIS 217
           KSDV+SFG+L+ EI++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  100 bits (250), Expect = 2e-24
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 18/207 (8%)

Query: 26  LGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 81  GCSLQKGER--LLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           G     G R   LV EYLP  SL D+       +E LD +K       I +G+ YL    
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQ---KHRERLDHRKLLLYASQICKGMEYL---G 125

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R +HRDL   NIL++ +   KI DFG+ +    ++ E    R  G     + +PE + 
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWYAPESLT 184

Query: 196 NGIVSMKSDVYSFGVLVLEIIS-SKKN 221
               S+ SDV+SFGV++ E+ + S K+
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 10/200 (5%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           F+   +LG G FG V++G   +   +AIK L         +F+ E + + +L+H +L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 80  LG-CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              CS+  GE + ++ E +   SL  F+  S + ++L      ++   + +G+ YL +  
Sbjct: 68  FAVCSV--GEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ- 123

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
               IHRDL A NIL+ + +  K++DFG+AR    +   ++  +I   + + +PE   +G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179

Query: 198 IVSMKSDVYSFGVLVLEIIS 217
             S KSDV+SFG+L+ E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.3 bits (242), Expect = 1e-23
 Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 15/196 (7%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           G  +G+G FG V +G+   GQ++A+K +    + Q    F  E  ++ KL H NLVRLLG
Sbjct: 11  GEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG 66

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
             L  G   +V E +   +L  F+  +  + L+   +       + +G+ YL      ++
Sbjct: 67  VILHNG-LYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           +HRDL A NIL+ +    K+SDFG+AR   +  +  + +++     + +PE + +   S 
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKL--PVKWTAPEALKHKKFSS 176

Query: 202 KSDVYSFGVLVLEIIS 217
           KSDV+S+GVL+ E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 97.5 bits (243), Expect = 2e-23
 Identities = 66/201 (32%), Positives = 116/201 (57%), Gaps = 14/201 (6%)

Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLG 81
           ++G+G +G VYKG+    GQ +A+K++  +S  +G+      E  L+ +LQH N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIF-DSSKK-ELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
             +Q+    L++E+L   S+D   + DS  K + +D +   + +  I+QG+L+ H     
Sbjct: 67  VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SR 120

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI- 198
           RV+HRDLK  N+L+D++   K++DFG+AR FG+  +   T+ +V T  Y +PE ++    
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLLGSPR 178

Query: 199 VSMKSDVYSFGVLVLEIISSK 219
            S   D++S G +  E+ + K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 2e-23
 Identities = 82/291 (28%), Positives = 115/291 (39%), Gaps = 61/291 (20%)

Query: 25  RLGQGGFGPVYKGKLLDGQ----EIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRL 79
           +LG G FG V +G+          +A+K L       I+ +F  EA ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE---------LLDWKKRFNIIEGIVQGL 130
            G  L     ++V E  P  SL     D  +K+         L D+         I  G+
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYA------VQIANGM 110

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE--LEANTNRIVGTHGY 188
            YL   S+ R IHRDL A NILL      KI DFG+ R    NE       +  V    +
Sbjct: 111 RYLE--SK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAW 166

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLW---NEGK 245
            +PE +     S  SDV+ FGV + E+ +                  Y  + W   +  +
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT------------------YGEEPWAGLSGSQ 208

Query: 246 ALELIDTTLH-----ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
            L+ ID         E+C  D       V L C      DRPT + +   L
Sbjct: 209 ILKKIDKEGERLERPEACPQDIYN----VMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.5 bits (241), Expect = 3e-23
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 24  NRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
             +G+G FG V K      GK+L  +EI    +++   Q +V   +E  ++ +L+H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV 62

Query: 78  RLLGCSLQKGERLL--VYEYLPNKSLDFFIFDSSKKELLDWKKRFN---IIEGIVQGLLY 132
           R     + +  + L  V EY     L   I    KKE    +K      I   + Q LL 
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKE----RKYIEEEFIWRILTQLLLA 117

Query: 133 LH-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           L+           V+HRDLK +NI LD   N K+ DFG+A+  G +   A T   VGT  
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPY 175

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
           YMSPE + +     KSD++S G L+ E+
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 15/196 (7%)

Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
            +G+G FG VYK       Q +AIK   L ++  + I + + E + +++ +   + +  G
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYITKYYG 66

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
             L KG +L ++ EY    S      D  K   LD      I+  ++ GL YLH+     
Sbjct: 67  SFL-KGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE---G 118

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
            IHRD+KA+NILL ++ + K++DFG++        + NT   VGT  +M+PE +      
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYD 176

Query: 201 MKSDVYSFGVLVLEII 216
            K+D++S G+  +E+ 
Sbjct: 177 EKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 97.6 bits (243), Expect = 3e-23
 Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 19/201 (9%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRLLG 81
           +G G FG VY  + +   + +AIK++S S  Q   ++++   E + + +L+H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           C L++    LV EY    + D  I +  KK L +  +   I  G +QGL YLH + R   
Sbjct: 83  CYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHSHER--- 136

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---NGI 198
           IHRD+KA NILL +    K++DFG A       L +  N  VGT  +M+PE ++    G 
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEGQ 190

Query: 199 VSMKSDVYSFGVLVLEIISSK 219
              K DV+S G+  +E+   K
Sbjct: 191 YDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 3e-23
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 54/291 (18%)

Query: 26  LGQGGFGPVYKGKLLD------GQEIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G             +AIK +++++     +EF NEA ++ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFI-------FDSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG        L+V E +    L  ++        ++        +K   +   I  G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH----G 187
           YL      + +HRDL A N ++ + +  KI DFGM R       E +  R  G       
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI----YETDYYRKGGKGLLPVR 186

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-------SKKNNGCYDTERHLNLVGYAWQL 240
           +M+PE + +G+ + KSDV+SFGV++ E+ +          N      E  L  V      
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVI----- 235

Query: 241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
             +G  L+L +        PD   + + +  +C Q     RPT  ++ S L
Sbjct: 236 --DGGHLDLPE------NCPD---KLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.5 bits (237), Expect = 7e-23
 Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 38/277 (13%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  LV+L    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVV 70

Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            K    ++ E++   SL DF   D   K+ L   K  +    I +G+ ++ + +    IH
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+   +  KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKS 184

Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH-------E 256
           DV+SFG+L++EI++                  Y    +      E+I            E
Sbjct: 185 DVWSFGILLMEIVT------------------YGRIPYPGMSNPEVIRALERGYRMPRPE 226

Query: 257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +C P+E+    ++ + C +++  +RPT   + S+L +
Sbjct: 227 NC-PEEL---YNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 95.1 bits (236), Expect = 1e-22
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 22/269 (8%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LG G FG V+ G      ++A+K L K        F  EA+++ KL+H  LV+L    +
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-V 70

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
            +    +V EY+   SL  F+ D   + L       ++   +  G+ Y+    R+  IHR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
           DL+++NIL+ D +  KI+DFG+AR    NE  A          + +PE  + G  ++KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSD 185

Query: 205 VYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVT 264
           V+SFG+L+ E+++  +             V Y     N  + LE ++      C  D   
Sbjct: 186 VWSFGILLTELVTKGR-------------VPYPGM--NNREVLEQVERGYRMPCPQDCPI 230

Query: 265 RCIHVGLLCVQDKATDRPTMSDVASMLTN 293
               + L C +    +RPT   + S L +
Sbjct: 231 SLHELMLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 80/270 (29%), Positives = 128/270 (47%), Gaps = 24/270 (8%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G      ++AIK L K        F  EA+++ KL+H  LV L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
            +    +V E++   SL  F+ +   K L    +  ++   I  G+ Y+    R+  IHR
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
           DL+A+NIL+ D +  KI+DFG+AR    NE  A          + +PE  + G  ++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSD 185

Query: 205 VYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVT 264
           V+SFG+L+ E+++  +             V Y   +  E   LE ++      C P    
Sbjct: 186 VWSFGILLTELVTKGR-------------VPYPGMVNRE--VLEQVERGYRMPC-PQGCP 229

Query: 265 RCIHVGL-LCVQDKATDRPTMSDVASMLTN 293
             +H  + LC +    +RPT   + S L +
Sbjct: 230 ESLHELMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 26/271 (9%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70

Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 184

Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 185 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPC-PPEC 228

Query: 264 TRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
              +H  +  C + +  +RPT   + + L +
Sbjct: 229 PESLHDLMCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 94.5 bits (235), Expect = 2e-22
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)

Query: 26  LGQGGFGPVY------KGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   +++  KRL K  G+ +    NE K++ K+    +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K +  LV   +    L + I++  +    + +  F   + I+ GL +LH   + 
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QR 114

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           R+++RDLK  N+LLDD  N +ISD G+A      +         GT GYM+PE +   + 
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEVY 171

Query: 200 SMKSDVYSFGVLVLEIISSK 219
               D ++ G  + E+I+ +
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 94.6 bits (235), Expect = 3e-22
 Identities = 83/305 (27%), Positives = 139/305 (45%), Gaps = 54/305 (17%)

Query: 19  NFSPGNRLGQGGFGPVYKG-----KLLDG-QEIAIKRLSKSSGQGIVEFK---NEAKLIA 69
           N   G  LG+G FG V K      K   G   +A+K L +++     E +   +E  L+ 
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLK 58

Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK------------------- 110
           ++ H ++++L G   Q G  LL+ EY    SL  F+ +S K                   
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 111 --KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
             +  L      +    I +G+ YL   + ++++HRDL A N+L+ +    KISDFG++R
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 169 TFGMNELEANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD 226
              + E ++   R  G     +M+ E + + I + +SDV+SFGVL+ EI++   N   Y 
Sbjct: 176 D--VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YP 231

Query: 227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSD 286
                 L    + L   G  +E       E+CS +E+   +   L C + +   RPT +D
Sbjct: 232 GIAPERL----FNLLKTGYRME-----RPENCS-EEMYNLM---LTCWKQEPDKRPTFAD 278

Query: 287 VASML 291
           ++  L
Sbjct: 279 ISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 19/207 (9%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 75
           FS    +G G FG VY  + +   E+ AIK++S S  Q   ++++   E + + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            ++  GC L++    LV EY    + D  + +  KK L + +    +  G +QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 133

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
           ++   +IHRD+KA NILL +    K+ DFG A       + A  N  VGT  +M+PE ++
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184

Query: 196 ---NGIVSMKSDVYSFGVLVLEIISSK 219
               G    K DV+S G+  +E+   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 95.2 bits (236), Expect = 3e-22
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 19/207 (9%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 75
           F+    +G G FG VY  + +   E+ AIK++S S  Q   ++++   E K + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            +   GC L++    LV EY    + D  + +  KK L + +    I  G +QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHS 143

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
           ++   +IHRD+KA NILL +    K++DFG A       + +  N  VGT  +M+PE ++
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194

Query: 196 ---NGIVSMKSDVYSFGVLVLEIISSK 219
               G    K DV+S G+  +E+   K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 5e-22
 Identities = 59/197 (29%), Positives = 108/197 (54%), Gaps = 12/197 (6%)

Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHTNLVRLLG 81
           ++G+G +G VYK +  L G+ +AIK++        +      E KL+ +L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
               KG+  LV+E++ +  L   I D  +   L      + +  ++QGL + H +    +
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVS 200
           +HRDLK  N+L++ +   K++DFG+AR+FG + +   T+ +V T  Y +PE ++     S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 201 MKSDVYSFGVLVLEIIS 217
              D++S G +  E++S
Sbjct: 178 TPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 93.6 bits (232), Expect = 7e-22
 Identities = 88/312 (28%), Positives = 149/312 (47%), Gaps = 55/312 (17%)

Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L++++G +  VEF +EA ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L V + +P+  L  ++ +       + LL+W  +      I +G++YL +
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+AR    +E E N +       +M+ E + 
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
               + +SDV+S+GV + E+++   K  +G    E           L  +G+ L      
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLP----- 231

Query: 254 LHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLT--------------NDTMAL 298
                 P   T  +++ ++ C    A  RP   ++A+  +              +D M L
Sbjct: 232 -----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKL 286

Query: 299 PTPRQPAFFINI 310
           P+P    FF N+
Sbjct: 287 PSPNDSKFFQNL 298

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.2 bits (229), Expect = 1e-21
 Identities = 71/279 (25%), Positives = 132/279 (47%), Gaps = 38/279 (13%)

Query: 19  NFSPGNRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKL 71
            +  G +LG G F   Y+      G L+  +++   R + S  + +VE  + E +L+A+L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQG 129
            H +++R+LG + +     L  E++   S+   +  + + K+ ++      N  E +++G
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARTF-----GMNELEANTNRIV 183
           L YLH+    ++IHRD+K +N+L+D      +I+DFG A        G  E +    +++
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLL 169

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
           GT  +M+PE +         DV+S G +++E+ ++K          HL L      ++  
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------IFKI 223

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP 282
             A       + E  SP    R   V L C++ +  DRP
Sbjct: 224 ASATTAPS--IPEHLSPG--LR--DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.0 bits (228), Expect = 2e-21
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 26  LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +   LL  Q+   +A+K L ++S     +F+ EA+L+  LQH ++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFF---------IFDSSKKEL---LDWKKRFNIIEGIV 127
            G   +    L+V+EY+ +  L+ F         I    +      L   +   I   I 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      R +    
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK 220
           +M PE ++    + +SD++SFGV++ EI +  K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.8 bits (229), Expect = 3e-21
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 35/205 (17%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKLQHTNLVR 78
           LG G FG V   +     +  A+K LSK     IV+ K      NE +++  ++H  LV 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQSIRHPFLVN 65

Query: 79  LLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG------IVQGLL 131
           L G S Q    L LV EY+P   L    F       L    RF           +V  L 
Sbjct: 66  LYG-SFQDDSNLYLVMEYVPGGEL----FS-----HLRKSGRFPEPVARFYAAQVVLALE 115

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YLH    L +++RDLK  N+LLD     KI+DFG A+      ++  T  + GT  Y++P
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAP 167

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEII 216
           E +++       D ++ G+L+ E++
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 63/220 (28%), Positives = 112/220 (50%), Gaps = 33/220 (15%)

Query: 26  LGQGGFGPVYKGK---LLDGQE---IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           +GQG FG V++ +   LL  +    +A+K L + +S     +F+ EA L+A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 79  LLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-------------------LDWKK 118
           LLG C++ K    L++EY+    L+ F+   S +                     L   +
Sbjct: 73  LLGVCAVGK-PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 119 RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART-FGMNELEA 177
           +  I + +  G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R  +  +  +A
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + N  +    +M PE +     + +SDV+++GV++ EI S
Sbjct: 189 SENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.7 bits (225), Expect = 4e-21
 Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 30/268 (11%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + + S     EF  EAK++ KL H  LV+L G   +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    +V EY+ N  L  ++ +  K+      +   + + + +G+ YL      + IHRD
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHRD 125

Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNGIVSMK 202
           L A N L+DDQ   K+SDFG++R    +E  ++    VG+     +  PE ++    S K
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSK 181

Query: 203 SDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD 261
           SDV++FGVL+ E+ S  K     ++    +  V    +L+    A E +   ++      
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS----- 236

Query: 262 EVTRCIHVGLLCVQDKATDRPTMSDVAS 289
                      C  +KA +RPT   + S
Sbjct: 237 -----------CWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHT---NLVRLL 80
           +G+G +G VY+GK +  G+ +A+K ++  +    V + + E  L+++L+ +   N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G  L+     ++ EY    S    +    K   +  K    II  ++  L Y+HK     
Sbjct: 69  GSYLKGPRLWIIMEYAEGGS----VRTLMKAGPIAEKYISVIIREVLVALKYIHKVG--- 121

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV- 199
           VIHRD+KA+NIL+ +  N K+ DFG+A     N  + +T   VGT  +M+PE +  G   
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179

Query: 200 SMKSDVYSFGVLVLEIIS 217
             K+D++S G+ + E+ +
Sbjct: 180 DTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.0 bits (227), Expect = 4e-21
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 44/220 (20%)

Query: 20  FSPGNRLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVEFKN---EAKLIAKLQH 73
           +    +LG+G +G VYK +    G+ +A+K  RL     +GI        E  L+ +L+H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGI--PSTALREISLLKELKH 57

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ----- 128
            N+V+LL     + +  LV+EY           D   K+ LD K+   +   +++     
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYC----------DMDLKKYLD-KRPGPLSPNLIKSIMYQ 106

Query: 129 ---GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
              GL Y H  S  R++HRDLK  NIL++     K++DFG+AR FG+  L   T+ +V T
Sbjct: 107 LLRGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV-T 161

Query: 186 HGYMSPEYVMN------GIVSMKSDVYSFGVLVLEIISSK 219
             Y +PE ++        +     D++S G +  E+I+ K
Sbjct: 162 LWYRAPEILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 4e-21
 Identities = 66/202 (32%), Positives = 114/202 (56%), Gaps = 17/202 (8%)

Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLG 81
           ++G+G +G VYK +  L G+ +A+K++  ++  +G+      E  L+ +L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIF-DSSKKELLDWK--KRFNIIEGIVQGLLYLHKYSR 138
               + +  LV+E+L    LD   + DSS    LD    K +  +  ++QG+ Y H  S 
Sbjct: 66  VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSY--LYQLLQGIAYCH--SH 118

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG- 197
            RV+HRDLK  N+L+D +   K++DFG+AR FG+  +   T+ +V T  Y +PE ++   
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSR 175

Query: 198 IVSMKSDVYSFGVLVLEIISSK 219
             S   D++S G +  E+++ +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 90.5 bits (224), Expect = 5e-21
 Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 17/211 (8%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQ 72
           N+  G  LGQG FG VY    +D G+E+A K++     S  + + +   + E +L+  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 73  HTNLVRLLGCSLQKGERLLV--YEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           H  +V+  GC   + E+ L    EY+P  S+ D      +  E +  K    I+EG    
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG---- 118

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR-IVGTHGY 188
           + YLH      ++HRD+K +NIL D   N K+ DFG ++      +     R + GT  +
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           MSPE +       K+DV+S G  V+E+++ K
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.9 bits (226), Expect = 5e-21
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 38/216 (17%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIV-EFKNEAKLIAKLQHTN 75
           +     +RLG+G  G V K +L +   I A+K ++      +  +   E ++    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 76  LVRLLGCSL--QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIV 127
           +V+  G  L        +  EY    SLD     S  K++     R        I E ++
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG--------MARTFGMNELEANT 179
           +GL YLH  SR ++IHRD+K SNILL  +   K+ DFG        +A TF         
Sbjct: 116 KGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF--------- 163

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
               GT  YM+PE +     S+ SDV+S G+ +LE+
Sbjct: 164 ---TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 90.3 bits (224), Expect = 5e-21
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 17/202 (8%)

Query: 26  LGQGGFGPVYKGKLLDGQ------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +G+G FG V+  +    Q      +I +++++K         +NE +++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSHPNIIEY 64

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
               L+    ++V EY P  +L  +I       LLD      I+   VQ LL LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDED---TILHFFVQILLALHHVHTK 120

Query: 140 RVIHRDLKASNILLDD-QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
            ++HRDLK  NILLD  +M  KI DFG+++    ++ +A T  +VGT  Y+SPE      
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELCEGKP 177

Query: 199 VSMKSDVYSFGVLVLEIISSKK 220
            + KSD+++ G ++ E+ S K+
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.9 bits (225), Expect = 5e-21
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 11/217 (5%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           F+   R+G+G FG VYKG     +E+ AIK +     +  +E  + E  ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           R  G  L+  +  ++ EYL   S      D  K   L+      I+  I++GL YLH   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
             R IHRD+KA+N+LL +Q + K++DFG+A      +++ NT   VGT  +M+PE +   
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
               K+D++S G+  +E+   +  N      R L L+
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.1 bits (224), Expect = 6e-21
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 14/199 (7%)

Query: 26  LGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVEF-KNEAKLIAKLQHTNLVRLLGCS 83
           +G G    VY    L   E +AIKR+     Q  V+  + E + +++  H N+V+    S
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY-TS 67

Query: 84  LQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
              G+ L LV  YL   SL   +  S  +  LD      +++ +++GL YLH   +   I
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---I 124

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTF--GMNELEANTNRIVGTHGYMSPEYVM---NG 197
           HRD+KA NILL +  + KI+DFG++ +   G +         VGT  +M+PE VM   +G
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHG 183

Query: 198 IVSMKSDVYSFGVLVLEII 216
               K+D++SFG+  +E+ 
Sbjct: 184 -YDFKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 9e-21
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 26  LGQGGFGPVYKGKLLDGQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG+G +G VY  + L  Q  IAIK + +   + +     E  L + L+H N+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG--IVQGLLYLHKYSRLRVI 142
           + G   +  E +P  SL   +   SK   L   ++  I     I++GL YLH     +++
Sbjct: 76  ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130

Query: 143 HRDLKASNILLDDQMNP-KISDFGMA-RTFGMNELEANTNRIVGTHGYMSPEYVMNGI-- 198
           HRD+K  N+L++      KISDFG + R  G+N     T    GT  YM+PE +  G   
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRG 187

Query: 199 VSMKSDVYSFGVLVLEIISSK 219
               +D++S G  ++E+ + K
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.6 bits (222), Expect = 1e-20
 Identities = 73/277 (26%), Positives = 131/277 (47%), Gaps = 36/277 (12%)

Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V++G L + G++   +AIK L    + +   +F +EA ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    +++ EY+ N +LD ++ D   +      +   ++ GI  G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
            +HRDL A NIL++  +  K+SDFG++R      LE +      T G      + +PE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                +  SDV+SFG+++ E++S          ER        W + N  + ++ I+   
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFG--------ERPY------WDMSNH-EVMKAINDGF 227

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                 D  +    + L C Q     RP   D+ ++L
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.3 bits (221), Expect = 1e-20
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 25/204 (12%)

Query: 25  RLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLLGC 82
           R+G+G FG V+ G+L  D   +A+K   ++    +  +F  EA+++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             QK    +V E +  +  DF  F  ++   L  K+   ++E    G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 143 HRDLKASNILLDDQMNPKISDFGMAR---------TFGMNELEANTNRIVGTHGYMSPEY 193
           HRDL A N L+ ++   KISDFGM+R         T GM ++            + +PE 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---------WTAPEA 167

Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +  G  S +SDV+SFG+L+ E  S
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 24  NRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
           + +G G FG VY        E+ A+K++S S  Q   ++++   E K + +L+H N +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
            GC L++    LV EY    + D  + +  KK L + +    I  G +QGL YLH ++  
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHSHNM- 142

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---N 196
             IHRD+KA NILL +    K++DFG A         +  N  VGT  +M+PE ++    
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDE 194

Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
           G    K DV+S G+  +E+   K
Sbjct: 195 GQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.9 bits (223), Expect = 1e-20
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 13/206 (6%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHT 74
           NF    ++G+G +G VYK +  L G+ +A+K++   +++ G      + E  L+ +L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 172

Query: 195 MNG-IVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.0 bits (221), Expect = 1e-20
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTN 75
           +F    +LG+G +G VYK K L D Q  A+K   L   S +   +  NE +++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 76  LVR-----LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQG 129
           ++      L G  L      +V EY P   L   I    K ++L+  ++ + I   +++G
Sbjct: 61  IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L  LH+    +++HRDLK++NILL      KI D G+++   + +  A T   +GT  YM
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQ--IGTPHYM 168

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +PE       S KSD++S G L+ E+ +
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMAT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 19/211 (9%)

Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIKRLS---------KSSGQGIVE-FKNEAKLIAKL 71
           G  +G+G +G VY    +  G+ +A+K++           S  + +V+  ++E + +  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+ LG    +    +  EY+P  S+   +    + E  +   RF   E +++GL 
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE--EQLVRF-FTEQVLEGLA 122

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YLH      ++HRDLKA N+L+D     KISDFG+++             + G+  +M+P
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 192 EYVMNGI--VSMKSDVYSFGVLVLEIISSKK 220
           E + +     S K D++S G +VLE+ + ++
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.8 bits (220), Expect = 2e-20
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 28/270 (10%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V+ GK     ++AIK +++ +     +F  EAK++ KL H  LV+L G   Q
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    +V E++ N  L  ++    ++  L      ++ + + +G+ YL + S    IHRD
Sbjct: 71  QKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125

Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L+      K+SDFGM R + +++   +++       +  PE       S KSDV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 206 YSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL---ELIDTTLHESCSPDE 262
           +SFGVL+ E+ +  K    ++ + +  +V    ++ + G  L   +L   T++E      
Sbjct: 185 WSFGVLMWEVFTEGKMP--FEKKSNYEVV----EMISRGFRLYRPKLASMTVYE------ 232

Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
                 V   C  +K   RPT +++   +T
Sbjct: 233 ------VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
             NF    ++G+G F  VYK   LLDG+ +A+K++       I E  +         E  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54

Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEG 125
           L+ +L H N+++ L   ++  E  +V E      L   I    K K L+  +  +     
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           +   L ++H  S+ R++HRD+K +N+ +      K+ D G+ R F      A++  +VGT
Sbjct: 115 LCSALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
             YMSPE +     + KSD++S G L+ E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.4 bits (217), Expect = 5e-20
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           GN++G G FG VY    LD G+ +A+K  R+  +  + I E  +E K++  L+H NLV+ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK--KRFNIIEGIVQGLLYLHKYS 137
            G  + + +  +  EY    +L+          +LD    + + +   +++GL YLH + 
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEEL---LEHGRILDEHVIRVYTL--QLLEGLAYLHSH- 118

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT--NRIVGTHGYMSPEYVM 195
              ++HRD+K +NI LD     K+ DFG A     N          + GT  YM+PE + 
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 196 NGIVSMK---SDVYSFGVLVLEIISSKKNNGCYDTE 228
            G        +D++S G +VLE+ + K+     D E
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.4 bits (217), Expect = 6e-20
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQH 73
           D+      LG G  G V K      G+ +A+K +     +     K    E  ++ K   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIV 127
             +V   G     G+  +  EY+   SLD        KE+   + R        I   ++
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKI-----LKEV---QGRIPERILGKIAVAVL 110

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +GL YLH   + ++IHRD+K SNIL++ +   K+ DFG++    +N L A T   VGT  
Sbjct: 111 KGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSL-AKTF--VGTSS 164

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
           YM+PE +     S+KSD++S G+ ++E+
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.0 bits (219), Expect = 7e-20
 Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 30/188 (15%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFK--NEAKLIAKLQ 72
            +  G +LG+G +  VYK +    G+ +AIK++    +   +  + F    E KL+ +L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLP--------NKSLDFFIFDSSKKELLDWKKRFNIIE 124
           H N++ LL     K    LV+E++         +KS+      +  K         + + 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLT--PADIK---------SYML 109

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
             ++GL YLH      ++HRDLK +N+L+      K++DFG+AR+FG    +      V 
Sbjct: 110 MTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VV 164

Query: 185 THGYMSPE 192
           T  Y +PE
Sbjct: 165 TRWYRAPE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 87.2 bits (216), Expect = 7e-20
 Identities = 68/272 (25%), Positives = 129/272 (47%), Gaps = 24/272 (8%)

Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L K     + EF  EA ++ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + + ++ ++      +   I   + YL K +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 185

Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSPD 261
           SDV++FGVL+ EI +       Y    +  + +   ++L  +G  +E       E C P 
Sbjct: 186 SDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKGYRME-----RPEGC-PP 232

Query: 262 EVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +V   +     C Q   +DRP+ +++      
Sbjct: 233 KVYELMRA---CWQWNPSDRPSFAEIHQAFET 261

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.5 bits (214), Expect = 1e-19
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 54/286 (18%)

Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G+L L G+    +AIK L    + +   +F +EA ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE------GIVQGLLYLH 134
           G   +    ++V EY+ N SLD F+    +K       +F +I+      GI  G+ YL 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------Y 188
             S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRW 175

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KA 246
            +PE +     +  SDV+S+G+++ E++S       Y    +       W++ N+   KA
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMS-------YGERPY-------WEMSNQDVIKA 221

Query: 247 LELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
           +E      +   +P +    +H  +L C Q    +RP    + S+L
Sbjct: 222 IE----EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 27  GQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFK------NEAKLIAKLQHTNLVRL 79
           G+G FG V   +  D +++ A+K ++K   Q  VE        NE +++ +L H  LV L
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNK---QKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 80  LGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
              S Q  E + LV + L    L + +  S K +  + + +F I E IV  L YLH    
Sbjct: 66  WY-SFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHSK-- 119

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
             +IHRD+K  NILLD+Q +  I+DF +A        +  T    GT GYM+PE +    
Sbjct: 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQG 175

Query: 199 VSMKSDVYSFGVLVLEIISSKK 220
            S+  D +S GV   E +  K+
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 2e-19
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 20/214 (9%)

Query: 20  FSPGNRLGQGGFGPVYKGKLL--DG--QEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQH 73
              G  LG+G FG V +G+L   DG   ++A+K  +L   +   I EF +EA  +    H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 74  TNLVRLLGCSLQKGER------LLVYEYLPNKSLDFFIFDSSKKEL---LDWKKRFNIIE 124
            N+++L+G   +          +++  ++ +  L  F+  S    L   L  +     + 
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I  G+ YL   S    IHRDL A N +L + M   ++DFG+++    +       RI  
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAK 176

Query: 185 TH-GYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               +++ E + + + + KSDV++FGV + EI +
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.7 bits (212), Expect = 3e-19
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 34/216 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVE-----FKNEAKLIAKLQHTNL 76
           G  LG+G +G VY G    GQ IA+K++   +S     E      + E  L+  L+H N+
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII---------EGIV 127
           V+ LG  L      +  E++P  S+   +             RF  +         + I+
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQIL 112

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV---- 183
            G+ YLH      V+HRD+K +N++L      K+ DFG AR      L    + ++    
Sbjct: 113 DGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           GT  +M+PE +       KSD++S G  V E+ + K
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 34/282 (12%)

Query: 26  LGQGGFGPVYK-------GKLLDGQEI-----AIKRLSKSSGQGIVEFKNEAKLIAK-LQ 72
           LG G FG VYK         LL  +EI     A  +  +   + I +  +E  +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           H N+VR     L+     +V + +    L + F     KK+    ++ +NI   +V  L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YLHK  R  ++HRDL  +NI+L +     I+DFG+A+       E+    +VGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP---ESKLTSVVGTILYSCP 182

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E V N     K+DV++FG ++ ++ +       Y T    N++  A ++      +E + 
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTL--QPPFYST----NMLSLATKI------VEAVY 230

Query: 252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
             L E    ++VT  I     C+   A  RP +  V++M+++
Sbjct: 231 EPLPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.9 bits (212), Expect = 3e-19
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 26  LGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++ +    ++VR
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   Q    L++ E +    L  ++        ++  +     KK   +   I  G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++ +    KI DFGM R     +      + +    +MSP
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEI 215
           E + +G+ +  SDV+SFGV++ EI
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 28/208 (13%)

Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNLVRLLG 81
           + +G +G V+   K   G   AIK + K+       + +   E  ++++ Q   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 82  CSLQKGERL-LVYEYLPN---KSL--DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            S Q  + L LV EYLP     SL  +    D       D  +    I  IV  L YLH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFG------MARTFGMNELEANTNRIVGTHGYM 189
                +IHRDLK  NIL+D   + K++DFG      + R   +N+ E    RIVGT  Y+
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +PE ++    S   D +S G ++ E + 
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 27/214 (12%)

Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFK---NE 64
           DFQ +           ++GQGG+G V+  K  D  EI A+KR+ KS    + E +    E
Sbjct: 2   DFQILT----------QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTE 51

Query: 65  AKLIAKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
             ++   +   LV+LL  + Q  E L L  EY+P    DF    ++   L +   RF + 
Sbjct: 52  RDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMA 108

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           E + + +  LH    L  IHRDLK  N L+D   + K++DFG+++      +    N +V
Sbjct: 109 E-MFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVV 159

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           G+  YM+PE +         D +S G ++ E + 
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.8 bits (210), Expect = 5e-19
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 27/207 (13%)

Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G L+D  GQ+I  A+K L++ +    VE F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 81  GCSL-QKGERLLVYEYLPNKSLDFFIFDSSK----KELLDWKKRFNIIEGIVQGLLYLHK 135
           G  L  +G  L+V  Y+ +  L  FI   +     K+L+ +  +      + +G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ------VAKGMEYL-- 114

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMS 190
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N    T       +M+
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH---TGAKLPVKWMA 170

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            E +     + KSDV+SFGVL+ E+++
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.3 bits (211), Expect = 6e-19
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 31/282 (10%)

Query: 26  LGQGGFGPV----YKGKLLD-GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRL 79
           LG+G FG V    Y       G+ +A+K L +  GQ     +K E  ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            GC  ++G +   L+ EY+P  SL     D   K  L+  +     + I +G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL-----EANTNRIVGTHGYMSPE 192
               IHRDL A N+LLD+    KI DFG+A+            E   + +     + + E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVE 180

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIIS---SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
            +     S  SDV+SFGV + E+++   SK++      ++   ++G         + +EL
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQS----PPKKFEEMIGPKQGQMTVVRLIEL 236

Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           ++  +   C  +       +   C + +A  RPT   +  +L
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.4 bits (209), Expect = 7e-19
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 18/222 (8%)

Query: 19  NFSPGNRLGQGGFGP--VYK----GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ 72
           ++ P   LG+G FG   +Y+      L+  +E+ + RLS+       +  NE  +++ LQ
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQ 57

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H N++      +     L+  EY    +L +      K +L + +     +  IV  + Y
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           +HK     ++HRD+K  NI L      K+ DFG+++  G     A T  +VGT  YMSPE
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPE 171

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
                  + KSD+++ G ++ E+++ K+    +D    LNLV
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRT---FDATNPLNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.1 bits (210), Expect = 7e-19
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 29/216 (13%)

Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +        D   +A+K L  +S     +F  EA+L+  LQH ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFI----------FDSSKKELLDWKKRFNIIEGIVQG 129
            G  ++    ++V+EY+ +  L+ F+           + ++   L   +  +I + I  G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-- 187
           ++YL   +    +HRDL   N L+ + +  KI DFGM+R     ++ +     VG H   
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYSTDYYRVGGHTML 184

Query: 188 ---YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK 220
              +M PE +M    + +SDV+S GV++ EI +  K
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 84.7 bits (209), Expect = 8e-19
 Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 15/207 (7%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLDG---QEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 75
           F+   R+G+G FG V+KG  +D    Q +AIK +     +  +E  + E  ++++     
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           + +  G  L+  +  ++ EYL   S      D  +    D  +   +++ I++GL YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +   IHRD+KA+N+LL +Q + K++DFG+A      +++ NT   VGT  +M+PE + 
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNN 222
                 K+D++S G+  +E+   +  N
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 83.8 bits (207), Expect = 1e-18
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 23/203 (11%)

Query: 25  RLGQGGFGPVY--KGKLLDGQE-------IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
           RLG+G FG VY  K K    +E       I +  L+ +     V+   EA+L++KL H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF---NIIEGIVQGLLY 132
           +V+     L++    ++ EY   + LD  +     +EL    K      + E  +Q LL 
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKL-----EELKHTGKTLSENQVCEWFIQLLLG 118

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           +H   + R++HRDLKA NI L + +  KI DFG++R   M   +  T    GT  YMSPE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATT-FTGTPYYMSPE 175

Query: 193 YVMNGIVSMKSDVYSFGVLVLEI 215
            + +     KSD++S G ++ E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 42/208 (20%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKL 71
              ++    +LG+G FG VYK  ++  G+ +A+K++   ++  G  I   + E K++ KL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLD-------FFIFDSSKKELLDWKKRFN--- 121
           +H N+V L+          +  E                   D     LL+         
Sbjct: 65  KHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTE 114

Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF------ 170
                 +  +++G+ YLH+     ++HRD+KA+NIL+D+Q   KI+DFG+AR +      
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 171 ---GMNELEANTNRIVGTHGYMSPEYVM 195
              G          +V T  Y  PE ++
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLL 199

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 17/211 (8%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQ 72
           N+  G  LGQG FG VY     D G+E+A+K++     S  + + +   + E +L+  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 73  HTNLVRLLGCSLQKGERLL--VYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           H  +V+  GC     ER L    E++P  S+ D      +  E +  K    I+EG+   
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV--- 119

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGY 188
             YLH      ++HRD+K +NIL D   N K+ DFG ++      L       + GT  +
Sbjct: 120 -SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           MSPE +       K+D++S G  V+E+++ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 19/207 (9%)

Query: 20  FSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSG-QGIVEFK-NEAKLIAKLQ---H 73
           +     +G+G +G VYK + L  G+ +A+K++      +GI      E  L+ +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 74  TNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
            N+VRLL  C   + +R     LV+E++ ++ L  ++    K  L     + +++  +++
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           G+ +LH +   R++HRDLK  NIL+      KI+DFG+AR +      A T+ +V T  Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTS-VVVTLWY 172

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEI 215
            +PE ++    +   D++S G +  E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 69/200 (34%), Positives = 99/200 (49%), Gaps = 21/200 (10%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN-EAKLIAK------LQHTNLV 77
           LG+G FG V   +L    E  AIK L K     ++E  + E  ++ +       +H  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDV---VLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 78  RLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
            L  C+ Q  E L  V EYL    L F I  S + +    + RF   E I+ GL +LHK 
Sbjct: 60  HLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARFYAAE-IICGLQFLHKK 115

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               +I+RDLK  N+LLD   + KI+DFGM +   MN  E   +   GT  Y++PE +  
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMN-GEGKASTFCGTPDYIAPEILKG 170

Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +   D +SFGVL+ E++
Sbjct: 171 QKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)

Query: 26  LGQGGFGPVY------KGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LG+GGFG V        GKL   +++  KRL K  G +G +    E +++AK+ H+  + 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV---EKRILAKV-HSRFIV 56

Query: 79  LLGCSLQ-KGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            L  + Q K +  LV   +    L + I+  D       + +  F   + I+ GL +LH+
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-IISGLEHLHQ 115

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R+I+RDLK  N+LLD+  N +ISD G+A    + + ++ T    GT G+M+PE + 
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
                   D ++ GV + E+I+++
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 52/172 (30%), Positives = 88/172 (51%), Gaps = 12/172 (6%)

Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRL-SKSSGQGI-VEFKNEAKLIAKLQHTNLVRLLG 81
           R+G+G  G V+K K  + G+ +A+K++  +    GI  +   E K +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
                G    LV EY+P+  L   + D  +       K +  +  +++G+ Y+H      
Sbjct: 67  VFP-HGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NG 119

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           ++HRDLK +N+L+      KI+DFG+AR F   E    +++ V T  Y +PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.0 bits (205), Expect = 3e-18
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 40/280 (14%)

Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V +G+L L G+    +AIK L S  + +   +F +EA ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE------GIVQGLLYLH 134
           G   +    +++ E++ N +LD F+  +          +F +I+      GI  G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL- 122

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSP 191
             S +  +HRDL A NIL++  +  K+SDFG++R    +  +      +G      + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +     +  SDV+S+G+++ E++S          ER        W + N+   +  I+
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYG--------ERPY------WDMSNQ-DVINAIE 225

Query: 252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                    D  T    + L C Q     RP    + S L
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 21/200 (10%)

Query: 24  NRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
            R+G G +G VYK + +   E+ AIK +    G      + E  ++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG- 67

Query: 83  SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  + ++L +V EY    SL   I+  ++  L + +  + +    ++GL YLH+      
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAY-VCRETLKGLAYLHE---TGK 122

Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYV--- 194
           IHRD+K +NILL +  + K++DFG++     T       A     +GT  +M+PE     
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATI------AKRKSFIGTPYWMAPEVAAVE 176

Query: 195 MNGIVSMKSDVYSFGVLVLE 214
             G    K D+++ G+  +E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +        D   +A+K L   +     +F+ EA+L+  LQH ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFF----------IFDSSKKEL---LDWKKRFNIIEGI 126
            G        ++V+EY+ +  L+ F          + D   ++    L   +  +I   I
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
             G++YL   +    +HRDL   N L+   +  KI DFGM+R     ++ +     VG H
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGGH 184

Query: 187 G-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK 220
                 +M PE +M    + +SDV+SFGV++ EI +  K
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QH 73
            T  F     +G+G +G VYK +    GQ +AIK +         E K E  ++ K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNH 62

Query: 74  TNLVRLLGCSLQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------ 121
            N+    G  ++K          LV E     S    + D  K  L    KR        
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKG-LRKKGKRLKEEWIAY 117

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           I+   ++GL YLH+    +VIHRD+K  NILL      K+ DFG++    ++      N 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172

Query: 182 IVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLE 214
            +GT  +M+PE +      +     +SDV+S G+  +E
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 36/211 (17%)

Query: 25  RLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN--------EAKLIAKLQ-HT 74
           +LG G FG VY  +  +  E+ AIK++ K       +F +        E K + KL  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHP 58

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+L     +  E   V+EY+   +L + +    K +        +II  I+QGL ++H
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 135 K--YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN---TNRIVGTHGYM 189
           K  +      HRDLK  N+L+      KI+DFG+AR     E+ +    T+  V T  Y 
Sbjct: 117 KHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYR 165

Query: 190 SPEYVM-NGIVSMKSDVYSFGVLVLEIISSK 219
           +PE ++ +   S   D+++ G ++ E+ + +
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N S G  LG G FG V +       K     ++A+K L  ++     E   +E K+++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           L  H N+V LLG     G  L++ EY     L  F+    ++  L  +   +    + +G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-- 187
           + +L   +    IHRDL A N+LL      KI DFG+AR   MN+    +N +V  +   
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDI-MND----SNYVVKGNARL 205

Query: 188 ---YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
              +M+PE + N + + +SDV+S+G+L+ EI S
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 82.3 bits (203), Expect = 7e-18
 Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 28/218 (12%)

Query: 25  RLGQGGFGPVY----KGKL---------LDGQE--IAIKRL-SKSSGQGIVEFKNEAKLI 68
           +LG+G FG V+    +G            DGQ   +A+K L +  +     +F  E K++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGI-V 127
           ++L++ N++RLLG  +      ++ EY+ N  L+ F+   S++E+       N I  + +
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128

Query: 128 QGLLYLH-------KY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             LLY+        KY + L  +HRDL   N L+ +    KI+DFGM+R     +     
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            R V    +M+ E ++ G  +  SDV++FGV + E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 41/209 (19%)

Query: 26  LGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE------FKNEAKLIAKLQHTNLVR 78
           LG GGFG V   K+    +  A+K + K     IVE        +E +++ +  H  +V+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRH---IVETGQQEHIFSEKEILEECNHPFIVK 57

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK-KELLD----------WKKRFNIIEGIV 127
           L             Y    +K   + + +     EL            +  RF  I  +V
Sbjct: 58  L-------------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVV 103

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH      +I+RDLK  N+LLD     K+ DFG A+     +    T    GT  
Sbjct: 104 LAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           Y++PE ++N       D +S G+L+ E++
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (201), Expect = 7e-18
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRL-----SKSSGQGIVEFKNEAKLIAKLQ 72
           N+  G  LG+G FG VY     D G+E+A+K++     S+ + + +   + E +L+  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 73  HTNLVRLLGCSLQKGERLL--VYEYLPNKSLDFFIFDSSKKE-LLDWKKRFNIIEGIVQG 129
           H  +V+  GC     E+ L    EY+P  S    I D  K    L           I+QG
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQG 118

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR---TFGMNELEANTNRIVGTH 186
           + YLH      ++HRD+K +NIL D   N K+ DFG ++   T  M+        + GT 
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS--GTGIKSVTGTP 173

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +MSPE +       K+DV+S    V+E+++ K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.9 bits (202), Expect = 8e-18
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 10/193 (5%)

Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++GQG  G VY    +  GQE+AIK+++           NE  ++ + +H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V EYL   SL     D   +  +D  +   +    +Q L +LH     +VIH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ NILL    + K++DFG        + + +T  +VGT  +M+PE V       K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196

Query: 204 DVYSFGVLVLEII 216
           D++S G++ +E++
Sbjct: 197 DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.7 bits (202), Expect = 9e-18
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRL-SKSSGQGIVEFKNEA---KL 67
           D  + G  LG+G FG V K + +          +A+K L   ++ + + +  +E    K+
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-- 125
           I K  H N++ LLG   Q+G   +V EY  + +L  F+                  E   
Sbjct: 72  IGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 126 -----------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                      + +G+ +L   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 130 TQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 62/202 (30%), Positives = 112/202 (55%), Gaps = 20/202 (9%)

Query: 26  LGQGGFGPVYKGKLL-DGQEI----AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  + +G+++    AIK L + +S +   E  +EA ++A + + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSK----KELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L + + +P   L  ++ +       + LL+W  +      I +G+ YL +
Sbjct: 75  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G +E E +         +M+ E ++
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
           + I + +SDV+S+GV V E+++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 70/274 (25%), Positives = 129/274 (47%), Gaps = 27/274 (9%)

Query: 24  NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG- 81
           N + +G  G  YKGK + +G +  +K ++  +     E  +    + KLQH N+V+L+G 
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGL 751

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           C  +KG   L++EY+  K+L      S     L W++R  I  GI + L +LH      V
Sbjct: 752 CRSEKGA-YLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAV 804

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           +  +L    I++D +  P +          +  L     +   +  Y++PE      ++ 
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857

Query: 202 KSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVGYAWQLWNEGKALELIDTTL--HES 257
           KSD+Y FG++++E+++ K      D E   H ++V +A   +++      ID ++    S
Sbjct: 858 KSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914

Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
            + +E+   +++ L C     T RP  +DV   L
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 69/213 (32%), Positives = 117/213 (54%), Gaps = 24/213 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           D +    ++G+G +G VYK +  +  + IA+K++  +   +G+      E  L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 75  NLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIF-DSSKKELLDWKKRFNIIEG----IVQ 128
           N+VRL    +   +RL LV+EYL    LD     DSS     D+ K   +I+     I++
Sbjct: 62  NIVRLQDV-VHSEKRLYLVFEYL---DLDLKKHMDSSP----DFAKNPRLIKTYLYQILR 113

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVGTHG 187
           G+ Y H +   RV+HRDLK  N+L+D + N  K++DFG+AR FG+  +   T+ +V T  
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLW 168

Query: 188 YMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSK 219
           Y +PE ++     S   D++S G +  E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 49/232 (21%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN--------------EAKL 67
           G  LG+G +G V K    L G+ +AIK++        V                  E K+
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------ 121
           + +++H N++ L+   ++     LV + +           S  K+++D K R        
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKC 123

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG---------- 171
           I+  I+ GL  LHK+     +HRDL  +NI ++ +   KI+DFG+AR +G          
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 172 ---MNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSK 219
              M   E  T+++V T  Y +PE +M         D++S G +  E+++ K
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 21/197 (10%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +G+G FG V  G    G ++A+K + + ++ Q    F  EA ++ +L+H+NLV+LLG  +
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 85  Q-KGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + KG   +V EY+   SL D+    S  + +L           + + + YL   +    +
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
           HRDL A N+L+ +    K+SDFG+ +       EA++ +  G     + +PE +     S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 177

Query: 201 MKSDVYSFGVLVLEIIS 217
            KSDV+SFG+L+ EI S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 11/198 (5%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           F+   ++G+G FG V+KG     Q++ AIK +     +  +E  + E  ++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +  G  L+  +  ++ EYL   S      D  +   LD  +   I+  I++GL YLH   
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
           +   IHRD+KA+N+LL +    K++DFG+A    + + +   N  VGT  +M+PE +   
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 198 IVSMKSDVYSFGVLVLEI 215
               K+D++S G+  +E+
Sbjct: 177 AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 39/94 (41%), Positives = 62/94 (65%), Gaps = 6/94 (6%)

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           I   +V+GL YL  Y+  R++HRD+K SNIL++ +   K+ DFG++    +N + A+T  
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSI-ADT-- 161

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
            VGT  YMSPE +  G  ++KSDV+S G+ ++E+
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 26  LGQGGFGPV------YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   +++  KR+ K  G+ +    NE +++ K+    +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K    LV   +    L F I+   +    + +  F   E I  GL  LH   + 
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLH---QE 121

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           R+++RDLK  NILLDD  + +ISD G+A    + E +    R VGT GYM+PE V N   
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERY 178

Query: 200 SMKSDVYSFGVLVLEIISSK 219
           +   D ++ G L+ E+I+ +
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 26  LGQGGFGPV------YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   +++  KR+ K  G+ +    NE +++ K+    +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K    LV   +    L F I++       + +  F   E I  GL  LH   R 
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLH---RE 121

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           R+++RDLK  NILLDD  + +ISD G+A      E        VGT GYM+PE V N   
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVVKNERY 178

Query: 200 SMKSDVYSFGVLVLEIISSK 219
           +   D +  G L+ E+I  K
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 63/202 (31%), Positives = 112/202 (55%), Gaps = 20/202 (9%)

Query: 26  LGQGGFGPVYKGKLL-DGQEI----AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  + DG+ +    AIK L + +S +   E  +EA ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L V + +P   L  ++ ++      ++LL+W  +      I +G+ YL +
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              +R++HRDL A N+L+    + KI+DFG+AR   ++E E + +       +M+ E ++
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
           +   + +SDV+S+GV V E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 55/196 (28%), Positives = 104/196 (53%), Gaps = 13/196 (6%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG G FG VYK +  + G   A K +   S + + +F  E  ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
            + +  ++ E+    +LD  I    ++ L + + R+ +   +++ L +LH +   +VIHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127

Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIV 199
           DLKA NILL    + K++DFG++     + L+   +  +GT  +M+PE V      +   
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKR-DTFIGTPYWMAPEVVACETFKDNPY 185

Query: 200 SMKSDVYSFGVLVLEI 215
             K+D++S G+ ++E+
Sbjct: 186 DYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 79.6 bits (196), Expect = 5e-17
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 15/200 (7%)

Query: 26  LGQGGFGPV------YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   +++  KRL K SG+ +     E +++ K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL--EKEILEKVNSPFIVNL 58

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K    LV   +    L + I++  ++ L + ++  +    I  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +++RD+K  N+LLDDQ N ++SD G+A    + + +  T R  GT+GYM+PE +     
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEPY 171

Query: 200 SMKSDVYSFGVLVLEIISSK 219
           S   D ++ G  + E+++ +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.8 bits (196), Expect = 6e-17
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 10/209 (4%)

Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK 70
           +I      ++   ++GQG  G V+    +  GQE+AIK+++           NE  ++ +
Sbjct: 13  SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           L++ N+V  L   L   E  +V EYL   SL     D   +  +D  +   +    +Q L
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
            +LH     +VIHRD+K+ N+LL    + K++DFG        + + +T  +VGT  +M+
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           PE V       K D++S G++ +E++  +
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 79.2 bits (195), Expect = 7e-17
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 17/206 (8%)

Query: 26  LGQGGFGPVYKG---KLLDGQ---EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G    ++ G+    +A+K +++S S +  +EF NEA ++      ++VR
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E + +G+ +  SD++SFGV++ EI S
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.9 bits (197), Expect = 8e-17
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)

Query: 12  TIAAATDNFSP---GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGI-VEFKNEAK 66
           +  +A  + S     NR+G G  G VYK      G+  A+K +  +    +  +   E +
Sbjct: 65  SAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE 124

Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLD-FFIFDSSKKELLDWKKRFNIIEG 125
           ++  + H N+V+        GE  ++ E++   SL+   I D  ++ L D  ++      
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD--EQFLADVARQ------ 176

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           I+ G+ YLH   R  ++HRD+K SN+L++   N KI+DFG++R   + +     N  VGT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGT 231

Query: 186 HGYMSPEYVMNGIVSMK-----SDVYSFGVLVLE 214
             YMSPE +   +          D++S GV +LE
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 78.9 bits (194), Expect = 9e-17
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 26  LGQGGFGPV------YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   +++  KR+ K  G+ +    NE +++ K+    +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K    LV   +    L F I++       + +  F   E +  GL  L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           R+++RDLK  NILLDD+ + +ISD G+A    + E E    R VGT GYM+PE + N   
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQ--IPEGETVRGR-VGTVGYMAPEVINNEKY 178

Query: 200 SMKSDVYSFGVLVLEII 216
           +   D +  G L+ E+I
Sbjct: 179 TFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 39/196 (19%)

Query: 24  NRLGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
            ++GQG FG V+K +     Q +A+K++   ++  G  I   + E K++  L+H N+V L
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76

Query: 80  L--------GCSLQKGERLLVYEY--------LPNKSLDFFIFDSSKKELLDWKKRFNII 123
           +          +  KG   LV+E+        L NK++ F         L + KK   ++
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF--------TLSEIKK---VM 125

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN---TN 180
           + ++ GL Y+H   R +++HRD+KA+NIL+      K++DFG+AR F +++       TN
Sbjct: 126 KMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182

Query: 181 RIVGTHGYMSPEYVMN 196
           R+V T  Y  PE ++ 
Sbjct: 183 RVV-TLWYRPPELLLG 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 20/202 (9%)

Query: 26  LGQGGFGPVYKGKLL-DGQEI----AIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG V+KG  + +G  I    AIK +   SG Q   E  +    +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 80  LG-C---SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG C   SLQ     LV +  P  SL   +     ++ LD ++  N    I +G+ YL +
Sbjct: 75  LGICPGASLQ-----LVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEE 127

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
           +   R++HR+L A NILL      +I+DFG+A     ++ +   +       +M+ E ++
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
            G  + +SDV+S+GV V E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 13/196 (6%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG G FG VYK K  + G   A K +   S + + ++  E +++A   H  +V+LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
             G+  ++ E+ P  ++D  + +  +   L   +   I   +++ L YLH    +++IHR
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIHR 134

Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIV 199
           DLKA N+LL    + K++DFG++    +  L+   +  +GT  +M+PE VM     +   
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQ-RRDSFIGTPYWMAPEVVMCETMKDTPY 192

Query: 200 SMKSDVYSFGVLVLEI 215
             K+D++S G+ ++E+
Sbjct: 193 DYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)

Query: 26  LGQGGFGPVYKGKLL-DG--QEIAIKRLSKSSGQGI-VEFKNEAKLIAKL-QHTNLVRLL 80
           +G+G FG V K ++  DG   + AIKR+ + + +    +F  E +++ KL  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 81  GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
           G    +G   L  EY P+ +L DF            F   +S    L  ++  +    + 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +G+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R       E    + +G   
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 186

Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M+ E +   + +  SDV+S+GVL+ EI+S
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 33/226 (14%)

Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLDG-----QEIAIKRLSKSSGQGIVE-FKNEAK 66
           IA + D  +  + L +G FG ++ G L+D      +E+ +K +   + +  V     E+ 
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKS-LDFFIFDS-----------SKKELL 114
           L+  L H N++ +L   ++ GE   V     N   L  F+              S ++L+
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-TFGM- 172
               +      I  G+ YLHK     VIH+D+ A N ++D+++  KI+D  ++R  F M 
Sbjct: 121 HMAIQ------IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Query: 173 -NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            + L  N NR V    +M+ E ++N   S  SDV+SFGVL+ E+++
Sbjct: 172 YHCLGDNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 36/228 (15%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKL--LDGQE------IAIKRLSKSSGQGIVEFKNEAKLIA 69
           D    G  LG+G FG V + +   +D         +A+K L  ++       K+ A LI+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-----KDLADLIS 66

Query: 70  KLQ-------HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK- 110
           +++       H N++ LLG   Q+G   ++ EY    +L  F+           FD +K 
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 111 -KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
            +E L +K   +    + +G+ YL   SR R IHRDL A N+L+ +    KI+DFG+AR 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               +    T+       +M+PE + + + + +SDV+SFG+L+ EI +
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 61/206 (29%), Positives = 112/206 (54%), Gaps = 13/206 (6%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNL 76
           NF    +LG+G +  VYKG+    G+ +A+K +   + +G       E  L+ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           VRL      + + +LV+EY+ +K L  ++     +  LD     +    +++G+ + H+ 
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT--NRIVGTHGYMSPEYV 194
              RV+HRDLK  N+L++ +   K++DFG+AR FG   +  NT  N +V T  Y +P+ +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVL 172

Query: 195 MNGIVSMKS-DVYSFGVLVLEIISSK 219
           +       S D++S G ++ E+I+ +
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 34/217 (15%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEI-AIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            F   NR+G+G +G VY+ +     EI A+K  R+        +    E  L+  L+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLD--FFIFDSSKKE---LLDWKKR-FN------II 123
           +V L              E +  K LD  F + +  +++   LLD     F+      ++
Sbjct: 68  IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             +++GL YLH      +IHRDLK SN+LL D+   KI+DFG+ART+G+   +  T ++V
Sbjct: 115 LQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVV 170

Query: 184 GTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
            T  Y +PE ++       + D+++ G ++ E+++ K
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 3e-16
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 49/210 (23%)

Query: 28  QGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL---------- 76
           +G FG VY   K   G   AIK L KS             +IAK Q TN+          
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSD------------MIAKNQVTNVKAERAIMMIQ 53

Query: 77  -----VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGI 126
                V  L  S Q  + L LV EYL        I     K L     DW K++  I  +
Sbjct: 54  GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQY--IAEV 106

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
           V G+  LH+     +IHRD+K  N+L+D   + K++DFG++R    N+      + VGT 
Sbjct: 107 VLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTP 157

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
            Y++PE ++       SD +S G ++ E +
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.0 bits (189), Expect = 3e-16
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKR------LSKSSGQGIVEFKNEAKLIAKL 71
           NF    ++G+G F  VY+   LLD + +A+K+      +   + Q  V+   E  L+ +L
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD-----WKKRFNIIEGI 126
            H N+++ L   ++  E  +V E      L   I    K++ L      WK    +   +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
                  H +SR RV+HRD+K +N+ +      K+ D G+ R F      A++  +VGT 
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
            YMSPE +     + KSD++S G L+ E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 15/200 (7%)

Query: 26  LGQGGFGPV------YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   + +  KR+ K  G+ +    NE +++ K+    +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K    LV   +    L F I++       + +  F   E I+ GL  LH   R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLH---RE 121

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
             ++RDLK  NILLDD  + +ISD G+A    + E E+   R VGT GYM+PE + N   
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEVLNNQRY 178

Query: 200 SMKSDVYSFGVLVLEIISSK 219
           ++  D +  G L+ E+I  +
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 4e-16
 Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 10/196 (5%)

Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++GQG  G VY    +  GQE+AIK+++           NE  ++ + ++ N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V EYL   SL     D   +  +D  +   +    +Q L +LH     +VIH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ NILL    + K++DFG        + + +T  +VGT  +M+PE V       K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196

Query: 204 DVYSFGVLVLEIISSK 219
           D++S G++ +E++  +
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 76.5 bits (188), Expect = 4e-16
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 22/204 (10%)

Query: 26  LGQGGFGPVY--KGKLLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G+G FG +Y  K K  D +   IK   L+K   +     K E  L+AK++H N+V    
Sbjct: 8   IGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDS-----SKKELLDWKKRFNIIEGIVQGLLYLHKY 136
              + G   +V EY     L   I        S+ ++L W  +      I  GL ++H  
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIHDR 120

Query: 137 SRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              +++HRD+K+ NI L  + M  K+ DFG+AR   +N+        VGT  Y+SPE   
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQ 175

Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
           N   + K+D++S G ++ E+ + K
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 28/212 (13%)

Query: 26  LGQGGFGPVYKGKLL-DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
           +G+G FG V +  +  DG ++  AIK L + +S     +F  E +++ KL  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 81  GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
           G    +G   +  EY P  +L DF            F  +      L  ++       + 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G+ YL   S  + IHRDL A N+L+ + +  KI+DFG++R       E    + +G   
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-----EEVYVKKTMGRLP 181

Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M+ E +   + + KSDV+SFGVL+ EI+S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLLG 81
            +G+G +G V K +    G+ +AIK+  +S     V+     E K++ +L+H N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQGLLYLHKYSRLR 140
              +KG   LV+EY+    L+  + ++S   L  D  +    I  ++Q + Y H      
Sbjct: 68  AFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRS--YIWQLLQAIAYCH---SHN 120

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR----IVGTHGYMSPEYVMN 196
           +IHRD+K  NIL+ +    K+ DFG AR      L A         V T  Y +PE ++ 
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARA-----LRARPASPLTDYVATRWYRAPELLVG 175

Query: 197 GIVSMKS-DVYSFGVLVLEIIS 217
                K  DV++ G ++ E++ 
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.9 bits (189), Expect = 5e-16
 Identities = 69/197 (35%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 26  LGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL--QHTNLVRLL 80
           LG+G FG V+  +L    Q  AIK L K        VE     K +  L  +H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 81  GCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
            C+ Q  E L  V EYL    L F I    K +L   +  F   E I+ GL +LH     
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP--RATFYAAE-IICGLQFLHSKG-- 116

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +++RDLK  NILLD   + KI+DFGM +   +   +A T    GT  Y++PE ++    
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQKY 173

Query: 200 SMKSDVYSFGVLVLEII 216
           +   D +SFGVL+ E++
Sbjct: 174 NTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.7 bits (188), Expect = 6e-16
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 10/196 (5%)

Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++GQG  G VY    +  GQE+AI++++           NE  ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V EYL   SL     D   +  +D  +   +    +Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ NILL    + K++DFG      +   ++  + +VGT  +M+PE V       K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 204 DVYSFGVLVLEIISSK 219
           D++S G++ +E+I  +
Sbjct: 198 DIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 43/230 (18%)

Query: 25  RLGQGGFGPVYKGKLLDGQE-----------------IAIKRL-SKSSGQGIVEFKNEAK 66
           +LG+G FG V+  ++++ Q+                 +A+K L   ++     +F  E K
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD----------- 115
           ++++L+  N++RLLG  + +    ++ EY+ N  L+ F+   S   L D           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 116 --------WKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 167
                   +    ++   I  G+ YL   S L  +HRDL   N L+ + +  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           R     +      R V    +M+ E ++ G  +  SDV++FGV + EI+ 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.8 bits (186), Expect = 9e-16
 Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 13/198 (6%)

Query: 26  LGQGGFGPVYKG--KLLDGQ-EIAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRLLG 81
           LG G FG V KG  K+   Q ++AIK L   + + +  E   EA+++ +L +  +VR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +    +LV E      L+ F+  S KK+ +       ++  +  G+ YL   +    
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---F 116

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIV 199
           +HRDL A N+LL +Q   KISDFG+++  G ++      R  G     + +PE +     
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRKF 175

Query: 200 SMKSDVYSFGVLVLEIIS 217
           S +SDV+S+G+ + E  S
Sbjct: 176 SSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 55/212 (25%), Positives = 109/212 (51%), Gaps = 20/212 (9%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLD--GQEIAIKRL---SKSSGQGIVEFKNEAKL--IAKLQ 72
           +     +G+G +G V+K + L   G+ +A+KR+   +   G  +   +  A L  +   +
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 73  HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           H N+VRL   C++ + +R     LV+E++ ++ L  ++ D   +  +  +   +++  ++
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +GL +LH +   RV+HRDLK  NIL+      K++DFG+AR +     +     +V T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y +PE ++    +   D++S G +  E+   K
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 10/202 (4%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHT 74
           NF    ++G+G F  VY+   LLDG  +A+K++        +   +   E  L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYL 133
           N+++     ++  E  +V E      L   I    K K L+  K  +     +   L ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H  SR RV+HRD+K +N+ +      K+ D G+ R F      A++  +VGT  YMSPE 
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     + KSD++S G L+ E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 37/223 (16%)

Query: 25  RLGQGGFGPVYKGKLLDGQEI--AIKRLSKSSGQ----------------GIVEFKNEAK 66
           +LG+G FG V+  +    Q+        + ++                     +F  E K
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI--------FDSSKKELLDWKK 118
           ++++L   N+ RLLG         ++ EY+ N  L+ F+          +   + L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 119 RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN 178
              +   I  G+ YL     L  +HRDL   N L+      KI+DFGM+R    N   ++
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184

Query: 179 TNRIVGTH----GYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             R+ G       +M+ E V+ G  + KSDV++FGV + EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 28/219 (12%)

Query: 23  GNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-Q 72
           G  LG+G FG V         K K      +A+K L   ++ + + +  +E +++  + +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELLDWKKR 119
           H N++ LLG   Q G   ++ EY    +L  ++           FD+ K  +E L +K  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-TFGMNELEAN 178
            +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR    ++  +  
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           TN  +    +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 194 TNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)

Query: 26  LGQGGFGPVYKGKL-----LDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V   +        G+++A+K L  +S G  I + K E +++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G   + G     L+ E+LP+ SL  ++     K  ++ K++      I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG--S 127

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN-ELEANTNRIVGTHGYMSPEYVMN 196
           R + +HRDL A N+L++ +   KI DFG+ +    + E     + +     + +PE ++ 
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 197 GIVSMKSDVYSFGVLVLEIIS 217
               + SDV+SFGV + E+++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 14/198 (7%)

Query: 26  LGQGGFGPVYKGKLL----DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
           LGQG FG V+  + +     GQ  A+K L K++   +  V  K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 +G+  L+ ++L  +  D F   S +    +   +F + E +   L +LH    L
Sbjct: 64  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLH---SL 117

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +I+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE V     
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 175

Query: 200 SMKSDVYSFGVLVLEIIS 217
           +  +D +SFGVL+ E+++
Sbjct: 176 TQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 14/197 (7%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNLVRLLGC 82
           +G+G +G V K K  + GQ +AIK+  +S    +V+     E +++ +L+H NLV L+  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
             +K    LV+E++ +  LD    D  K    LD  +    +  I++G+ + H ++   +
Sbjct: 69  FRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           IHRD+K  NIL+      K+ DFG ART      E  T+  V T  Y +PE ++      
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKYG 179

Query: 202 KS-DVYSFGVLVLEIIS 217
           ++ D+++ G LV E+++
Sbjct: 180 RAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEI---AIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           G  LG+G FG V +G+L     I   A+K  +++  +   + +F +EA  + +  H N++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 78  RLLGCSLQKGER------LLVYEYLPNKSLDFFIFDS---SKKELLDWKKRFNIIEGIVQ 128
           RL+G  LQ  E       +++  ++ +  L  F+  S      + L  +     +  I  
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-G 187
           G+ YL   S    IHRDL A N +L++ MN  ++DFG+++    N       RI      
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVK 179

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
           +++ E + + + + KSDV+SFGV + EI
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 59/223 (26%), Positives = 109/223 (48%), Gaps = 26/223 (11%)

Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLS-KSSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++   E +
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 71/296 (23%), Positives = 131/296 (44%), Gaps = 40/296 (13%)

Query: 25  RLGQGGFGPVY------------KGKLLDGQE-----IAIKRLSKSSGQGIV-EFKNEAK 66
           +LG+G FG V+            K   LD        +A+K L + + +    +F  E K
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI--------FDSSKKELLDWKK 118
           ++++L+  N++RLL   +      ++ EY+ N  L+ F+         + +    + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 119 RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN 178
              +   I  G+ YL   S L  +HRDL   N L+      KI+DFGM+R     +    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN--GCYDTERHLNLVGY 236
             R V    +MS E ++ G  +  SDV++FGV + EI++  K         E+ +   G 
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248

Query: 237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
            ++  ++G+ + L       +  PD + + +   L C +  A +RP+  ++ + L 
Sbjct: 249 FFR--DQGRQVYL----PKPALCPDSLYKLM---LSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 28/213 (13%)

Query: 27  GQGGFGPVYKGKLL---DGQEIAIKRL--SKSSGQGIVEFK-NEAKLIAKLQHTNLVRLL 80
           G+G +G VYK K     DG+E AIK+    K    GI +    E  L+ +L+H N+V L+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 81  GCSLQKGERL--LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQGLLY 132
              L+  ++   L+++Y  +       F    K     +          ++  I+ G+ Y
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-----RVSIPPSMVKSLLWQILNGVHY 123

Query: 133 LHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTF-GMNELEANTNRIVGTHG 187
           LH      V+HRDLK +NIL+     ++   KI D G+AR F    +  A+ + +V T  
Sbjct: 124 LHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 188 YMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
           Y +PE ++      K+ D+++ G +  E+++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 21/200 (10%)

Query: 26  LGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKN-------EAKLIAKLQHTNLV 77
           LG+G FG V   +L   G+  A+K L K     +V   +       E +++A       +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKD----VVLIDDDVECTMVEKRVLALAWENPFL 58

Query: 78  RLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             L C+ Q  E L  V E+L    L F I D  + +L  ++  F   E IV GL +LH  
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAE-IVCGLQFLHSK 115

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               +I+RDLK  N++LD   + KI+DFGM +     +  A+T    GT  Y++PE +  
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQG 170

Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +   D +SFGVL+ E++
Sbjct: 171 LKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 48/151 (31%), Positives = 85/151 (56%), Gaps = 9/151 (5%)

Query: 25  RLGQGGFGPVYKGKLLDGQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLG 81
           ++G+G +G V+K K  +  EI A+KR+      +G+      E  L+ +L+H N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                 +  LV+EY  ++ L  + FDS   ++ D +   + +  +++GL + H +    V
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGM 172
           +HRDLK  N+L++     K++DFG+AR FG+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 14/196 (7%)

Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           R+G G +G VYK   L  G+  A+K +    G      + E  ++ + +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 84  LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           L + +  +  EY    SL D +       EL    +   +    +QGL YLH   ++   
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAYLHSKGKM--- 128

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---NGIV 199
           HRD+K +NILL D  + K++DFG+A    +    A     +GT  +M+PE      NG  
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 200 SMKSDVYSFGVLVLEI 215
           +   D+++ G+  +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 40/154 (25%), Positives = 76/154 (49%), Gaps = 9/154 (5%)

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           EA L+  + H +++R+    +      +V   LP+ S D + + + +   L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
           + I++GL YLH     R+IHRD+K  NI ++D     I D G A+      +      + 
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLA 217

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           GT    +PE +     + K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.0 bits (181), Expect = 4e-15
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 28/212 (13%)

Query: 26  LGQGGFGPVYKGKLL-DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
           +G+G FG V K ++  DG  +  AIKR+ + +S     +F  E +++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 81  GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
           G    +G   L  EY P+ +L DF            F   +S    L  ++  +    + 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +G+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R       E    + +G   
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 174

Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M+ E +   + +  SDV+S+GVL+ EI+S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.6 bits (180), Expect = 5e-15
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 18/202 (8%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSL 84
           +G G +G VYKG+ +   ++A  ++   +G    E K E  ++ K   H N+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 85  QKG------ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
           +K       +  LV E+    S+   I  ++K   L  +    I   I++GL +LH++  
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM--- 195
            +VIHRD+K  N+LL +    K+ DFG++    ++      N  +GT  +M+PE +    
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 196 --NGIVSMKSDVYSFGVLVLEI 215
             +     KSD++S G+  +E+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 26/225 (11%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGKL--LDGQE------IAIKRL-SKSSGQGIVEFKNEAK 66
             D    G  LG+G FG V   +   LD ++      +A+K L S ++ + + +  +E +
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75

Query: 67  LIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKE 112
           ++  + +H N++ LLG   Q G   ++ EY    +L  ++                  +E
Sbjct: 76  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135

Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
            L +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR    
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192

Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +    T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 27/219 (12%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQH 73
           D F    ++G+G +G VYK +  D G+ +A+K++   ++  G  I   + E K++ +L H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65

Query: 74  TNLVRL----------LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN-- 121
            N+V L          L     KG   LV+EY+     D  +    +  L+ + +     
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKS 120

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
            ++ +++GL Y HK + L   HRD+K SNILL+++   K++DFG+AR +   E    TN+
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 182 IVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIISSK 219
           ++ T  Y  PE ++         DV+S G ++ E+ + K
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 23/203 (11%)

Query: 26  LGQGGFGPVYKG--KLLDGQE-IAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  K+   ++ +A+K L   +    +  E   EA ++ +L +  +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 81  GCSLQKGER-LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G  + + E  +LV E      L+ F+    K + +  K    ++  +  G+ YL + +  
Sbjct: 63  G--ICEAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSPEYV 194
             +HRDL A N+LL  Q   KISDFG+++  G +E   N  +   THG     + +PE +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYK-AKTHGKWPVKWYAPECM 170

Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                S KSDV+SFGVL+ E  S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 36/219 (16%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRL---SKSSGQGIVEFKNEAKLIAKLQH 73
           D +   NR+ +G +G VY+ +     EI A+K+L    +  G  I   + E  ++ KLQH
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 74  TNLVRL----LGCSLQKGERLLVYEYLPN--KSLDFFIFDSSKKELLDWKKRFNIIE--G 125
            N+V +    +G +L K    +V EY+ +  KSL           +   K+ F   E   
Sbjct: 64  PNIVTVKEVVVGSNLDK--IYMVMEYVEHDLKSL-----------METMKQPFLQSEVKC 110

Query: 126 IVQGLL----YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           ++  LL    +LH      ++HRDLK SN+LL+++   KI DFG+AR +G   L+  T +
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYT-Q 165

Query: 182 IVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           +V T  Y +PE ++     S   D++S G +  E+++ K
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.2 bits (177), Expect = 1e-14
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 25  RLGQGGFGPVYKGKLL----DGQEIAIKRL--SKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           ++G+G FG   K  L+    DG++  IK +  SK S +   E + E  +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS-----SKKELLDWKKRFNIIEGIVQGLLYL 133
                 + G   +V +Y     L   I         + ++LDW          VQ  L L
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---------FVQICLAL 114

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
                 +++HRD+K+ NI L      K+ DFG+AR        A T   +GT  Y+SPE 
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
             N   + KSD+++ G ++ E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 14/203 (6%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           ++F    R+G G +G VYK + ++ G+  AIK +    G+     + E  ++   +H+N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           V   G  L++ +  +  E+    SL D +       E     +   +    +QGL YLH 
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES----QIAYVSRETLQGLYYLHS 124

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +   +HRD+K +NILL D  + K++DFG++    +    A     +GT  +M+PE   
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEVAA 179

Query: 196 ---NGIVSMKSDVYSFGVLVLEI 215
               G  +   D+++ G+  +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN------EAKLIAKLQHTNLVR 78
           LG+G FG V   +L    E+ AIK L K     I++  +      E +++A       + 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDV---ILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 79  LLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            L C  Q  +RL  V EY+    L F I  S K +  + + RF   E +   L++LH++ 
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD--EPRSRFYAAE-VTLALMFLHRHG 116

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
              VI+RDLK  NILLD + + K++DFGM +  G+      T    GT  Y++PE +   
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQEL 171

Query: 198 IVSMKSDVYSFGVLVLEIISSK 219
                 D ++ GVL+ E+++ +
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 52/225 (23%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT-- 74
           D+      LG+G +G V K + +  G  +A+KR+  +     V  + + +L+  L  +  
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-----VNSQEQKRLLMDLDISMR 55

Query: 75  -----NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF------NII 123
                  V   G   ++G+  +  E + + SLD F      K++ D            I 
Sbjct: 56  SVDCPYTVTFYGALFREGDVWICME-VMDTSLDKFY-----KKVYDKGLTIPEDILGKIA 109

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG--------MARTFGMNEL 175
             IV+ L YLH  S+L VIHRD+K SN+L++     K+ DFG        +A+T      
Sbjct: 110 VSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID---- 163

Query: 176 EANTNRIVGTHGYMSPEYVMNGIVSM-----KSDVYSFGVLVLEI 215
                   G   YM+PE + N  ++      KSDV+S G+ ++E+
Sbjct: 164 -------AGCKPYMAPERI-NPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKR-LSKSSGQGIVEFK-NEAKLIAKLQHT 74
           D +    ++G+G +G VYK +    G+ +A+K+   +   +GI      E  L+  L  +
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 75  N-LVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKEL---LDWKKRFNIIEG 125
             +VRLL          K    LV+EYL +  L  F+ DS+ +     L  K   + +  
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQ 118

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVG 184
           +++G+ + HK+    V+HRDLK  N+L+D Q    KI+D G+ R F +  +++ T+ IV 
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV- 173

Query: 185 THGYMSPEYVMNGI-VSMKSDVYSFGVLVLEII 216
           T  Y +PE ++     S   D++S G +  E+ 
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 20  FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQ---H 73
           + P   +G G +G VYK +    G  +A+K +   + +  +      E  L+ +L+   H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 74  TNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
            N+VRL+  C+  + +R     LV+E++ ++ L  ++ D      L  +   +++   ++
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLR 119

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           GL +LH      ++HRDLK  NIL+      K++DFG+AR +     +     +V T  Y
Sbjct: 120 GLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWY 173

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +PE ++    +   D++S G +  E+   K
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 19/212 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLLG 81
           G ++G+G +G VYK K  DG++     L +  G GI +    E  L+ +L+H N++ L  
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65

Query: 82  CSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY-----LH 134
             L   +R   L+++Y  +       F  + K     KK   +  G+V+ LLY     +H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 122

Query: 135 KYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTFG--MNELEANTNRIVGTHGY 188
                 V+HRDLK +NIL+     ++   KI+D G AR F   +  L A+ + +V T  Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTFWY 181

Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
            +PE ++      K+ D+++ G +  E+++S+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQ--HTNLVRLL 80
           LG+G FG V   +L    E+ A+K L K        VE     K +  L   H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 81  GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
            C  Q  +RL  V EY+    L F I  S +    + + RF   E IV GL +LH+    
Sbjct: 63  SC-FQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAE-IVLGLQFLHERG-- 116

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +I+RDLK  N+LLD + + KI+DFGM +  G+      T+   GT  Y++PE +     
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILG-GVTTSTFCGTPDYIAPEILSYQPY 173

Query: 200 SMKSDVYSFGVLVLEII 216
               D ++ GVL+ E++
Sbjct: 174 GPAVDWWALGVLLYEML 190

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.5 bits (173), Expect = 6e-14
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKG--KLLDGQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQ 72
           ++ + G  +G+G FG VY+G     + ++I  A+K     +   + E F  EA ++ +  
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 73  HTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           H ++V+L+G  +       +V E  P   L  ++     K  LD          +   L 
Sbjct: 66  HPHIVKLIGVITENP--VWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALA 121

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL-EANTNRIVGTHGYMS 190
           YL      R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+
Sbjct: 122 YLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMA 176

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           PE +     +  SDV+ FGV + EI+ 
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 24/193 (12%)

Query: 42  GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL-VYEYLP 97
           G E+AIK L   + +       F+ E  L A+L H N+V LL         L  V+EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 98  NKSLDFFIFDSSKKELLDWKKRFNIIEG---IVQGLLYLHKYSRLRVIHRDLKASNILL- 153
            ++L         +E+L         E    ++Q L  L       ++HRDLK  NI++ 
Sbjct: 63  GRTL---------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113

Query: 154 --DDQMNPKISDFGMARTF-GMNELEAN----TNRIVGTHGYMSPEYVMNGIVSMKSDVY 206
               + + K+ DFG+     G+ + +      T  ++GT  Y +PE +    V+  SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 207 SFGVLVLEIISSK 219
           ++G++ LE ++ +
Sbjct: 174 AWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 50/172 (29%), Positives = 91/172 (52%), Gaps = 13/172 (7%)

Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK---NEAKLIAKLQHTNLVRLL 80
           ++G+G +G V+K +  + GQ +AIK+  +S    +++ K    E +++ +L+H NLV L+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALREIRMLKQLKHPNLVNLI 66

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
               +K +  LV+EY  +  L+    + + + + +   +  II   +Q + + HK++   
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLN--ELEKNPRGVPEHLIK-KIIWQTLQAVNFCHKHN--- 120

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            IHRD+K  NIL+  Q   K+ DFG AR   +     +    V T  Y +PE
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           +G+G FG V   K   DG+  A+K L K +    +  K E K        L+  ++H  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           V L   S Q  ++L  V +Y+    L F +    ++   + + RF   E I   L YLH 
Sbjct: 59  VGL-HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS 114

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              L +I+RDLK  NILLD Q +  ++DFG+ +  G+ E    T+   GT  Y++PE + 
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPEVLR 169

Query: 196 NGIVSMKSDVYSFGVLVLEIIS------SKKNNGCYD 226
                   D +  G ++ E++       S+     YD
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 9e-14
 Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 10/193 (5%)

Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++G+G  G V   +    G+++A+K +     Q      NE  ++   QH N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  ++ E+L   +L     D   +  L+ ++   + E ++Q L YLH      VIH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ +ILL      K+SDFG       +  +  +  +VGT  +M+PE +       + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198

Query: 204 DVYSFGVLVLEII 216
           D++S G++V+E++
Sbjct: 199 DIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 50/231 (21%)

Query: 10  FQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAK 66
           F T+   T+ +     +G G FG V   +  L GQ +AIK++ K     ++  +   E K
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 67  LIAKLQHTNLV-----------------RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSS 109
           L+  L+H N++                  LLG  L    RLL    L  + + +F++   
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQFIQYFLYQ-- 116

Query: 110 KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
                           I++GL Y+H      V+HRDLK SNIL+++  + KI DFG+AR 
Sbjct: 117 ----------------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
                 +      V T  Y +PE ++      ++ D++S G +  E++  K
Sbjct: 158 -----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 33/215 (15%)

Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G +G VYK      G  +  +EI ++ L +S    I+    E  ++ K     +V  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIM---ELDILHKAVSPYIVDF 64

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
            G    +G   +  EY+   SLD         E +       I   +V+GL +L +    
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN---TNRIVGTHGYMSPEYVM- 195
            +IHRD+K +N+L++     K+ DFG++       L A+   TN  +G   YM+PE +  
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTN--IGCQSYMAPERIKS 175

Query: 196 -----NGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
                N   +++SDV+S G+ +LE+       G Y
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMAL-----GRY 205

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 10/197 (5%)

Query: 26  LGQGGFG-PVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G FG  +    +   Q+ A+K  RL KSS   + + + EA L+AK++H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
               G   +V EY     L   I     K   +      I++  VQ  L +      RV+
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED----TILQWFVQMCLGVQHIHEKRVL 122

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRD+K+ NI L      K+ DFG AR        A T   VGT  Y+ PE   N   + K
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNK 180

Query: 203 SDVYSFGVLVLEIISSK 219
           SD++S G ++ E+ + K
Sbjct: 181 SDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 26  LGQGGFGPVYKG--KLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           LG G FG + +G  KL   +E  +AI  L    S +    F  EA  + +  H+N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE-LLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G   +    ++V EY+ N +LD F+    K E  L   +   ++ G+  G+ YL   S +
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNG 197
             +H+ L A  +L++  +  KIS F   +    ++ EA    + G     + +PE +   
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 198 IVSMKSDVYSFGVLVLEIIS 217
             S  SDV+SFG+++ E++S
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 43/233 (18%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS----SGQGIVEFKNEAKLIAKLQ 72
           D+F     +G+G FG V+  +  D  ++ A+K L KS      Q I   + E  ++A   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59

Query: 73  HTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWK-KRFNIIEGIVQGL 130
              +V+L   S Q  E L LV EY+P       +    +K++   +  RF I E +V  L
Sbjct: 60  SPWIVKLY-YSFQDEEHLYLVMEYMPGGD---LMNLLIRKDVFPEETARFYIAE-LVLAL 114

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF-----GMNELEANTNR---- 181
             +HK   L  IHRD+K  NIL+D   + K++DFG+ +           L  + N     
Sbjct: 115 DSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 182 ------------------IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
                              VGT  Y++PE +      ++ D +S GV++ E++
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 13/200 (6%)

Query: 24  NRLGQGGFGPVYKGKL-LDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           ++LG+G +  VYKG+  L    +A+K  RL    G      + E  L+  L+H N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
                +    LV+EYL +K L  ++ D      +   K F  +  +++GL Y H   R +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI-V 199
           V+HRDLK  N+L++++   K++DFG+AR   +   +  +N +V T  Y  P+ ++     
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDY 182

Query: 200 SMKSDVYSFGVLVLEIISSK 219
           S + D++  G +  E+ + +
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.0 bits (168), Expect = 3e-13
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 13/203 (6%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHT 74
           D++    +LG+G +  VYKGK  ++G+ +A+K  RL +  G      + EA L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V L      K    LV+EY+      +   D     L     +  + + +++GL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYIH 120

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           +     ++HRDLK  N+L+ D    K++DFG+AR   +      +N +V T  Y  P+ +
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVV-TLWYRPPDVL 175

Query: 195 MNGI-VSMKSDVYSFGVLVLEII 216
           +     S   D++  G + +E+I
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)

Query: 20  FSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
           F+ G  LG+G FG V + +L       Q++A+K L     S   I EF  EA  + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 74  TNLVRLLGCSLQKGER------LLVYEYLPNKSLDFFIFDSSKKE---LLDWKKRFNIIE 124
            N+++L+G SL+   +      +++  ++ +  L  F+  S   E    L  +     + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I  G+ YL   S    IHRDL A N +L++ M   ++DFG+++     +          
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
              +++ E + + + +  SDV++FGV + EI++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 21/200 (10%)

Query: 26  LGQGGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG G FG VYK +  +   +A  K +   S + + ++  E  ++A   H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
            +    ++ E+    ++D  + +  ++ L + + R  + +  ++ L YLH+    ++IHR
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHR 127

Query: 145 DLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM----- 195
           DLKA NIL     + K++DFG++    RT          +  +GT  +M+PE VM     
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYWMAPEVVMCETSK 181

Query: 196 NGIVSMKSDVYSFGVLVLEI 215
           +     K+DV+S G+ ++E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 30/208 (14%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCS 83
           +G G +G VYKG+ +  GQ  AIK +  +  +   E K E  ++ K   H N+    G  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 84  LQKG------ERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKY 136
           ++K       +  LV E+    S+   + ++    L  DW     I   I++GL +LH +
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPE 192
              +VIHRD+K  N+LL +    K+ DFG++    RT G        N  +GT  +M+PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPE 191

Query: 193 YVM-----NGIVSMKSDVYSFGVLVLEI 215
            +      +     +SD++S G+  +E+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V        G+++A+K++     Q      NE  ++   QH N+
Sbjct: 22  DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   +++ L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIATVCLAVLKALSFLHAQ 134

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEY 193
               VIHRD+K+ +ILL      K+SDFG        ++     R   +VGT  +M+PE 
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEV 186

Query: 194 VMNGIVSMKSDVYSFGVLVLEII 216
           +       + D++S G++V+E++
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 41/213 (19%)

Query: 26  LGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRLLG 81
           +G G +G V        G+++AIK+LS+   Q  +  K    E +L+  + H N++ LL 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 82  CSLQKGERLLVYEYLPNKSLDFF--------IFDSS------KKELLDWKKRFNIIEGIV 127
                        + P  SL+ F        +  +        ++L D   +F ++  I+
Sbjct: 82  V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQIL 128

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +GL Y+H      +IHRDLK SNI +++    KI DFG+AR     + E      V T  
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTG--YVATRW 180

Query: 188 YMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
           Y +PE ++N +   ++ D++S G ++ E+++ K
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 18/199 (9%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G+GGFG VY  +  D G+  A+K L K      QG     NE +++  L  T     + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60

Query: 82  C---SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
           C   +    ++L     L N   D     S      + + RF   E I+ GL ++H  +R
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEAEMRFYAAE-IILGLEHMH--NR 116

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
             V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGTHGYM+PE +  G+
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGV 171

Query: 199 VSMKS-DVYSFGVLVLEII 216
               S D +S G ++ +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 15/198 (7%)

Query: 26  LGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL--QHTNLVRLL 80
           LG+G FG V   +L   G+  A+K L K        VE     K I  L   H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 81  GCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
            C  Q  +RL  V E++    L F I  S + +  + + RF   E I   L++LH     
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAE-ITSALMFLHDKG-- 116

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +I+RDLK  N+LLD + + K++DFGM +    N    +T    GT  Y++PE +   + 
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEMLY 173

Query: 200 SMKSDVYSFGVLVLEIIS 217
               D ++ GVL+ E++ 
Sbjct: 174 GPSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 39/243 (16%)

Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNE 64
           D + I            +G G FG V+  +  +     A+K ++       +      NE
Sbjct: 2   DLERIKT----------VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNE 51

Query: 65  AKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
            +++ ++ H  ++RL      +    ++ EY+P   L  F +  +     +    F   E
Sbjct: 52  KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE 109

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            IV  L YLH      +++RDLK  NILLD + + K++DFG A+     +L   T  + G
Sbjct: 110 -IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCG 160

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS------SKKNNGCYDT--------ERH 230
           T  Y++PE + +   +   D ++ G+L+ E++            G Y+          RH
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH 220

Query: 231 LNL 233
           L+L
Sbjct: 221 LDL 223

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 26  LGQGGFGPVYKGKLLDGQE----IAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNLV 77
           LG+GG+G V++ + + G +     A+K L K+    + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 78  RLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKE--LLDWKKRFNIIEGIVQGLLYLH 134
            L+  + Q G +L L+ EYL    L    F   ++E   ++    F + E I   L +LH
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSE-ISLALEHLH 117

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           +     +I+RDLK  NILLD Q + K++DFG+ +          T+   GT  YM+PE +
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE--SIHEGTVTHTFCGTIEYMAPEIL 172

Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
           M        D +S G L+ ++++
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLT 195

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.3 bits (168), Expect = 6e-13
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 51/221 (23%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAKLIAKLQHTN 75
           +G G +G V        G+++AIK++S         F +         E KL+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDF----FIFD----------SSKKELLDWKKRFN 121
           ++ LL         +L     P    DF     + +           S + L D   ++ 
Sbjct: 61  IIGLL--------DILR----PPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY- 107

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN--T 179
            +  I++GL YLH      VIHRDLK SNIL++   + KI DFG+AR    +E E    T
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
             +V T  Y +PE +++     K+ D++S G +  E+++ K
Sbjct: 165 EYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 29/224 (12%)

Query: 10  FQTIAAATDNFSPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLI 68
            +++   TD +     +G+G +G VYK     DG   A+K L   S     E + E  ++
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72

Query: 69  AKL-QHTNLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
             L  H N+V+  G       L  G+  LV E     S+   +     K LL   +R + 
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127

Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
                I+ G + GL +LH     R+IHRD+K +NILL  +   K+ DFG++       L 
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 177 ANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
            NT+  VGT  +M+PE +      +     + DV+S G+  +E+
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 19/212 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLLG 81
           G ++G+G +G VYK K  DG++     L +  G GI +    E  L+ +L+H N++ L  
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 82  CSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY-----LH 134
             L   +R   L+++Y  +       F  + K     KK   +   +V+ LLY     +H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIH 122

Query: 135 KYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTFG--MNELEANTNRIVGTHGY 188
                 V+HRDLK +NIL+     ++   KI+D G AR F   +  L A+ + +V T  Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTFWY 181

Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
            +PE ++      K+ D+++ G +  E+++S+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.3 bits (164), Expect = 7e-13
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G +G V   +   DG++  IK+L+   +S +     + EA+L+++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE- 66

Query: 83  SLQKGERLL--VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           S +  + LL  V  +     L +      K +LL   +       I   L YLH+     
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           ++HRDLK  N+ L      K+ D G+AR        A+T  ++GT  YMSPE   N   +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYN 180

Query: 201 MKSDVYSFGVLVLEIISSK 219
            KSDV++ G  V E+ + K
Sbjct: 181 YKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 23/206 (11%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
           +F  G  LG G FG V   K    G+  AIK L K   + I++ K       E  ++ +L
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---REILKMKQVQHVAQEKSILMEL 75

Query: 72  QHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
            H  +V ++ CS Q   R+  + E++    L F     + +   D  K F   E +V   
Sbjct: 76  SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPNDVAK-FYHAE-LVLAF 131

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
            YLH      +I+RDLK  N+LLD++ + K++DFG A+     ++   T  + GT  Y++
Sbjct: 132 EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLA 183

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEII 216
           PE + +       D ++ GVL+ E I
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 15/202 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V K +      I  ++L     +  +  +   E +++ +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  + ++ +  +E+L       +   +++GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 173

Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.3 bits (164), Expect = 9e-13
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 26/203 (12%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G+GGFG VY  +  D G+  A+K L K      QG     NE +++  L  T     + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60

Query: 82  C---SLQKGERL-LVYEYLPNKSLDFFIFDS---SKKELLDWKKRFNIIEGIVQGLLYLH 134
           C   +    ++L  + + +    L + +      S+KE+     RF   E I+ GL ++H
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATE-IILGLEHMH 114

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
             +R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VGTHGYM+PE +
Sbjct: 115 --NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVL 167

Query: 195 MNGIV-SMKSDVYSFGVLVLEII 216
             G      +D +S G ++ +++
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 21/200 (10%)

Query: 26  LGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK-------LQHTNLV 77
           +G+G FG V   K   DG   A+K L K +   I++ K +  ++A+       L+H  LV
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKT---ILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 78  RLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
            L   S Q  E+L  V +Y+    L F +    ++  L+ + RF   E +   + YLH  
Sbjct: 60  GL-HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS- 114

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
             L +I+RDLK  NILLD Q +  ++DFG+ +  G+ E E  T+   GT  Y++PE +  
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GV-EPEETTSTFCGTPEYLAPEVLRK 170

Query: 197 GIVSMKSDVYSFGVLVLEII 216
                  D +  G ++ E++
Sbjct: 171 EPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)

Query: 24  NRLGQGGFGPVYKGKL-LDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
            +LG+G +  V+KG+  L    +A+K  RL    G      + E  L+  L+H N+V L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
                     LV+EYL +K L  ++ D      +   K F  +  I++GL Y H   R +
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-NGIV 199
           V+HRDLK  N+L++++   K++DFG+AR   +   +  +N +V T  Y  P+ ++ +   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEY 182

Query: 200 SMKSDVYSFGVLVLEIISSK 219
           S + D++  G +  E+ S +
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 49/209 (23%)

Query: 24  NRLGQGGFGPVYKGKLLD---GQEIAIKRLSKSSGQGIVEFKN---------EAKLIAKL 71
            +LG+G +G V+K   +D    + +A+K++  +       F+N         E   + +L
Sbjct: 13  QKLGKGAYGIVWKA--IDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFLQEL 63

Query: 72  -QHTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEG 125
             H N+V+LL  ++ K E      LV+EY+    L   I    +  +L D  KR+ I+  
Sbjct: 64  GDHPNIVKLL--NVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQ 115

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI--- 182
           +++ L Y+H  S   VIHRDLK SNILL+     K++DFG+AR+    E E   N +   
Sbjct: 116 LLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE-ENPENPVLTD 171

Query: 183 -VGTHGYMSPEYVMNGIVSMKSDVYSFGV 210
            V T  Y +PE      + + S  Y+ GV
Sbjct: 172 YVATRWYRAPE------ILLGSTRYTKGV 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 25/203 (12%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN--------EAKLIAKLQHTNL 76
           LG+G FG V   +     E+ AIK L K      V  ++        E +++A       
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKD-----VIIQDDDVECTMVEKRVLALPGKPPF 62

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLH 134
           +  L    Q  +RL  V EY+    L + I    K KE       F   E I  GL +LH
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP---HAVFYAAE-IAIGLFFLH 118

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                 +I+RDLK  N++LD + + KI+DFGM +   +      T    GT  Y++PE +
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFG-GKTTRTFCGTPDYIAPEII 173

Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                    D ++FGVL+ E+++
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 10/193 (5%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN--EAKLIAKLQHTNLVRLLGC 82
           +G+G +G V K +  + +EI AIK+   S     V+     E K++  L+  N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++G+  LV+EY+    L+  + +     +   K R  I + +++ + + HK     ++
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHWCHKND---IV 122

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRD+K  N+L+      K+ DFG AR        AN    V T  Y SPE ++       
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 203 SDVYSFGVLVLEI 215
            D++S G ++ E+
Sbjct: 182 VDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 24/154 (15%)

Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +LG+G +  VYKG+  L GQ +A+K  RL    G      + EA L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF----NI---IEGIVQGLLYLH 134
               K    LV+EYL          D+  K+ +D         N+   +  +++GL Y H
Sbjct: 71  IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
           +    RV+HRDLK  N+L+ ++   K++DFG+AR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 15/197 (7%)

Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLLG 81
           +LG+G +  VYKG   ++GQ +A+K +S  + +G V F    EA L+  L+H N+V LL 
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV-LLH 69

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
             +   E L  V+EY+      + I       L  +  R  + + +++GL Y+H      
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLAYIH---GQH 123

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI-V 199
           ++HRDLK  N+L+      K++DFG+AR   +   +  ++ +V T  Y  P+ ++     
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVV-TLWYRPPDVLLGATDY 181

Query: 200 SMKSDVYSFGVLVLEII 216
           S   D++  G + +E++
Sbjct: 182 SSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 16/155 (10%)

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           + IHRDL A NILL +    KI DFG+AR    +              +M+PE + + + 
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252

Query: 200 SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCS 259
           + +SDV+SFGVL+ EI S             L    Y     +E     L + T     +
Sbjct: 253 TTQSDVWSFGVLLWEIFS-------------LGASPYPGVQIDEEFCRRLKEGT--RMRA 297

Query: 260 PDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
           P+  T  I+  +L C  +   DRPT S++  +L +
Sbjct: 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 19  NFSPGNRLGQGGFGPVY----KGKLLDGQEIAIKRLSKSSGQGIVE-------FKNEAKL 67
           NF     LG G +G V+     G    G+  A+K L K++   IV+        + E ++
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKAT---IVQKAKTAEHTRTERQV 57

Query: 68  IAKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGI 126
           +  ++    +  L  + Q   +L L+ +Y+    L  F     ++   + + R  I E I
Sbjct: 58  LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL--FTHLYQREHFTESEVRVYIAE-I 114

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
           V  L +LH+   L +I+RD+K  NILLD + +  ++DFG+++ F   E E       GT 
Sbjct: 115 VLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTI 170

Query: 187 GYMSPEYVMNGIVSMKS--DVYSFGVLVLEIIS 217
            YM+PE +  G        D +S GVL  E+++
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 10/196 (5%)

Query: 25  RLGQGGFGPV-YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++G+G  G V    +   G+++A+K++     Q      NE  ++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V E+L   +L   +  +   E    ++   +   +++ L YLH      VIH
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIATVCLSVLRALSYLHNQG---VIH 141

Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +       + 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 204 DVYSFGVLVLEIISSK 219
           D++S G++V+E+I  +
Sbjct: 200 DIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 52/221 (23%)

Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT-------NLV 77
           +G+G FG V K      G  +A+KR+  +  +     K + +L+  L           +V
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-----KEQKRLLMDLDVVMRSSDCPYIV 66

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFF---IFDSSKKELLDWKKRFNIIEGI----VQGL 130
           +  G   ++G+  +  E L + SLD F   +++  K  + +      I+  I    V+ L
Sbjct: 67  KFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKAL 120

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM--------ARTFGMNELEANTNRI 182
            YL +   L++IHRD+K SNILLD   N K+ DFG+        A+T           R 
Sbjct: 121 NYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT-----------RD 167

Query: 183 VGTHGYMSPEYV----MNGIVSMKSDVYSFGVLVLEIISSK 219
            G   YM+PE +     +G   ++SDV+S G+ + E+ + K
Sbjct: 168 AGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 13/203 (6%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V    +   G+ +A+K++     Q      NE  ++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   +++ L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLKALSVLHAQ 135

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               VIHRD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +  
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISR 190

Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
                + D++S G++V+E++  +
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.0 bits (156), Expect = 9e-12
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 39/226 (17%)

Query: 26  LGQGGFGPVYKGKL---------LDGQEIAIKR-LSKSSGQGIVEFKNEAKLIAKLQHTN 75
           LGQG F  +YKG L           GQE+++   +  S  +  + F   A L+++L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LV+L G  ++  E ++V EY+    LD F+        L WK   ++ + +   L YL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 136 YSRLRVIHRDLKASNILL----DDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGY 188
               +++H ++   NIL+     ++      K+SD G+  T      E    RI     +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----PW 170

Query: 189 MSPEYVMNGIVSMKS--DVYSFGVLVLEIISSKKNNGCYDTERHLN 232
           ++PE + NG  S+    D +SFG  +LEI        C + E  L+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI--------CSNGEEPLS 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)

Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 21  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 76

Query: 75  NLVRLL-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 132

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 184

Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 22/199 (11%)

Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK----NEAKLIAKLQHTNLVRLL 80
           LG G  G VYK   LL  + +A+K +        VE +    +E +++ K     ++   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G    +    +  E++   SLD  ++    + +L       I   +V+GL YL     L+
Sbjct: 66  GAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LK 115

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           ++HRD+K SN+L++ +   K+ DFG++    +N + A T   VGT+ YM+PE +      
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSI-AKT--YVGTNAYMAPERISGEQYG 171

Query: 201 MKSDVYSFGVLVLEIISSK 219
           + SDV+S G+  +E+   +
Sbjct: 172 IHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 51/202 (25%), Positives = 101/202 (50%), Gaps = 15/202 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        I  ++L     +  +  +   E +++ +     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 119

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 173

Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 26/203 (12%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAKLIAK---LQHTNLVRL-- 79
           +G+G FG VY+ +  D + I A+K LSK     IV  K  A  I +   L  T L     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE---IVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 80  ---LGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
              L  S Q    L LV +Y+    L + +    +    + + +F I E +V  L +LHK
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS--EDRAKFYIAE-LVLALEHLHK 114

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN--TNRIVGTHGYMSPEY 193
           Y    +++RDLK  NILLD   +  + DFG+++      L  N  TN   GT  Y++PE 
Sbjct: 115 YD---IVYRDLKPENILLDATGHIALCDFGLSKA----NLTDNKTTNTFCGTTEYLAPEV 167

Query: 194 VMNGIVSMKS-DVYSFGVLVLEI 215
           +++     K  D +S GVLV E+
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 46/196 (23%)

Query: 42  GQEIAIKRLSKSSGQGIVEFKN---------EAKLIAKLQHTNLVRLLGCSLQKGERLLV 92
           GQ +AIK+LS+        F+N         E  L+  + H N++ LL            
Sbjct: 41  GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83

Query: 93  YEYLPNKSLDFF--------IFDSSKKE----LLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
             + P KSL+ F        + D++  +     LD ++   ++  ++ G+ +LH      
Sbjct: 84  --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           +IHRDLK SNI++      KI DFG+ART G + +   T  +V T  Y +PE ++     
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYK 195

Query: 201 MKSDVYSFGVLVLEII 216
              D++S G ++ E+I
Sbjct: 196 ENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 31/90 (34%), Positives = 59/90 (65%), Gaps = 6/90 (6%)

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           +++GL YL +  + +++HRD+K SNIL++ +   K+ DFG++   G   +++  N  VGT
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQ-LIDSMANSFVGT 161

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
             YMSPE +     +++SD++S G+ ++E+
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 16/203 (7%)

Query: 26  LGQGGFGPVYKGKLLDGQEIA---IKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G G FG V  G+   G   A   +K L  S+     + F  E +   +L H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF--NIIEGIVQGLLYLHKYSRL 139
             ++    LLV E+ P   L  ++  +        +K     +   +  GLL+LH   + 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV----- 194
             IH DL   N  L   ++ KI D+G+A      +     +       +++PE V     
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 195 --MNGIVSMKSDVYSFGVLVLEI 215
             +    + KS+++S GV + E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 34/101 (33%), Positives = 60/101 (59%), Gaps = 13/101 (12%)

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           + QG+ +L   +    IHRD+ A N+LL D    KI DFG+AR     ++  ++N +V  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272

Query: 186 HG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN 221
           +      +M+PE + + + +++SDV+S+G+L+ EI S  K+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 27/207 (13%)

Query: 24  NRLGQGGFGPVYKGKL-LDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           ++LG+G +  V+KG+  L    +A+K  RL    G      + E  L+  L+H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGI-------VQGLLYL 133
                +    LV+EYL          DS  K+ LD       +  +       ++GL Y 
Sbjct: 70  DIIHTERCLTLVFEYL----------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           HK    +++HRDLK  N+L++++   K++DFG+AR   +   +  +N +V T  Y  P+ 
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDV 174

Query: 194 VMNGI-VSMKSDVYSFGVLVLEIISSK 219
           ++     S   D++  G ++ E+ + +
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 16/155 (10%)

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           + IHRDL A NILL +    KI DFG+AR    +              +M+PE + + + 
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253

Query: 200 SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCS 259
           + +SDV+SFGVL+ EI S             L    Y     NE     L D T     +
Sbjct: 254 TTQSDVWSFGVLLWEIFS-------------LGASPYPGVQINEEFCQRLKDGTRMR--A 298

Query: 260 PDEVTRCIH-VGLLCVQDKATDRPTMSDVASMLTN 293
           P+  T  I+ + L C Q    +RPT S +  +L +
Sbjct: 299 PENATPEIYRIMLACWQGDPKERPTFSALVEILGD 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 30/205 (14%)

Query: 26  LGQGGFGPV----YKGKLLDGQEIAIKRLSKSSGQGIVE------FKNEAKL---IAKLQ 72
           LG+G FG V    YK     G+  AIK L K     I+          E ++       +
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKK---GDIIARDEVESLMCEKRIFETANSER 60

Query: 73  HTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           H  LV L  C  Q  + +  V EY     L   I         + +  F     +V GL 
Sbjct: 61  HPFLVNLFAC-FQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAAC-VVLGLQ 115

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YLH+    ++++RDLK  N+LLD +   KI+DFG+ +  GM      T+   GT  +++P
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMG-FGDRTSTFCGTPEFLAP 170

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEII 216
           E +     +   D +  GVL+ E++
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQ--EIAIKRLSKSS---GQGIVEFKNEAKLIAKLQ 72
           ++F+    LG G FG V      +     +AIKR  KS     + +    +E K++  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGI---VQG 129
           H   V L G    +    LV E++     +FF F       L   KRF    G     Q 
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-------LRRNKRFPNDVGCFYAAQI 140

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           +L       L +++RDLK  N+LLD     K++DFG A+      ++  T  + GT  Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYI 195

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEII 216
           +PE ++N      +D ++ G+ + EI+
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 26  LGQGGFGPVYKGKLLDG---QEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G G FG V  G++  G    ++ +K L  S+  Q  ++F  EA+    LQH+NL++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELL--DWKKRFNIIEGIVQGLLYLHKYSRL 139
              +    LLV E+ P   L  ++    K EL+  D      +   I  GLL+LHK +  
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV----M 195
             IH DL   N LL   +  KI D+G++      +     +++     +++PE V     
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 196 NGIV---SMKSDVYSFGVLVLEI 215
           N +V   + +S+V+S GV + E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 11/95 (11%)

Query: 126 IVQGLLYL-HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
           IV+ L YL  K+    VIHRD+K SNILLD   N K+ DFG++    + + +A T R  G
Sbjct: 123 IVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR--LVDSKAKT-RSAG 176

Query: 185 THGYMSPEYV----MNGIVSMKSDVYSFGVLVLEI 215
              YM+PE +     N    +++DV+S G+ ++E+
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.0 bits (148), Expect = 9e-11
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 33/244 (13%)

Query: 26  LGQGGFGPVYKGK---LLDGQ-----EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           LGQG F  ++KG    + D       E+ +K L KS       F   A ++++L H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              G  +   E ++V EY+   SLD ++  +     + WK     +E   Q    LH   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK-----LEVAKQLAWALHFLE 117

Query: 138 RLRVIHRDLKASNILL-----DDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYM 189
              + H ++ A N+LL         NP   K+SD G++ T  +   E    RI     ++
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT--VLPKEILLERI----PWV 171

Query: 190 SPEYVMNG-IVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERHLNLVGYAWQL----WNE 243
            PE + N   +S+ +D +SFG  + EI S   K     D+++ L       QL    W E
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE 231

Query: 244 GKAL 247
              L
Sbjct: 232 LANL 235

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 30/207 (14%)

Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLLGC 82
           +G G +G V        G+++AIK+LS+     I   +   E  L+  +QH N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80

Query: 83  SLQKGERLLVYEYLPNKSLDFFIF------DSSK---KELLDWKKRFNIIEGIVQGLLYL 133
                  +       ++  DF++       D  K     L + K ++ ++  ++ GL Y+
Sbjct: 81  ------DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-LVYQMLCGLKYI 133

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H      +IHRDLK  N+ +++    KI DFG+AR       +A     V T  Y +PE 
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEV 185

Query: 194 VMNGIVSMKS-DVYSFGVLVLEIISSK 219
           ++N +   ++ D++S G ++ E+++ K
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 51/230 (22%)

Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKS-SGQGIVE--FKNEAKLIAKLQHTNLVRLLG 81
           +G+GG G VY     +  + +A+K++ +  S   +++  F  EAK+ A L H  +V +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 82  -CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--WKKR---------------FNII 123
            CS   G+   VY  +P      +I   + K LL   W+K                 +I 
Sbjct: 70  ICS--DGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEAN 178
             I   + Y+H  S+  V+HRDLK  NILL       I D+G A    + E     ++ +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 179 TN-----------RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                        +IVGT  YM+PE ++    S  +D+Y+ GV++ ++++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 32/81 (39%), Positives = 49/81 (60%), Gaps = 10/81 (12%)

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSPEYVMN 196
           IHRDL A NILL      KI DFG+AR     ++  ++N +V  +      +M+PE + N
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFN 290

Query: 197 GIVSMKSDVYSFGVLVLEIIS 217
            + + +SDV+S+G+L+ EI S
Sbjct: 291 CVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 24  NRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQ-HTNLVRL 79
            ++G+G F  V K +    G+  AIK + K   + + +  N  E + + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 80  LGCSL-QKGERL-LVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYLHK 135
           +     +K  RL LV+E +     D  +++  K  K  L  K+  + +  +++ L ++H 
Sbjct: 64  IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             R  + HRD+K  NIL+ D    K++DFG  R  G+      T  I  T  Y +PE ++
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLL 171

Query: 196 -NGIVSMKSDVYSFGVLVLEIIS 217
            +G    K D+++ G +  EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 10  FQTIAAATDNFSPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLI 68
           F +    +D +     +G+G +G V+K     +G + A+K L         E + E  ++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68

Query: 69  AKLQ-HTNLVRLLGCSLQK----GERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
             L  H N+V+  G   +K    G++L LV E     S+   +     K  L   +R   
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEE 123

Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
                I+   + GL +LH     + IHRD+K +NILL  +   K+ DFG++       L 
Sbjct: 124 PIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180

Query: 177 ANTNRIVGTHGYMSPEYV-----MNGIVSMKSDVYSFGVLVLEI 215
            NT+  VGT  +M+PE +     ++     + DV+S G+  +E+
Sbjct: 181 RNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 18/210 (8%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSS----GQGIVEFKNEAKLIAK 70
           NF     LG G +G V+  + + G +     A+K L K++     +     + E +++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 71  LQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           ++ +  +  L  + Q   +L L+ +Y+    L  F   S ++   + + +    E IV  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L +LHK   L +I+RD+K  NILLD   +  ++DFG+++ F  +E+E       GT  YM
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173

Query: 190 SPEYVMNGIVSMKS--DVYSFGVLVLEIIS 217
           +P+ V  G        D +S GVL+ E+++
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 23/201 (11%)

Query: 26  LGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           +G+G FG V   K  LDG+  A+K L K     IV  + E K        L+  ++H  L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKK----IVLNRKEQKHIMAERNVLLKNVKHPFL 58

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           V L   S Q  E+L  V +++    L F +    ++   + + RF   E I   L YLH 
Sbjct: 59  VGL-HYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS 114

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              + +++RDLK  NILLD Q +  ++DFG+ +  G+ + +  T    GT  Y++PE + 
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIR 169

Query: 196 NGIVSMKSDVYSFGVLVLEII 216
                   D +  G ++ E++
Sbjct: 170 KQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 54/206 (26%), Positives = 105/206 (50%), Gaps = 27/206 (13%)

Query: 26  LGQGGFGPV---YKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
           +G G +G V   Y  +L   Q++A+K+LS+   Q ++  +    E +L+  ++H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 80  L-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           L       S++    + +   L    L+  +     ++L D   +F +I  +++GL Y+H
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIH 135

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                 +IHRDLK SN+ +++    +I DFG+AR     + +      V T  Y +PE +
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIM 187

Query: 195 MNGI-VSMKSDVYSFGVLVLEIISSK 219
           +N +  +   D++S G ++ E++  K
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN------EAKLIAKL 71
           +F+    LG+G FG V   +     E+ AIK L K     +++  +      E +++A  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV---VIQDDDVECTMVEKRVLALQ 57

Query: 72  QHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
                +  L    Q  +RL  V EY+    L + I    K    + +  F   E I  GL
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAE-ISVGL 114

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR-IVGTHGYM 189
            +LH+     +I+RDLK  N++LD + + KI+DFGM +    + ++  T R   GT  Y+
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPDYI 168

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           +PE +         D +++GVL+ E+++ +
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 41/221 (18%)

Query: 20  FSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 75
             P   +G G FG V+      DG+ +A+K++     Q +V  K    E K++   +H N
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDN 60

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFF----------------IFDSSKKELLDWKKR 119
           ++  L             + L    +D F                I  S +    D  K 
Sbjct: 61  VLSAL-------------DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV 107

Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
           F  +  I++GL YLH      ++HRD+K  N+L++     KI DFG+AR    +E +  T
Sbjct: 108 F--LYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 180 NRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
             +V T  Y +PE +M     +   D++S G +  E++  +
Sbjct: 163 QEVV-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 32/216 (14%)

Query: 20  FSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAKLIA 69
           + P   +G+G +G V   K     +++AIK+++ +       F N         E KL+ 
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLR 59

Query: 70  KLQHTNLVRLLGCSLQKGER-----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
            L H N++ +                +VYE L +  L   I   S + L D   ++ + +
Sbjct: 60  HLDHENVIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQII--RSSQTLSDDHCQYFLYQ 116

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            +++GL Y+H  +   V+HRDLK SN+LL+   + KI DFG+ART   +E        V 
Sbjct: 117 -LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVV 170

Query: 185 THGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
           T  Y +PE ++N      + DV+S G +  E++  K
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 31/78 (39%), Positives = 45/78 (57%)

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           + IHRDL A NILL +    KI DFG+AR    +              +M+PE + + + 
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258

Query: 200 SMKSDVYSFGVLVLEIIS 217
           +++SDV+SFGVL+ EI S
Sbjct: 259 TIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 15/177 (8%)

Query: 47  IKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF 106
           I +  K+  +  ++ +NE   + +L H N++++     ++  R     Y+  +  DF ++
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLY 250

Query: 107 DSSKKELLDWKKR------FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK 160
                E  DWK R        I++ ++  + Y+H     ++IHRD+K  NI L+      
Sbjct: 251 SFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIV 307

Query: 161 ISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + DFG A  F   E EA     VGT    SPE +        +D++S G+++L+++S
Sbjct: 308 LGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)

Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEF 61
           +K  DF  I            +G+G FG V   +    +++ A+K LSK     +    F
Sbjct: 40  MKAEDFDVIKV----------IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF 89

Query: 62  KNEAKLIAKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
             E + I    ++  +  L  + Q  + L +V EY+P    D     S+      W  RF
Sbjct: 90  FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG--DLVNLMSNYDIPEKWA-RF 146

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
              E +V  L  +H       IHRD+K  N+LLD   + K++DFG       N +    +
Sbjct: 147 YTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCD 201

Query: 181 RIVGTHGYMSPEYVMN----GIVSMKSDVYSFGVLVLEII 216
             VGT  Y+SPE + +    G    + D +S GV + E++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 62

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 63  AYRELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM 121

Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 122 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 175

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 36/236 (15%)

Query: 2   KRDLKIFDFQ------TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG 55
           KRD   +  +      T+     N  P     QG     Y   L   + +AIK+LS+   
Sbjct: 5   KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-- 60

Query: 56  QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFD 107
                F+N+    AK  +  LV L+ C   K    L+  + P KSL+ F        + D
Sbjct: 61  -----FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD 112

Query: 108 SSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 163
           ++  ++    LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI D
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 169

Query: 164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           FG+ART G + +       V T  Y +PE ++        D++S G ++ E+I   
Sbjct: 170 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 14/214 (6%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY+    L F +  S ++   + + RF   E IV  L YLH     +
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAE-IVSALDYLHSG---K 115

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           +++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + +    
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE-GITD-AATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D E+   L+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 61

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 115

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 14/197 (7%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G+G FG V + +  D Q I A+K + K+   S   +     E  ++A++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  E+L LV  ++    L   +    + +L   + RF   E +   L  LHK++   
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDL--SRARFYTAELLC-ALENLHKFN--- 113

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           VI+RDLK  NILLD Q +  + DFG+ +   M + +  TN   GT  Y++PE ++    +
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDD-KTNTFCGTPEYLAPELLLGHGYT 171

Query: 201 MKSDVYSFGVLVLEIIS 217
              D ++ GVL+ E+++
Sbjct: 172 KAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 54/209 (25%), Positives = 105/209 (50%), Gaps = 17/209 (8%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSS----GQGIVEFKNEAKLIAK 70
           NF     LG G +G V+  + + G +     A+K L K++     + +   + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 71  LQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           ++ +  +  L  + Q   +L L+ +Y+    +  F     +    + + RF   E I+  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM--FTHLYQRDNFSEDEVRFYSGE-IILA 117

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L +LHK   L +++RD+K  NILLD + +  ++DFG+++ F ++E +  T    GT  YM
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 190 SPEYVMNGIVSMKS-DVYSFGVLVLEIIS 217
           +PE +       K+ D +S G+L+ E+++
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 28/187 (14%)

Query: 42  GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL 101
           G  +A+K+LS+        F+N+    AK  +  LV LL C   K    L+  + P KSL
Sbjct: 46  GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95

Query: 102 DFF--------IFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKAS 149
           + F        + D++  ++    LD ++   ++  ++ G+ +LH      +IHRDLK S
Sbjct: 96  EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152

Query: 150 NILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFG 209
           NI++      KI DFG+ART   N +       V T  Y +PE ++        D++S G
Sbjct: 153 NIVVKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209

Query: 210 VLVLEII 216
            ++ E++
Sbjct: 210 CIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 35/212 (16%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V        G ++AIK++S    Q   +    E K++ + +H N++ +L   
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGIL--D 70

Query: 84  LQKGERL-------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           + +           +V E +     D +    ++    D  + F  +  I++GL Y+H  
Sbjct: 71  IIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYF--LYQILRGLKYIHSA 125

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMAR--------TFGMNELEANTNRIVGTHGY 188
           +   V+HRDLK SN+LL+   + KI DFG+AR        T  + E        V T  Y
Sbjct: 126 N---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY-------VATRWY 175

Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
            +PE ++N     K+ D++S G ++ E++S++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 32/163 (19%)

Query: 26  LGQGGFGPVYKGKLLD---GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           LG G  G V+    +D    + +A+K++  +  Q +     E K+I +L H N+V++   
Sbjct: 13  LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIE--------------GI 126
               G        L          +S    +E ++     N++E               +
Sbjct: 71  LGPSGSD------LTEDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLSEEHARLFMYQL 123

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMAR 168
           ++GL Y+H  +   V+HRDLK +N+ ++ + +  KI DFG+AR
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H  LV L  C   +     V EY+    L F +    +++L +   RF   E I   L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH+     +I+RDLK  N+LLD + + K++D+GM +  G+   +  T+   GT  Y++PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +         D ++ GVL+ E+++ +
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 18  DNFSPGNRLGQGGFGPVY--KGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQH 73
            +F   + +G+G FG V   + K   G   A+K + KS    Q  V F  E + I  + +
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 74  TNLVRLLGCSLQKGERL-LVYEYLP--------NKSLDFFIFDSSKKELLDWKKRFNIIE 124
           +  +  L  + Q  + L LV EY P        N+  D   FD           +F + E
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMA-------QFYLAE 110

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            ++     +H   ++  +HRD+K  N+L+D   + K++DFG A     N++  N+   VG
Sbjct: 111 LVLA----IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVG 165

Query: 185 THGYMSPEY--VMNG----IVSMKSDVYSFGVLVLEII 216
           T  Y++PE    MNG       ++ D +S GV+  E+I
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 20/199 (10%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +     +  A+K L K    +   +     E++++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALGYLH---SCD 115

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMAR---TFGMNELEANTNRIVGTHGYMSPEYVMNG 197
           V++RDLK  N++LD   + KI+DFG+ +   + G     A      GT  Y++PE + + 
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPEYLAPEVLEDN 170

Query: 198 IVSMKSDVYSFGVLVLEII 216
                 D +  GV++ E++
Sbjct: 171 DYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   K    G+  A+K L K    +   +     E +++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-K 61

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH  S   
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 116

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + +    
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 201 MKSDVYSFGVLVLEIISSK 219
              D +  GV++ E++  +
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 55/226 (24%), Positives = 103/226 (45%), Gaps = 37/226 (16%)

Query: 11  QTIAAATDNFSPGNRLGQGGFGPV-YKGKLLDGQEIAIKRLSKSSGQGIVEFK--NEAKL 67
           +TI    D +    ++G G +G V        G ++AIK+L +     +   +   E +L
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF-------------IFDSSKKELL 114
           +  ++H N++ LL              + P+ SLD F             +    K E L
Sbjct: 68  LKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115

Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
              +   ++  +++GL Y+H      +IHRDLK  N+ +++    KI DFG+AR     +
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 167

Query: 175 LEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
            ++     V T  Y +PE ++N +  +   D++S G ++ E+++ K
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAK-------LIAKLQHTNLV 77
           +G+G FG V   +   + +  A+K L K   + I++ K E         L+  ++H  LV
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 78  RLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
            L   S Q  ++L  V +Y+    L  F     ++  L+ + RF   E I   L YLH  
Sbjct: 60  GL-HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS- 114

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN--TNRIVGTHGYMSPEYV 194
             L +++RDLK  NILLD Q +  ++DFG+ +      +E N  T+   GT  Y++PE +
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 195 MNGIVSMKSDVYSFGVLVLEII 216
                    D +  G ++ E++
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 2/95 (2%)

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR-IVGT 185
           +Q LL +H      +IHRD+K++NILL      K+ DFG ++ +    +  +  R   GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA-ATVSDDVGRTFCGT 208

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK 220
             Y++PE       S K+D++S GVL+ E+++ K+
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 26  LGQGGFGPVYKGKLL---DGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQ-HTNLVRL 79
           LGQG +G V   +     + + +AIK+++    + I+  +   E KL+   + H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 80  LGCSL---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
               +        L +YE L    L   I   S + L D   +  I + I+ GL Y+H  
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQ-ILCGLKYIHSA 124

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI---VGTHGYMSPEY 193
           +   V+HRDLK  N+L++     KI DFG+AR F  N  E N   +   V T  Y +PE 
Sbjct: 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEYVATRWYRAPEI 180

Query: 194 VMNGIVSMKS-DVYSFGVLVLEIISSK 219
           +++     K+ DV+S G ++ E++  K
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 52/242 (21%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS----GQGIVEFKNEAKLIAKLQ 72
           D+F     +G+G FG V   +  D   I A+K+L KS      Q +   + E  ++A+  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAE-A 58

Query: 73  HTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGL 130
               V  L  S Q    L L+ EYLP   +   +    KK+    ++ RF I E I    
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETI---- 111

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA---RTFGMNELEANT-------- 179
           L +    +L  IHRD+K  N+LLD + + K+SDFG+    +     E             
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 180 -------------------NRI------VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
                              NR       VGT  Y++PE  +    + + D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 215 II 216
           ++
Sbjct: 232 ML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHT 74
             + P   +G G +G V        G+++AIK++  +     +  +   E K++   +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFD----------SSKKELLDWKKRFNIIE 124
           N++ +       G           K + + + D           S + L +   R+ + +
Sbjct: 65  NIIAIRDILRPPGADF--------KDV-YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT--NRI 182
            +++GL Y+H  +   VIHRDLK SN+L+++    +I DFGMAR    +  E        
Sbjct: 116 -LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 183 VGTHGYMSPE--YVMNGIVSMKSDVYSFGVLVLEII 216
           V T  Y +PE    +    +   D++S G +  E++
Sbjct: 172 VATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 16/199 (8%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G FG V   +    Q++ A+K LSK     +    F  E + I    ++  V  L C
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110

Query: 83  SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           + Q  + L +V EY+P   L   + +    E   W K +       + +L L     + +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYT-----AEVVLALDAIHSMGL 163

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM----NG 197
           IHRD+K  N+LLD   + K++DFG         +    +  VGT  Y+SPE +     +G
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 198 IVSMKSDVYSFGVLVLEII 216
               + D +S GV + E++
Sbjct: 223 YYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR-IVG 184
           I  GL +LH      +I+RDLK  N++LD + + KI+DFGM +    N  +  T +   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTKTFCG 163

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           T  Y++PE +         D ++FGVL+ E+++ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 22/196 (11%)

Query: 34  VYKGKLLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL 90
           +YKG   + +E+ I+      K     I   +NE K + ++   N++++ G  +   + L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 91  ----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDL 146
               L+ EY     L   +    K++ L +K + ++     +GL  L+KY+     +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 147 KASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS---MKS 203
            + + L+ +    KI   G+ +       + N N +V    Y S + ++N I S   +K 
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYK-MLNDIFSEYTIKD 203

Query: 204 DVYSFGVLVLEIISSK 219
           D+YS GV++ EI + K
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 13/166 (7%)

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  ++  + H  ++ L+     K    +V   +P    D F +   +   L  ++   I 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY-VDRSGPLPLEQAITIQ 191

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             +++ L YLH      +IHRD+K  NI LD+  N  + DFG A     +          
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEI------ISSKKNNG 223
           GT    SPE +       K+D++S G+++ E+      +  K+   
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294

Length = 392

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LV L  C        LV EY+    L F +    +++L +   RF   E I   L +LH+
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHE 114

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
                +I+RDLK  N+LLD   + K++D+GM +  G+   +  T+   GT  Y++PE + 
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169

Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
                   D ++ GVL+ E+++ +
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 52/236 (22%)

Query: 26  LGQGGFGPVYKGKLL-----------------------DGQE--IAIKRLSKSSGQGIVE 60
           LGQG    +Y G+L                        +G+E  + +K L  S     + 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 61  FKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
           F   A L++++ H +L  + G  ++  E ++V E++ +  LD  +     +  + WK   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL-----LDDQMNP--KISDFGMARTFGMN 173
            + + +   L YL   +   ++H ++ A NIL     L +  +P  K+SD G+  +F   
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV--SFTAL 175

Query: 174 ELEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSKKNNGCYDTE 228
             E    RI     +++PE V  G  +S  +D +SFG  +LEI        C+D E
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI--------CFDGE 219

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 10/148 (6%)

Query: 73  HTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           H  LV L  C  Q   RL  V E++    L F +    +++L +   RF   E I   L 
Sbjct: 55  HPFLVGLHSC-FQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALN 110

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +LH+     +I+RDLK  N+LLD + + K++D+GM +  G+   +  T+   GT  Y++P
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGTPNYIAP 165

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           E +         D ++ GVL+ E+++ +
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 41/181 (22%), Positives = 85/181 (46%), Gaps = 21/181 (11%)

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           EA ++  + H ++++L G         L+   LP    D + + ++K+ +        I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI-AICDILAIE 188

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             +++ + YLH+    R+IHRD+KA NI ++   +  + DFG A       ++ N N+  
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA----CFPVDINANKYY 241

Query: 184 GTHGYM---SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN-------NGCYDTERHLNL 233
           G  G +   +PE +         D++S G+++ E+ +   +       +G  D++R + L
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301

Query: 234 V 234
           +
Sbjct: 302 I 302

Length = 391

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.6 bits (128), Expect = 7e-08
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 25  RLGQGGFGPVYKGKLLDGQE------IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           ++G G FG V+  K    QE      I+ + L +     +V    E  ++ +L+H N+VR
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI---EVNVMRELKHKNIVR 76

Query: 79  LLGCSLQKGERLL--VYEYLPNKSLDFFIFDSSKK-ELLDWKKRFNIIEGIVQGLLYLHK 135
            +   L K  + L  + E+     L   I    K    ++     +I   ++  L Y H 
Sbjct: 77  YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136

Query: 136 Y----SRLRVIHRDLKASNILLDD----------QMN-------PKISDFGMARTFGMNE 174
                +  RV+HRDLK  NI L            Q N        KI DFG+++  G   
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG--- 193

Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSM--KSDVYSFGVLVLEIISSK 219
           +E+  +  VGT  Y SPE +++   S   KSD+++ G ++ E+ S K
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 37/231 (16%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQH 73
            +F     LG+G  G V+  +L   G+  A+K L K       + K    E +++A L H
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 74  TNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
             L  L   S Q    L LV +Y P   L   +     K L +   RF   E ++  L Y
Sbjct: 61  PFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-VLLALEY 118

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA------------------RTFGMNE 174
           LH    L +++RDLK  NILL +  +  +SDF ++                  R   +N 
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 175 LE---------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           +            +N  VGT  Y++PE +         D ++ G+L+ E++
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 27/76 (35%), Positives = 42/76 (55%)

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           +HRDL A N+LL      KI DFG+AR    +    +         +M+PE + + + + 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 202 KSDVYSFGVLVLEIIS 217
            SDV+S+G+L+ EI S
Sbjct: 319 LSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 43/236 (18%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           D+F     +G+G FG V   +  D G   A+K L K+     + +   + E  ++ +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
             +V++      K    L+ E+LP    D       K  L +   +F I E +    L +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETV----LAI 114

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA-------RTFGMNELEAN-------- 178
               +L  IHRD+K  N+LLD + + K+SDFG+        RT     L  N        
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 179 ------------TNR------IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
                        NR       VGT  Y++PE  M    +   D +S GV++ E++
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 27/76 (35%), Positives = 43/76 (56%)

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           +HRDL A N+L+ +    KI DFG+AR    +    +         +M+PE + N + + 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 202 KSDVYSFGVLVLEIIS 217
            SDV+SFG+L+ EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVEFKNEAKLIAK-LQ 72
           +   ++  GN +G G FG VY+   +D  E +AIK++ +       ++KN   LI K L 
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117

Query: 73  HTNLVRLLGC----SLQKGERLL----VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
           H N++ L         +K E+ +    V E++P     +    +     L          
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTF--GMNELEANTNR 181
            + + L Y+H  S+  + HRDLK  N+L+D   +  K+ DFG A+    G   +    +R
Sbjct: 178 QLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234

Query: 182 IVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEII 216
                 Y +PE ++     +   D++S G ++ E+I
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 43/236 (18%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F     +G+G FG V   +  D G   A+K L K+     + +   + E  ++ +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
             +V++      K    L+ E+LP    D       K  L + + +F I E +    L +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETV----LAI 114

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR----------------------TF- 170
               +L  IHRD+K  N+LLD + + K+SDFG+                        TF 
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 171 GMN-ELEANT---NR------IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
            MN + +A T   NR       VGT  Y++PE  M    +   D +S GV++ E++
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 51/165 (30%), Positives = 75/165 (45%), Gaps = 26/165 (15%)

Query: 18  DNFSPGNRLGQGGFGPV-YKGKLLDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQH 73
           ++F     +G+G FG V    K   G+  A+K L KS       +   K E  ++A+   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 74  TNLVRLLGCSLQKGERL-LVYEYLPNKSL-------DFFIFDSSKKELLDWKKRFNIIEG 125
             +V L   S Q  + L L+ E+LP   L       D F  D +         RF + E 
Sbjct: 61  PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---------RFYMAE- 109

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
            V  +  +HK   L  IHRD+K  NIL+D   + K+SDFG++  F
Sbjct: 110 CVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 43.5 bits (103), Expect = 2e-06
 Identities = 15/48 (31%), Positives = 27/48 (56%)

Query: 293 NDTMALPTPRQPAFFINISSDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
           ++T  +P P+QP F +  S    +   +  + E  +VN VT+S ++AR
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 46/219 (21%), Positives = 81/219 (36%), Gaps = 35/219 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           G          + K K      +A+K+  L   S + +   + E     +LQH N++  +
Sbjct: 7   GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFI---FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              +   E  +V   +   S +  +   F     EL        I++ ++  L Y+H   
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA----IAFILKDVLNALDYIHS-- 119

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY--------- 188
               IHR +KAS+ILL       +S    + +        +  R    H +         
Sbjct: 120 -KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM-----IKHGKRQRVVHDFPKSSVKNLP 173

Query: 189 -MSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGC 224
            +SPE +   +   + KSD+YS G+   E+      NG 
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACEL-----ANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 56/242 (23%), Positives = 94/242 (38%), Gaps = 63/242 (26%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G G FG V   + +D   + A+K L K+           K E  ++A+  +  +V+L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67

Query: 82  CSLQKGERL-LVYEYLPNKSL-----DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            S Q  + L  V +Y+P   +        IF+           RF I E +   +  +HK
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYIAE-LTCAIESVHK 119

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGM------------------ARTFGM---NE 174
              +  IHRD+K  NIL+D   + K++DFG+                   R   M    E
Sbjct: 120 ---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 175 LEANTNR--------------------IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
                                      +VGT  Y++PE ++    +   D +S GV++ E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 215 II 216
           ++
Sbjct: 237 ML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 40/224 (17%)

Query: 26  LGQGGFGPVYKGKLLD---------GQEIAIKRLSKSSGQG----IVEFKNEAKLIAKLQ 72
           LG+G    +Y G L             E  IK + K          + F   A ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H ++V L G  ++  E ++V E++    LD F+   S      WK  F + + +   L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120

Query: 133 LHKYSRLRVIHRDLKASNILL-----DDQMNP--KISDFGMARTFGMNELEANTNRIVGT 185
           L       ++H ++   NILL     D +  P  K+SD G+  T  +   +    RI   
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT--VLSRQECVERI--- 172

Query: 186 HGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTE 228
             +++PE V +   +S+ +D +SFG  + EI        CY+ E
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI--------CYNGE 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 29/209 (13%)

Query: 26  LGQGGFGPVYKGKLLDGQEIA---IKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G G FG V   ++     +A   +K L  ++  +   EF  +      LQH N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR-FNIIE------GIVQGLLYLH 134
             ++    LLV+EY     L  ++          W +R   ++        I  G+ ++H
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHMH 116

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMART-FGMNELEANTNRIVGTHGYMSPEY 193
           K++ L   H DL   N  L   +  K+ D+G+  + +  + +E   ++ V    +++PE 
Sbjct: 117 KHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR-WLAPEL 172

Query: 194 V---MNGIVSMK----SDVYSFGVLVLEI 215
           V     G+++ +    S+V++ GV + E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 36/186 (19%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKR--LSKSSGQGIVE-FKNE------AKLI 68
           D+F  G +LG+G FG VYK  L++ Q     +  L K++  G VE + NE          
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSC 191

Query: 69  AKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSL-------DF------FIFDSSKKELL 114
           A   +  L  +   S +K +   LV+ Y    +L       +F      ++    +    
Sbjct: 192 ADFVYGFLEPV---SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248

Query: 115 DWKKRFNIIEGIVQGLLY----LHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMART 169
             ++   II+ I++ +L+    LH      ++HRD+K  NI+  +     KI D G A  
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAAD 305

Query: 170 --FGMN 173
              G+N
Sbjct: 306 LRVGIN 311

Length = 566

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 36/209 (17%)

Query: 26  LGQGGFG-----------PVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 74
           +G+G FG            VY  KLL   E+ IKR S S+      F  E + I    ++
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKR-SDSA------FFWEERDIMAFANS 102

Query: 75  NLVRLLGCSLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLL 131
             V  L  + Q    L +V EY+P   L   +  +D  +K    W  RF   E +V  L 
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTAE-VVLALD 156

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
            +H    +  IHRD+K  N+LLD   + K++DFG         +    +  VGT  Y+SP
Sbjct: 157 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISP 212

Query: 192 EYVM----NGIVSMKSDVYSFGVLVLEII 216
           E +     +G    + D +S GV + E++
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 27/90 (30%), Positives = 50/90 (55%)

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           Q +L L +    +++HRDLK++NI L      K+ DFG ++ +  +      +   GT  
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE       S K+D++S GV++ E+++
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 6/96 (6%)

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           I + +L +H   +L  +HRD+K  N+LLD   + +++DFG        +    ++  VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM-NQDGTVQSSVAVGT 166

Query: 186 HGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEII 216
             Y+SPE +       G    + D +S GV + E++
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 30/143 (20%), Positives = 52/143 (36%), Gaps = 15/143 (10%)

Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV--RLLGC 82
            L  G    VY     D  +  +K     S +   + + E  ++  L    L   ++L  
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
               G   L+ E++  ++LD    +  +               + + L  LH+   L + 
Sbjct: 62  GESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLVLC 111

Query: 143 HRDLKASNILLDDQMNPKISDFG 165
           H DL   NIL+DD     I D+ 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 18/149 (12%)

Query: 28  QGGFGPVYKG-KLLDGQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           +G FG VY G K  + +  A+K + K+    + +V   + E   +A L  +  +  L  S
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVHLYYS 72

Query: 84  LQKGERL-LVYEYLPN---KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           LQ    + LV EYL     KSL   I+    +E+        I E +   L YLH++   
Sbjct: 73  LQSANNVYLVMEYLIGGDVKSL-LHIYGYFDEEM----AVKYISE-VALALDYLHRHG-- 124

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMAR 168
            +IHRDLK  N+L+ ++ + K++DFG+++
Sbjct: 125 -IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 16/106 (15%)

Query: 119 RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA---RTFGMNEL 175
           RF + E +    L +    +L  +HRD+K  N+LLD   + +++DFG        G    
Sbjct: 105 RFYLAEMV----LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--- 157

Query: 176 EANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEII 216
              +N  VGT  Y+SPE +       G    + D +S GV + E++
Sbjct: 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 28/103 (27%), Positives = 53/103 (51%), Gaps = 16/103 (15%)

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN--------ELEAN 178
           V  L YLH Y    ++HRDLK  N+L+    + K++DFG+++   M+         +E +
Sbjct: 111 VLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167

Query: 179 T-----NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           T      ++ GT  Y++PE ++        D ++ G+++ E +
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSK-----SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +G+G +G V        G+++AIK+++      S    I+    E KL+  L+H ++V +
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIVEI 64

Query: 80  LGCSLQKGER-----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
               L    R      +V+E + +   D      +  +L     +F + + +++ L Y+H
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQ-LLRALKYIH 120

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT--NRIVGTHGYMSPE 192
             +   V HRDLK  NIL +     KI DFG+AR    N+          V T  Y +PE
Sbjct: 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPE 176

Query: 193 YVMN--GIVSMKSDVYSFGVLVLEIISSK 219
              +     +   D++S G +  E+++ K
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 34/148 (22%)

Query: 113 LLDWKKR---FN------IIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNP- 159
           LLDW  +   F+      II      L Y H  + L ++H DLK  NIL+   D  ++P 
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275

Query: 160 ------------KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS-DVY 206
                       +I D G     G  +   +   IV T  Y SPE V+ G+  M S D++
Sbjct: 276 TNRALPPDPCRVRICDLG-----GCCDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMW 329

Query: 207 SFGVLVLEIISSKKNNGCYDTERHLNLV 234
           S G ++ E+ + K     +D   HL+L+
Sbjct: 330 SMGCIIYELYTGKLLYDTHDNLEHLHLM 357

Length = 467

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 15/200 (7%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE---FKNEAKLIAKLQHTNLVRLLG 81
           +G+G FG V   KL +  ++ A+K L+K       E   F+ E  ++    +  +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
               +    LV +Y     L   +    +  L +   RF + E ++     +    +L  
Sbjct: 69  AFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMVIA----IDSVHQLHY 123

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----N 196
           +HRD+K  NIL+D   + +++DFG      M +    ++  VGT  Y+SPE +       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 197 GIVSMKSDVYSFGVLVLEII 216
           G    + D +S GV + E++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.9 bits (102), Expect = 9e-05
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 19/134 (14%)

Query: 90  LLVYEYLPNKSLDFFIFDSSKKE-LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKA 148
           +L+ +Y+ +  L    FD  KKE  L   +   II  +V+ L  LHK+    +IH D+K 
Sbjct: 85  VLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKL 137

Query: 149 SNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM--NGIVSMKSDV 205
            N+L D   +   + D+G+ +  G            GT  Y SPE +   N  VS   D 
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPEKIKGHNYDVSF--DW 189

Query: 206 YSFGVLVLEIISSK 219
           ++ GVL  E+++ K
Sbjct: 190 WAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 32/114 (28%), Positives = 56/114 (49%), Gaps = 26/114 (22%)

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
           NI+ G ++GL YLH+      IHR++KAS+IL        IS  G+    G++ L +   
Sbjct: 105 NILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVR 153

Query: 181 -----RIV--------GTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSK 219
                ++V            ++SPE +   +   ++KSD+YS G+   E+ + +
Sbjct: 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 8/153 (5%)

Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
           +EA+L+ +L H  ++ LL   +  G   LV   LP    D + +  ++   L   +   +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAV 265

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR- 181
              ++  + Y+H      +IHRD+K  N+L++   +  + DFG A  F         +  
Sbjct: 266 ARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAA-CFARGSWSTPFHYG 321

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
           I GT    +PE +     +   D++S G+++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 12/150 (8%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG G FG V   + +D + + A+K L K        +   K E  ++A+  +  +VRL  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 82  CSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
               K     V +Y+P   +    I      E L    RF I E +   +  +HK   + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAE-LTCAVESVHK---MG 121

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF 170
            IHRD+K  NIL+D   + K++DFG+   F
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 59/242 (24%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG G FG V     +D   + A+K L K    +   +   K E  ++A+  +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67

Query: 82  CSLQKGERL-LVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
            S Q  + L  V +Y+P   +    I      E+L    RF I E +   +  +HK   +
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK---M 120

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTF----------------------------- 170
             IHRD+K  NIL+D   + K++DFG+   F                             
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 171 -------GMNELEANTNR---------IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
                   +  LE    +         +VGT  Y++PE ++    +   D +S GV++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240

Query: 215 II 216
           ++
Sbjct: 241 ML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 70/218 (32%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQE-----------------IAIKR--------- 49
           ++D+F   ++LG G FG  ++G  L   +                 + +KR         
Sbjct: 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVR 202

Query: 50  --------LSKSSGQ-GIVEFKNEAKLIAKLQHTNLV-----RLLGC--------SLQKG 87
                   L+K S + G+VE    A + AK++   +        LG         +  KG
Sbjct: 203 QDFLKTGTLAKGSAETGMVE----AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKG 258

Query: 88  ERLLVYEYLPNKSL----------------DFFIFDSSKKELLDWKKR-FNIIEGIV-QG 129
            + LV+++  + +L                +F +      + +   KR  N+I+G++ Q 
Sbjct: 259 SQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 167
           L  L K  R+ ++HRD+K  N+L+      KI DFG A
Sbjct: 319 LTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 17/115 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           DN   G  LG G FG V +      GK  +   +A+K L  S+     E   +E K+++ 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEY---------LPNKSLDFFIFDSSKKELLD 115
           L QH N+V LLG     G  L++ EY         L  K+  F  F  +  E+ +
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISE 152

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	340
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
COG4248	637	Uncharacterized protein with protein kinase and he	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.24
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.09
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.08
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.93
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.91
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.91
PRK09902	216	hypothetical protein; Provisional	98.84
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.66
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.63
PF01636	239	APH: Phosphotransferase enzyme family This family	98.54
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.51
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.34
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.3
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.29
PLN02876	822	acyl-CoA dehydrogenase	98.28
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.19
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.16
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.15
PRK05231	319	homoserine kinase; Provisional	98.12
PRK10593	297	hypothetical protein; Provisional	98.12
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.11
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.99
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.85
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.76
PLN02236	344	choline kinase	97.59
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.57
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.48
KOG2270	520	consensus Serine/threonine protein kinase involved	97.43
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.35
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.26
PLN02756	418	S-methyl-5-thioribose kinase	97.17
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.15
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.1
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.06
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.94
PRK12396	409	5-methylribose kinase; Reviewed	96.84
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.66
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.66
PRK11768	325	serine/threonine protein kinase; Provisional	96.64
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.63
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.6
COG2334	331	Putative homoserine kinase type II (protein kinase	96.39
PRK06148	1013	hypothetical protein; Provisional	96.34
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.32
PTZ00384	383	choline kinase; Provisional	96.05
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.81

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-53  Score=378.26  Aligned_cols=288  Identities=44%  Similarity=0.742  Sum_probs=251.0

Q ss_pred             ccccccHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEE
Q 041345            4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS   83 (340)
Q Consensus         4 ~~~~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (340)
                      ..+.|++.+|..++++|.....||+|+||.||+|...+++.||||.+.........+|.+|+.++.+++|||+++++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            57889999999999999999999999999999999988899999988655433144599999999999999999999999


Q ss_pred             eeCC-eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           84 LQKG-ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        84 ~~~~-~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                      .+.+ ..++|+||+++|+|++.++..... +++|..+++|+.++|.||+|||.....+|+|||||+.|||+|.+.+.||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9988 599999999999999999775443 78999999999999999999999887789999999999999999999999


Q ss_pred             cccccccccCcccccccccc-cccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 041345          163 DFGMARTFGMNELEANTNRI-VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      |||+++.....  ....... .||.+|+|||++..+..+.|+||||||++++||++|+.+...........+..+.+..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654321  1111111 78999999999999999999999999999999999998887655455555778888888


Q ss_pred             hcCccccccccccc-CCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          242 NEGKALELIDTTLH-ESCSP-DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       242 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..+...+++|+.+. ...+. .+...+..+..+|++.+|.+||+|.+|++.|+.+
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            88899999999887 55554 6778899999999999999999999999999654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-52  Score=370.02  Aligned_cols=255  Identities=30%  Similarity=0.459  Sum_probs=221.1

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +++.+.||+|.||.||+|.+++...||+|.+... ....+.|.+|+.+|++|+|++||++++++..+..++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4557889999999999999988889999999654 344567889999999999999999999999988999999999999


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT  179 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~  179 (340)
                      +|.+++... .+..++..+.+.++.|||+|++||++++   +|||||.++||||+++..+||+|||+|+...++.... .
T Consensus       287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~  361 (468)
T KOG0197|consen  287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-S  361 (468)
T ss_pred             cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-c
Confidence            999999763 3456999999999999999999999999   9999999999999999999999999999655443332 2


Q ss_pred             ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       180 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      ....-+..|.|||.+..+.++.||||||||++||||+| |+.|++.....+.                .+.++...+...
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev----------------~~~le~GyRlp~  425 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV----------------LELLERGYRLPR  425 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------------HHHHhccCcCCC
Confidence            33334678999999999999999999999999999998 6677766555443                334566778888


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      |..++..++++|..||+.+|++|||++.+...|+++..
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            99999999999999999999999999999999987644

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-52  Score=369.36  Aligned_cols=248  Identities=24%  Similarity=0.402  Sum_probs=215.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+|..++.||+|+|+.||.+++ ..|..||+|++.+.   .....+...+|+++.+.++|||||+++++|++.+..|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999988 67999999999763   3344667889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |+|+.++|..++.   ...++++.++..++.||+.|+.|||+++   |+|||||..|+|++++.+|||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999984   4566999999999999999999999999   999999999999999999999999999987643


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .  ......+|||.|+|||++.....+..+||||+||++|.|+.|++||+...-.+....+..       .         
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------~---------  233 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------N---------  233 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------c---------
Confidence            2  334558999999999999988999999999999999999999999986655544333321       1         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                       .-..|...+.+..+||.++|+.||.+|||+++|+..
T Consensus       234 -~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 -EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             111234566778999999999999999999999963

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-51  Score=359.47  Aligned_cols=261  Identities=29%  Similarity=0.445  Sum_probs=214.5

Q ss_pred             CCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-eeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-ERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~e~   95 (340)
                      ...+.+.||.|+||+||+|.+.+...||+|.+.....  .....|.+|+.++.+++|||||+++|++.... .+++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3445566999999999999996655599999965532  22568999999999999999999999999887 79999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~~~~~  174 (340)
                      +++|+|..++... ....++...++.|+.|||.|+.|||+++.  |+||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999764 35569999999999999999999999873  89999999999999997 99999999998754322


Q ss_pred             cccccccccccCCCCChhhhc--cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVM--NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                        ...+...||+.|+|||++.  ...|+.|+||||||+++|||+||..||......+.      .....         ..
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~---------~~  261 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVV---------VG  261 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHH---------hc
Confidence              2233367999999999998  56899999999999999999999999976554221      11111         12


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                      ..+...+..++..+..|+.+||..||..||++.+++..|+.+.....
T Consensus       262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            33344445577889999999999999999999999999987544333

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=343.20  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=208.1

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-eeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-ERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~e~   95 (340)
                      +.+..+.||.|..|+||++++. +++.+|+|++... ......++.+|+++++..+||+||.++|.|.... ...|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            5667889999999999999865 4788999999544 4556788999999999999999999999999988 49999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++|+|++++...   +.+++....+++.++++||.|||. ++   |+||||||+||||+..|+|||||||.+..+.+. 
T Consensus       160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999543   559999999999999999999995 76   999999999999999999999999999876543 


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCC--CcccccchhHHHHHHhhcCcccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY--DTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                         ......||..|||||.+.+..|+.++||||||++++|+++|+.|+...  .......++.+.   ..          
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~----------  296 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VD----------  296 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hc----------
Confidence               345578999999999999999999999999999999999999998653  111222222211   11          


Q ss_pred             cccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          253 TLHESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ......|.. .+.++..++..||++||.+|||+.|+++.
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            111222333 67889999999999999999999999863

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=346.72  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .++|.+.+.||.|+||+||+|+... +..||||.+.+.  .....+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4689999999999999999998654 789999999666  5667778899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC------CCeeEeccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ------MNPKISDFGMA  167 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~------~~~~l~Dfg~~  167 (340)
                      |||++|+|.++++..   +.+++..+..++.|++.|+++||+++   |+||||||.|||++.+      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999643   35999999999999999999999999   9999999999999864      45899999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      +.+...   ......+|++.|||||+++..+|+.|+|+||+|+++|++++|+.||......+....+...      ..  
T Consensus       163 R~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~------~~--  231 (429)
T KOG0595|consen  163 RFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG------NE--  231 (429)
T ss_pred             hhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc------cc--
Confidence            988643   3344578999999999999999999999999999999999999999766665544322111      01  


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                            .....+......+.+|+...++.+|.+|-++.+...
T Consensus       232 ------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  232 ------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             ------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence                  111122233344556666677777777766665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-50  Score=345.77  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=204.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCCh-------hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSG-------QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (340)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||++++...       .......+|+++|+++.|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456799999999999999999965 4699999999954311       11223579999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC---CCeeEecc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDF  164 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~---~~~~l~Df  164 (340)
                      ..||||||++||.|.+++.   .++.+.+.....+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999984   4556889999999999999999999999   9999999999999866   67999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCC---CCccCceehhhHHHHHHHhCCCCCCCCCccc-ccchhHHHHHH
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTER-HLNLVGYAWQL  240 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~  240 (340)
                      |+|+..+.   .......+||+.|.|||++.++.   +..++|+||+||+||-+++|.+||....... ....+      
T Consensus       324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------  394 (475)
T KOG0615|consen  324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------  394 (475)
T ss_pred             chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence            99998763   23455689999999999997664   3458899999999999999999995433332 11111      


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ..+...      .........+.+..+||.+||..||++|||+.|+++
T Consensus       395 -~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  395 -LKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -hcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             111111      112223556778999999999999999999999986

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-50  Score=332.26  Aligned_cols=264  Identities=22%  Similarity=0.307  Sum_probs=210.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +.|+.+.++|+|+||+||++++++ |+-||||.+....  +....-..+|+.+|++++|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            458888999999999999998765 8999999985543  3334456899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ||+..-|+++-...   .-++...+.++++|++.|+.|+|+++   ++||||||+||+++.+|.+||||||+|+.+..  
T Consensus        82 ~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            99887776665322   22889999999999999999999999   99999999999999999999999999998753  


Q ss_pred             cccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhcCc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWNEGK  245 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  245 (340)
                      .....+.+..|.+|+|||.+.+ .+|...+||||+||++.||++|.+.|.+....++..++...        ...+....
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            1223445677999999999877 68999999999999999999999999988888776555432        12222222


Q ss_pred             cccccccccc------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLH------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+.-...      ...-+..+..+.++++.||+.||++|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2221111000      0111344557889999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-51  Score=332.24  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=210.4

Q ss_pred             cCCCCCCcccccCCeeEEEEE-ECCCCEEEEEEccC--CChhcHHHHHHHHHHHHcCCCCceeeeeeE-EeeCCe-eEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNLVRLLGC-SLQKGE-RLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~-~~iv   92 (340)
                      .+|++.++||.|+||.||+++ ..+|..+|.|.+.-  .+....+....|+.+|++++|||||++++. +..++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458889999999999999996 45789999998853  355667788999999999999999999984 444444 8999


Q ss_pred             EeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCC-CceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           93 YEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSR-LRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ||+|+.|+|..++... ..++.+++..+++++.|++.||.++|++-. ..++||||||.||+++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999764 345679999999999999999999999321 24999999999999999999999999999988


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .+..  .......|||.|++||.+.+.+|+.+|||||+||++|||+.-++||.+.+-...       ...+..       
T Consensus       179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L-------~~KI~q-------  242 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL-------CKKIEQ-------  242 (375)
T ss_pred             cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH-------HHHHHc-------
Confidence            6543  234457899999999999999999999999999999999999999976522221       111112       


Q ss_pred             cccccCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          251 DTTLHESCS-PDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       251 ~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                        .-.+.+| ...+..+..||..|+..||+.||+...++..+..
T Consensus       243 --gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  243 --GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              2223344 5678899999999999999999996666555543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.1e-48  Score=315.03  Aligned_cols=280  Identities=24%  Similarity=0.331  Sum_probs=225.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChh--cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|...++||+|.||+||+|++ .+|+.||||++......  ......+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5788889999999999999975 45999999998654322  23457899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++ .+|+..+.+.  ...++...+..++.++++|++|||++.   |+||||||.|++++.+|.+||+|||+++.++...
T Consensus        82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 5888888643  446999999999999999999999999   9999999999999999999999999999987654


Q ss_pred             cccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc-
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT-  252 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  252 (340)
                      .....  ..-|.+|+|||.+.|. .|+..+|+||.|||+.||+.|.+-|.+.+..++...+-.+.-......|+++..- 
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            43322  2568999999999876 6999999999999999999999999888888777666544333333333332211 


Q ss_pred             ----------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCcee
Q 041345          253 ----------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFF  307 (340)
Q Consensus       253 ----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~  307 (340)
                                .......+.++..+.+|+..||.+||.+|+|+.|+++.  ......|.|..|..+
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~~l  296 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPSKL  296 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChhhC
Confidence                      11111234566778999999999999999999999974  344556776666554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-49  Score=332.00  Aligned_cols=242  Identities=26%  Similarity=0.359  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      -++|++.+.||+|+||.|+.++..+ ++.+|+|++++.   ......+...|..+|.+++||+||+++-.|.+..++|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4789999999999999999997654 888999999665   234567788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      +||+.||.|...+.   ..+.+++..+.-++..|+.||.|||++|   |+||||||+|||++.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999884   4556999999999999999999999999   99999999999999999999999999986432


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .  ...+...+||+.|+|||++.+..|+.++|.||||+++|+|++|.+||...+.......+..       ++       
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-------~k-------  241 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-------GK-------  241 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-------Cc-------
Confidence            2  2234457999999999999999999999999999999999999999976655543332211       11       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRP  282 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  282 (340)
                        ....+.-.+.+..+++..+|+.||++|.
T Consensus       242 --~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              1112233567788999999999999996

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-49  Score=341.86  Aligned_cols=267  Identities=25%  Similarity=0.318  Sum_probs=215.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHH--HHHHHHHHHcCC-CCceeeeeeEEeeCC-ee
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQ-HTNLVRLLGCSLQKG-ER   89 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~   89 (340)
                      .+.++|.+.++||.|.||.||+|+.. .+..||||.++..-.. +++  -.+|+..|+++. ||||+++..++.+.+ .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            45688999999999999999999754 4889999988554322 333  367999999997 999999999998887 89


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++|||||+. +|.+++.+.  +.++++..+..|+.||++||+|+|.+|   +.|||+||+||||..+..+||+|||+|+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            999999965 788888654  667999999999999999999999999   99999999999999988999999999998


Q ss_pred             ccCcccccccccccccCCCCChhhh-ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ..+.   ...+.+..|.+|+|||++ +.+.|+.+.|+|++|||++|+++-++.|.+.+..++...+....-......+.+
T Consensus       160 v~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  160 VRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            7543   334556789999999987 677899999999999999999999999998888777655543322222222222


Q ss_pred             c--cccccc-----------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          249 L--IDTTLH-----------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       249 ~--~~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      .  +...+.           ...-+..+.++.+||.+|++.||++|||+.++++.-
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1  001111           111134778899999999999999999999999853

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=337.92  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=210.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   90 (340)
                      -..+|.+++.||.|+|++|++|+.. .++.||||++.+.   ..........|-.+|.+| .||.|++++..|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3478999999999999999999764 4889999998554   223344567888999999 8999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|+||+++|.|.+++..   -+.+++.-...++.+|+.||+|||++|   ||||||||+|||++++++++|+|||.|+.+
T Consensus       151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999999999954   355999999999999999999999999   999999999999999999999999999987


Q ss_pred             cCcccc---------ccc--ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 041345          171 GMNELE---------ANT--NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       171 ~~~~~~---------~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      ......         ...  ...+||..|.+||++.++..++.+|+|+|||+||+|+.|.+||...+.--.+..+..   
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~---  301 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA---  301 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH---
Confidence            532211         111  347899999999999999999999999999999999999999976555443332211   


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                                    +.-..++..+..+.+|+.++|..||.+|+|.++|-+.-
T Consensus       302 --------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  302 --------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             --------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                          01122334447788999999999999999999998753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-47  Score=330.72  Aligned_cols=265  Identities=24%  Similarity=0.314  Sum_probs=207.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv   92 (340)
                      +.|+.+++||+|.||.||+|++. +|+.||+|.++...  ........+|+.+|+++.||||+++.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            55777889999999999999854 58999999986543  44555678999999999999999999988776  579999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      +|||++ +|.-++..  ..-.+++.++..++.|++.||+|||++|   ++|||||..|||||++|.+||+|||+|+++..
T Consensus       197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999977 45555532  2334999999999999999999999999   99999999999999999999999999998765


Q ss_pred             cccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc--cc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL--EL  249 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  249 (340)
                      ..... .+...-|.+|+|||++.|. .|+.++|+||.||||.||++|++.|.+....++...+-...-...+..|.  ++
T Consensus       271 ~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 SGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            54333 3334569999999999876 69999999999999999999999999888877665553322111122222  10


Q ss_pred             cc-ccccC--CC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 ID-TTLHE--SC-------SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~-~~~~~--~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      -. ..+..  .+       ....+....+|+..+|..||.+|.|+.+++.
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00 00000  00       1223556788999999999999999999886

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-47  Score=324.93  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC--eeEEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG--ERLLVY   93 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv~   93 (340)
                      ..+|..++.||+|+||.||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            4568889999999999999998654 8999999886554333677899999999999999999999744444  689999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~~~~  172 (340)
                      ||+++|+|.+++.....  .+++..+..+..|+++||+|||++|   ++||||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999965433  5999999999999999999999999   999999999999999 79999999999987653


Q ss_pred             -cccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          173 -NELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       173 -~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                       ...........||+.|+|||++.++ ....++|||||||++.||+||..||...     ..............      
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------  239 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------  239 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence             1112223346799999999999854 3446999999999999999999998653     11111111111111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                         .....|...+.+..+++..|++.+|++|||+.+++...
T Consensus       240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence               11244555777889999999999999999999999854

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-47  Score=354.84  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=221.6

Q ss_pred             CCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      +-...+.||+|+||.||+|+..+      ...||||.++..... ...+|.+|++++..++|||||+++|+|.+++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            44556889999999999997433      346999999776544 67889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCc-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCee
Q 041345           92 VYEYLPNKSLDFFIFDSSK-----------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK  160 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~  160 (340)
                      |+|||..|+|.+||.....           ..+++..+.+.|+.|||.|+.||-++.   +|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence            9999999999999965322           123889999999999999999999998   99999999999999999999


Q ss_pred             EecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHH
Q 041345          161 ISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      |+|||+++...+.++........-..+|||||.+..+.||.+||||||||+|||+++ |..|+.+...++....+     
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i-----  718 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI-----  718 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH-----
Confidence            999999998776666554444556789999999999999999999999999999998 77888766665543332     


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                                 ..+-..++|..++.++++||..||+.+|++||++.||-..|+....+
T Consensus       719 -----------~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  719 -----------RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -----------HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                       22223567888999999999999999999999999999999875443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-46  Score=335.13  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC-
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK-   86 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-   86 (340)
                      ..++|++.+.||+|+||.||+|..      ..++.||+|++.... ......+.+|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            357899999999999999999964      225679999986543 23345688999999999 899999999987654 


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc--------------------------------------------------------
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK--------------------------------------------------------  110 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  110 (340)
                      ..++++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            458899999999999999864311                                                        


Q ss_pred             ---cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCC
Q 041345          111 ---KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG  187 (340)
Q Consensus       111 ---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~  187 (340)
                         ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++................++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134778889999999999999999999   99999999999999999999999999976533222222223345678


Q ss_pred             CCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHH
Q 041345          188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRC  266 (340)
Q Consensus       188 y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (340)
                      |+|||.+.+..++.++|||||||++|+|++ |..||.........      ......+..         ...+...+..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGTR---------MRAPENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH------HHHHhcCCC---------CCCCCCCCHHH
Confidence            999999988899999999999999999997 99998654332110      111111111         11123345678


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          267 IHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       267 ~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      .+++.+||+.||++|||+.++++.|+++.
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-46  Score=330.98  Aligned_cols=255  Identities=23%  Similarity=0.321  Sum_probs=209.2

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC----Ch-hcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCC
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS----SG-QGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKG   87 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   87 (340)
                      ...++|.+++.||+|+||.|+.|.. .+++.||+|++...    .. .....+.+|+.+++.+. ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999965 45899999977543    12 23456778999999998 999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEecccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGM  166 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~Dfg~  166 (340)
                      .+++|||||.+|.|.+++..   .+.+.+..+..+++|++.|++|||++|   |+||||||+||+++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999954   455889999999999999999999999   9999999999999999 9999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCC-CC-ccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGI-VS-MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      +....  .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||...+.......       ...+
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i~~~  238 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------IRKG  238 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------HhcC
Confidence            98763  1223445678999999999998876 75 789999999999999999999976332222111       1111


Q ss_pred             cccccccccccCCCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          245 KALELIDTTLHESCSPDE-VTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                                ...+|... +.++..|+.+||..||.+|+|+.+++ .-..+.
T Consensus       239 ----------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  239 ----------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             ----------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence                      11222333 77899999999999999999999999 544444

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-46  Score=319.70  Aligned_cols=263  Identities=23%  Similarity=0.343  Sum_probs=211.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..+.|++...||.|..++||+|+. +.+..||||++.-... .....+.+|+..+..+.||||++++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            457899999999999999999974 5589999999965432 23678899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      +||.+|++.+++......+ +++..+..+++++++||.|||.+|   .+|||||+.||||+.+|.|+|+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999998765555 999999999999999999999999   999999999999999999999999987665433


Q ss_pred             cccc-cc-ccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          174 ELEA-NT-NRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       174 ~~~~-~~-~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .... .. ....|+++|+|||++..  ..|+.|+||||||++..||.+|..||..+.+.+..-+      .. .+..+..
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~------tL-qn~pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL------TL-QNDPPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH------Hh-cCCCCCc
Confidence            2221 11 45689999999999643  4699999999999999999999999987766542211      11 1111111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .-..+..+........+.+++..||++||++|||+.++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1111111111233457889999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=305.46  Aligned_cols=237  Identities=26%  Similarity=0.334  Sum_probs=205.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||.|+||.|.+++.+. |..+|+|++.+..   -...++..+|..+|+.+.||+++++++.+.+...+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            4679999999999999999998754 7889999996653   33466788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||.+||-|..+++.   .+.+++..+.-++.||+.|++|||+++   |++|||||+|||+|.+|.+||+|||+|+... 
T Consensus       123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-  195 (355)
T ss_pred             EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence            999999999999953   445999999999999999999999999   9999999999999999999999999999753 


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                          ..+...+||+.|+|||++..+.+..++|.||||+++|||+.|..||...+..+....+-       +++       
T Consensus       196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-------~~~-------  257 (355)
T KOG0616|consen  196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-------EGK-------  257 (355)
T ss_pred             ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-------hCc-------
Confidence                34566899999999999999999999999999999999999999998766644332221       111       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDR  281 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~R  281 (340)
                         -..|...+..+.+|+..+|+.|-.+|
T Consensus       258 ---v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 ---VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence               22345566788999999999999999

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=332.59  Aligned_cols=269  Identities=25%  Similarity=0.424  Sum_probs=215.3

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ...-.+...++..||+|.||+||+|+|.  ..||||++...  ..+..+.|.+|+.++++-+|.||+-+.|++..... .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            3334456778999999999999999983  35899999655  44567889999999999999999999999988766 9


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ||+.+|.|.+|..+++...  ..+++.+.+.|+.|+++|+.|||.++   |+|+|||..|||+.+++.|||+|||++..-
T Consensus       464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence            9999999999999997643  45999999999999999999999999   999999999999999999999999998754


Q ss_pred             cCcccccccccccccCCCCChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ..-..........|...|+|||+++.   .+|++.+||||||+|+|||++|..||.....++..-.++.++-.      .
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~------p  612 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM------P  612 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC------c
Confidence            32211222233557888999999853   47999999999999999999999999844444433333221100      0


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTP  301 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  301 (340)
                      .      .......++.++.+|+..||..++++||++.+|+..|+.+...+|.-
T Consensus       613 d------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki  660 (678)
T KOG0193|consen  613 D------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI  660 (678)
T ss_pred             c------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence            0      01112456678999999999999999999999999999887766553

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.3e-45  Score=321.06  Aligned_cols=265  Identities=25%  Similarity=0.422  Sum_probs=205.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-----------------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-----------------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVR   78 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~   78 (340)
                      .++|++.++||+|+||.||+|.+.+                 +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999997532                 2369999986543 334567889999999999999999


Q ss_pred             eeeEEeeCCeeEEEEeccCCCChhhHhhccCc----------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 041345           79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK----------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI  142 (340)
Q Consensus        79 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~  142 (340)
                      +++++.+.+..++||||+++++|.+++.....                ...+++..+..++.|++.||.|||+++   ++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99999998899999999999999998854211                124678889999999999999999999   99


Q ss_pred             ecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh--CCC
Q 041345          143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS--SKK  220 (340)
Q Consensus       143 H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~  220 (340)
                      |+||||+||+++.++.++|+|||++................++..|+|||.+.++.++.++||||||+++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999886543322222233445778999999988899999999999999999987  556


Q ss_pred             CCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          221 NNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ||......+...   ...........      ......++.++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       241 p~~~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQVIE---NAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHHHHH---HHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            776544332211   11111111100      00111223445678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-46  Score=332.86  Aligned_cols=247  Identities=27%  Similarity=0.341  Sum_probs=210.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +-|++++.||.|+.|.|-+|++. +|+..|||++.+.   .......+.+|+.+|+.+.|||++++++++.+..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            56999999999999999999764 5999999999655   2233456889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++|-|.+++.   .++++++.++.++++||+.|+.|+|..+   |+||||||+|++++..+++||+|||+|..-.. 
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            9999999999995   4556999999999999999999999999   99999999999999999999999999976332 


Q ss_pred             ccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                        .......+|++.|.|||++.|.+| +.++||||.|||||.|++|+.||++.+.......+.       .+        
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~-------~G--------  227 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ-------RG--------  227 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH-------cC--------
Confidence              234456799999999999999887 579999999999999999999998544333222221       11        


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        ....|...+.++++|+.+|+..||++|.|+++|++.
T Consensus       228 --~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 --VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             --cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence              123456677889999999999999999999999985

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=327.19  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=210.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      ..|....+||+|+.|.||.|+. ..++.||+|.+........+-+.+|+.+|+..+|+|||++++.+...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4588888999999999999965 458889999996665556667899999999999999999999999899999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++|+|.+.+.    ...+++.++..++.+++.||+|||.+|   |+|||||.+||+++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999983    334999999999999999999999999   99999999999999999999999999987754332 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                       ......||+.|+|||+.....|++++||||||++++||+-|.+||-..+...      ..+....++.        ...
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng~--------P~l  489 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGT--------PKL  489 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcCC--------CCc
Confidence             3445679999999999999999999999999999999999999985432222      2222222221        122


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+...+..+.+++.+||+.|+++|+|+.|+|+
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            334567788999999999999999999999997

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-44  Score=316.45  Aligned_cols=244  Identities=20%  Similarity=0.288  Sum_probs=198.4

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhc---HHHHHHHHHHHHcCCCCceeeeeeEEee----CCeeEEEEecc
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGERLLVYEYL   96 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~iv~e~~   96 (340)
                      ..||+|++|.||+|.. +|+.||+|.+.......   ...+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999988 78999999986543222   4677899999999999999999999876    34689999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      ++|+|.+++..   ...+++.....++.|++.|+.+||+. +   ++||||||+||+++.++.+||+|||++..+.... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999854   34588999999999999999999984 6   8899999999999999999999999987653221 


Q ss_pred             ccccccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                          ....++..|+|||.+.+  ..++.++|||||||++|+|++|..||...+..+....      .....         
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~------i~~~~---------  238 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL------IINKN---------  238 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhcC---------
Confidence                22457889999999876  6789999999999999999999999975433221111      10011         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11122334567899999999999999999999999999864

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=326.31  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=211.0

Q ss_pred             ccHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC
Q 041345            8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG   87 (340)
Q Consensus         8 ~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (340)
                      .+|++|..       ++-||.|+.|.||+|+. .++.||||+++...       +.+++=|++|+||||+.+.|+|....
T Consensus       121 iPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP  185 (904)
T KOG4721|consen  121 IPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP  185 (904)
T ss_pred             CCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc
Confidence            45566544       56799999999999988 67899999874433       45677889999999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .+|||||||..|-|...|.   .+..+.......|..+||.|+.|||.+.   |+|||||.-||||..+..|||+|||.+
T Consensus       186 cyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  186 CYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             eeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccch
Confidence            9999999999999999995   3455888899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      +.....   ...-..+||..|+|||++++.+.+.|+||||||||||||+||..||...+......-+             
T Consensus       260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-------------  323 (904)
T KOG4721|consen  260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-------------  323 (904)
T ss_pred             Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-------------
Confidence            876432   2233478999999999999999999999999999999999999999755444322111             


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                        -...+....|..++..+.-|+++||+..|.+||+|.+++..|......
T Consensus       324 --GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  324 --GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             --cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence              122344556677888899999999999999999999999999876443

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=293.26  Aligned_cols=265  Identities=24%  Similarity=0.271  Sum_probs=211.4

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEE-ECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----   87 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   87 (340)
                      -...++|++.+.||.|||+-||+++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+.     
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3456899999999999999999997 4458889999997777778888999999999999999999998765443     


Q ss_pred             eeEEEEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      ..|++++|+..|+|.+.+.... ++..+++.+++.|+.++++||.+||... .++.|+||||.||++.+++.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            3899999999999999886643 3447999999999999999999999986 4799999999999999999999999999


Q ss_pred             cccccCccccc----cc---ccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH
Q 041345          167 ARTFGMNELEA----NT---NRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       167 ~~~~~~~~~~~----~~---~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~  236 (340)
                      +......-...    ..   .....|..|+|||.+.   +...++++|||||||+||.|+.|..||+..-.         
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------  246 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------  246 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence            87653211000    00   1234688999999883   45689999999999999999999999953211         


Q ss_pred             HHHHhhcCcccc--cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          237 AWQLWNEGKALE--LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       237 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                            .+....  .....+..+-....+..+.+++++|++.||.+||++.+++..+.++
T Consensus       247 ------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 ------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                  111111  1111222222233778899999999999999999999999998765

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-44  Score=326.66  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=203.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   88 (340)
                      .++|++.+.||+|+||.||+|.+      ..+..||+|++.... ......+.+|+.++..+ +||||+++++++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35799999999999999999963      235679999986432 33445688999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCc----------------------------------------------------------
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSK----------------------------------------------------------  110 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  110 (340)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999854221                                                          


Q ss_pred             --------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345          111 --------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus       111 --------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                                    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788889999999999999999999   999999999999999999999999999865433221


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........      .......+.         .
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~---------~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGY---------R  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCc---------c
Confidence            11222334567999999999999999999999999999998 7888854332211      111111111         1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+...+.++.+++.+||+.||++|||+.+|++.|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            111222346789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=310.49  Aligned_cols=271  Identities=25%  Similarity=0.317  Sum_probs=213.1

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccC--CChhcHHHHHHHHHHHHcCCCCceeeeeeEEee----
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----   85 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   85 (340)
                      ...+...|...+.||+|+||.|+.+.+. +|+.||+|++..  .......+..+|+.+++.++|+||+.+.+++..    
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            3445567777899999999999999764 489999999862  344567778899999999999999999998765    


Q ss_pred             -CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecc
Q 041345           86 -KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF  164 (340)
Q Consensus        86 -~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Df  164 (340)
                       -+..|+|+|+| +.+|...+.   .++.++...+..+++|++.|+.|+|+.+   ++||||||.|++++.++.+||+||
T Consensus        97 ~f~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence             24589999999 678888884   3344899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      |+|+...........+....|.+|+|||+.. ...|+.+.||||+|||+.||++|+..|.+.+...+..++........+
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            9999875442233335567799999999874 557999999999999999999999999998887776655432111111


Q ss_pred             --------Cccccccccccc------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          244 --------GKALELIDTTLH------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       244 --------~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                              ......+.....      ....+...+...+|+.+||..||.+|+|++|.++.
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                    111111111110      01113456678899999999999999999999863

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-44  Score=327.96  Aligned_cols=261  Identities=27%  Similarity=0.411  Sum_probs=204.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   87 (340)
                      -.++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+.+++.+ +|+||+++++++....
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3467999999999999999998742      23579999996543 33455688999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCc---------------------------------------------------------
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSK---------------------------------------------------------  110 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  110 (340)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999998854211                                                         


Q ss_pred             ----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccc
Q 041345          111 ----------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN  180 (340)
Q Consensus       111 ----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~  180 (340)
                                ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.++|+|||++.............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                      124788899999999999999999999   9999999999999999999999999987654332211122


Q ss_pred             cccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCC
Q 041345          181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCS  259 (340)
Q Consensus       181 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (340)
                      ...++..|+|||++.+..++.++|||||||++|+|++ |..||.........      ......         ......+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~------~~~~~~---------~~~~~~~  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF------YKMVKR---------GYQMSRP  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH------HHHHHc---------ccCccCC
Confidence            2334567999999988899999999999999999997 99998653322110      111111         1111122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          260 PDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       260 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-45  Score=320.83  Aligned_cols=251  Identities=23%  Similarity=0.333  Sum_probs=215.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe-eEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE-RLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~iv~   93 (340)
                      ++|..++++|+|+||.+++++.. +++.+|+|.+....  ........+|+.++.+++|||||.+.+.|..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            67999999999999999999754 47789999885442  2334467899999999999999999999999888 89999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      +||+||++.+.+.... ...+++..+..|+.|++.|+.|||+++   |+|||||+.|||++.++.|+|+|||+|+.++..
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997654 456999999999999999999999988   999999999999999999999999999988654


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .  .......||+.|++||++.+.+|..|+|||||||++|||++-+++|...+.......+.                ..
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~----------------~~  221 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN----------------RG  221 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh----------------hc
Confidence            3  23445789999999999999999999999999999999999999997655554332221                11


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ...+.|.....++..++..|++.+|..||++.+++..
T Consensus       222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2345567778899999999999999999999999976

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=346.79  Aligned_cols=262  Identities=30%  Similarity=0.440  Sum_probs=220.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--CC----EEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--GQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      ..+.+..+.||+|.||.||.|...+  +.    .||+|.+... +......|.+|..+|..+.||||++++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3556778899999999999997543  43    3899998655 456678899999999999999999999999999899


Q ss_pred             EEEEeccCCCChhhHhhccCc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSK----KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      +|++|||.+|+|..++++...    ...+++...+.++.|||+|+.||++++   +|||||.++|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999976522    335999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      +|+.+....+........-...|+|||.+.++.++.|+|||||||++||++| |..||+..++.+.....          
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~----------  917 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV----------  917 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH----------
Confidence            9996655555444444445678999999999999999999999999999998 77888766665533211          


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                            ....+...|..++..++++|..||+.+|++||++..|++.+..+..+
T Consensus       918 ------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  918 ------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                  11124566788889999999999999999999999999999876543

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1e-43  Score=311.13  Aligned_cols=257  Identities=30%  Similarity=0.491  Sum_probs=207.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ++|++.+.||+|+||.||+|....      ...+++|.+.... ......+.+|+..+..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            578899999999999999997543      2568999886443 334556889999999999999999999999888899


Q ss_pred             EEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           91 LVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      ++|||+++++|.+++.....             ...+++..+..++.|++.|++|||+++   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999864321             135888999999999999999999999   99999999999999999


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHH
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~  236 (340)
                      .++|+|||++................++..|+|||.+.++.++.++|||||||++|+|++ |..||......+..     
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-----  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-----  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            999999999876543322222333456788999999988899999999999999999998 99998654433211     


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                        .....+         .....+...+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus       237 --~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 --EMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              111111         1122344566889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=317.05  Aligned_cols=245  Identities=22%  Similarity=0.256  Sum_probs=201.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999875 58899999985432   233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999853   345889999999999999999999999   999999999999999999999999998765321


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                           .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...........       ...+.        
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~-------i~~~~--------  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK-------ILAGK--------  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhCC--------
Confidence                 2234688999999999888899999999999999999999999965433221111       11110        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  290 (340)
                        ...+......+.+++.+||+.||.+||+     ++++++.
T Consensus       215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              1122333567889999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.5e-44  Score=315.64  Aligned_cols=254  Identities=21%  Similarity=0.301  Sum_probs=208.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++++.||+|+||.||+|+.++ |..+|+|++++..   ...+.+...|..+|....+|.||+++..|.+...+|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45889999999999999999998654 8899999997663   3456678889999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||++||++-.+|.   ..+.+++..+..++.+++.|+..||+.|   ++||||||+|+|||..|++||+|||++.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   5567999999999999999999999999   9999999999999999999999999985332


Q ss_pred             Cc----------------------cccc----c-------------------cccccccCCCCChhhhccCCCCccCcee
Q 041345          172 MN----------------------ELEA----N-------------------TNRIVGTHGYMSPEYVMNGIVSMKSDVY  206 (340)
Q Consensus       172 ~~----------------------~~~~----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  206 (340)
                      ..                      ....    .                   .....|||-|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      0000    0                   0124699999999999999999999999


Q ss_pred             hhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---
Q 041345          207 SFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT---  283 (340)
Q Consensus       207 slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---  283 (340)
                      |||||+|||+.|.+||...++.+....+......+..+             .......+..+||.+|+. ||++|.-   
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP-------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP-------------EEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC-------------CcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            99999999999999998877776655554333322211             112234778899999999 9999976   


Q ss_pred             HHHHHH
Q 041345          284 MSDVAS  289 (340)
Q Consensus       284 ~~evl~  289 (340)
                      ++||-+
T Consensus       439 ~~EIK~  444 (550)
T KOG0605|consen  439 AEEIKK  444 (550)
T ss_pred             HHHHhc
Confidence            555543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-44  Score=322.52  Aligned_cols=246  Identities=24%  Similarity=0.281  Sum_probs=200.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            478999999999999999999875 48899999985432   23345678999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+.+..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999998854   345889999999999999999999999   99999999999999999999999999886532


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .     .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.........       .....+.       
T Consensus       171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~-------  231 (329)
T PTZ00263        171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-------EKILAGR-------  231 (329)
T ss_pred             C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------HHHhcCC-------
Confidence            2     12346899999999999888999999999999999999999999654322211       1111111       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~  290 (340)
                         ...+...+..+.+++.+||+.||.+||+     +.+++..
T Consensus       232 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 ---LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               1112223456889999999999999997     5776643

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-43  Score=317.89  Aligned_cols=265  Identities=23%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            478999999999999999999875 47789999886542 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++..   ...+++..+..++.|++.|+.|||+++  +++|+||||+||+++.++.++|+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999854   234889999999999999999999853  3999999999999999999999999998765321 


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc--------
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA--------  246 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  246 (340)
                         ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.................        
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               223346889999999999889999999999999999999999999654432211110000000000000        


Q ss_pred             -------------------ccccc----ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          247 -------------------LELID----TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       247 -------------------~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                                         .+..+    ...........+.++.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                               00000    000000112345679999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-44  Score=321.06  Aligned_cols=253  Identities=22%  Similarity=0.351  Sum_probs=204.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|++.. ++.||+|++....   ......+.+|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            479999999999999999998754 8899999986432   223456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999843   345889999999999999999999999   99999999999999999999999999876432 


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                          ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+..    +  ..   .+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~--~~---~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY----W--KE---TLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh----c--cc---cccCC
Confidence                23345689999999999988999999999999999999999999976544332211110    0  00   00000


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .........+.++.+++.+||..+|++|||+.++++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000012345678899999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=324.52  Aligned_cols=243  Identities=24%  Similarity=0.325  Sum_probs=208.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   90 (340)
                      ..++|.+.++||+|+||.|+++..++ ++.+|||++++.   ..+.++..+.|..++... +||.+++++.+|.+.+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            34789999999999999999998654 788999999765   345677888888888877 5999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+.||++...    ...+.+++..+.-++..++.||.|||++|   |++||||.+|||+|..|++||+|||+++.-
T Consensus       446 fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            99999999984333    34456999999999999999999999999   999999999999999999999999999864


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      -..  ...+...+||+.|+|||++.+..|+.++|.|||||+||||+.|+.||.+.+.++.+.-+..              
T Consensus       519 m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------------  582 (694)
T KOG0694|consen  519 MGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------------  582 (694)
T ss_pred             CCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence            322  2356678999999999999999999999999999999999999999988777776544321              


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                         ....+|...+.+...+++++|..+|++|.-+
T Consensus       583 ---d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 ---DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               1233566677889999999999999999776

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-43  Score=314.08  Aligned_cols=241  Identities=27%  Similarity=0.347  Sum_probs=190.3

Q ss_pred             CcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+..+ ++.||+|++....   .........|..++... +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998654 7789999986431   22334455566666644 899999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++..   ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988853   335899999999999999999999999   9999999999999999999999999987643222  22


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+...      ... ..          ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~-~~----------~~~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SIL-ND----------RPHF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-cC----------CCCC
Confidence            334568999999999998899999999999999999999999997544322111      110 00          1112


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMS-DVAS  289 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  289 (340)
                      +...+..+.+++.+||+.+|++||++. ++++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            233456788999999999999999975 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=323.69  Aligned_cols=263  Identities=29%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC--C--CE-EEEEEccC---CChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD--G--QE-IAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (340)
                      ..++-.+.++||+|+||.||+|+...  +  .. ||+|....   ........+.+|+.++++++||||++++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34566677999999999999997533  2  23 89998864   23566778999999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .+++|||+|+||+|.+++.....  .++..+...++.+.|.||+|||+++   ++||||.++|+|++.++.+||+|||++
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999965432  5899999999999999999999999   999999999999999989999999998


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ....  ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....+            
T Consensus       310 ~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI------------  375 (474)
T KOG0194|consen  310 RAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI------------  375 (474)
T ss_pred             cCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH------------
Confidence            7532  11111112234678999999999999999999999999999998 78888765554322111            


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT  300 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  300 (340)
                         +....+...+...+..+..++.+||..+|++||||.++.+.|+.+.....+
T Consensus       376 ---~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  376 ---VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ---HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence               122334445556678888999999999999999999999999887655443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.9e-45  Score=321.48  Aligned_cols=246  Identities=25%  Similarity=0.372  Sum_probs=208.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+..  ......+.+|+++++.++||||+.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57899999999999999999754 47889999996653  3346678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ||.+ +|..++.   ..+.++++.+..++.+++.||.|||+++   |+|||+||.||+++.++.+|+||||+|+....+ 
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9966 8999984   4556999999999999999999999999   999999999999999999999999999987643 


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       ....+.+.||+.|+|||...+++|+..+|.||+||++||+++|++||-.....+..      ..+..+           
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv------~~I~~d-----------  215 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLV------KSILKD-----------  215 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHH------HHHhcC-----------
Confidence             33455678999999999999999999999999999999999999999432221111      111100           


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....|...+..+..++...|.+||.+|.|-.+++.
T Consensus       216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            12234567788999999999999999999998875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-43  Score=309.74  Aligned_cols=251  Identities=26%  Similarity=0.344  Sum_probs=200.6

Q ss_pred             CCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .|++.+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.++..+.|++++++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            477889999999999999976 458899999885432   2223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|...+.... ...+++..+..++.|++.|++|||+++   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999988875432 235899999999999999999999999   9999999999999999999999999987653221


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.............   .....          .
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~----------~  220 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKE----------D  220 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhc----------c
Confidence               1223468999999999999999999999999999999999999997554332111111   10000          0


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                      ....+...+..+.+|+.+||+.||++||+     ++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11122334567889999999999999997     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-43  Score=315.99  Aligned_cols=242  Identities=22%  Similarity=0.281  Sum_probs=195.9

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.||+|+||.||+++.. +++.||+|++...   .......+.+|+.+++.+.||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999864 4889999998643   2234556788999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT  179 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~  179 (340)
                      +|...+..   ...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++......  ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            99888743   345899999999999999999999999   999999999999999999999999998753221  1122


Q ss_pred             ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCC
Q 041345          180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCS  259 (340)
Q Consensus       180 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (340)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......      .. ..          ....+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~------~~-~~----------~~~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------IL-ME----------DIKFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH------hc-cC----------CccCC
Confidence            335689999999999888999999999999999999999999965433221110      00 00          01122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 041345          260 PDEVTRCIHVGLLCVQDKATDRP-----TMSDVASM  290 (340)
Q Consensus       260 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  290 (340)
                      ...+..+.+++.+||+.||++||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            33456788999999999999997     88988864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.7e-44  Score=307.60  Aligned_cols=256  Identities=24%  Similarity=0.408  Sum_probs=211.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ...+|++.+.||.|+||.||+|...+++.+++|.+..........+.+|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34679999999999999999999888899999999776665667889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||.+........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999996543 345899999999999999999999999   99999999999999999999999999876543221


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.....       .         ...
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~-------~---------~~~  221 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-------T---------AGY  221 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-------H---------hCC
Confidence            1  112335667999999988889999999999999999998 78888654422211111       0         111


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            122234556778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.3e-44  Score=298.12  Aligned_cols=288  Identities=23%  Similarity=0.286  Sum_probs=222.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh-hc-HHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG-QG-IVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv   92 (340)
                      +.|+.+.+|++|+||+||+|++.. ++.||+|.++.... .. .-...+|+.+|.+.+|||||.+-.+.+-.  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            568888999999999999998654 78899999965421 11 22457999999999999999998876533  569999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||||+. +|..++..-.  +++...++.-++.|++.|++|||.+.   |+|||||++|+|+++.|.+||+|||+|+.++.
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999965 6777775432  46999999999999999999999999   99999999999999999999999999999875


Q ss_pred             cccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      .  ....+...-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++.|.+....++.+.+-...-...+..|+.+..
T Consensus       230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            4  2223345568999999999876 699999999999999999999999988887776655533222222222222111


Q ss_pred             c--------------cccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCceeeecCCCCC
Q 041345          252 T--------------TLHESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYE  315 (340)
Q Consensus       252 ~--------------~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~  315 (340)
                      .              .++...+.. ....-++|+..+|.+||.+|.|+.+.|+  .+.....|.|.+|.++...+...+
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~~~Pt~P~k~~  384 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPSMFPTWPAKSE  384 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChhhcCCCccccc
Confidence            1              011111111 3456788999999999999999999987  466677788888888877665544

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-43  Score=309.60  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=206.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|.+.+.||+|+||.||+|...+      ++.||+|.+...... ....+.+|+++++.++|+|++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4578899999999999999997633      478999998655433 456789999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccC-----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           90 LLVYEYLPNKSLDFFIFDSS-----------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                      +++|||+++++|.+++....           ....+++..+..++.|++.|+.+||+++   ++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999986432           1234788899999999999999999999   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  237 (340)
                      ++|+|||++................++..|+|||.+.++.++.++||||||+++|+|++ |..||...........    
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~----  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC----  236 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----
Confidence            99999999876533222222223345678999999999999999999999999999998 9999865443321111    


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                         ...+.         ....+...+..+.+++.+||+.||++|||+.||++.|.
T Consensus       237 ---~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ---ITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               11111         11112334567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-44  Score=331.80  Aligned_cols=259  Identities=24%  Similarity=0.319  Sum_probs=214.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCC-CEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeE-Eee------CC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDG-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGC-SLQ------KG   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~------~~   87 (340)
                      ..++++.+.|.+|||+.||+|+...+ ..+|+|++-..+....+.+.+|+.+|++|+ |+|||.+++. ...      ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45678889999999999999998775 999999987777788889999999999996 9999999993 221      13


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .+.|.||||.+|.|-+++....... |++.++++|++|+++|+++||... .+|+|||||-+||||+.+++.||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            4689999999999999997655544 999999999999999999999984 78999999999999999999999999998


Q ss_pred             ccccCccccccc-------ccccccCCCCChhhh---ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH
Q 041345          168 RTFGMNELEANT-------NRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       168 ~~~~~~~~~~~~-------~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~  237 (340)
                      .-..........       -....|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+...           
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-----------  262 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-----------  262 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence            754322211100       112358999999977   67789999999999999999999999996422           


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                              ...++...+..+..+..+..+.+||+.||+.||.+||++-+|+..+-.+..
T Consensus       263 --------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  263 --------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                    233445555555567889999999999999999999999999999876543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-43  Score=316.82  Aligned_cols=241  Identities=22%  Similarity=0.276  Sum_probs=196.0

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999764 5889999998643   2233456778999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT  179 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~  179 (340)
                      +|.+.+..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||++......  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99888853   345899999999999999999999999   999999999999999999999999998753211  1122


Q ss_pred             ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCC
Q 041345          180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCS  259 (340)
Q Consensus       180 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (340)
                      ....|++.|+|||++.+..++.++||||+||++|+|++|..||...+.......       .....          ...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-------~~~~~----------~~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------ILMEE----------IRFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH-------HHcCC----------CCCC
Confidence            335689999999999988999999999999999999999999965433221111       00110          1123


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          260 PDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       260 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                      ...+..+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            34456789999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-43  Score=306.87  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.+.... ......+.+|+..+++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            467899999999999999999653    35689999986553 2334568899999999999999999999999899999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...  ...+++..++.++.|++.|++|||+++   ++|+||||+||+++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998543  235899999999999999999999999   9999999999999999999999999876532


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .... .......++..|+|||.+.+..++.++|||||||++|++++ |..||.........       .....+      
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~------  224 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------KAVEDG------  224 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCC------
Confidence            2211 11112234568999999999999999999999999999775 99998654332211       111111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                         .....+...+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       225 ---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               11122344567789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-43  Score=304.87  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=206.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.++||+|++|.||+|...++..|++|.+.... .....+.+|+.+++.++|+||+++++++......+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            36799999999999999999998788889999885443 33567889999999999999999999998888899999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999986532 334888999999999999999999998   999999999999999999999999999876432221


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       ......++..|+|||.+.++.++.++||||||+++|+|++ |..||.........       ......         ..
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~---------~~  222 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-------SALQRG---------YR  222 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH-------HHHHcC---------CC
Confidence             1222345678999999988889999999999999999998 88998643322211       111111         01


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      .......+..+.+++.+||..+|++|||++++.+.|++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11112344678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=314.63  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=210.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..|+..+.||+|+||.||+|.+.. ++.||+|++.-. ....++.+.+|+.++.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            468888999999999999998654 788999999655 344577889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      |.+|++.+.+.   ....+++..+.-++++++.|+.|||..+   .+|||||+.||++..+|.+||+|||.+..+.+...
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999984   3444588888899999999999999999   99999999999999999999999999987654322


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                        ......||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+.....+                +.+...
T Consensus       167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------------Ipk~~P  228 (467)
T KOG0201|consen  167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------------IPKSAP  228 (467)
T ss_pred             --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------ccCCCC
Confidence              23567899999999999988999999999999999999999999976555433222                222222


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .......+..+.+++..||.+||+.||||.++++.
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            22233566779999999999999999999999864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.9e-45  Score=309.61  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=211.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.+++.   +.++.-++.+|+++|..+.||||+.++.+|++.+.++||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46799999999999999999975 67999999999655   445566789999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||..+|.|.+++.   ..+.+++.++..++.||..|+.|+|+++   ++|||||.+|||+|.|+++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999994   4556999999999999999999999998   99999999999999999999999999988754


Q ss_pred             cccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      .   ...+..+|++-|.+||++.|.+| .+.+|-||||++||.|+.|..||.+.+.....       +.+..+...    
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-------rQIs~GaYr----  271 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-------RQISRGAYR----  271 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH-------HHhhccccc----
Confidence            3   33456899999999999998887 58999999999999999999999876554322       111122111    


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                          .   +..+....-||++||..||++|.|+.+|....
T Consensus       272 ----E---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 ----E---PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----C---CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                1   22344566799999999999999999998875

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.9e-44  Score=312.53  Aligned_cols=265  Identities=21%  Similarity=0.267  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||+|+||.||+|+.. +++.+|+|++....  ......+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999875 47889999985432  2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++++++..+..   ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999887766542   2235899999999999999999999999   9999999999999999999999999998754322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhh-cCc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWN-EGK  245 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~  245 (340)
                      . .......|+..|+|||++.+..++.++||||+||++|+|++|+.||...+..+....+...        ...+. ...
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 1222346789999999998888999999999999999999999999765433221111100        00000 000


Q ss_pred             cccccccccc------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLH------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..........      .......+..+.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000      0011124567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-43  Score=320.99  Aligned_cols=262  Identities=23%  Similarity=0.376  Sum_probs=206.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   87 (340)
                      ..++|.++++||+|+||.||+|.+..      +..||+|++.... ....+.+.+|+.+++.+. ||||+++++++....
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35789999999999999999997532      3469999996543 233467889999999995 999999999999989


Q ss_pred             eeEEEEeccCCCChhhHhhccCc---------------------------------------------------------
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSK---------------------------------------------------------  110 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  110 (340)
                      ..++|||||++|+|.+++.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999988754210                                                         


Q ss_pred             ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC
Q 041345          111 ------------------------------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus       111 ------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~  154 (340)
                                                          ...+++..+..++.|++.|++|||+++   ++|+||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                123778888999999999999999998   99999999999999


Q ss_pred             CCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccch
Q 041345          155 DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNL  233 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~  233 (340)
                      .++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.........  
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence            999999999999886543322222223446778999999988899999999999999999997 88888643221110  


Q ss_pred             hHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                          ......+         .....+...+..+.+++.+||+.+|++|||+.+|.+.|+...
T Consensus       350 ----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 ----YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ----HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                1111111         111222345677899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.4e-43  Score=309.16  Aligned_cols=263  Identities=26%  Similarity=0.406  Sum_probs=211.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            56888999999999999999743      245688998876665556678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           92 VYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                      ||||+++++|.+++.....             ...+++..++.++.|++.|++|||+++   ++|+||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999864321             234789999999999999999999999   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  237 (340)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........       
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-------  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence            99999999876543322222233446788999999988899999999999999999998 8898855433221       


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                      ......+....         .+...+..+.+++.+||+.+|++|||+.+|++.|.++.++.|
T Consensus       235 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~  287 (291)
T cd05094         235 IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP  287 (291)
T ss_pred             HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence            11111121111         122345678999999999999999999999999998766433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-43  Score=329.06  Aligned_cols=252  Identities=18%  Similarity=0.192  Sum_probs=203.9

Q ss_pred             CCCCCCcccccCCeeEEEEEECC--CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .|.+.+.||+|++|.||+|....  ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            38899999999999999997543  5678888775555455566788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           97 PNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        97 ~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      ++++|.+.+... ....++++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++..+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542 22345889999999999999999999999   99999999999999999999999999987653322


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..||.........      .... .+..         
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~------~~~~-~~~~---------  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM------QQVL-YGKY---------  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCCC---------
Confidence            22334456899999999998889999999999999999999999999654322111      1111 0110         


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1112334567899999999999999999999864

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-43  Score=310.15  Aligned_cols=265  Identities=21%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            367999999999999999999765 58899999986443 2234467789999999999999999999998889999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++ +|.+++...  ...++...+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          84 YLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            9975 787777432  234788999999999999999999999   9999999999999999999999999987643221


Q ss_pred             cccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH-----HHhhcC----
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW-----QLWNEG----  244 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~----  244 (340)
                        .......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+....     ..+..-    
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence              11223457889999998865 468999999999999999999999997655443222111100     000000    


Q ss_pred             cccccccccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALELIDTTLHE----SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ............    ...+....++.+|+.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000000    001123456889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.9e-43  Score=302.44  Aligned_cols=252  Identities=28%  Similarity=0.377  Sum_probs=202.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      ++|++.+.||+|+||.||++++.++..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688899999999999999998778889999885433 234578889999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++....  ..+++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++|+|||.+......... 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999999885432  34889999999999999999999999   999999999999999999999999998765332211 


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+       ..+..         .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i-------~~~~~---------~  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-------SRGFR---------L  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCC---------C
Confidence            1122234567999999988889999999999999999999 88888654332211111       11110         1


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            111223457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-43  Score=310.06  Aligned_cols=241  Identities=21%  Similarity=0.268  Sum_probs=193.0

Q ss_pred             ccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ||+|+||.||+|+... ++.||+|++...   .......+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999998754 788999998543   233455678899999999999999999999999999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR  181 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  181 (340)
                      .+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            998853   345899999999999999999999999   9999999999999999999999999987532211  12234


Q ss_pred             ccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       182 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      ..|++.|+|||.+.+..++.++||||+||++|+|++|..||...+.....      .... ..          ....+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~------~~~~-~~----------~~~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY------RKIL-QE----------PLRFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH------HHHH-cC----------CCCCCCc
Confidence            56899999999999989999999999999999999999999654322111      1111 10          0112334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          262 EVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      .+..+.+++.+||+.||++||++..+.+.|
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            456788999999999999998654443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-43  Score=303.00  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=207.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||.|++|.||+|...+++.||+|.+.... .....+.+|+.++++++|+|++++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46799999999999999999988778889999986543 33567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.|+.+||+++   ++|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985533 335899999999999999999999999   999999999999999999999999999876532111


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.........       ......         ..
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~---------~~  222 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQG---------YR  222 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC---------CC
Confidence             1111223457999999988889999999999999999999 88888644322211       111111         11


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ...+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            12233445778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-43  Score=302.51  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=206.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|.+..    ...|++|.+.... ......+.+|+.+++.++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3679999999999999999998643    3578999886543 3344568889999999999999999999998889999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +|||+++++|.+++....  ..+++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++|+|||++..+.
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999985432  35899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||.........       ......      
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~------  224 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-------KAVEDG------  224 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-------HHHHcC------
Confidence            2222222222334678999999988889999999999999999998 88888544322211       111111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                         .....+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       225 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 ---YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               01111233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=306.84  Aligned_cols=256  Identities=24%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--------------hhcHHHHHHHHHHHHcCCCCceeee
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--------------GQGIVEFKNEAKLIAKLQHTNLVRL   79 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~~   79 (340)
                      +-.++|++.+.||.|.||.|-+|+.. +++.||+|++.+..              ....+...+|+.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34588999999999999999999864 48899999995431              1123467899999999999999999


Q ss_pred             eeEEeeC--CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           80 LGCSLQK--GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        80 ~~~~~~~--~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      +.+..+.  +.+|||+|||..|.+...   .....-+++.+++.++.++..||+|||.+|   |+||||||.|+|++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            9997654  579999999998866333   233323899999999999999999999999   99999999999999999


Q ss_pred             CeeEecccccccccCc---ccccccccccccCCCCChhhhccCC----CCccCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          158 NPKISDFGMARTFGMN---ELEANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                      ++||+|||.+..+...   ..........||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+....+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999999876221   1222233478999999999886632    46789999999999999999999965444333


Q ss_pred             cchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      +..+               +...+..+..++....+.+||.++|++||++|.+..+|....
T Consensus       328 ~~KI---------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  328 FDKI---------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHH---------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            3222               233333344456778899999999999999999999998654

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.5e-43  Score=307.94  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=208.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .++|.+.+.||.|+||.||++...      ++..+|+|.+..........+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467999999999999999999742      24568999987666556677899999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccC----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCee
Q 041345           91 LVYEYLPNKSLDFFIFDSS----------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK  160 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~  160 (340)
                      +||||+++++|.+++....          ....+++..+..++.|++.||+|||+++   ++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999985432          1234899999999999999999999999   99999999999999999999


Q ss_pred             EecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHH
Q 041345          161 ISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      |+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........       ..
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------IE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HH
Confidence            999999876543222222223345678999999988889999999999999999998 8888854432221       11


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      ....+...         ..+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus       234 ~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         234 CITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11111111         1112234568999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.7e-43  Score=306.71  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=203.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      ..++|++.+.||+|+||.||.|...      .+..+|+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            5678999999999999999998753      24679999885432 2334567899999999999999999999998889


Q ss_pred             eEEEEeccCCCChhhHhhccCc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSK-------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      .++||||+++++|.+++.....       ...+++..+..++.|++.|++|||+++   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       123677889999999999999999998   999999999999999999999


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      +|||++................++..|+|||.+.++.++.++||||||+++|+|++ |..||.........       ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-------~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-------RF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HH
Confidence            99999876543322222222345678999999988899999999999999999999 67888654332211       11


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ......         ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111111         1112234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.2e-43  Score=312.24  Aligned_cols=241  Identities=22%  Similarity=0.281  Sum_probs=194.6

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.||+|+||.||+++.. +++.||+|++...   .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999864 5889999998643   2233456778999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT  179 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~  179 (340)
                      +|..++..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888743   345899999999999999999999999   9999999999999999999999999987532211  112


Q ss_pred             ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCC
Q 041345          180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCS  259 (340)
Q Consensus       180 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (340)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+......      ... ...          ...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~~~-~~~----------~~~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------LIL-MEE----------IRFP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHh-cCC----------CCCC
Confidence            23568999999999988899999999999999999999999996543322111      111 000          1122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          260 PDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       260 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                      ...+..+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            33456788999999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-43  Score=316.30  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=200.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|.+.+.||+|+||.||+|.+.+  +..||+|.+...   .......+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3679999999999999999997543  368999988543   22345567889999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999854   335899999999999999999999999   9999999999999999999999999987653


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.....       .....+.      
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-------~~i~~~~------  244 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-------QKILEGI------  244 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-------HHHhcCC------
Confidence            21     22356899999999998888999999999999999999999999654332211       1111111      


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVASM  290 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  290 (340)
                          ...+...+..+.+++.+||+.+|++|+     |++++++.
T Consensus       245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                111233345678999999999999995     89988764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.5e-43  Score=311.77  Aligned_cols=263  Identities=22%  Similarity=0.301  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||.|+||.||++.+. ++..+|+|.+... .......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999875 4778899987654 23345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |+++++|.+++..   ...+++..+..++.|++.|+.|||+. +   ++|+||||+||+++.++.++|+|||++..+...
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999853   33588999999999999999999975 5   999999999999999999999999998754321


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH-------------
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL-------------  240 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-------------  240 (340)
                          ......++..|+|||.+.+..++.++|+|||||++|+|++|..||..................             
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence                122346789999999998888999999999999999999999998654332211110000000             


Q ss_pred             -------hhcCc-----cccccccccc---CCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          241 -------WNEGK-----ALELIDTTLH---ESC-SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       241 -------~~~~~-----~~~~~~~~~~---~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                             .....     .....+....   ... ....+.++.+++.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                   00000     0000000000   000 0113456889999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.8e-43  Score=307.51  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=195.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC--CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcC---CCCceeeeeeEEee-----
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL--DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQ-----   85 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----   85 (340)
                      ++|++.+.||+|+||.||+|+..  +++.||+|.+....  ......+.+|+.+++.+   .||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999863  36789999885432  22233456677776665   69999999998752     


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 57888875432 234889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ++......   .......|+..|+|||.+.+..++.++|||||||++|+|++|..||......+....+...........
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            98765432   223345678999999999888999999999999999999999999976554432221111000000000


Q ss_pred             ccccc---ccccc--C-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELI---DTTLH--E-----SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~---~~~~~--~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +....   .....  .     ...+..+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000   00000  0     011234566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-42  Score=301.61  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=205.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .+|.+.+.||.|++|.||+|.+.+ ++.+++|.+.... .....+.+|+.+++.++|+||+++++++......+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            458888999999999999997654 7889999986443 34567889999999999999999999999888999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...++...+..++.|++.|+++||+++   ++|+||||+||++++++.++|+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999985432 335889999999999999999999998   999999999999999999999999998876433221


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..       .....         ...
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~---------~~~  223 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEK---------GYR  223 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHC---------CCC
Confidence             1112233567999999988899999999999999999998 88888654332211       11111         111


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            122334457799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6e-43  Score=313.37  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC-C
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK-G   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~   87 (340)
                      .++|++.+.||.|+||.||+|...      .++.||+|++.... ......+..|+.++.++ .|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            468999999999999999999632      24789999986442 23345678899999999 799999999987644 5


Q ss_pred             eeEEEEeccCCCChhhHhhccCc---------------------------------------------------------
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSK---------------------------------------------------------  110 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  110 (340)
                      .++++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68899999999999998854221                                                         


Q ss_pred             -cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCC
Q 041345          111 -KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM  189 (340)
Q Consensus       111 -~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  189 (340)
                       ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125789999999999999999999998   9999999999999999999999999998764332222222344567899


Q ss_pred             ChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHH
Q 041345          190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIH  268 (340)
Q Consensus       190 aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (340)
                      |||.+.+..++.++|||||||++|+|++ |..||......+.      .......+.         ....+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGT---------RMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccC---------CCCCCccCCHHHHH
Confidence            9999999999999999999999999998 9999864322211      111111111         11112334567899


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          269 VGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       269 li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ++.+||+.+|++|||+.+|++.|+++
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.4e-43  Score=310.55  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CC----EEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .+|++.+.||+|+||.||+|.+.. +.    .||+|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            568999999999999999997533 33    38999986543 34456788999999999999999999998765 5789


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +++|+++|+|.+++...  ...++...++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++..+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998643  234788999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..       .....+      
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-------~~~~~~------  227 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKG------  227 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhCC------
Confidence            3322222222334668999999988899999999999999999997 89998654322211       111111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                         .....++.+...+.+++.+||+.+|.+|||+.+++..|..+.
T Consensus       228 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         228 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               111122334567889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.1e-44  Score=307.78  Aligned_cols=250  Identities=32%  Similarity=0.501  Sum_probs=194.6

Q ss_pred             CCCcccccCCeeEEEEEEC-----CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           22 PGNRLGQGGFGPVYKGKLL-----DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        22 ~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ......+.+|+..+++++||||+++++++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999876     25679999996543 34477899999999999999999999999988889999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++|+|.+++... ....+++..+..|+.|++.||.|||+++   ++|++|+++||+++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999764 2345899999999999999999999998   99999999999999999999999999987632222


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                      ............|+|||.+.+..++.++||||||+++|||++ |..||......+..   .    ....+         .
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~---~----~~~~~---------~  222 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII---E----KLKQG---------Q  222 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH---H----HHHTT---------E
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c----ccccc---------c
Confidence            222333446778999999998889999999999999999999 67887554332211   1    11111         1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      +...+...+..+.+++..||..+|++|||+.++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1222334567788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-43  Score=297.36  Aligned_cols=267  Identities=23%  Similarity=0.305  Sum_probs=207.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-h-cHHHHHHHHHHHHcCCCCc-eeeeeeEEeeCC------
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-Q-GIVEFKNEAKLIAKLQHTN-LVRLLGCSLQKG------   87 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------   87 (340)
                      ..|...++||+|+||+||+|+.. +|+.||+|+++-... + ......+|+.+++.++|+| |+.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34555677999999999999754 588999999865533 1 2345689999999999999 999999998877      


Q ss_pred             eeEEEEeccCCCChhhHhhccCcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKK-ELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      .+++||||+ ..+|..++...... ..++...+..++.||+.|++|||+++   |+||||||.||+|+.+|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            789999998 56888888654321 34677889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      |+.+.-+.  ...+...+|.+|+|||++.+. .|+...||||+|||+.||++++..|.+....++...+-.......+..
T Consensus       167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            98654322  223445678999999999887 799999999999999999999999988877665555544333333333


Q ss_pred             ccccccc-----cccCCC-C-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          246 ALELIDT-----TLHESC-S-------PDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       246 ~~~~~~~-----~~~~~~-~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      |+....-     ...... +       +.......+++.+||+++|.+|.|+...++.
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            3332211     011111 1       1112477899999999999999999999975

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.1e-43  Score=307.03  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=207.6

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      ...++|++.+.||+|+||.||++...+      ...+|+|.+... .......+.+|+.+++.+ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345679999999999999999997532      357899988654 233455688999999999 799999999999998


Q ss_pred             CeeEEEEeccCCCChhhHhhcc-------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDS-------------SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ...+++|||+++++|..++...             .....+++..+..++.|++.|++|||+++   ++|+||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            8999999999999999998542             12345889999999999999999999998   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      +.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999999999987643322222222334677999999988889999999999999999997 888886543322111


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                             ....+.         ....+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus       246 -------~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         246 -------LLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -------HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                   111111         1112234456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.7e-42  Score=303.45  Aligned_cols=257  Identities=32%  Similarity=0.468  Sum_probs=203.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|++.+.||+|+||.||+|..     ..+..+++|.+.... ......+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5688899999999999999974     235789999986433 3344678899999999999999999999999899999


Q ss_pred             EEeccCCCChhhHhhccCc--------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           92 VYEYLPNKSLDFFIFDSSK--------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      +|||+++++|.+++.....              ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853211              234788899999999999999999999   99999999999999999


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHH
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~  236 (340)
                      .++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........     
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~-----  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-----  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            999999999986543322222233345677999999988889999999999999999998 88888543321111     


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                        ........         ...+...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus       237 --~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 --EMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              11111111         11223345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-42  Score=299.56  Aligned_cols=252  Identities=29%  Similarity=0.425  Sum_probs=202.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      ++|++.+.||+|++|.||.|+..++..+|+|.+.... .....+.+|+.+++.++||||+++++++......+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            5688999999999999999988777779999886443 234578899999999999999999999988888999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++....  ..+++..++.++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||.+........ .
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            999999985432  25899999999999999999999999   99999999999999999999999999876543221 1


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........      .. ..+.         ..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~------~~-~~~~---------~~  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE------KV-SQGL---------RL  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH------HH-hcCC---------CC
Confidence            1112234567999999988889999999999999999998 888986544322111      11 1111         01


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            111223567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=317.33  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++..+.|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999875 58899999986432   233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998543   45899999999999999999999998   999999999999999999999999998865432


Q ss_pred             c---------------------------cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCC
Q 041345          174 E---------------------------LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD  226 (340)
Q Consensus       174 ~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~  226 (340)
                      .                           .........|++.|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011233568999999999999999999999999999999999999997554


Q ss_pred             cccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 041345          227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-MSDVASM  290 (340)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~  290 (340)
                      .....      .......       ...........+..+.+++.+||. +|.+||+ +.++++.
T Consensus       235 ~~~~~------~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETY------NKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHH------HHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            32211      1111000       000111111145778899999997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.8e-43  Score=327.88  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=208.2

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG   87 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (340)
                      .+.....++|++.+.||+|+||.||+|+.. +++.||+|.+...  .......+.+|+.++..++|+|+++++..+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            455566789999999999999999999754 5899999998543  3344566788999999999999999887664322


Q ss_pred             --------eeEEEEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           88 --------ERLLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        88 --------~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                              .+++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    3689999999999999886432 2346899999999999999999999999   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~  238 (340)
                      ++|+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|+|++|..||.........      .
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~------~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM------H  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------H
Confidence            9999999998764332223334467899999999999999999999999999999999999999654322211      1


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ... .+.         ....++..+..+.+++.+||+.+|++|||+.+++..
T Consensus       256 ~~~-~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTL-AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHh-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111 111         112234456778999999999999999999999863

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.6e-43  Score=305.05  Aligned_cols=257  Identities=29%  Similarity=0.451  Sum_probs=203.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .+|++.+.||.|+||.||+|...+      +..||+|.+..... .....+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457778999999999999997533      46799999865432 23456888999999999999999999999888999


Q ss_pred             EEEeccCCCChhhHhhccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           91 LVYEYLPNKSLDFFIFDSS-------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      +++||+++++|.+++....             ....++...+..++.|++.||.|||+++   ++||||||.||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999999984321             1234788889999999999999999999   99999999999999999


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHH
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~  236 (340)
                      .++|+|||++................+++.|+|||.+.++.++.++|||||||++|+|++ |..||......+..     
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-----  236 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI-----  236 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            999999999876543222222223345678999999988889999999999999999998 77787654332211     


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                        .....+.         ....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       237 --~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 --EMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              1111111         112234456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.1e-43  Score=313.47  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999865 58899999986432   234456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998543  245899999999999999999999999   999999999999999999999999999876432


Q ss_pred             ccccccccccccCCCCChhhhc------cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVM------NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ... ......|++.|+|||++.      +..++.++|||||||++|+|++|..||.........      ......... 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~-  227 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRF-  227 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCc-
Confidence            221 223346899999999986      456789999999999999999999999654332211      111111110 


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                            ......+..+..+.+|+..||+ +|++|||+.+++.
T Consensus       228 ------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 ------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                  1111112345678889999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=298.70  Aligned_cols=252  Identities=28%  Similarity=0.381  Sum_probs=202.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      .+|++.+.||+|++|.||++.+.++..+|+|.+..... ....+.+|+.+++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            45889999999999999999887777899999854432 33467789999999999999999999998889999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++....  ..+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||.+........ .
T Consensus        83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~  156 (256)
T cd05059          83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T  156 (256)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence            999999986432  25899999999999999999999999   99999999999999999999999999876542211 1


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+...      . ...         ....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~-~~~---------~~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE------S-VSA---------GYRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH------H-HHc---------CCcC
Confidence            1112223457999999988899999999999999999998 788886543322111      1 111         1111


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            222335667999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.9e-44  Score=301.68  Aligned_cols=260  Identities=23%  Similarity=0.287  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----eeEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----ERLLV   92 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~iv   92 (340)
                      +|.-.+++|.|+||+||.|...+ ++.||||..-....    .-.+|+.+|+.++|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            47778899999999999998654 68999998754432    2257899999999999999998876432     24589


Q ss_pred             EeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEecccccccc
Q 041345           93 YEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARTF  170 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~Dfg~~~~~  170 (340)
                      |||++. +|.+.+... ..+..++...+.-+.+||++|++|||+.|   |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 677777542 22445888889999999999999999998   9999999999999965 88999999999987


Q ss_pred             cCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh-------
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN-------  242 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------  242 (340)
                      ..+..   ......|..|+|||.+.|. .|+.+.||||.|||+.||+-|+..|.+.+..++...+-...-...       
T Consensus       177 ~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            54322   2335568899999999876 699999999999999999999999988877766544432211100       


Q ss_pred             cC-----cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 EG-----KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 ~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +.     +..++.......-.....+++..+|+.++|+++|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            01     111111111111123455678999999999999999999999885

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-42  Score=313.50  Aligned_cols=253  Identities=22%  Similarity=0.310  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .|++++.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+...+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999764 47899999986532   2345568899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++|+|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.+++++|+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999853   345889999999999999999999999   9999999999999999999999999875431100


Q ss_pred             c---------------------------------------------ccccccccccCCCCChhhhccCCCCccCceehhh
Q 041345          175 L---------------------------------------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFG  209 (340)
Q Consensus       175 ~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG  209 (340)
                      .                                             ........||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001234689999999999888899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHh--ccCCCCCCCCCHHHH
Q 041345          210 VLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL--CVQDKATDRPTMSDV  287 (340)
Q Consensus       210 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~ev  287 (340)
                      |++|+|++|..||.........      .........       .........+.++.+++.+  |+..+|..||++.++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQ------LKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHH------HHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999999654432211      111100000       0111111234567777776  556677779999999


Q ss_pred             HHH
Q 041345          288 ASM  290 (340)
Q Consensus       288 l~~  290 (340)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-42  Score=305.60  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=196.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.+.||.|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999875 588999999865432 22345678999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||++ ++|.+++...  ...++...+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          83 EYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             ECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            9996 5666666432  234888999999999999999999999   999999999999999999999999998754322


Q ss_pred             ccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC---ccc--
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG---KAL--  247 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~--  247 (340)
                      .  .......+++.|+|||++.+ ..++.++||||+||++|+|++|..||........  ............   .+.  
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccch
Confidence            1  12223457899999998865 4578899999999999999999999975433211  111111100000   000  


Q ss_pred             ----ccccccccCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          248 ----ELIDTTLHESCS---------PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       248 ----~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ...........+         ......+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                000000000000         012346789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=283.60  Aligned_cols=249  Identities=25%  Similarity=0.337  Sum_probs=210.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      -++|++++.||+|-||.||.|+.+. +--||+|++.+.   ......++.+|+++...++||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            3789999999999999999998654 667899998544   223345788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      +||.++|.+...++... ...+++.....+..|+|.|+.|+|.++   ++||||||+|+|++..+.+|++|||-+.... 
T Consensus       101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999997543 345899999999999999999999999   9999999999999999999999999987632 


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                         .......+||.-|.|||...+...+..+|+|++|++.||++.|.+||+.....+....+..                
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----------------  236 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----------------  236 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----------------
Confidence               2334457899999999999999999999999999999999999999976554333322211                


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                       .....|...+.+..++|.+|+..+|.+|.+..+++..
T Consensus       237 -~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 -VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence             1223345566788999999999999999999999864

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-42  Score=302.06  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ..+|.+.++||+|+||.||++...      ++..+++|.+..........+.+|+.+++.++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            467888999999999999999642      25578999887666666778999999999999999999999999988999


Q ss_pred             EEEeccCCCChhhHhhccCc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           91 LVYEYLPNKSLDFFIFDSSK------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                      ++|||+++++|.+++.....            ...+++..+..++.|++.|++|||+++   ++|+||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999999864321            134789999999999999999999999   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  237 (340)
                      ++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.........   .. 
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~-  236 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---EC-  236 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HH-
Confidence            99999999875533222122222334678999999988899999999999999999998 88888543322211   00 


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                         ...+.         ....+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       237 ---~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 ---ITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ---HHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence               00110         011122345668899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4e-42  Score=297.44  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=203.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.++||+|++|.||+|...++..+|+|.+..... ....+.+|+.++++++|++++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            467999999999999999999887888899999865432 3456889999999999999999999875 45678999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999986432 334889999999999999999999999   999999999999999999999999999765432211


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..      .. ...         ...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~------~~-~~~---------~~~  221 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL------EQ-VER---------GYR  221 (260)
T ss_pred             -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH------HH-HHc---------CCC
Confidence             1112234567999999988889999999999999999999 78888643322211      11 111         111


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ...+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            22234455679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.7e-42  Score=297.09  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=197.1

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      +.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999864 58889999875443 34456788999999999999999999999999999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR  181 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  181 (340)
                      .+++...  ...+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9998532  234889999999999999999999999   99999999999999999999999999876442211111111


Q ss_pred             ccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCH
Q 041345          182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSP  260 (340)
Q Consensus       182 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (340)
                      ...+..|+|||.+.++.++.++||||||+++|+|++ |..||........       .....         .......+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~---------~~~~~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIE---------QGVRLPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHH---------cCCCCCCcc
Confidence            223456999999988889999999999999999998 8888854332211       11111         111122233


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       261 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            44567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.4e-43  Score=314.90  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=195.9

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----CeeE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----GERL   90 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   90 (340)
                      +|++.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5889999999999999999865 5889999998543  223345678999999999999999999987543     2479


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+. ++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 678887743   335899999999999999999999999   999999999999999999999999998764


Q ss_pred             cCcccc-cccccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HH
Q 041345          171 GMNELE-ANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQ  239 (340)
Q Consensus       171 ~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~  239 (340)
                      ...... .......|+..|+|||++.+  ..++.++|||||||++|+|++|+.||...+.......+...        ..
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            322111 11233568999999998865  67899999999999999999999999665433221111000        00


Q ss_pred             HhhcCccccccc---ccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          240 LWNEGKALELID---TTLHES---CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       240 ~~~~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .+........+.   ......   ..+..+..+.+++.+||+.||++|||+.++++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000000000   000000   001234567899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.6e-42  Score=304.93  Aligned_cols=244  Identities=23%  Similarity=0.304  Sum_probs=192.7

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.+|+|++....   ......+.+|..++.++ .||+|+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 47889999996532   23345677898988888 699999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++..   ...+++..+..++.|++.|++|||+++   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999888743   335899999999999999999999999   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.......................          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCC
Confidence            2335689999999999999999999999999999999999999965443322222222222211110          112


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMS  285 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~  285 (340)
                      +...+..+.+++.+||+.||++|+++.
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            233456688999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.2e-42  Score=309.58  Aligned_cols=251  Identities=21%  Similarity=0.299  Sum_probs=197.4

Q ss_pred             CCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCC----ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCee
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   89 (340)
                      +|++.+.||+|+||.||+++..    +++.||+|++...    .......+..|+.+++.+ .|++|+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999999753    4788999998543    122345677899999999 599999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999998853   345899999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      +..... .......|+..|+|||.+.+. .++.++|||||||++|+|++|..||............  ..... .     
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~-~-----  225 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL-K-----  225 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHh-c-----
Confidence            532221 122335689999999998765 4788999999999999999999999644332211111  01110 0     


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                           .....+...+..+.+++.+||+.||++||     +++++++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 -----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                 01112233456788999999999999999     6667765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-42  Score=297.46  Aligned_cols=256  Identities=27%  Similarity=0.423  Sum_probs=207.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..++|++.+.||.|++|.||+|...+++.+++|.+.... .....+.+|+.+++.++|+|++++++++......+++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            357899999999999999999998778889999986543 3456788999999999999999999999888889999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++.... ...++...+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||.+..+.....
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999986532 235899999999999999999999999   99999999999999999999999999877643211


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.........   ..    ...         ..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~----~~~---------~~  221 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---EQ----VER---------GY  221 (261)
T ss_pred             -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHc---------CC
Confidence             11112234568999999988889999999999999999998 88998543322211   10    000         11


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ....+...+..+.+++.+||+.+|++||++.++.+.|++
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            112223335678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=303.41  Aligned_cols=264  Identities=23%  Similarity=0.381  Sum_probs=202.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC---------------CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD---------------GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL   80 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~   80 (340)
                      .++|++.+.||+|+||.||+++..+               ...||+|.+... .......+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3689999999999999999986532               224899998654 333456788999999999999999999


Q ss_pred             eEEeeCCeeEEEEeccCCCChhhHhhccCc---------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCe
Q 041345           81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSK---------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNI  151 (340)
Q Consensus        81 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  151 (340)
                      +++......++||||+++++|.+++.....         ...+++..++.++.|++.|++|||+++   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999998999999999999999999854321         123688899999999999999999999   99999999999


Q ss_pred             EeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh--CCCCCCCCCccc
Q 041345          152 LLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTER  229 (340)
Q Consensus       152 lv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p~~~~~~~~  229 (340)
                      +++.++.++|+|||++................++..|+|||.+.++.++.++|+||||+++|+|++  +..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999876543222222223345678999999988889999999999999999998  556765443322


Q ss_pred             ccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ....   ....+.....      ......++..+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       241 ~~~~---~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIEN---TGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHH---HHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111   1111111000      0001112234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-42  Score=298.21  Aligned_cols=256  Identities=24%  Similarity=0.417  Sum_probs=201.6

Q ss_pred             CCCCCcccccCCeeEEEEEECC----CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe-----
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE-----   88 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   88 (340)
                      |++++.||+|+||.||.|....    +..+|+|.+...  .......+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999997543    367999998643  23345678899999999999999999998765543     


Q ss_pred             -eEEEEeccCCCChhhHhhccC---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecc
Q 041345           89 -RLLVYEYLPNKSLDFFIFDSS---KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF  164 (340)
Q Consensus        89 -~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Df  164 (340)
                       .++++||+++++|..++....   ....+++..+..++.|++.||+|||+++   ++|+||||+||++++++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998885432   2235899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhc
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      |++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.   ...    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~----~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDY----LRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHc
Confidence            99886643332222222334668999999988889999999999999999999 7888854333221   111    111


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      +.         ....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11         1112334556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.3e-42  Score=297.19  Aligned_cols=255  Identities=29%  Similarity=0.442  Sum_probs=205.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..++|++.++||.|+||.||+|...+++.+|+|.+.... .....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            357899999999999999999998888999999986543 33567889999999999999999999864 4568999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +.+++|.+++.... ...++...+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999885533 345889999999999999999999998   99999999999999999999999999876542221


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........       .....         .
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~---------~  220 (260)
T cd05067         158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-------NLERG---------Y  220 (260)
T ss_pred             c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-------HHHcC---------C
Confidence            1 1122335678999999988889999999999999999998 999986543222111       11111         1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ....+...+..+.+++.+||+.+|++|||++++++.|++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            111223345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.2e-42  Score=297.67  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=204.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.++||.|++|.||+|++.++..|++|.+.... .....+.+|+.+++.++||||+++++.+.. ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            46799999999999999999988777789999986543 234578899999999999999999998754 5579999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.||++||+++   ++|+||||+||++++++.++|+|||.+..+......
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999986432 234789999999999999999999999   999999999999999999999999999765432211


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       ......++..|+|||...+..++.++|+||||+++|+|++ |..||..........      .. ..         ...
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~------~~-~~---------~~~  221 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------QV-ER---------GYR  221 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH------HH-hc---------CCC
Confidence             1122345677999999988889999999999999999999 777886443222110      10 00         011


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+...+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            122344567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-42  Score=308.19  Aligned_cols=242  Identities=24%  Similarity=0.355  Sum_probs=194.5

Q ss_pred             CCcccccCCeeEEEEEEC----CCCEEEEEEccCC----ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           23 GNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .+.||+|+||.||+++..    .++.||+|++...    .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            367999999999999752    4788999998543    12234456789999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+.+..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999998843   345788899999999999999999999   9999999999999999999999999987532221


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.....      .... .+          
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~-~~----------  215 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKIL-KG----------  215 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHH-cC----------
Confidence              1223356899999999998888999999999999999999999999654332211      1111 11          


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                      ....++..+..+.+++.+||+.+|++||     ++.++++
T Consensus       216 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         216 KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1112333456788999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-42  Score=302.31  Aligned_cols=269  Identities=25%  Similarity=0.367  Sum_probs=203.3

Q ss_pred             cCC-CCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--Ce
Q 041345           18 DNF-SPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GE   88 (340)
Q Consensus        18 ~~y-~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   88 (340)
                      ++| ++.+.||+|+||+||++..     .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455 8899999999999988642     347789999986543 23456678899999999999999999987653  35


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .+++|||+++++|.+++..    ..+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            8899999999999999843    24899999999999999999999999   9999999999999999999999999988


Q ss_pred             cccCccccc-ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          169 TFGMNELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       169 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ......... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLI  234 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhh
Confidence            664322111 11222345679999999888899999999999999999999999754332110 0000000000001111


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..++.......+...+..+.+++..||+.+|++|||++++++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11222222233445567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=315.65  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999875 4889999998543   2233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999854   335899999999999999999999999   999999999999999999999999998754321


Q ss_pred             cccc------------------------------------ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh
Q 041345          174 ELEA------------------------------------NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS  217 (340)
Q Consensus       174 ~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt  217 (340)
                      ....                                    ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112358999999999988899999999999999999999


Q ss_pred             CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 041345          218 SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT---MSDVAS  289 (340)
Q Consensus       218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~  289 (340)
                      |..||.........      ..........       ........+..+.+++.+|+. +|.+|++   +.++++
T Consensus       235 G~~Pf~~~~~~~~~------~~i~~~~~~~-------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQETY------RKIINWKETL-------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHHHH------HHHHcCCCcc-------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999754432211      1111100000       000111234567888999996 9999998   888776

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.3e-42  Score=302.74  Aligned_cols=258  Identities=27%  Similarity=0.427  Sum_probs=204.4

Q ss_pred             CCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      +|++.+.||+|+||.||+|....      ...+++|.+.... ......+.+|+.+++.+.||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            57889999999999999997532      3568888886543 3345678899999999999999999999998889999


Q ss_pred             EEeccCCCChhhHhhccC---------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 041345           92 VYEYLPNKSLDFFIFDSS---------------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASN  150 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  150 (340)
                      ++||+++++|.+++....                     ....+++..++.++.|++.|++|||+++   ++|+||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1234788999999999999999999998   9999999999


Q ss_pred             eEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccc
Q 041345          151 ILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTER  229 (340)
Q Consensus       151 ilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~  229 (340)
                      |++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999876533222222223345678999999988889999999999999999998 888886543322


Q ss_pred             ccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ..       ....         .......+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       238 ~~-------~~~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 LF-------NLLK---------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HH-------HHHh---------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            11       1111         11111222334567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=297.81  Aligned_cols=262  Identities=22%  Similarity=0.299  Sum_probs=214.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +.|++.+.||.|.-|+||+++..+ +..+|+|++.+..   .....+...|.++|..++||.++.+++.+..+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            568888999999999999999766 5789999996653   334456778999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |||+||+|..+.+.. ....+++..+.-++..++.||+|||..|   ||+|||||+||||.++|++.|+||+++..+...
T Consensus       157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999998654 4556999999999999999999999999   999999999999999999999999987644210


Q ss_pred             c---------------------------------c---------------------ccccccccccCCCCChhhhccCCC
Q 041345          174 E---------------------------------L---------------------EANTNRIVGTHGYMSPEYVMNGIV  199 (340)
Q Consensus       174 ~---------------------------------~---------------------~~~~~~~~~~~~y~aPE~~~~~~~  199 (340)
                      .                                 .                     ........||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence            0                                 0                     001123458889999999999999


Q ss_pred             CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCC
Q 041345          200 SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKAT  279 (340)
Q Consensus       200 ~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  279 (340)
                      +.++|.|+||+++|||+.|..||.+.+..+.+..+               +.+.+.....+..+..+.+||+++|.+||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999888777654332               122222222345667899999999999999


Q ss_pred             CCCC----HHHHHH--HhhcCCCCC
Q 041345          280 DRPT----MSDVAS--MLTNDTMAL  298 (340)
Q Consensus       280 ~RPt----~~evl~--~L~~~~~~~  298 (340)
                      +|.-    +.||-+  +++++..++
T Consensus       378 kRlg~~rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             hhhccccchHHhhcCccccCCChhh
Confidence            9998    888765  456655554

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.8e-42  Score=305.12  Aligned_cols=248  Identities=22%  Similarity=0.308  Sum_probs=193.7

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.||+|++...   .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999865 4788999998643   223345677899999888 799999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999888743   345899999999999999999999999   999999999999999999999999998642211  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccc--cchhHHHHHHhhcCcccccccccccC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH--LNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      .....|+..|+|||++.+..++.++|+|||||++|+|++|..||........  ...............          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------C
Confidence            2345689999999999998999999999999999999999999964332221  111111111111110          1


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPT------MSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~  289 (340)
                      ..+...+..+.+++.+||+.||.+|||      +.++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            122334567889999999999999998      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-42  Score=310.20  Aligned_cols=242  Identities=22%  Similarity=0.277  Sum_probs=194.5

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.||+|+||.||+++.. +++.||+|++...   .......+.+|+.+++.+.||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999764 5889999998643   2233456778999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      +|..++..   ...+++..+..++.|++.||.|||+ ++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99888743   3458999999999999999999997 67   9999999999999999999999999987532211  11


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+      . ..          ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~-~~----------~~~~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L-ME----------EIRF  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------h-cC----------CCCC
Confidence            22356899999999999889999999999999999999999999654332211111      0 00          0112


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRP-----TMSDVASM  290 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  290 (340)
                      +...+..+.+++.+||+.||++|+     ++.++++.
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            233456788999999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.8e-42  Score=300.34  Aligned_cols=257  Identities=28%  Similarity=0.424  Sum_probs=202.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|.+.+.||+|++|.||+|.+.+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4779999999999999999997643      4678999886443 33345688899999999999999999999888889


Q ss_pred             EEEEeccCCCChhhHhhccCc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC---CeeEe
Q 041345           90 LLVYEYLPNKSLDFFIFDSSK----KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKIS  162 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~---~~~l~  162 (340)
                      ++||||+++++|.+++.....    ...+++..+..++.||+.|++|||+++   ++|+||||+||+++.++   .++|+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    124889999999999999999999999   99999999999998654   58999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHh
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      |||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||..........       ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-------~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-------FV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HH
Confidence            9999887533222222222233567999999988899999999999999999997 888886543332111       11


Q ss_pred             hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ...         .....+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       235 ~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111         011123334567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6e-42  Score=301.88  Aligned_cols=264  Identities=24%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-----------------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-----------------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVR   78 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~   78 (340)
                      .++|++.+.||+|+||.||+|....                 +..+|+|.+.... ......+.+|+.++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999987533                 2458999986543 344667889999999999999999


Q ss_pred             eeeEEeeCCeeEEEEeccCCCChhhHhhccCc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 041345           79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASN  150 (340)
Q Consensus        79 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  150 (340)
                      +++++..+...+++||++++++|.+++.....        ...+++..++.++.|++.||+|||+++   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999998899999999999999999865321        125899999999999999999999999   9999999999


Q ss_pred             eEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh--CCCCCCCCCcc
Q 041345          151 ILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE  228 (340)
Q Consensus       151 ilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p~~~~~~~  228 (340)
                      |+++.++.++|+|||++................++..|+|||.+.++.++.++||||||+++|+|++  +..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543322222333445778999999988889999999999999999998  66777543322


Q ss_pred             cccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          229 RHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..   .......+....      .......+...+.++.+++.+||+.+|++|||+.+|++.|.
T Consensus       241 ~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QV---IENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HH---HHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            21   111111111110      01111122334567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=300.53  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=205.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|++.+.||.|+||.||+|...+      +..+++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4689999999999999999997643      3679999985443 23445678899999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           90 LLVYEYLPNKSLDFFIFDSSK-------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                      ++||||+++++|.+++.....       ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999864321       223688899999999999999999998   9999999999999999999999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHh
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      |||++................++..|+|||.+.++.++.++|||||||++|++++ |..||......+...       ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-------~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-------FV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-------HH
Confidence            9999876543322222233345778999999988889999999999999999998 888886443332111       11


Q ss_pred             hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ..+..         ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            11111         11222335778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.5e-42  Score=300.18  Aligned_cols=257  Identities=26%  Similarity=0.342  Sum_probs=200.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CC----EEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|++.+.||.|+||.||+|.+.. ++    .+++|.+.... ......+..|+..+..+.||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            578889999999999999998643 44    47788775432 233456778888899999999999999875 445788


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ++||+++++|.+++...  ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||.+....
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999998543  235899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ............++..|+|||.+.++.++.++||||||+++|+|++ |..||.........       .....+..    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~----  229 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGER----  229 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCc----
Confidence            3322222233456778999999988899999999999999999998 88898654332211       11111111    


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                           ...+..+...+.+++.+||..+|++|||+.++++.|..+..
T Consensus       230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 -----LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                 11112234567889999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=310.96  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|+..+.||.|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++|+||+++++++.....+++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            356778899999999999999865 58899999985443 2335678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|....       ..++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++..+....
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            99999885432       2567788899999999999999999   9999999999999999999999999987653221


Q ss_pred             cccccccccccCCCCChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                        .......|+..|+|||.+..     ...+.++|||||||++|+|++|+.||.............   ...        
T Consensus       223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~--------  289 (353)
T PLN00034        223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AIC--------  289 (353)
T ss_pred             --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHh--------
Confidence              11223468999999998743     234568999999999999999999997333222111111   000        


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        .......+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       290 --~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 --MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              001112233456679999999999999999999999974

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-42  Score=311.38  Aligned_cols=258  Identities=17%  Similarity=0.148  Sum_probs=193.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .+|++.+.||+|+||.||+|.+. .++.||+|...      ...+.+|+.++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            67999999999999999999864 47889999653      224578999999999999999999999999999999998


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      . ++|..++..   ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++....... .
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            5 677777643   234889999999999999999999999   9999999999999999999999999987532211 1


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc----chhHHHHHHhhc--Ccc----
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL----NLVGYAWQLWNE--GKA----  246 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~----  246 (340)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||-........    ..+.........  ...    
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            1223456899999999998889999999999999999999999876432211100    000000000000  000    


Q ss_pred             ----cccc----c-----ccccCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 ----LELI----D-----TTLHES--CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ----~~~~----~-----~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ....    .     ...+..  .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                0000    0     000000  00124567889999999999999999999985

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-42  Score=308.69  Aligned_cols=244  Identities=24%  Similarity=0.328  Sum_probs=193.4

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHH---HcCCCCceeeeeeEEeeCCeeEEE
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLI---AKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      |++.+.||+|+||.||+|... +++.||+|++....   ......+.+|..++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999865 48899999986432   22334556665554   456899999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|...+.    ...+++..+..++.|++.|+.|||++|   ++||||||+||+++.++.++|+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988873    235899999999999999999999999   99999999999999999999999999865321


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .  ........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......       .....       
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~-------i~~~~-------  217 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS-------IVNDE-------  217 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhCC-------
Confidence            1  1122345689999999999988999999999999999999999999975443321111       00110       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                         ...+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       218 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 ---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               112233456788999999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=314.67  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=215.0

Q ss_pred             CCCCCcccccCCeeEEEEEECC---CC--EEEEEEccC-CChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD---GQ--EIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      -.+.+.||.|-||.||.|...+   |+  .||||.-+. ...+..+.|..|..+|+.++||||++++|+|.+. ..||||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            3455689999999999997532   33  488998866 3556688899999999999999999999998765 689999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |.++.|-|..++...  ...++......+++||+.|++|||++.   +|||||.++||+|.....|||+|||+++.+..+
T Consensus       470 EL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999653  345899999999999999999999998   999999999999999999999999999988765


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ...... ...-...|+|||.+.-..++.++|||-||+.+||++. |..||.+-...+.                ..-++.
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I~~iEn  607 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------IGHIEN  607 (974)
T ss_pred             chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------EEEecC
Confidence            544333 3445778999999998999999999999999999986 8899865444443                333455


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      +-+.++|+.+++.|+.|+.+||+++|.+||++.++...|+++.
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            6678899999999999999999999999999999999987643

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-42  Score=308.53  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=193.4

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCC-CceeeeeeEEeeCCeeEEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH-TNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +|++.+.||+|+||.||+|+..+ ++.||+|++...   .......+..|..++..+.| ++|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58899999999999999998654 678999998643   22345567788889988865 56888999998889999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|..++..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988853   334889999999999999999999999   999999999999999999999999998653211


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .  .......|++.|+|||++.+..++.++||||+||++|+|++|..||...+.......       ....         
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~-------i~~~---------  216 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS-------IMEH---------  216 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcC---------
Confidence            1  122345689999999999998999999999999999999999999965443221111       1111         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                       ....+...+..+.+++.+||+.||.+|++.
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             111223345678899999999999999987

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=300.37  Aligned_cols=252  Identities=27%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            5888999999999999999864 58899999985432   1223456789999999999999999999999899999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++... ....+++..+..++.|++.|+.|||+++   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887543 2345899999999999999999999999   9999999999999999999999999987653221


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                      .   .....|+..|+|||.+.+..++.++||||+|+++|+|++|..||............   ......          .
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~----------~  220 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKE----------D  220 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhh----------c
Confidence            1   12346789999999998888999999999999999999999999754432211111   000000          0


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVASM  290 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  290 (340)
                      ....+...+..+.+++.+||+.||++||     ++.++++.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1122334566789999999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-41  Score=300.27  Aligned_cols=265  Identities=23%  Similarity=0.369  Sum_probs=203.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-----------------CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-----------------GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVR   78 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~   78 (340)
                      .++|++.+.||+|+||.||+++..+                 +..+|+|.+... .......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3579999999999999999985421                 335899998654 3334567889999999999999999


Q ss_pred             eeeEEeeCCeeEEEEeccCCCChhhHhhccCc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 041345           79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASN  150 (340)
Q Consensus        79 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  150 (340)
                      +++++......+++|||+++++|.+++.....        ...+++..+..++.|++.|++|||+++   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999998899999999999999999865321        123778889999999999999999999   9999999999


Q ss_pred             eEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh--CCCCCCCCCcc
Q 041345          151 ILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE  228 (340)
Q Consensus       151 ilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt--g~~p~~~~~~~  228 (340)
                      |+++.++.++|+|||++..+.............++..|+|||...++.++.++|+|||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999876543222222222334678999999888889999999999999999998  66787544333


Q ss_pred             cccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          229 RHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      +...   .....+......      .....+..++..+.+++.+||+.||++|||+.+|++.|++
T Consensus       241 ~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QVIE---NTGEFFRDQGRQ------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHH---HHHHHHhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            2211   111111111000      0111123345778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.1e-42  Score=301.39  Aligned_cols=262  Identities=23%  Similarity=0.362  Sum_probs=207.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-----CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee-CCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ-KGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   88 (340)
                      ..++|++.+.||+|+||.||+|.+.+     +..|++|.+... .......+.+|+.+++.++|+|++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45789999999999999999998755     678999988644 33345668899999999999999999998766 466


Q ss_pred             eEEEEeccCCCChhhHhhccCcc-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEec
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKK-----ELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD  163 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~D  163 (340)
                      .+++++|+++++|.+++......     ..+++..+..++.|++.|++|||+++   ++|+||||+||++++++.++|+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998653222     45899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhh
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      ||+++.+.............++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+.   .    ....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---A----AYLK  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---H----HHHH
Confidence            999986543222222222345677999999988889999999999999999998 9999865433221   1    1111


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      .+         .....+...+..+.+++.+||..+|++|||+.++++.|+++.+
T Consensus       234 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 DG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             cC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11         1111122345678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=310.94  Aligned_cols=265  Identities=24%  Similarity=0.398  Sum_probs=221.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhc-HHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .....+.++||+|.||.|.++...++..||+|.++...... ...|.+|+++|.+++||||+.++++|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            45678899999999999999998778999999998775444 47899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++|+|.+++..+.... +......+++.||+.|++||.+.+   ++||||.++|+|+++++++||+|||+++.+..++.
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999997654433 566677889999999999999999   99999999999999999999999999998776666


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHH--hCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII--SSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      ........-..+|+|||.+.-+.++.++|||+||+++||++  +...||.....++.....   ...+..+..      .
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~---~~~~~~~~~------~  763 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA---GEFFRDQGR------Q  763 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh---hhhcCCCCc------c
Confidence            66566666789999999999999999999999999999986  477888655544432222   111111111      1


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .....|+-++..++++|.+||..+.++|||++++...|.+.
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            12334567888999999999999999999999999988753

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.5e-42  Score=297.18  Aligned_cols=259  Identities=22%  Similarity=0.353  Sum_probs=206.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||.|+||.||+|+.. +++.||+|.+...   .......+.+|+.+++.++|||++++++++......++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            58999999999999999999864 5889999987532   2334456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||+++++|.+++.... ....++...+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998875322 2345889999999999999999999998   99999999999999999999999999887543


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ...  ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... .....    ......       
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~----~~~~~~-------  224 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQ----KIEQCD-------  224 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHH----HHhcCC-------
Confidence            221  1223457888999999988889999999999999999999999985322111 11111    010100       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                       .........+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             01111234556789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6e-42  Score=304.39  Aligned_cols=241  Identities=27%  Similarity=0.364  Sum_probs=190.8

Q ss_pred             CcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHc-CCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAK-LQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+..+ ++.||+|++....   .........|..++.. ++||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999998754 7889999985431   2233445667777765 4899999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999998853   235889999999999999999999999   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++||||+||++|+|++|..||...+..+....+       ....          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-------~~~~----------~~~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RMDN----------PCY  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCC----------CCC
Confidence            23356899999999999889999999999999999999999999754433211111       0000          111


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMS-DVAS  289 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  289 (340)
                      +......+.+++.+||+.||++||++. ++++
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            223456788999999999999999997 5643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-42  Score=301.82  Aligned_cols=272  Identities=25%  Similarity=0.394  Sum_probs=203.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   89 (340)
                      ..+|++.+.||+|+||.||++..     .++..|++|.+..........+.+|+.+++.++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46899999999999999999974     2478899999876666666788999999999999999999998654  3468


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++|+||+++++|.+++...  ...+++..+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            9999999999999998543  234889999999999999999999999   99999999999999999999999999887


Q ss_pred             ccCccccc-ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH-HhhcCccc
Q 041345          170 FGMNELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ-LWNEGKAL  247 (340)
Q Consensus       170 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~  247 (340)
                      ........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..++......- ......... ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccccccccchHHHH
Confidence            54322111 1111223456999999988889999999999999999999887653322110 000000000 00000000


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      +.+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            01111111122234456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=314.25  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||.|+||.||+++.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999764 5889999988543   2233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   345889999999999999999999999   999999999999999999999999998633210


Q ss_pred             cc-------------c--------------------------------cccccccccCCCCChhhhccCCCCccCceehh
Q 041345          174 EL-------------E--------------------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSF  208 (340)
Q Consensus       174 ~~-------------~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  208 (340)
                      ..             .                                .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00             0                                00012358999999999988899999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCC---CCHH
Q 041345          209 GVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDR---PTMS  285 (340)
Q Consensus       209 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~  285 (340)
                      ||++|+|++|..||..........      .........       ........+..+.+++.+||+ +|.+|   +|+.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~------~i~~~~~~~-------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYR------KIINWRETL-------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHH------HHHccCCcc-------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999996544322111      111100000       001111234668889999997 67765   5999


Q ss_pred             HHHHH
Q 041345          286 DVASM  290 (340)
Q Consensus       286 evl~~  290 (340)
                      +++..
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.6e-42  Score=305.67  Aligned_cols=262  Identities=25%  Similarity=0.401  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      ..+|++++.||+|+||.||+|+..+        +..+|+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3579999999999999999997422        2368999886442 33456788999999999 799999999999988


Q ss_pred             CeeEEEEeccCCCChhhHhhccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSS-------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ...++++||+++++|.+++....             ....+++..+..++.|++.||+|||+++   ++|+||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            88999999999999999986432             1234788899999999999999999999   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      +.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.. 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence            9999999999999876543222222222334567999999988899999999999999999998 77888654332211 


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                            .......         ....+...+..+.+++.+||+.+|.+|||+.++++.|..+...
T Consensus       247 ------~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         247 ------KLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             ------HHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence                  1111111         1112233456788999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9e-42  Score=297.08  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=198.7

Q ss_pred             CCCCCcccccCCeeEEEEEECCCC---EEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC------Ce
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQ---EIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK------GE   88 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~   88 (340)
                      |.+++.||+|+||.||+|++....   .+|+|.+...  .......+.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            467899999999999999875532   5899988543  344466788899999999999999999976432      24


Q ss_pred             eEEEEeccCCCChhhHhhcc---CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDS---SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      .+++|||+++++|.+++...   .....+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998887432   12334889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ++................+++.|+|||...+..++.++||||||+++|+|++ |..||.......   ..    .....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcC
Confidence            9987643322222223345678999999988889999999999999999999 778886433221   11    111111


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...         ..++..+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111         11223456689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-42  Score=303.92  Aligned_cols=262  Identities=25%  Similarity=0.411  Sum_probs=207.7

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEEC--------CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEE
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLL--------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCS   83 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   83 (340)
                      ....++|.+.+.||+|+||.||+|+..        ++..+++|.+... .......+.+|+.+++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            345688999999999999999999641        2346899988644 234456788999999999 899999999999


Q ss_pred             eeCCeeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 041345           84 LQKGERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASN  150 (340)
Q Consensus        84 ~~~~~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  150 (340)
                      ......+++|||+++++|.+++.....             ...+++..+..++.|++.||.|||++|   ++|+||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence            998899999999999999999865321             234788889999999999999999999   9999999999


Q ss_pred             eEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccc
Q 041345          151 ILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTER  229 (340)
Q Consensus       151 ilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~  229 (340)
                      |+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            9999999999999999987654332222233345678999999988889999999999999999998 777775443222


Q ss_pred             ccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...       ....+.         ....+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus       248 ~~~-------~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         248 LFK-------LLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHH-------HHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            111       111111         1112234557788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.1e-42  Score=304.03  Aligned_cols=240  Identities=25%  Similarity=0.339  Sum_probs=190.0

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.||+|.+....   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999875 47889999985431   22344556677777654 899999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++..   ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999988843   345889999999999999999999999   999999999999999999999999998643211  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|+..|+|||++.+..++.++||||+||++|+|++|..||...+......       .....          ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~-------~~~~~----------~~~~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVD----------TPHY  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhC----------CCCC
Confidence            234568999999999999999999999999999999999999996544322111       11000          0111


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMS-DVA  288 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl  288 (340)
                      +......+.+++.+||+.||++||++. +++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            223456788999999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-42  Score=309.26  Aligned_cols=239  Identities=24%  Similarity=0.299  Sum_probs=192.5

Q ss_pred             CCcccccCCeeEEEEEE----CCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           23 GNRLGQGGFGPVYKGKL----LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .+.||+|+||.||+++.    .+++.+|+|++....  ......+.+|+.++++++||||+++++++......++||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999874    347899999986432  123345678999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          81 RGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            99999998843   345899999999999999999999999   9999999999999999999999999987643221  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.....      .... ..          ..
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~-~~----------~~  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMIL-KA----------KL  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHH-cC----------CC
Confidence            1223356899999999998888999999999999999999999999654332211      1111 00          01


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSD  286 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  286 (340)
                      ..+...+..+.+++.+||+.||++|||+.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            122334567889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.8e-42  Score=311.57  Aligned_cols=254  Identities=21%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999765 48899999986432   233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   345899999999999999999999999   999999999999999999999999998754321


Q ss_pred             ccc---------------------------------cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCC
Q 041345          174 ELE---------------------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK  220 (340)
Q Consensus       174 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~  220 (340)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123468999999999998899999999999999999999999


Q ss_pred             CCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 041345          221 NNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQ--DKATDRPTMSDVASM  290 (340)
Q Consensus       221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~evl~~  290 (340)
                      ||...........+      ........     ...  ....+..+.+++.+++.  .++..||+++++++.
T Consensus       235 Pf~~~~~~~~~~~i------~~~~~~~~-----~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQETYKKV------MNWKETLI-----FPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHHHHHHHH------HcCcCccc-----CCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99654433221111      10000000     000  01123456666666443  344467899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.4e-42  Score=296.51  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=201.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++++++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            46799999999999999999986 45788999998655444556778899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++..   ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            999999998843   335899999999999999999999998   9999999999999999999999999988653221 


Q ss_pred             ccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                       .......++..|+|||.+.   ...++.++|+||+||++|+|++|+.||............       ....   ....
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~~~  229 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQPP  229 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CCCC
Confidence             1122345788999999874   345788999999999999999999998533222111000       0000   0000


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                        ........+..+.+++.+||+.+|++|||++++++.|
T Consensus       230 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 --KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              0001123456789999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.1e-42  Score=305.74  Aligned_cols=242  Identities=24%  Similarity=0.323  Sum_probs=193.5

Q ss_pred             CcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+... ++.||+|++...   .......+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999998754 789999998643   223345567788888766 799999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|...+..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988853   335889999999999999999999999   9999999999999999999999999987543221  11


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......      .. ...          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~-~~~----------~~~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------IL-HDD----------VLY  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HH-cCC----------CCC
Confidence            2335689999999999888999999999999999999999999975543322111      11 110          011


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRP-------TMSDVASM  290 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~~  290 (340)
                      +...+.++.+++.+||+.||++||       ++.++++.
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            222356788999999999999999       77777754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.3e-42  Score=304.45  Aligned_cols=260  Identities=26%  Similarity=0.404  Sum_probs=205.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      .++|.+.+.||+|+||.||+++..+        ...+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4789999999999999999997532        3469999986542 33455688899999999 799999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ...++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+++   ++|+||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999865321             134888999999999999999999998   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      +.++.++|+|||.+................++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999876543221111222234568999999988889999999999999999998 778885433222111


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                             .....         .....+...+..+.+++.+||..+|++|||+.++++.|..+.
T Consensus       254 -------~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         254 -------LLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             -------HHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                   11111         111223344568889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=326.16  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=219.2

Q ss_pred             CCCCCcccccCCeeEEEEEECC----CCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..|.+.||.|.||.|++|+.+-    ...||||.++.... .....|..|+.+|-+++||||+++.|+........||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            4677899999999999998643    34699999976643 345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ||++|+|+.||+...+  .+...++..+++.|+.|+.||-+.|   +|||||.++||||+.+..+|++|||+++.+.++.
T Consensus       711 yMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999987553  3889999999999999999999999   9999999999999999999999999999876544


Q ss_pred             ccc-ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          175 LEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       175 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ... .+....-..+|.|||.+....++.++||||+|+++||.++ |..|+..+.+++                +.+.++.
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIkaIe~  849 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKAIEQ  849 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHHHHh
Confidence            222 2223334678999999999999999999999999999886 778986554443                3344566


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      .++.+.|.+++..|++||..||++|..+||++.+|+..|.++.
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            7788889999999999999999999999999999999998753

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-42  Score=315.22  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=197.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36999999999999999999864 48899999985432   223456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999854   345889999999999999999999999   999999999999999999999999997532100


Q ss_pred             c-----------------------------------------cccccccccccCCCCChhhhccCCCCccCceehhhHHH
Q 041345          174 E-----------------------------------------LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV  212 (340)
Q Consensus       174 ~-----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl  212 (340)
                      .                                         .........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001124689999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCC---CHHHHHH
Q 041345          213 LEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP---TMSDVAS  289 (340)
Q Consensus       213 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~  289 (340)
                      |+|++|..||...........+      .....       ..........+..+.+++.+|+ .+|.+|+   |+.++++
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i------~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKV------INWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHH------hccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999999765433211110      00000       0011111223456677777766 5999999   8888886


Q ss_pred             H
Q 041345          290 M  290 (340)
Q Consensus       290 ~  290 (340)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-42  Score=306.07  Aligned_cols=236  Identities=23%  Similarity=0.337  Sum_probs=189.8

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.||+|++...   .......+..|..++..+ .||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 4788999998643   223345567788888776 699999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988853   335899999999999999999999999   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+......       ......          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-------~i~~~~----------~~~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-------AILNDE----------VVY  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-------HHhcCC----------CCC
Confidence            233568999999999998899999999999999999999999997544332111       111111          111


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                      +...+..+.+++.+||+.||++||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            22345678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=293.31  Aligned_cols=250  Identities=32%  Similarity=0.475  Sum_probs=204.0

Q ss_pred             CcccccCCeeEEEEEECC----CCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||.|+||.||+|....    +..+++|.+...... ....+.+|+..++.++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998754    778999998665433 367788999999999999999999999998899999999999


Q ss_pred             CChhhHhhccCc------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           99 KSLDFFIFDSSK------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        99 ~~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ++|.+++.....      ...+++..+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865421      256899999999999999999999999   99999999999999999999999999987654


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ...........++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+....       ...        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~--------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-------LRK--------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHc--------
Confidence            332223334556889999999988889999999999999999999 5888866533221111       111        


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                       ......+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             1112223444678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.6e-42  Score=299.78  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|++.+.||.|+||.||+|...      ++..+|+|.+.... ......+.+|+.+++.+.|||++++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            468999999999999999999763      35789999986543 33456688999999999999999999999998899


Q ss_pred             EEEEeccCCCChhhHhhccCc-------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 041345           90 LLVYEYLPNKSLDFFIFDSSK-------------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASN  150 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  150 (340)
                      +++|||+++++|.+++.....                   ...+++..++.++.|++.||+|||+++   ++|+||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999864211                   124778889999999999999999998   9999999999


Q ss_pred             eEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccc
Q 041345          151 ILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTER  229 (340)
Q Consensus       151 ilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~  229 (340)
                      |+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876532222111222334567999999988899999999999999999997 777875433222


Q ss_pred             ccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ..       .....+..         ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       241 ~~-------~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 VI-------YYVRDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HH-------HHHhcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            11       11111111         11223345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-42  Score=319.87  Aligned_cols=262  Identities=19%  Similarity=0.279  Sum_probs=192.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--------C
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--------G   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~   87 (340)
                      .++|++++.||+|+||.||+|... +++.||+|.+....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999864 58899999885432    1335799999999999999998876432        2


Q ss_pred             eeEEEEeccCCCChhhHhhc-cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEeccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFD-SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFG  165 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg  165 (340)
                      .+++||||+++ ++.+++.. ......+++..+..++.|++.||+|||+++   |+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 56555532 223456899999999999999999999999   99999999999998654 69999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH------
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW------  238 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~------  238 (340)
                      +++.+....   ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+....      
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            998654321   12234678999999988664 68999999999999999999999997655433221111000      


Q ss_pred             --HH----hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          239 --QL----WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       239 --~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ..    +..-.........+....+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence              00    0000000000011111122234567899999999999999999999984

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.5e-42  Score=305.81  Aligned_cols=241  Identities=23%  Similarity=0.311  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +|++.+.||+|+||.||+|+... ++.||+|++....   ......+..|..++..+ .|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58889999999999999998654 6789999986432   22334556677777777 5899999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|...+..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   335889999999999999999999999   999999999999999999999999998753321


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .  .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+      . ..         
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------~-~~---------  216 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------M-EH---------  216 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------H-hC---------
Confidence            1  1223456899999999999999999999999999999999999999754433221111      0 11         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                       ....+...+.++.+++.+||+.+|++|++.
T Consensus       217 -~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             011223445678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.2e-42  Score=311.66  Aligned_cols=253  Identities=22%  Similarity=0.269  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999865 4889999998542   223344577899999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++|+|.+++..    ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999998843    24788899999999999999999999   99999999999999999999999999876543


Q ss_pred             cccccccccccccCCCCChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ... .......|++.|+|||.+.+.    .++.++|||||||++|+|++|..||...+.....      .......... 
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~~~-  266 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKNSL-  266 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCCcC-
Confidence            221 122335689999999988643    4789999999999999999999999754432211      1111111000 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATD--RPTMSDVASM  290 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  290 (340)
                            ........+..+.+++.+||+.+|++  |||+.+++..
T Consensus       267 ------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 ------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                  01111234577889999999999998  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-41  Score=302.93  Aligned_cols=243  Identities=23%  Similarity=0.314  Sum_probs=190.6

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.+|+|++...   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 4788999998643   223345577888888776 799999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|...+..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence            999888743   345899999999999999999999999   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc--chhHHHHHHhhcCcccccccccccC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL--NLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|..||.........  ..............          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence            23356899999999999999999999999999999999999999533222111  11111111111111          1


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                      ..+...+..+.+++.+||+.||++|||+
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1233445678899999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.9e-42  Score=301.59  Aligned_cols=261  Identities=25%  Similarity=0.406  Sum_probs=205.8

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      ...++|.+.+.||+|+||.||++...      .+..+|+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34468999999999999999999642      24479999886543 33456788999999999 799999999999988


Q ss_pred             CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      +..+++|||+++++|.+++.... ...+++.++..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence            89999999999999999986432 233899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      +................++..|+|||.+.++.++.++||||+||++|+|++ |..||.........      ......+ 
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~-  260 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEG-  260 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcC-
Confidence            886543222111222345678999999988899999999999999999998 88888543322110      1111111 


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                              .....+...+..+.+++.+||..+|++|||+.++++.|.+.
T Consensus       261 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 --------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                    11111223356789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.9e-42  Score=311.84  Aligned_cols=261  Identities=23%  Similarity=0.382  Sum_probs=204.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   87 (340)
                      ..++|.+.+.||+|+||.||+|++.+      +..||+|++.... ......+.+|+.++.++. ||||+++++++....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            34678899999999999999998532      4579999996543 233456889999999997 999999999999988


Q ss_pred             eeEEEEeccCCCChhhHhhccCc---------------------------------------------------------
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSK---------------------------------------------------------  110 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  110 (340)
                      ..++||||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999864311                                                         


Q ss_pred             --------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeE
Q 041345          111 --------------------------------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL  152 (340)
Q Consensus       111 --------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nil  152 (340)
                                                            ...+++..+..++.|++.||+|||+++   ++|+||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                  123677788899999999999999998   999999999999


Q ss_pred             eCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccccc
Q 041345          153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHL  231 (340)
Q Consensus       153 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~  231 (340)
                      +++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999876532221111222346788999999988889999999999999999998 88888543322210


Q ss_pred             chhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          232 NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                            ......+         .+...+...+..+.+++.+||..+|.+||++.+|+..|+++
T Consensus       352 ------~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         352 ------YNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ------HHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  1111111         11122334457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-41  Score=301.92  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=205.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC--------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      .++|.+.+.||+|+||.||+|+..        ....+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            368899999999999999999742        24468999886442 33456788899999999 699999999999988


Q ss_pred             CeeEEEEeccCCCChhhHhhccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSS-------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ...+++|||+++++|.+++....             ....+++..+..++.|++.||.|||++|   ++|+||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            88999999999999999986532             1235889999999999999999999998   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      +.++.++|+|||.+................++..|+|||.+.++.++.++||||||+++|+|++ |..||......+...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999986543222111222234467999999988899999999999999999999 788886543322111


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      ..       ..+.         ....+...+..+.+++.+||..+|++|||+.++++.|.++..
T Consensus       248 ~~-------~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         248 LL-------REGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HH-------HcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11       1111         111223345678899999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.1e-41  Score=292.78  Aligned_cols=258  Identities=23%  Similarity=0.355  Sum_probs=207.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||.|++|.||+|... +++.+++|.++..   .......+.+|+.++++++|++++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999876 6889999988532   2233567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||+++++|..++... .....++...+..++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988543 22345899999999999999999999999   99999999999999999999999999876543


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ...  ......++..|.|||.+.+..++.++|+||+|+++|+|++|..||......    .... ......+        
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~--------  223 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEKC--------  223 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-HhhhhcC--------
Confidence            211  122345788899999998888999999999999999999999998533211    0000 0011111        


Q ss_pred             cccCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          253 TLHESCSP-DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       253 ~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                       .....+. ..+..+.+++.+||..+|++|||+.+|++.|+++
T Consensus       224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence             1111222 4556789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.2e-42  Score=312.87  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=194.1

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +|++.+.||+|+||.||+|+.. +++.+|+|++....   ......+.+|+.+++.+.|+||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6889999999999999999864 47889999986432   2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++|+|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998854   245889999999999999999999999   9999999999999999999999999975321000


Q ss_pred             c---------------------------------------------ccccccccccCCCCChhhhccCCCCccCceehhh
Q 041345          175 L---------------------------------------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFG  209 (340)
Q Consensus       175 ~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG  209 (340)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001124689999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHH
Q 041345          210 VLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT---MSD  286 (340)
Q Consensus       210 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e  286 (340)
                      |++|+|++|..||...+.....      ........       ..........+.++.+++.+|+ .+|.+|++   +.+
T Consensus       236 vil~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQ------MKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHH------HHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999999754432211      11111000       0011111223456677777765 49999997   777


Q ss_pred             HHH
Q 041345          287 VAS  289 (340)
Q Consensus       287 vl~  289 (340)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-41  Score=298.82  Aligned_cols=261  Identities=26%  Similarity=0.431  Sum_probs=203.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+..++.++||||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999643      24579999886443 2234457789999999999999999999988889


Q ss_pred             eEEEEeccCCCChhhHhhccCc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSK-------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      .++||||+++++|.+++.....       ...++...+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964221       233567788999999999999999999   999999999999999999999


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      +|||++................++..|+|||.+.++.++.++|+|||||++|+|++ |..||......+..       ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~-------~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL-------KF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HH
Confidence            99999876533222222222334677999999988899999999999999999998 67888643332211       11


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ...+...         ..+...+..+.+++.+||+.+|++|||+.++++.|.+..
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111111         111233467999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=294.45  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-----hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|.+.+.||.|++|.||.|... +++.+++|.+....     ......+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999764 58899999885432     1223567889999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ++||+++++|.+.+..   ...++...+..++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853   335889999999999999999999999   9999999999999999999999999987653


Q ss_pred             Ccccccc-cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEAN-TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ....... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........      .......       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~-------  222 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQ-------  222 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhcc-------
Confidence            2211111 1234567889999999888899999999999999999999999854322211      0111000       


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        ......+......+.+++.+||..+|++|||+.++++.
T Consensus       223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 --PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              11112233456678999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-41  Score=293.42  Aligned_cols=247  Identities=28%  Similarity=0.377  Sum_probs=196.3

Q ss_pred             cccccCCeeEEEEEE---CCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           25 RLGQGGFGPVYKGKL---LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      .||+|+||.||+|.+   .++..+|+|++....  ......+.+|+.+++.+.||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964   247789999986443  234567889999999999999999999875 45678999999999


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc-c
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA-N  178 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~  178 (340)
                      +|.+++..   ...+++..+..++.|++.|+++||+++   ++|+||||.||+++.++.++|+|||++.......... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   235899999999999999999999999   9999999999999999999999999998764332211 1


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES  257 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (340)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........       ...+         ....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------i~~~---------~~~~  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-------IESG---------ERME  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCC---------CCCC
Confidence            122234578999999988889999999999999999998 8999865433221111       1111         1122


Q ss_pred             CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       258 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .+...+..+.++|.+||+.||++||++.+|...|++.
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            2334567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.5e-42  Score=309.71  Aligned_cols=256  Identities=20%  Similarity=0.262  Sum_probs=199.4

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      ....++|++.+.||+|+||.||+++... ++.+|+|++...   .......+.+|+.+++.+.||||+++++++.++...
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            3345789999999999999999998754 788999998542   222344577899999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++||||+++|+|.+++..    ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence            999999999999999843    24788999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCcccccccccccccCCCCChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ...... .......||+.|+|||++.+.    .++.++|+||+||++|+|++|..||...+.....      ........
T Consensus       192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~  264 (370)
T cd05621         192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKN  264 (370)
T ss_pred             cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCc
Confidence            542221 122345689999999998653    3788999999999999999999999654332211      11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATD--RPTMSDVASM  290 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  290 (340)
                      ..       ........+..+.+++..||..++.+  |+|+.++++.
T Consensus       265 ~~-------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 SL-------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cc-------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00       01111233566788889999865544  8999999886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-41  Score=292.84  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=202.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||.|++|.||+|.+.++..+|+|.+.... .....+.+|+.+++.++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            36799999999999999999988777789999885443 23456788999999999999999999875 45678999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999986532 334789999999999999999999998   999999999999999999999999998765432211


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       ......++..|+|||...+..++.++|+||||+++|+|++ |..||.........       ......         ..
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~---------~~  221 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-------EQVERG---------YR  221 (260)
T ss_pred             -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------CC
Confidence             1122335677999999988889999999999999999999 88888643322111       111111         11


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ...+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            12234456779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7e-42  Score=301.65  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=202.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-C--CEEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-G--QEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.+... .......+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999997644 3  24788887643 333456788999999999 799999999999988889999


Q ss_pred             EeccCCCChhhHhhccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCe
Q 041345           93 YEYLPNKSLDFFIFDSS-------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP  159 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~  159 (340)
                      +||+++++|.+++....             ....+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985432             1134888999999999999999999998   9999999999999999999


Q ss_pred             eEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 041345          160 KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  238 (340)
                      +|+|||++......   ........+..|+|||...+..++.++|||||||++|+|++ |..||.........       
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-------  228 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-------  228 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------
Confidence            99999998642211   11111223457999999988889999999999999999997 98998654332211       


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL  298 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  298 (340)
                      .....         ......+...+..+.+++.+||+.+|.+|||+.++++.|.++....
T Consensus       229 ~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         229 EKLPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111         1111122334567899999999999999999999999998765544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=313.02  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=216.6

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      +....++||.|.||.||.|.|+. .-.||||.++ .+.-..++|..|+.+|+.++|||+|+++|+|..+..+|||.|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            34566899999999999999876 5679999994 445668899999999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      .|+|.+++++-.. ..++....+.++.||+.|++||..++   ++||||.++|.||.++..||++|||+++++..+.+..
T Consensus       347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999977543 34778888999999999999999999   9999999999999999999999999999876444333


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      .. ...-.+.|.|||.+....++.|+|||+||++|||+.| |..|+.+.+-.+.+                .+++..++.
T Consensus       423 HA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY----------------~LLEkgyRM  485 (1157)
T KOG4278|consen  423 HA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------GLLEKGYRM  485 (1157)
T ss_pred             cc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH----------------HHHhccccc
Confidence            22 2233678999999999999999999999999999998 55777654433332                234556667


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ..|..|++.+++||+.||+.+|.+||++.|+-+.|+.+.
T Consensus       486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            777888899999999999999999999999999997653

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-41  Score=295.78  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-C---CEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-G---QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ..|++.+.||+|+||.||+|.... +   ..|++|.+... .......+..|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            458889999999999999998643 3   35999998654 344566789999999999999999999999988899999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++...  ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999998543  234889999999999999999999999   99999999999999999999999999876543


Q ss_pred             ccccccccc-c--cccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          173 NELEANTNR-I--VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       173 ~~~~~~~~~-~--~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ......... .  ..+..|+|||.+.+..++.++||||+|+++|++++ |..||...........+       ..     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-------~~-----  226 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-------EQ-----  226 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-------Hc-----
Confidence            221111111 1  12357999999988899999999999999999886 89998644332211110       00     


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          ......+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 ----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                011112233456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-41  Score=296.89  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=202.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCC----EEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .++|++.+.||.|+||.||+|++. +++    .||+|.+.... ......+.+|+..+..+.||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            467889999999999999999753 344    48999986543 33455678899999999999999999988754 578


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ++++|+++|+|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||++++++.++|+|||++..+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999998543  335899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .............++..|+|||...+..++.++|||||||++|+|++ |..||.........       .......    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~----  228 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-------DLLEKGE----  228 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCC----
Confidence            43322212222334678999999988889999999999999999998 88888543322211       1111111    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                           ....+...+..+.+++.+||+.||++|||+.++++.|..+..
T Consensus       229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                 111123345678899999999999999999999999987633

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-41  Score=295.97  Aligned_cols=246  Identities=23%  Similarity=0.321  Sum_probs=194.5

Q ss_pred             ccccCCeeEEEEEEC-CCCEEEEEEccCCCh---hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           26 LGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999764 588999999854321   2335567899999999999999999999998999999999999999


Q ss_pred             hhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccc
Q 041345          102 DFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN  180 (340)
Q Consensus       102 ~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~  180 (340)
                      ...+... .....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8887542 23345899999999999999999999999   99999999999999999999999999876543221  223


Q ss_pred             cccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCH
Q 041345          181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSP  260 (340)
Q Consensus       181 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (340)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|..||............  .....         ..  ....+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~---------~~--~~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRIL---------ND--SVTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhc---------cc--CCCCcc
Confidence            356889999999999999999999999999999999999999654332111000  00000         00  012233


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          261 DEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       261 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                      ..+..+.+++.+||+.||++||     |++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            4566788999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.4e-42  Score=303.89  Aligned_cols=242  Identities=26%  Similarity=0.337  Sum_probs=193.9

Q ss_pred             CcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||.|+||.||+|+... ++.||+|++...   .......+..|..+++.+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998754 788999998643   223345567788888877 799999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|...+..   ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999988843   335899999999999999999999999   9999999999999999999999999986532111  11


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.....       .......          ...
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------~~i~~~~----------~~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------QSILEDE----------VRY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCC----------CCC
Confidence            22346889999999999999999999999999999999999999654432211       1111110          111


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTM-----SDVASM  290 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~~  290 (340)
                      +...+..+.+++.+||+.||++|||+     .++++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            23345678999999999999999999     887753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-41  Score=291.14  Aligned_cols=250  Identities=28%  Similarity=0.365  Sum_probs=203.9

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|.+.+.||+|++|.||+|... +++.+++|.+...  .......+.+|+.+++.++|||++++++++......++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999864 4889999988543  334556788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++.... ...++...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999986532 345889999999999999999999998   99999999999999999999999999886543221


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.....       .....+.         .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~---------~  218 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI-------LKIIRGV---------F  218 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC---------C
Confidence              123345788999999998888999999999999999999999999654422111       1011111         1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11222455678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=292.41  Aligned_cols=250  Identities=27%  Similarity=0.435  Sum_probs=205.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||.|++|.||+|.. .++.+++|.+..... ...++.+|+.+++.++|+|++++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            56899999999999999999987 578999999965543 4567889999999999999999999999888999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||.+.......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            9999999985432 235899999999999999999999999   9999999999999999999999999988653221  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                         .....+..|.|||.+.++.++.++|+||||+++|++++ |..||.........       ......         ..
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~---------~~  217 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PHVEKG---------YR  217 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhcC---------CC
Confidence               12234567999999988889999999999999999997 88888544322211       111111         01


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ...+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            11223345778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-41  Score=297.80  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..+|++.+.||.|++|.||+|... +++.+++|.+..........+.+|+.+++.+.|+|++++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            368999999999999999999864 5889999998765555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++..    ..++...+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-  170 (296)
T cd06654          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (296)
T ss_pred             cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence            999999998842    34788999999999999999999999   9999999999999999999999999987643221 


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       .......+++.|+|||.+.+..++.++|||||||++|+|++|..||.........      ........        ..
T Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~--------~~  235 (296)
T cd06654         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT--------PE  235 (296)
T ss_pred             -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCC--------CC
Confidence             1122345788999999998888999999999999999999999999644332111      00000000        01


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+...+..+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            1122345567889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-41  Score=293.81  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=206.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||.|++|.||+|+. .+++.+++|.+...   .......+.+|+.+++.+.|+||+++++++......+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5788999999999999999985 46889999987543   2233457889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||+++++|.+++... .....+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988542 22345899999999999999999999999   99999999999999999999999999876543


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....    ......        
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~~--------  223 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC----KKIEQC--------  223 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHh----hhhhcC--------
Confidence            221  1223457889999999988889999999999999999999999985432211 0000    000000        


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ......+...+..+.+++.+||+.+|++|||+.+|++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            001111223566799999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-41  Score=289.62  Aligned_cols=248  Identities=27%  Similarity=0.389  Sum_probs=199.5

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChh
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLD  102 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~  102 (340)
                      ++||.|++|.||++...+++.|++|.+...... ....+.+|+.+++++.|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999998867999999988655433 4567889999999999999999999999999999999999999999


Q ss_pred             hHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccc
Q 041345          103 FFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI  182 (340)
Q Consensus       103 ~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  182 (340)
                      +++...  ...++...+..++.+++.|+++||+++   ++|+||+|+||+++.++.++|+|||.+...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998543  234789999999999999999999999   999999999999999999999999998765422211111222


Q ss_pred             cccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       183 ~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      ..+..|+|||.+.++.++.++|+||||+++|+|++ |..||..........       ....         ......+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-------~~~~---------~~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-------RIES---------GYRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-------HHhc---------CCCCCCCcc
Confidence            33567999999988889999999999999999999 778875543322111       1100         111122334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          262 EVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      .+..+.+++.+||..+|++|||+.++++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            5668999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-41  Score=300.76  Aligned_cols=237  Identities=24%  Similarity=0.302  Sum_probs=187.6

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHH-HHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAK-LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 58899999985432   122234444544 56778999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++..   ...+++..+..++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999988843   345899999999999999999999999   999999999999999999999999998753221  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+...      ... ...          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~-~~~----------~~~  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NIL-NKP----------LRL  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHH-cCC----------CCC
Confidence            234568999999999999899999999999999999999999996543322111      111 110          111


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMS  285 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~  285 (340)
                      ++..+..+.+++.+||+.||.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            223356788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-41  Score=308.06  Aligned_cols=260  Identities=21%  Similarity=0.264  Sum_probs=201.6

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK   86 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (340)
                      .++....++|++.+.||+|+||.||+++.. +++.+|+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555689999999999999999999875 4788999998542   222344577899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      ...++||||+++++|.+++..    ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999999843    23788899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+.....      .....
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~  261 (371)
T cd05622         189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMN  261 (371)
T ss_pred             eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHc
Confidence            986543221 122345689999999998653    3789999999999999999999999754332211      11111


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATD--RPTMSDVASML  291 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L  291 (340)
                      .....       ........+..+.+++..||..++.+  ||++.++++..
T Consensus       262 ~~~~~-------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         262 HKNSL-------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCCcc-------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111       11112344567888999999844443  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=303.71  Aligned_cols=254  Identities=24%  Similarity=0.298  Sum_probs=215.1

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh---hcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCe
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGE   88 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   88 (340)
                      ..+...|.+.+.||+|.||.||.++.+. |+.+|+|.+.+...   .....+.+|+.+|+++. ||||+.+.+++++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            3455789999999999999999998766 99999999966533   24568899999999998 9999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC----CCCeeEecc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD----QMNPKISDF  164 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~----~~~~~l~Df  164 (340)
                      +++|||+|.||.|.+.+...    .+++..+..++.|++.++.|||+.|   ++||||||+|+|+..    ++.++++||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            99999999999999999655    2999999999999999999999999   999999999999963    357999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      |++.....   .......+||+.|+|||++....|+..+|+||+|+++|.|++|..||.+.........+.       .+
T Consensus       184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------~~  253 (382)
T KOG0032|consen  184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------RG  253 (382)
T ss_pred             CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------cC
Confidence            99998654   334556889999999999998999999999999999999999999997665544332111       11


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..      .+.....+..+..+.+++..|+..||.+|+|+.++++.
T Consensus       254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            11      22333445667889999999999999999999999984

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5e-41  Score=293.59  Aligned_cols=251  Identities=21%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+.+++++.||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4688899999999999999976 45888999998554 333455688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|..+.       .+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999986542       3678889999999999999999999   999999999999999999999999998765322  


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........................        
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  218 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--------  218 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--------
Confidence              2233567889999999988889999999999999999999999996533222111110001111111100        


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .......+..+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00112234578899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.9e-41  Score=291.26  Aligned_cols=254  Identities=25%  Similarity=0.425  Sum_probs=204.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||+|+||.||++...++..+++|.+.... .....+.+|+.+++.++|+|++++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            47899999999999999999987778889999886443 335678899999999999999999998877 6789999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999999986532 334788899999999999999999998   99999999999999999999999999876543221 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .......++..|+|||.+.++.++.++|+||||+++|++++ |..||...+.....       .....+         ..
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~---------~~  221 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERG---------YR  221 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCC---------CC
Confidence            11222335677999999988889999999999999999998 88888644322211       111111         11


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ...+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11223445678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-41  Score=308.05  Aligned_cols=262  Identities=22%  Similarity=0.304  Sum_probs=197.6

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----eeE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----ERL   90 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   90 (340)
                      +|++.+.||+|+||.||++... +++.||+|.+...  .......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5788999999999999999864 5899999998543  2234557889999999999999999999988766     789


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|+||+. ++|...+.   ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 46766663   2345899999999999999999999999   999999999999999999999999998765


Q ss_pred             cCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH------------
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA------------  237 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~------------  237 (340)
                      ..... .......++..|+|||.+.+. .++.++||||+||++|+|++|+.||...+.......+...            
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32221 112234578899999998764 5789999999999999999999999766544322211100            


Q ss_pred             ----HHHh-hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 ----WQLW-NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 ----~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          .... ............  .......+.++.+|+.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                0000 000000000000  01112235678899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.4e-41  Score=290.73  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=202.3

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +|++.+.||.|+||.||+++.. +++.+|+|.+... .......+.+|+.+++.++|+|++++++.+......+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5888999999999999999865 4888999988543 3344567788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++... ....++...+..++.|++.|+.+||+++   ++|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999998887542 2345789999999999999999999999   99999999999999999999999999876543211 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                       ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....      .. ...+.         ..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~-~~~~~---------~~  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------LK-VCQGS---------YK  218 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH------HH-HhcCC---------CC
Confidence             122345788899999998888999999999999999999999999643322110      11 11111         11


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..+...+..+.+++.+||+.||++|||+.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1223345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-41  Score=305.50  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=200.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC-C
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK-G   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~   87 (340)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|.+.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999963      246789999986543 23455688899999999 689999999987654 4


Q ss_pred             eeEEEEeccCCCChhhHhhccCc---------------------------------------------------------
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSK---------------------------------------------------------  110 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  110 (340)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999999854211                                                         


Q ss_pred             -------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccccc
Q 041345          111 -------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV  183 (340)
Q Consensus       111 -------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  183 (340)
                             ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123678888999999999999999999   9999999999999999999999999987653222211222233


Q ss_pred             ccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHH
Q 041345          184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE  262 (340)
Q Consensus       184 ~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (340)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||........  .    ......+..         ...+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~---------~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTR---------MRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCC---------CCCCCCC
Confidence            5677999999988899999999999999999997 8888854322111  0    111111111         1111123


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       263 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      +..+.+++..||+.+|++|||+.+|++.|+.+.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.4e-41  Score=292.80  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=204.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|.+..    +..+|+|.+.... ......+.+|+.++++++||||+++++++..+...++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            3678999999999999999997632    3368999886543 3345678899999999999999999999998889999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...  ...++...+..++.|++.|+++||+++   ++|+||||+||+++.++.++|+|||.+....
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999998543  234789999999999999999999999   9999999999999999999999999988764


Q ss_pred             Cccccc-ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          172 MNELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       172 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ...... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+       ...     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-------~~~-----  225 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-------EEG-----  225 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-------hCC-----
Confidence            332111 1112223567999999988889999999999999999886 99998654432211111       111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          .....+...+..+.+++.+||+.+|.+|||+.++++.|.++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                01111233456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.4e-42  Score=295.47  Aligned_cols=252  Identities=28%  Similarity=0.438  Sum_probs=199.3

Q ss_pred             CCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHH--HHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      |++++.||+|+||+||+++... ++.+|+|.+.........  ...+|+..+++++||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6778999999999999998766 568999999766544322  3356999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.   ....++...+..++.|++.||++||+++   ++|+||||+||+++.++.++|+|||.+.....  ..
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            9999999995   3455899999999999999999999999   99999999999999999999999999876411  12


Q ss_pred             cccccccccCCCCChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .......++..|.|||.+. +..++.++|+||+|+++|+|++|..||.......................          
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  222 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS----------  222 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----------
Confidence            2333456788999999998 78899999999999999999999999976522222111111100000000          


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..........+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000111278999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.9e-41  Score=289.64  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=195.6

Q ss_pred             cccccCCeeEEEEEEC---CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCC
Q 041345           25 RLGQGGFGPVYKGKLL---DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~  100 (340)
                      .||+|+||.||+|.+.   .+..||+|++..... .....+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   345699999865532 33456889999999999999999999875 456899999999999


Q ss_pred             hhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc-cc
Q 041345          101 LDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA-NT  179 (340)
Q Consensus       101 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~  179 (340)
                      |.+++...  ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||++.......... ..
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99988532  335899999999999999999999998   9999999999999999999999999987654322111 11


Q ss_pred             ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       180 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      ....++..|+|||.+.+..++.++||||||+++|++++ |..||.........       .....+         .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~~~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQG---------KRLDC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCC---------CCCCC
Confidence            11223568999999988889999999999999999996 99998654332211       111111         11223


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      +...+.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            344567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.6e-41  Score=290.17  Aligned_cols=249  Identities=28%  Similarity=0.393  Sum_probs=199.2

Q ss_pred             CcccccCCeeEEEEEECC--CC--EEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD--GQ--EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|++|.||+|.+.+  ++  .+|+|.+..... .....+.+|+..+++++||||+++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  33  589999976655 556678999999999999999999999888 889999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc-c
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE-A  177 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~  177 (340)
                      ++|.+.+..... ..+++..+..++.|++.||++||+++   ++|+||+|+||+++.++.++|+|||++..+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865432 45899999999999999999999999   999999999999999999999999999876432211 1


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.....      .....         ..
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------~~~~~---------~~  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI------DKEGE---------RL  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HhcCC---------cC
Confidence            1223446778999999988889999999999999999998 99998544332211111      00000         11


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            112234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-41  Score=290.03  Aligned_cols=249  Identities=25%  Similarity=0.394  Sum_probs=199.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEe-eCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL-QKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||++.. .+..+++|.+....  ....+.+|+.++++++|+|++++++++. .....++++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            35789999999999999999976 57889999885443  3456889999999999999999999754 45678999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++.... ...+++..+..++.|++.|+++||+++   ++|+||||+||++++++.++|+|||++......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  155 (256)
T cd05082          82 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  155 (256)
T ss_pred             CCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc--
Confidence            99999999986432 234889999999999999999999999   999999999999999999999999998754321  


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.........       .....+         .
T Consensus       156 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-------~~~~~~---------~  216 (256)
T cd05082         156 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKG---------Y  216 (256)
T ss_pred             ---CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcC---------C
Confidence               122234567999999988889999999999999999997 88888643222211       111111         1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ....+...+..+.+++.+||+.+|++|||+.++++.|..
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            112233446678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-41  Score=298.89  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=199.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CC--EEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|++.+.||+|+||.||+|.+.. +.  .+++|.+... .......+.+|+.++.++ +|+||+++++++......++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            578899999999999999998643 44  3577776543 233455788899999999 899999999999999999999


Q ss_pred             EeccCCCChhhHhhccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCe
Q 041345           93 YEYLPNKSLDFFIFDSS-------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP  159 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~  159 (340)
                      |||+++++|.+++....             ....+++..++.++.|++.|++|||++|   ++||||||+||+++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986432             1235789999999999999999999999   9999999999999999999


Q ss_pred             eEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 041345          160 KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  238 (340)
                      +|+|||++.....   .........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+...      
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------  234 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------  234 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH------
Confidence            9999999864211   111111223567999999988889999999999999999998 999986443322111      


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                       .....         .....+...+..+.+++.+||+.+|++|||+.++++.|..+
T Consensus       235 -~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 -KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             -HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             11111         01111222345688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-41  Score=303.00  Aligned_cols=242  Identities=22%  Similarity=0.265  Sum_probs=189.0

Q ss_pred             CcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHH-HHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEA-KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+... ++.+|+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999998754 6789999985432   11222333343 456778999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|.+++..   ...+++..+..++.|++.||.|||++|   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999998853   344788899999999999999999999   999999999999999999999999998753221  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........      ... ..          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~-~~----------~~~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILN-KP----------LQL  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH------HHh-CC----------cCC
Confidence            3345689999999999998999999999999999999999999965443321111      110 00          111


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ++..+..+.+++.+||+.+|.+||++.+.+..
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            23345678899999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.6e-41  Score=287.65  Aligned_cols=247  Identities=28%  Similarity=0.416  Sum_probs=197.7

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChh
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLD  102 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~  102 (340)
                      +.||.|+||.||+|...+++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999988788999999986553 233456889999999999999999999999988999999999999999


Q ss_pred             hHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccc
Q 041345          103 FFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI  182 (340)
Q Consensus       103 ~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  182 (340)
                      +++...  ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence            988543  234789999999999999999999999   99999999999999999999999999875432211 111122


Q ss_pred             cccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       183 ~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      .++..|+|||.+.++.++.++||||||+++|++++ |..||.........       .....+         .....+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~---------~~~~~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKG---------YRMSCPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcC---------CCCCCCCC
Confidence            34567999999988889999999999999999998 88898643222111       111111         11122233


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          262 EVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      .+..+.+++.+||..+|++|||+.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            4577899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.6e-42  Score=308.35  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-C-----CceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-H-----TNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~   89 (340)
                      .-+|.+.+.||+|+||.|.+|.+. +++.||||++++.. .-..+...|+.+|..++ |     -|+|+++++|...++.
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            347899999999999999999764 48999999996553 44567778999999985 4     3899999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC--CCeeEeccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKISDFGMA  167 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~--~~~~l~Dfg~~  167 (340)
                      |||+|.+ ..+|.+++.... ...+++..+..++.||+.||.+||+.+   |||+||||+|||+.+.  ..|||+|||++
T Consensus       264 ciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence            9999998 679999997643 344999999999999999999999999   9999999999999754  36999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH----------
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA----------  237 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~----------  237 (340)
                      +.....     ......+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.+..++...+.-.          
T Consensus       339 c~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  339 CFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             cccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            875421     11455688899999999999999999999999999999999999888777655333210          


Q ss_pred             -----HHHhhc-Cccccccc--------------c-----cccCCCC-----------HHHHHHHHHHHHhccCCCCCCC
Q 041345          238 -----WQLWNE-GKALELID--------------T-----TLHESCS-----------PDEVTRCIHVGLLCVQDKATDR  281 (340)
Q Consensus       238 -----~~~~~~-~~~~~~~~--------------~-----~~~~~~~-----------~~~~~~l~~li~~cl~~~p~~R  281 (340)
                           ...+.. ....+...              .     ......|           ......+.+++++||+.||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                 000111 00000000              0     0000011           1344567999999999999999


Q ss_pred             CCHHHHHHH
Q 041345          282 PTMSDVASM  290 (340)
Q Consensus       282 Pt~~evl~~  290 (340)
                      +|..+.++.
T Consensus       494 ~tp~qal~H  502 (586)
T KOG0667|consen  494 ITPAQALNH  502 (586)
T ss_pred             CCHHHHhcC
Confidence            999999874

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-41  Score=302.06  Aligned_cols=240  Identities=22%  Similarity=0.287  Sum_probs=188.3

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHH-HHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAK-LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.+|+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999764 58899999985431   222334445544 56778999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|...+..   ...+++..+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            999888743   345899999999999999999999999   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+...      ... ...          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~-~~~----------~~~  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NIL-HKP----------LVL  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHH-cCC----------ccC
Confidence            234568999999999999999999999999999999999999996544322111      111 110          011


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVA  288 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl  288 (340)
                      ++..+..+.+++.+||+.+|.+||++.+.+
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            123456688899999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-41  Score=294.53  Aligned_cols=252  Identities=22%  Similarity=0.345  Sum_probs=201.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||.|+||.||++.+. .++.+|+|.+... .......+.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47899999999999999999875 5889999988644 334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|..++........+++..+..++.|++.|+.|||+ .+   ++|+||+|+||+++.++.++|+|||.+..+... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999988654334468999999999999999999997 46   999999999999999999999999998765321 


Q ss_pred             cccccccccccCCCCChhhhccC------CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                         ......++..|+|||.+.+.      .++.++|+|||||++|+|++|..||............   ... ..     
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~-~~-----  224 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---SAI-VD-----  224 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---HHH-hh-----
Confidence               12234577889999988544      3588999999999999999999999543222111110   000 00     


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ......+...+..+.+++.+||+.+|++||++.+++.
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 ----GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                1112234456778899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.8e-41  Score=297.27  Aligned_cols=263  Identities=23%  Similarity=0.292  Sum_probs=200.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||+|+||.||++.+. ++..+++|.+.... .....++.+|++++++++||||+++++++..++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            47999999999999999999865 47788989886542 33445688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||+ .+   ++|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998543   458899999999999999999997 46   999999999999999999999999998654321 


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc--------
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA--------  246 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  246 (340)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....................        
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               122346788999999998888999999999999999999999998544322211111100000000000        


Q ss_pred             ---------cccccccc---cCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          247 ---------LELIDTTL---HESC-SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       247 ---------~~~~~~~~---~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                               .+..+...   .... ....+.++.+++.+||..+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     00000000   0000 11245578999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.4e-41  Score=299.76  Aligned_cols=237  Identities=22%  Similarity=0.271  Sum_probs=186.7

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHH-HHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAK-LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 47889999985432   122333444544 67788999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|...+..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            999888743   345889999999999999999999999   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.....      .... ..          ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~-~~----------~~~~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY------DNIL-HK----------PLQL  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH------HHHh-cC----------CCCC
Confidence            23456899999999998889999999999999999999999999654322211      1111 10          0122


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMS  285 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~  285 (340)
                      ++.....+.+++.+||+.+|.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            334456788999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.5e-41  Score=291.55  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-C---CEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-G---QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|+..+.||+|++|.||+|.... +   ..+++|.+... .......+.+|+.+++.++|+|++++.+++......++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578889999999999999998643 3   26899988654 23345678899999999999999999999999899999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...  ...+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999998543  245889999999999999999999999   9999999999999999999999999987654


Q ss_pred             Ccccccc-cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          172 MNELEAN-TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       172 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ....... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||........       .......     
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~-------~~~i~~~-----  226 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------MKAINDG-----  226 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-------HHHHhcC-----
Confidence            3221111 111223457999999988889999999999999999997 9999854332211       1111111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          .....+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                11112233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.6e-41  Score=301.35  Aligned_cols=241  Identities=23%  Similarity=0.333  Sum_probs=192.6

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...   .......+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999865 4889999998643   1233455677888888775 578888999999889999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|..++..   ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++......
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998843   345899999999999999999999999   999999999999999999999999998754322


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .  .......|++.|+|||++.+..++.++||||+||++|+|++|..||..........      ... ..         
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~------~i~-~~---------  216 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ------SIM-EH---------  216 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hC---------
Confidence            1  12233568999999999988899999999999999999999999997544322111      111 00         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                       ....+...+..+.+++.+||+.+|.+|++.
T Consensus       217 -~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 -NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             011223345678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-41  Score=295.72  Aligned_cols=263  Identities=24%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--Cee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   89 (340)
                      ..|++.+.||+|+||.||.++.     .++..||+|.+.... ......+.+|+.+++.+.|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999973     347789999986543 34456788999999999999999999988765  568


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998543  234899999999999999999999999   99999999999999999999999999887


Q ss_pred             ccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccc--------ccchhHHHHHH
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER--------HLNLVGYAWQL  240 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~--------~~~~~~~~~~~  240 (340)
                      +...... .......++..|+|||.+.+..++.++||||||+++|+|+++..|+.......        ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6432211 11223446678999999988889999999999999999999876542211000        00000000011


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+         .....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111         11122233567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.4e-41  Score=290.66  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             CCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC------hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      +|++.+.||.|+||.||+|...+++.+|+|.+....      ......+.+|+..++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            588999999999999999988788999999885432      12245688899999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      +||+++++|.+++...   ..+++..+..++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998532   34789999999999999999999998   99999999999999999999999999876532


Q ss_pred             ccc----ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          173 NEL----EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       173 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ...    ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.....      .......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~----  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHR----  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhcc----
Confidence            111    11122345788999999998888999999999999999999999999643322111      0000000    


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ......+......+.+++.+||+.+|++|||+.++++
T Consensus       225 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 ----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                0011122335567899999999999999999999885

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.4e-41  Score=290.54  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=199.9

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChh---------cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQ---------GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      +|.+.+.||.|++|.||+|... +++.+|+|.+......         ....+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5888999999999999999764 4788999988543221         23467889999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++++||+++++|.+++..   ...++...+..++.|++.|+++||+++   ++|+||+|+||++++++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999853   245888999999999999999999998   9999999999999999999999999988


Q ss_pred             cccCcccc----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          169 TFGMNELE----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       169 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ........    .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........      .... .. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~-  226 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKI-GE-  226 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHH-hc-
Confidence            76422111    111223578899999999888899999999999999999999999964322110      0000 00 


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                              ......+...+..+.+++.+||+.+|.+||++.++++
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                    1112223345677899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.2e-41  Score=306.93  Aligned_cols=262  Identities=18%  Similarity=0.211  Sum_probs=199.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC---CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL---DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..+|.+.+.||.|+||.||++...   .+..|++|.+....     ...+|+.+++.++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999653   35679999875432     3467999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |++. ++|..++.   ....+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++......
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9985 56777762   3345899999999999999999999999   999999999999999999999999999876543


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc--c-----
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK--A-----  246 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~-----  246 (340)
                      ..........||..|+|||++.+..++.++|||||||++|+|++|+.||...........+...........  .     
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            333333345789999999999988999999999999999999999999966554332211111111100000  0     


Q ss_pred             ccc------ccccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          247 LEL------IDTTLHESCS-------PDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       247 ~~~------~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..+      .....+....       .....++.+++.+||..||++|||+.+++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000      0000000000       1124567889999999999999999999974

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.7e-41  Score=291.74  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=193.1

Q ss_pred             ccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           26 LGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ||+|+||.||+++.. +|+.+|+|.+....   ......+..|+++++.++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999864 48999999985432   11233456699999999999999999999999999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR  181 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  181 (340)
                      .+.+... ....+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            8887543 2334889999999999999999999999   9999999999999999999999999987654321   1223


Q ss_pred             ccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       182 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      ..++..|+|||++.+..++.++||||+||++|+|++|..||.........  ........ ...        .. .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~-~~~--------~~-~~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL-EDE--------VK-FEHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh-ccc--------cc-ccccc
Confidence            45788999999998888999999999999999999999999654322111  11111111 000        00 00123


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          262 EVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      .+.++.+++.+||+.||++||++.|+++.+.
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            4567899999999999999999987765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=311.06  Aligned_cols=252  Identities=28%  Similarity=0.380  Sum_probs=211.0

Q ss_pred             CCCCCCcccccCCeeEEEEEECC--CC--EEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD--GQ--EIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +.++.++||+|+||+|++|.|..  |+  .||||++...... ....|.+|+..|.+++|+|+++++|+..+ ....+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34567889999999999998743  44  4799999665433 56789999999999999999999999877 6788999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |+++.|+|.+.|.. .....+.......++.|||.|+.||.+++   +|||||.++|+++-.-..|||+|||+.+.++.+
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999987 56667889999999999999999999999   999999999999998889999999999987643


Q ss_pred             c-cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          174 E-LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       174 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      . .........-.+.|||||.++...++.++|||+|||++|||++ |..||.+....+.                .+.+|
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----------------L~~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----------------LKNID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------------HHhcc
Confidence            2 2222223334678999999999999999999999999999998 5578765544443                23345


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      ..-+...+..++.++++++..||..+|++||||..|.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            5556667788999999999999999999999999997443

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=288.12  Aligned_cols=248  Identities=31%  Similarity=0.443  Sum_probs=196.4

Q ss_pred             CcccccCCeeEEEEEECC----CCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      ++||+|+||.||+|.+..    +..+|+|.+..... .....+.+|+.+++.+.|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999996532    26899999865543 34557889999999999999999999875 4568999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|.+++...   ..+++..+..++.|++.|+++||..+   ++|+||||+||+++.++.++|+|||++...........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999998543   25899999999999999999999998   99999999999999999999999999886643322111


Q ss_pred             -cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          179 -TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       179 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...       ......         ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~-------~~~~~~---------~~  217 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA-------MLESGE---------RL  217 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHHcCC---------cC
Confidence             111223467999999988899999999999999999998 899986543322111       111111         11


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..+...+..+.+++.+||..+|++|||+.++++.|++.
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            22334456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.3e-41  Score=295.28  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=192.3

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcC---CCCceeeeeeEEee-----CC
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQ-----KG   87 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~   87 (340)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|+.+++.+   .||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999875 48889999885432  11223455666666655   79999999998764     24


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..+++||++++ +|..++.... ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999975 7777775432 234899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      .......   ......++..|+|||.+.+..++.++||||+||++|+|++|..||......+....+...........+.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            7654221   1223457889999999988899999999999999999999999996554432221111000000000000


Q ss_pred             ccc---cccc-------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          248 ELI---DTTL-------HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       248 ~~~---~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...   ....       .....+..+..+.+++.+||+.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000   0000       00111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-40  Score=289.71  Aligned_cols=254  Identities=27%  Similarity=0.370  Sum_probs=191.3

Q ss_pred             CcccccCCeeEEEEEECC---CCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLLD---GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.||+|+||.||+|...+   +..+++|.+..... .....+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999997643   45689998865432 33346888999999999999999999998888899999999999


Q ss_pred             ChhhHhhccCc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345          100 SLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus       100 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +|.+++.....  ....+...+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999864322  224567788899999999999999999   9999999999999999999999999987543332222


Q ss_pred             ccccccccCCCCChhhhccC-------CCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          178 NTNRIVGTHGYMSPEYVMNG-------IVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ......++..|+|||++.+.       .++.++|+||||+++|+|++ |..||......+...   .   .. .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~---~~-~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y---TV-REQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H---Hh-hcccCCC
Confidence            22334567889999988532       35789999999999999996 999996543332111   0   00 0111111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      .....    ....+..+.+++..|| .+|++|||+++|+..|+
T Consensus       231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111    1123445778999999 68999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-41  Score=300.99  Aligned_cols=264  Identities=22%  Similarity=0.351  Sum_probs=198.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|.+.+.||+|+||.||+|+.. +++.+|+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999865 478899999864432 2334567899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++ +|.+++...  ...++...+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++....... 
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            975 676666432  334789999999999999999999999   9999999999999999999999999987643221 


Q ss_pred             ccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhcCcc
Q 041345          176 EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWNEGKA  246 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~  246 (340)
                       .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+..+....+...        ++.+.....
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence             11223456889999998865 46889999999999999999999999765543322211110        110000000


Q ss_pred             cccccc-ccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDT-TLH----ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~-~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...... ...    ....+..+.++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000 000    0011224567889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-41  Score=292.58  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=204.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CC----EEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQ----EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .++|++.+.||+|+||.||+|.+.. ++    .+++|.+.... ......+.+|+..++.++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3678999999999999999997543 32    58999886553 3345678899999999999999999999887 6789


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|+||+++++|.+++...  ...+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||.+...
T Consensus        85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999999999999998643  234899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .............++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+       ..+     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~-----  227 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-------EKG-----  227 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------hCC-----
Confidence            43222111122223567999999988889999999999999999998 99998654333211111       111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                          .....+......+.+++.+||..+|.+|||+.++++.|..+..
T Consensus       228 ----~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         228 ----ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                1111223344578899999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-40  Score=293.24  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .+.|++.+.||.|+||.||+|+... ++.+++|.+..........+.+|+.+++.++|+|++++++++..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            3679999999999999999998754 788999999777666677888999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|..++...  ...+++..+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--  163 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--  163 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence            9999998877432  234899999999999999999999998   999999999999999999999999987653221  


Q ss_pred             ccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ........++..|+|||.+.     ...++.++|+|||||++|+|++|..||........      .... ......   
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~~~---  233 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKI-AKSEPP---  233 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHH-hcCCCc---
Confidence            11223345788999999874     34578899999999999999999999865432211      0111 111100   


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ....+...+..+.+++.+||..+|++||++.++++
T Consensus       234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 ----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                01112334567889999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-40  Score=287.51  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=204.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||.|++|.||+|.... ++.+++|.+.....  ...+.+|+.+++.++|+|++++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3689999999999999999998765 78999999865432  66889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999998532  345899999999999999999999999   99999999999999999999999999887543221


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|..||...........       ....       ....
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~-------~~~~  218 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNK-------PPPT  218 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccC-------CCCC
Confidence              22234478899999999888899999999999999999999999865333221100       0000       0001


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+......+.+++.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1122344567899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.3e-41  Score=294.46  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=204.5

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ....+|++.+.||.|++|.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++++..+...++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34478999999999999999999864 58999999986554445567888999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..    ..++...+..++.|++.|+.+||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999842    34788899999999999999999998   999999999999999999999999998764322


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .  .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+........      ...        ..
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~--------~~  232 (297)
T cd06656         169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN--------GT  232 (297)
T ss_pred             c--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccC--------CC
Confidence            1  1122345788999999998888999999999999999999999999654332211000      000        00


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            001122334566889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-41  Score=307.46  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=195.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.++..++||+|+++++.+.+...+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999865 4889999998643   2233556788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853   345899999999999999999999999   999999999999999999999999998754211


Q ss_pred             ccc---------------------------------cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCC
Q 041345          174 ELE---------------------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK  220 (340)
Q Consensus       174 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~  220 (340)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            000                                 00113468999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH---HHHHH
Q 041345          221 NNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM---SDVAS  289 (340)
Q Consensus       221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~---~evl~  289 (340)
                      ||...........+      ......       +........+..+.+++.+|+ .+|.+|++.   .++++
T Consensus       235 Pf~~~~~~~~~~~i------~~~~~~-------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQETYRKV------MNWKET-------LVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHHHHHHHH------HcCCCc-------eecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            99755443221111      100000       000001113456777888776 499999964   55544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.3e-41  Score=288.78  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=201.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      .+|++.+.||.|+||.||++.+.+++.+++|.+.... .....+.+|+.+++++.|||++++++++......+++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4688889999999999999988778899999886443 234578899999999999999999999998889999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++...  ...+++..+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            99999988542  234789999999999999999999999   999999999999999999999999998765432211 


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......++..|+|||.+.++.++.++||||||+++|+|++ |..||.........       .....+         ...
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~~  220 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-------ETINAG---------FRL  220 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-------HHHhCC---------CCC
Confidence            1112234568999999988889999999999999999998 88888643322211       111110         001


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            111223467999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=282.67  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=205.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEE-ECCCCEEEEEEccC--CChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++++|.+.+.||+|.|++|+++. ..+|+.+|+|.+..  ....+.+.+.+|+.+-+.++||||+++.+........|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            46789999999999999999985 45688999998743  2444678899999999999999999999999888899999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC---CCCCeeEeccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMART  169 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~---~~~~~~l~Dfg~~~~  169 (340)
                      +|+++|+.|-.-+..   +..+++..+-..+.||++||.|+|.++   |+|||+||+|+++-   .+.-+||+|||++..
T Consensus        89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999988766632   355889999999999999999999999   99999999999995   344589999999998


Q ss_pred             ccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ++.+..   .....|||.|+|||+++..+|+..+|||+.|++||-|+.|..||-+.+....+..+       ..+..   
T Consensus       163 l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I-------~~g~y---  229 (355)
T KOG0033|consen  163 VNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI-------KAGAY---  229 (355)
T ss_pred             eCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH-------hcccc---
Confidence            763322   23457899999999999999999999999999999999999999664444433222       11111   


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         ...+...+...++..+|+++||..||.+|.|+.|.+.
T Consensus       230 ---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 ---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               1122233556678899999999999999999988764

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.6e-41  Score=322.99  Aligned_cols=261  Identities=20%  Similarity=0.259  Sum_probs=202.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.++||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            58999999999999999999875 48899999986432   223456889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCc--------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           94 EYLPNKSLDFFIFDSSK--------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ||+++++|.+++.....        ....+...+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998854211        123566778899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCccc----------------ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccc
Q 041345          166 MARTFGMNEL----------------EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER  229 (340)
Q Consensus       166 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~  229 (340)
                      ++........                ........||+.|+|||.+.+..++.++||||+||++|+|++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                001112468999999999999999999999999999999999999996533221


Q ss_pred             ccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhcCC
Q 041345          230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-TMSDVASMLTNDT  295 (340)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~  295 (340)
                      ....     .     ..    ............+..+.+++.+||+.||++|| +++++++.|+...
T Consensus       239 i~~~-----~-----~i----~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 ISYR-----D-----VI----LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhh-----h-----hc----cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1100     0     00    00000000123446688999999999999995 5677777776543

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-40  Score=292.11  Aligned_cols=251  Identities=27%  Similarity=0.344  Sum_probs=198.2

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .|++.+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.+++.++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4778899999999999999765 48899999885432   2223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++.... ...+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999999885432 234899999999999999999999999   9999999999999999999999999987543221


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||............   ......          .
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~----------~  220 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE----------V  220 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh----------h
Confidence               112346889999999998889999999999999999999999999654322111000   000000          0


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                      ....+......+.+++.+||+.||++|||     +.++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            01112334566889999999999999999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8e-41  Score=290.64  Aligned_cols=251  Identities=29%  Similarity=0.491  Sum_probs=198.0

Q ss_pred             CcccccCCeeEEEEEECC-------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           24 NRLGQGGFGPVYKGKLLD-------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.||.|+||.||+|+..+       +..+++|.+.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999997643       2578999875443 23456788999999999999999999999988889999999


Q ss_pred             cCCCChhhHhhccC----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-----CeeEecccc
Q 041345           96 LPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-----NPKISDFGM  166 (340)
Q Consensus        96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-----~~~l~Dfg~  166 (340)
                      +++++|.+++....    ....+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986532    1234788999999999999999999998   99999999999999877     899999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      +................++..|+|||.+.++.++.++||||||+++|+|++ |..||......+..   .   .. ..+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~---~---~~-~~~-  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL---Q---HV-TAG-  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH---H---HH-hcC-
Confidence            876543322222223345678999999998999999999999999999998 89998643322211   0   00 000 


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                              .....+...+..+.+++.+||+.+|++||++.+|++.|.+
T Consensus       230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    1112233456778999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.6e-41  Score=294.60  Aligned_cols=264  Identities=25%  Similarity=0.345  Sum_probs=197.8

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|++|.||+|... ++..||+|.+....  ......+.+|+.+++.++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5888999999999999999865 58899999885432  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      ++ ++|.+++........++...+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 578777755444456899999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH-----HHHhhcC-----
Q 041345          176 EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA-----WQLWNEG-----  244 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~-----  244 (340)
                       .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...............     ...|...     
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             112223467889999988654 4788999999999999999999999654332211000000     0000000     


Q ss_pred             ---cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 ---KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         .......... .......+.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence               0000000000 0001124567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-40  Score=291.14  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             CCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      |++.+.||.|+||.||+|.... +..+++|.+..........+.+|+.+++.++|||++++++++......++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            6788999999999999998754 677899988666656667788999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  ...
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~  159 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  159 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--ccc
Confidence            9998887532  345899999999999999999999999   999999999999999999999999998764321  112


Q ss_pred             cccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          179 TNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .....++..|+|||.+.     +..++.++|+||+||++|+|++|+.||.........      .... .....      
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~-~~~~~------  226 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKIA-KSEPP------  226 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HHHh-hcCCC------
Confidence            23345788999999873     345788999999999999999999998654322111      1110 00000      


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         227 -TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             01112334567899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-41  Score=292.51  Aligned_cols=253  Identities=24%  Similarity=0.355  Sum_probs=204.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||.|++|.||++... ++..+|+|.+..........+.+|+.+++.++|+|++++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            367999999999999999999864 5788999998766666667888999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999998543  235899999999999999999999999   9999999999999999999999999887643221 


Q ss_pred             ccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                       .......++..|+|||.+.     +..++.++|+||||+++|+|++|..||.........      .. .......   
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~---  226 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL------LK-ILKSEPP---  226 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH------HH-HhcCCCC---
Confidence             1223345788999999874     345778999999999999999999999654332211      01 1111100   


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          ....+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 ----TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                011123345678899999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.6e-41  Score=290.67  Aligned_cols=256  Identities=22%  Similarity=0.345  Sum_probs=203.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|.+.+.||.|+||.||+|.+.+    ...+++|...... ....+.+.+|+.+++.++|||++++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568899999999999999997543    2468999886554 4455678999999999999999999998875 45789


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...  ...+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999998543  234899999999999999999999998   9999999999999999999999999987654


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ...... .....++..|+|||.+.+..++.++||||||+++|++++ |..||......+...      . ...+.     
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~-~~~~~-----  225 (270)
T cd05056         159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG------R-IENGE-----  225 (270)
T ss_pred             ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------H-HHcCC-----
Confidence            332111 112234567999999888889999999999999999986 999986543322111      1 11111     


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                          ....+...+..+.+++.+||..+|++|||+.++++.|.++.
T Consensus       226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                11123344567999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.1e-41  Score=305.33  Aligned_cols=264  Identities=22%  Similarity=0.234  Sum_probs=196.8

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC----
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG----   87 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   87 (340)
                      ...++|++.+.||+|+||.||++... .+..||+|.+...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34689999999999999999999764 4889999998543  2334556788999999999999999999886443    


Q ss_pred             --eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           88 --ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        88 --~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                        ..++||||+++ ++...+.     ..++...+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence              47999999976 4555442     23788899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhH----------
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVG----------  235 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~----------  235 (340)
                      ++......   .......++..|+|||.+.+..++.++|||||||++|+|++|..||...+.........          
T Consensus       169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            98754321   12233467899999999999899999999999999999999999997654332111000          


Q ss_pred             ------HHHHHhhc-Ccccc-----cccccc---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          236 ------YAWQLWNE-GKALE-----LIDTTL---HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       236 ------~~~~~~~~-~~~~~-----~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            ........ .....     ......   ...........+.+|+.+||+.||++|||+.|++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  00000000 00000     000000   000111234568899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.6e-41  Score=290.88  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=199.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|.+.+.||+|+||.||+|+.. +++.+|+|.++.........+.+|+.+++.++||||+++++++......+++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888999999999999999764 4888999998665545556678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++..   .+.+++..+..++.|++.|+.|||++|   ++|+||||+||+++.++.++|+|||++......  
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            999999998843   345899999999999999999999999   999999999999999999999999998765322  


Q ss_pred             ccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ........|+..|+|||.+.   .+.++.++|+|||||++|+|++|..||.........      ...........    
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~~~----  229 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQPP----  229 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCCCC----
Confidence            11223346789999999874   456889999999999999999999998543321110      00000000000    


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..  ......+..+.+++.+||+.+|++|||+.+|++
T Consensus       230 ~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00  001123456889999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=287.47  Aligned_cols=254  Identities=23%  Similarity=0.360  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||.|++|.||+|... +++.+++|.+..........+.+|+.++++++|||++++++++......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367999999999999999999864 4788999998766555677889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++...  ...+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            9999999988543  245899999999999999999999998   9999999999999999999999999987654321 


Q ss_pred             ccccccccccCCCCChhhhccC---CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNG---IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                       .......++..|+|||.+.+.   .++.++|+||+|+++|+|++|..||...........      .. ....     .
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~-~~~~-----~  222 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------IS-KSNF-----P  222 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hccC-----C
Confidence             112234578889999998766   789999999999999999999999865432221100      00 0000     0


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..........+..+.+++.+||..+|.+|||+.+|+.
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0001122345677999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-41  Score=294.45  Aligned_cols=264  Identities=25%  Similarity=0.365  Sum_probs=205.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-----CCCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEee--CCe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-----DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   88 (340)
                      .+.|++.+.||+|+||.||+|...     .+..+|+|.+...... ....+.+|+..++.+.|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            357888899999999999999753     3678999998655433 46678999999999999999999998877  557


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .+++|||+++++|.+++....  ..+++..+..++.|++.||++||+++   ++|+||||+||+++.++.++|+|||.+.
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            899999999999999985432  24899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc--------chhHHHHH
Q 041345          169 TFGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL--------NLVGYAWQ  239 (340)
Q Consensus       169 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~--------~~~~~~~~  239 (340)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+.........        ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76532211 1111233456799999998888999999999999999999999987543221100        00000011


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                               .+........+..++..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       238 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 ---------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ---------HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                     1111111222334457799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=289.85  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=202.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47899999999999999999865 47889999986543 33456688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++...    .+++..+..++.|++.|+.+||+++   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999998532    6899999999999999999999998   9999999999999999999999999998765321 


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|..||...+......       ........        
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-------~~~~~~~~--------  216 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-------LIPKNNPP--------  216 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-------HhhhcCCC--------
Confidence             12233457888999999988889999999999999999999999996544221110       00011100        


Q ss_pred             CCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ..+.. .+..+.+++.+||..+|++|||+.++++
T Consensus       217 -~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 -SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             11111 4567889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-40  Score=291.62  Aligned_cols=251  Identities=27%  Similarity=0.340  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .|+..+.||.|+||.||+|.+. +++.+|+|.+....   ......+.+|+.+++.++|++++++.+++..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4777889999999999999764 48899999985432   2223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+.+.... ...+++..+..++.|++.||.|||+++   |+|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            999999998875432 335899999999999999999999999   9999999999999999999999999987643221


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||............   .......          
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~----------  220 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLET----------  220 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhcc----------
Confidence               122346889999999998888999999999999999999999999654332211111   0100000          


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                      ....+...+..+.+++.+||+.||++|||     +.+++.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            01112334556789999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-42  Score=281.02  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=204.7

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC----h----hcHHHHHHHHHHHHcC-CCCceeeeeeE
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS----G----QGIVEFKNEAKLIAKL-QHTNLVRLLGC   82 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~   82 (340)
                      -+.....|...+.||+|..++|-++.. .+|+.+|+|++....    .    ...+.-.+|+.+|+++ .||+|+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            345567899999999999999988854 468889999883221    1    1123345789999998 69999999999


Q ss_pred             EeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        83 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                      +..+...++|+|.|+.|-|.+++.   ..-.++++...+++.|+.+|++|||.++   |+||||||+||+++++.+++|+
T Consensus        92 yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence            999999999999999999999994   3445999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhc------cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVM------NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~  236 (340)
                      |||+++.+..+   ......+||++|+|||.+.      ...|+..+|.|++|+++|.|+.|.+||-...+.-       
T Consensus       166 DFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-------  235 (411)
T KOG0599|consen  166 DFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-------  235 (411)
T ss_pred             ccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-------
Confidence            99999876532   2345678999999999883      2358889999999999999999999994322211       


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+...+++.      .+..+-..+.+....+||.+||+.||.+|.|+.|+++
T Consensus       236 MLR~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  236 MLRMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1222222221      1122333566778899999999999999999999986

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=296.51  Aligned_cols=249  Identities=20%  Similarity=0.351  Sum_probs=212.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEE-ECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      +.+-|.+.+.||+|-|.+|-+|+ ...|..||||++.+.  +.....++.+|+.+|+.++|||||+++.+.....++|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            45668999999999999999996 457999999999665  444566889999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe-CCCCCeeEeccccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL-DDQMNPKISDFGMARTFG  171 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv-~~~~~~~l~Dfg~~~~~~  171 (340)
                      +|.-++|+|.+++.....+  +++..+.+++.||+.|+.|+|+.+   +|||||||+|+.+ ..-|-|||+|||++..+.
T Consensus        96 LELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999999765443  899999999999999999999999   9999999999976 567889999999998765


Q ss_pred             CcccccccccccccCCCCChhhhccCCCC-ccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVS-MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .+   ...+..+|+..|.|||++.|..|+ +++||||||+|||.|++|+.||...+..+...++               +
T Consensus       171 PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------m  232 (864)
T KOG4717|consen  171 PG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------M  232 (864)
T ss_pred             Cc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------h
Confidence            33   234457899999999999998775 6899999999999999999999776666544332               2


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +-.  -..|...+.++.+||.+||..||++|.|.++|..
T Consensus       233 DCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  233 DCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            221  1245677889999999999999999999999986

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.7e-41  Score=291.22  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC------
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK------   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------   86 (340)
                      ..++.|++.+.||.|+||.||+|... +++.+|+|.+.... .....+.+|+.++..+ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678999999999999999999865 47889999985543 3345678899999988 699999999998753      


Q ss_pred             CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      ...+++|||+++++|.+++... ....+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4589999999999999998643 2345889999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      +......  ........|+..|+|||++.     +..++.++|+||+||++|+|++|..||.........      ....
T Consensus       158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~~  229 (272)
T cd06637         158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIP  229 (272)
T ss_pred             ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHHh
Confidence            8764321  11223456788999999885     345788999999999999999999998543322111      0101


Q ss_pred             hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...         .........+..+.+++.+||..+|.+|||+.++++
T Consensus       230 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNP---------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCC---------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            000         011111233457889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.3e-41  Score=294.59  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .+|++.+.||.|++|.||+|.. .+++.|++|.+..........+.+|+.+++.++|||++++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3699999999999999999975 458899999986555455667889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|..++..    ..+++..+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999998842    34899999999999999999999999   99999999999999999999999999876532211 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+......      ...... ..       ..
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~~~-~~-------~~  235 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-TP-------EL  235 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcC-Cc-------cc
Confidence             1223457889999999988889999999999999999999999996544322110      000000 00       01


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+...+..+.+++.+||..+|++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            112334567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-40  Score=287.48  Aligned_cols=239  Identities=21%  Similarity=0.338  Sum_probs=186.7

Q ss_pred             CcccccCCeeEEEEEECC-------------CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           24 NRLGQGGFGPVYKGKLLD-------------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      +.||+|+||.||+|....             ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997432             2258899886655555567888999999999999999999999888899


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC-------eeEec
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-------PKISD  163 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~-------~~l~D  163 (340)
                      ++|||+++++|..++...  ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999998887532  345899999999999999999999999   999999999999986654       89999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhc-cCCCCccCceehhhHHHHHHH-hCCCCCCCCCcccccchhHHHHHHh
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEII-SSKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      ||++.....      .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.       ....
T Consensus       156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~  222 (262)
T cd05077         156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY  222 (262)
T ss_pred             CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence            998865432      12234678899999886 467899999999999999997 57777654322111       0111


Q ss_pred             hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      . ...        .  ........+.+++.+||+.||.+||++.+|++.|
T Consensus       223 ~-~~~--------~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 E-GQC--------M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             h-cCc--------c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1 100        0  0111245688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=288.29  Aligned_cols=249  Identities=27%  Similarity=0.418  Sum_probs=194.2

Q ss_pred             CcccccCCeeEEEEEECC-CC--EEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD-GQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|+..+ +.  .+++|.+... .......+.+|+.++.++ .||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998754 33  4688888643 234456788999999999 799999999999988889999999999


Q ss_pred             CChhhHhhccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           99 KSLDFFIFDSS-------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        99 ~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ++|.+++....             ....+++..+..++.|++.|++|||+++   ++|+||||+||++++++.++|+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985432             1124789999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ++.....   .........+..|+|||.+.+..++.++||||||+++|+|++ |..||...+.....       .....+
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~  227 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------EKLPQG  227 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-------HHHhCC
Confidence            9753211   111111223567999999988889999999999999999997 99998543322111       111111


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                               .....+...+..+.+++.+||..+|.+|||+.+++..|.++
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                     01111223445788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4e-40  Score=287.56  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ...|+..+.||.|+||.||.|.+. ++..+|+|.+.... ......+.+|+.+++.+.|+|++++++++.++...++|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            356888899999999999999865 47889999886443 3445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++..    ..++...+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999998842    34788999999999999999999998   9999999999999999999999999987654322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        .......++..|.|||.+.+..++.++|+||||+++|+|++|..||...........                +....
T Consensus       156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~~  217 (277)
T cd06640         156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKNN  217 (277)
T ss_pred             --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcCC
Confidence              122234567889999999888899999999999999999999999864433221100                01111


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ....+...+..+.+++.+||+.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            122334567789999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.9e-41  Score=295.92  Aligned_cols=265  Identities=21%  Similarity=0.313  Sum_probs=198.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      -++|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            367999999999999999999865 47889999885442 2234456789999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++ ++|..++...  ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            997 5787777542  334889999999999999999999999   9999999999999999999999999987643221


Q ss_pred             cccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc--
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID--  251 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  251 (340)
                      .  ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+...........+..+..  
T Consensus       159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            1  11223468899999988654 578899999999999999999999976544322211110000000000000000  


Q ss_pred             -------ccccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 -------TTLHES----CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 -------~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                             ......    ..+..+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                   000000    11223556889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2e-40  Score=288.27  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=188.6

Q ss_pred             CcccccCCeeEEEEEECC---CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLLD---GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            468999999999996533   3468888775443 233456788999999999999999999999888999999999999


Q ss_pred             ChhhHhhccCc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345          100 SLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus       100 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +|.+++.....  ....++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865432  223567788899999999999999999   9999999999999999999999999986543222111


Q ss_pred             ccccccccCCCCChhhhcc-------CCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          178 NTNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ......++..|+|||++..       ..++.++|||||||++|+|++ |..||......+..      ....... ...+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~~-~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL------KQVVREQ-DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------HHHhhcc-CccC
Confidence            1223345677999998742       356889999999999999999 67787543322211      1111111 1111


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..    ...+...+..+.+++..|| .||++|||+.+|++.|.
T Consensus       231 ~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11    1122334556777888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3e-40  Score=284.99  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=203.2

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|+||.||.++.. +++.+++|.+...  .......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5889999999999999999754 4888999987543  334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++.... ...++...+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986432 345899999999999999999999998   99999999999999999999999999876543321


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                        ......++..|.|||.+.+..++.++|+||+|+++|+|++|..||......+..      ... ..+..         
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~-~~~~~---------  218 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKI-VQGNY---------  218 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HcCCC---------
Confidence              223345789999999998888899999999999999999999998643322211      111 11111         


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ...+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            11123345678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9e-41  Score=302.83  Aligned_cols=264  Identities=23%  Similarity=0.245  Sum_probs=197.4

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   86 (340)
                      ...++|++.+.||+|+||.||++... .++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34689999999999999999999864 4788999998643  233455678899999999999999999887543     


Q ss_pred             -CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           87 -GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        87 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                       ...++||||+++ +|...+.     ..++...+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999965 5656552     13788899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------  237 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------  237 (340)
                      ++......   .......++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...        
T Consensus       172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99765322   1223346789999999999999999999999999999999999999765543322111000        


Q ss_pred             --------HHHhhc-Ccccc-----cccccc---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 --------WQLWNE-GKALE-----LIDTTL---HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 --------~~~~~~-~~~~~-----~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                              ...... .....     ......   ...........+.+|+.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    000000 00000     000000   000111124568899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-40  Score=286.69  Aligned_cols=247  Identities=27%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      ++|++.+.||+|+||.||.+.. .++.+|+|.+....  ....+.+|+.+++.++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5689999999999999999975 67889999986543  245788999999999999999999988654 5799999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++.... ...+++..+..++.|++.|+.+||+++   ++||||||+||+++.++.++|+|||++......    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999986532 334889999999999999999999998   999999999999999999999999998754221    


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                       ......+..|+|||.+.++.++.++|+||||+++|+|++ |..||.........       .....+         ...
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~~  216 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKG---------YRM  216 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCC---------CCC
Confidence             112233567999999988899999999999999999997 88888654332211       111111         111


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1223345678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.9e-40  Score=287.09  Aligned_cols=256  Identities=24%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .++++......||+|+||.||+|.+. ++..|++|.+..........+.+|+.+++.++|+||+++++++..++..++++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            44566666778999999999999864 47789999987666666778899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~~~~  172 (340)
                      ||+++++|.+++.........+...+..++.|++.|++|||+++   ++|+||||+||+++. ++.++|+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999864322211278888899999999999999998   999999999999976 67899999999876532


Q ss_pred             cccccccccccccCCCCChhhhccCC--CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ...  ......++..|+|||.+.+..  ++.++|+||+|+++|+|++|..||..........     +..   .      
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-----~~~---~------  225 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-----FKV---G------  225 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----hhh---h------
Confidence            211  122235788999999986543  7889999999999999999999985432211100     000   0      


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ........+......+.+++.+||+.+|++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            000112223445567899999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-40  Score=294.76  Aligned_cols=198  Identities=28%  Similarity=0.446  Sum_probs=159.1

Q ss_pred             CCcccccCCeeEEEEEEC---CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCeeEEEEeccC
Q 041345           23 GNRLGQGGFGPVYKGKLL---DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGERLLVYEYLP   97 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~   97 (340)
                      +++||+|+||.||+|+..   +++.+|+|.+....  ....+.+|+.++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   46789999985443  23356789999999999999999998854  456899999985


Q ss_pred             CCChhhHhhccC------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe----CCCCCeeEeccccc
Q 041345           98 NKSLDFFIFDSS------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMA  167 (340)
Q Consensus        98 ~~~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv----~~~~~~~l~Dfg~~  167 (340)
                      + +|.+++....      ....+++..+..++.|++.||.|||++|   ++||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 6766653221      1224889999999999999999999999   9999999999999    45678999999999


Q ss_pred             ccccCcccc-cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCC
Q 041345          168 RTFGMNELE-ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYD  226 (340)
Q Consensus       168 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~  226 (340)
                      ......... .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876432211 122345678999999998764 58999999999999999999999996544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.3e-40  Score=284.76  Aligned_cols=251  Identities=31%  Similarity=0.505  Sum_probs=200.7

Q ss_pred             CCCCCcccccCCeeEEEEEECC-----CCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-----GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +++.+.||.|+||.||++.+..     +..+|+|.+...... ....+..|+..++.+.|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4678899999999999998754     378999999655433 5668889999999999999999999999989999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..... ..+++..+..++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854322 12899999999999999999999999   999999999999999999999999999876543


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ...... ...++..|+|||.+.+..++.++|+||+|+++|+|++ |..||..........       ......       
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~-------~~~~~~-------  221 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE-------YLKKGY-------  221 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhcCC-------
Confidence            222211 2236788999999988889999999999999999998 677775432222111       111111       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                        ....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 --RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              1111223566789999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.9e-40  Score=285.16  Aligned_cols=249  Identities=25%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee-CCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ-KGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e   94 (340)
                      +|++.+.||.|++|.||.+... +++.+++|.+...  .......+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5889999999999999999865 4788999998543  23345567889999999999999999988764 446799999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+.+... ....+++.++..++.|++.|+++||++|   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999988643 2345899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+....      ..... .+.         
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~---------  218 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGK---------  218 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcC---------
Confidence              122334578899999999888899999999999999999999999864332211      11111 111         


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11223445678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=296.63  Aligned_cols=255  Identities=21%  Similarity=0.263  Sum_probs=195.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            57999999999999999999865 4889999998542   2233455788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998542  334889999999999999999999999   999999999999999999999999998765432


Q ss_pred             ccccccccccccCCCCChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      .. .......|++.|+|||++.+     +.++.++||||+||++|+|++|..||......+..      ...........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~  228 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQ  228 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCccc
Confidence            21 11223458999999999863     45788999999999999999999999654322211      11111111111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQD--KATDRPTMSDVASM  290 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~  290 (340)
                      +      .......+..+.+++.+|+..  ++..||++.+++..
T Consensus       229 ~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 F------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0      011122455677788887754  33347899888875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-40  Score=288.86  Aligned_cols=256  Identities=27%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ++|++.+.||.|+||.||+|+..      +.+.+++|.+...... ....+.+|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            67899999999999999999853      2457899988554333 4567899999999999999999999998888899


Q ss_pred             EEEeccCCCChhhHhhccCcc------ccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKK------ELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF  164 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Df  164 (340)
                      +||||+++++|.+++......      ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998654322      15899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhc
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      |++........ .......++..|+|||.+.+...+.++||||||+++|+|++ |..||.........       .....
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~-------~~~~~  233 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL-------NRLQA  233 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH-------HHHHc
Confidence            99865432211 11222345677999999888888999999999999999998 77788543322211       11111


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      +...        ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1110        1112234467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.3e-41  Score=303.37  Aligned_cols=264  Identities=22%  Similarity=0.248  Sum_probs=197.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   86 (340)
                      ...++|++.+.||+|+||.||++... .++.+|+|.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45689999999999999999999764 4888999998643  233455677899999999999999999987643     


Q ss_pred             -CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           87 -GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        87 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                       ...++||||+++ ++...+.     ..++...+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             347999999976 4555542     23788899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH---------
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY---------  236 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~---------  236 (340)
                      ++......   .......++..|+|||++.+..++.++|||||||++|+|++|..||...+..........         
T Consensus       165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99765322   112334678999999999988999999999999999999999999976543322110000         


Q ss_pred             -------HHHHhhc-Cccc-----cccccc-c--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          237 -------AWQLWNE-GKAL-----ELIDTT-L--HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       237 -------~~~~~~~-~~~~-----~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                             ....... ....     ...... .  ....+......+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   0000000 0000     000000 0  001112234578899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2e-40  Score=290.71  Aligned_cols=264  Identities=23%  Similarity=0.307  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||+|++|.||+|+.. +++.||+|.+....  ......+.+|+.+++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            57999999999999999999875 48899999885432  2233457889999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|..+...   ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999988877632   234899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhcCc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWNEGK  245 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  245 (340)
                      .  ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+....+...        ...+....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223456788999998876 45789999999999999999999999765543221111100        00000000


Q ss_pred             ccccc-cccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELI-DTTLHES-----CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..... .......     ..+..+..+.+++.+||+.+|++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000 0000000     01123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-40  Score=289.23  Aligned_cols=239  Identities=23%  Similarity=0.323  Sum_probs=186.0

Q ss_pred             cccccCCeeEEEEEECC-------------------------CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeee
Q 041345           25 RLGQGGFGPVYKGKLLD-------------------------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL   79 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   79 (340)
                      .||+|+||.||+|....                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999986411                         13488998865554455678889999999999999999


Q ss_pred             eeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC--
Q 041345           80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM--  157 (340)
Q Consensus        80 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~--  157 (340)
                      ++++......++||||+++++|..++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999888542  335889999999999999999999998   99999999999997543  


Q ss_pred             -----CeeEecccccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHH-hCCCCCCCCCcccc
Q 041345          158 -----NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEII-SSKKNNGCYDTERH  230 (340)
Q Consensus       158 -----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~ell-tg~~p~~~~~~~~~  230 (340)
                           .++++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3799999987643211      12346778999998865 56899999999999999985 68888865433221


Q ss_pred             cchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ..   .    ....           ...+......+.+++.+||+.+|++|||+.++++.|+
T Consensus       231 ~~---~----~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ER---F----YEKK-----------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH---H----HHhc-----------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11   0    0000           0011112346889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-40  Score=294.01  Aligned_cols=256  Identities=30%  Similarity=0.460  Sum_probs=199.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CC----EEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQ----EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|+..+.||+|+||.||+|.+.. +.    .+|+|.+..... .....+.+|+.+++.+.||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            567888999999999999997643 43    478898865432 3344678899999999999999999988654 4679


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +++|+++|+|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998543  234789999999999999999999998   9999999999999999999999999998764


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |+.||..........       ....+.     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~-----  228 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-------LLEKGE-----  228 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHCCC-----
Confidence            3222222223345678999999988889999999999999999997 889986543222111       111111     


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                          ....+..++..+.+++.+||..+|++||++.++++.|..+.
T Consensus       229 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         229 ----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                11112233457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.4e-40  Score=284.46  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=205.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|+.+++.++|+|++++++.+......++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            57999999999999999999854 57889999986442 23566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++........+++..+..++.|++.|+++||+++   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433345899999999999999999999999   99999999999999999999999999877654322


Q ss_pred             cc--ccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EA--NTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..  ......++..|+|||.+... .++.++|+||||+++|+|++|..||......+....      ... ....     
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~------~~~-~~~~-----  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML------TLQ-NDPP-----  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH------Hhc-CCCC-----
Confidence            21  22334578899999998776 789999999999999999999999965443321110      000 0000     


Q ss_pred             cccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESC-SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...... ....+..+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000000 1234577889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-40  Score=304.10  Aligned_cols=262  Identities=17%  Similarity=0.190  Sum_probs=194.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ...|.+.+.||+|+||.||+|.+.. ++.||+|...      ...+.+|+.++++++|+||+++++++......++||++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999998754 7889999542      22356899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +. ++|..++...  ...+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++........
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6777776432  235899999999999999999999999   99999999999999999999999999986543222


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCC-cccccchhHHHHHHhhcC-----ccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD-TERHLNLVGYAWQLWNEG-----KALEL  249 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~  249 (340)
                      ........||..|+|||++.+..++.++|||||||++|||++|..++-... ..................     .....
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            222234568999999999999999999999999999999999886542221 111000000001110000     00000


Q ss_pred             -----ccc-------cccC--CCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          250 -----IDT-------TLHE--SCS-----PDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       250 -----~~~-------~~~~--~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           ...       ....  ..+     ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 000       0000  000     0123468899999999999999999999973

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-40  Score=285.36  Aligned_cols=247  Identities=27%  Similarity=0.417  Sum_probs=201.0

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-----hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ......+.+|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5888899999999999999876 68899999885432     23456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      +||+++++|.+++...   ..+++..+..++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999998532   34889999999999999999999999   99999999999999999999999999876543


Q ss_pred             cccccccccccccCCCCChhhhccCC-CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|+|++|..||.........      ........      
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~------  219 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKE------  219 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhccc------
Confidence            22   223455788899999987666 899999999999999999999999654321111      11000000      


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         ....+......+.+++.+||+.+|++|||+.+++.
T Consensus       220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               11223344577889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.4e-40  Score=284.61  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=195.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-----hhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   89 (340)
                      .+|++.+.||+|+||.||+|... +++.|++|.+....     ......+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47999999999999999999764 48899999875331     2234567889999999999999999998765  3568


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++++||+++++|.+.+..   ...++...+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   234889999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCccc-ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          170 FGMNEL-EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       170 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ...... ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||.........      ......     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~-----  224 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQ-----  224 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcC-----
Confidence            532111 11112345788999999998888999999999999999999999999643221110      010000     


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ......+......+.+++ +||..+|++|||+.+|++
T Consensus       225 ----~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         225 ----PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                111222334455667777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-41  Score=300.86  Aligned_cols=256  Identities=23%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEcc--CCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCee
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   89 (340)
                      |...+..|+++++||.||.+.||++...+.+.+|+|.+.  ..+.....-|.+|+.+|.+| .|.+|+.+++|-..+..+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            455678899999999999999999988778888888763  34556677899999999999 599999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      |+|||| .+-+|...|......  ++.-.+..+..||+.|+.++|..|   |||.||||.|+++..+ .+||+|||+|..
T Consensus       436 YmvmE~-Gd~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~a  508 (677)
T KOG0596|consen  436 YMVMEC-GDIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANA  508 (677)
T ss_pred             EEEeec-ccccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcc
Confidence            999997 467899988654332  333377889999999999999999   9999999999999765 899999999998


Q ss_pred             ccCcccccccccccccCCCCChhhhccC-----------CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNG-----------IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~  238 (340)
                      ...+.........+||..|++||.+...           ..++++||||||||||+|+.|+.||+.+...     +.   
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~a---  580 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----IA---  580 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----HH---
Confidence            8766655556667899999999988432           2678999999999999999999999643211     11   


Q ss_pred             HHhhcCcccccccccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          239 QLWNEGKALELIDTTLHESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                            +...+.++.-...++.. ...++.++|+.||+.||++|||..++|+
T Consensus       581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                  11111222111111110 1122899999999999999999999997

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7e-41  Score=289.35  Aligned_cols=240  Identities=24%  Similarity=0.383  Sum_probs=188.4

Q ss_pred             CcccccCCeeEEEEEECC--------CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           24 NRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.||.|+||.||+|....        ...+++|.+........+.+.+|..+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997532        234788887655545556788899999999999999999999998889999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC--------eeEeccccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--------PKISDFGMA  167 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~--------~~l~Dfg~~  167 (340)
                      +++++|..++....  ..+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.        ++++|||.+
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999986432  25889999999999999999999999   999999999999987655        689999987


Q ss_pred             ccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCC-CCCCCCCcccccchhHHHHHHhhcCc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSK-KNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      .....      .....++..|+|||.+.+. .++.++||||||+++|+|++|. .||..........       ....  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~--  220 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED--  220 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc--
Confidence            65432      1224567889999998764 5789999999999999999985 5554322221100       0000  


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                               ....+......+.+++.+||+.+|++|||++++++.|+
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     11122233467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-40  Score=290.76  Aligned_cols=264  Identities=23%  Similarity=0.306  Sum_probs=203.8

Q ss_pred             cccHHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEe
Q 041345            7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSL   84 (340)
Q Consensus         7 ~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   84 (340)
                      .+.+..+..+.++|++.+.||+|+||.||+|... +++.+++|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3556677778899999999999999999999764 47889999875432 2235677899999998 6999999999874


Q ss_pred             -----eCCeeEEEEeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           85 -----QKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        85 -----~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                           .+...++||||+++++|.+++... .....+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence                 345689999999999999887532 22345889999999999999999999998   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccch
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNL  233 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~  233 (340)
                      ++|+|||++........  ......|+..|+|||.+..     ..++.++||||+||++|+|++|..||.......... 
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-  239 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-  239 (286)
T ss_pred             EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-
Confidence            99999999876542211  2223457899999998743     457889999999999999999999986443221110 


Q ss_pred             hHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           . ........       ...+......+.+++.+||+.+|++|||+.++++.
T Consensus       240 -----~-~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 -----K-IPRNPPPT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -----h-ccccCCCc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                 0 00000000       01112234568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-41  Score=301.14  Aligned_cols=262  Identities=22%  Similarity=0.280  Sum_probs=194.9

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   86 (340)
                      ...++|++.+.||.|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            35689999999999999999999764 57889999986542  22345577899999999999999999887533     


Q ss_pred             -CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           87 -GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        87 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                       ...+++++++ +++|..++.    ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999987 778887763    234899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH-------
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA-------  237 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-------  237 (340)
                      ++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...       
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            98865321     223467899999999876 56899999999999999999999999654432211110000       


Q ss_pred             -HHHhhcCcccccccccccCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 -WQLWNEGKALELIDTTLHESC-------SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 -~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                       ............+.. +....       .......+.+|+.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             000000000000000 00000       00123457899999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.9e-40  Score=288.38  Aligned_cols=263  Identities=25%  Similarity=0.374  Sum_probs=204.8

Q ss_pred             cccccHHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeE
Q 041345            5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGC   82 (340)
Q Consensus         5 ~~~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   82 (340)
                      .+..++.++....+.|++.+.||.|+||.||+|... .++.+|+|++.... .....+..|+.++.++ .|+|+++++++
T Consensus         3 ~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            344567777778899999999999999999999864 47889999885543 3345678899999988 69999999998


Q ss_pred             Eee------CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC
Q 041345           83 SLQ------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ  156 (340)
Q Consensus        83 ~~~------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~  156 (340)
                      +..      ....+++|||+++++|.+++.... ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence            853      456899999999999999886432 334788889999999999999999999   9999999999999999


Q ss_pred             CCeeEecccccccccCcccccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc
Q 041345          157 MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL  231 (340)
Q Consensus       157 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~  231 (340)
                      +.++|+|||++.......  .......++..|+|||.+.     +..++.++|+||||+++|+|++|..||.........
T Consensus       158 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             CCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            999999999987543211  1122345788999999875     346788999999999999999999999543322111


Q ss_pred             chhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          232 NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..      . ...        ..........+..+.+++.+||..||.+|||+.++++
T Consensus       236 ~~------~-~~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 FL------I-PRN--------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hh------H-hhC--------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00      0 000        0011111234567999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-40  Score=295.39  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=195.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..+.|++|+.+++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999865 4788999998542   2223445778899999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998642  235889999999999999999999999   999999999999999999999999998765432


Q ss_pred             ccccccccccccCCCCChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      .. .......|++.|+|||++.+     +.++.++|+||||+++|+|++|..||...+..+..      ...........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEERFQ  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCCccc
Confidence            21 11223468999999998865     46788999999999999999999999644332211      11111110000


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATD--RPTMSDVASM  290 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  290 (340)
                      +      .......+..+.+++.+|+..++++  |++++++++.
T Consensus       229 ~------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 F------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0      0111223567888999998876544  4678877754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.7e-40  Score=284.63  Aligned_cols=253  Identities=25%  Similarity=0.456  Sum_probs=202.4

Q ss_pred             CCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC------hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+....      ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588899999999999999975 458899999986432      1234578899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEecccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTF  170 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~  170 (340)
                      |+||+++++|.+++..   ...+++..+..++.|++.|+++||++|   ++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   345889999999999999999999999   99999999999998775 5899999998776


Q ss_pred             cCcccc--cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          171 GMNELE--ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       171 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ......  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||............   ...        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~--------  223 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKI--------  223 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHH--------
Confidence            432111  1122345788999999998888999999999999999999999998644332211111   000        


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       .........+......+.+++.+||+.+|++|||+.+++.
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 -ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             0011122344556678999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-40  Score=292.52  Aligned_cols=250  Identities=21%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +.|.....||.|+||.||++... ++..||+|.+..........+.+|+..++.++|+|++++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            44555678999999999999764 48899999986655555667889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++..    ..+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||++.......  
T Consensus       102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658         102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            99999998732    34889999999999999999999999   9999999999999999999999999987543221  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........   ....    ..     .....  
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~----~~-----~~~~~--  238 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIR----DN-----LPPRV--  238 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hc-----CCCcc--
Confidence            1223345788999999998888999999999999999999999998643322211   0000    00     00000  


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ......+..+.+++.+||..+|.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0112344568889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.1e-40  Score=285.71  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=198.4

Q ss_pred             CCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC------
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG------   87 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------   87 (340)
                      |++.+.||+|+||.||+|...    .++.+|+|.+...  .......+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999753    3678999988654  2344567889999999999999999999876532      


Q ss_pred             eeEEEEeccCCCChhhHhhccC---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSS---KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF  164 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Df  164 (340)
                      ..+++++|+.+++|..++....   ....++...+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988874321   1224788899999999999999999998   999999999999999999999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhc
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      |.+................++..|++||.+.+..++.++||||||+++|+|++ |..||.........       .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY-------NYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH-------HHHHc
Confidence            99886543322222223345677999999988889999999999999999999 77887643322111       11111


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...         ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       231 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110         111233456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.9e-40  Score=294.29  Aligned_cols=255  Identities=19%  Similarity=0.256  Sum_probs=195.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+++... ++.+|+|++.+.   .......+.+|+.++..++|++|+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            479999999999999999998754 778999998542   1223345778899999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++|+|.+++...  ...+++..+..++.|++.|+.|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999998542  235889999999999999999999999   999999999999999999999999998754322


Q ss_pred             ccccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      . ........|++.|+|||++.     ...++.++|||||||++|+|++|+.||...+..+...      ..........
T Consensus       156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~~  228 (332)
T cd05623         156 G-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKERFQ  228 (332)
T ss_pred             C-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCcccc
Confidence            1 11223356899999999885     3468899999999999999999999996543322111      1111110000


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATD--RPTMSDVASM  290 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  290 (340)
                            ........+..+.+++.+|+..++++  |+++.++++.
T Consensus       229 ------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                  01111234567888888888654444  6889988865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.6e-40  Score=286.35  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=190.2

Q ss_pred             CcccccCCeeEEEEEECC----CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEe-eCCeeEEEEeccC
Q 041345           24 NRLGQGGFGPVYKGKLLD----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL-QKGERLLVYEYLP   97 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~e~~~   97 (340)
                      +.||+|+||.||+|.+.+    ...+|+|.+... .......+.+|+.+++.++|||++++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999997532    346899988543 3344567888999999999999999999765 3455789999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++....  ...++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            999999985432  23677788899999999999999998   9999999999999999999999999987653221111


Q ss_pred             --ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCC-CCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          178 --NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK-KNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       178 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+ .||.......   ...   ... .+.         
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~---~~~-~~~---------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV---YLL-QGR---------  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHh-cCC---------
Confidence              111234567899999998888999999999999999999965 4554322111   111   111 110         


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ....+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0111122345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-40  Score=292.14  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=202.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh---hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||.|++|.||+|...+ ++.+|+|.+.....   .....+.+|+++++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            478999999999999999998754 88999999865432   24556888999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+.+++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988543 2345899999999999999999999998   999999999999999999999999998765322


Q ss_pred             ccc---------------------------cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCC
Q 041345          174 ELE---------------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD  226 (340)
Q Consensus       174 ~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~  226 (340)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01112357888999999988889999999999999999999999996544


Q ss_pred             cccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 041345          227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT----MSDVAS  289 (340)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~  289 (340)
                      .....      ....         ............+..+.+++.+||+.+|++|||    +.+++.
T Consensus       237 ~~~~~------~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDETF------SNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHHH------HHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            32211      1111         001111111225678999999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-40  Score=296.95  Aligned_cols=193  Identities=22%  Similarity=0.319  Sum_probs=162.7

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ....+|++.+.||.|+||.||+|+... ++.||+|......      ...|+.+++.++|+||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            344679999999999999999998754 6789999753322      246889999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |++. ++|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++......
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 567777643  2345899999999999999999999999   999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCC
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~  222 (340)
                         .......|+..|+|||++.+..++.++|||||||++|+|+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1223356899999999998889999999999999999999866554

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6e-40  Score=289.47  Aligned_cols=264  Identities=24%  Similarity=0.337  Sum_probs=199.5

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChh-----cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQ-----GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      +|.+.+.||.|++|.||+|... +++.|++|.+......     ....+..|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            5888899999999999999865 5889999998654322     234567899999999999999999999998899999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+ +++|.+++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999985432  35899999999999999999999999   99999999999999999999999999987643


Q ss_pred             cccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH-----HHhhc-Cc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW-----QLWNE-GK  245 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~-~~  245 (340)
                      ...  ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..+|................     ..+.. ..
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            221  1222345778999998854 467899999999999999999987776544332211111000     00000 00


Q ss_pred             ccccccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          246 ALELIDTTLHESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       246 ~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .............     ....+..+.+++.+||+.+|++|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0011110011111     12345678999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.3e-40  Score=293.05  Aligned_cols=257  Identities=18%  Similarity=0.235  Sum_probs=192.8

Q ss_pred             CCCccccc--CCeeEEEEEE-CCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           22 PGNRLGQG--GFGPVYKGKL-LDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        22 ~~~~Lg~G--~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +.++||+|  +|++||++.. .+++.||+|.+...  .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7889999976 45889999998654  2334456778999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985432 234889999999999999999999999   999999999999999999999999865433211100


Q ss_pred             -----cccccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          177 -----ANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       177 -----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                           .......++..|+|||.+.+  ..++.++|||||||++|+|++|..||............      . .+.....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~------~-~~~~~~~  230 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK------L-NGTVPCL  230 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH------h-cCCcccc
Confidence                 01122345678999999865  45889999999999999999999999653322110000      0 0000000


Q ss_pred             cc-------------------c-----------------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 ID-------------------T-----------------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~-------------------~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ++                   .                 .............+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00                   0                 0000111234567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.1e-40  Score=284.05  Aligned_cols=254  Identities=25%  Similarity=0.369  Sum_probs=199.7

Q ss_pred             CCCCCCcccccCCeeEEEEEECC--CCEEEEEEccCC----------ChhcHHHHHHHHHHHHc-CCCCceeeeeeEEee
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD--GQEIAIKRLSKS----------SGQGIVEFKNEAKLIAK-LQHTNLVRLLGCSLQ   85 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~   85 (340)
                      +|++.+.||.|+||.||+|....  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999998755  678999987432          22234456778887765 699999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEec
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISD  163 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~D  163 (340)
                      ....+++|||+++++|.+++... .....+++..++.++.|++.|+.+||+ .+   ++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887442 233458999999999999999999996 56   99999999999999999999999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      ||.+.......   ......++..|+|||.+.++.++.++|+||||+++|+|++|..||.........       .....
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-------~~~~~  227 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-------TKIVE  227 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-------HHHhh
Confidence            99998754332   223455788999999998888999999999999999999999998533221110       00111


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ....        .......+..+.+++.+||+.||++|||+.++.+++++
T Consensus       228 ~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         228 AVYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ccCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            1100        00111234678999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.3e-40  Score=286.61  Aligned_cols=255  Identities=24%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|++|.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            467888999999999999999865 47889999875443 3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |+++++|.+++..   .+.+++..+..++.+++.|+.|||+ .+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999988743   3458999999999999999999997 46   999999999999999999999999987654221


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc-----chhHHHHHHhhcCcccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL-----NLVGYAWQLWNEGKALE  248 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  248 (340)
                          ......++..|+|||.+.++.++.++|+|||||++|+|++|..||.........     ............ .   
T Consensus       158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---  229 (284)
T cd06620         158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P---  229 (284)
T ss_pred             ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c---
Confidence                122346789999999998888999999999999999999999999654432111     011111111100 0   


Q ss_pred             cccccccCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          249 LIDTTLHESCS-PDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       249 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                            ....+ ...+..+.+++.+||+.||++|||+.++++..
T Consensus       230 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 ------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                  01111 12456789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-39  Score=283.20  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=196.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC-----hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--Cee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   89 (340)
                      .+|++.+.||+|+||.||.|...+ ++.|++|.+....     ......+.+|+.+++++.||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            478999999999999999998644 8899999874321     22345788899999999999999999988663  467


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      +++|||+++++|.+++...   ..++...+..++.|++.||++||+++   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999988532   34788899999999999999999999   99999999999999999999999999876


Q ss_pred             ccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........      ....       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~-------  222 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIA-------  222 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHh-------
Confidence            5321111 1122345788999999998888999999999999999999999998643222110      0100       


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ........+......+.+++.+||. +|++|||+++|++
T Consensus       223 --~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 --TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              0011122345566778889999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=304.08  Aligned_cols=246  Identities=26%  Similarity=0.411  Sum_probs=207.6

Q ss_pred             cccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChhh
Q 041345           25 RLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDF  103 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  103 (340)
                      +||+|.||+||.|++.+ ...+|||.+...+....+-+..|+.+.++++|.|||+++|.+..+..+-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999999866 45689999988877778889999999999999999999999998888999999999999999


Q ss_pred             HhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCCeeEecccccccccCcccccccccc
Q 041345          104 FIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRI  182 (340)
Q Consensus       104 ~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  182 (340)
                      ++....+.-.-++.++--+.+||++||.|||.+.   |||||||-+|++|+ -.|.+||+|||.++.+-  .....+...
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence            9976554333388889999999999999999998   99999999999997 56789999999998763  345566778


Q ss_pred             cccCCCCChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCH
Q 041345          183 VGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSP  260 (340)
Q Consensus       183 ~~~~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (340)
                      .||.-|+|||++..+  .|..++|||||||++.||.||++||-.....+-              .+.+.-.-......|.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AMFkVGmyKvHP~iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AMFKVGMYKVHPPIPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hhhhhcceecCCCCcH
Confidence            899999999999766  489999999999999999999999943222210              0111111123466778


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          261 DEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       261 ~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +.+.+...+|.+|+.++|.+||++.+++.
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            88999999999999999999999999986

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.5e-40  Score=287.97  Aligned_cols=247  Identities=26%  Similarity=0.390  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .|+..+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4566778999999999999764 47789999886443 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++..    ..+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            99999988732    35889999999999999999999998   9999999999999999999999999987654321  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........       .....         ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~---------~~~  219 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKN---------SPP  219 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcC---------CCC
Confidence            11222457888999999988889999999999999999999999985433221110       00011         011


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            1223345678899999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.4e-40  Score=288.69  Aligned_cols=244  Identities=26%  Similarity=0.325  Sum_probs=199.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||.|++|.||++.+. +++.+|+|++....   ......+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47899999999999999999865 48899999985432   233456788999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++...   ..++...+..++.|++.||.+||+++   ++|+||+|.||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998543   45899999999999999999999999   999999999999999999999999998875433


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                           .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+....       ......+         
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~---------  213 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-------YEKILEG---------  213 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcC---------
Confidence                 2234578899999999888889999999999999999999999865442111       0100011         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                       ....+...+..+.+++.+||+.+|.+|+     ++.++++
T Consensus       214 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         214 -KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence             0112233457788999999999999999     6777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-40  Score=311.49  Aligned_cols=266  Identities=21%  Similarity=0.238  Sum_probs=192.4

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC------CCceeeeeeEE
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ------HTNLVRLLGCS   83 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~   83 (340)
                      +++....++|++.+.||+|+||.||+|.+. .++.||||++.... ........|+.+++.++      |.+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            445556789999999999999999999764 47789999985432 22334456777766664      45688888888


Q ss_pred             eeC-CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCC----
Q 041345           84 LQK-GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQM----  157 (340)
Q Consensus        84 ~~~-~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~----  157 (340)
                      ... ..+++||+++ +++|.+++..   ...+++..+..++.||+.||.|||+ .|   |+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            754 4689999988 6677777743   3458999999999999999999998 48   99999999999998665    


Q ss_pred             ------------CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCC
Q 041345          158 ------------NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY  225 (340)
Q Consensus       158 ------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~  225 (340)
                                  .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                        49999999875422     1223457899999999999999999999999999999999999999766


Q ss_pred             CcccccchhHHHH----HHhhcC----cccccccc---------------cccCC--CCHHHHHHHHHHHHhccCCCCCC
Q 041345          226 DTERHLNLVGYAW----QLWNEG----KALELIDT---------------TLHES--CSPDEVTRCIHVGLLCVQDKATD  280 (340)
Q Consensus       226 ~~~~~~~~~~~~~----~~~~~~----~~~~~~~~---------------~~~~~--~~~~~~~~l~~li~~cl~~~p~~  280 (340)
                      +..+....+....    ..|...    ....+...               .....  ........+.+||.+||+.||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            5433222211100    000000    00000000               00000  00112356789999999999999


Q ss_pred             CCCHHHHHH
Q 041345          281 RPTMSDVAS  289 (340)
Q Consensus       281 RPt~~evl~  289 (340)
                      |||+.|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999997

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9e-40  Score=281.95  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|+||.||.+... +++.+++|.+...  .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5889999999999999999764 5889999988543  233445788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+.+.... ...+++..+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999885422 234788999999999999999999998   99999999999999999999999999876543221


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                        ......++..|+|||.+.+..++.++|+||||+++++|++|..||...+....      ..... .+.         .
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~---------~  218 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKII-RGS---------Y  218 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHh-cCC---------C
Confidence              12234578889999999888899999999999999999999999854322211      11111 111         1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+...+..+.+++.+||+.+|++||++.+|++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1123345667899999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.1e-40  Score=283.38  Aligned_cols=238  Identities=24%  Similarity=0.405  Sum_probs=187.5

Q ss_pred             CcccccCCeeEEEEEECCCC-----------EEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           24 NRLGQGGFGPVYKGKLLDGQ-----------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999875433           4778877544333 5678899999999999999999999887 678999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-------CeeEeccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-------NPKISDFG  165 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-------~~~l~Dfg  165 (340)
                      |||+++++|.+++.....  .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++       .++|+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999865322  5889999999999999999999998   99999999999999877       79999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccC--CCCccCceehhhHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhh
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      ++.....      .....++..|+|||.+.+.  .++.++|+||||+++|+|++| ..||..........       .+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHh
Confidence            9876432      2223456789999998776  789999999999999999994 66665443221110       000


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ....           .+......+.+++.+||..+|++|||+.++++.|+
T Consensus       221 ~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0000           00111267889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=296.95  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=184.5

Q ss_pred             ccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcC---CCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           26 LGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      ||+|+||.||+|+.. +++.||+|++....   .........|..++...   .||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999865 48899999985432   12233344566666554   699999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|...+..   ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999888843   345899999999999999999999999   9999999999999999999999999987533221  12


Q ss_pred             cccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCC
Q 041345          179 TNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES  257 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (340)
                      .....|+..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+..       .....+.. .+     .  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~-~~-----~--  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-------RNIAFGKV-RF-----P--  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-------HHHHcCCC-CC-----C--
Confidence            2345689999999998764 4899999999999999999999999654332211       11111110 00     0  


Q ss_pred             CCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 041345          258 CSPDEVTRCIHVGLLCVQDKATDRPT----MSDVAS  289 (340)
Q Consensus       258 ~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~  289 (340)
                       ....+..+.+++.+||+.||++||+    +.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             0123456788999999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-39  Score=282.33  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=202.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|++.++++.||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999875 48889999886553 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|.+++....  ..+++..+..++.|++.|+++||+ .+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999986432  458899999999999999999999 88   9999999999999999999999999987653221


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                          .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........... ...         
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~---------  220 (265)
T cd06605         156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-NEP---------  220 (265)
T ss_pred             ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-cCC---------
Confidence                111567889999999988899999999999999999999999986543211 11111111111 110         


Q ss_pred             cCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+.. .+..+.++|.+||..+|++|||+.+++.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1111222 5667899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-40  Score=320.73  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-   86 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   86 (340)
                      .+.....++|++.+.||.|+||.||+|+... +..+|+|.+...  .......+..|+.+++.++||||+++++++... 
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            3344556899999999999999999998754 677899988543  333456788999999999999999999988653 


Q ss_pred             -CeeEEEEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCC----CceeecCCCCCCeEeCC-----
Q 041345           87 -GERLLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSR----LRVIHRDLKASNILLDD-----  155 (340)
Q Consensus        87 -~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~----~~i~H~dlk~~Nilv~~-----  155 (340)
                       ..+|+||||+++++|.+++.... ....+++..++.|+.||+.||+|||+.+.    .+|+|+||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence             56899999999999999985422 23458999999999999999999998431    24999999999999964     


Q ss_pred             ------------CCCeeEecccccccccCcccccccccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCCCC
Q 041345          156 ------------QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSKKN  221 (340)
Q Consensus       156 ------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p  221 (340)
                                  .+.++|+|||++..+....   ......|++.|+|||++.+  ..++.++|||||||+||+|++|..|
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                        2348999999998654322   1233468999999999854  4588999999999999999999999


Q ss_pred             CCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          222 NGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      |........  +.    .......  .        ......+..+.+||..||+.+|.+|||+.+++.
T Consensus       243 F~~~~~~~q--li----~~lk~~p--~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        243 FHKANNFSQ--LI----SELKRGP--D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcCCcHHH--HH----HHHhcCC--C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            964332211  11    1111100  0        001123467889999999999999999999984

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.5e-40  Score=287.90  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=205.4

Q ss_pred             ccccHHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEE
Q 041345            6 KIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCS   83 (340)
Q Consensus         6 ~~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   83 (340)
                      .+++..++..+.++|.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            35667788888999999999999999999999864 58889999985442 2345677889999988 799999999998


Q ss_pred             eeC-----CeeEEEEeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           84 LQK-----GERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        84 ~~~-----~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      ...     ...++||||+++++|.+++... .....+++..+..++.|++.|+.+||+.+   ++|+||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCC
Confidence            653     3589999999999999987532 22345899999999999999999999998   99999999999999999


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccC-----CCCccCceehhhHHHHHHHhCCCCCCCCCcccccc
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN  232 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~  232 (340)
                      .++|+|||++........  ......++..|+|||.+...     .++.++|||||||++|+|++|..||......... 
T Consensus       166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-  242 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-  242 (291)
T ss_pred             CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-
Confidence            999999999876542211  12234578889999987543     3688999999999999999999998654322111 


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                           ... .......+       ..+......+.+++.+||+.+|++||++.++++
T Consensus       243 -----~~~-~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 -----FKI-PRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -----HHH-hcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 111 11111111       112234457899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-39  Score=281.15  Aligned_cols=252  Identities=26%  Similarity=0.356  Sum_probs=206.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||.|++|.||+|.... ++.+++|.+..... .....+.+|+..+..++|+|++++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            468899999999999999998764 89999999866543 4456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|.+++...   ..+++..+..++.|++.|+++||+ ++   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998543   458999999999999999999999 98   9999999999999999999999999988654322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............   .... ..         .
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~-~~---------~  219 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAIC-DG---------P  219 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHh-cC---------C
Confidence            11  12345788999999998888999999999999999999999999655431111111   1111 11         0


Q ss_pred             cCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          255 HESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       255 ~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ....+.. .+..+.+++.+||..+|++|||+.++++.
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1112223 56789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-39  Score=281.33  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|++|.||++... +++.+++|.+...  .......+.+|+.+++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999764 5788999988544  233456788999999999999999999999988999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|.+++.... ...+++..+..++.|++.|+++||+++   ++|+||+|+||+++.++ .++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999986532 334889999999999999999999999   99999999999998554 57999999988764322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         ......++..|+|||.+.+..++.++||||+|+++|+|++|..||...+......      .. ....         
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~------~~-~~~~---------  217 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL------KI-MSGT---------  217 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH------HH-HhcC---------
Confidence               1223457889999999988889999999999999999999999986543322110      00 0000         


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11122334567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-39  Score=286.47  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=204.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ...++|.+.+.||.|+||.||++... +++.+++|.+..........+.+|+.+++.++|||++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            33478999999999999999999754 57889999986554445567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..    ..+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             ecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            99999999999843    24788899999999999999999999   999999999999999999999999988755322


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      ..  ......+++.|+|||.+.++.++.++|+||||+++|++++|..||...+.........      ..+        .
T Consensus       169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~~--------~  232 (293)
T cd06647         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG--------T  232 (293)
T ss_pred             cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cCC--------C
Confidence            11  1223457888999999988889999999999999999999999996543322111110      000        0


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .....+...+..+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111123345678899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=289.12  Aligned_cols=265  Identities=22%  Similarity=0.345  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||.|++|.||+|.+. +++.|++|.+....  ......+.+|+.+++.++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47899999999999999999875 47889999885432  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++++++..+...   ...++...+..++.|++.|++|||+++   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998877766532   334899999999999999999999999   9999999999999999999999999988765332


Q ss_pred             cccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH--------HHhhcCc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW--------QLWNEGK  245 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  245 (340)
                      . .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+.........        ..+....
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            2 122234567889999999887 78999999999999999999999986543322111110000        0000000


Q ss_pred             cc---ccccc----cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 AL---ELIDT----TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~---~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..   +....    ......+...+..+.+++++||..+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00   00000    0000112223678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5e-40  Score=290.96  Aligned_cols=256  Identities=18%  Similarity=0.259  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||.|+||.||++.... ++.|++|.+....   ......+.+|+.+++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            478999999999999999998654 7889999886543   233456778999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999987642111


Q ss_pred             ccc-------------cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          174 ELE-------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       174 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      ...             .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......+..   .   ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~---~---~~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF---G---QV  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HH
Confidence            000             0111234678899999998888999999999999999999999999644322211   1   10


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      . .....       ........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       229 ~-~~~~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 I-SDDIE-------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             H-hcccC-------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            0 00000       001112345678999999999999999998777777764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-40  Score=290.04  Aligned_cols=264  Identities=24%  Similarity=0.336  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||.|++|.||+|... +++.+|+|.+.....  .....+.+|+.+++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47889999999999999999875 488999998754322  234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|..+...   ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999998887643   234899999999999999999999998   9999999999999999999999999987654322


Q ss_pred             cccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhcCc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWNEGK  245 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  245 (340)
                        .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...        ........
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence              11223456888999998865 45788999999999999999999988654332211000000        00000000


Q ss_pred             ------ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ------ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                            ..............+..+..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                  00000000000011234577899999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-39  Score=284.01  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh----------hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG----------QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG   87 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (340)
                      +|.+.+.||.|++|.||+|... +++.+|+|.+.....          ...+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5788999999999999999754 588999998743211          11345778999999999999999999999989


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..++||||+++++|.+++...   ..++...+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   45889999999999999999999998   999999999999999999999999998


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCC--CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ................++..|+|||.+.+..  ++.++|+||||+++|++++|..||.......      ..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhcccc
Confidence            7653221112223345788999999987654  7899999999999999999999985322211      0111111110


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....     ........+..+.+++.+||..+|++|||+.++++
T Consensus       230 ~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 APPI-----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCcC-----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0000     11112234578899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.2e-40  Score=288.05  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=200.4

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|++|.||+|.+. +++.|++|.+....  ......+.+|+.++++++|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999864 58899999986543  23356788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      + +++|.+++....  ..+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999885433  45899999999999999999999999   99999999999999999999999999887643321


Q ss_pred             ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH-----HHHhhcCc-ccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA-----WQLWNEGK-ALE  248 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~  248 (340)
                       .......++..|+|||.+.+. .++.++||||+|+++|+|++|..+|...............     ...+.... ...
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence             112234578899999988654 4689999999999999999998877554432211111000     00000000 000


Q ss_pred             c--cccccc-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 L--IDTTLH-----ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~--~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .  +.....     ....+.....+.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0  000000     0011233578899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=284.14  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCC-----
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKG-----   87 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-----   87 (340)
                      ...++|++.+.||.|++|.||+|... +++.+++|.+..... ....+.+|+.+++++ .|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45689999999999999999999875 478899999865543 346788999999998 7999999999987544     


Q ss_pred             -eeEEEEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           88 -ERLLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        88 -~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999885432 2346899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      .+.......  .......++..|+|||.+..     ..++.++||||||+++|+|++|..||.........      ...
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~  230 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL------FKI  230 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH------HHh
Confidence            987653221  12233457889999998753     34678999999999999999999999643221110      111


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      . .....       ....+...+..+.+++.+||..||++|||+.++++
T Consensus       231 ~-~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 P-RNPPP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             h-ccCCC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0 11000       11112335568899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-39  Score=281.01  Aligned_cols=250  Identities=27%  Similarity=0.463  Sum_probs=200.7

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|.+.+.||+|++|.||+|... +++.+++|.+.....  .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            6889999999999999999864 588999999865543  3567789999999999999999999999989999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++..   ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   334788999999999999999999999   99999999999999999999999999887653322


Q ss_pred             ccc--cccccccCCCCChhhhccCC---CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          176 EAN--TNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       176 ~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ...  .....++..|+|||.+.+..   ++.++||||||+++|++++|..||...+....     ...... ...     
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~~~-----  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHVG-AGH-----  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHHh-cCC-----
Confidence            111  12345788999999987765   88999999999999999999999964331110     000000 000     


Q ss_pred             cccccCCCCH--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSP--DEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ....+.  .....+.+++.+||+.+|++|||+.+++.
T Consensus       224 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 ----KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ----CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                011111  23567889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.1e-40  Score=288.78  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=198.9

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      |.....||.|+||.||++... +++.||+|.+..........+.+|+..++.+.|||++++++++..+...++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            455668999999999999764 5889999998655444556788999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|..++..    ..+++..+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~  173 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK  173 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence            999987732    34889999999999999999999999   9999999999999999999999999987543221  11


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||..........       .........       ...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~-------~~~  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-------RLRDSPPPK-------LKN  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhccCCCC-------ccc
Confidence            223557889999999988889999999999999999999999986443322111       111110000       001


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ....+..+.+++.+||+.+|++|||+.++++.
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            12234568899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.1e-40  Score=287.87  Aligned_cols=263  Identities=21%  Similarity=0.294  Sum_probs=194.0

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|++|.||+|+.. +|+.+++|.+....  ......+.+|+.+++.++|||++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5888999999999999999875 48899999885432  22234567899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++ +|.+++...  ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            975 676666432  345899999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCc-ccccchhHH--------HHHHhhcCc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDT-ERHLNLVGY--------AWQLWNEGK  245 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~-~~~~~~~~~--------~~~~~~~~~  245 (340)
                       .......++..|+|||.+.+. .++.++|||||||++|+|++|+.|+..... ......+..        .+.......
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence             112233567899999988765 478999999999999999999988632222 111111000        000000000


Q ss_pred             ccccccc----cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDT----TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .......    .......+..+..+.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000    0000111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2e-39  Score=281.79  Aligned_cols=254  Identities=20%  Similarity=0.306  Sum_probs=187.4

Q ss_pred             CcccccCCeeEEEEEECCC---CEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLLDG---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.||+|+||.||++...++   ..+++|.+.... ......+.+|+..++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975443   345677765443 234567889999999999999999999999888999999999999


Q ss_pred             ChhhHhhccCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345          100 SLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus       100 ~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      +|.+++..... ....+...+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865322 234677788899999999999999998   99999999999999999999999998764322221122


Q ss_pred             cccccccCCCCChhhhcc-------CCCCccCceehhhHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          179 TNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .....++..|+|||++..       ..++.++||||||+++|+|+++ ..||.........      ..... +......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~-~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL------NHVIK-DQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHh-hcccccC
Confidence            233457889999998743       2457899999999999999975 5676433222111      11111 1111111


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      +.    ..+......+.+++..|| .+|++|||+++|++.|.
T Consensus       231 ~~----~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KP----QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC----ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11    111223456788899999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-39  Score=288.30  Aligned_cols=261  Identities=24%  Similarity=0.331  Sum_probs=185.5

Q ss_pred             CCcccccCCeeEEEEEECC---CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCeeEEEEeccC
Q 041345           23 GNRLGQGGFGPVYKGKLLD---GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGERLLVYEYLP   97 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~   97 (340)
                      +.+||+|+||.||+|+..+   +..+|+|.+....  ....+.+|+.+++.++||||+++++++..  ....++++||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4689999999999998643   5689999886543  23356789999999999999999998854  456899999986


Q ss_pred             CCChhhHhhcc------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe----CCCCCeeEeccccc
Q 041345           98 NKSLDFFIFDS------SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMA  167 (340)
Q Consensus        98 ~~~L~~~l~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv----~~~~~~~l~Dfg~~  167 (340)
                      + +|.+++...      .....+++..+..++.|++.||.|||+++   ++|+||||+||++    +.++.++|+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 565555321      11234888999999999999999999999   9999999999999    45678999999999


Q ss_pred             ccccCcccc-cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCccccc----ch--hHHHHH
Q 041345          168 RTFGMNELE-ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL----NL--VGYAWQ  239 (340)
Q Consensus       168 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~----~~--~~~~~~  239 (340)
                      ......... .......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.........    ..  ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            876433211 122335678999999998764 5899999999999999999999999654332110    00  000000


Q ss_pred             Hhhc------------Cccccccccccc------------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          240 LWNE------------GKALELIDTTLH------------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       240 ~~~~------------~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....            ............            ..........+.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            0000            000000000000            0001112346888999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=288.85  Aligned_cols=267  Identities=22%  Similarity=0.288  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCCeeEEEEEECC---CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD---GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERL   90 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~   90 (340)
                      +|++.+.||.|++|.||+|....   ++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48889999999999999998644   7899999986632   33345678899999999999999999999888  7899


Q ss_pred             EEEeccCCCChhhHhhcc-Cc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC----CCCeeEecc
Q 041345           91 LVYEYLPNKSLDFFIFDS-SK-KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD----QMNPKISDF  164 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~-~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~----~~~~~l~Df  164 (340)
                      +||||+++ ++.+.+... .. ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.    ++.++|+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 555554322 12 235899999999999999999999999   999999999999998    889999999


Q ss_pred             cccccccCccc-ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccc------hhHH
Q 041345          165 GMARTFGMNEL-EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN------LVGY  236 (340)
Q Consensus       165 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~------~~~~  236 (340)
                      |++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|..||..........      ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99887643322 1122334578889999988664 57899999999999999999999997655433100      0000


Q ss_pred             HHHHhh------------cCcccccccccccCCCC-----------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          237 AWQLWN------------EGKALELIDTTLHESCS-----------PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       237 ~~~~~~------------~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ......            ........+.......+           ......+.+++.+||+.||++|||+.+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000            00000000000000011           023456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8e-40  Score=282.64  Aligned_cols=247  Identities=25%  Similarity=0.287  Sum_probs=201.5

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +|++.+.||.|+||.||+|+.. +++.+++|.+....   ......+.+|+.++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999875 48899999986542   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+.+++|.+++...   ..++...+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998542   46899999999999999999999998   9999999999999999999999999988654322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............    .....          .
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~----------~  217 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET----------A  217 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc----------c
Confidence               223345788899999998888999999999999999999999999755442111111    00000          1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTM--SDVA  288 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl  288 (340)
                      ....+...+..+.+++.+||+.||.+||++  .+++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            122233445788999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.4e-39  Score=281.75  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=204.9

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ...+.|++.+.||.|++|.||+|... +++.+++|++..... ....+.+|+..++.++|+|++++++++......++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34577999999999999999999876 588899999865544 4567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++....  ..++...+..++.|++.|+++||+.|   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999996532  35899999999999999999999998   999999999999999999999999988755322


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      ..  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......      . ........     
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~-----  235 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------L-ITTKGIPP-----  235 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhcCCCC-----
Confidence            11  1123346788999999988889999999999999999999999986543322110      0 00110000     


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ...+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 --LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              1111224567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=281.10  Aligned_cols=246  Identities=25%  Similarity=0.432  Sum_probs=197.9

Q ss_pred             CCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCC---CCceeeeeeEEeeCCeeEEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQ---HTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .|++.+.||.|+||.||+|.+ .+++.+++|.+... .......+.+|+.+++.+.   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            578889999999999999986 45889999998654 3344567888999999886   999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..    ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    25889999999999999999999999   999999999999999999999999998876533


Q ss_pred             ccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .  .......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||............       ....       
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~-------  218 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PKSK-------  218 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------ccCC-------
Confidence            2  112234578899999988654 5789999999999999999999999654332211100       0000       


Q ss_pred             cccCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSP-DEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ....+. ..+..+.+++.+||+.||++|||+.+++.
T Consensus       219 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 --PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             --CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence              011111 14567889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.4e-39  Score=279.37  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCeeEEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGERLLVY   93 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~   93 (340)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .......+.+|+.+++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5888999999999999999754 5788999988543  33345668889999999999999999997754  35679999


Q ss_pred             eccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHH-----hCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           94 EYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLH-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ||+++++|.+++... .....+++..++.++.|++.|+++||     +.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998543 22356899999999999999999999     666   999999999999999999999999998


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...   ..    .....+   
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~---  225 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA----SKIKEG---  225 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH----HHHhcC---
Confidence            87653321  1223457889999999988889999999999999999999999997544221   11    111111   


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            .....+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus       226 ------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 ------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  1122334556788999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.5e-39  Score=284.84  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~i   91 (340)
                      .++|++.+.||.|++|.||+|.+. +++.+++|.+.....  .....+.+|+.++++++||||+++++++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357999999999999999999875 478899999864432  2233567899999999999999999998877  78999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |+||+++ +|.+++....  ..+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++..+.
T Consensus        84 v~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            9999974 8888875432  35899999999999999999999999   9999999999999999999999999988765


Q ss_pred             CcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH--------HHHHhh
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY--------AWQLWN  242 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~  242 (340)
                      ...  .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+..        .+..+.
T Consensus       158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            432  112234567889999988654 468999999999999999999999976554332211110        010000


Q ss_pred             c------CcccccccccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 E------GKALELIDTTLHESCSPD-EVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 ~------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .      ..........+....+.. .+..+.+++.+||+.+|++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0      000000011111112222 3567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-38  Score=279.15  Aligned_cols=260  Identities=25%  Similarity=0.313  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~   93 (340)
                      ++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|+++++.++||||+++++++...  ..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888899999999999999874 478899998865432 3456688999999999999999999988653  4689999


Q ss_pred             eccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||+++++|.+++... .....++...+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999886532 22345889999999999999999999999   99999999999999999999999999875432


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....... ..........+...
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~  231 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELL-SYIVNMPNPELKDE  231 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHH-HHHhcCCchhhccC
Confidence            21    123446788999999988899999999999999999999999997553311 1111111 11111111111000


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         .......+..+.+++.+||+.+|.+|||+.|+++
T Consensus       232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 ---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence               0000124567899999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=285.23  Aligned_cols=263  Identities=23%  Similarity=0.340  Sum_probs=195.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||.|++|.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            478999999999999999999865 578999999864432 223356789999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++ +|.+++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9975 8888775432  35889999999999999999999999   9999999999999999999999999987543221


Q ss_pred             cccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc---Ccc----
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE---GKA----  246 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----  246 (340)
                      .  ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........  ...........   ..+    
T Consensus       158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhh
Confidence            1  1122345788999998865 4588999999999999999999999965442110  00000000000   000    


Q ss_pred             --ccccc--------ccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 --LELID--------TTLHESC-SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 --~~~~~--------~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        .....        ..+.... .......+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              00000        0000000 0011267789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.7e-39  Score=279.87  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +-|++.+.||.|+||.||+|.+. ++..+|+|.+.... ......+.+|+..+..++||||+++++++..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34778899999999999999764 57889999875432 23455788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|..++..    ..++...+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            999999988842    34889999999999999999999998   9999999999999999999999999987654321 


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........       .......         .
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~---------~  218 (277)
T cd06641         156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-------FLIPKNN---------P  218 (277)
T ss_pred             -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH-------HHHhcCC---------C
Confidence             1122245688899999998888899999999999999999999998643322111       0011111         1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11223345678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-39  Score=282.85  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=191.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHH-HHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKL-IAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||.|+||.||+|.+. +|+.||+|.+.... ......+..|... ++...|||++++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47899999999999999999875 48999999986542 2223344555554 566789999999999999899999999


Q ss_pred             ccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           95 YLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        95 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |++ ++|.+++... .....+++..+..++.|++.|++|||++ +   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6777776442 2335689999999999999999999997 7   99999999999999999999999999876532


Q ss_pred             cccccccccccccCCCCChhhhcc----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMN----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ..   ......++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||.......     ....... ......
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~~~~  227 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVV-EEPSPQ  227 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHH-hcCCCC
Confidence            21   1222457888999998854    456889999999999999999999985432210     1111111 010000


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .        .....+..+.+++.+||..+|++|||+.++++
T Consensus       228 ~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 L--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0        01124567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=295.58  Aligned_cols=244  Identities=30%  Similarity=0.421  Sum_probs=200.1

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      |.-++.||-|+||.||.|++. +.+.||||.++-..   .+.++.+..|+..|+++.|||++.+-||+..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            666678999999999999864 47789999986543   44567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      | -|+-.+++..  ...++.+..+..|+.+.+.||+|||+.+   .+|||||+.||++++.|.|||+|||.+...     
T Consensus       108 C-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~-----  176 (948)
T KOG0577|consen  108 C-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM-----  176 (948)
T ss_pred             H-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc-----
Confidence            9 5677777754  3456999999999999999999999999   999999999999999999999999998753     


Q ss_pred             ccccccccccCCCCChhhh---ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                       ...+...|||.|+|||++   ..+.|+-++||||||++-.||.-.++|.-..+...-      .+.+- .+..+.    
T Consensus       177 -~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------LYHIA-QNesPt----  244 (948)
T KOG0577|consen  177 -APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNESPT----  244 (948)
T ss_pred             -CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------HHHHH-hcCCCC----
Confidence             345567899999999988   357899999999999999999999988643333221      12211 111111    


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          -..++.+..+..++..||++-|.+|||.++++..
T Consensus       245 ----Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 ----LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ----CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                1135667788999999999999999999998763

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.2e-39  Score=283.79  Aligned_cols=247  Identities=29%  Similarity=0.426  Sum_probs=195.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ...|.+.+.||+|+||.||+|... +++.|++|.+....   ......+.+|+.+++.++|||++++.+++......++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356999999999999999999865 58899999885432   23345678999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      +||++ +++.+++...  ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 4666665332  235899999999999999999999999   99999999999999999999999998875432


Q ss_pred             cccccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                            .....++..|+|||.+.   ...++.++||||||+++|+|++|..||...+.....      .... ....   
T Consensus       168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~-~~~~---  231 (307)
T cd06607         168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QNDS---  231 (307)
T ss_pred             ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHh-cCCC---
Confidence                  12345678899999874   456889999999999999999999998543322210      1100 0000   


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           ....+...+..+.+++.+||+.+|++|||+.+++..
T Consensus       232 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 -----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 011122345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-38  Score=273.75  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=205.3

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLLVY   93 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~   93 (340)
                      +|++.+.||+|++|.||+|... +++.+++|++.....  .....+.+|+..+++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5788899999999999999876 588999999865542  4466788999999999999999999999888  7899999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |++++++|.+++....   .+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999985432   6899999999999999999999998   999999999999999999999999998876543


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      ..........++..|+|||.+.+...+.++||||||+++++|++|..||.....     ..........         ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~~  220 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------SG  220 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------cC
Confidence            321112335678899999999888899999999999999999999999976541     1111111110         11


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .....+...+..+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            112233444678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.3e-39  Score=280.76  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      .|...+.||.|++|.||++... +++.+++|.+..........+.+|+.+++.+.|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4566679999999999999764 588899998865554555678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++..    ..++...+..++.|++.|+++||+++   ++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--P  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--c
Confidence            9999998853    34889999999999999999999999   9999999999999999999999999876543221  1


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES  257 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (340)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....   .   .. .......       ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~---~~-~~~~~~~-------~~  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---K---RI-RDNLPPK-------LK  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---H---HH-HhcCCCC-------Cc
Confidence            122345788999999998888999999999999999999999998543322111   1   10 0010000       00


Q ss_pred             CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       258 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11224567999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-38  Score=273.63  Aligned_cols=249  Identities=28%  Similarity=0.435  Sum_probs=203.1

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      .|++.+.||.|++|.||++... +++.+++|.+..........+.+|+..++.+.|++++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999875 588899999976654456788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++....  ..+++..+..++.|++.|+.+||.++   ++|+||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985432  45899999999999999999999998   99999999999999999999999999877653321  


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES  257 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (340)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+........       ........       .
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~-------~  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------ATNGPPGL-------R  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------HhcCCCCc-------C
Confidence             23456788999999998888999999999999999999999998644322111000       00100000       0


Q ss_pred             CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       258 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+...+..+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11112567899999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5e-39  Score=290.25  Aligned_cols=264  Identities=24%  Similarity=0.262  Sum_probs=198.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   86 (340)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            45689999999999999999999864 5889999998543  233445677899999999999999999987543     


Q ss_pred             -CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           87 -GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        87 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                       ...++||||+.+ +|.+.+..     .++...+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence             346999999964 77776632     1788999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH---------
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY---------  236 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~---------  236 (340)
                      ++.......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..         
T Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            998654321   12234568899999999999999999999999999999999999975543221111000         


Q ss_pred             ------HHHHhh-cCc------cccccccccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          237 ------AWQLWN-EGK------ALELIDTTLH----ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       237 ------~~~~~~-~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            ....+. ...      ..+.......    ...+...+..+.+++.+||+.||++|||+.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  000000 000      0000000000    00112345678899999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.1e-39  Score=281.50  Aligned_cols=263  Identities=25%  Similarity=0.362  Sum_probs=199.7

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +|++.+.||.|++|.||+|+.. +++.||+|.+..... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5889999999999999999875 488899999865432 23456778999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++ +|.+++........+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            75 78777755443456899999999999999999999998   9999999999999999999999999987654321  


Q ss_pred             cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhcCccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWNEGKAL  247 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~  247 (340)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+...        +....  ...
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  232 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QLP  232 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cCc
Confidence            112223467889999988654 5788999999999999999999999765543322111000        00000  000


Q ss_pred             ccccccc------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          248 ELIDTTL------HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       248 ~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+.....      .....+..+..+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000      00111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=299.09  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCC-EEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +-|.|+..||.|+||.||+|..++.. ..|.|++.....+..+.|.-|+++|...+||+|+++++.|...+.++|..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34778889999999999999876533 34778887777778889999999999999999999999998899999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      .||..+..+..-  ...+.+.++.-+++|++.||.|||+++   |+|||||+.|||++-+|.++|+|||.+....  ...
T Consensus       112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR  184 (1187)
T ss_pred             CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence            999998887543  445999999999999999999999999   9999999999999999999999999876532  222


Q ss_pred             cccccccccCCCCChhhh-----ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYV-----MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      .......||+.|+|||+.     .+.+|+.++||||||++|.+|..+.+|-...+...      .... ......+.   
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------VllK-iaKSePPT---  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLK-IAKSEPPT---  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHHH-HhhcCCCc---
Confidence            334457899999999976     46789999999999999999999988853222211      1111 11111111   


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          .-.|......+.+++.+||.+||..||++.++++.
T Consensus       255 ----LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 ----LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ----ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                11245667789999999999999999999999863

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.4e-39  Score=282.94  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=194.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCe-----
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGE-----   88 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----   88 (340)
                      ++|++.+.||.|+||.||+|.+. +++.||+|.+....  ......+.+|+.+++.+. |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999865 48899999875432  123356788999999995 6999999998876655     


Q ss_pred             eEEEEeccCCCChhhHhhccCc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEeccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFG  165 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg  165 (340)
                      .++||||+++ +|.+++.....  ...+++..+..++.||+.||.|||+++   ++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 77777654322  245899999999999999999999999   999999999999998 8899999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ++..+....  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+   .......
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI---FKLLGTP  231 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHhCCC
Confidence            987653221  11122346788999998865 45789999999999999999999999754433211111   0000000


Q ss_pred             ---ccccccc--------cc---ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 ---KALELID--------TT---LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ---~~~~~~~--------~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         .+.....        ..   ......+..+..+.++|.+||..||.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               0000000        00   000001234567889999999999999999999885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-38  Score=320.26  Aligned_cols=265  Identities=24%  Similarity=0.425  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .....|...+.||+|+||.||+|+. .++..||+|.+.......    ..|+..+++++||||+++++++.+....++||
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3346688889999999999999986 468899999986443221    34578899999999999999999998999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++|+|.+++.      .+++..+..++.|++.|++|||.....+++||||||+||+++.++..++. |+......  
T Consensus       763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--  833 (968)
T PLN00113        763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--  833 (968)
T ss_pred             eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc--
Confidence            9999999999984      27889999999999999999995433449999999999999988887765 55443221  


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                          ......++..|+|||++.+..++.++|||||||++|||++|+.||..... .......+............+++..
T Consensus       834 ----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        834 ----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             ----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcc
Confidence                11223578899999999988999999999999999999999999843222 1222333333222222233333433


Q ss_pred             ccC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          254 LHE--SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       254 ~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                      +..  ..+..+..++.+++.+||+.+|++|||+.++++.|+++...
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            322  23456667889999999999999999999999999987553

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-38  Score=276.03  Aligned_cols=242  Identities=24%  Similarity=0.324  Sum_probs=195.3

Q ss_pred             ccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ||.|++|.||+|.... ++.+++|++....   ......+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999998754 8899999986432   23345788999999999999999999999999999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR  181 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  181 (340)
                      .+++..   ...++...+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999853   234889999999999999999999998   9999999999999999999999999988764332   2223


Q ss_pred             ccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       182 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ....   ....         ........+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~---------~~~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---NDIL---------KGNGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---HHHh---------ccCCCCCCCcc
Confidence            457889999999888889999999999999999999999997554211 1011   1100         00111222333


Q ss_pred             HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          262 EVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                      .+..+.+++.+||+.+|++|||     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            4678999999999999999999     777775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.2e-39  Score=282.10  Aligned_cols=263  Identities=23%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|++|.||+|+.. +++.|++|.+....  ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5889999999999999999865 58899999885432  22335688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +. ++|..++.... ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 57877775432 345899999999999999999999998   9999999999999999999999999987654321 


Q ss_pred             ccccccccccCCCCChhhhccCC-CCccCceehhhHHHHHHHhCCCCCCCCCcccccchh-HH-------HHHHhh----
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV-GY-------AWQLWN----  242 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~-~~-------~~~~~~----  242 (340)
                       .......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+........ ..       .+....    
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence             1122234578899999876644 688999999999999999999999654332211000 00       000000    


Q ss_pred             -cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 -EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ............ ....+.....+.+++.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             000000000000 0001223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=277.59  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      |.++.+||+|+||.||+|.++ .|+.+|+|.+...  .+.+.+..|+.++++.+.|++|+++|.+.....+|||||||.-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            667889999999999999654 4899999988554  3567889999999999999999999999888899999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      |++.+.++.  .+.++++.++..++..-++||+|||...   -+|||||+.||+++.+|..||+|||.+-.+..  .-..
T Consensus       113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAK  185 (502)
T KOG0574|consen  113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAK  185 (502)
T ss_pred             CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHHh
Confidence            999999965  3456999999999999999999999988   89999999999999999999999999876532  2233


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .+...||+.|+|||++..-.|+.++||||||++..||..|++|+....+..-.-.+.              ..+......
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--------------T~PPPTF~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--------------TKPPPTFKK  251 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--------------CCCCCCCCC
Confidence            455789999999999999999999999999999999999999986544333211110              011112223


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      |...+.++.+++++||-++|++|-|+.++++.
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            45667789999999999999999999998874

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-38  Score=280.34  Aligned_cols=264  Identities=22%  Similarity=0.286  Sum_probs=194.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++++|++.+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++|+||+++.+++..+...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999764 588999999865432 22345678999999999999999999999988999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+. +++.+.+...  ...++...+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 5666655332  234778888999999999999999998   999999999999999999999999998754322


Q ss_pred             ccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC--------
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--------  244 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  244 (340)
                      ..  ......++..|+|||.+.+. .++.++||||||+++|+|++|..||.......  ......+......        
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhh
Confidence            11  11223468899999988654 57889999999999999999999996544321  1111111100000        


Q ss_pred             -cccccccccccCCC---------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 -KALELIDTTLHESC---------SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 -~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ..............         .......+.+++.+|++.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             00000000000000         0012457789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-39  Score=289.49  Aligned_cols=266  Identities=24%  Similarity=0.339  Sum_probs=197.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----C
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----G   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   87 (340)
                      +.++|.+.+.||.|+||.||+|+.. +++.||+|.+...  .......+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3568999999999999999999764 4889999988643  223345677899999999999999999987643     3


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..++++||+. ++|.+++..   ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999995 678777743   345899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------H
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------W  238 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~  238 (340)
                      .......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...        .
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            8654321  11223456888999998765 46889999999999999999999999654332211111000        0


Q ss_pred             HHhhcCccccccccc---cc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          239 QLWNEGKALELIDTT---LH---ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~---~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .........+.+...   ..   ....+..+..+.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000000000   00   00112346778999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=290.37  Aligned_cols=264  Identities=23%  Similarity=0.318  Sum_probs=195.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----Ce
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----GE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   88 (340)
                      .+++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            4578999999999999999999764 58899999986432 23445678899999999999999999876543     34


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++++||+.+ ++...+.    ...+++..+..++.|++.||++||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            7999999964 6766663    235899999999999999999999999   9999999999999999999999999987


Q ss_pred             cccCccccc-ccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC--
Q 041345          169 TFGMNELEA-NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--  244 (340)
Q Consensus       169 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  244 (340)
                      ......... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+........   .......  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~---~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI---LGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCCH
Confidence            654321111 1123457889999998754 46889999999999999999999999654332211100   0000000  


Q ss_pred             ---------ccccccc---ccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          245 ---------KALELID---TTLHE---SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       245 ---------~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                               .....+.   .....   ...+..+..+.+++.+||+.+|++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     0000000   00000   0012235678899999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-38  Score=281.59  Aligned_cols=247  Identities=30%  Similarity=0.424  Sum_probs=194.9

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .|...+.||+|+||.||+++.. ++..+|+|.+...   .......+.+|+.+++.++|||++++++++......++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3788899999999999999864 5789999998543   22334568889999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+.+ ++.+.+...  ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 666665432  345899999999999999999999999   99999999999999999999999998765432  


Q ss_pred             cccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                          .....++..|+|||.+.   ++.++.++||||||+++|+|++|..||.........      .......       
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-------  240 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE-------  240 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhcc-------
Confidence                22345788899999873   456889999999999999999999998543222111      1110000       


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                        .........+..+.+++.+||+.+|.+|||+.++++.+-
T Consensus       241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence              001112234567899999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-39  Score=303.51  Aligned_cols=270  Identities=20%  Similarity=0.252  Sum_probs=187.0

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEECC--CCEEEEE------------------EccCCChhcHHHHHHHHHHHHcCCC
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLLD--GQEIAIK------------------RLSKSSGQGIVEFKNEAKLIAKLQH   73 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h   73 (340)
                      ....++|++.+.||+|+||.||++....  +...+.|                  .+. ........+.+|+.++++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            3456789999999999999999986432  2111211                  111 122334567899999999999


Q ss_pred             CceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCe
Q 041345           74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNI  151 (340)
Q Consensus        74 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  151 (340)
                      |||+++++++......+++++++.+ ++..++.....  ........+..++.|++.||.|||+++   |+||||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            9999999999999999999999854 56565533211  122346677889999999999999999   99999999999


Q ss_pred             EeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCC-CCCCCcccc
Q 041345          152 LLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN-NGCYDTERH  230 (340)
Q Consensus       152 lv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p-~~~~~~~~~  230 (340)
                      |++.++.++|+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+|++|..+ ++.......
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999999999987643221 122235689999999999998999999999999999999998854 433222111


Q ss_pred             cchhHHHHHHh-hcCcc-------ccccccccc----CCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          231 LNLVGYAWQLW-NEGKA-------LELIDTTLH----ESCS-----PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       231 ~~~~~~~~~~~-~~~~~-------~~~~~~~~~----~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+........ .....       ...+.....    ...+     ...+..+.+++.+||+.||++|||+.|+++
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11111000000 00000       000000000    0000     012345677899999999999999999986

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=279.88  Aligned_cols=260  Identities=18%  Similarity=0.223  Sum_probs=185.0

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECCC----CEEEEEEccCCChhcH-H----------HHHHHHHHHHcCCCCceeee
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLDG----QEIAIKRLSKSSGQGI-V----------EFKNEAKLIAKLQHTNLVRL   79 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~-~----------~~~~e~~~l~~l~h~~i~~~   79 (340)
                      ...++|++.+.||+|+||.||+|...++    ..+++|+......... +          ....++..+..+.|++++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3457899999999999999999986543    4566665432221110 0          11223344556789999999


Q ss_pred             eeEEeeCC----eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC
Q 041345           80 LGCSLQKG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD  155 (340)
Q Consensus        80 ~~~~~~~~----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~  155 (340)
                      ++++....    ..+++++++.. ++.+.+..   ....++..+..++.|++.|++|||+++   ++||||||+||+++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            98765543    34678887643 55555532   223577888999999999999999998   999999999999999


Q ss_pred             CCCeeEecccccccccCcccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          156 QMNPKISDFGMARTFGMNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       156 ~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                      ++.++|+|||++..+......     .......||+.|+|||.+.+..++.++|||||||++|+|++|..||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999876422111     112234689999999999999999999999999999999999999976533221


Q ss_pred             cc-hhHH-HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          231 LN-LVGY-AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       231 ~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      .. .... .......+.        .   ..+..+..+.+++..||+.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGK--------I---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHHHhhhhh--------h---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11 1100 001111110        0   01223567889999999999999999999998763

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-38  Score=276.58  Aligned_cols=244  Identities=24%  Similarity=0.335  Sum_probs=192.1

Q ss_pred             ccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           26 LGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ||.|+||.||+|... +++.+++|.+....   ......+.+|+.+++.++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999754 48899999885432   22344567899999999999999999999998999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR  181 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  181 (340)
                      .+++..... ..+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||.+......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            998865332 35899999999999999999999999   999999999999999999999999998765321   11223


Q ss_pred             ccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       182 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.       ....      ......+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~------~~~~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------RRTL------EMAVEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------hccc------cccccCCcc
Confidence            456788999999988889999999999999999999999996544322111110       0000      001122333


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          262 EVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                      .+..+.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            466789999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8e-39  Score=283.78  Aligned_cols=266  Identities=24%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~i   91 (340)
                      .++|++.+.||.|+||.||+|... +++.||+|.+....  ......+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999875 48899999985432  12233456899999999999999999998654  46899


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+.+ +|.+++...  ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999965 777777432  245899999999999999999999999   9999999999999999999999999988764


Q ss_pred             CcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc---
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL---  247 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  247 (340)
                      ...  .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+.......+...........+.   
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            322  11122334778999998865 457899999999999999999999997655433222111100000000000   


Q ss_pred             -----ccc--c-cccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          248 -----ELI--D-TTLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       248 -----~~~--~-~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           ...  . ....  .......+..+.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 000  0 0000  00001135667899999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.2e-38  Score=273.18  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=204.4

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|.+.+.||.|++|.||++.+. +++.+++|.+....  ......+.+|+++++.++|+|++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888999999999999999875 48899999986543  24556788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|.+++.... ....++...+..++.+++.|+++||+++   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 1356899999999999999999999998   9999999999999999999999999988765432


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        .......+++.|+|||...+..++.++|+||+|+++++|++|..||.......   ...   . .....         
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~-~~~~~---------  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---K-ILKGQ---------  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH---H-HhcCC---------
Confidence              12233467889999999988889999999999999999999999986543221   111   1 11111         


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+...+..+.+++.+||..+|++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11122344567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.3e-38  Score=276.68  Aligned_cols=242  Identities=23%  Similarity=0.315  Sum_probs=186.6

Q ss_pred             cccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHc---CCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           25 RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAK---LQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      .||+|+||.||++... +++.+|+|.+....   ......+.++..+++.   ..||+++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 48899999885432   1112223444443333   479999999999998889999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++..   ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988843   345899999999999999999999999   9999999999999999999999999987543221   


Q ss_pred             ccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                       .....|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||............    ...          .....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~----------~~~~~  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT----------LTVNV  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHh----------hcCCc
Confidence             223458899999998864 56889999999999999999999999654332211110    000          00112


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVASM  290 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  290 (340)
                      ..+...+..+.+++.+||..||++||     |+.++++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            23344567889999999999999999     59988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=272.38  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=202.1

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|++|.||++... +++.+++|.+.....  .....+.+|++++++++|+|++++++++......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5889999999999999999765 478899999866543  4556789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++...   ..+++..+..++.|++.|+.+||++|   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998533   45899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .  .....++..|+|||...+..++.++|+||+|+++|+|++|..||.......      ..+... ...         .
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~---------~  216 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIV-QDD---------H  216 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-ccC---------C
Confidence            1  223457889999999888788999999999999999999999986433211      011110 010         1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+...+..+.+++.+||..+|++|||+.+++.
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1122334567889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=273.85  Aligned_cols=250  Identities=25%  Similarity=0.377  Sum_probs=197.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-----ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--Cee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   89 (340)
                      .+|++.+.||+|++|.||+|.+. ++..+++|.+...     .......+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999864 4889999987432     223445788999999999999999999988764  458


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++++||+++++|.+++..   ...+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998853   234789999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||........      .....       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-------  222 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIA-------  222 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHH-------
Confidence            5321111 111234578899999999888889999999999999999999999964322111      01110       


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ........+......+.+++.+||+ +|..|||+.+++.
T Consensus       223 --~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 --TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              1111123345566789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-38  Score=273.72  Aligned_cols=248  Identities=27%  Similarity=0.367  Sum_probs=202.9

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|++.+.||.|++|.||++... +++.+++|.+...  .......+.+|+.+++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5888999999999999999754 5788999998643  233455677899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|..++.... ....+++..+..++.|++.|+++||++|   ++|+||+|.||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999885522 2345889999999999999999999999   999999999999999999999999998876533 


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.....       ......         .
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~---------~  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRG---------K  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcC---------C
Confidence               122245788999999998888999999999999999999999999654432211       111111         1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            12223456678999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=279.41  Aligned_cols=263  Identities=22%  Similarity=0.301  Sum_probs=197.4

Q ss_pred             CCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEEEEe
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLLVYE   94 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~e   94 (340)
                      |++.+.||.|++|.||+|...+ ++.+|+|.+....  ......+.+|+.+++.++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6788999999999999998764 7889999996653  33345678899999999999999999999887  78999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++ +|..++...  ...+++..+..++.|++.|+++||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 777777432  235899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc--
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID--  251 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  251 (340)
                      . .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...........+....+  
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            1 11222345778999997765 4578999999999999999999999976554332211111000000000000000  


Q ss_pred             ------------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 ------------TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                  ..+.......++..+.+++.+||..+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                        00000000112567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-38  Score=275.35  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=198.9

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +|.+.+.||.|+||.||+|.... +..+|+|.+....  ......+.+|+.+++.++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58889999999999999998654 7889999885432  23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC-eeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-PKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~-~~l~Dfg~~~~~~~~~  174 (340)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++. ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999885432 234789999999999999999999998   999999999999998764 6999999987664322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                      .  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.      ..... ....        
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~--------  219 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKIC-QGYF--------  219 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh-cccC--------
Confidence            1  12224578899999999888899999999999999999999999864332211      11111 1110        


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ...++..+..+.+++.+||+.+|++|||+.++++
T Consensus       220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             1112334567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.6e-38  Score=272.52  Aligned_cols=251  Identities=20%  Similarity=0.244  Sum_probs=195.3

Q ss_pred             cHHHHHHHhcCCCCCCcc--cccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEe
Q 041345            9 DFQTIAAATDNFSPGNRL--GQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSL   84 (340)
Q Consensus         9 ~~~~i~~~~~~y~~~~~L--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   84 (340)
                      +..++....++|++.+.+  |.|+||.||++... ++..+|+|.+........     |......+ +|||++++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            455666777899998887  99999999999764 478899998854422211     22222222 6999999999999


Q ss_pred             eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEec
Q 041345           85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISD  163 (340)
Q Consensus        85 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~D  163 (340)
                      ..+..++||||+++++|.+++...   ..+++..+..++.|++.|+.+||+.+   ++|+||+|+||+++.++ .++|+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999998543   36899999999999999999999999   99999999999999888 999999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      ||++......      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ..........   
T Consensus       154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---  223 (267)
T PHA03390        154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---  223 (267)
T ss_pred             CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---
Confidence            9998765322      22357889999999988889999999999999999999999997433222 1111111000   


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-MSDVAS  289 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  289 (340)
                      ..         ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       224 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 QK---------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cc---------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00         11122345678999999999999999996 588874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.7e-39  Score=287.74  Aligned_cols=268  Identities=21%  Similarity=0.321  Sum_probs=199.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEee----CCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~   88 (340)
                      ..++|++.+.||.|++|.||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            3488999999999999999999764 48899999986542  2345567789999999999999999987753    346


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+. ++|.+++..   ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999995 578887743   344899999999999999999999998   9999999999999999999999999987


Q ss_pred             cccCcccc--cccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------
Q 041345          169 TFGMNELE--ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------  237 (340)
Q Consensus       169 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------  237 (340)
                      ........  .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+.......+...        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            65432211  11123467889999998865 46889999999999999999999999655443221111100        


Q ss_pred             HHHhhcCccccccccc-ccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 WQLWNEGKALELIDTT-LHESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..........+..... .....     .+..+..+.+++.+||+.+|++|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000000000000000 00011     12346779999999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.1e-38  Score=278.24  Aligned_cols=255  Identities=24%  Similarity=0.357  Sum_probs=193.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666788999999999999865 47899999986443 234556788999999985 9999999999988888999999


Q ss_pred             ccCCCChhhHhhc--cCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           95 YLPNKSLDFFIFD--SSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        95 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |+.. ++.++...  ......+++..+..++.|++.|++|||+. +   ++||||||+||+++.++.++|+|||++....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9854 55443321  11234589999999999999999999975 7   9999999999999999999999999987654


Q ss_pred             CcccccccccccccCCCCChhhhccC---CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNG---IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ...   ......++..|+|||.+.+.   .++.++||||+|+++|+|++|+.||.....     ......... .+... 
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~~-  229 (288)
T cd06616         160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGDPP-  229 (288)
T ss_pred             cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCCCC-
Confidence            321   11223578889999998765   689999999999999999999999965431     111111110 01100 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          .+....+...+..+.+|+.+||+.+|++|||+.+|++.
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                11111223356679999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=278.97  Aligned_cols=259  Identities=24%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      |++.+.||.|++|.||+|... +++.+++|.+.....  .....+.+|+.+++.++|+|++++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            678899999999999999864 588899998865432  23557788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++ ++..++...  ...+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 777776442  245899999999999999999999999   9999999999999999999999999987765432  


Q ss_pred             cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC---ccccccc-
Q 041345          177 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG---KALELID-  251 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  251 (340)
                      .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+......   ......   .+..... 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCchHhcccchhh
Confidence            111223467889999998776 78999999999999999999999996655433221111   000000   0000000 


Q ss_pred             ---------ccc---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 ---------TTL---HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ---------~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                               ...   .....+..+..+.+++.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                     000   00112345678999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.6e-38  Score=279.42  Aligned_cols=244  Identities=20%  Similarity=0.286  Sum_probs=195.6

Q ss_pred             CCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           23 GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ..+||+|+||.||++... +++.+|+|.+..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999764 5889999998655544566788999999999999999999999999999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR  181 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  181 (340)
                      .+++..    ..+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            988732    24789999999999999999999998   9999999999999999999999999887553221  11223


Q ss_pred             ccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       182 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||............   .    ... .    ..  ......
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~----~~~-~----~~--~~~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R----DNL-P----PK--LKNLHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H----hhC-C----cc--cCCccc
Confidence            45788999999988888899999999999999999999998653332211111   0    000 0    00  001122


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          262 EVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+..+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            3456888999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-39  Score=279.77  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=195.7

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      |++.+.||.|++|.||+|... ++..||+|++....  ......+.+|+.+++.++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999864 58999999886442  223356788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      + ++|.+++..... ..+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 688888754322 35899999999999999999999998   99999999999999999999999999876542211 


Q ss_pred             cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH-----HHhhc-Cccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW-----QLWNE-GKALEL  249 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~  249 (340)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+............     ..+.. ......
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence             11223457889999987654 57889999999999999999999996544322111100000     00000 000000


Q ss_pred             ccc------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDT------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...      .......+..+..+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000      0001112233467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=272.95  Aligned_cols=244  Identities=23%  Similarity=0.260  Sum_probs=189.0

Q ss_pred             CcccccCCeeEEEEEEC-CCCEEEEEEccCCChh---cHHHHHHHHHH-HHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQ---GIVEFKNEAKL-IAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||.|++|.||+|... +++.||+|.+......   ....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999764 4789999998654321   12233444444 3445899999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999853   235889999999999999999999998   99999999999999999999999998875432      


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      .....++..|+|||.+.+..++.++||||+|+++|+|++|..||...+......       ........      .....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~------~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD-------NILSRRIN------WPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhcccC------CCCcc
Confidence            223457888999999988888999999999999999999999996543322111       11111000      01111


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ....+..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            2234577899999999999999998877766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.2e-38  Score=279.96  Aligned_cols=267  Identities=24%  Similarity=0.301  Sum_probs=196.0

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC----
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG----   87 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   87 (340)
                      ...++|++.+.||.|++|.||+|... +++.|++|.+....  ......+.+|+.+++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45688999999999999999999875 47899999986442  223346678999999999999999999887654    


Q ss_pred             ------eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           88 ------ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        88 ------~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                            ..++|+||+++ ++...+...  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999976 565665332  335899999999999999999999999   999999999999999999999


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      +|||.+........ .......++..|+|||.+.+. .++.++||||+||++|+|++|+.||...........+......
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999886543221 111223457789999987653 5789999999999999999999999654332221111111000


Q ss_pred             hhcCcccccccc--------------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          241 WNEGKALELIDT--------------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       241 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .....+..+...              .... .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000000              0000 01123567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-38  Score=286.51  Aligned_cols=268  Identities=23%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC--Ce
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK--GE   88 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   88 (340)
                      .+.++|++.+.||.|+||.||+|.+. +++.+|+|.+...  .......+.+|+.+++++ +||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            35688999999999999999999875 4788999988542  233445677899999999 999999999987643  46


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||++ ++|..++...    .+++..+..++.|++.||+|||++|   ++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            899999997 5888877432    5788899999999999999999998   9999999999999999999999999988


Q ss_pred             cccCcccc---cccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH------
Q 041345          169 TFGMNELE---ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW------  238 (340)
Q Consensus       169 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~------  238 (340)
                      ........   .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            66432211   12233457889999998754 467889999999999999999999996554432211110000      


Q ss_pred             --HHhhcCccccccccc---c---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          239 --QLWNEGKALELIDTT---L---HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       239 --~~~~~~~~~~~~~~~---~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        ..........+++..   .   .....+..+..+.+++.+||+.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              000000000000000   0   000111245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-38  Score=274.79  Aligned_cols=244  Identities=26%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             ccccCCeeEEEEEECC-CCEEEEEEccCCCh---hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ||.|+||.||++.... ++.+++|.+.....   .....+.+|+.++++++|||++++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999998764 89999999865433   3456788899999999999999999999989999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc------
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL------  175 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~------  175 (340)
                      .+++...   ..+++..+..++.|++.||++||+++   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998542   25899999999999999999999999   99999999999999999999999999876533211      


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      ........++..|+|||...+...+.++|+||||+++|+|++|..||..........       ....+.          
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~~~~~----------  217 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ-------NILNGK----------  217 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcCC----------
Confidence            112233457788999999988888999999999999999999999996544322111       010100          


Q ss_pred             CCCCHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          256 ESCSPD--EVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       256 ~~~~~~--~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ...+..  .+..+.+++.+||+.+|++|||+..+.+.|+
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            011111  2577889999999999999999977766665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-38  Score=281.46  Aligned_cols=268  Identities=21%  Similarity=0.294  Sum_probs=193.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   87 (340)
                      ..++|++.+.||.|+||.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999865 48899999885432  222334568999999999999999999876543     


Q ss_pred             ---eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecc
Q 041345           88 ---ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF  164 (340)
Q Consensus        88 ---~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Df  164 (340)
                         ..++||||+.+ +|.+.+...  ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence               45999999965 676666432  235899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCcccc--cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 041345          165 GMARTFGMNELE--ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       165 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      |++..+......  .......++..|+|||.+.+. .++.++||||+|+++|+|++|..||...+.......+.......
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999866432211  111233467889999988664 47889999999999999999999986554432222211111000


Q ss_pred             hcCccc-----cccccc-ccCC---------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          242 NEGKAL-----ELIDTT-LHES---------CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       242 ~~~~~~-----~~~~~~-~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ......     ...+.. ....         .+......+.+++.+||..||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000000     000000 0000         00012345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=286.23  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=209.2

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .....|.+.+.||+|.|+.|.+|+.. ++..||+|.+.+.  +....+.+.+|+.+|..+.||||++++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34567999999999999999999754 5899999999765  34445668899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+.+|.+.+++..   .+...+..+..++.|+..|++|||+++   |+|||||++||+++.+.++||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999954   444677889999999999999999999   9999999999999999999999999999876


Q ss_pred             CcccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .   ....+..+|++.|.|||++.+..+ ++.+|+||+|+++|.|+.|..||.+..-.......               +
T Consensus       207 ~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l  268 (596)
T KOG0586|consen  207 Y---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------L  268 (596)
T ss_pred             c---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------e
Confidence            3   334566889999999999988765 68999999999999999999999754433322111               1


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ...  -..+.....++.++++++|-.+|.+|++.+++.+.
T Consensus       269 ~gk--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  269 RGK--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eee--ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            111  11233445678889999999999999999999764

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-39  Score=286.77  Aligned_cols=265  Identities=26%  Similarity=0.317  Sum_probs=201.6

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----eeE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----ERL   90 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   90 (340)
                      +|++.+.||.|++|.||+|+... ++.+++|.+....  ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58899999999999999998754 8899999986543  334567889999999999999999999987765     789


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ++|+|++ ++|.+.+..   ...+++..+..++.|++.|+++||++|   ++|+||||.||+++.++.++|+|||.+...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 478777743   236899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccc-cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH--------
Q 041345          171 GMNELE-ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL--------  240 (340)
Q Consensus       171 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------  240 (340)
                      ...... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+......        
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            543210 112234568889999999877 7899999999999999999999999766543322111100000        


Q ss_pred             hhcCccccccccccc------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          241 WNEGKALELIDTTLH------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .........+.....      ....+..+..+.+++.+||+.+|.+|||+.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000000001110000      00112245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-38  Score=278.00  Aligned_cols=249  Identities=28%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|.+.+.||.|++|.||+|... +++.+++|++...   .......+.+|..+++++. |+||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999865 5889999998543   2233456788999999998 99999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||++++++|.+++...   ..+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999998543   35999999999999999999999999   99999999999999999999999999887643


Q ss_pred             cccc------------------cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchh
Q 041345          173 NELE------------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV  234 (340)
Q Consensus       173 ~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~  234 (340)
                      ....                  .......++..|+|||...+..++.++|+||||++++++++|..||.........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF---  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH---
Confidence            3211                  1122345678899999998888999999999999999999999999755422111   


Q ss_pred             HHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 041345          235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM----SDVAS  289 (340)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~  289 (340)
                         ....           ......+...+..+.+++.+||+.+|++|||+    .++++
T Consensus       232 ---~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 ---QKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               0000           01112223346678999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.6e-38  Score=275.83  Aligned_cols=260  Identities=21%  Similarity=0.299  Sum_probs=191.2

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeC--CeeEEEEe
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQK--GERLLVYE   94 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~iv~e   94 (340)
                      |++.+.||.|+||.||+|... +++.+|+|.+.... ........+|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999764 58889999886542 222233457888888884 99999999999887  78999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++ ++.+.+...  ...+++..+..++.|++.||+|||+++   ++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 666666432  245899999999999999999999999   999999999999999 999999999987654321


Q ss_pred             cccccccccccCCCCChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH--------HHHHhhcCc
Q 041345          175 LEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY--------AWQLWNEGK  245 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  245 (340)
                      .   .....++..|+|||.+. ++.++.++||||+||++|+|++|..||...+..+.......        .........
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            1   12234688999999764 45678999999999999999999999966544321111100        000000000


Q ss_pred             cccccccccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLH----ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..........    ....+..+..+.+++.+||+.+|++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000    0011234678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.8e-38  Score=277.45  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=194.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||.|++|.||+|... +++.||+|.+....  ......+.+|+.+++.++|||++++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999865 58899999885432  2233567889999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEecccccccccCc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARTFGMN  173 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~~~~~  173 (340)
                      |+++ ++.+.+... ....+++..+..++.|++.||+|||+++   ++|+||+|+||+++. ++.++|+|||++......
T Consensus        82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 676666432 2233678889999999999999999998   999999999999985 557999999999765432


Q ss_pred             ccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC---cc---
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG---KA---  246 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---  246 (340)
                      .  .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||......+.....   .......   .+   
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEETWPGV  231 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhcccc
Confidence            1  11122346788999998866 45789999999999999999999999754432211110   0000000   00   


Q ss_pred             ---cccccccc--cC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 ---LELIDTTL--HE----SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ---~~~~~~~~--~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         ........  ..    ...+..+..+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00000000  00    011223456889999999999999999999986

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.9e-38  Score=278.03  Aligned_cols=248  Identities=30%  Similarity=0.410  Sum_probs=195.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .+.|...+.||.|++|.||+|+.. ++..+++|.+...   .......+.+|+.+++.++|+|++++.+++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            345788899999999999999865 4778999988532   223345678899999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+. +++.+.+...  ...++...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99996 5776666432  334889999999999999999999998   99999999999999999999999999876432


Q ss_pred             cccccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                            .....++..|+|||.+.   ...++.++|||||||++|+|++|..||..........      . ......   
T Consensus       168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~-~~~~~~---  231 (308)
T cd06634         168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQNES---  231 (308)
T ss_pred             ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------H-HhhcCC---
Confidence                  12345788999999874   3567889999999999999999999985433221110      0 001110   


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                           ........+..+.+++.+||+.+|++||++.+++...
T Consensus       232 -----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                 0111234556788999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.3e-38  Score=279.51  Aligned_cols=262  Identities=20%  Similarity=0.239  Sum_probs=191.6

Q ss_pred             Cccccc--CCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQG--GFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G--~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      ..||+|  +||+||++++. .++.||+|++...  .....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999864 5899999998543  233456788899999999999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc-
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA-  177 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~-  177 (340)
                      +++.+++.... ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999886532 234889999999999999999999998   9999999999999999999999998654332111100 


Q ss_pred             ----ccccccccCCCCChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchh-H-------------HH
Q 041345          178 ----NTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV-G-------------YA  237 (340)
Q Consensus       178 ----~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~-~-------------~~  237 (340)
                          ......++..|+|||++.+.  .++.++||||+||++|+|++|..||............ .             ..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112345679999998764  4789999999999999999999999654332111000 0             00


Q ss_pred             HHHh-------hc---------CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          238 WQLW-------NE---------GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       238 ~~~~-------~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+       ..         ...............+......+.+|+++||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0000       00         0000000111112223446678999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.9e-38  Score=283.35  Aligned_cols=268  Identities=22%  Similarity=0.284  Sum_probs=197.0

Q ss_pred             HHhcCCCC-CCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhc--------------HHHHHHHHHHHHcCCCCceee
Q 041345           15 AATDNFSP-GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG--------------IVEFKNEAKLIAKLQHTNLVR   78 (340)
Q Consensus        15 ~~~~~y~~-~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~   78 (340)
                      .+.++|.. .+.||.|+||.||+|.+. +++.||+|.+.......              ...+.+|+.+++.++|+||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            34577875 567999999999999865 58899999885432211              114678999999999999999


Q ss_pred             eeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        79 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                      +++++......+++|||++ ++|.+++..   ...+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence            9999999999999999996 578888743   345899999999999999999999999   999999999999999999


Q ss_pred             eeEecccccccccCccc------------ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCC
Q 041345          159 PKISDFGMARTFGMNEL------------EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCY  225 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~  225 (340)
                      ++|+|||.+.....+..            ........++..|+|||.+.+. .++.++|+|||||++|+|++|..||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876652111            1111123457789999988664 4689999999999999999999999765


Q ss_pred             CcccccchhHHHHHHhhcCccccccc--------cccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          226 DTERHLNLVGYAWQLWNEGKALELID--------TTLH---ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +..+....+...........+.....        ....   .......+..+.+++.+||+.+|++|||+.+++.
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            54332211111000000000000000        0000   0001223567889999999999999999999997

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.3e-38  Score=278.24  Aligned_cols=262  Identities=19%  Similarity=0.188  Sum_probs=192.4

Q ss_pred             CCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           21 SPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      .+++.+|.|+++.|+.+.. +++.||+|++...  .......+.+|+..++.++|+||+++++++......+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3445555555555555544 6899999998654  344566789999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc---
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL---  175 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~---  175 (340)
                      ++|.+++..... ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||.+........   
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999999865322 34889999999999999999999999   99999999999999999999999998875532111   


Q ss_pred             --ccccccccccCCCCChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH----h------
Q 041345          176 --EANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL----W------  241 (340)
Q Consensus       176 --~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~----~------  241 (340)
                        ........++..|+|||.+.+.  .++.++|+||+||++|+|++|..||........  ........    .      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence              1112234467789999998653  588999999999999999999999965432211  00000000    0      


Q ss_pred             -hcCcccc--------cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          242 -NEGKALE--------LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       242 -~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       .......        .................+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence             0000000        00001111222344567889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-37  Score=276.27  Aligned_cols=244  Identities=29%  Similarity=0.417  Sum_probs=191.7

Q ss_pred             CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           20 FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      |...+.||.|++|.||+|+.. +++.+++|.+....   ......+.+|+.+++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            777788999999999999864 48889999985432   23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +.+ ++.+++..  ....+++..+..++.|++.|+.|||++|   ++|+||+|+||+++.++.++|+|||++....    
T Consensus       103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            964 66666543  2345889999999999999999999999   9999999999999999999999999876432    


Q ss_pred             ccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                        ......++..|+|||.+.   ++.++.++||||||+++|+|++|..||...+......      .... ....     
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~~~-----  238 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NDSP-----  238 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHh-cCCC-----
Confidence              122346788999999874   4568899999999999999999999985543322111      1100 0000     


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                         .......+..+.+++.+||+.+|.+||++.+++..
T Consensus       239 ---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 ---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               01112234568899999999999999999999963

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.7e-38  Score=275.06  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCCC----hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCee
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   89 (340)
                      +|++.+.||.|++|.||+++..    +++.+|+|.+....    ......+.+|+.++.++ .||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999998742    46789999885432    22344678899999999 599999999999988999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++||||+++++|.+.+..   ...+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999988843   345889999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCcccccccccccccCCCCChhhhccCC--CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      +..... .......++..|+|||.+.+..  .+.++|+||||+++|+|++|..||..........  .........    
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~----  227 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISRRILKS----  227 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHHHHHcc----
Confidence            543211 1122345788999999987654  7889999999999999999999986432221111  111111000    


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                             ....+...+..+.+++.+||+.+|++|||+.++.+.|..
T Consensus       228 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                   112223345678899999999999999999988887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-38  Score=285.99  Aligned_cols=265  Identities=20%  Similarity=0.265  Sum_probs=193.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC---------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK---------   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---------   86 (340)
                      ..+|++.+.||.|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            578999999999999999999864 4889999998666555567788999999999999999999766543         


Q ss_pred             -----CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCCee
Q 041345           87 -----GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPK  160 (340)
Q Consensus        87 -----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~~~  160 (340)
                           ...++||||++ ++|.+++.    ...+++..+..++.|++.|+.|||+.|   ++|+||||+||+++ .++.++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999996 57877763    234889999999999999999999999   99999999999997 455789


Q ss_pred             EecccccccccCccc-ccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 041345          161 ISDFGMARTFGMNEL-EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~  238 (340)
                      |+|||.+........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999876532111 111122356888999998754 467889999999999999999999996544322111110000


Q ss_pred             HHhhc---C----ccccccc-ccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          239 QLWNE---G----KALELID-TTLHES-----CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       239 ~~~~~---~----~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .....   .    ....... ......     ..+..+.++.+++.+||+.||.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000   0    0000000 000000     01123467889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-37  Score=271.23  Aligned_cols=241  Identities=24%  Similarity=0.315  Sum_probs=186.0

Q ss_pred             cccccCCeeEEEEEEC-CCCEEEEEEccCCCh---hcHHHHHHHHH---HHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           25 RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAK---LIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+++.+++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999764 488999998865321   11112333333   3444579999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++..   ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||++..+...    
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            9999988843   345899999999999999999999998   999999999999999999999999998755322    


Q ss_pred             ccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......|+..|+|||.+.++ .++.++||||+|+++|+|++|..||............    ....          ....
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~----------~~~~  216 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL----------TMAV  216 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh----------ccCC
Confidence            12234688999999998754 6899999999999999999999999654332211110    0000          0011


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                      ..+...+..+.+++.+||..+|.+||     ++.++++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            22233457789999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.7e-39  Score=264.97  Aligned_cols=269  Identities=23%  Similarity=0.310  Sum_probs=196.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-C----CCEEEEEEccCCC-hhc-HHHHHHHHHHHHcCCCCceeeeeeEEee-CCee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-D----GQEIAIKRLSKSS-GQG-IVEFKNEAKLIAKLQHTNLVRLLGCSLQ-KGER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   89 (340)
                      ..|+..+.||+|.||.||+|... +    ...+|+|.+.... ... .....+|+.+++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            56999999999999999999432 2    2368999986542 112 2356799999999999999999999877 7789


Q ss_pred             EEEEeccCCCChhhHhhcc--CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC----CCeeEec
Q 041345           90 LLVYEYLPNKSLDFFIFDS--SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ----MNPKISD  163 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~----~~~~l~D  163 (340)
                      ++++||.+. +|...+...  .....++...+..+++||+.|+.|||++-   ++||||||.||||..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 455555332  22345888999999999999999999999   9999999999999888    8999999


Q ss_pred             ccccccccCccccc-ccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCccccc----c--hhH
Q 041345          164 FGMARTFGMNELEA-NTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL----N--LVG  235 (340)
Q Consensus       164 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~----~--~~~  235 (340)
                      ||+++.+.+.-... ......-|.+|+|||.+.|. .||++.|||++|||+.||++-.+.|.+.......    .  -+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999886542222 34456679999999999876 6999999999999999999999888655443211    1  111


Q ss_pred             HHHHHhh---cCccccccc---------cc---ccCCCC-HH-------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          236 YAWQLWN---EGKALELID---------TT---LHESCS-PD-------EVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       236 ~~~~~~~---~~~~~~~~~---------~~---~~~~~~-~~-------~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .......   ...|+.+..         ..   ....++ ..       .+...++|+..+|++||-+|.|+.+.++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1111111   111111110         00   001110 00       12236789999999999999999998874

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=277.78  Aligned_cols=251  Identities=26%  Similarity=0.328  Sum_probs=203.7

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .-.+.|+..++||+|+||.|+-++.. +|+.+|.|.+.+..   ........+|..++.++..+.||.+--.++..+.+|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            33467889999999999999999754 58999999885442   233445678999999999999999988899999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|+..|.||+|...+..... .-+++..+.-++.+|+.||++||..+   ||.|||||+|||+|+.|+++|+|+|+|..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999999876543 45999999999999999999999999   999999999999999999999999999987


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ..+..   .....||.+|+|||++.++.|+...|.|||||++|+|+.|+.||..+....-..-+.  ....         
T Consensus       338 ~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~---------  403 (591)
T KOG0986|consen  338 PEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTL---------  403 (591)
T ss_pred             CCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHh---------
Confidence            54332   223379999999999999999999999999999999999999996544433211110  0000         


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMS  285 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  285 (340)
                        .....++...++++.++++..|+.||++|.--.
T Consensus       404 --~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  404 --EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             --cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence              011334556677888899999999999996433

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-40  Score=314.46  Aligned_cols=257  Identities=26%  Similarity=0.378  Sum_probs=206.1

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      +.+.+-++.-+..||.|.||.||.|.+. +|.-.|+|.+...  .........+|+.++..+.|||+|+++|+-.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            3344567888899999999999999754 4888899987543  233455678999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      +|.||||.+|+|.+++..   ++..++.....+..|++.|++|||++|   ||||||||.||+++.+|.+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            999999999999999954   334667677778999999999999999   99999999999999999999999999988


Q ss_pred             ccCcc--cccccccccccCCCCChhhhccC---CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          170 FGMNE--LEANTNRIVGTHGYMSPEYVMNG---IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       170 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ..+..  .....+...||+.|+|||++.+.   .-..++||||||||+.||+||+.||...+..=..     .++.    
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI-----My~V---- 1454 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI-----MYHV---- 1454 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH-----HhHH----
Confidence            76542  22233456799999999999653   3567999999999999999999998644433111     1111    


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            ...-....|...+.+-.+++..||+.||++|.++.|+++.
T Consensus      1455 ------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 ------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                  1112244556677788899999999999999999988874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=271.92  Aligned_cols=262  Identities=22%  Similarity=0.339  Sum_probs=193.2

Q ss_pred             CCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh--hcHHHHHHHHHHHHcC---CCCceeeeeeEEeeCCe-----
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG--QGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQKGE-----   88 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----   88 (340)
                      |++.+.||.|++|.||+|.... ++.+|+|.+.....  .....+.+|+.+++++   .|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999998764 88999999864322  1233455677776665   59999999999987766     


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .+++|||+++ +|.+++.... ...+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7877775432 234899999999999999999999999   9999999999999999999999999987


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH-----HHhhc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW-----QLWNE  243 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~  243 (340)
                      .+.....   .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......+....+-...     ..+..
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            7643321   122346788999999988899999999999999999999999986544332211110000     00000


Q ss_pred             Ccc--ccccccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          244 GKA--LELIDTTLH---ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       244 ~~~--~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...  .........   ....+.....+.+++.+||+.||++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000  000000000   1111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.5e-38  Score=279.78  Aligned_cols=267  Identities=22%  Similarity=0.316  Sum_probs=193.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-------   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------   86 (340)
                      .++|++.+.||.|++|.||+|.+. +++.+++|.+.....  .....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999865 488999998854322  1233567899999999999999999887543       


Q ss_pred             -CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           87 -GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        87 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                       ..+++|++|+.+ ++...+..  ....+++..+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence             346999999865 56555533  2345999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCccccc---------ccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhH
Q 041345          166 MARTFGMNELEA---------NTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVG  235 (340)
Q Consensus       166 ~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~  235 (340)
                      ++..........         ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            987654321111         11223567889999987654 58899999999999999999999996554433221111


Q ss_pred             HHHHHhhcC------cccccccccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          236 YAWQLWNEG------KALELIDTTLHESCS-------PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       236 ~~~~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .........      ..............+       ......+.+++.+||+.+|++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            100000000      000000000000011       122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-37  Score=271.92  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=195.1

Q ss_pred             CCCCCCcccccCCeeEEEEEE----CCCCEEEEEEccCCC----hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCee
Q 041345           19 NFSPGNRLGQGGFGPVYKGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   89 (340)
                      +|++.+.||.|+||.||.|..    .+|+.||+|++....    ......+.+|+.+++.+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            588899999999999999975    357889999986432    12345678899999999 599999999999988899


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++|+||+++++|.+++..   ...++...+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345889999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCcccccccccccccCCCCChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ....... ......++..|+|||.+.+.  .++.++||||||+++|+|++|..||.........  ..........    
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~----  227 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS----  227 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhcc----
Confidence            5432211 12234578899999988653  4678999999999999999999998643221111  1111110000    


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                             ....+......+.+++.+||+.+|++||     ++.+++.
T Consensus       228 -------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                   1112334556788999999999999997     6666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=267.10  Aligned_cols=276  Identities=22%  Similarity=0.285  Sum_probs=220.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|..+++||+|.||.|.+++.+ .++.+|+|++++.   ..+...+-..|-.+|+..+||.+..+--.|...+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            67888999999999999999865 4889999999765   3344556677889999999999999888888999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||..||.|...+   .....+++....-+-..|+.||.|||+++   |+.||||.+|.|+|.+|++||+|||+++.-.. 
T Consensus       248 eyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-  320 (516)
T KOG0690|consen  248 EYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-  320 (516)
T ss_pred             EEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-
Confidence            999999998777   34566999999999999999999999998   99999999999999999999999999885321 


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                       ........+||+.|+|||++.+..|..++|.|.+|+++|||++|+.||-..+....+.++-..                
T Consensus       321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------------  383 (516)
T KOG0690|consen  321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------------  383 (516)
T ss_pred             -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------------
Confidence             123345689999999999999999999999999999999999999999766666655544211                


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH--hhc------CCCCCCCCCCCceeeecCCCCCCCc
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVASM--LTN------DTMALPTPRQPAFFINISSDYEEPE  318 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~--L~~------~~~~~~~~~~~~~~~~~~~~~~~~~  318 (340)
                       ....|...+++...|+.-+|.+||.+|.-     +.||.+.  +..      ..+.++||..|.-..+....+...|
T Consensus       384 -d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~E  460 (516)
T KOG0690|consen  384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEE  460 (516)
T ss_pred             -hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhh
Confidence             11234445566777888899999999953     4444432  222      2456778887766666655554333

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=286.82  Aligned_cols=205  Identities=29%  Similarity=0.428  Sum_probs=175.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC------ee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG------ER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~   89 (340)
                      ..|...+.||+|+||.||+|++. .|+.||||.++... ....+...+|++++++++|+|||+++++-+...      .-
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            45667789999999999999854 59999999997643 334567889999999999999999998755433      35


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC--CCCC--eeEeccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD--DQMN--PKISDFG  165 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~--~~~~--~~l~Dfg  165 (340)
                      ++|||||.+|+|...+....+..-+++.+.+.++.+++.|+.|||.+|   |+||||||.||++-  .+|+  .||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            799999999999999988877777999999999999999999999999   99999999999984  3344  6999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCcc
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE  228 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~  228 (340)
                      .|+.+..+.   .-+...||..|.+||.+. .+.|+..+|.|||||++|+++||..||......
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            999876543   344578999999999997 488999999999999999999999999554444

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=297.10  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=209.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      .++..+.+.||.|.||.|++|....        ...||||.++... ......+..|+++++.+ .|+|++.++|++...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            3445677799999999999996321        3468999986553 34567789999999999 699999999999998


Q ss_pred             CeeEEEEeccCCCChhhHhhccC------c-----c--ccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSS------K-----K--ELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~------~-----~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ...++|.||+..|+|..+++...      .     .  ..++....+.+++|||.|++||++..   ++||||.++||++
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence            89999999999999999997654      0     0  23889999999999999999999998   9999999999999


Q ss_pred             CCCCCeeEecccccccccCccccc-ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHL  231 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~  231 (340)
                      ..+..+||+|||+++......... ......-...|+|||.+....|+.++||||||++||||++ |..|+.+...... 
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~-  530 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE-  530 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH-
Confidence            999999999999998654433322 1111113556999999999999999999999999999998 6688765221110 


Q ss_pred             chhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          232 NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                       +             .+.+..+.+...|..+..+++++|+.||+.+|++||++.++.+.|+..
T Consensus       531 -l-------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  531 -L-------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence             0             112334445566777889999999999999999999999999999984

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-38  Score=281.76  Aligned_cols=270  Identities=22%  Similarity=0.267  Sum_probs=199.3

Q ss_pred             ccHHHHHHHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEe
Q 041345            8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSL   84 (340)
Q Consensus         8 ~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (340)
                      ....++..+.++|.+.+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34466777889999999999999999999975 458899999986432  223456778999999999999999999875


Q ss_pred             eC------CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           85 QK------GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        85 ~~------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                      ..      ...+++++++ +++|.+.+..    ..+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence            43      3467888876 7788877732    24889999999999999999999999   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~  237 (340)
                      ++|+|||++.....     ......++..|+|||.+.+ ..++.++||||+||++|+|++|..||...+.......+...
T Consensus       159 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         159 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             EEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999999876432     1223457888999998866 46888999999999999999999999654432211111000


Q ss_pred             --------HHHhhcCcccccc---ccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 --------WQLWNEGKALELI---DTTLH---ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 --------~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                              ............+   .....   .......+..+.+++.+||+.+|.+|||+.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                    0000000000000   00000   00001134568899999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=271.05  Aligned_cols=262  Identities=26%  Similarity=0.329  Sum_probs=194.6

Q ss_pred             CCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh-hcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEecc
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      |.+.+.||.|++|.||+|...+ ++.+++|.+..... .......+|+..++++. |+|++++++++......++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6788999999999999998754 78899998855432 22234457889999998 999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                       +++|.+.+.... ...+++..+..++.|++.++.|||+++   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             778888775432 235899999999999999999999999   99999999999999999999999999876543211 


Q ss_pred             cccccccccCCCCChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH-----HHHhhcC-----c
Q 041345          177 ANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA-----WQLWNEG-----K  245 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~-----~  245 (340)
                        .....++..|+|||.+. +..++.++|+||||+++++|++|+.||......+........     ...+...     .
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              12245678899999874 445789999999999999999999998655433221111000     0000000     0


Q ss_pred             cccccccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLH---ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+.....   ....+.....+.+++++||+.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000   0001122467889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.3e-37  Score=276.43  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=197.5

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee-CCe
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ-KGE   88 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   88 (340)
                      +..++++|++.+.||.|+||.||+|... +++.+|+|.+...  .......+.+|+.+++.++|||++++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3457889999999999999999999765 5889999987543  22334567889999999999999999998865 457


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++++||+ +++|..++.    ...++...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            89999998 567887773    234788888999999999999999999   9999999999999999999999999987


Q ss_pred             cccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH--------HHH
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY--------AWQ  239 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~  239 (340)
                      ....     ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..        ...
T Consensus       157 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            5432     1122356788999998765 5689999999999999999999999965443221111100        000


Q ss_pred             HhhcCccccccccc-ccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          240 LWNEGKALELIDTT-LHESCS-----PDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       240 ~~~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ........+++... .....+     +..+..+.+++.+||+.+|++|||+.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000110000 001111     1234678999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-38  Score=282.01  Aligned_cols=274  Identities=22%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             ccHHHHHHH----hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeee
Q 041345            8 FDFQTIAAA----TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLL   80 (340)
Q Consensus         8 ~~~~~i~~~----~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~   80 (340)
                      |+.+++...    .++|.+.+.||+|++|.||+|... +++.||+|.+....  ......+.+|+.+++.++||||++++
T Consensus         1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~   80 (342)
T cd07879           1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL   80 (342)
T ss_pred             CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence            344555544    489999999999999999999864 58899999885432  22344678899999999999999999


Q ss_pred             eEEeeC------CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC
Q 041345           81 GCSLQK------GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        81 ~~~~~~------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~  154 (340)
                      +++...      ..+++|+||+.. +|....     ...+++..+..++.|++.|++|||+++   ++||||||+||+++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~  151 (342)
T cd07879          81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN  151 (342)
T ss_pred             heecccccCCCCceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence            987654      346899999864 665554     124889999999999999999999999   99999999999999


Q ss_pred             CCCCeeEecccccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccch
Q 041345          155 DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNL  233 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~  233 (340)
                      .++.++|+|||++.....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......
T Consensus       152 ~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~  226 (342)
T cd07879         152 EDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  226 (342)
T ss_pred             CCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999875421     1223456788999998866 4688999999999999999999999975443221110


Q ss_pred             hHHH--------HHHhhcCcccccccc---cccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcCC
Q 041345          234 VGYA--------WQLWNEGKALELIDT---TLHES---CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM--LTNDT  295 (340)
Q Consensus       234 ~~~~--------~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~  295 (340)
                      +...        ............+..   .....   ..+.....+.+++.+||+.||++|||+.+++..  ++...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0000        000000000000000   00000   011234568899999999999999999999954  55543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-37  Score=267.72  Aligned_cols=249  Identities=25%  Similarity=0.348  Sum_probs=193.6

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC-----ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      +|.+.+.||.|+||.||++.... +..+++|.+...     ......++..|+.+++.++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58899999999999999997644 344555554321     122334566788999999999999999999988899999


Q ss_pred             EeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           93 YEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +||+++++|.+++... .....+++..+..++.|++.|+.|||+++   ++|+||+|+||++++ +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887542 22345899999999999999999999999   999999999999975 579999999987654


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ....  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......   ..   ... ..+       
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~---~~~-~~~-------  220 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VV---LRI-VEG-------  220 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HH---HHH-HcC-------
Confidence            3211  1223457888999999888888999999999999999999999985332111   00   111 011       


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        .....+...+..+.+++.+||..+|++||++.++++
T Consensus       221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 --PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             --CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence              111223455678899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-39  Score=271.80  Aligned_cols=267  Identities=19%  Similarity=0.204  Sum_probs=203.7

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCC-C-C----ceeeeeeEEe
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-H-T----NLVRLLGCSL   84 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~   84 (340)
                      .-...+++|.+.+.||+|.||.|..+.+.. +..||||+++... .-.+...-|+++++++. + |    .++.+.++|.
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            334558899999999999999999996544 6889999996543 33445567899999983 2 3    3677778888


Q ss_pred             eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---------
Q 041345           85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---------  155 (340)
Q Consensus        85 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---------  155 (340)
                      -.++.|||+|.+ |.++.+++... +-.+++...+..+++|+++++++||+.+   ++|.||||+||++.+         
T Consensus       162 yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence            899999999987 66888888553 3456999999999999999999999999   999999999999832         


Q ss_pred             -----------CCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCC
Q 041345          156 -----------QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC  224 (340)
Q Consensus       156 -----------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~  224 (340)
                                 +..++|+|||.|..-.     ........|..|+|||++.+-.++..+||||+||||+|+++|...|..
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                       3458999999998633     223456789999999999999999999999999999999999999988


Q ss_pred             CCcccccchhHHHHHHhhcCc-------------ccccccc--------cc--------cCCCCHHHHHHHHHHHHhccC
Q 041345          225 YDTERHLNLVGYAWQLWNEGK-------------ALELIDT--------TL--------HESCSPDEVTRCIHVGLLCVQ  275 (340)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~--------~~--------~~~~~~~~~~~l~~li~~cl~  275 (340)
                      .++.+...+++......+...             ...+-+.        ..        .......+...|++|++.||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            776654433332211110000             0000000        00        011224567789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 041345          276 DKATDRPTMSDVAS  289 (340)
Q Consensus       276 ~~p~~RPt~~evl~  289 (340)
                      .||.+|+|+.|++.
T Consensus       392 fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  392 FDPARRITLREALS  405 (415)
T ss_pred             cCccccccHHHHhc
Confidence            99999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=271.45  Aligned_cols=269  Identities=21%  Similarity=0.315  Sum_probs=206.1

Q ss_pred             cHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC--CCCceeeeeeEEeeC
Q 041345            9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL--QHTNLVRLLGCSLQK   86 (340)
Q Consensus         9 ~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~   86 (340)
                      ++-....+.++..+.+.||+|.||.||+|++ .|+.||||++...+..   .+.+|.++++..  +|+||+.+++.-..+
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            3445567788899999999999999999999 7899999999655433   557888998875  999999999875443


Q ss_pred             ----CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-----CCCCceeecCCCCCCeEeCCCC
Q 041345           87 ----GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-----YSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        87 ----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-----~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                          .++++|.+|.+.|+|.|+|..    ..++....++++..+|.||++||.     +|+..|.|||||..||+|..++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence                358999999999999999943    458999999999999999999994     5677899999999999999999


Q ss_pred             CeeEecccccccccCc--ccccccccccccCCCCChhhhccCC----C--CccCceehhhHHHHHHHhCC----------
Q 041345          158 NPKISDFGMARTFGMN--ELEANTNRIVGTHGYMSPEYVMNGI----V--SMKSDVYSFGVLVLEIISSK----------  219 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~vl~elltg~----------  219 (340)
                      .+.|+|+|+|......  ......+...||-+|+|||++...-    +  -..+||||||.|+||++..-          
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            9999999999876543  2333445578999999999985431    1  13689999999999997532          


Q ss_pred             CCCCCCCcccccchhHHHHHHhhcCcccc-cccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          220 KNNGCYDTERHLNLVGYAWQLWNEGKALE-LIDTTLHESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      .||-...+.+.  -.         ..+.+ .....++...     +......+.++|+.||..||.-|.|+--+-+.|.+
T Consensus       434 ~Pyyd~Vp~DP--s~---------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  434 LPYYDVVPSDP--SF---------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             CCcccCCCCCC--CH---------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence            33321111110  00         00111 1112233332     34567788999999999999999999999999987


Q ss_pred             CCC
Q 041345          294 DTM  296 (340)
Q Consensus       294 ~~~  296 (340)
                      +.+
T Consensus       503 l~~  505 (513)
T KOG2052|consen  503 LSN  505 (513)
T ss_pred             Hhc
Confidence            654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=270.51  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=198.0

Q ss_pred             CCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      |++.+.||.|++|.||+|.... ++.+++|.+....  ......+.+|+.+++.++|+|++++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            6778899999999999998754 8899999986543  333456788999999999999999999999888999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      + ++|.+++....  ..+++..+..++.|++.|+++||+++   ++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 58988885432  35899999999999999999999999   99999999999999999999999999876543221 


Q ss_pred             cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH--------HHHHhhc----
Q 041345          177 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY--------AWQLWNE----  243 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~----  243 (340)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+..        .+..+..    
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             12223456789999998766 789999999999999999999999866443322111110        0000000    


Q ss_pred             -CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          244 -GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ........... ....+..+..+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             00000000000 0001123567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.4e-37  Score=270.96  Aligned_cols=253  Identities=22%  Similarity=0.343  Sum_probs=192.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ..++|++.+.||.|++|.||+|.+.. ++.+|+|.+.... ......+..|+..+... .|+||+++++++......+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            44789999999999999999998765 8899999986543 22334556677666666 599999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |||+. +++..+....  ...+++..+..++.|++.|++|||+ .+   ++|+||+|+||++++++.++|+|||++..+.
T Consensus        93 ~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99985 4676666432  2358999999999999999999997 47   9999999999999999999999999987654


Q ss_pred             CcccccccccccccCCCCChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ....   .....++..|+|||.+.+.    .++.++|+||||+++|+|++|+.||.......  ...   ...... ...
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~---~~~~~~-~~~  237 (296)
T cd06618         167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVL---TKILQE-EPP  237 (296)
T ss_pred             CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHH---HHHhcC-CCC
Confidence            3211   1223467889999998654    37889999999999999999999986432211  011   111111 100


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .       .......+.++.+++.+||..+|++|||+.++++.
T Consensus       238 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 S-------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0       00111235678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=258.25  Aligned_cols=254  Identities=20%  Similarity=0.200  Sum_probs=194.1

Q ss_pred             HhcCCCCCC-cccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC----Ce
Q 041345           16 ATDNFSPGN-RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK----GE   88 (340)
Q Consensus        16 ~~~~y~~~~-~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~   88 (340)
                      ++++|++.. +||-|-.|.|..+..+ +++.+|+|++....     ...+|+++.-.. .|||||.+++++.+.    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            567888776 7999999999999654 58899999984332     335666665544 799999999998653    45


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC---CCCCeeEeccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFG  165 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~---~~~~~~l~Dfg  165 (340)
                      +.+|||.++||.|...+... +...+++.++..|+.||+.|+.|||+.+   |.||||||+|+|..   .|..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999999998664 4456999999999999999999999999   99999999999996   45568999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      +|+....   .......+-|+.|.|||++....|+...|+||+|+++|-|++|.+||-........   .-....+..+.
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~gq  283 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTGQ  283 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhccC
Confidence            9987432   23344567799999999998888999999999999999999999999322221110   00111111110


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .      .+...-....+....++|+.+|..+|.+|.|+.+++..
T Consensus       284 y------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  284 Y------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             c------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            0      01111123456677889999999999999999999863

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=289.35  Aligned_cols=254  Identities=29%  Similarity=0.403  Sum_probs=215.2

Q ss_pred             CCCCcccccCCeeEEEEEE-CCCC----EEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           21 SPGNRLGQGGFGPVYKGKL-LDGQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +..++||+|+||+||+|.+ +.|+    +||+|++... ..+....+.+|+-.|.+++|||++++++++..+. .-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3467899999999999965 3444    5899988544 4455678899999999999999999999988765 789999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++.|+|.++++.  .+..+.....+.|..|||+|+.|||.+.   ++||||.++||||..-..+|+.|||+++.+....
T Consensus       778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            9999999999976  4456899999999999999999999998   9999999999999999999999999999876554


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .........-.+.|+|-|.+....++.++|||||||++||++| |..|+.+....+.                .++++..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~g  916 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKG  916 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhcc
Confidence            4444444455778999999999999999999999999999998 8888866555443                3334455


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      .+...|+.++.+++.++.+||-.|+..||+|.++...++.+..
T Consensus       917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            5677889999999999999999999999999999999987543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-38  Score=283.58  Aligned_cols=263  Identities=24%  Similarity=0.300  Sum_probs=196.9

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe--
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE--   88 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   88 (340)
                      ..+.++|++.+.||.|++|.||+|+.. +++.||+|.+...  .......+.+|+.+++.++|+|++++.+++.....  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            345788999999999999999999875 4788999988543  22334567789999999999999999987765544  


Q ss_pred             ----eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecc
Q 041345           89 ----RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF  164 (340)
Q Consensus        89 ----~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Df  164 (340)
                          .++|+||+ +++|.+++..    ..+++..+..++.|++.|+++||+.|   ++|+||+|+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence                89999998 6688888743    35899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH------
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA------  237 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~------  237 (340)
                      |.+......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...      
T Consensus       163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            998765322     223456788999998865 36789999999999999999999999654433211111000      


Q ss_pred             --HHHhhcCcccccccccccC---C---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          238 --WQLWNEGKALELIDTTLHE---S---CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       238 --~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ...+.......++......   .   .....+..+.+++.+||+.+|++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence              0000000000000000000   0   00123567899999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-37  Score=277.73  Aligned_cols=264  Identities=25%  Similarity=0.310  Sum_probs=191.1

Q ss_pred             CCCCCCcccccCCeeEEEEEECC---CCEEEEEEccCC--ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC----Ce
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD---GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK----GE   88 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~   88 (340)
                      +|++.+.||+|+||.||+++...   +..+|+|.+...  .......+.+|+.+++++ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            58888999999999999998643   678999988643  222345678899999999 599999999875432    35


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .+++++++. ++|.+.+.   ....+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788999885 57877774   2345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccc--cccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH--------H
Q 041345          169 TFGMNELE--ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY--------A  237 (340)
Q Consensus       169 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------~  237 (340)
                      .+......  .......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+..        .
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65432211  11223467889999998765 4689999999999999999999999976543221110000        0


Q ss_pred             HHHhhcCccccccc---c---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          238 WQLWNEGKALELID---T---TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       238 ~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+..........   .   .......+.....+.+++.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000000   0   0000011123467889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=257.21  Aligned_cols=251  Identities=22%  Similarity=0.337  Sum_probs=193.6

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.+.+..||.|+.|.||+++... |...|||.+... +.+...++...+.++..- .+|+||+++|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            34556789999999999998755 788899998655 445556666666666554 589999999999999999999998


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      | ...++.++...  .+++++..+-++...++.||.||..++  +|+|||+||+|||+|+.|++||||||++-++-.+. 
T Consensus       173 M-s~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  173 M-STCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             H-HHHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            8 55677777543  345899999999999999999998876  79999999999999999999999999998765332 


Q ss_pred             ccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                        ..+...|.+.|+|||.+.   ...|+..+||||||+.++||.||+.||.+.+.+-.  .+   -...+ ...+     
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~l---tkvln-~ePP-----  313 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VL---TKVLN-EEPP-----  313 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HH---HHHHh-cCCC-----
Confidence              233456889999999884   34689999999999999999999999976444321  11   11111 1111     


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .+...  ...+..+.+++..||++|+.+||...++++.
T Consensus       314 ~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            11111  1145678899999999999999999999873

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-38  Score=283.22  Aligned_cols=244  Identities=23%  Similarity=0.366  Sum_probs=191.0

Q ss_pred             CCCCcccccCCeeEEEEEEC-CCCEEE---EEEcc-CCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe--eEEEE
Q 041345           21 SPGNRLGQGGFGPVYKGKLL-DGQEIA---IKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE--RLLVY   93 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~~-~~~~va---vK~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~iv~   93 (340)
                      +....||+|+|-+||+|.+. .|-.||   +|.-. .......+.+..|+.+|+.|+||||+++++++.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44567999999999999763 255554   22111 1133456789999999999999999999999987655  78999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~Dfg~~~~~~~  172 (340)
                      |.+..|+|..|+..   .+.++...+..|++||++||.|||++. .+|+|||||-+||||+++ |.|||+|+|+|.....
T Consensus       123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999954   445889999999999999999999985 799999999999999854 8899999999998653


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCC-cccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD-TERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      +    ......|||.|||||.+. ..|+..+||||||++++||+|+..||.... +.+.       ++....+..+.-+.
T Consensus       199 s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI-------YKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  199 S----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI-------YKKVTSGIKPAALS  266 (632)
T ss_pred             c----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH-------HHHHHcCCCHHHhh
Confidence            2    233468999999999875 789999999999999999999999984322 2222       12222222111111


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                              .-..+++.++|.+|+.. .++|||+.|+|.
T Consensus       267 --------kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 --------KVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             --------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                    11246789999999999 999999999986

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-37  Score=278.21  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC--
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG--   87 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   87 (340)
                      +-...++|++.+.||.|++|.||+|... ++..||+|.+....  ......+.+|+.+++.++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            4446788999999999999999999754 58899999885432  223456788999999999999999999886543  


Q ss_pred             ----eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEec
Q 041345           88 ----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD  163 (340)
Q Consensus        88 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~D  163 (340)
                          .+++||+|+ +++|.+++.    ...+++..+..++.|++.|++|||+.|   ++|+||||+||+++.++.++|+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                358999998 678887773    235899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH------
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY------  236 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~------  236 (340)
                      ||++......     .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+..      
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9998764321     223356888999998866 4588899999999999999999999975443211100000      


Q ss_pred             --HHHHhhcCccccccccccc------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          237 --AWQLWNEGKALELIDTTLH------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       237 --~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        .............+.....      ....+..+..+.+++.+|++.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0000000000000000000      0011233456889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=271.16  Aligned_cols=270  Identities=25%  Similarity=0.369  Sum_probs=201.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC--CCCceeeeeeEEeeCC----eeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL--QHTNLVRLLGCSLQKG----ERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~i   91 (340)
                      ...++...+|+|.||.||+|+. .++.||||+++...   .+.+.+|.++.+..  +|+||+.+++.-....    .+++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3456677899999999999988 56999999996443   55677888887764  8999999999866554    7899


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC------CCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS------RLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      |++|.+.|+|.++|.    ...+++....+++..+++||+|||+--      +.+|+|||||..||||..|++..|+|||
T Consensus       286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999994    335899999999999999999999733      5579999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCC-CC-----ccCceehhhHHHHHHHhCCCCCCC--CCcccc-------
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGI-VS-----MKSDVYSFGVLVLEIISSKKNNGC--YDTERH-------  230 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~vl~elltg~~p~~~--~~~~~~-------  230 (340)
                      +|..+.........-...||.+|||||++.+.. +.     .+.||||+|.|+|||+++-.-+..  ....+.       
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999887554444445578999999999996652 22     368999999999999986543311  111100       


Q ss_pred             -c-chhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          231 -L-NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       231 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                       . ...+.......+...+.+-+....    ......+.+.+..||..||+-|.|+.=+.+.+.++....+
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence             0 000111111111222221111111    2345678899999999999999999999999988655433

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-37  Score=297.46  Aligned_cols=254  Identities=27%  Similarity=0.411  Sum_probs=189.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--------
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--------   85 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   85 (340)
                      -..+|+.+..||+||||.||+++++ +|+.||||+++.. .......+.+|+..+.++.|||||+++..+.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3466778899999999999999864 7999999998655 34456678899999999999999998842210        


Q ss_pred             --------------------------------------------------------------------------------
Q 041345           86 --------------------------------------------------------------------------------   85 (340)
Q Consensus        86 --------------------------------------------------------------------------------   85 (340)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------C--------CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHH
Q 041345           86 -----------------------K--------GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH  134 (340)
Q Consensus        86 -----------------------~--------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  134 (340)
                                             +        ..+||-||||+..++.+++......  -.....++++.+|++||+|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence                                   0        1357889999998888888543221  146788999999999999999


Q ss_pred             hCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc----------------CcccccccccccccCCCCChhhhccC-
Q 041345          135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG----------------MNELEANTNRIVGTHGYMSPEYVMNG-  197 (340)
Q Consensus       135 ~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~-  197 (340)
                      ++|   |+||||||.|||++.+++|||+|||++....                .+......+...||.-|.|||++.+. 
T Consensus       715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            999   9999999999999999999999999998721                01112234556799999999998654 


Q ss_pred             --CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccC
Q 041345          198 --IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQ  275 (340)
Q Consensus       198 --~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  275 (340)
                        .|+.|+|+||||+||+||+.   ||+....  ....    ......+.++.-      ..........-..+|++|++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHH--HHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence              49999999999999999985   4542111  1111    111112222211      12233444556789999999


Q ss_pred             CCCCCCCCHHHHHH
Q 041345          276 DKATDRPTMSDVAS  289 (340)
Q Consensus       276 ~~p~~RPt~~evl~  289 (340)
                      .||.+||||.|+|.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999986

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-37  Score=262.17  Aligned_cols=236  Identities=26%  Similarity=0.324  Sum_probs=191.4

Q ss_pred             ccccCCeeEEEEEECC-CCEEEEEEccCCCh---hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ||.|++|.||.+...+ ++.+++|.+.....   .....+..|+.+++.++|+|++++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999998754 88999999865432   2455788899999999999999999999999999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR  181 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  181 (340)
                      .+++...   ..+++..+..++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            9998543   35899999999999999999999998   9999999999999999999999999987654321  12233


Q ss_pred             ccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       182 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      ..++..|+|||.+.+...+.++|+||||+++|++++|..||...+....   ..   ... .          .....+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~-~----------~~~~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YE---KIL-K----------DPLRFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHh-c----------CCCCCCCC
Confidence            4578889999999888889999999999999999999999965443111   10   000 0          01122233


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHH
Q 041345          262 EVTRCIHVGLLCVQDKATDRPTMSD  286 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt~~e  286 (340)
                      .+..+.+++.+||..||++|||+.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            3677899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=237.64  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .|.-.++||+|.||+||+|++.+ ++.||+|.++-.+  .-......+|+-+++.++|.||++++++...++++.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45666889999999999998654 7789999885443  22345678999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      |+. .|..+...  -++.++...+..++.|++.|+.++|+++   +.||||||.|.+++.+|.+||+|||+++.++..- 
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-  155 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence            954 56666532  3455899999999999999999999999   9999999999999999999999999999876432 


Q ss_pred             ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCC-CCCCCCCcccccchhHHHHHHhhcCccccc---c
Q 041345          176 EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSK-KNNGCYDTERHLNLVGYAWQLWNEGKALEL---I  250 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  250 (340)
                       .......-|.+|++|.++.+. -|+.+.|+||-||++.|+...+ +.|.+.+..++...+-+..-...+..|+.+   -
T Consensus       156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence             233344568999999999876 4899999999999999999755 557766666555444333333333333332   2


Q ss_pred             cccccCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCS---------PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +......++         +.....=.+|+...|.-+|.+|.++++.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            222222222         122233467888899999999999998875

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=258.35  Aligned_cols=263  Identities=21%  Similarity=0.269  Sum_probs=202.4

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEE-ECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCC
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKG   87 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   87 (340)
                      |++.-+.++     +.||+|+|+.|-.+. ..+|..+|||++.+..........+|++++.+. .|+||+.++.+|+++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            455544443     469999999999985 557999999999877666777889999999998 5999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC---eeEecc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDF  164 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~---~~l~Df  164 (340)
                      .+|+|||.|.||.|...+..   +..+++.++.++..+|+.||.+||.+|   |.||||||+|||.....+   ||||||
T Consensus       150 ~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             eEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence            99999999999999998853   455999999999999999999999999   999999999999986655   799999


Q ss_pred             ccccccc--Cc---ccccccccccccCCCCChhhh-----ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchh
Q 041345          165 GMARTFG--MN---ELEANTNRIVGTHGYMSPEYV-----MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV  234 (340)
Q Consensus       165 g~~~~~~--~~---~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~  234 (340)
                      ++..-..  ++   .........+|+..|||||+.     ....|+.+.|.||||+|+|-|++|..||.+.-..+...-.
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            8764332  11   112223356788999999976     2346899999999999999999999999666554432111


Q ss_pred             HH--------HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          235 GY--------AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       235 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +.        ....+.++...      +........+.+..+|+..+|..++.+|.++.+++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkYe------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKYE------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHHHHHHHhccCCc------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            10        11111111100      011112345667788999999999999999999887

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=270.19  Aligned_cols=265  Identities=27%  Similarity=0.386  Sum_probs=203.9

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEcc--CCChh-----cHHHHHHHHHHHHcCCCCceeeeee
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLS--KSSGQ-----GIVEFKNEAKLIAKLQHTNLVRLLG   81 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~   81 (340)
                      |.+-....++|-++++||+|+|+.||+|.+- ..+.||+|+-.  +...+     -..+..+|..+.+.+.||.||++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            3444556688999999999999999999754 47788999752  22211     1234678999999999999999999


Q ss_pred             EEeeC-CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CC
Q 041345           82 CSLQK-GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QM  157 (340)
Q Consensus        82 ~~~~~-~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~  157 (340)
                      ++.-+ ..+|-|+|||+|.+|+.++.   .+..+++.++..|+.||+.||.||... +.+|+|.||||.|||+.+   .|
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence            98654 56899999999999999994   456699999999999999999999887 478999999999999954   46


Q ss_pred             CeeEecccccccccCccccc-----ccccccccCCCCChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCcc
Q 041345          158 NPKISDFGMARTFGMNELEA-----NTNRIVGTHGYMSPEYVMNG----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTE  228 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~vl~elltg~~p~~~~~~~  228 (340)
                      .+||+|||+++.+..+....     .+....||.+|+|||.+.-+    .++.++||||+|+|+|+.+.|+.||+.....
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            79999999999886543332     23345789999999988433    4788999999999999999999999865444


Q ss_pred             cccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          229 RHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +..  +       ....+.+..+  ...+..+..+.+...+|++||++.-++|....++..
T Consensus       691 QdI--L-------qeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 QDI--L-------QENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHH--H-------hhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            321  1       1122222111  112223455677889999999999999988777653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-37  Score=275.53  Aligned_cols=240  Identities=22%  Similarity=0.240  Sum_probs=192.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +.+.|.+...+|.|+|++|-.+.. .+++..++|++.....+    -.+|+.++... .|||++++.+++.+....|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            357899999999999999998865 45788999999665222    23456555554 7999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe-CCCCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL-DDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv-~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |.+.++-+.+.++..   ..+. ..+..|+.+|+.|+.|||.+|   ++||||||+|||+ ++.++++|+|||.+.....
T Consensus       396 e~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999888777432   2233 677789999999999999999   9999999999999 5888999999999987543


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      +     ....+-|..|.|||+.....|++++|+||||++||+|++|+.||......  ..+..                .
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----------------~  525 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----------------R  525 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----------------h
Confidence            3     22335578899999999889999999999999999999999999765554  11111                0


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ......+...+....+|+.+||+.||.+||++.++..
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            1112222455677889999999999999999999986

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=292.61  Aligned_cols=257  Identities=21%  Similarity=0.256  Sum_probs=202.0

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG   87 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (340)
                      .++-..++|.+++.||+|+||.|..++.++ ++.||+|++++.   .......|..|..+|..-..+=|+.++-.|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            445556899999999999999999998755 778899999762   3345567888999998888999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ++|+||||++||+|-.++..   ...+++..+.-++..|..||.-||+.|   +|||||||+|||+|.+|+++|+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999843   336999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhc----c-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVM----N-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      -.+..+.. .......|||-|++||++.    + +.|++.+|.||+||++|||+.|..||-...-.+.+.      .+.+
T Consensus       223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~------KIm~  295 (1317)
T KOG0612|consen  223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG------KIMN  295 (1317)
T ss_pred             HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH------HHhc
Confidence            88764332 3344568999999999984    3 569999999999999999999999994322222111      1111


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT---MSDVAS  289 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~  289 (340)
                      .....       ..+.....+....+||++.+ -+|+.|..   ++++-.
T Consensus       296 hk~~l-------~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  296 HKESL-------SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hhhhc-------CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence            11111       11111335566777777655 46888888   777665

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=270.07  Aligned_cols=244  Identities=26%  Similarity=0.346  Sum_probs=194.7

Q ss_pred             CCcccccCCeeEEEEEE-CCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           23 GNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      .+.||.|.||+||-|.. ++|+.||||++.+..  .....++.+|+.+|+.+.||.||.+...|+..+..++|||.+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            46899999999999965 469999999997653  23446889999999999999999999999999999999999955 


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC---CCeeEecccccccccCcccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELE  176 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~---~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      +..+++... ..+.+++....-++.||+.||.|||.+|   |+|+||||+||++...   .++||||||+|+.++.... 
T Consensus       648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            555555443 3455899988899999999999999999   9999999999999643   5799999999998875432 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                        .....||+.|+|||+++++.|...-|+||+|+|+|--++|..||......  .+.++.+.-.+             ..
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMy-------------Pp  785 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMY-------------PP  785 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcccccc-------------CC
Confidence              34578999999999999999999999999999999999999999533222  11222111111             11


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+......+||..+|+..-.+|-|.+..+.
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            122344567789999999999999998877654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.5e-36  Score=288.93  Aligned_cols=145  Identities=26%  Similarity=0.414  Sum_probs=129.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|.+.++||.|+||.||+|.+. .++.||+|++....   ......+..|+.++..++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            68999999999999999999875 48899999986432   233467888999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      ||+.+++|.+++..   ...+++..++.++.||+.||.|||.++   |+|+||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999853   234888999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.8e-36  Score=255.31  Aligned_cols=220  Identities=20%  Similarity=0.134  Sum_probs=174.3

Q ss_pred             cCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhc
Q 041345           29 GGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFD  107 (340)
Q Consensus        29 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~  107 (340)
                      |.+|.||++++. +++.+|+|.+.....     ..+|...+....|||++++++++......+++|||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999864 478899999865431     23344444555799999999999999999999999999999998854


Q ss_pred             cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCC
Q 041345          108 SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG  187 (340)
Q Consensus       108 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~  187 (340)
                      .   ..+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++++|||.+......     .....++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            2   34899999999999999999999999   999999999999999999999999987654321     122345677


Q ss_pred             CCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHH
Q 041345          188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCI  267 (340)
Q Consensus       188 y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (340)
                      |+|||.+.+..++.++|+||+|+++|+|++|..|+.......                     ........+...+..+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCCHHHH
Confidence            999999888889999999999999999999998764221110                     00001112333456788


Q ss_pred             HHHHhccCCCCCCCCCHH
Q 041345          268 HVGLLCVQDKATDRPTMS  285 (340)
Q Consensus       268 ~li~~cl~~~p~~RPt~~  285 (340)
                      +++.+||+.||++|||+.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=261.27  Aligned_cols=241  Identities=24%  Similarity=0.318  Sum_probs=197.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .+|..+.+||+|+||.|.+|..++ .+.+|||++++..   .++.+--+.|-.+|... +-|.++.++.+|..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467888999999999999996544 6679999996652   22233335566677665 568999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+.||+|--.++.   -+.+.+..+.-++..|+-||-+||++|   |+.||||.+|||++..|++||+|||+++.--.
T Consensus       429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999777743   345888889999999999999999999   99999999999999999999999999885322


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      +  ...+...+||+-|+|||++...+|+.++|.||+|++||||+.|+.||++.+..+.+..+-       +         
T Consensus       503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-------e---------  564 (683)
T KOG0696|consen  503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-------E---------  564 (683)
T ss_pred             C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------H---------
Confidence            2  233456899999999999999999999999999999999999999998877766543321       0         


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPT  283 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  283 (340)
                       -...+|...+.+...++...|.+.|.+|.-
T Consensus       565 -hnvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  565 -HNVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence             124456777888899999999999999953

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.9e-34  Score=245.93  Aligned_cols=238  Identities=27%  Similarity=0.332  Sum_probs=190.9

Q ss_pred             CCeeEEEEEECC-CCEEEEEEccCCChhc-HHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhc
Q 041345           30 GFGPVYKGKLLD-GQEIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFD  107 (340)
Q Consensus        30 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~  107 (340)
                      +||.||+|...+ ++.+++|++....... ...+.+|+..+++++|+|++++++++......++++|++++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999998764 8899999997654443 67889999999999999999999999998999999999999999999854


Q ss_pred             cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCC
Q 041345          108 SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG  187 (340)
Q Consensus       108 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~  187 (340)
                      ..   .++...+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            32   2889999999999999999999998   9999999999999999999999999998765332   2233457888


Q ss_pred             CCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHH
Q 041345          188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCI  267 (340)
Q Consensus       188 y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (340)
                      |+|||.+.+..++.++|+||+|+++++|++|..||........  .    ...........       .......+..+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~----~~~~~~~~~~~-------~~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--L----FKKIGKPKPPF-------PPPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--H----HHHHhccCCCC-------ccccccCCHHHH
Confidence            9999999888899999999999999999999999865311110  1    11111110000       000001456789


Q ss_pred             HHHHhccCCCCCCCCCHHHHHH
Q 041345          268 HVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       268 ~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +++.+||..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=248.49  Aligned_cols=256  Identities=24%  Similarity=0.321  Sum_probs=193.1

Q ss_pred             CCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCCh-hcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.+-...||.|+||+|++-.. +.|+..|||.++.... ....++..|.+...+- ++||||+++|....+...||.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            344457799999999999865 4589999999976643 4456677777765544 799999999999989999999999


Q ss_pred             cCCCChhhHhhc--cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           96 LPNKSLDFFIFD--SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        96 ~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      | ..+++.+...  ..+...+++..+-.+......||.||...-  .|+|||+||+|||++..|.+||||||++-.+.++
T Consensus       145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            9 4566665422  123445889888889888999999998644  6999999999999999999999999998665322


Q ss_pred             ccccccccccccCCCCChhhhc--cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVM--NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                         ...+.-.|...|+|||.+.  +..|+.+|||||||++|||+.||..|+..++..-     +. ......+..+.+..
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-----eq-l~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-----EQ-LCQVVIGDPPILLF  292 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-----HH-HHHHHcCCCCeecC
Confidence               1223346788999999884  3458999999999999999999999997665521     11 11112233222221


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .    .-....+..+..++.-||.+|-.+||.+.++.++
T Consensus       293 ~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 D----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             c----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1    1113356678999999999999999999998863

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-37  Score=247.93  Aligned_cols=267  Identities=20%  Similarity=0.338  Sum_probs=196.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hh-cHHHHHHHHHHHHcCCCCceeeeeeEEee--------C
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--------K   86 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~   86 (340)
                      ..|.-..++|+|.||.||+|+.. +++.||+|++...+ .. --....+|+.++..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666778999999999999764 47888988763321 11 22356789999999999999999987653        2


Q ss_pred             CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      ..+|+||++|.. +|.-++..  ....++..++..++.++..||.|+|.+.   |+|||+||.|++|+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999966 45555522  2345899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCcc--cccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 041345          167 ARTFGMNE--LEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       167 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      ++.+....  .....+...-|.+|++||.+.|. .|+++.|||+-|||+.+|+++.+.+.+....++...+....-....
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            97664322  22223334458999999988764 7999999999999999999999999877776666555433222222


Q ss_pred             Cccccccccccc-----CCCC-------------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          244 GKALELIDTTLH-----ESCS-------------PDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       244 ~~~~~~~~~~~~-----~~~~-------------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..|+..-.-.+.     .+.+             --...+..+|+..++..||.+|+++++++..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            222211110000     0000             0112366789999999999999999999864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=266.06  Aligned_cols=242  Identities=22%  Similarity=0.288  Sum_probs=207.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCC-EEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQ-EIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+++++..||-|+||.|=+++.++.. .+|+|++++.   +....++...|..+|...+.|.||+++..|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            56777788999999999999875544 3788888654   3445667889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |-|-||.+...+.   .++.++..+..-++..+.+|++|||++|   |++|||||+|.+++.+|-+||.|||+|+.++.+
T Consensus       500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999994   4556888999999999999999999999   999999999999999999999999999998753


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                         ..+...+||+.|.|||++.++..+.++|.||||+++|||++|.+||.+.++....+++-.....+            
T Consensus       574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------  638 (732)
T KOG0614|consen  574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------  638 (732)
T ss_pred             ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence               34556899999999999999999999999999999999999999999888887776664433322            


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPT  283 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  283 (340)
                         ..|........+||+++...+|.+|.-
T Consensus       639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 ---EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence               223445566788999999999999976

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=273.69  Aligned_cols=243  Identities=25%  Similarity=0.352  Sum_probs=185.4

Q ss_pred             CCcccccCCe-eEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEeccCCCC
Q 041345           23 GNRLGQGGFG-PVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        23 ~~~Lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~  100 (340)
                      .+.+|.|+.| .||+|.. +++.||||.+-...   .....+|+..++.- +||||+++++.-.+....||..|.| .-+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS  588 (903)
T ss_pred             HHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence            3568999888 5788977 88999999884433   33457899999988 6999999999888888899999999 458


Q ss_pred             hhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---C--CCeeEecccccccccCcc
Q 041345          101 LDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---Q--MNPKISDFGMARTFGMNE  174 (340)
Q Consensus       101 L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~--~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++++... ...........+.++.|++.||++||+.+   |+||||||.||||+.   +  .+++|+|||+++.+..+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999664 11111222445788999999999999998   999999999999975   2  458999999999886543


Q ss_pred             cc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          175 LE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       175 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .. .......||.+|+|||++....-+.++||||+||++|+.++| .+||+..-..+              .++......
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------------~NIl~~~~~  731 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------------ANILTGNYT  731 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------------hhhhcCccc
Confidence            32 234556799999999999888888899999999999999986 79997532221              111111111


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ........++  +..+||.+|+..+|..||++.+|+.
T Consensus       732 L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1112222222  7889999999999999999999984

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=251.14  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=217.5

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEE
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCS   83 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (340)
                      +++.....+++....+-+|.||.||.|.+.+      .+.|.+|.++... .-....+..|.-++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4566666788889999999999999996533      4456778775442 23455678888899999999999999987


Q ss_pred             eeC-CeeEEEEeccCCCChhhHhh-----ccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           84 LQK-GERLLVYEYLPNKSLDFFIF-----DSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        84 ~~~-~~~~iv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      .+. ...+++++++.-|+|..++.     +....+.++..+...++.|++.|++|||+.+   ++|.||.++|.+|++..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            654 56788999999999999997     4445556888889999999999999999999   99999999999999999


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHH
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~  236 (340)
                      ++||+|=.+++.+-..+....+...-.+..|++||.+.+..|+.++||||||+++|||+| |+.|+...++.+..     
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-----  508 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-----  508 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence            999999988887665555555555556788999999999999999999999999999987 88888655554422     


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                                 ..+..+.+...|.+++.+++.+|.-||+..|++||++++++.-|++.
T Consensus       509 -----------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 -----------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -----------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                       12334455566788899999999999999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.8e-34  Score=271.33  Aligned_cols=260  Identities=20%  Similarity=0.244  Sum_probs=165.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-----CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeE------Ee
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-----GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC------SL   84 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~   84 (340)
                      ..++|.+.+.||+|+||.||+|...+     +..||+|.+......  +....+  .++...+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            55789999999999999999998654     588999987543221  111111  1111122222222111      23


Q ss_pred             eCCeeEEEEeccCCCChhhHhhccCcc-----------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 041345           85 QKGERLLVYEYLPNKSLDFFIFDSSKK-----------------ELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK  147 (340)
Q Consensus        85 ~~~~~~iv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk  147 (340)
                      .....++|+||+++++|.+++......                 .......+..++.|++.||+|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            456789999999999999988543210                 01123446689999999999999998   9999999


Q ss_pred             CCCeEeCC-CCCeeEecccccccccCcccccccccccccCCCCChhhhccC----------------------CCCccCc
Q 041345          148 ASNILLDD-QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG----------------------IVSMKSD  204 (340)
Q Consensus       148 ~~Nilv~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  204 (340)
                      |+|||++. ++.+||+|||++..+.... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 5789999999997653221 1122345678999999976322                      1334669


Q ss_pred             eehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC----ccccccccccc------CCCCHHHHHHHHHHHHhcc
Q 041345          205 VYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG----KALELIDTTLH------ESCSPDEVTRCIHVGLLCV  274 (340)
Q Consensus       205 vwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl  274 (340)
                      |||+||++|||+++..++...  .     ..........+    .+...+.....      ............+|+.+||
T Consensus       362 VwSlGviL~el~~~~~~~~~~--~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN--L-----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH--H-----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            999999999999876554211  0     00000000000    00000000000      0000111234558999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 041345          275 QDKATDRPTMSDVASM  290 (340)
Q Consensus       275 ~~~p~~RPt~~evl~~  290 (340)
                      +.||++|||+.++++.
T Consensus       435 ~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        435 RFKGRQRISAKAALAH  450 (566)
T ss_pred             cCCcccCCCHHHHhCC
Confidence            9999999999999974

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=268.93  Aligned_cols=261  Identities=24%  Similarity=0.374  Sum_probs=210.3

Q ss_pred             cHHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEee-
Q 041345            9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQ-   85 (340)
Q Consensus         9 ~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-   85 (340)
                      .+..++--++-|++...+|.|.+|.||+++.. +++..|+|+..... +..+.++.|.++++.. .|||++.+++++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            44555555678999999999999999999754 58888999885443 4455778889999988 69999999999863 


Q ss_pred             ----CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           86 ----KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        86 ----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                          ++++|+|||||.+|+..+++.... +..+.+..+..|++.++.|+.+||.+.   ++|||+|-.||+++.++.|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                467999999999999999997755 666999999999999999999999998   999999999999999999999


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~  236 (340)
                      +|||.+..+.  ..........||+.|+|||++.-     ..|+..+|+||||++..||.-|.+|+.......-.-.+  
T Consensus       165 vDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--  240 (953)
T KOG0587|consen  165 VDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--  240 (953)
T ss_pred             eeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--
Confidence            9999987654  22334455679999999999843     34788999999999999999999998654443321111  


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          ..        .+......+...+..+.++|..||.+|.++||++.++++.
T Consensus       241 ----pR--------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  241 ----PR--------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----CC--------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                00        1111222356678899999999999999999999998863

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=244.95  Aligned_cols=265  Identities=21%  Similarity=0.318  Sum_probs=199.0

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----eeE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----ERL   90 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   90 (340)
                      +.+..+.||.|+||+||.+.++ +|+.|++|++...  +-.....+.+|+.++.-++|.|++..+++..-..     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3466789999999999999764 5899999988544  2334567889999999999999999887654322     357


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ++.|.+ ..+|...+.   ....++...+.-+++||+.||.|||+.+   |.||||||.|.+++.|..+||||||+++..
T Consensus       134 V~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            888888 557777773   3455888899999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH--------HHh
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW--------QLW  241 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~  241 (340)
                      ..+..... +...-|..|+|||++.|. .|+.+.||||+||++.||+..+..|...++.++..++.-..        +.-
T Consensus       207 e~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  207 DQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             chhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            54433332 334458899999999886 59999999999999999999999998777776665443210        000


Q ss_pred             hcCcccccccc---------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          242 NEGKALELIDT---------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       242 ~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      -++....++..         ......+.....+...+...++..+|++|.+..+.+..+
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            01111111111         111222234455667788889999999999998887765

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=240.99  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|.++++||+|+|..|..++... .+.+|+|++++.   +.+++.-...|..+..+. .||.+|.+..+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            3679999999999999999998654 777899988654   334455566777888776 69999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |.||+++|+|-..+   .....+++..+.-+...|+.||.|||++|   |+.||||.+|++++..|++||+|+|+++.--
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999986665   34445999999999999999999999999   9999999999999999999999999987532


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc-chhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL-NLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  250 (340)
                      .  ....+...+||+.|+|||++++..|..++|.|+||++++||+.|+.||..-...... +...+.....-+       
T Consensus       403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-------  473 (593)
T KOG0695|consen  403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-------  473 (593)
T ss_pred             C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------
Confidence            1  122345689999999999999999999999999999999999999999654433221 122333333222       


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRP  282 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  282 (340)
                       ..+  ..|...+.....+++..|.+||.+|.
T Consensus       474 -kqi--riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  474 -KQI--RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -hcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence             111  22344455566778889999999984

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-33  Score=256.32  Aligned_cols=262  Identities=19%  Similarity=0.249  Sum_probs=177.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-----------------CCCCEEEEEEccCCChhcHHH--------------HHHH
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-----------------LDGQEIAIKRLSKSSGQGIVE--------------FKNE   64 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e   64 (340)
                      ..++|.+.++||+|+||+||+|..                 ..++.||||.+..........              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999853                 235679999985443222222              2346


Q ss_pred             HHHHHcCCCCc-----eeeeeeEEee--------CCeeEEEEeccCCCChhhHhhccCc---------------------
Q 041345           65 AKLIAKLQHTN-----LVRLLGCSLQ--------KGERLLVYEYLPNKSLDFFIFDSSK---------------------  110 (340)
Q Consensus        65 ~~~l~~l~h~~-----i~~~~~~~~~--------~~~~~iv~e~~~~~~L~~~l~~~~~---------------------  110 (340)
                      +.++.+++|.+     ++++++++..        ....++||||+++++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66666666554     3566676643        3457999999999999998864211                     


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCC
Q 041345          111 KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS  190 (340)
Q Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  190 (340)
                      ...+++..+..++.|++.++.|||+.+   ++||||||+||+++.++.++|+|||++........ .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            112466788899999999999999998   99999999999999999999999999876432211 11112334789999


Q ss_pred             hhhhccCC--------------------C--CccCceehhhHHHHHHHhCCC-CCCCCCccccc----chhHHHHHHhhc
Q 041345          191 PEYVMNGI--------------------V--SMKSDVYSFGVLVLEIISSKK-NNGCYDTERHL----NLVGYAWQLWNE  243 (340)
Q Consensus       191 PE~~~~~~--------------------~--~~~~DvwslG~vl~elltg~~-p~~~~~~~~~~----~~~~~~~~~~~~  243 (340)
                      ||.+....                    +  ..+.|+||+||++++|++|.. ||.........    ......++....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875322                    1  124799999999999999875 65322111100    000011111111


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKA---TDRPTMSDVAS  289 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~  289 (340)
                      .        ...............+|+.+||..+|   .+|+|+.|+++
T Consensus       459 ~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 Q--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             c--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1        11111223345678889999999766   68999999986

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-33  Score=252.02  Aligned_cols=216  Identities=23%  Similarity=0.367  Sum_probs=177.2

Q ss_pred             cHHHHHHHh---cCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeee
Q 041345            9 DFQTIAAAT---DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLG   81 (340)
Q Consensus         9 ~~~~i~~~~---~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~   81 (340)
                      .|..++.+-   .-|..++.||-|+||.|.+++..+ ...+|+|.+.+.+   ...+.+...|..+|...+.+-||+++-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            344444443   236677889999999999997544 5568999987653   344556788999999999999999999


Q ss_pred             EEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        82 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      .|.+.+.+|+||+|++||++-.+|.   .-+.+.+..+.-++..+..|++++|..|   ++||||||+|||||.+|++||
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceee
Confidence            9999999999999999999988884   4456889999999999999999999999   999999999999999999999


Q ss_pred             eccccccccc---------Ccccc-------------------------------cccccccccCCCCChhhhccCCCCc
Q 041345          162 SDFGMARTFG---------MNELE-------------------------------ANTNRIVGTHGYMSPEYVMNGIVSM  201 (340)
Q Consensus       162 ~Dfg~~~~~~---------~~~~~-------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~  201 (340)
                      +|||++.-+.         .++..                               ...-...||+.|+|||++....++.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            9999985331         11000                               0011245899999999999999999


Q ss_pred             cCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          202 KSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       202 ~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                      .+|.||.|+|||+|+.|+.||-.....+.
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            99999999999999999999966655543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.3e-34  Score=250.63  Aligned_cols=267  Identities=21%  Similarity=0.234  Sum_probs=203.6

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCC------CCceeeeeeEEeeC
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ------HTNLVRLLGCSLQK   86 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~   86 (340)
                      .....+|.+....|+|-|++|..|.+.. |+.||||++.+...- ...=..|+++|++|.      --|+++++..|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3456789999999999999999997644 889999999765422 223367999999984      24789999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEeccc
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFG  165 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg  165 (340)
                      +++|+|||-+ ..+|.+++.....+--+....+..++.|++.||..|-..|   ++|+||||+||||+++. .+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            9999999987 6789999977666666888999999999999999999999   99999999999999664 47999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchh-HH----HHHH
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV-GY----AWQL  240 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~-~~----~~~~  240 (340)
                      .|...+.+...+    +.-+..|.|||++.|-+|+...|+||+||+||||+||+..|.+....+.+.+. ..    ....
T Consensus       583 SA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  583 SASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             cccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            998776544433    23356799999999999999999999999999999999999877665433211 10    0000


Q ss_pred             hhcC---------------------------cccccccc------ccc-----CCCCHHHHHHHHHHHHhccCCCCCCCC
Q 041345          241 WNEG---------------------------KALELIDT------TLH-----ESCSPDEVTRCIHVGLLCVQDKATDRP  282 (340)
Q Consensus       241 ~~~~---------------------------~~~~~~~~------~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RP  282 (340)
                      ...+                           .++..+.+      .+.     ..-.+.....+.+|+..||..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            0000                           00000000      000     111234566788999999999999999


Q ss_pred             CHHHHHH
Q 041345          283 TMSDVAS  289 (340)
Q Consensus       283 t~~evl~  289 (340)
                      |..+.|.
T Consensus       739 t~nqAL~  745 (752)
T KOG0670|consen  739 TVNQALK  745 (752)
T ss_pred             CHHHHhc
Confidence            9998875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=218.13  Aligned_cols=207  Identities=27%  Similarity=0.390  Sum_probs=166.2

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHc-CCCCceeeeeeEEeeCCee
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAK-LQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~   89 (340)
                      +....+....+..||+|++|.|-+-++. +|...|+|.+... +.+...+..+|+.+..+ ..+|.+|+++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344556666788999999999888754 5888999998655 33445566777776554 4799999999998888899


Q ss_pred             EEEEeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      +|.||.| ..+|+.+.... ..+..+++..+-+++..+..|+.|||++=  .++|||+||+|||++.+|++|+||||.+-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 45777775442 34556999999999999999999999864  69999999999999999999999999987


Q ss_pred             cccCcccccccccccccCCCCChhhhc----cCCCCccCceehhhHHHHHHHhCCCCCCCC
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVM----NGIVSMKSDVYSFGVLVLEIISSKKNNGCY  225 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~vl~elltg~~p~~~~  225 (340)
                      .+.++-.   .+...|...|+|||.+.    ...|+.++||||||+.+.||.+++.|+..+
T Consensus       198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            7653321   22235778899999874    346899999999999999999999998543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-32  Score=236.36  Aligned_cols=132  Identities=26%  Similarity=0.332  Sum_probs=109.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCC-----C---CceeeeeeEEee--
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----H---TNLVRLLGCSLQ--   85 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~--   85 (340)
                      .++|.+.++||-|-|++||++.+.. .+.||+|+.+.. ..-.+....|+.+|++++     |   .+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            4789999999999999999997654 678999998433 233456688999999883     3   379999998864  


Q ss_pred             --CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           86 --KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        86 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                        +.+.|+|+|++ |.+|..++.....++ ++...+.+|++||+.||.|||...  +|+|.||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              56799999998 667778876654444 899999999999999999999877  79999999999997

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=5.3e-31  Score=219.57  Aligned_cols=210  Identities=33%  Similarity=0.546  Sum_probs=181.2

Q ss_pred             ccccCCeeEEEEEECC-CCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChhh
Q 041345           26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDF  103 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  103 (340)
                      ||.|.+|.||++...+ ++.+++|++...... ....+.+|+..++.+.|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998755 889999998655432 34678899999999999999999999998889999999999999999


Q ss_pred             HhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEecccccccccCcccccccccc
Q 041345          104 FIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARTFGMNELEANTNRI  182 (340)
Q Consensus       104 ~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~  182 (340)
                      ++....  ..++...+..++.+++.++.+||+.+   ++|+||+|.||+++. +++++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985432  35889999999999999999999998   999999999999999 89999999999886543221  12234


Q ss_pred             cccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHH
Q 041345          183 VGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD  261 (340)
Q Consensus       183 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (340)
                      .+...|.+||..... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            567889999998776 788999999999999999                                              


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          262 EVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       262 ~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        ..+.+++.+|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              457889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.4e-32  Score=218.84  Aligned_cols=255  Identities=19%  Similarity=0.294  Sum_probs=191.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeC--CeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQK--GERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~i   91 (340)
                      ..++|++.+++|+|.++.||.|.. .+.+.++||+++...   ...+.+|+.+|+.+. ||||++++++..+.  ....+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            457899999999999999999974 457889999985443   346789999999995 99999999988765  34679


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEecccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARTF  170 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~Dfg~~~~~  170 (340)
                      |+||+.+.++..+.      +.++.-.+..++.+++.||.|+|+.|   |.|||+||.|++++.. ..++|+|+|+|.++
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999888776664      23777889999999999999999999   9999999999999954 56999999999987


Q ss_pred             cCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCC-CCCCcccccchhHHH----------H
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNN-GCYDTERHLNLVGYA----------W  238 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~-~~~~~~~~~~~~~~~----------~  238 (340)
                      ..+...   +....+..|--||.+.+ ..|+.+-|+|||||++..|+..+.|| .+.+..++...+...          .
T Consensus       184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            643222   12234667889998855 46889999999999999999999987 344443333222110          0


Q ss_pred             H--Hhhc------------CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          239 Q--LWNE------------GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       239 ~--~~~~------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .  .--.            ..+..++..    ....-..++..+++..+|.+|-++|||+.|...
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~----~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINS----ENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCc----cccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0  0000            111111111    111112467889999999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=227.37  Aligned_cols=262  Identities=24%  Similarity=0.258  Sum_probs=196.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   87 (340)
                      ...+|.-++.+|.|.- .|..+.+ -.++.||+|.....  ....+....+|+.++..+.|+|+++++.++.-..     
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3467888889999988 5555533 34889999987443  3445667789999999999999999999876433     


Q ss_pred             -eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           88 -ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        88 -~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                       ..|+|||+| ..+|...+..     .++-.++..++.|++.|+.|||+.+   |+||||||+||++..++.+||.|||+
T Consensus        94 ~e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   94 QEVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HhHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence             468999999 5578777742     2677889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH--------
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW--------  238 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------  238 (340)
                      +..-+.   ....+.+..+..|+|||++.+..+.+.+||||+||++.||++|...|.+.+..++...+....        
T Consensus       165 ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            986432   234455667889999999988889999999999999999999999997766655443222100        


Q ss_pred             -------HHhhc--Ccc-----cccc-ccccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          239 -------QLWNE--GKA-----LELI-DTTLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       239 -------~~~~~--~~~-----~~~~-~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                             ..+..  +..     .+.+ +....  ...++.....+.+++.+||-.||++|.|++++|+.
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                   00000  000     0000 00000  11123345567889999999999999999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=248.56  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=203.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|+...++|.|.+|.||++++. .++..|+|+++-.....+.-..+|+-+++..+||||+.+++.+......++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            378999999999999999999864 4888999999777667777888999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      |.+|+|++..+   ..+++++.++..+++..++|++|||+.|   =+|||||-.||++++.|.+|++|||.+-.+..  .
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence            99999999874   4567999999999999999999999999   89999999999999999999999999876542  2


Q ss_pred             ccccccccccCCCCChhhh---ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ........||+.|+|||+.   +.+.|...+|||++|+..-|+---+.|.....+.+...+.     ....-.       
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-----TkS~~q-------  233 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-----TKSGFQ-------  233 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-----hccCCC-------
Confidence            2334457799999999987   4567999999999999999997666664222221111000     000001       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...........+.+.++++.|+.++|++|||++.++.
T Consensus       234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1111122345677889999999999999999988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=3e-31  Score=228.49  Aligned_cols=268  Identities=22%  Similarity=0.339  Sum_probs=198.3

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEee
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQ   85 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   85 (340)
                      +.+....+.|.+..+||.|.|++||++...    ..+.||+|.+....  ....+.+|+++|..+ .+.||+++.+++..
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            557778899999999999999999999642    46789999886554  344688999999999 59999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCCeeEecc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDF  164 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~~~l~Df  164 (340)
                      ++...+|+||+++....++...      ++...+..+++.++.||.++|++|   |+||||||+|++.+ ..+.-.|+||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence            9999999999999999888843      778899999999999999999999   99999999999998 4567899999


Q ss_pred             cccccccCcc------c------c------------------------------cccccccccCCCCChhhhcc-CCCCc
Q 041345          165 GMARTFGMNE------L------E------------------------------ANTNRIVGTHGYMSPEYVMN-GIVSM  201 (340)
Q Consensus       165 g~~~~~~~~~------~------~------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~  201 (340)
                      |++.......      .      .                              .......||++|+|||++.. +..++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9997221000      0      0                              00012358999999999865 45789


Q ss_pred             cCceehhhHHHHHHHhCCCCCCCCCccc-ccchhH--HHHHH-----hhcCc-----------ccccc--------cccc
Q 041345          202 KSDVYSFGVLVLEIISSKKNNGCYDTER-HLNLVG--YAWQL-----WNEGK-----------ALELI--------DTTL  254 (340)
Q Consensus       202 ~~DvwslG~vl~elltg~~p~~~~~~~~-~~~~~~--~~~~~-----~~~~~-----------~~~~~--------~~~~  254 (340)
                      ++||||.|+|++-++++..||-.....- -...+-  .++..     ...+.           ..+..        ....
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            9999999999999999999984333221 110000  00000     00011           00000        0000


Q ss_pred             --------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 --------HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 --------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                              ........+..+++|+.+|++.||.+|.|+++.|.
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                    00111123447899999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=239.09  Aligned_cols=197  Identities=25%  Similarity=0.344  Sum_probs=165.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh---hc-----HHHHHHHHHHHHcCC---CCceeeeeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG---QG-----IVEFKNEAKLIAKLQ---HTNLVRLLGCS   83 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~-----~~~~~~e~~~l~~l~---h~~i~~~~~~~   83 (340)
                      .-.+|...+.||.|+||.|++|.++. ...|++|.+.+..-   .+     .-....|+.+|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            33569999999999999999997655 56789998865421   11     112456999999996   99999999999


Q ss_pred             eeCCeeEEEEecc-CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           84 LQKGERLLVYEYL-PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        84 ~~~~~~~iv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                      ++.+.+|++||.. ++-+|.+++.   -+..+++.++..|+.|++.|+++||+.|   |+|||||-+|+.++.+|-+||+
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence            9999999999986 3447778873   4455999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCC
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~  222 (340)
                      |||.+....++..    ....||..|.|||++.|..| ...-|||++|++||.++....||
T Consensus       713 dfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  713 DFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             eccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            9999987654432    34679999999999988765 66789999999999998887776

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-31  Score=214.27  Aligned_cols=253  Identities=19%  Similarity=0.317  Sum_probs=188.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeE-EeeCCeeEEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGC-SLQKGERLLVY   93 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~iv~   93 (340)
                      .+.|.|.+.||+|.||.+.+++++. .+.+|+|.++..- .....|.+|...--.| .|.||+..+++ |...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3679999999999999999998765 6678999886553 3466788888876666 58999987765 55667788999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC--CCCCeeEeccccccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD--DQMNPKISDFGMARTFG  171 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~--~~~~~~l~Dfg~~~~~~  171 (340)
                      ||++.|+|..-+..    .-+.+.....++.|++.|+.|||+++   +||||||.+||||-  +..++||||||.....+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999888733    23788899999999999999999999   99999999999994  44579999999987654


Q ss_pred             CcccccccccccccCCCCChhhhccC-----CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNG-----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      .-     .........|.|||.....     ...+.+|+|.||+++|.++||..||......+ ...  +-+..|..+..
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y--~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPY--WEWEQWLKRKN  246 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chH--HHHHHHhcccC
Confidence            21     1112235679999976322     35788999999999999999999997332222 111  12344444444


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                      +..-+..      ...++.+.++.++-|..+|++|--..++.++.
T Consensus       247 ~~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCchhh------cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            4322111      22345678888999999999995555555444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.5e-29  Score=213.46  Aligned_cols=199  Identities=30%  Similarity=0.448  Sum_probs=170.6

Q ss_pred             CCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      |++.+.||.|++|.||++...+ ++.+++|.+...... ....+.+|+..++.++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6778899999999999998765 889999999765544 56788899999999999999999999998889999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +++|.+++.....  .+++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            9999999854321  1788999999999999999999998   99999999999999999999999999887653320 1


Q ss_pred             ccccccccCCCCChhhh-ccCCCCccCceehhhHHHHHHHhCCCCCCC
Q 041345          178 NTNRIVGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIISSKKNNGC  224 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~p~~~  224 (340)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334567889999988 666788899999999999999999999943

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=7.7e-29  Score=245.22  Aligned_cols=192  Identities=17%  Similarity=0.208  Sum_probs=133.5

Q ss_pred             CceeeeeeEE-------eeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Q 041345           74 TNLVRLLGCS-------LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDL  146 (340)
Q Consensus        74 ~~i~~~~~~~-------~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dl  146 (340)
                      .||.++++++       .....++.++|++ +++|.+++...  ...++...+..++.||+.||+|||++|   |+||||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDl  106 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNV  106 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            4666666665       2234577888987 66999998532  345899999999999999999999999   999999


Q ss_pred             CCCCeEeCCC-------------------CCeeEecccccccccCccc--------------ccccccccccCCCCChhh
Q 041345          147 KASNILLDDQ-------------------MNPKISDFGMARTFGMNEL--------------EANTNRIVGTHGYMSPEY  193 (340)
Q Consensus       147 k~~Nilv~~~-------------------~~~~l~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~  193 (340)
                      ||+|||++..                   +.+|++|||+++.......              ........||+.|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999654                   4456666666543211000              000112357888999999


Q ss_pred             hccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhc
Q 041345          194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLC  273 (340)
Q Consensus       194 ~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  273 (340)
                      +.+..++.++|||||||++|||++|..|+.....     ...   . ....    ...     ............++.+|
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~---~-~~~~----~~~-----~~~~~~~~~~~~~~~~~  248 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMS---S-LRHR----VLP-----PQILLNWPKEASFCLWL  248 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHH---H-HHHh----hcC-----hhhhhcCHHHHHHHHHh
Confidence            9999999999999999999999998877632110     000   0 0000    000     00011233456788899


Q ss_pred             cCCCCCCCCCHHHHHH
Q 041345          274 VQDKATDRPTMSDVAS  289 (340)
Q Consensus       274 l~~~p~~RPt~~evl~  289 (340)
                      |+.+|.+|||+.++++
T Consensus       249 L~~~P~~Rps~~eil~  264 (793)
T PLN00181        249 LHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CCCChhhCcChHHHhh
Confidence            9999999999999986

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-26  Score=204.63  Aligned_cols=261  Identities=20%  Similarity=0.228  Sum_probs=192.2

Q ss_pred             CCCCCCcccccCCeeEEEEEECCC--CEEEEEEccCCChhcHHHHHHHHHHHHcCC----CCceeeeeeEE-eeCCeeEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLDG--QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ----HTNLVRLLGCS-LQKGERLL   91 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~i   91 (340)
                      +|++.++||+|+||.||.|.....  ..+|+|............+..|..++..+.    .+++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999987553  478999876543332225667788887775    36888888888 46677899


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-----CCeeEecccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-----MNPKISDFGM  166 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-----~~~~l~Dfg~  166 (340)
                      ||+.+ |.+|.++..... .+.++..++..++.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 889999875544 556999999999999999999999999   9999999999999854     3589999999


Q ss_pred             cc--cccCccc----ccc--cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 041345          167 AR--TFGMNEL----EAN--TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       167 ~~--~~~~~~~----~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~  238 (340)
                      ++  .+.....    ...  .....||..|+++..+.+...+.+.|+||+++++.+++.|..||................
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98  4322111    111  123459999999999999999999999999999999999999985444332211111000


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      .   ...    ...  .....+   ..+.++...+-..+..++|....+...|.+...
T Consensus       254 ~---~~~----~~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  254 R---KLL----TDR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             h---hhc----ccc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0   000    000  112223   344444444555899999999999999876433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=5.9e-27  Score=190.43  Aligned_cols=166  Identities=15%  Similarity=0.099  Sum_probs=123.1

Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN  178 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~  178 (340)
                      |+|.+++...  +..+++..++.++.|++.||.|||+++         ||+||+++.++.+++  ||++......     
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence            6788888532  345999999999999999999999975         999999999999999  9998765321     


Q ss_pred             cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          179 TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                        ...|++.|+|||++.+..++.++|||||||++|+|++|..||........  .............      .. ....
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~------~~-~~~~  131 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPADD------PR-DRSN  131 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccCC------cc-cccc
Confidence              12578999999999999999999999999999999999999854332111  1111110000000      00 0011


Q ss_pred             CHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          259 SPDEVT--RCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       259 ~~~~~~--~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      +.....  .+.+++.+||+.+|.+|||+.++++.+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            122222  68999999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=8.8e-27  Score=187.20  Aligned_cols=279  Identities=17%  Similarity=0.178  Sum_probs=216.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEE-ECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .+.|+++++||.|+||.+|.|. ..+|..||+|+-+....  ..++..|..+.+.++ ...|..+..++.+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4789999999999999999996 45699999998755432  236677888888886 4677777778888888899999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCeeEeccccccccc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMARTFG  171 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~~l~Dfg~~~~~~  171 (340)
                      .+ |.+|+++..-  ....++..+++.++-|++.-++|+|.++   ++||||||+|++..-   ..++.|+|||+++.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            87 8899988753  3445999999999999999999999999   999999999999963   3468999999999875


Q ss_pred             Ccccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          172 MNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       172 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      +....     .......||.+|.+--.+.+...+...|+-|+|++|.++..|..||.+.......+..+...+......+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            43221     1233467899999999888888899999999999999999999999776665543333322221111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCceeeecCC
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISS  312 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~  312 (340)
                      ..     +    ....+.++.-.+.-|-..--++-|...-+.+.+..+...+.....-.+.|.+..
T Consensus       246 e~-----L----C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk  302 (341)
T KOG1163|consen  246 EV-----L----CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK  302 (341)
T ss_pred             HH-----H----hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence            11     1    112345666677789999999999999999999888888888888888886654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.4e-25  Score=199.22  Aligned_cols=169  Identities=18%  Similarity=0.217  Sum_probs=129.8

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEEC--CCCEEEEEEccCC-----ChhcHHHHHHHHHHHHcCCCCceeeeeeEE
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLL--DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLVRLLGCS   83 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (340)
                      .......++|.+.+.||+|+||+||+|++.  +++.+|||.+...     .......+.+|+.++++++|+|+++.+.. 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            345567789999999999999999999764  4677899986432     12235568999999999999999853322 


Q ss_pred             eeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCCeEeCCCCCeeEe
Q 041345           84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDL-KASNILLDDQMNPKIS  162 (340)
Q Consensus        84 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dl-k~~Nilv~~~~~~~l~  162 (340)
                        ....++||||+++++|....    ..   .   ...++.|++.+|.|||++|   |+|||| ||+||+++.+++++|+
T Consensus        90 --~~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             --cCCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence              24579999999999986321    11   1   1467899999999999999   999999 9999999999999999


Q ss_pred             cccccccccCcccccc------cccccccCCCCChhhhc
Q 041345          163 DFGMARTFGMNELEAN------TNRIVGTHGYMSPEYVM  195 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~  195 (340)
                      |||++..+........      .....+++.|.|||.+.
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999987654321111      12455778899999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=189.64  Aligned_cols=248  Identities=17%  Similarity=0.292  Sum_probs=194.8

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      ..+..+|.....|..|+|++ .|..+++|++...  .......|..|.-.++-+.||||+.+++.|....+..++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            44556788899999999999 6666777877433  23334468889999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe--cccccccccCccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS--DFGMARTFGMNEL  175 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~--Dfg~~~~~~~~~~  175 (340)
                      .|+|...++.... -..+..++.+++.+++.|++|||+.. .-|.---|+...+++|++.+.+|.  |--++..      
T Consensus       271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq------  342 (448)
T KOG0195|consen  271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------  342 (448)
T ss_pred             chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee------
Confidence            9999999976433 34788899999999999999999986 223344689999999998776653  3222211      


Q ss_pred             ccccccccccCCCCChhhhccCCC---CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIV---SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                         .....-.+.|++||.++.++-   -.++|+|||++++|||.|...||....+.+....               +.-.
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------iale  404 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------IALE  404 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------------hhhc
Confidence               111234688999999977653   3589999999999999999999976655543221               2234


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .++...|+..+..+.+|+.-|+..||.+||.++.|+-+|+++
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            566777888888899999999999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.6e-25  Score=184.99  Aligned_cols=260  Identities=18%  Similarity=0.238  Sum_probs=198.3

Q ss_pred             cCCCCCCcccccCCeeEEEEE-ECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      -.|+++++||.|+||+++.|. .-+++.||||.-+..  ..+.++..|....+.| ..++|...+-+...+.+-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            469999999999999999996 346899999976443  3455788899999888 579999988887788788899998


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-----CeeEecccccccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-----NPKISDFGMARTF  170 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-----~~~l~Dfg~~~~~  170 (340)
                      + |-+|+++..  .....++.+++..+|.|++.-++++|+++   +|.|||||+|+||...+     .+.++|||+|+.+
T Consensus       106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            7 889998874  23456999999999999999999999999   99999999999997433     4789999999988


Q ss_pred             cCccccc-----ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          171 GMNELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       171 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      .+.....     ......||.+|++--.+.|...+...|+-|||-++++.+.|..||.+..........+.    +.+.+
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~K  255 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGETK  255 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hcccc
Confidence            7554322     12345689999999999999999999999999999999999999977666554333322    11111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...-++..     ....+.++..-++-.-..+..+-|..+-+...+.+.
T Consensus       256 r~T~i~~L-----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  256 RSTPIEVL-----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             ccCCHHHH-----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            11111111     111234455555555667788888888877777554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.9e-25  Score=210.82  Aligned_cols=254  Identities=22%  Similarity=0.262  Sum_probs=183.6

Q ss_pred             CCCCcccccCCeeEEEEEEC-CCCEEEEEEcc----CC-ChhcHH-HHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           21 SPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLS----KS-SGQGIV-EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~----~~-~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .....+|.|++|.|+.+... .....+.|.+.    .. ...... .+..|+-+-..+.|+|++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977776532 23334444332    11 111111 1445666666788999988777666655555559


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |||++ +|..++..   ...+....+-.++.|++.|+.|+|+.|   +.|||+|++|+++..+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 88888843   235888899999999999999999999   999999999999999999999999999877654


Q ss_pred             ccc--cccccccccCCCCChhhhccCCCCc-cCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          174 ELE--ANTNRIVGTHGYMSPEYVMNGIVSM-KSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       174 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ...  .......|+..|.|||.+.+..|.+ ..||||.|+++..|++|+.||......+.....      ..........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hccccccccc
Confidence            443  4556678999999999998888865 689999999999999999999655554432100      0000000000


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ..........+.....+|.+||+.+|.+|.|+++|++
T Consensus       548 --~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 --EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              0011122345667788999999999999999999986

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=7.4e-23  Score=182.22  Aligned_cols=262  Identities=26%  Similarity=0.363  Sum_probs=196.3

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChh---cHHHHHHHHHHHHcCCCC-ceeeeeeEEeeCCeeEEEEec
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ---GIVEFKNEAKLIAKLQHT-NLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      |.+.+.||.|+||.||.+...  ..+++|.+......   ....+.+|+..++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            778889999999999999875  78899988654322   366788999999999888 799999999777778999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEecccccccccCcc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFGMNE  174 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~~~~~  174 (340)
                      +.++++.+++........+.......++.|++.++.++|+.+   ++|||+||+||+++..+ .++++|||.+..+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643221125889999999999999999999999   99999999999999988 69999999998654332


Q ss_pred             ccc----ccccccccCCCCChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          175 LEA----NTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       175 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ...    ......++..|.|||.+.+   .......|+||+|++++++++|..||........   ..............
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---TSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc---HHHHHHHHHhcCCc
Confidence            221    2355678999999999987   5788999999999999999999999765543200   00001111111000


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                       .................+.+++..|+..+|..|.+..+....
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             000000000002233567889999999999999999987764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=4.2e-24  Score=176.84  Aligned_cols=171  Identities=13%  Similarity=0.112  Sum_probs=131.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcH---HH------HHHHHHHHHcCCCCceeeeeeEEeeC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGI---VE------FKNEAKLIAKLQHTNLVRLLGCSLQK   86 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (340)
                      ..++|++.+.||.|+||.||++.. +++.+|+|++........   ..      +.+|+..+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            458999999999999999999766 677899999965432221   22      57899999999999999998886643


Q ss_pred             --------CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           87 --------GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        87 --------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                              ...+++|||++|.+|.+...       ++.    ..+.+++.++..+|..|   ++|||++|+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    24789999999999977731       222    24568999999999999   99999999999999888 


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII  216 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ell  216 (340)
                      ++|+|||...........              ..+.....+..++|+||||+.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999987643211100              01233445667999999999987664

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-24  Score=204.61  Aligned_cols=264  Identities=19%  Similarity=0.205  Sum_probs=185.6

Q ss_pred             ccccHHHHHHHhc-CCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC-hhcHHHHHHHHHH--HHcCCCCceeeeee
Q 041345            6 KIFDFQTIAAATD-NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS-GQGIVEFKNEAKL--IAKLQHTNLVRLLG   81 (340)
Q Consensus         6 ~~~~~~~i~~~~~-~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~i~~~~~   81 (340)
                      ++..++...+... .|...+.||.+.|=.|.+|++.+|. |+||++-+.. .-....+.++++-  ...+++||++++..
T Consensus        10 Qi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk   88 (1431)
T KOG1240|consen   10 QISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQK   88 (1431)
T ss_pred             ccchHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHH
Confidence            4555555544443 7888899999999999999987777 8899985543 2233344443333  44458999999988


Q ss_pred             EEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        82 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      +-......|+|-+|.. .+|.|.+   .-+..+...+...|+.|++.|+..+|..|   |+|||||.+||||+.=+-+.|
T Consensus        89 ~~~t~kAAylvRqyvk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~L  161 (1431)
T KOG1240|consen   89 VLVTDKAAYLVRQYVK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYL  161 (1431)
T ss_pred             HHHhhHHHHHHHHHHh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhh
Confidence            8777777889999984 4788887   34555888888899999999999999999   999999999999999889999


Q ss_pred             ecccccccccCccc-cccccccc----ccCCCCChhhhccC----------C-CCccCceehhhHHHHHHHhC-CCCCCC
Q 041345          162 SDFGMARTFGMNEL-EANTNRIV----GTHGYMSPEYVMNG----------I-VSMKSDVYSFGVLVLEIISS-KKNNGC  224 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~-~~~~~~~~----~~~~y~aPE~~~~~----------~-~~~~~DvwslG~vl~elltg-~~p~~~  224 (340)
                      +||...+....... ........    .-..|+|||.+..+          . .+++.||||+||++.||++- .++|..
T Consensus       162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            99987765432111 11111112    23469999987431          2 67899999999999999984 566631


Q ss_pred             CCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      .      ++..  ++.-. ....+.+   +.    .-+...+..|+..|++.||.+|.++++.|+.-.+
T Consensus       242 S------QL~a--Yr~~~-~~~~e~~---Le----~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  242 S------QLLA--YRSGN-ADDPEQL---LE----KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             H------HHHh--HhccC-ccCHHHH---HH----hCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1      1111  11000 0001100   00    0112368899999999999999999999998554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=4.3e-23  Score=175.86  Aligned_cols=233  Identities=19%  Similarity=0.273  Sum_probs=151.2

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCC----------CCceeeeeeEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQ----------HTNLVRLLGCSL   84 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~   84 (340)
                      .+..++.||.|+++.||.+.+.. ++.+++|++....   ....+++.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            44556789999999999998765 8899999874332   234566666665555532          223333333322


Q ss_pred             e---------C---C-----eeEEEEeccCCCChhhHhhc---cCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Q 041345           85 Q---------K---G-----ERLLVYEYLPNKSLDFFIFD---SSK-KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH  143 (340)
Q Consensus        85 ~---------~---~-----~~~iv~e~~~~~~L~~~l~~---~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H  143 (340)
                      .         .   .     +.+++|+-+ .++|.+++..   ... ...+.....+.+..|+++.+++||+.|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence            1         1   1     236788876 6678777532   111 223445556677899999999999999   999


Q ss_pred             cCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhcc--------CCCCccCceehhhHHHHHH
Q 041345          144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN--------GIVSMKSDVYSFGVLVLEI  215 (340)
Q Consensus       144 ~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~vl~el  215 (340)
                      +||+|+|++++.+|.+.|+||+.....+.....     ...+..|.|||....        ..++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999887765422111     223577999997633        2478899999999999999


Q ss_pred             HhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 041345          216 ISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDR  281 (340)
Q Consensus       216 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  281 (340)
                      .++..||+..........                    .-..|. +.++.+..||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999976544332211                    224566 788899999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=5.1e-23  Score=168.40  Aligned_cols=141  Identities=19%  Similarity=0.172  Sum_probs=108.1

Q ss_pred             CCCcccccCCeeEEEEEECCCCEEEEEEccCCChh--c------------------------HHHHHHHHHHHHcCCCCc
Q 041345           22 PGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ--G------------------------IVEFKNEAKLIAKLQHTN   75 (340)
Q Consensus        22 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~   75 (340)
                      +...||+|++|.||+|...+|+.||+|+++.....  .                        ......|+..+..+.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            35789999999999998878999999998543211  0                        012245889999997776


Q ss_pred             eeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHH-HhCCCCceeecCCCCCCeEeC
Q 041345           76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL-HKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        76 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~dlk~~Nilv~  154 (340)
                      +.....+..  ...++||||++++++.....   ....++...+..++.|++.+|.++ |+.|   ++||||||+||+++
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            644333222  22389999999887765432   223588999999999999999999 6888   99999999999998


Q ss_pred             CCCCeeEeccccccccc
Q 041345          155 DQMNPKISDFGMARTFG  171 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~  171 (340)
                       ++.++|+|||++....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=6.4e-22  Score=162.50  Aligned_cols=141  Identities=21%  Similarity=0.239  Sum_probs=110.1

Q ss_pred             CCCcccccCCeeEEEEEECCCCEEEEEEccCCChh--------------------------cHHHHHHHHHHHHcCCCCc
Q 041345           22 PGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ--------------------------GIVEFKNEAKLIAKLQHTN   75 (340)
Q Consensus        22 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~   75 (340)
                      +.+.||+|++|.||+|...+|+.||||+++.....                          .......|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            46789999999999998778999999998654211                          0112357888999998888


Q ss_pred             eeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeC
Q 041345           76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        76 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~  154 (340)
                      +.....+...  ..++||||++++++.....   ....++......++.|++.++.++|+ .|   ++|+||||+||+++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            7544443332  2489999998885544321   12347788899999999999999999 88   99999999999998


Q ss_pred             CCCCeeEeccccccccc
Q 041345          155 DQMNPKISDFGMARTFG  171 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~  171 (340)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-21  Score=176.39  Aligned_cols=215  Identities=23%  Similarity=0.364  Sum_probs=161.6

Q ss_pred             HHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCce-eecCC
Q 041345           68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV-IHRDL  146 (340)
Q Consensus        68 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i-~H~dl  146 (340)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+...  ...++......++++++.|++|||+..   | .|+.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence            35678999999999999999999999999999999999652  334888888999999999999999875   4 99999


Q ss_pred             CCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccC-------CCCccCceehhhHHHHHHHhCC
Q 041345          147 KASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-------IVSMKSDVYSFGVLVLEIISSK  219 (340)
Q Consensus       147 k~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~vl~elltg~  219 (340)
                      ++.|.+++....+||+|||+....................-|.|||.+.+.       ..+.+.||||+|++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998765321111111122235579999988653       1467899999999999999999


Q ss_pred             CCCCCCCccccc-chhHHHHHHhhcCcccccccccccCCCC-H-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          220 KNNGCYDTERHL-NLVGYAWQLWNEGKALELIDTTLHESCS-P-DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       220 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      .||......... .++.....   .+      ...++.... . .....+..++..||..+|.+||++.++...++.+..
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~---~~------~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK---GG------SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccccccccCChHHHHHHHHh---cC------CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            999654443322 12222111   00      111111111 1 233368899999999999999999999999987644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.4e-21  Score=188.77  Aligned_cols=199  Identities=19%  Similarity=0.254  Sum_probs=159.5

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC---CCceeeeeeEEeeCCee
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ---HTNLVRLLGCSLQKGER   89 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~   89 (340)
                      +..-.+.|.|.+.||+|+||.||+|...+|+.||+|+-+......   |.=-.+++.+|+   -+.|+++..++.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            334567899999999999999999988889999999986665432   111223344443   34556666655666778


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-------CCCCeeEe
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-------DQMNPKIS  162 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-------~~~~~~l~  162 (340)
                      ++|++|.+.|+|.+++.   ..+.+++..+..+..|++..+++||..+   ||||||||+|+++.       ++-.++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999995   4556999999999999999999999999   99999999999994       23458999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCC
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK  220 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~  220 (340)
                      |||.+..+..-.........++|-.+-.+|...|.+++..+|.|.++-+++-|+.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999876543322334455678899999999999999999999999999999999874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=183.40  Aligned_cols=232  Identities=23%  Similarity=0.257  Sum_probs=181.9

Q ss_pred             cccccCCeeEEEEEE----CCCCEEEEEEccCCChh--cHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEeccC
Q 041345           25 RLGQGGFGPVYKGKL----LDGQEIAIKRLSKSSGQ--GIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      .+|.|++|.|++++.    ..+.-+++|++.+....  .......|..++...+ ||.++++.-.+..+.+.++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998853    23667888888554211  1124556778888886 9999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +|.+...+   .....+.+.....+...++.+++++|+.+   ++|+|+|++||+++.+|++++.|||+++..-.     
T Consensus        81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~-----  149 (612)
T KOG0603|consen   81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-----  149 (612)
T ss_pred             cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh-----
Confidence            98887766   34445777777778888999999999999   99999999999999999999999999886432     


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES  257 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (340)
                       ....+||..|+|||++.  ....++|.||+|++.++|++|..||..    +      ......           .....
T Consensus       150 -~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~~Il-----------~~~~~  205 (612)
T KOG0603|consen  150 -EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMKRIL-----------KAELE  205 (612)
T ss_pred             -hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHHHHh-----------hhccC
Confidence             12228899999999987  557799999999999999999999975    1      001100           11234


Q ss_pred             CCHHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHh
Q 041345          258 CSPDEVTRCIHVGLLCVQDKATDRPTM--SDVASML  291 (340)
Q Consensus       258 ~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl~~L  291 (340)
                      .|........+++..++..+|.+|.-.  ..+.+..
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence            567778888999999999999999766  4555544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.2e-20  Score=153.01  Aligned_cols=186  Identities=18%  Similarity=0.148  Sum_probs=138.0

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChh----cHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEe
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..+...|++|+||+|+.+.. .+.+++.+.+......    ....+.+|+++|+++. |+++++++++    +..+++|+
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            34567899999999998866 6788887777444321    1124789999999995 5889998886    34699999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCCeEeCCCCCeeEecccccccccCc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDL-KASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dl-k~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |+.|.+|.....    .      ....++.|++.++.++|.+|   |+|+|| ||+||+++.++.++|+|||++......
T Consensus        79 yI~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         79 YLAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             eecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999988865431    0      11357789999999999999   999999 799999999999999999999865432


Q ss_pred             ccc----cc-------cccccccCCCCChhhhccC-CCC-ccCceehhhHHHHHHHhCCCCCC
Q 041345          174 ELE----AN-------TNRIVGTHGYMSPEYVMNG-IVS-MKSDVYSFGVLVLEIISSKKNNG  223 (340)
Q Consensus       174 ~~~----~~-------~~~~~~~~~y~aPE~~~~~-~~~-~~~DvwslG~vl~elltg~~p~~  223 (340)
                      ...    ..       ......++.|+.|+...-- ..+ ...+.++.|+-+|.++|++.+.-
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            210    00       1112357788888754322 222 56788999999999999998763

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=4e-21  Score=165.14  Aligned_cols=197  Identities=21%  Similarity=0.270  Sum_probs=137.6

Q ss_pred             CCCceeeeeeEEee---------------------------CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHH
Q 041345           72 QHTNLVRLLGCSLQ---------------------------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE  124 (340)
Q Consensus        72 ~h~~i~~~~~~~~~---------------------------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~  124 (340)
                      +|||||.+.++|.+                           ...+|+||..++. +|..++..    ...+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            59999999887642                           2357899998855 78888853    2356677788999


Q ss_pred             HHHHHHHHHHhCCCCceeecCCCCCCeEeC--CC--CCeeEecccccccccCc----ccccccccccccCCCCChhhhcc
Q 041345          125 GIVQGLLYLHKYSRLRVIHRDLKASNILLD--DQ--MNPKISDFGMARTFGMN----ELEANTNRIVGTHGYMSPEYVMN  196 (340)
Q Consensus       125 qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~--~~--~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~  196 (340)
                      |+++|+.|||.+|   +.|||+|.+||++.  ++  ..++|+|||.+-...+-    ......-...|+..-+|||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999994  33  34789999986543221    11111223447788999998743


Q ss_pred             C--C----CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHH
Q 041345          197 G--I----VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVG  270 (340)
Q Consensus       197 ~--~----~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (340)
                      .  +    .-.|+|.|+.|.+.||+++...||-.... .......+.     +.         .....|..++..+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yq-----e~---------qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQ-----ES---------QLPALPSRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhh-----hh---------hCCCCcccCChHHHHHH
Confidence            2  2    23589999999999999999999843211 111111111     11         11223445566788888


Q ss_pred             HhccCCCCCCCCCHHHHHHHh
Q 041345          271 LLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       271 ~~cl~~~p~~RPt~~evl~~L  291 (340)
                      ...|+.||.+|++..-....|
T Consensus       491 ~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHhcCCccccCCccHHHhHH
Confidence            889999999999977655554

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=4e-20  Score=152.70  Aligned_cols=137  Identities=20%  Similarity=0.266  Sum_probs=105.8

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-----CCCceeeeeeEEeeCC---e-eE
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLLGCSLQKG---E-RL   90 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~   90 (340)
                      +.-.+.||+|++|.||.  ++.....+||++..........+.+|+.+++.+     .||||+++++++.++.   . +.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34457899999999995  444444479988655444456789999999999     5799999999998874   3 34


Q ss_pred             EEEec--cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHH-HHHHhCCCCceeecCCCCCCeEeCC----CCCeeEec
Q 041345           91 LVYEY--LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL-LYLHKYSRLRVIHRDLKASNILLDD----QMNPKISD  163 (340)
Q Consensus        91 iv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~i~H~dlk~~Nilv~~----~~~~~l~D  163 (340)
                      +|+||  +.+++|.+++...    .+++.  ..++.|++.++ +|||+++   |+||||||+||+++.    +.+++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  5579999999432    25554  35677888777 9999999   999999999999973    34799999


Q ss_pred             cccc
Q 041345          164 FGMA  167 (340)
Q Consensus       164 fg~~  167 (340)
                      ++.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5443

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.6e-19  Score=151.42  Aligned_cols=149  Identities=18%  Similarity=0.203  Sum_probs=112.9

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEE--ECCCCEEEEEEccCCChh------------------------cHHHHHHHHH
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGK--LLDGQEIAIKRLSKSSGQ------------------------GIVEFKNEAK   66 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~   66 (340)
                      +.+...-|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|+.
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33444569999999999999999998  457999999998643210                        0123567999


Q ss_pred             HHHcCCCC--ceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Q 041345           67 LIAKLQHT--NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR  144 (340)
Q Consensus        67 ~l~~l~h~--~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  144 (340)
                      .+.++.+.  .+.+++++   . ..++||||+++.++.....   ....+....+..++.|++.++.+||+.|  .++|+
T Consensus       103 ~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~  173 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG  173 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence            99988653  33444432   2 3589999999988766542   2223566677899999999999999986  59999


Q ss_pred             CCCCCCeEeCCCCCeeEeccccccccc
Q 041345          145 DLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus       145 dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+||+++ ++.++|+|||.+...+
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999999 7899999999987644

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=4.5e-19  Score=146.74  Aligned_cols=146  Identities=21%  Similarity=0.247  Sum_probs=114.5

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChh----------------------cHHHHHHHHHH
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ----------------------GIVEFKNEAKL   67 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~   67 (340)
                      .+++......|.+.+.||.|+||.||++...+|+.+|||++......                      .......|+.+
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            46677777779999999999999999998878999999987543200                      11125678888


Q ss_pred             HHcCCCCc--eeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 041345           68 IAKLQHTN--LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD  145 (340)
Q Consensus        68 l~~l~h~~--i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d  145 (340)
                      +..+.|++  +...++.    ...+++|||+++++|.....         ......++.+++.++.++|+.|   ++|+|
T Consensus        87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~D  150 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGD  150 (198)
T ss_pred             HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence            88887663  4444432    34589999999998876542         0234578899999999999998   99999


Q ss_pred             CCCCCeEeCCCCCeeEeccccccccc
Q 041345          146 LKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus       146 lk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |+|+||+++.++.++|+|||.+..+.
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=1.2e-20  Score=168.08  Aligned_cols=174  Identities=22%  Similarity=0.306  Sum_probs=131.2

Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .++|.|++|...+|.+.+.........++...+.++.|++.|+.|   ++   .+|+|+||.||+...+.+++|+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999765555568888999999999999999   67   999999999999999999999999998


Q ss_pred             ccccCcc----cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhh
Q 041345          168 RTFGMNE----LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       168 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      .......    .....+...||..|++||.+.+..|+.++||||||++|+|++. -...++..          .+..-..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence            7765433    2234455679999999999999999999999999999999987 22222110          0111111


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSD  286 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  286 (340)
                      .+.++.    ..     ....+.-+.|+.+++...|.+||++.+
T Consensus       474 ~g~ip~----~~-----~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  474 DGIIPP----EF-----LQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             cCCCCh----HH-----hhcCcHHHHHHHHhcCCCcccCchHHH
Confidence            122110    00     112233457888999999999995444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=8.6e-19  Score=146.67  Aligned_cols=134  Identities=20%  Similarity=0.277  Sum_probs=111.1

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChh--------cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ--------GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.||+|++|.||+|.. .+..+++|+.......        ....+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6778999976432211        123467899999999999888777777777788999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++|++|.+.+...      .. ....++.+++.++.++|+.+   ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988431      11 77889999999999999999   99999999999999 77899999998764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=9.4e-20  Score=173.56  Aligned_cols=210  Identities=20%  Similarity=0.265  Sum_probs=146.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..+|..++.+..|++|.||.++++. .+.+|+|+- +.+.-.    .+   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~lil----Rn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLIL----RN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccchhh----hc---cccccCCccee------------------
Confidence            4679999999999999999998765 566787432 221110    11   22222344433                  


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      -+..+|   +.   .-++++..        ++.+++|||+.+   |+|||+||+|.+|..-|++|++|||+++.......
T Consensus       136 gDc~tl---lk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 GDCATL---LK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             chhhhh---cc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence            122222   21   11223322        278899999999   99999999999999999999999999875432111


Q ss_pred             c-------------cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          176 E-------------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       176 ~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      .             ......+||+.|+|||++....|...+|.|++|+|+|+.+.|..||.+...++.+.....-...|.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence            1             112345799999999999888999999999999999999999999988877776544432222222


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT  283 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  283 (340)
                      ++              ....+.+..+++.++|+.+|..|--
T Consensus       279 E~--------------dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  279 EE--------------DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cc--------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            22              1233467888999999999999943

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2e-18  Score=143.05  Aligned_cols=130  Identities=23%  Similarity=0.347  Sum_probs=104.4

Q ss_pred             cccccCCeeEEEEEECCCCEEEEEEccCCCh---h-----cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG---Q-----GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .||+|++|.||+|.. .+..+++|.......   .     ....+.+|+.++..+.|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998643211   1     1245678999999998877655555555666779999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++++|.+.+...   ..       .++.+++.++.+||+.+   ++|+|++|.||+++ ++.+++.|||.+..
T Consensus        80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998887321   10       78999999999999999   99999999999999 78999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2e-18  Score=163.68  Aligned_cols=144  Identities=20%  Similarity=0.315  Sum_probs=114.4

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEc-cCC-C------hhcHHHHHHHHHHHHcCCCCceeeeee
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRL-SKS-S------GQGIVEFKNEAKLIAKLQHTNLVRLLG   81 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~e~~~l~~l~h~~i~~~~~   81 (340)
                      +.........|...+.||+|+||.||++.+.+. .+++|+. ... .      ......+.+|+.+++.++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            344444556677889999999999999987443 4444432 211 1      112345788999999999999988877


Q ss_pred             EEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        82 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      ++......++||||+++++|.+++.           ....++.+++.++.+||+.+   ++||||||+||++ +++.++|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence            7777777899999999999998873           34678999999999999999   9999999999999 6779999


Q ss_pred             eccccccc
Q 041345          162 SDFGMART  169 (340)
Q Consensus       162 ~Dfg~~~~  169 (340)
                      +|||++..
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99999875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=6.4e-17  Score=132.67  Aligned_cols=138  Identities=20%  Similarity=0.255  Sum_probs=97.0

Q ss_pred             CCCcccccCCeeEEEEEECCCCEEEEEEccCCChh--cHHH----------------------HHHHHHHHHcCCCC--c
Q 041345           22 PGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ--GIVE----------------------FKNEAKLIAKLQHT--N   75 (340)
Q Consensus        22 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--~   75 (340)
                      +.+.||+|+||.||+|...+++.||+|++......  ....                      ...|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            35789999999999998878999999988543211  1111                      12445555555332  2


Q ss_pred             eeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeC
Q 041345           76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        76 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~  154 (340)
                      +.+++++    ...+++|||++++.+.........   . ...+..++.+++.++.++|. .+   ++|+||+|+||+++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            4444433    235899999998543221111000   1 15678899999999999999 88   99999999999999


Q ss_pred             CCCCeeEeccccccccc
Q 041345          155 DQMNPKISDFGMARTFG  171 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~  171 (340)
                       ++.++|+|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.4e-18  Score=164.40  Aligned_cols=255  Identities=20%  Similarity=0.236  Sum_probs=192.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~i   91 (340)
                      ...|.+.+.||+|+++.|-......  ...++.|.+....  .....+...|..+-..+. |.|+++.++........++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4678899999999999998886533  3345666554432  223344455777777775 9999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecCCCCCCeEeCCCC-CeeEeccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-KYSRLRVIHRDLKASNILLDDQM-NPKISDFGMART  169 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~  169 (340)
                      ++++.+++++...+... .....+......++.|+..++.|+| ..+   +.|+|+||+|.+++.++ ..++.|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999988887321 1213566677789999999999999 887   99999999999999999 999999999998


Q ss_pred             ccC-cccccccccccc-cCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          170 FGM-NELEANTNRIVG-THGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       170 ~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      +.. ...........| ++.|.|||...+. ...+..|+||.|+++..+++|..|+.........              .
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~  240 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------Y  240 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------c
Confidence            876 455555556677 9999999988774 5678899999999999999999998655444411              1


Q ss_pred             cccccccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTL--HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+.....  .............+++..++..+|..|.+..++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  241 SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            11111110  11222334455677888899999999999888764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=2e-16  Score=124.83  Aligned_cols=135  Identities=23%  Similarity=0.249  Sum_probs=111.5

Q ss_pred             CCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCC--CceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           22 PGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH--TNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        22 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.+.||.|.++.||++...+ ..+++|.......  ...+.+|+..++.+.|  .++++++.+....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            46789999999999998744 7899999865543  4567889999999975  58888888887777899999999887


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      .+..+          +......++.+++.+++.||.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            66443          4456677889999999999986434499999999999999988999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=4.8e-16  Score=131.80  Aligned_cols=134  Identities=22%  Similarity=0.266  Sum_probs=101.9

Q ss_pred             Cccc-ccCCeeEEEEEECCCCEEEEEEccCCC-------------hhcHHHHHHHHHHHHcCCCCce--eeeeeEEeeCC
Q 041345           24 NRLG-QGGFGPVYKGKLLDGQEIAIKRLSKSS-------------GQGIVEFKNEAKLIAKLQHTNL--VRLLGCSLQKG   87 (340)
Q Consensus        24 ~~Lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~   87 (340)
                      ..|| .|+.|+||.+.. ++..++||.+....             ......+.+|+.++..+.|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4577 889999999977 47788988774211             1223457789999999988774  66666543322


Q ss_pred             ----eeEEEEeccCC-CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           88 ----ERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        88 ----~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                          ..++|||++++ .+|.+++..    ..++..    .+.+++.++.+||++|   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 688888742    234443    3578999999999999   9999999999999988899999


Q ss_pred             ccccccc
Q 041345          163 DFGMART  169 (340)
Q Consensus       163 Dfg~~~~  169 (340)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998865

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.8e-14  Score=132.50  Aligned_cols=140  Identities=23%  Similarity=0.306  Sum_probs=97.2

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHH----------------------------------------HHHH
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV----------------------------------------EFKN   63 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~   63 (340)
                      +.||.|++|.||+|+..+|+.||||+.+........                                        .+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            579999999999999989999999998654211110                                        1334


Q ss_pred             HHHHHHcC----CCCceeeeeeEE-eeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHH-HHHHHHhCC
Q 041345           64 EAKLIAKL----QHTNLVRLLGCS-LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ-GLLYLHKYS  137 (340)
Q Consensus        64 e~~~l~~l----~h~~i~~~~~~~-~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~  137 (340)
                      |+..+.++    ++.+-+.+-.++ ...+..++||||++|++|.+........  .+   ...++.+++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhCC
Confidence            44444444    232223322222 2234579999999999998876432111  22   2345555655 467889988


Q ss_pred             CCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345          138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus       138 ~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                         ++|+|++|.||+++.+++++++|||++..+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               9999999999999999999999999987764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=5.5e-15  Score=134.46  Aligned_cols=251  Identities=21%  Similarity=0.264  Sum_probs=181.4

Q ss_pred             hcCCCCCCcccc--cCCeeEEEEEE--C-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCe
Q 041345           17 TDNFSPGNRLGQ--GGFGPVYKGKL--L-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   88 (340)
                      ...+-+.+.+|.  |.+|.||.++.  . ++..+|+|.-....  ......-.+++.....+ .|++.++....+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            456778889999  99999999976  2 47788988743322  22222335667777777 49999998888898999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHH----HHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEec
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ----GLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISD  163 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~D  163 (340)
                      .++-+|+|. .++..+...  ....++...++..+.+...    |+.++|+.+   ++|-|+||.||+...+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            999999985 677777643  2334778888888888888    999999999   9999999999999998 7899999


Q ss_pred             ccccccccCcccccc---cccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          164 FGMARTFGMNELEAN---TNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       164 fg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      ||+...++.......   .....+...|++||.. .+-++.+.|+|++|.++.+..++.+.+-......+..+       
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-------  338 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-------  338 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-------
Confidence            999998876543222   2233578889999965 56778899999999999999988866532211111100       


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                       ....        +..........++...+.++++.+|-.|++++.+...
T Consensus       339 -r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  339 -RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence             0000        1111111123345558888999999999999887764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=4.9e-14  Score=119.10  Aligned_cols=202  Identities=20%  Similarity=0.253  Sum_probs=136.6

Q ss_pred             HHcCCCCceeeeeeEEeeCC-----eeEEEEeccCCCChhhHhhccCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 041345           68 IAKLQHTNLVRLLGCSLQKG-----ERLLVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKYSRLRV  141 (340)
Q Consensus        68 l~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  141 (340)
                      +-++.|.||++++.|+.+..     ...++.||+..|++..+|..... ...+......+|+.||..||.|||+. ..++
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            34456999999999876543     46889999999999999976433 34578888889999999999999997 4789


Q ss_pred             eecCCCCCCeEeCCCCCeeEecc--cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCC
Q 041345          142 IHRDLKASNILLDDQMNPKISDF--GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK  219 (340)
Q Consensus       142 ~H~dlk~~Nilv~~~~~~~l~Df--g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~  219 (340)
                      +|+++..+.|++..++-+|++--  ......-+...........+.++|.|||.=.....+.++|||++|....+|..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999998888877521  1111100111112223345678999999655556778999999999999998776


Q ss_pred             CCCCCCCcc-cccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          220 KNNGCYDTE-RHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       220 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .-....... .....+         ....-.+...+           -..++..|++..|..||++..++..
T Consensus       280 iq~tnseS~~~~ee~i---------a~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENI---------ANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eccCCCcceeehhhhh---------hhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence            432111111 000000         00000111111           1346677999999999999988754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.9e-13  Score=110.12  Aligned_cols=131  Identities=19%  Similarity=0.170  Sum_probs=95.3

Q ss_pred             CCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCcee-eeeeEEeeCCeeEEEEeccCCCCh
Q 041345           23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV-RLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      .+.|+.|.++.||+++. .++.+++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++|||++++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            35789999999999987 478899998754432 223457888888888554443 444433  3345899999999877


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS--RLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ....        .   ....++.+++.+++.||+.+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430        1   11235678999999999987  12359999999999999 56899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=5.3e-13  Score=124.40  Aligned_cols=142  Identities=17%  Similarity=0.203  Sum_probs=93.2

Q ss_pred             CCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhc----------------------------------HHH---
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQG----------------------------------IVE---   60 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~---   60 (340)
                      .|.. +.||+|++|.||+|+..+ |+.||||+++......                                  ...   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4776 789999999999999877 9999999996442110                                  011   


Q ss_pred             ---HHHHHHHHHcC----CCCceeeeeeEEee-CCeeEEEEeccCCCChhhHhhccCcc---ccCCHHHHHHHHHHHHHH
Q 041345           61 ---FKNEAKLIAKL----QHTNLVRLLGCSLQ-KGERLLVYEYLPNKSLDFFIFDSSKK---ELLDWKKRFNIIEGIVQG  129 (340)
Q Consensus        61 ---~~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~  129 (340)
                         +.+|+..+.++    .+...+.+-.++.+ ....++||||++|+.+.+.......+   ..+....+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence               23344333333    23333333333322 34578999999999998753211111   123333334444444   


Q ss_pred             HHHHHhCCCCceeecCCCCCCeEeCCCC----CeeEeccccccccc
Q 041345          130 LLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDFGMARTFG  171 (340)
Q Consensus       130 l~~LH~~~~~~i~H~dlk~~Nilv~~~~----~~~l~Dfg~~~~~~  171 (340)
                          ...|   ++|+|++|.||+++.++    ++++.|||++..+.
T Consensus       277 ----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                3466   99999999999999887    89999999988764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.44  E-value=5.7e-12  Score=110.42  Aligned_cols=267  Identities=12%  Similarity=0.092  Sum_probs=164.1

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeE------EeeC-CeeEE
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGC------SLQK-GERLL   91 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~------~~~~-~~~~i   91 (340)
                      -..++.||+|+.+.+|..-.- +. -+.|++.........+.   ...|... .||-+..-+.+      .-+. ....+
T Consensus        13 i~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecchh-hc-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            356788999999999976321 22 25588766654433322   2333333 57654432211      1122 23678


Q ss_pred             EEeccCCCC-hhhHhhc---cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           92 VYEYLPNKS-LDFFIFD---SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        92 v~e~~~~~~-L~~~l~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .|+.+++.- +..++.-   .......++...++.++.++.+.+.||..|   .+-||++++|+||++++.|.|.|=+.-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            888887652 2222211   122234788999999999999999999999   999999999999999999999987665


Q ss_pred             ccccCcccccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhC-CCCCCCCCcccc-cchhHH-HHH
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERH-LNLVGY-AWQ  239 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~~-~~~~~~-~~~  239 (340)
                      ....++.   ...-..|.+.|.+||...     +..-+...|.|.||+++++++.| .+||.+...... ....+. ...
T Consensus       165 qi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         165 QINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             eeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            5432221   122346788999999764     23456789999999999999876 799855433221 111110 000


Q ss_pred             -Hhh-cCcccccccccccCCCCHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHhhcCCCC
Q 041345          240 -LWN-EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQD--KATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       240 -~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L~~~~~~  297 (340)
                       .+. ..+...............-.++.+..|..+|+..  ++.-|||++.++..|......
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence             000 0000000011111111123456777788888876  467999999999988654433

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=4.5e-12  Score=116.94  Aligned_cols=167  Identities=17%  Similarity=0.257  Sum_probs=124.1

Q ss_pred             EECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHH
Q 041345           38 KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK  117 (340)
Q Consensus        38 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~  117 (340)
                      +..++.+|.|+..............+-++-++.++||||+++++.++.....|+|+|-+.  -|..++..      +...
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~  104 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE  104 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence            344588888888765554455667788889999999999999999999999999999763  45555532      3355


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccC
Q 041345          118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG  197 (340)
Q Consensus       118 ~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  197 (340)
                      ....-+.||+.||-+||..+  +++|++|....|+|+..|.-||++|..+.....-.  ...........|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~--~~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN--APAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC--cccccchhhhcccChhhcCcc
Confidence            66677899999999998655  49999999999999999999999998875432111  111122223346666643221


Q ss_pred             CCCccCceehhhHHHHHHHhC
Q 041345          198 IVSMKSDVYSFGVLVLEIISS  218 (340)
Q Consensus       198 ~~~~~~DvwslG~vl~elltg  218 (340)
                      .  -..|.|.|||++++++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            1  346999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=5.3e-12  Score=102.59  Aligned_cols=137  Identities=15%  Similarity=0.101  Sum_probs=97.0

Q ss_pred             CCcccccCCeeEEEEEECC-------CCEEEEEEccCCC----------------------hhcHHH----HHHHHHHHH
Q 041345           23 GNRLGQGGFGPVYKGKLLD-------GQEIAIKRLSKSS----------------------GQGIVE----FKNEAKLIA   69 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~e~~~l~   69 (340)
                      ...||.|--+.||.|...+       +..+|||+.+...                      ......    ..+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            5679999999999997543       4789999873210                      001112    237888888


Q ss_pred             cCCC--CceeeeeeEEeeCCeeEEEEeccCCCChhh-HhhccCccccCCHHHHHHHHHHHHHHHHHH-HhCCCCceeecC
Q 041345           70 KLQH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDF-FIFDSSKKELLDWKKRFNIIEGIVQGLLYL-HKYSRLRVIHRD  145 (340)
Q Consensus        70 ~l~h--~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~d  145 (340)
                      ++..  -++..++++    ..-++||||+.+..+.. .+.    ...++......+..+++.++..| |..|   ++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            8742  455555554    34589999997653321 221    11245556778889999999988 8888   99999


Q ss_pred             CCCCCeEeCCCCCeeEeccccccccc
Q 041345          146 LKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus       146 lk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |++.||++.+ +.+.|+|||.+....
T Consensus       151 Ls~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEEC-CcEEEEECCCceeCC
Confidence            9999999974 589999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.29  E-value=4.3e-11  Score=100.68  Aligned_cols=142  Identities=17%  Similarity=0.238  Sum_probs=107.3

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCC--CceeeeeeEEeeC---CeeEEEEeccC
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQH--TNLVRLLGCSLQK---GERLLVYEYLP   97 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~iv~e~~~   97 (340)
                      +.|+.|.++.||++...+|+.+++|....... .....+..|..+++.+.+  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999876668999998754432 134567889999999865  3456677765543   25689999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS----------------------------------------  137 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  137 (340)
                      +.++...+..    ..++......++.+++.++..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888776521    23677777788888888888888531                                        


Q ss_pred             -------------CCceeecCCCCCCeEeCC--CCCeeEeccccccc
Q 041345          138 -------------RLRVIHRDLKASNILLDD--QMNPKISDFGMART  169 (340)
Q Consensus       138 -------------~~~i~H~dlk~~Nilv~~--~~~~~l~Dfg~~~~  169 (340)
                                   ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         134799999999999998  56688999987754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=5e-12  Score=115.35  Aligned_cols=246  Identities=19%  Similarity=0.180  Sum_probs=171.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE--CCCCEEEEEEccCCChhcHHH--HHHHHHHHHcC-CCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL--LDGQEIAIKRLSKSSGQGIVE--FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..+|..+..||.|.|+.|+....  .++..|++|.+.+.......+  -..|..+...+ .|.+++.....+....+.++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            46788889999999999998853  357789999875553322222  23455555555 57888887776666677789


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEecccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARTF  170 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~Dfg~~~~~  170 (340)
                      -.|||.++++.....   -...+++...+.+..|++.++.++|+..   ++|.|++|.||++..+ +..++.|||....+
T Consensus       344 p~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence            999999998877762   2334788889999999999999999998   9999999999999876 67789999987642


Q ss_pred             cCcccccccccccccCCC-CChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGY-MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ....    ......+..| .+|.......+..++|++|||.-+.+.+++..-......                  +.. 
T Consensus       418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------~~~-  474 (524)
T KOG0601|consen  418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------SLT-  474 (524)
T ss_pred             ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------cee-
Confidence            2111    1112223334 356555667888999999999999999987743211000                  000 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      +...... ..+.....+..+.+.+...++..||++.++.....
T Consensus       475 i~~~~~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  475 IRSGDTP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             eeccccc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            0001001 11223356667777899999999999988876543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=9.6e-11  Score=92.22  Aligned_cols=131  Identities=23%  Similarity=0.328  Sum_probs=98.5

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEc-cCC--ChhcHH-----HHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRL-SKS--SGQGIV-----EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~-~~~--~~~~~~-----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..+++|+-+.++.+.+. |.++++|.= ++.  .+...+     .-.+|+.++.++.--.|.-..-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999763 445777753 322  122222     235688888887655555555566677778999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++|..|.+.+...          ...++..+-.-+.-||.+|   |+|+||.++||++.++ ++.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC-cEEEEECCcccc
Confidence            9999999888543          2456777888889999999   9999999999999877 499999999875

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.24  E-value=1.5e-10  Score=90.71  Aligned_cols=143  Identities=24%  Similarity=0.278  Sum_probs=103.0

Q ss_pred             CCCcccccCCeeEEEEEECCCCEEEEEEc-cCC--Chh-----cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           22 PGNRLGQGGFGPVYKGKLLDGQEIAIKRL-SKS--SGQ-----GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        22 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~-~~~--~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ....+-+|+-+.|+++.+ .|+..+||.= .+.  .+.     ......+|+.++.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567788999999999987 6787777753 222  111     1223567888888875444444444566666778999


Q ss_pred             eccCC-CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-C--eeEeccccccc
Q 041345           94 EYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-N--PKISDFGMART  169 (340)
Q Consensus        94 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~--~~l~Dfg~~~~  169 (340)
                      ||+++ .++.++++........ ......++..|-..+.-||.++   |+||||..+||++..++ +  +.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4788888765444322 2333678899999999999999   99999999999996443 3  58999999764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.20  E-value=2.2e-12  Score=124.00  Aligned_cols=250  Identities=18%  Similarity=0.211  Sum_probs=169.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEcc---CCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..+.+.+.+-+.+|+++.++.+.-.. |...+.|+..   +......+....+-.++-...+|.++....-+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            34667777888899999998886433 4333333331   1122222222233333333455666665555555677899


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +++|..+++|...++...   ..+..........+..+.++||+..   +.|+|++|.|++...+++.++.||+.....+
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            999999999988886543   3455555566667888999999987   9999999999999999999999998433221


Q ss_pred             Cc---------------------cc----c----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCC
Q 041345          172 MN---------------------EL----E----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       172 ~~---------------------~~----~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~  222 (340)
                      .-                     ..    .    .......+|+.|.+||...+......+|.|+.|+++++.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00                     00    0    0112346899999999999999999999999999999999999999


Q ss_pred             CCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041345          223 GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMS  285 (340)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  285 (340)
                      ......+.+..+......|              ...+...+....+++...+..+|.+|..+.
T Consensus      1036 na~tpq~~f~ni~~~~~~~--------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPW--------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhhhhhccccCCCCC--------------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            7665555432221111111              112234455677888889999999997776

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.16  E-value=1.6e-09  Score=97.64  Aligned_cols=217  Identities=20%  Similarity=0.260  Sum_probs=148.2

Q ss_pred             CCeeEEEEE-ECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee----CCeeEEEEeccCCC-Chhh
Q 041345           30 GFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGERLLVYEYLPNK-SLDF  103 (340)
Q Consensus        30 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~iv~e~~~~~-~L~~  103 (340)
                      -..+.|++. ..+|..|++|.+.............-.++++++.|+|+|++..++..    +..+++|++|+++. +|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345778885 44699999999944433333334456788899999999999988763    34689999999764 6666


Q ss_pred             HhhccCc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345          104 FIFDSSK------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus       104 ~l~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +-+....            +...++..+|.++.|+..||.++|+.|   +.-.-|.+.+|+++++.+++|...|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5543222            234778999999999999999999999   8889999999999999999999888876654


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      .+.              .+|  +.+   ..+-|.=.||.+++.|.||...-...+..+.. ..                 
T Consensus       445 ~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-~~-----------------  487 (655)
T KOG3741|consen  445 EDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS-HL-----------------  487 (655)
T ss_pred             CCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH-HH-----------------
Confidence            322              011  111   12568889999999999986542111111100 00                 


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML  291 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L  291 (340)
                          ...-...+.++.+++.-....++.+ -+..+++.++
T Consensus       488 ----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  488 ----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                0011334555666666666777766 4677776655

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.14  E-value=1.8e-09  Score=92.76  Aligned_cols=140  Identities=15%  Similarity=0.138  Sum_probs=96.7

Q ss_pred             cccccCCeeEEEEEECCCCEEEEEEccCCChh-----------cHHHHHHHHHHHHcCCCC--ceeeeeeEEee-----C
Q 041345           25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ-----------GIVEFKNEAKLIAKLQHT--NLVRLLGCSLQ-----K   86 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~-----~   86 (340)
                      .+-......|+++.. +|+.+.||........           ....+.+|+..+..+...  ..+.++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444444667655 6788999976433211           011367888888777322  22334444433     2


Q ss_pred             CeeEEEEeccCCC-ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-------CCC
Q 041345           87 GERLLVYEYLPNK-SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-------QMN  158 (340)
Q Consensus        87 ~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-------~~~  158 (340)
                      ...++|+|++++. +|.+++.... ....+......++.+++..++.||.+|   ++|+|+++.|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3468999999886 7888874321 233566777889999999999999999   999999999999975       467


Q ss_pred             eeEeccccccc
Q 041345          159 PKISDFGMART  169 (340)
Q Consensus       159 ~~l~Dfg~~~~  169 (340)
                      +.|+||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            89999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=2.2e-09  Score=86.94  Aligned_cols=126  Identities=26%  Similarity=0.314  Sum_probs=81.0

Q ss_pred             eEEEEEECCCCEEEEEEccCCC-------------h-------------hcHHHHHHHHHHHHcCCCC--ceeeeeeEEe
Q 041345           33 PVYKGKLLDGQEIAIKRLSKSS-------------G-------------QGIVEFKNEAKLIAKLQHT--NLVRLLGCSL   84 (340)
Q Consensus        33 ~V~~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~   84 (340)
                      .||.|...+|..+|+|......             .             .......+|+..|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999874210             0             0112356799999998654  455665542 


Q ss_pred             eCCeeEEEEeccC--CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHH-HHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           85 QKGERLLVYEYLP--NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY-LHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        85 ~~~~~~iv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                         .-++||||++  +..+..+....     ++......++.+++..+.. +|..|   ++||||.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               3479999998  55554443211     1133445677777775554 57888   9999999999999988 9999


Q ss_pred             eccccccccc
Q 041345          162 SDFGMARTFG  171 (340)
Q Consensus       162 ~Dfg~~~~~~  171 (340)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.08  E-value=1.2e-09  Score=91.27  Aligned_cols=137  Identities=20%  Similarity=0.268  Sum_probs=98.3

Q ss_pred             CCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC------------------h----hcHHHHHHHHHHHHcCCCC--
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS------------------G----QGIVEFKNEAKLIAKLQHT--   74 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~----~~~~~~~~e~~~l~~l~h~--   74 (340)
                      =+.++..||-|--+.||.|..+.|.++|||.-+...                  .    .......+|.++|..+.-.  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            467788999999999999999899999999542110                  0    1122356899999998544  


Q ss_pred             ceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC
Q 041345           75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        75 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~  154 (340)
                      .+.+.+++    +.-.+|||++++.-|...-        ++....-.++..|+.-+..+-..|   ++|||+++-||+++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            66666664    3447999999886554332        122333344555555555555667   99999999999999


Q ss_pred             CCCCeeEecccccccc
Q 041345          155 DQMNPKISDFGMARTF  170 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~  170 (340)
                      ++|.+.++||-.+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999776543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.93  E-value=9e-09  Score=95.69  Aligned_cols=141  Identities=18%  Similarity=0.224  Sum_probs=92.3

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHH----------------------------------------HHHH
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV----------------------------------------EFKN   63 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~   63 (340)
                      ..|+.++-|.||+|+..+|+.||||+.+..-.....                                        .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            678999999999999999999999998654221111                                        1234


Q ss_pred             HHHHHHcC----C-CCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 041345           64 EAKLIAKL----Q-HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR  138 (340)
Q Consensus        64 e~~~l~~l----~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  138 (340)
                      |...+.++    + .+++.-..=+..-.+..+++|||++|..+.+.......  .++.+.+.....++.  +..+=..| 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHhcC-
Confidence            44444444    1 23332222222334567999999999999888533222  244333333322222  22222245 


Q ss_pred             CceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345          139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                        ++|+|..|.||+++.+|++.+.|||+...+.
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              9999999999999999999999999987664

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=4.9e-10  Score=104.09  Aligned_cols=153  Identities=17%  Similarity=0.242  Sum_probs=105.1

Q ss_pred             HHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccc-------cccccCCCCChhhhcc
Q 041345          124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN-------RIVGTHGYMSPEYVMN  196 (340)
Q Consensus       124 ~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~-------~~~~~~~y~aPE~~~~  196 (340)
                      .+++.|+.++|..-  ++||++|.|++|.++.++..||+.|+++.............       -......|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34559999999765  69999999999999999999999999876543211111111       1123557999999988


Q ss_pred             CCCCccCceehhhHHHHHHHhCCCC-CCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccC
Q 041345          197 GIVSMKSDVYSFGVLVLEIISSKKN-NGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQ  275 (340)
Q Consensus       197 ~~~~~~~DvwslG~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  275 (340)
                      ...+.++|+||+|+++|.+..|+.+ +...........             ....+.......+...+.++.+-+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHhc
Confidence            8889999999999999999965544 322111111000             00111122233345667778888888999


Q ss_pred             CCCCCCCCHHHHHHHh
Q 041345          276 DKATDRPTMSDVASML  291 (340)
Q Consensus       276 ~~p~~RPt~~evl~~L  291 (340)
                      .++.-||++.++....
T Consensus       251 ~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLSIP  266 (700)
T ss_pred             CCcccCcchhhhhccc
Confidence            9999999888776543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=1.9e-08  Score=83.53  Aligned_cols=106  Identities=22%  Similarity=0.252  Sum_probs=80.4

Q ss_pred             HHHHHHHHHHHHcCC--CCceeeeeeEEeeC----CeeEEEEeccCCC-ChhhHhhccCccccCCHHHHHHHHHHHHHHH
Q 041345           58 IVEFKNEAKLIAKLQ--HTNLVRLLGCSLQK----GERLLVYEYLPNK-SLDFFIFDSSKKELLDWKKRFNIIEGIVQGL  130 (340)
Q Consensus        58 ~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~----~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l  130 (340)
                      .....+|+..+..+.  .-.....+++....    ...++|+|++++. +|.+++.....   .+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            335677888777763  22344555555442    2358999999874 78888853221   56667788999999999


Q ss_pred             HHHHhCCCCceeecCCCCCCeEeCCCC---CeeEeccccccc
Q 041345          131 LYLHKYSRLRVIHRDLKASNILLDDQM---NPKISDFGMART  169 (340)
Q Consensus       131 ~~LH~~~~~~i~H~dlk~~Nilv~~~~---~~~l~Dfg~~~~  169 (340)
                      +-||.+|   ++|+|+++.|||++.++   .+.++||+.+..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999   99999999999999886   799999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.84  E-value=7.1e-08  Score=78.79  Aligned_cols=138  Identities=14%  Similarity=0.173  Sum_probs=99.7

Q ss_pred             ccccCCeeEEEEEECCCCEEEEEEccCC------ChhcHHHHHHHHHHHHcCCC--CceeeeeeEEe-e--C--CeeEEE
Q 041345           26 LGQGGFGPVYKGKLLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIAKLQH--TNLVRLLGCSL-Q--K--GERLLV   92 (340)
Q Consensus        26 Lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~-~--~--~~~~iv   92 (340)
                      -|+||.+.|+.... +|..+-+|.-...      .+.....|.+|+..++.+..  -.+.+++ ++. .  +  ...+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            46689999999876 5567888976421      13355678999999998842  2244444 222 1  1  235799


Q ss_pred             EeccCC-CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC--eeEeccccccc
Q 041345           93 YEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--PKISDFGMART  169 (340)
Q Consensus        93 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~--~~l~Dfg~~~~  169 (340)
                      +|-+++ .+|.+.+.... -.+.+......++.+++.+++-||..|   +.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997754 47777764322 224677778899999999999999999   999999999999986667  89999976653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=1.2e-07  Score=77.77  Aligned_cols=137  Identities=18%  Similarity=0.182  Sum_probs=92.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHH---------HHHHHHHHHcC---CCCceeeeeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE---------FKNEAKLIAKL---QHTNLVRLLGCS   83 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l---~h~~i~~~~~~~   83 (340)
                      ..++|.+.+.+-......|.+... +|+.+++|..+.........         +.+.+.....+   .....+.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            347899889999888888888876 67999999886554322222         12333333333   222333322222


Q ss_pred             -----eeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           84 -----LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        84 -----~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                           .-....+++|||++|..|.++..       ++.    .++..+.+++.-||+.|   ++|||.+|+|++++++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence                 22234678999999987766531       222    24456778899999999   9999999999999865 5


Q ss_pred             eeEecccccc
Q 041345          159 PKISDFGMAR  168 (340)
Q Consensus       159 ~~l~Dfg~~~  168 (340)
                      +++.||+...
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=4.1e-07  Score=76.58  Aligned_cols=132  Identities=17%  Similarity=0.180  Sum_probs=83.3

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc--eeeeeeEEeeCCeeEEEEeccCCCC-
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN--LVRLLGCSLQKGERLLVYEYLPNKS-  100 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~iv~e~~~~~~-  100 (340)
                      ..||+|..+.||+.   .+..+++|......  ......+|..+++.+..-.  +.+.+++....+...+||++++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   35567889876533  2345688999988875332  4566777777777889999998863 


Q ss_pred             hhhHhhccCccccCCHHHHHHHHHHHHHHH---------------------------------------HHHHh-CCCCc
Q 041345          101 LDFFIFDSSKKELLDWKKRFNIIEGIVQGL---------------------------------------LYLHK-YSRLR  140 (340)
Q Consensus       101 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l---------------------------------------~~LH~-~~~~~  140 (340)
                      +...+..       +......++.+++..+                                       .+|.. .....
T Consensus        82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            2211100       0001111111111111                                       12211 11235


Q ss_pred             eeecCCCCCCeEeCCCCCeeEecccccc
Q 041345          141 VIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus       141 i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      ++|+|+.|.||++++++ +.++||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            79999999999999887 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.66  E-value=6.6e-07  Score=74.27  Aligned_cols=152  Identities=21%  Similarity=0.232  Sum_probs=101.0

Q ss_pred             ccHHHHHHHhcCCCCCCccc---ccCCeeEEEEEECCCCEEEEEEccCCChhc-------------------HH-----H
Q 041345            8 FDFQTIAAATDNFSPGNRLG---QGGFGPVYKGKLLDGQEIAIKRLSKSSGQG-------------------IV-----E   60 (340)
Q Consensus         8 ~~~~~i~~~~~~y~~~~~Lg---~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~   60 (340)
                      .+...|.....+..+....|   .|.-+.||+|...++..+|+|++.......                   ..     -
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            45566777777777766544   677779999987789999999985432110                   00     1


Q ss_pred             HHHHHHHHHcCC--CCceeeeeeEEeeCCeeEEEEeccCCCCh-hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-C
Q 041345           61 FKNEAKLIAKLQ--HTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-Y  136 (340)
Q Consensus        61 ~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~  136 (340)
                      ...|+.-|.++.  +-.+.+.+++.    .-.+||||+..... .-.|    ..-.+.......+..++++.+.-|-. .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            235666666662  34445555543    34799999855411 1111    01112233566777888888887776 6


Q ss_pred             CCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345          137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus       137 ~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +   +||+||+.-|||+. ++.+.++||+.+....
T Consensus       187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             C---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            6   99999999999999 7799999999887654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=4.9e-07  Score=84.04  Aligned_cols=161  Identities=17%  Similarity=0.214  Sum_probs=99.7

Q ss_pred             ccccccHHHHHHHhcC---------CC--CCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHH-------------
Q 041345            4 DLKIFDFQTIAAATDN---------FS--PGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV-------------   59 (340)
Q Consensus         4 ~~~~~~~~~i~~~~~~---------y~--~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------------   59 (340)
                      +...|+++++...-+.         |.  -.+.||.-+.|.|++|+.++|+.||||+-+..-.....             
T Consensus       136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l  215 (538)
T KOG1235|consen  136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVL  215 (538)
T ss_pred             cCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHH
Confidence            4566777776655432         21  13578999999999999999999999998543211100             


Q ss_pred             ------------------------HHHHHHHHHHcC----CCCc---eeeeeeEE-eeCCeeEEEEeccCCCChhhHhhc
Q 041345           60 ------------------------EFKNEAKLIAKL----QHTN---LVRLLGCS-LQKGERLLVYEYLPNKSLDFFIFD  107 (340)
Q Consensus        60 ------------------------~~~~e~~~l~~l----~h~~---i~~~~~~~-~~~~~~~iv~e~~~~~~L~~~l~~  107 (340)
                                              .|.+|++-..++    .|-+   -+.+-.++ .-....+++||||+|..+.+.-.-
T Consensus       216 ~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i  295 (538)
T KOG1235|consen  216 QKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI  295 (538)
T ss_pred             HHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH
Confidence                                    133444433333    3444   11222222 223467999999999988777432


Q ss_pred             cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC----CCCCeeEeccccccccc
Q 041345          108 SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD----DQMNPKISDFGMARTFG  171 (340)
Q Consensus       108 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~----~~~~~~l~Dfg~~~~~~  171 (340)
                      ..  ..++...+..-+.+...  ..+=..|   ++|+|=.|.||++.    .++.+.+.|||+.....
T Consensus       296 ~~--~gi~~~~i~~~l~~~~~--~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  296 DK--RGISPHDILNKLVEAYL--EQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HH--cCCCHHHHHHHHHHHHH--HHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            22  12555544433333321  1222335   99999999999998    46789999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.54  E-value=1.2e-06  Score=74.18  Aligned_cols=77  Identities=23%  Similarity=0.326  Sum_probs=54.4

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCC--ceeeeeeEEe---eCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT--NLVRLLGCSL---QKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~iv~e~~~~   98 (340)
                      +.|+.|..+.||.+...+ +.+++|.....  .....+.+|..+++.+...  .+.+++....   .....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568999999999998866 69999987544  3455677888888877422  3445555332   23346899999999


Q ss_pred             CChhh
Q 041345           99 KSLDF  103 (340)
Q Consensus        99 ~~L~~  103 (340)
                      ..+..
T Consensus        80 ~~~~~   84 (239)
T PF01636_consen   80 RPLDD   84 (239)
T ss_dssp             EEHHH
T ss_pred             ccccc
Confidence            88777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.51  E-value=2e-06  Score=73.50  Aligned_cols=76  Identities=16%  Similarity=0.211  Sum_probs=52.5

Q ss_pred             cccccCC-eeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEeccCCCChh
Q 041345           25 RLGQGGF-GPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYEYLPNKSLD  102 (340)
Q Consensus        25 ~Lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~  102 (340)
                      .|..|.+ +.||+.... +..+++|......   ...+.+|+.+++.+. +--+.+++++....+..++||++++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3455555 788999653 4788889875443   335667888888773 444556777666656678999999998776


Q ss_pred             hH
Q 041345          103 FF  104 (340)
Q Consensus       103 ~~  104 (340)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            44

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.34  E-value=1.8e-05  Score=64.73  Aligned_cols=128  Identities=19%  Similarity=0.231  Sum_probs=88.9

Q ss_pred             CCcccccCCeeEEEEEECCCCEEEEEEccCCC----------------hhcHHHHHHHHHHHHcCC------CCceeeee
Q 041345           23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS----------------GQGIVEFKNEAKLIAKLQ------HTNLVRLL   80 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~   80 (340)
                      ...||+|+.-.||.  ++++...+||+.....                .....+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999985  3566778899886554                122345556666555544      88999999


Q ss_pred             eEEeeCCeeEEEEeccCC------CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC
Q 041345           81 GCSLQKGERLLVYEYLPN------KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        81 ~~~~~~~~~~iv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~  154 (340)
                      |+..++....+|+|.+.+      -+|.+++..    +.++. ...+.   +-+-..+|-.++   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999888999988643      267777732    22444 33333   334456777777   99999999999996


Q ss_pred             CCC----CeeEec
Q 041345          155 DQM----NPKISD  163 (340)
Q Consensus       155 ~~~----~~~l~D  163 (340)
                      .+.    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            332    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.31  E-value=2.4e-05  Score=63.75  Aligned_cols=105  Identities=24%  Similarity=0.182  Sum_probs=81.1

Q ss_pred             HHHHHHHHcCCC-CceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 041345           62 KNEAKLIAKLQH-TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR  140 (340)
Q Consensus        62 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~  140 (340)
                      .+|..+++.+++ +++.+++|+|    ..+++.||.+.+++......-..-...++..+.+++.++++.+.+++..-...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888865 6999999998    34788999886654321000001112689999999999999999999865556


Q ss_pred             eeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345          141 VIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus       141 i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +.-+|++++|+-+++++++|++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.30  E-value=1e-07  Score=88.25  Aligned_cols=186  Identities=16%  Similarity=0.127  Sum_probs=130.5

Q ss_pred             CCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc-eeeeeeEEeeCCeeEEEEeccC
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-LVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      -|...+-+++|+++.+++.+....+....+.+...     ....-++++|.+++||| .+..++-+..+...++.++++.
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            34444668899999999987655555556655433     23456789999999999 6666665566677899999997


Q ss_pred             CC-ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           98 NK-SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        98 ~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      .+ +-.....  ...-.+..-+...++..-+++++++|+.-   =+|+|    ||+..+ +..+..||+....+....  
T Consensus       318 ~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  318 TGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             CCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--
Confidence            77 2211110  11112344445566677778899999864   48888    666655 578999999887654221  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~  222 (340)
                       ..+...+++.|+|||......+..+.|+|++|.-..++.-|-+|-
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence             234466899999999999999999999999998777777666653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.29  E-value=6.4e-06  Score=64.84  Aligned_cols=129  Identities=22%  Similarity=0.307  Sum_probs=89.1

Q ss_pred             CCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceee-eeeEEeeCCeeEEEEeccCCC
Q 041345           21 SPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR-LLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +..+.|++|.+|.||++.+ .|..+|+|+-...++  ...+..|++++..+.--++.+ ++.+.    .-++.|||++|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            3456899999999999988 556889998755443  446788999888886554443 33332    234569999988


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC-CCCeEeCCCCCeeEeccccccc
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK-ASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk-~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      .|.+.....      +-..    +..+++...-|...|   |-|+.|+ |...++.+++.+.|+||..|..
T Consensus        98 ~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887665211      1222    234556666777778   9999997 4555555555999999998874

>PLN02876 acyl-CoA dehydrogenase

Probab=98.28  E-value=1.2e-05  Score=80.47  Aligned_cols=79  Identities=16%  Similarity=0.341  Sum_probs=56.1

Q ss_pred             CCcccccCCeeEEEEEECCC---CEEEEEEccCCC-hhcHHHHHHHHHHHHcCC-CCce--eeeeeEEeeC---CeeEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLDG---QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQ-HTNL--VRLLGCSLQK---GERLLV   92 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~iv   92 (340)
                      .+.|+.|.++.+|+....++   ..+++|+..... ......+.+|+.+++.+. |.++  .+++.++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56788999999999876553   467888764332 123456789999999885 6654  6677766553   356899


Q ss_pred             EeccCCCCh
Q 041345           93 YEYLPNKSL  101 (340)
Q Consensus        93 ~e~~~~~~L  101 (340)
                      ||++++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988654

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.19  E-value=2.1e-05  Score=63.93  Aligned_cols=126  Identities=27%  Similarity=0.419  Sum_probs=87.5

Q ss_pred             hcCCCCCCcccccCC-eeEEEEEECCCCEEEEEEccC---CCh------------------hcHHHHHHHHHHHHcC---
Q 041345           17 TDNFSPGNRLGQGGF-GPVYKGKLLDGQEIAIKRLSK---SSG------------------QGIVEFKNEAKLIAKL---   71 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l---   71 (340)
                      +.+++..+.||.|.. |.||+++. +|+.+|+|++..   ...                  ....-|..|-.+..++   
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            378899999999999 99999988 778999999311   100                  0112356676666666   


Q ss_pred             CCCce--eeeeeEEeeC------------------CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHH
Q 041345           72 QHTNL--VRLLGCSLQK------------------GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL  131 (340)
Q Consensus        72 ~h~~i--~~~~~~~~~~------------------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~  131 (340)
                      .+.++  ++++||..-.                  ..+.||.||.+...            .+....    +.+|..-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            34455  8999987422                  12457888775532            123333    345666678


Q ss_pred             HHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345          132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus       132 ~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .+|..|   |+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            899999   999999999976     4589999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=2.2e-05  Score=66.70  Aligned_cols=73  Identities=15%  Similarity=0.264  Sum_probs=44.3

Q ss_pred             CcccccCCe-eEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCC---ceeeeeeEEeeC---CeeEEEEecc
Q 041345           24 NRLGQGGFG-PVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT---NLVRLLGCSLQK---GERLLVYEYL   96 (340)
Q Consensus        24 ~~Lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~iv~e~~   96 (340)
                      ..++.|+.. .||..    +..+++|..+..  .....+.+|...++.+...   -+..+++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467766666 58876    245777875432  2344678899988877421   233333333222   1347899999


Q ss_pred             CCCChh
Q 041345           97 PNKSLD  102 (340)
Q Consensus        97 ~~~~L~  102 (340)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.16  E-value=2.6e-05  Score=66.19  Aligned_cols=73  Identities=16%  Similarity=0.278  Sum_probs=48.1

Q ss_pred             CcccccCCeeEEEEEECC--CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc-eeeeeeEEeeCCeeEEEEeccCCCC
Q 041345           24 NRLGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-LVRLLGCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~iv~e~~~~~~  100 (340)
                      +.|..|-.+.+|++...+  ++.+++|....... ......+|+.+++.+...+ ..+++..+.    -.++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467889999999997654  67899997754322 2223457888888874333 334443322    247999998876


Q ss_pred             h
Q 041345          101 L  101 (340)
Q Consensus       101 L  101 (340)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            6

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.16  E-value=1.5e-05  Score=79.12  Aligned_cols=199  Identities=18%  Similarity=0.192  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE----EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHH
Q 041345           59 VEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH  134 (340)
Q Consensus        59 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  134 (340)
                      .....|+..+....|+|++.++.|........    +..++|...++...+.   .-..++......+..++.+|++++|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence            33455777888889999999999877654333    3457777777777763   3345888899999999999999999


Q ss_pred             hCCCCceeecCCCCC---CeEeCCCCCeeEe--cccccccccCcccccccccccccCCCCChhhhccCCCCc--cCceeh
Q 041345          135 KYSRLRVIHRDLKAS---NILLDDQMNPKIS--DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM--KSDVYS  207 (340)
Q Consensus       135 ~~~~~~i~H~dlk~~---Nilv~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Dvws  207 (340)
                      +..   +.|.-|..+   +.-++..+.+..+  ||+.+..+.+....   .....+..+.+||.........  ..|+|+
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence            986   666656555   4444556666666  88888776533221   1122345677888765554443  479999


Q ss_pred             hhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041345          208 FGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV  287 (340)
Q Consensus       208 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  287 (340)
                      +|..+..+..|..+......                  ...+++        ......+.+....|+..++++|+++.++
T Consensus       378 lgll~~~~~~~~~i~~~~~~------------------~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAV------------------PVSLLD--------VLSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHhhhhhcCcccccccc------------------hhhhhc--------cccchhhhhhhhhhcchhhhhccchhhh
Confidence            99999999988765421100                  000111        1111156677788999999999999999


Q ss_pred             HHHhh
Q 041345          288 ASMLT  292 (340)
Q Consensus       288 l~~L~  292 (340)
                      +...-
T Consensus       432 l~~~f  436 (1351)
T KOG1035|consen  432 LTHPF  436 (1351)
T ss_pred             hhchh
Confidence            98653

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.15  E-value=2e-05  Score=67.82  Aligned_cols=139  Identities=17%  Similarity=0.152  Sum_probs=78.0

Q ss_pred             cccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCce-eeeeeEEeeCCeeEEEEeccCCCChhh
Q 041345           25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-VRLLGCSLQKGERLLVYEYLPNKSLDF  103 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~~~L~~  103 (340)
                      .+..|-.+.+|+... +++.+++|..............+|..+++.+....+ .+++...  .  -++|++|++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence            456788899999874 577888997644322211235678888888853333 3333332  2  368999998876542


Q ss_pred             H-----------------hhccCc-cccCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCceeecCCCCCC
Q 041345          104 F-----------------IFDSSK-KELLDWKK-RFNIIEGI---------VQGLLYLHKY-----SRLRVIHRDLKASN  150 (340)
Q Consensus       104 ~-----------------l~~~~~-~~~~~~~~-~~~i~~qi---------~~~l~~LH~~-----~~~~i~H~dlk~~N  150 (340)
                      .                 ++.... ..+++... +..+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 111000 11122211 11111111         1111212111     02248999999999


Q ss_pred             eEeCCCCCeeEeccccccc
Q 041345          151 ILLDDQMNPKISDFGMART  169 (340)
Q Consensus       151 ilv~~~~~~~l~Dfg~~~~  169 (340)
                      |++++++ +.|.||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999987754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=98.12  E-value=9.8e-05  Score=65.74  Aligned_cols=158  Identities=17%  Similarity=0.207  Sum_probs=83.5

Q ss_pred             ccHHHHHHHhcCCCCC-----CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-----CCCcee
Q 041345            8 FDFQTIAAATDNFSPG-----NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLV   77 (340)
Q Consensus         8 ~~~~~i~~~~~~y~~~-----~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~   77 (340)
                      .+.+++......|.++     +.|+.|....+|.....+| .+++|++....   ......+..+++.+     ..|.++
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence            3456677766778662     4566777789999976554 68889875222   22333344444444     233333


Q ss_pred             eee---eEEeeCCeeEEEEeccCCCChhh-----------Hh---hccCcc------ccCC---HHHHH-----------
Q 041345           78 RLL---GCSLQKGERLLVYEYLPNKSLDF-----------FI---FDSSKK------ELLD---WKKRF-----------  120 (340)
Q Consensus        78 ~~~---~~~~~~~~~~iv~e~~~~~~L~~-----------~l---~~~~~~------~~~~---~~~~~-----------  120 (340)
                      +..   .+....+..++++++++|..+..           .+   +.....      ....   +....           
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            211   01223456789999998874321           11   100000      0001   00100           


Q ss_pred             -HHHHH-HHHHHHHHHhC----CCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          121 -NIIEG-IVQGLLYLHKY----SRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       121 -~i~~q-i~~~l~~LH~~----~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                       ..+.+ +...+..+...    -..+++|+|+.+.||+++++...-|.||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             01111 11122232211    123599999999999999765568999988753

>PRK10593 hypothetical protein; Provisional

Probab=98.12  E-value=7.6e-05  Score=65.64  Aligned_cols=76  Identities=14%  Similarity=0.094  Sum_probs=54.2

Q ss_pred             CCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-C--CceeeeeeEEeeC---CeeEEEEecc
Q 041345           23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-H--TNLVRLLGCSLQK---GERLLVYEYL   96 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~iv~e~~   96 (340)
                      .+.||.|..+.||.....++ .+++|..+...  ....+..|...++.+. +  -.+.++++++..+   +..++|||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            45799999999999976455 46777753321  2347788999888874 2  3577777776543   5589999999


Q ss_pred             CCCCh
Q 041345           97 PNKSL  101 (340)
Q Consensus        97 ~~~~L  101 (340)
                      ++.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.11  E-value=6e-05  Score=66.34  Aligned_cols=154  Identities=18%  Similarity=0.162  Sum_probs=86.6

Q ss_pred             HHHHHhcCCCC-----CCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCC--ceeeeeeE--
Q 041345           12 TIAAATDNFSP-----GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT--NLVRLLGC--   82 (340)
Q Consensus        12 ~i~~~~~~y~~-----~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~--   82 (340)
                      ++....++|.+     .+.|..|....+|+.... +..+++|.....   .......|+.+++.+.+.  .+.+++..  
T Consensus         3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~   78 (296)
T cd05153           3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRD   78 (296)
T ss_pred             HHHHHHHHcCCCchhheecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence            45555556664     345777888899998764 457888987542   233556677777776322  23343331  


Q ss_pred             ----EeeCCeeEEEEeccCCCChhh----Hh----------hccCcc--------ccCCHHHH----------HHHHHHH
Q 041345           83 ----SLQKGERLLVYEYLPNKSLDF----FI----------FDSSKK--------ELLDWKKR----------FNIIEGI  126 (340)
Q Consensus        83 ----~~~~~~~~iv~e~~~~~~L~~----~l----------~~~~~~--------~~~~~~~~----------~~i~~qi  126 (340)
                          ....+..++++++++|..+..    ..          +.....        ....+...          ......+
T Consensus        79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  158 (296)
T cd05153          79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL  158 (296)
T ss_pred             CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence                122345689999998876532    00          000000        00000000          0011112


Q ss_pred             HHHHHHHHhC----CCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          127 VQGLLYLHKY----SRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       127 ~~~l~~LH~~----~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ..++.++...    -...++|+|+.|.||++++++.+.|.||+.+..
T Consensus       159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            2334444431    123499999999999999876678999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.99  E-value=0.00014  Score=66.01  Aligned_cols=76  Identities=13%  Similarity=0.191  Sum_probs=52.4

Q ss_pred             CCcccccCCeeEEEEEECCC-CEEEEEEccCC-----C--hhcHHHHHHHHHHHHcCC---CCceeeeeeEEeeCCeeEE
Q 041345           23 GNRLGQGGFGPVYKGKLLDG-QEIAIKRLSKS-----S--GQGIVEFKNEAKLIAKLQ---HTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~i   91 (340)
                      .+.||.|.++.||++...+| +.++||.-...     .  +-.......|.+.|+.+.   -.++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35789999999999998776 48999975321     1  123455667788887762   2356666665  3455789


Q ss_pred             EEeccCCCC
Q 041345           92 VYEYLPNKS  100 (340)
Q Consensus        92 v~e~~~~~~  100 (340)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.87  E-value=3.2e-05  Score=66.84  Aligned_cols=148  Identities=16%  Similarity=0.217  Sum_probs=99.8

Q ss_pred             cccHHHHHHHhcC---CCCCCcccccCCeeEEEEEECCCCEEEEEEccCC-----------------ChhcH-----HHH
Q 041345            7 IFDFQTIAAATDN---FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS-----------------SGQGI-----VEF   61 (340)
Q Consensus         7 ~~~~~~i~~~~~~---y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~-----------------~~~~~-----~~~   61 (340)
                      .++|--|+....+   +.++..||-|.-+.||.+-+..|++.++|.-+-.                 ...++     -..
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            3455556655544   7889999999999999999888999988853211                 00001     123


Q ss_pred             HHHHHHHHcCC-CCc-eeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 041345           62 KNEAKLIAKLQ-HTN-LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL  139 (340)
Q Consensus        62 ~~e~~~l~~l~-h~~-i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~  139 (340)
                      .+|+..|+.+. |.. +.+.+++    +.-++|||++.+..|...-.      ..+..+   +...+...+--|-.+|  
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G--  222 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG--  222 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC--
Confidence            46777777773 332 3444443    34589999998877654431      122233   3344445556677777  


Q ss_pred             ceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345          140 RVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus       140 ~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                       ++|||.+--||++.+++.++++||..+...
T Consensus       223 -lIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  223 -LIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             -ceecccchheeEEecCCCEEEeechHhhcc
Confidence             999999999999999999999999765543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.85  E-value=0.00082  Score=59.51  Aligned_cols=157  Identities=19%  Similarity=0.149  Sum_probs=86.2

Q ss_pred             cHHHHHHHhcCCCCC-----CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCC--ceeeeee
Q 041345            9 DFQTIAAATDNFSPG-----NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT--NLVRLLG   81 (340)
Q Consensus         9 ~~~~i~~~~~~y~~~-----~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~   81 (340)
                      +.+.|....++|.+.     +.++.|....+|.+...+ ..+++|.......  ......+..++..+...  .+.+++.
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~-~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~   84 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDV-GRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVK   84 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCC-CcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence            346666666677663     457777778999987644 4688897744321  22344556666665321  1333333


Q ss_pred             E------EeeCCeeEEEEeccCCCChhhH--------------hhccCcc--cc----CCHH---HHH------------
Q 041345           82 C------SLQKGERLLVYEYLPNKSLDFF--------------IFDSSKK--EL----LDWK---KRF------------  120 (340)
Q Consensus        82 ~------~~~~~~~~iv~e~~~~~~L~~~--------------l~~~~~~--~~----~~~~---~~~------------  120 (340)
                      .      ....+..+++++|++|..+...              ++.....  ..    ....   ...            
T Consensus        85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~  164 (307)
T TIGR00938        85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA  164 (307)
T ss_pred             CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence            1      1223457899999988543210              0110000  00    0000   000            


Q ss_pred             HHHHHHHHHHHHHHh----CCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345          121 NIIEGIVQGLLYLHK----YSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus       121 ~i~~qi~~~l~~LH~----~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .....+...++++..    .-...++|+|+++.||++++++.+.|.||+.+.
T Consensus       165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            001112334444432    113459999999999999988767899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.76  E-value=0.00021  Score=63.13  Aligned_cols=74  Identities=22%  Similarity=0.354  Sum_probs=48.1

Q ss_pred             CcccccCCeeEEEEEECC-------CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc-eeeeeeEEeeCCeeEEEEec
Q 041345           24 NRLGQGGFGPVYKGKLLD-------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-LVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.|..|-...+|++...+       ++.+++|+..... .......+|..++..+...+ ..+++.++. +   .+|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            456778888999997654       4789999875443 22335577888888774322 334444442 2   368999


Q ss_pred             cCCCChh
Q 041345           96 LPNKSLD  102 (340)
Q Consensus        96 ~~~~~L~  102 (340)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            8887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.59  E-value=0.00082  Score=60.40  Aligned_cols=141  Identities=18%  Similarity=0.249  Sum_probs=80.5

Q ss_pred             CcccccCCeeEEEEEECC-----CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCce-eeeeeEEeeCCeeEEEEeccC
Q 041345           24 NRLGQGGFGPVYKGKLLD-----GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-VRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      ..|..|-...+|++...+     ++.+++|........ .-...+|..+++.+...++ .++++.+..+    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345568899999987533     367899988554332 2234678888888743333 3455554332    5788887


Q ss_pred             CCChhhH-----------------hhccC--c-cccCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 041345           98 NKSLDFF-----------------IFDSS--K-KELLDWKKRFNIIEGI-----------------VQGLLYL----HK-  135 (340)
Q Consensus        98 ~~~L~~~-----------------l~~~~--~-~~~~~~~~~~~i~~qi-----------------~~~l~~L----H~-  135 (340)
                      +.++...                 ++...  . ........+..++.++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7666421                 01100  0 0011122333333222                 1111122    11 


Q ss_pred             CCCCceeecCCCCCCeEeCC-CCCeeEeccccccc
Q 041345          136 YSRLRVIHRDLKASNILLDD-QMNPKISDFGMART  169 (340)
Q Consensus       136 ~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~  169 (340)
                      .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            11235899999999999986 46799999987653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.57  E-value=0.0012  Score=58.06  Aligned_cols=140  Identities=15%  Similarity=0.156  Sum_probs=85.9

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccC--CChhcHHHHHHHHHHHHcCCC--CceeeeeeEEeeCC--eeEEEE
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQH--TNLVRLLGCSLQKG--ERLLVY   93 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~iv~   93 (340)
                      ..+.+.+..|....+|..... ++.+++. .+.  ..........+|+..++.+.-  --+...+++|.++.  ..+.||
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            344455555655566666543 7788888 332  233445566778888887632  23334455555554  568999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHH-HHHHHHHHHHHh-------------------------------------
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNII-EGIVQGLLYLHK-------------------------------------  135 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~-~qi~~~l~~LH~-------------------------------------  135 (340)
                      +++.|..+.+....        .....+.+ ..++..|+.||+                                     
T Consensus       105 ~~veGe~~~~~~~~--------~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173         105 EWVEGEVVWSALPP--------ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             EEecceeccCcCCc--------ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence            99988533222211        00011222 255555666664                                     


Q ss_pred             -------------C-----CCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          136 -------------Y-----SRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       136 -------------~-----~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                                   +     +...++|||+++.|++++.++-+-+.||+++..
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                         1     124599999999999999988899999999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.48  E-value=0.0018  Score=56.26  Aligned_cols=30  Identities=27%  Similarity=0.535  Sum_probs=25.0

Q ss_pred             ceeecCCCCCCeEeCCCCC-eeEeccccccc
Q 041345          140 RVIHRDLKASNILLDDQMN-PKISDFGMART  169 (340)
Q Consensus       140 ~i~H~dlk~~Nilv~~~~~-~~l~Dfg~~~~  169 (340)
                      .++|+|+++.||++++++. +-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 45999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.43  E-value=0.002  Score=56.96  Aligned_cols=143  Identities=22%  Similarity=0.187  Sum_probs=90.4

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC------------------------h--hcHHHHHHHHHHHHcCCC
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS------------------------G--QGIVEFKNEAKLIAKLQH   73 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~--~~~~~~~~e~~~l~~l~h   73 (340)
                      -.+-..|+.|--+.||.|...+|..+|||+++...                        +  -..-....|+.-|.++..
T Consensus       146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            34567789999999999998889999999873210                        0  001113456666776644


Q ss_pred             CceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        74 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ..|.-.--+..  ..-++||+++.....-.-.   -..-.++...+..+-.|++.-+.-|-+..  .+||.||.--|+|+
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            33221111111  1237999998533221111   12223666677777777777777666555  59999999999999


Q ss_pred             CCCCCeeEecccccccc
Q 041345          154 DDQMNPKISDFGMARTF  170 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~  170 (340)
                      -++ .+.++|.+.+...
T Consensus       299 hdG-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 HDG-KLYIIDVSQSVEH  314 (520)
T ss_pred             ECC-EEEEEEccccccC
Confidence            654 8999998766543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.35  E-value=0.0018  Score=56.44  Aligned_cols=72  Identities=19%  Similarity=0.301  Sum_probs=46.1

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC---CCCceeeeeeEEeeCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~iv~e~~~~~   99 (340)
                      +.++.|..+.+|+.. .+++.+.||+-..   .....+..|+.-|+.+   .--.+.+++++....+..+++|||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            468889999999987 5788899998752   2234667788877777   2446778888887777779999998776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.26  E-value=0.0069  Score=53.67  Aligned_cols=31  Identities=23%  Similarity=0.292  Sum_probs=27.6

Q ss_pred             CceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          139 LRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ..++|+|+.++|+++++++.+-++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3599999999999999998999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.17  E-value=0.007  Score=55.04  Aligned_cols=73  Identities=15%  Similarity=0.082  Sum_probs=48.6

Q ss_pred             CCcccccCCeeEEEEEECCCCEEEEEEccCC----C---hhcHHHHHHHHHHHHcCC---CCceeeeeeEEeeCCeeEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS----S---GQGIVEFKNEAKLIAKLQ---HTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .+.||.|....||+... +++.++||.-...    .   +-.......|...|+.+.   -..+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            45789999999999987 4567999976411    1   112333445566666653   246777777765  446888


Q ss_pred             EeccCC
Q 041345           93 YEYLPN   98 (340)
Q Consensus        93 ~e~~~~   98 (340)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.15  E-value=0.0069  Score=54.10  Aligned_cols=73  Identities=15%  Similarity=0.183  Sum_probs=46.8

Q ss_pred             cccccCCeeEEEEEECCC-CEEEEEEccC-------CChhcHHHHHHHHHHHHcCC--CC-ceeeeeeEEeeCCeeEEEE
Q 041345           25 RLGQGGFGPVYKGKLLDG-QEIAIKRLSK-------SSGQGIVEFKNEAKLIAKLQ--HT-NLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+|.|....||++...+| +.++||.-..       ..+-...+..-|...|+...  .| .+.+++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999987654 5799996421       11233444556777776652  34 3444443  3445567999


Q ss_pred             eccCCC
Q 041345           94 EYLPNK   99 (340)
Q Consensus        94 e~~~~~   99 (340)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.10  E-value=0.0054  Score=54.85  Aligned_cols=141  Identities=16%  Similarity=0.268  Sum_probs=78.3

Q ss_pred             CcccccCCeeEEEEEECC----CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCce-eeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-VRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.|..|-...+|+....+    +..|++|+...... ..-...+|..+++.+..-++ .++++++.  +.  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence            455568888999986533    23789998755432 23334678888888854444 34555442  22  58888877


Q ss_pred             CChhhH-------h----------hccC-c--cccCCHHHHHHHHHHH----------------------HHHHHH---H
Q 041345           99 KSLDFF-------I----------FDSS-K--KELLDWKKRFNIIEGI----------------------VQGLLY---L  133 (340)
Q Consensus        99 ~~L~~~-------l----------~~~~-~--~~~~~~~~~~~i~~qi----------------------~~~l~~---L  133 (340)
                      .++..-       +          +... .  ..+.-+..+..+..++                      ..-+..   +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            655221       0          1100 0  0011122222222221                      111111   1


Q ss_pred             H-hCC-CCceeecCCCCCCeEeCC-CCCeeEeccccccc
Q 041345          134 H-KYS-RLRVIHRDLKASNILLDD-QMNPKISDFGMART  169 (340)
Q Consensus       134 H-~~~-~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~  169 (340)
                      . ..+ ...++|+|+.+.||++++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 111 224899999999999974 56899999987753

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.06  E-value=0.00095  Score=40.61  Aligned_cols=44  Identities=48%  Similarity=0.753  Sum_probs=34.6

Q ss_pred             CCCCCCCCCCceeeecCCCCCCCccccccc--cccccccceeeccccC
Q 041345          295 TMALPTPRQPAFFINISSDYEEPEVTEIKL--EVCSVNDVTISRMEAR  340 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  340 (340)
                      ...||.|.+|.|+..-......  ++..+.  +.+|.|++|++-|++|
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~--sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETD--SSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcC--CCcccccCCCCCeeeEEEEeEecC
Confidence            3578999999999887655444  334444  8999999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.94  E-value=0.0036  Score=52.13  Aligned_cols=30  Identities=33%  Similarity=0.464  Sum_probs=21.2

Q ss_pred             ceeecCCCCCCeEe-CCCCCeeEeccccccc
Q 041345          140 RVIHRDLKASNILL-DDQMNPKISDFGMART  169 (340)
Q Consensus       140 ~i~H~dlk~~Nilv-~~~~~~~l~Dfg~~~~  169 (340)
                      .++|+||.+.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 7888999999987753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.84  E-value=0.0065  Score=54.96  Aligned_cols=74  Identities=11%  Similarity=0.114  Sum_probs=48.5

Q ss_pred             CCcccccCCeeEEEEEECC-CCEEEEEEccC------CChhcHHHHHHHHHHHHcCC--CC-ceeeeeeEEeeCCeeEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSK------SSGQGIVEFKNEAKLIAKLQ--HT-NLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~iv   92 (340)
                      .+.||.|.-.-||++...+ ++.|+||.-..      ..+-...+..-|.++|+...  .| .+.+++.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            4578999999999998743 56799996421      12333455566777777662  45 3444544  344556788


Q ss_pred             EeccCC
Q 041345           93 YEYLPN   98 (340)
Q Consensus        93 ~e~~~~   98 (340)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.66  E-value=0.075  Score=46.99  Aligned_cols=29  Identities=31%  Similarity=0.394  Sum_probs=25.0

Q ss_pred             CceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345          139 LRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            35999999999999987 578999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.66  E-value=0.00097  Score=61.34  Aligned_cols=49  Identities=24%  Similarity=0.292  Sum_probs=38.3

Q ss_pred             HHHHHHHHHHHHcCCCCceeeeeeEEeeC-CeeEEEEeccCCCChhhHhhc
Q 041345           58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQK-GERLLVYEYLPNKSLDFFIFD  107 (340)
Q Consensus        58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~  107 (340)
                      ..++...+.+++.+.|+|+...+++.... ....+|+|++ +.++++.+..
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            34667788999999999999999876543 3468899998 7788888754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.64  E-value=0.17  Score=45.16  Aligned_cols=95  Identities=15%  Similarity=0.106  Sum_probs=56.3

Q ss_pred             cccccHHHHHHHhcCCCCC--C--cccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC---CCcee
Q 041345            5 LKIFDFQTIAAATDNFSPG--N--RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ---HTNLV   77 (340)
Q Consensus         5 ~~~~~~~~i~~~~~~y~~~--~--~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~   77 (340)
                      ...++.+.+..+...+-+.  .  ..=.+.-..||.....+++.+++|+.+... ....++..|...+..+.   -| ++
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gip-v~   85 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIP-VV   85 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCC-CC
Confidence            4456667777777776442  1  111345677999987778889999875332 23445566777666552   22 22


Q ss_pred             eee---e--EEeeCCeeEEEEeccCCCCh
Q 041345           78 RLL---G--CSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        78 ~~~---~--~~~~~~~~~iv~e~~~~~~L  101 (340)
                      ...   |  ....++..+.++++++|...
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            211   1  12234567889999877643

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.63  E-value=0.012  Score=48.46  Aligned_cols=101  Identities=15%  Similarity=0.121  Sum_probs=63.2

Q ss_pred             EEEEEccCCChh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHH
Q 041345           45 IAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII  123 (340)
Q Consensus        45 vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~  123 (340)
                      ..+|+++..... ...-|.++..++.++.  .|+++..  .+...+.++.|+|-...            ......+    
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~------------i~~~N~i----  147 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK------------INFSNFI----  147 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc------------cchhHHH----
Confidence            445655443322 3345677777777653  4566552  24456789999983211            1111111    


Q ss_pred             HHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345          124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus       124 ~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      ..=+.+|.-.|+.+ ...+|||..|+|||.|..|-+||.|=+.
T Consensus       148 ~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  148 TAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence            11136677888532 3699999999999999999999999654

The function of this family is unknown.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.60  E-value=0.00014  Score=74.46  Aligned_cols=157  Identities=11%  Similarity=-0.052  Sum_probs=111.0

Q ss_pred             HHHHHHcCCCCceeeeeeEEee--CCeeEEEEeccCCCChhhHhhccCcc-ccCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 041345           64 EAKLIAKLQHTNLVRLLGCSLQ--KGERLLVYEYLPNKSLDFFIFDSSKK-ELLDWKKRFNIIEGIVQGLLYLHKYS--R  138 (340)
Q Consensus        64 e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--~  138 (340)
                      |...++...|+++.....-...  ....+.+++++..|.+...+..+..+ .+++..-+.....+......-+|+..  .
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            4444455678887765554332  23468899999999998888665443 33444444444444355555555544  3


Q ss_pred             CceeecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhC
Q 041345          139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISS  218 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg  218 (340)
                      ..-+|.++|+-|.++..+..++++++|+.+...  ..........+++.|+.|++...-.++.++|+|..|+.+|..-.|
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence            457999999999999999999999999988322  112223334567788999988777888889999999999999888


Q ss_pred             CCCC
Q 041345          219 KKNN  222 (340)
Q Consensus       219 ~~p~  222 (340)
                      ..+|
T Consensus      1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred             cHHH
Confidence            8776

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.39  E-value=0.08  Score=47.11  Aligned_cols=155  Identities=23%  Similarity=0.279  Sum_probs=83.5

Q ss_pred             HHHHHHhcCCCCCC-----cccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC---CCceee---e
Q 041345           11 QTIAAATDNFSPGN-----RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ---HTNLVR---L   79 (340)
Q Consensus        11 ~~i~~~~~~y~~~~-----~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~---~   79 (340)
                      .++..+...|.++-     .|.+ .-..||.....+|+. ++|+....  ....++..|...++.+.   .+-.++   .
T Consensus        14 ~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~   89 (331)
T COG2334          14 DEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSL   89 (331)
T ss_pred             HHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            44444444444432     2333 567889998766666 88988665  33445666777777762   121122   1


Q ss_pred             ee----EEeeCCeeEEEEeccCCCChhh-Hh--------------hcc----C--cc---ccCCHH----H---------
Q 041345           80 LG----CSLQKGERLLVYEYLPNKSLDF-FI--------------FDS----S--KK---ELLDWK----K---------  118 (340)
Q Consensus        80 ~~----~~~~~~~~~iv~e~~~~~~L~~-~l--------------~~~----~--~~---~~~~~~----~---------  118 (340)
                      -|    ....+....-+++|++|..+.. ..              +..    .  ..   ....+.    .         
T Consensus        90 dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~  169 (331)
T COG2334          90 DGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVE  169 (331)
T ss_pred             CcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccC
Confidence            11    1111136778999999887762 11              000    0  00   011111    0         


Q ss_pred             HHHHHHHHHHHHHHHHhC----CC-Cc--eeecCCCCCCeEeCCCCC-eeEeccccccc
Q 041345          119 RFNIIEGIVQGLLYLHKY----SR-LR--VIHRDLKASNILLDDQMN-PKISDFGMART  169 (340)
Q Consensus       119 ~~~i~~qi~~~l~~LH~~----~~-~~--i~H~dlk~~Nilv~~~~~-~~l~Dfg~~~~  169 (340)
                      -.....++...+..+...    -. .+  +||+|+.|.||+++++.. +-+.||+.+..
T Consensus       170 ~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         170 PEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             chhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            001122222333333321    11 22  899999999999998875 88999997653

>PRK06148 hypothetical protein; Provisional

Probab=96.34  E-value=0.062  Score=55.40  Aligned_cols=94  Identities=20%  Similarity=0.265  Sum_probs=52.6

Q ss_pred             cccHHHHHHH-hcCCCCC---CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-------CCCc
Q 041345            7 IFDFQTIAAA-TDNFSPG---NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-------QHTN   75 (340)
Q Consensus         7 ~~~~~~i~~~-~~~y~~~---~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~   75 (340)
                      .++.+++... .+.|-+.   +.|+ |....+|+....+++.+++|+.+.....  .....|...+..+       ..|.
T Consensus        10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~   86 (1013)
T PRK06148         10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPR   86 (1013)
T ss_pred             CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCe
Confidence            3445554333 3556553   3454 5678889998777889999998654322  2233344444433       3344


Q ss_pred             eeeeee-----EEee-CC--eeEEEEeccCCCChhh
Q 041345           76 LVRLLG-----CSLQ-KG--ERLLVYEYLPNKSLDF  103 (340)
Q Consensus        76 i~~~~~-----~~~~-~~--~~~iv~e~~~~~~L~~  103 (340)
                      +++..+     .... ..  ..+.+++|++|..+.+
T Consensus        87 ~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~  122 (1013)
T PRK06148         87 LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE  122 (1013)
T ss_pred             eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence            443221     1111 11  4677899999977654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.32  E-value=0.049  Score=45.31  Aligned_cols=75  Identities=19%  Similarity=0.327  Sum_probs=53.7

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC---CCCceeeeeeEEeeCCeeEEEEeccCCCC
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~iv~e~~~~~~  100 (340)
                      +.+..|.-...|...+ +..++.+|+-.   ......|..|+.-|+.+   +.-.+.+++.+.......|+|++|++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            4566677777777765 56788889643   23344667777766666   34678888888888889999999998876


Q ss_pred             hh
Q 041345          101 LD  102 (340)
Q Consensus       101 L~  102 (340)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            64

>PTZ00384 choline kinase; Provisional

Probab=96.05  E-value=0.06  Score=49.07  Aligned_cols=74  Identities=18%  Similarity=0.362  Sum_probs=44.7

Q ss_pred             CcccccCCeeEEEEEECCC--CE-----EEEEEccCCChhcHHHHHHHHHHHHcCCCCce-eeeeeEEeeCCeeEEEEec
Q 041345           24 NRLGQGGFGPVYKGKLLDG--QE-----IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-VRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~   95 (340)
                      +.|..|-.+.+|++...++  ..     |.++..... ....-.-.+|+.+++.+...++ .++++.+.    -+++.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            4565688999999975433  22     444443222 2222234678888888864444 44555543    2689999


Q ss_pred             cCCCChh
Q 041345           96 LPNKSLD  102 (340)
Q Consensus        96 ~~~~~L~  102 (340)
                      ++|.++.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9887764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.81  E-value=0.089  Score=46.16  Aligned_cols=30  Identities=30%  Similarity=0.386  Sum_probs=24.1

Q ss_pred             CceeecCCCCCCeEeCCC--C---CeeEecccccc
Q 041345          139 LRVIHRDLKASNILLDDQ--M---NPKISDFGMAR  168 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~--~---~~~l~Dfg~~~  168 (340)
                      .-++|||+.++|||+..+  |   .+++.||-.+.
T Consensus       215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence            359999999999999654  3   58999997654

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	340
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-41
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-36
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-34
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-23
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-22
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-22
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-20
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-18
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
3soa_A	444	Full-Length Human Camkii Length = 444		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  204 bits (520), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 116/300 (38%), Positives = 174/300 (58%), Gaps = 11/300 (3%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQG-IVEFKN 63
           LK F  + +  A+DNFS  N LG+GGFG VYKG+L DG  +A+KRL +   QG  ++F+ 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNI 122
           E ++I+   H NL+RL G  +   ERLLVY Y+ N S+   + +  + +  LDW KR  I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
             G  +GL YLH +   ++IHRD+KA+NILLD++    + DFG+A+     +       +
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 203
Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-----LVGYA 237
            GT G+++PEY+  G  S K+DV+ +GV++LE+I+ ++    +D  R  N     L+ + 
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR---AFDLARLANDDDVMLLDWV 260
Query: 238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA 297
             L  E K   L+D  L  +   +EV + I V LLC Q    +RP MS+V  ML  D +A
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  201 bits (511), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 172/300 (57%), Gaps = 11/300 (3%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQG-IVEFKN 63
           LK F  + +  A+DNF   N LG+GGFG VYKG+L DG  +A+KRL +   QG  ++F+ 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNI 122
           E ++I+   H NL+RL G  +   ERLLVY Y+ N S+   + +  + +  LDW KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
             G  +GL YLH +   ++IHRD+KA+NILLD++    + DFG+A+     +       +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 195
Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-----LVGYA 237
            G  G+++PEY+  G  S K+DV+ +GV++LE+I+ ++    +D  R  N     L+ + 
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR---AFDLARLANDDDVMLLDWV 252
Query: 238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA 297
             L  E K   L+D  L  +   +EV + I V LLC Q    +RP MS+V  ML  D +A
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 161/274 (58%), Gaps = 6/274 (2%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
           AT+NF     +G G FG VYKG L DG ++A+KR +  S QGI EF+ E + ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQGLLYLH 134
           LV L+G   ++ E +L+Y+Y+ N +L   ++ S    + + W++R  I  G  +GL YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV-GTHGYMSPEY 193
             +   +IHRD+K+ NILLD+   PKI+DFG+++  G    + +   +V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLGYIDPEY 212
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
            + G ++ KSDVYSFGV++ E++ ++           +NL  +A +  N G+  +++D  
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           L +   P+ + +     + C+   + DRP+M DV
Sbjct: 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 97/274 (35%), Positives = 161/274 (58%), Gaps = 6/274 (2%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
           AT+NF     +G G FG VYKG L DG ++A+KR +  S QGI EF+ E + ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQGLLYLH 134
           LV L+G   ++ E +L+Y+Y+ N +L   ++ S    + + W++R  I  G  +GL YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV-GTHGYMSPEY 193
             +   +IHRD+K+ NILLD+   PKI+DFG+++  G    + +   +V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVVKGTLGYIDPEY 212
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
            + G ++ KSDVYSFGV++ E++ ++           +NL  +A +  N G+  +++D  
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           L +   P+ + +     + C+   + DRP+M DV
Sbjct: 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 106/304 (34%), Positives = 155/304 (50%), Gaps = 25/304 (8%)
Query: 8   FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
           F F  +   T+NF        GN++G+GGFG VYKG  ++   +A+K+L+     ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
             +F  E K++AK QH NLV LLG S    +  LVY Y+PN SL   +        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
            R  I +G   G+ +LH+      IHRD+K++NILLD+    KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH----LNL 233
             +RIVGT  YM+PE  + G ++ KSD+YSFGV++LEII+     G    + H    L L
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 244
Query: 234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
                    E    + ID  ++++ S   V     V   C+ +K   RP +  V  +L  
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 294 DTMA 297
            T +
Sbjct: 304 MTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 106/302 (35%), Positives = 153/302 (50%), Gaps = 21/302 (6%)
Query: 8   FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
           F F  +   T+NF        GN++G+GGFG VYKG  ++   +A+K+L+     ++ + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
             +F  E K++AK QH NLV LLG S    +  LVY Y+PN SL   +        L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
            R  I +G   G+ +LH+      IHRD+K++NILLD+    KISDFG+AR         
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVG 235
              RIVGT  YM+PE  + G ++ KSD+YSFGV++LEII+        D  R   L L  
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDI 240
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT 295
                  E    + ID  ++++ S   V     V   C+ +K   RP +  V  +L   T
Sbjct: 241 KEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299
Query: 296 MA 297
            +
Sbjct: 300 AS 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 106/302 (35%), Positives = 153/302 (50%), Gaps = 21/302 (6%)
Query: 8   FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
           F F  +   T+NF        GN++G+GGFG VYKG  ++   +A+K+L+     ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
             +F  E K++AK QH NLV LLG S    +  LVY Y+PN SL   +        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
            R  I +G   G+ +LH+      IHRD+K++NILLD+    KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVG 235
              RIVGT  YM+PE  + G ++ KSD+YSFGV++LEII+        D  R   L L  
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDI 246
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT 295
                  E    + ID  ++++ S   V     V   C+ +K   RP +  V  +L   T
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 296 MA 297
            +
Sbjct: 306 AS 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 149/302 (49%), Gaps = 21/302 (6%)
Query: 8   FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
           F F  +   T+NF        GN+ G+GGFG VYKG  ++   +A+K+L+     ++ + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
             +F  E K+ AK QH NLV LLG S    +  LVY Y PN SL   +        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
            R  I +G   G+ +LH+      IHRD+K++NILLD+    KISDFG+AR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVG 235
             +RIVGT  Y +PE  + G ++ KSD+YSFGV++LEII+        D  R   L L  
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDI 237
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT 295
                  E    + ID   +++ S   V     V   C+ +K   RP +  V  +L   T
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDADST-SVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXT 296
Query: 296 MA 297
            +
Sbjct: 297 AS 298

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 137/271 (50%), Gaps = 23/271 (8%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
            RLG G FG V+ G   +  ++A+K L K     +  F  EA L+  LQH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 84  LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
            ++    ++ EY+   SL DF   D   K LL   K  +    I +G+ Y+    R   I
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYI 132
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL+A+N+L+ + +  KI+DFG+AR    NE  A          + +PE +  G  ++K
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIK 191
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
           SDV+SFG+L+ EI++  K    Y    + +++       ++G  +  +     E+C PDE
Sbjct: 192 SDVWSFGILLYEIVTYGKIP--YPGRTNADVM----TALSQGYRMPRV-----ENC-PDE 239
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +   +    +C ++KA +RPT   + S+L +
Sbjct: 240 LYDIMK---MCWKEKAEERPTFDYLQSVLDD 267

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 118/214 (55%), Gaps = 6/214 (2%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++G G FG V++ +   G ++A+K L +     + + EF  E  ++ +L+H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             Q     +V EYL   SL   +  S  +E LD ++R ++   + +G+ YLH  +   ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDLK+ N+L+D +   K+ DFG++R      L +      GT  +M+PE + +   + K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKX--AAGTPEWMAPEVLRDEPSNEK 219
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY 236
           SDVYSFGV++ E+ + ++  G  +  + +  VG+
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 119/214 (55%), Gaps = 6/214 (2%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++G G FG V++ +   G ++A+K L +     + + EF  E  ++ +L+H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             Q     +V EYL   SL   +  S  +E LD ++R ++   + +G+ YLH  +   ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HR+LK+ N+L+D +   K+ DFG++R      L + +    GT  +M+PE + +   + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNEK 219
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY 236
           SDVYSFGV++ E+ + ++  G  +  + +  VG+
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LG G FG V+ G   +  ++A+K L K     +  F  EA L+  LQH  LVRL     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           ++    ++ E++   SL DF   D   K LL   K  +    I +G+ Y+    R   IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+N+L+ + +  KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIKS 191
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           +V+SFG+L+ EI++  K    Y    + +++    Q +   +          E+C PDE+
Sbjct: 192 NVWSFGILLYEIVTYGKIP--YPGRTNADVMSALSQGYRMPR---------MENC-PDEL 239
Query: 264 TRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
              +    +C ++KA +RPT   + S+L +
Sbjct: 240 YDIMK---MCWKEKAEERPTFDYLQSVLDD 266

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 87  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 140
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 199
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 244
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
           +E+ + +    LC +++  DRPT   + S+L +   A     QP
Sbjct: 245 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 285

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
           +E+ + +    LC +++  DRPT   + S+L +   A     QP
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 89  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 142
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 201
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 246
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
           +E+ + +    LC +++  DRPT   + S+L +   A     QP
Sbjct: 247 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 287

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 84
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 138
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 197
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 242
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
           +E+ + +    LC +++  DRPT   + S+L +   A     QP
Sbjct: 243 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 283

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 88  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 141
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 200
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 245
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
           +E+ + +    LC +++  DRPT   + S+L +   A     QP
Sbjct: 246 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQFQP 286

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 80
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 81  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 134
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 193
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                 +     P
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 238
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 239 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 268

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 79
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 80  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 133
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 192
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 237
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 238 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 267

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                 +     P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                 +     P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 84
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 85  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 138
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 197
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 242
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 243 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 83
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 84  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 241
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 242 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 271

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 135/273 (49%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  L   K  ++   I +G+ ++ + +    IH
Sbjct: 74  QE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 186
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                 +     P
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 231
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 232 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 261

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 137/273 (50%), Gaps = 30/273 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  L   K  ++   I +G+ ++ + +    IH
Sbjct: 75  QE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN---YIH 128
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           R+L+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G  ++KS
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 187
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------------RMVRPDNC-P 232
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +E+ + +    LC +++  DRPT   + S+L +
Sbjct: 233 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 262

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 42/288 (14%)
Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG+  FG VYKG L         Q +AIK L  K+ G    EF++EA L A+LQH N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKELLDWKKRFNIIEG 125
           LLG   +     +++ Y  +  L  F+              D + K  L+     +++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-TFGMNELEANTNRIVG 184
           I  G+ YL   S   V+H+DL   N+L+ D++N KISD G+ R  +  +  +   N ++ 
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG 244
              +M+PE +M G  S+ SD++S+GV++ E+ S      C          GY+ Q     
Sbjct: 211 IR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC----------GYSNQ----- 254
Query: 245 KALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
             +E+I       C PD+    ++  ++ C  +  + RP   D+ S L
Sbjct: 255 DVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 42/288 (14%)
Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG+  FG VYKG L         Q +AIK L  K+ G    EF++EA L A+LQH N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKELLDWKKRFNIIEG 125
           LLG   +     +++ Y  +  L  F+              D + K  L+     +++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-TFGMNELEANTNRIVG 184
           I  G+ YL   S   V+H+DL   N+L+ D++N KISD G+ R  +  +  +   N ++ 
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG 244
              +M+PE +M G  S+ SD++S+GV++ E+ S      C          GY+ Q     
Sbjct: 194 IR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC----------GYSNQ----- 237
Query: 245 KALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
             +E+I       C PD+    ++  ++ C  +  + RP   D+ S L
Sbjct: 238 DVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 139/284 (48%), Gaps = 30/284 (10%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G  G V+ G      ++A+K L + S      F  EA L+ +LQH  LVRL     
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           Q+    ++ EY+ N SL DF    S  K  ++  K  ++   I +G+ ++ + +    IH
Sbjct: 79  QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ D ++ KI+DFG+AR     E  A          + +PE +  G  ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
           DV+SFG+L+ EI++  +    G  + E   NL  GY                   ++C P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------------RMVRPDNC-P 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
           +E+ + +    LC +++  DRPT   + S+L +   A     QP
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           S  K +  +V ++    SL   +  S  K   + KK  +I     +G+ YLH  S   +I
Sbjct: 77  S-TKPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 143 HRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM--- 195
           HRDLK++NI L +    KI DFG+A    R  G ++ E  +  I+    +M+PE +    
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQD 186
Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
           +   S +SDVY+FG+++ E+++ +
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           S  K +  +V ++    SL   +  S  K   + KK  +I     +G+ YLH  S   +I
Sbjct: 89  ST-KPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 143 HRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM--- 195
           HRDLK++NI L +    KI DFG+A    R  G ++ E  +  I+    +M+PE +    
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQD 198
Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
           +   S +SDVY+FG+++ E+++ +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 128/281 (45%), Gaps = 22/281 (7%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           RLG G FG V+ G      ++AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAV-V 73
Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
            +    +V EY+   SL  F+ D   + L    K  N+++   Q    +    R+  IHR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRAL----KLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
           DL+++NIL+ + +  KI+DFG+AR    NE  A          + +PE  + G  ++KSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSD 188
Query: 205 VYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVT 264
           V+SFG+L+ E+++  +             V Y     N  + LE ++      C  D   
Sbjct: 189 VWSFGILLTELVTKGR-------------VPYPGM--NNREVLEQVERGYRMPCPQDCPI 233
Query: 265 RCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
               + + C +    +RPT   + S L +   A     QP 
Sbjct: 234 SLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           S    +  +V ++    SL   +  S  K   + KK  +I     +G+ YLH  S   +I
Sbjct: 89  STAP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 143 HRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM--- 195
           HRDLK++NI L +    KI DFG+A    R  G ++ E  +  I+    +M+PE +    
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQD 198
Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
           +   S +SDVY+FG+++ E+++ +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 29/210 (13%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           +G GGFG VY+   + G E+A+K           Q I   + EAKL A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKE----LLDWKKRFNIIEGIVQGLLYLHKYS 137
             L++    LV E+     L+  +  S K+     L++W  +      I +G+ YLH  +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ------IARGMNYLHDEA 125
Query: 138 RLRVIHRDLKASNILLDDQMNP--------KISDFGMARTFGMNELEANTNRIVGTHGYM 189
            + +IHRDLK+SNIL+  ++          KI+DFG+AR +             G + +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTKMSAAGAYAWM 181
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           +PE +   + S  SDV+S+GVL+ E+++ +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 75
           FS    +G G FG VY  + +   E+ AIK++S S  Q   ++++   E + + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            ++  GC L++    LV EY    + D  + +  KK L +  +   +  G +QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
           ++   +IHRD+KA NILL +    K+ DFG A       + A  N  VGT  +M+PE ++
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 196 ---NGIVSMKSDVYSFGVLVLEIISSK 219
               G    K DV+S G+  +E+   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 130
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 186
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 93  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 145
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 201
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 75
           FS    +G G FG VY  + +   E+ AIK++S S  Q   ++++   E + + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            ++  GC L++    LV EY    + D  + +  KK L +  +   +  G +QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 172
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
           ++   +IHRD+KA NILL +    K+ DFG A       + A  N  VGT  +M+PE ++
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 223
Query: 196 ---NGIVSMKSDVYSFGVLVLEIISSK 219
               G    K DV+S G+  +E+   K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 127
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 183
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 125
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 125
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 100 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 152
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 208
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 153
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 209
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 130
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 186
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S  K +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 153
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 209
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/312 (28%), Positives = 149/312 (47%), Gaps = 55/312 (17%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L++++G +  VEF +EA ++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L V + +P+  L  ++ +       + LL+W  +      I +G++YL +
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+AR    +E E N +       +M+ E + 
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
               + +SDV+S+GV + E+++   K  +G    E           L  +G+ L      
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP--------DLLEKGERLP----- 239
Query: 254 LHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLT--------------NDTMAL 298
                 P   T  +++ ++ C    A  RP   ++A+  +              +D M L
Sbjct: 240 -----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKL 294
Query: 299 PTPRQPAFFINI 310
           P+P    FF N+
Sbjct: 295 PSPNDSKFFQNL 306

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 113/202 (55%), Gaps = 20/202 (9%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L++++G +  VEF +EA ++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L V + +P+  L  ++ +       + LL+W  +      I +G++YL +
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+AR    +E E N +       +M+ E + 
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               + +SDV+S+GV + E+++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMT 237

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
             +G G FG V+ G  L+  ++AIK + +       +F  EA+++ KL H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L++    LV+E++ +  L  ++   +++ L   +    +   + +G+ YL + S   VIH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL A N L+ +    K+SDFGM R F +++   ++        + SPE       S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFGVL+ E+ S  K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVE-FKNEAKLI 68
           I    ++F  GN LG+G F  VY+ + +  G E+AIK + K +    G+V+  +NE K+ 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
            +L+H +++ L           LV E   N  ++ ++ +  K    +  + F  +  I+ 
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIIT 123
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           G+LYLH +    ++HRDL  SN+LL   MN KI+DFG+A    M   +  T  + GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           +SPE        ++SDV+S G +   ++
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLL 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 362
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 363 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 406
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C + +  +RPT   + + L +   +     QP 
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++  +G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 83  SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           S    +  +V ++    SL   +    +K E++   K  +I     QG+ YLH  S   +
Sbjct: 73  STAP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 125
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
           IHRDLK++NI L + +  KI DFG+A    R  G ++ E  +  I+    +M+PE +   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
                S +SDVY+FG+++ E+++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 362
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 363 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 406
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C + +  +RPT   + + L +   +     QP 
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 331
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 445
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 446 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 489
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C + +  +RPT   + + L +   +     QP 
Sbjct: 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
             +G G FG V+ G  L+  ++AIK + +       +F  EA+++ KL H  LV+L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L++    LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VIH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL A N L+ +    K+SDFGM R F +++   ++        + SPE       S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFGVL+ E+ S  K
Sbjct: 184 DVWSFGVLMWEVFSEGK 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
             +G G FG V+ G  L+  ++AIK + +       +F  EA+++ KL H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L++    LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VIH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL A N L+ +    K+SDFGM R F +++   ++        + SPE       S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFGVL+ E+ S  K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 362
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 363 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 406
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C + +  +RPT   + + L +   +     QP 
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
             +G G FG V+ G  L+  ++AIK + +       +F  EA+++ KL H  LV+L G  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L++    LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VIH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL A N L+ +    K+SDFGM R F +++   ++        + SPE       S KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFGVL+ E+ S  K
Sbjct: 189 DVWSFGVLMWEVFSEGK 205

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
             +G G FG V+ G  L+  ++AIK + + S     +F  EA+++ KL H  LV+L G  
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L++    LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +     VIH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL A N L+ +    K+SDFGM R F +++   ++        + SPE       S KS
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFGVL+ E+ S  K
Sbjct: 206 DVWSFGVLMWEVFSEGK 222

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 75
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 189
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 190 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 233
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C + +  +RPT   + + L +   +     QP 
Sbjct: 234 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 276

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 26/271 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 72
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKS 186
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 187 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 230
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTN 293
              +H +   C + +  +RPT   + + L +
Sbjct: 231 PESLHDLMCQCWRKEPEERPTFEYLQAFLED 261

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 37/278 (13%)
Query: 26  LGQGGFGPVYKG--KLLDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +G G FG VYKG  K   G++   +AIK L    + +  V+F  EA ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
            G   +    +++ EY+ N +LD F+ +  K       +   ++ GI  G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEY 193
             +HRDL A NIL++  +  K+SDFG++R      LE +      T G      + +PE 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
           +     +  SDV+SFG+++ E+++       Y    +       W+L N  + ++ I+  
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT-------YGERPY-------WELSNH-EVMKAINDG 266
Query: 254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                  D  +    + + C Q +   RP  +D+ S+L
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-WTAPEAALYGRFTIKS 193
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 194 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 237
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C + +  +RPT   + + L +   +     QP 
Sbjct: 238 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   ++ K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 193
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 194 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 237
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C + +  +RPT   + + L +   +     QP 
Sbjct: 238 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
             +G G FG V+ G  L+  ++AIK + +       +F  EA+++ KL H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L++    LV E++ +  L  ++   +++ L   +    +   + +G+ YL +     VIH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL A N L+ +    K+SDFGM R F +++   ++        + SPE       S KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFGVL+ E+ S  K
Sbjct: 187 DVWSFGVLMWEVFSEGK 203

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 71
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 185
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 186 DVWSFGILLTELTTKGR 202

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 24/271 (8%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
            +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  LV+L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 78
Query: 84  LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + K    ++ E++   SL DF   D   K+ L   K  +    I +G+ ++ + +    I
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL+A+NIL+   +  KI+DFG+AR    NE  A          + +PE +  G  ++K
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIK 192
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
           SDV+SFG+L++EI++  +    Y    +  ++          +ALE           P+E
Sbjct: 193 SDVWSFGILLMEIVTYGRIP--YPGMSNPEVI----------RALERGYRMPRPENCPEE 240
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +    ++ + C +++  +RPT   + S+L +
Sbjct: 241 L---YNIMMRCWKNRPEERPTFEYIQSVLDD 268

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+KL H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+KL H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 73
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 187
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 188 DVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 212 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 259
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 260 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 150
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 211 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 258
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 259 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 24/271 (8%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
            +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 84  LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + K    ++ E++   SL DF   D   K+ L   K  +    I +G+ ++ + +    I
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL+A+NIL+   +  KI+DFG+AR    NE  A          + +PE +  G  ++K
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIK 365
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
           SDV+SFG+L++EI++  +    Y    +  ++          +ALE           P+E
Sbjct: 366 SDVWSFGILLMEIVTYGRIP--YPGMSNPEVI----------RALERGYRMPRPENCPEE 413
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +    ++ + C +++  +RPT   + S+L +
Sbjct: 414 L---YNIMMRCWKNRPEERPTFEYIQSVLDD 441

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 157
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +   
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 218 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 265
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 266 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 297

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 214 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 261
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 262 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 26/283 (9%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 249
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 304
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+ R    NE  A          + +PE  + G  ++KS
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 363
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
           DV+SFG+L+ E+ +  +             V Y   +  E   L+ ++      C P E 
Sbjct: 364 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 407
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
              +H +   C +    +RPT   + + L +   +     QP 
Sbjct: 408 PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ K++H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+   SL DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 147
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 208 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 255
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 256 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 287

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 211
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +   
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 272 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 319
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 320 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 351

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 135 KYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 214 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 261
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 262 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 293

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 144
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 205 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 252
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 253 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 149
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 210 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 257
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 258 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 289

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 171
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 232 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 279
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 280 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 311

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 31/297 (10%)
Query: 24  NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
            +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 79  LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
              R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE +
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESL 193
Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                S+ SDV+SFGV++ E+ +  + +     E  + ++G   Q   +     LI+   
Sbjct: 194 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRMIGNDKQ--GQMIVFHLIELLK 250
Query: 255 H-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN--DTMALPTPR 302
           +       + C PDE+     +   C  +    RP+  D+A  +    D MA   PR
Sbjct: 251 NNGRLPRPDGC-PDEI---YMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGLVPR 303

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 212 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 259
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 260 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 170
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 231 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 278
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 279 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 310

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+    L DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
           +G+G FG VY G LLD  G++I  A+K L++ +  G + +F  E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C   +G  L+V  Y+ +  L  FI + +    +     F +   + +G+ YL   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 150
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
           + +HRDL A N +LD++   K++DFG+AR     E  +  N+        +M+ E +   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             + KSDV+SFGVL+ E+++  +    Y      ++  Y  Q    G+ L      L   
Sbjct: 211 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 258
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
             PD +     V L C   KA  RP+ S++ S ++
Sbjct: 259 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 290

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85  QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            +    +V EY+    L DF   +  K   L   +  ++   I  G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
           DV+SFG+L+ E+ +  +
Sbjct: 197 DVWSFGILLTELTTKGR 213

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 26  LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +   LL  Q+   +A+K L ++S     +F+ EA+L+  LQH ++VR 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE------------LLDWKKRFNIIEGIV 127
            G   +    L+V+EY+ +  L+ F+                    L   +   +   + 
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      R +    
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           +M PE ++    + +SDV+SFGV++ EI +                  Y  Q W +    
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT------------------YGKQPWYQLSNT 238
Query: 248 ELIDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
           E ID            +C P+     I  G  C Q +   R ++ DV + L     A P 
Sbjct: 239 EAIDCITQGRELERPRACPPE--VYAIMRG--CWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 196
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 189
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 26  LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +   LL  Q+   +A+K L ++S     +F+ EA+L+  LQH ++VR 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE------------LLDWKKRFNIIEGIV 127
            G   +    L+V+EY+ +  L+ F+                    L   +   +   + 
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      R +    
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           +M PE ++    + +SDV+SFGV++ EI +                  Y  Q W +    
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT------------------YGKQPWYQLSNT 244
Query: 248 ELIDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
           E ID            +C P+     I  G  C Q +   R ++ DV + L     A P 
Sbjct: 245 EAIDCITQGRELERPRACPPE--VYAIMRG--CWQREPQQRHSIKDVHARLQALAQAPPV 300

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 24  NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
            +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 79  LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
              R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE +
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESL 187
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                S+ SDV+SFGV++ E+ +
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 24  NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
            +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 79  LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
              R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESL 220
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                S+ SDV+SFGV++ E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 197
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 190
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 190
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 135 KYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMAR              +    +M P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 26  LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +   LL  Q+   +A+K L ++S     +F+ EA+L+  LQH ++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE------------LLDWKKRFNIIEGIV 127
            G   +    L+V+EY+ +  L+ F+                    L   +   +   + 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G++YL   + L  +HRDL   N L+   +  KI DFGM+R     +      R +    
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           +M PE ++    + +SDV+SFGV++ EI +                  Y  Q W +    
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT------------------YGKQPWYQLSNT 267
Query: 248 ELIDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
           E ID            +C P+     I  G  C Q +   R ++ DV + L     A P 
Sbjct: 268 EAIDCITQGRELERPRACPPE--VYAIMRG--CWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 208
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 208
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 33/210 (15%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG--- 81
           R+G G FG VYKGK      + I ++   + +    F+NE  ++ K +H N++  +G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 82  -----CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
                   Q  E   +Y++L  +   F +F     +L+D      I     QG+ YLH  
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMF-----QLID------IARQTAQGMDYLHAK 151
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPE 192
           +   +IHRD+K++NI L + +  KI DFG+A    R  G  ++E  T  ++    +M+PE
Sbjct: 152 N---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPE 204
Query: 193 YVM---NGIVSMKSDVYSFGVLVLEIISSK 219
            +    N   S +SDVYS+G+++ E+++ +
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26  LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
           LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
            +G SLQ   R ++ E +    L  F+ ++    S+   L      ++   I  G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +      IHRD+ A N LL         KI DFGMA+              +    +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E  M GI + K+D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ E+LP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSPE 192
             R IHRDL   NIL++++   KI DFG+ +    ++      E   + I     + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAPE 187
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIIS 217
            +     S+ SDV+SFGV++ E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++   +  E +D  K       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHRDL   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG+AR      LE +      T G      
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLARV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 23  GNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLL 80
           G ++G+G FG V+ G+L  D   +A+K   ++    +  +F  EA+++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   QK    +V E +  +  DF  F  ++   L  K    ++     G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
            IHRDL A N L+ ++   KISDFGM+R        A+         + +PE +  G  S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 201 MKSDVYSFGVLVLEIIS 217
            +SDV+SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 23  GNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLL 80
           G ++G+G FG V+ G+L  D   +A+K   ++    +  +F  EA+++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   QK    +V E +  +  DF  F  ++   L  K    ++     G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
            IHRDL A N L+ ++   KISDFGM+R        A+         + +PE +  G  S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 201 MKSDVYSFGVLVLEIIS 217
            +SDV+SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLV 77
           F+  +R+G+G FG VYKG     +E+ AIK +  + +   I + + E  ++++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           R  G  L+  +  ++ EYL   S      D  K   L+      I+  I++GL YLH   
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 135
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
             R IHRD+KA+N+LL +Q + K++DFG+A    + + +   N  VGT  +M+PE +   
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
               K+D++S G+  +E+   +  N      R L L+
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25  RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +LG+G FG V   +   L D  G+ +A+K+L  S+ + + +F+ E +++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 80  LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
             R IHR+L   NIL++++   KI DFG+ +    ++ E    +  G     + +PE + 
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWYAPESLT 191
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S+ SDV+SFGV++ E+ +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 161
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 162 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 213
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 258
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 259 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 164 ---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 48/283 (16%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G+L + G+    +AIK L    + +   +F +EA ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE--GIVQGLLYLHKY-S 137
           G   +    +++ EY+ N SLD F+  +          RF +I+  G+++G+    KY S
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 148
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
            +  +HRDL A NIL++  +  K+SDFGM+R      LE +      T G      + +P
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAYTTRGGKIPIRWTAP 203
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALEL 249
           E +     +  SDV+S+G+++ E++S          ER        W + N+   KA+E 
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEVMSY--------GERPY------WDMSNQDVIKAIE- 248
Query: 250 IDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
                +    P +    +H  +L C Q + +DRP    + +ML
Sbjct: 249 ---EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 134
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 186
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 231
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 232 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG+ R      LE +      T G      
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V EY+ N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 151
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 152 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 248
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 249 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 143/293 (48%), Gaps = 54/293 (18%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLVRLLGC 82
           LG+G FG V K K  +  QE A+K ++K+S +         E +L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL--- 86
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDS--SKKELLDW---KKRFN------IIEGIVQGLL 131
                     +E L + S  F+I     +  EL D    +KRF+      II+ +  G+ 
Sbjct: 87  ----------FEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           Y+HK++   ++HRDLK  NILL+ +    + KI DFG++  F  N         +GT  Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYY 189
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSK-----KNNGCYDTERHLNLVGYAWQL--W 241
           ++PE V+ G    K DV+S GV++  ++S       KN   YD  + +    YA+ L  W
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQW 246
Query: 242 ----NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM 290
               ++ K L     T H S      T+C+      +Q  +++ PT+SD+ S+
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRI-TATQCLEHP--WIQKYSSETPTISDLPSL 296

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 48/283 (16%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G+L + G+    +AIK L    + +   +F +EA ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE--GIVQGLLYLHKY-S 137
           G   +    +++ EY+ N SLD F+  +          RF +I+  G+++G+    KY S
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 127
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
            +  +HRDL A NIL++  +  K+SDFGM+R      LE +      T G      + +P
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAYTTRGGKIPIRWTAP 182
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALEL 249
           E +     +  SDV+S+G+++ E++S          ER        W + N+   KA+E 
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSY--------GERPY------WDMSNQDVIKAIE- 227
Query: 250 IDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
                +    P +    +H  +L C Q + +DRP    + +ML
Sbjct: 228 ---EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 48/283 (16%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G+L + G+    +AIK L    + +   +F +EA ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE--GIVQGLLYLHKY-S 137
           G   +    +++ EY+ N SLD F+  +          RF +I+  G+++G+    KY S
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 133
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
            +  +HRDL A NIL++  +  K+SDFGM+R      LE +      T G      + +P
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAYTTRGGKIPIRWTAP 188
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALEL 249
           E +     +  SDV+S+G+++ E++S          ER        W + N+   KA+E 
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSY--------GERPY------WDMSNQDVIKAIE- 233
Query: 250 IDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
                +    P +    +H  +L C Q + +DRP    + +ML
Sbjct: 234 ---EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 117/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 173
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +        D   +A+K L  +S     +F  EA+L+  LQH ++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFI----------FDSSKKELLDWKKRFNIIEGIVQG 129
            G  ++    ++V+EY+ +  L+ F+           + +    L   +  +I + I  G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-- 187
           ++YL   +    +HRDL   N L+ + +  KI DFGM+R     ++ +     VG H   
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYSTDYYRVGGHTML 192
Query: 188 ---YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN 221
              +M PE +M    + +SDV+S GV++ EI +  K 
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 130/271 (47%), Gaps = 34/271 (12%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
            +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  LV+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 245
Query: 84  LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + K    ++ E++   SL DF   D   K+ L   K  +    I +G+ ++ + +    I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL+A+NIL+   +  KI+DFG+AR      ++           + +PE +  G  ++K
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIK 349
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
           SDV+SFG+L++EI++  +    Y    +  ++          +ALE           P+E
Sbjct: 350 SDVWSFGILLMEIVTYGRIP--YPGMSNPEVI----------RALERGYRMPRPENCPEE 397
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +    ++ + C +++  +RPT   + S+L +
Sbjct: 398 L---YNIMMRCWKNRPEERPTFEYIQSVLDD 425

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 179
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
           + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H N+V+LL     + +  LV+E+L     DF   D+S    +      + +  ++QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
            ++     S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G  G V  G+L + GQ    +AIK L    + +   +F +EA ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    ++V EY+ N SLD F+     +  +   +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
            +HRDL A N+L+D  +  K+SDFG++R      LE + +    T G      + +PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRV-----LEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                S  SDV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 195 MNG-IVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G  G V  G+L + GQ    +AIK L    + +   +F +EA ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    ++V EY+ N SLD F+     +  +   +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
            +HRDL A N+L+D  +  K+SDFG++R      LE + +    T G      + +PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRV-----LEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                S  SDV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 113/220 (51%), Gaps = 11/220 (5%)
Query: 2   KRDLKIFDFQTIAAATDN-FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIV 59
           +R LK  D  ++    +  F    +LG+G +G VYK    + GQ +AIK++   S   + 
Sbjct: 12  RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQ 69
Query: 60  EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR 119
           E   E  ++ +    ++V+  G   +  +  +V EY    S+   I    + + L   + 
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEI 127
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             I++  ++GL YLH    +R IHRD+KA NILL+ + + K++DFG+A    + +  A  
Sbjct: 128 ATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDXMAKR 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           N ++GT  +M+PE +     +  +D++S G+  +E+   K
Sbjct: 183 NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 113/209 (54%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L     DF   D+S    +      + +  ++QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 113/209 (54%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L     DF   D+S    +      + +  ++QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 117/226 (51%), Gaps = 15/226 (6%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLDG---QEIAIKRLS-KSSGQGIVEFKNEAKLI 68
           IA   + F+   R+G+G FG V+KG  +D    Q +AIK +  + +   I + + E  ++
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           ++   + + +  G  L+  +  ++ EYL   S      D  +    D  +   +++ I++
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILK 131
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           GL YLH   +   IHRD+KA+N+LL +Q + K++DFG+A      +++ NT   VGT  +
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFW 186
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
           M+PE +       K+D++S G+  +E+   +  N      R L L+
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E++ ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + K       EF  EAK++  L H  LV+L G   +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +HRD
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 129
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L++DQ   K+SDFG++R    +E  ++         +  PE +M    S KSD+
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 188
Query: 206 YSFGVLVLEIIS 217
           ++FGVL+ EI S
Sbjct: 189 WAFGVLMWEIYS 200

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/319 (26%), Positives = 148/319 (46%), Gaps = 38/319 (11%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 141
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ 239
           + +    +MSPE + +G+ +  SDV+SFGV++ EI + +++       E+ L  V     
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----- 253
Query: 240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
              EG  L+  D     +C PD +   +    +C Q     RP+  ++ S +  +    P
Sbjct: 254 --MEGGLLDKPD-----NC-PDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME--P 300
Query: 300 TPRQPAFFINISSDYEEPE 318
             R+ +F+ +  +   EPE
Sbjct: 301 GFREVSFYYSEENKLPEPE 319

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + + S     EF  EAK++  L H  LV+L G   +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +HRD
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 136
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L++DQ   K+SDFG++R    +E  ++         +  PE +M    S KSD+
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 195
Query: 206 YSFGVLVLEIISSKK 220
           ++FGVL+ EI S  K
Sbjct: 196 WAFGVLMWEIYSLGK 210

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + + S     EF  EAK++  L H  LV+L G   +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L++DQ   K+SDFG++R    +E  ++         +  PE +M    S KSD+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 204
Query: 206 YSFGVLVLEIISSKK 220
           ++FGVL+ EI S  K
Sbjct: 205 WAFGVLMWEIYSLGK 219

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + + S     EF  EAK++  L H  LV+L G   +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L++DQ   K+SDFG++R    +E  ++         +  PE +M    S KSD+
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 189
Query: 206 YSFGVLVLEIISSKK 220
           ++FGVL+ EI S  K
Sbjct: 190 WAFGVLMWEIYSLGK 204

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + K       EF  EAK++  L H  LV+L G   +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +HRD
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 125
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L++DQ   K+SDFG++R    +E  ++         +  PE +M    S KSD+
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 184
Query: 206 YSFGVLVLEIIS 217
           ++FGVL+ EI S
Sbjct: 185 WAFGVLMWEIYS 196

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 133/277 (48%), Gaps = 16/277 (5%)
Query: 24  NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           ++LG+G FG V   +   L D  G  +A+K+L  S      +F+ E +++  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 79  LLGCSLQKG--ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             G S   G  E  LV EYLP+  L  F+     +  LD  +       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 128
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
           SR R +HRDL A NIL++ + + KI+DFG+A+   +++ +    R  G     + +PE +
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DXXVVREPGQSPIFWYAPESL 186
Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
            + I S +SDV+SFGV++ E+  +  +  C  +   L ++G    +    + LEL++   
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQ 245
Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                P        +  LC      DRP+ S +   L
Sbjct: 246 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 282

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + + S     EF  EAK++  L H  LV+L G   +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 145
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L++DQ   K+SDFG++R + +++ E ++        +  PE +M    S KSD+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 206 YSFGVLVLEIISSKK 220
           ++FGVL+ EI S  K
Sbjct: 205 WAFGVLMWEIYSLGK 219

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V +      G+E     +A+K L  ++     E   +E K+++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-------LDWKKRFNI 122
           L QH N+V LLG     G  L++ EY     L  F+   ++ +L       L+ +   + 
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
              + QG+ +L   +    IHRD+ A N+LL +    KI DFG+AR   MN+    +N I
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND----SNYI 209
Query: 183 VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTERHLNLVG 235
           V  +      +M+PE + + + +++SDV+S+G+L+ EI S   N   G     +   LV 
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
             +Q+                + +P  +   +     C   + T RPT   + S L
Sbjct: 270 DGYQM-------------AQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 309

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 251
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 252 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 286

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V +G+L   G++   +AIK L    + +   EF +EA ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G        +++ E++ N +LD F+  +  +  ++   +   ++ GI  G+ YL + S  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 138
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMN 196
             +HRDL A NIL++  +  K+SDFG++R    N  +      +G      + +PE +  
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 197 GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE 256
              +  SD +S+G+++ E++S          ER        W + N+   +  I+     
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSF--------GERPY------WDMSNQ-DVINAIEQDYRL 242
Query: 257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
              PD  T    + L C Q     RP    V S L
Sbjct: 243 PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 52/318 (16%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL--LDGQE----IAIKRLSK-SSGQG 57
            KI +         N   G  LG+G FG V K     L G+     +A+K L + +S   
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK------- 110
           + +  +E  ++ ++ H ++++L G   Q G  LL+ EY    SL  F+ +S K       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 111 ------KELLDWKKRFNIIEG--------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
                    LD      +  G        I QG+ YL   + ++++HRDL A NIL+ + 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 157 MNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
              KISDFG++R   + E ++   R  G     +M+ E + + I + +SDV+SFGVL+ E
Sbjct: 187 RKMKISDFGLSRD--VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 215 IISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLC 273
           I++   N       ER  NL+         G  +E  D     +CS +E+ R +   L C
Sbjct: 245 IVTLGGNPYPGIPPERLFNLL-------KTGHRMERPD-----NCS-EEMYRLM---LQC 288
Query: 274 VQDKATDRPTMSDVASML 291
            + +   RP  +D++  L
Sbjct: 289 WKQEPDKRPVFADISKDL 306

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           G  LG+G FG   K    + G+ + +K L +   +    F  E K++  L+H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
             L K +RL  + EY+   +L   I   S      W +R +  + I  G+ YLH    + 
Sbjct: 75  V-LYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF--------GMNELEANTNR----IVGTHGY 188
           +IHRDL + N L+ +  N  ++DFG+AR          G+  L+    +    +VG   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           M+PE +       K DV+SFG+++ EII
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V E + N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 164 ---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 115/210 (54%), Gaps = 13/210 (6%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF-DSSKKELLDWKKRFNIIEGIVQGL 130
            H N+V+LL     + +  LV+E+L   S+D   F D+S    +      + +  ++QGL
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
            + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +
Sbjct: 120 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRA 174
Query: 191 PEYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           PE ++     S   D++S G +  E+++ +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 126
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG G FG V  GK     ++AIK + + S     EF  EAK++  L H  LV+L G   +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
           +    ++ EY+ N  L  ++ +   +     ++   + + + + + YL      + +HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
           L A N L++DQ   K+SDFG++R    +E  ++         +  PE +M    S KSD+
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-WSPPEVLMYSKFSSKSDI 189
Query: 206 YSFGVLVLEIISSKK 220
           ++FGVL+ EI S  K
Sbjct: 190 WAFGVLMWEIYSLGK 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 115/210 (54%), Gaps = 13/210 (6%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF-DSSKKELLDWKKRFNIIEGIVQGL 130
            H N+V+LL     + +  LV+E+L   S+D   F D+S    +      + +  ++QGL
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
            + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRA 172
Query: 191 PEYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           PE ++     S   D++S G +  E+++ +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 83  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 134/280 (47%), Gaps = 42/280 (15%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G+L L G+    +AIK L    + +   +F  EA ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    ++V EY+ N SLD F+  +  +  +   +   ++ GI  G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL---SDMG 144
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
            +HRDL A NIL++  +  K+SDFG++R      LE +      T G      + +PE +
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALELIDT 252
                +  SDV+S+G+++ E++S          ER        W++ N+   KA+E    
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSY--------GERPY------WEMTNQDVIKAVE---- 241
Query: 253 TLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
             +   SP +    ++  +L C Q +   RP   ++ +ML
Sbjct: 242 EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 80  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEGMNYLED 132
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 133 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 224

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V +      G+E     +A+K L  ++     E   +E K+++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-------LDWKKRFNI 122
           L QH N+V LLG     G  L++ EY     L  F+   ++ +L       L+ +   + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
              + QG+ +L   +    IHRD+ A N+LL +    KI DFG+AR   MN+    +N I
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND----SNYI 217
Query: 183 VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTERHLNLVG 235
           V  +      +M+PE + + + +++SDV+S+G+L+ EI S   N   G     +   LV 
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 277
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
             +Q+                + +P  +   +     C   + T RPT   + S L
Sbjct: 278 DGYQM-------------AQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 317

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 77  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 129
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+ ++   +  +G+      E  L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+ ++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +   T+ +V T  Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
           + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
            ++     S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V +G+L   G++   +AIK L    + +   EF +EA ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G        +++ E++ N +LD F+  +  +  ++   +   ++ GI  G+ YL + S  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 136
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMN 196
             +HRDL A NIL++  +  K+SDFG++R    N  +      +G      + +PE +  
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 197 GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE 256
              +  SD +S+G+++ E++S          ER        W + N+   +  I+     
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSF--------GERPY------WDMSNQ-DVINAIEQDYRL 240
Query: 257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
              PD  T    + L C Q     RP    V S L
Sbjct: 241 PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 139
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 89  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 141
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 142 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 233

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 52/318 (16%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL--LDGQE----IAIKRLSK-SSGQG 57
            KI +         N   G  LG+G FG V K     L G+     +A+K L + +S   
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK------- 110
           + +  +E  ++ ++ H ++++L G   Q G  LL+ EY    SL  F+ +S K       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 111 ------KELLDWKKRFNIIEG--------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
                    LD      +  G        I QG+ YL   + ++++HRDL A NIL+ + 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 157 MNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
              KISDFG++R   + E ++   R  G     +M+ E + + I + +SDV+SFGVL+ E
Sbjct: 187 RKMKISDFGLSRD--VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 215 IISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLC 273
           I++   N       ER  NL+         G  +E  D     +CS +E+ R +   L C
Sbjct: 245 IVTLGGNPYPGIPPERLFNLL-------KTGHRMERPD-----NCS-EEMYRLM---LQC 288
Query: 274 VQDKATDRPTMSDVASML 291
            + +   RP  +D++  L
Sbjct: 289 WKQEPDKRPVFADISKDL 306

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
           + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
            ++     S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
           + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
            ++     S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 84  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 136
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 173
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 135
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 173
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
           + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
            ++     S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 86  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 176
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V E + N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L ++ L  F+ D+S    +      + +  ++QGL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +PE +
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 84  LGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 136
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 108 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 160
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 161 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 252

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
           N S    +G G FG V  G+L    +  I    K+   G  E     F  EA ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G   +    ++V E + N SLD F+     +  +   +   ++ GI  G+ YL
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 134
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G      
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 186
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           + SPE +     +  SDV+S+G+++ E++S          ER        W++ N+   +
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 231
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           + +D         D       + L C Q    +RP    + S+L
Sbjct: 232 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 93  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 145
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 146 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 237

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 85  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 22/280 (7%)
Query: 24  NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           ++LG+G FG V   +   L D  G  +A+K+L  S      +F+ E +++  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 79  LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             G S   G +   LV EYLP+  L  F+     +  LD  +       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSP 191
              R +HRDL A NIL++ + + KI+DFG+A+   +++      E   + I     + +P
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 186
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E + + I S +SDV+SFGV++ E+  +  +  C  +   L ++G    +    + LEL++
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGSERDVPALSRLLELLE 245
Query: 252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                   P        +  LC      DRP+ S +   L
Sbjct: 246 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 83  LGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 22/280 (7%)
Query: 24  NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           ++LG+G FG V   +   L D  G  +A+K+L  S      +F+ E +++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 79  LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             G S   G +   LV EYLP+  L  F+     +  LD  +       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSP 191
              R +HRDL A NIL++ + + KI+DFG+A+   +++      E   + I     + +P
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 199
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E + + I S +SDV+SFGV++ E+  +  +  C  +   L ++G    +    + LEL++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                   P        +  LC      DRP+ S +   L
Sbjct: 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 38/283 (13%)
Query: 25  RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNL 76
           ++G+GGFG V+KG+L+ D   +AIK L     +G         EF+ E  +++ L H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V+L G  L      +V E++P   L   + D  K   + W  +  ++  I  G+ Y+   
Sbjct: 86  VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 137 SRLRVIHRDLKASNILLD--DQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +   ++HRDL++ NI L   D+  P   K++DFG+++     +   + + ++G   +M+P
Sbjct: 142 NP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 192 EYV--MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           E +       + K+D YSF +++  I++ +   G +D E     + +   +  EG     
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-EYSYGKIKFINMIREEG----- 246
Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
           +  T+ E C P    R  +V  LC       RP  S +   L+
Sbjct: 247 LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 32/224 (14%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           DN      +G+G +G VYKG L D + +A+K  S ++ Q  +  KN  + +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYR-VPLMEHDNIA 70
Query: 78  RLLGCSLQ-----KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           R +    +     + E LLV EY PN SL  ++   +     DW     +   + +GL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAY 126
Query: 133 LHK------YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL----EANTNRI 182
           LH       + +  + HRDL + N+L+ +     ISDFG++     N L    E +   I
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 183 --VGTHGYMSPEYVMNGIVSMKS--------DVYSFGVLVLEII 216
             VGT  YM+PE V+ G V+++         D+Y+ G++  EI 
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 147/319 (46%), Gaps = 38/319 (11%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S +  + +          K  
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 141
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ 239
           + +    +MSPE + +G+ +  SDV+SFGV++ EI + +++       E+ L  V     
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----- 253
Query: 240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
              EG  L+  D     +C PD +   +    +C Q     RP+  ++ S +  +    P
Sbjct: 254 --MEGGLLDKPD-----NC-PDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME--P 300
Query: 300 TPRQPAFFINISSDYEEPE 318
             R+ +F+ +  +   EPE
Sbjct: 301 GFREVSFYYSEENKLPEPE 319

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 22/224 (9%)
Query: 24  NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           ++LG+G FG V   +   L D  G  +A+K+L  S      +F+ E +++  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 79  LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
             G S   G +   LV EYLP+  L  F+     +  LD  +       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSP 191
              R +HRDL A NIL++ + + KI+DFG+A+   +++      E   + I     + +P
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 187
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVG 235
           E + + I S +SDV+SFGV++ E+  +  +  C  +   L ++G
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMG 230

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 144/318 (45%), Gaps = 52/318 (16%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL--LDGQE----IAIKRLSK-SSGQG 57
            KI +         N   G  LG+G FG V K     L G+     +A+K L + +S   
Sbjct: 10  FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK------- 110
           + +  +E  ++ ++ H ++++L G   Q G  LL+ EY    SL  F+ +S K       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 111 ------KELLDWKKRFNIIEG--------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
                    LD      +  G        I QG+ YL + S   ++HRDL A NIL+ + 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEG 186
Query: 157 MNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
              KISDFG++R   + E ++   R  G     +M+ E + + I + +SDV+SFGVL+ E
Sbjct: 187 RKMKISDFGLSRD--VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 215 IISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLC 273
           I++   N       ER  NL+         G  +E  D     +CS +E+ R +   L C
Sbjct: 245 IVTLGGNPYPGIPPERLFNLL-------KTGHRMERPD-----NCS-EEMYRLM---LQC 288
Query: 274 VQDKATDRPTMSDVASML 291
            + +   RP  +D++  L
Sbjct: 289 WKQEPDKRPVFADISKDL 306

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           +F     +G GGFG V+K K  +DG+   IKR+  ++ +     + E K +AKL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 78  RLLGC---------------SLQKGERLLV-YEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
              GC               S  K + L +  E+    +L+ +I +  + E LD      
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           + E I +G+ Y+H     ++I+RDLK SNI L D    KI DFG+  +    + +    R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXR 180
Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
             GT  YMSPE + +     + D+Y+ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 134
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 253
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 254 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 288

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 134
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 132
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 139
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG A+  G  E E +         +M+ E ++
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 135
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 128
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG A+  G  E E +         +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 112/198 (56%), Gaps = 11/198 (5%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           ++G+G +G VYK K   G+ +A+KR+   +  +GI      E  L+ +L H N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
              +    LV+E++  K L   + D +K  L D + +  + + +++G+ + H++   R++
Sbjct: 88  IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RIL 141
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSM 201
           HRDLK  N+L++     K++DFG+AR FG+  + + T+ +V T  Y +P+ +M     S 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 202 KSDVYSFGVLVLEIISSK 219
             D++S G +  E+I+ K
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 134/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HRDL A N ++      KI DFGM R            + +    +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG A+  G  E E +         +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 112/198 (56%), Gaps = 11/198 (5%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           ++G+G +G VYK K   G+ +A+KR+   +  +GI      E  L+ +L H N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
              +    LV+E++  K L   + D +K  L D + +  + + +++G+ + H++   R++
Sbjct: 88  IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RIL 141
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSM 201
           HRDLK  N+L++     K++DFG+AR FG+  + + T+ +V T  Y +P+ +M     S 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 202 KSDVYSFGVLVLEIISSK 219
             D++S G +  E+I+ K
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 25  RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNL 76
           ++G+GGFG V+KG+L+ D   +AIK L     +G         EF+ E  +++ L H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V+L G  L      +V E++P   L   + D  K   + W  +  ++  I  G+ Y+   
Sbjct: 86  VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 137 SRLRVIHRDLKASNILLD--DQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +   ++HRDL++ NI L   D+  P   K++DFG ++     +   + + ++G   +M+P
Sbjct: 142 NP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 192 EYV--MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           E +       + K+D YSF +++  I++ +   G +D E     + +   +  EG     
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-EYSYGKIKFINMIREEG----- 246
Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
           +  T+ E C P    R  +V  LC       RP  S +   L+
Sbjct: 247 LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L  C  Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 97  PFFVKLYFC-FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 147
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVA 234

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG A+  G  E E +         +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 85  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG A+  G  E E +         +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 163
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG A+  G  E E +         +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
            + +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+      E  L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N+V+LL     + +  LV+E++ ++ L  F+ D+S    +      + +  ++QGL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG+  +    + +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
           E ++     S   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 26  LGQGGFGPVYKGKLL-DG--QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
           +G+G FG V K ++  DG   + AIKR+ + +S     +F  E +++ KL  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 81  GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
           G    +G   L  EY P+ +L DF            F   +S    L  ++  +    + 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +G+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R       E    + +G   
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 194
Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M+ E +   + +  SDV+S+GVL+ EI+S
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 26  LGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V+  +        D   +A+K L   +     +F+ EA+L+  LQH ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFF----------IFDSSKKEL---LDWKKRFNIIEGI 126
            G        ++V+EY+ +  L+ F          + D   ++    L   +  +I   I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
             G++YL   +    +HRDL   N L+   +  KI DFGM+R     ++ +     VG H
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGGH 194
Query: 187 G-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN 221
                 +M PE +M    + +SDV+SFGV++ EI +  K 
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 54/302 (17%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V +      G+E     +A+K L  ++     E   +E K+++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG---- 125
           L QH N+V LLG     G  L++ EY      D   F   K  +L+    F I       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTLST 163
Query: 126 ---------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
                    + QG+ +L   +    IHRD+ A N+LL +    KI DFG+AR   MN+  
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND-- 217
Query: 177 ANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTER 229
             +N IV  +      +M+PE + + + +++SDV+S+G+L+ EI S   N   G     +
Sbjct: 218 --SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
              LV   +Q+     A + I + +                  C   + T RPT   + S
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQA----------------CWALEPTHRPTFQQICS 319
Query: 290 ML 291
            L
Sbjct: 320 FL 321

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 24  NRLGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           ++LG GG   VY  +  +   ++AIK +    +   + +  F+ E    ++L H N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           +    +     LV EY+   +L  +I        L      N    I+ G+ + H    +
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---M 130
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           R++HRD+K  NIL+D     KI DFG+A+      L   TN ++GT  Y SPE       
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEAT 189
Query: 200 SMKSDVYSFGVLVLEII 216
              +D+YS G+++ E++
Sbjct: 190 DECTDIYSIGIVLYEML 206

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 26  LGQGGFGPVYKGKLL-DG--QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
           +G+G FG V K ++  DG   + AIKR+ + +S     +F  E +++ KL  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 81  GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
           G    +G   L  EY P+ +L DF            F   +S    L  ++  +    + 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +G+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R       E    + +G   
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 204
Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M+ E +   + +  SDV+S+GVL+ EI+S
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 54/302 (17%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V +      G+E     +A+K L  ++     E   +E K+++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG---- 125
           L QH N+V LLG     G  L++ EY      D   F   K  +L+    F I       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 126 ---------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
                    + QG+ +L   +    IHRD+ A N+LL +    KI DFG+AR   MN+  
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND-- 217
Query: 177 ANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTER 229
             +N IV  +      +M+PE + + + +++SDV+S+G+L+ EI S   N   G     +
Sbjct: 218 --SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
              LV   +Q+     A + I + +                  C   + T RPT   + S
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQA----------------CWALEPTHRPTFQQICS 319
Query: 290 ML 291
            L
Sbjct: 320 FL 321

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HR+L A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 255
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 256 D-----NC-PERVTDLMR---MCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26  LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LGQG FG VY+G   D   G+    +A+K +++S+  +  +EF NEA ++      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
           LLG   +    L+V E + +  L  ++        ++  +     ++   +   I  G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL+     + +HR+L A N ++      KI DFGM R     +      + +    +M+P
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           E + +G+ +  SD++SFGV++ EI S +++       E+ L  V        +G  L+  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
           D     +C P+ VT  +    +C Q     RPT  ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           L  G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L++ + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 90  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  +   E     +AI  L + +S +   E  +EA ++A + + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 117 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 169
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 170 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 261

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           L  G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S + E+ +          K  
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 128
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N  + +    KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
           L  G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A + + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L+  + +P   L  ++ +       + LL+W  +      I +G+ YL  
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
           + I + +SDV+S+GV V E+++  SK  +G   +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
              +    +V EY+P  +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQ-ISSAMEYLEKKN---FI 152
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNTFSIK 211
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 212 SDVWAFGVLLWEIAT 226

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
           A +  +    LGQG FG VY    KG + D  E  +AIK ++++ S +  +EF NEA ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
            +    ++VRLLG   Q    L++ E +    L  ++  S +  + +          K  
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 131
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +    +MSPE + +G+ +  SDV+SFGV++ EI +
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 41/228 (17%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           +F     +G GGFG V+K K  +DG+   I+R+  ++ +     + E K +AKL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIV 68
Query: 78  RLLGC----------------------------SLQKGERLLV-YEYLPNKSLDFFIFDS 108
              GC                            S  K + L +  E+    +L+ +I + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 109 SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
            + E LD      + E I +G+ Y+H     ++IHRDLK SNI L D    KI DFG+  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           +   +       R  GT  YMSPE + +     + D+Y+ G+++ E++
Sbjct: 185 SLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 25  RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNL 76
           ++G+GGFG V+KG+L+ D   +AIK L     +G         EF+ E  +++ L H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V+L G  L      +V E++P   L   + D  K   + W  +  ++  I  G+ Y+   
Sbjct: 86  VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 137 SRLRVIHRDLKASNILLD--DQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +   ++HRDL++ NI L   D+  P   K++DF +++     +   + + ++G   +M+P
Sbjct: 142 NP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 192 EYV--MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           E +       + K+D YSF +++  I++ +   G +D E     + +   +  EG     
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-EYSYGKIKFINMIREEG----- 246
Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
           +  T+ E C P    R  +V  LC       RP  S +   L+
Sbjct: 247 LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
             LG G FG V  GK     ++A+K + + S     EF  EA+ + KL H  LV+  G  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            ++    +V EY+ N  L  ++    K   L+  +   +   + +G+ +L  +   + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNGIVS 200
           RDL A N L+D  +  K+SDFGM R      L+      VGT     + +PE       S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 201 MKSDVYSFGVLVLEIIS 217
            KSDV++FG+L+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +     S  SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVA 229

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 113/232 (48%), Gaps = 35/232 (15%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLVRLLGC 82
           LG+G FG V K K  +  QE A+K ++K+S +         E +L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQGLLYLHKY 136
                   +V E      L    FD   K     +KRF+      II+ +  G+ Y+HK+
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 SRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           +   ++HRDLK  NILL+ +    + KI DFG++  F  N         +GT  Y++PE 
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE- 193
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK-----KNNGCYDTERHLNLVGYAWQL 240
           V+ G    K DV+S GV++  ++S       KN   YD  + +    YA+ L
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDL 243

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7   IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
           +F   + A  +D +     LG+G FG V   K  + GQE A+K +SK   +   + ++  
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 64  -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
            E +L+ +L H N+++L      KG   LV E      L    FD    E++  +KRF+ 
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 131
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
                II  ++ G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F   
Sbjct: 132 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 185
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           E        +GT  Y++PE V++G    K DV+S GV++  ++S     GC
Sbjct: 186 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 230

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG G FG VYK K  + G   A K +   S + + ++  E +++A   H  +V+LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
             G+  ++ E+ P  ++D  + +  +   L   +   +   +++ L +LH     R+IHR
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIHR 133
Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIV 199
           DLKA N+L+  + + +++DFG++    +  L+   +  +GT  +M+PE VM     +   
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQ-KRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 200 SMKSDVYSFGVLVLEI 215
             K+D++S G+ ++E+
Sbjct: 192 DYKADIWSLGITLIEM 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7   IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
           +F   + A  +D +     LG+G FG V   K  + GQE A+K +SK   +   + ++  
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 64  -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
            E +L+ +L H N+++L      KG   LV E      L    FD    E++  +KRF+ 
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 125
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
                II  ++ G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F   
Sbjct: 126 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 179
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           E        +GT  Y++PE V++G    K DV+S GV++  ++S     GC
Sbjct: 180 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 224

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG G FG VYK K  + G   A K +   S + + ++  E +++A   H  +V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
             G+  ++ E+ P  ++D  + +  +   L   +   +   +++ L +LH     R+IHR
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIHR 141
Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIV 199
           DLKA N+L+  + + +++DFG++    +  L+   +  +GT  +M+PE VM     +   
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQ-KRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 200 SMKSDVYSFGVLVLEI 215
             K+D++S G+ ++E+
Sbjct: 200 DYKADIWSLGITLIEM 215

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 113/232 (48%), Gaps = 35/232 (15%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLVRLLGC 82
           LG+G FG V K K  +  QE A+K ++K+S +         E +L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQGLLYLHKY 136
                   +V E      L    FD   K     +KRF+      II+ +  G+ Y+HK+
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 SRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           +   ++HRDLK  NILL+ +    + KI DFG++  F  N         +GT  Y++PE 
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE- 193
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK-----KNNGCYDTERHLNLVGYAWQL 240
           V+ G    K DV+S GV++  ++S       KN   YD  + +    YA+ L
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDL 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 26  LGQGGFGPVYKGKLL-DG--QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
           +G+G FG V K ++  DG   + AIKR+ + +S     +F  E +++ KL  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 81  GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
           G    +G   L  EY P+ +L DF            F   +S    L  ++  +    + 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +G+ YL   S+ + IHR+L A NIL+ +    KI+DFG++R       E    + +G   
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 201
Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M+ E +   + +  SDV+S+GVL+ EI+S
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 26  LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVR 78
           +G+G FG V++ +   LL  +    +A+K L + +   +  +F+ EA L+A+  + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFI---------------------FDSSKKELLDWK 117
           LLG         L++EY+    L+ F+                       S     L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART-FGMNELE 176
           ++  I   +  G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R  +  +  +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           A+ N  +    +M PE +     + +SDV+++GV++ EI S
Sbjct: 232 ADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G L L G+    +AIK L S  + +   +F +EA ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    +++ E++ N SLD F+  +  +  +   +   ++ GI  G+ YL   + + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 155
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNG 197
            +HRDL A NIL++  +  K+SDFG++R    +  +      +G      + +PE +   
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 198 IVSMKSDVYSFGVLVLEIIS 217
             +  SDV+S+G+++ E++S
Sbjct: 216 KFTSASDVWSYGIVMWEVMS 235

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V +      G+E     +A+K L  ++     E   +E K+++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELLDW 116
           L QH N+V LLG     G  L++ EY     L  F+           ++ S   +E L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
           +   +    + QG+ +L   +    IHRD+ A N+LL +    KI DFG+AR   MN+  
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND-- 219
Query: 177 ANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTER 229
             +N IV  +      +M+PE + + + +++SDV+S+G+L+ EI S   N   G     +
Sbjct: 220 --SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 277
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
              LV   +Q+     A + I + +                  C   + T RPT   + S
Sbjct: 278 FYKLVKDGYQMAQPAFAPKNIYSIMQA----------------CWALEPTHRPTFQQICS 321
Query: 290 ML 291
            L
Sbjct: 322 FL 323

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7   IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
           +F   + A  +D +     LG+G FG V   K  + GQE A+K +SK   +   + ++  
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 97
Query: 64  -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
            E +L+ +L H N+++L      KG   LV E      L    FD    E++  +KRF+ 
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 148
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
                II  ++ G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F   
Sbjct: 149 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 202
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           E        +GT  Y++PE V++G    K DV+S GV++  ++S     GC
Sbjct: 203 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 247

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 26  LGQGGFGPVYKGKLL-DGQ----EIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG VYKG  + DG+     +AIK L + +S +   E  +EA ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           LG  L    +L V + +P   L   + ++      ++LL+W  +      I +G+ YL  
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              +R++HRDL A N+L+    + KI+DFG+AR   ++E E + +       +M+ E ++
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               + +SDV+S+GV V E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7   IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
           +F   + A  +D +     LG+G FG V   K  + GQE A+K +SK   +   + ++  
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 98
Query: 64  -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
            E +L+ +L H N+++L      KG   LV E      L    FD    E++  +KRF+ 
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 149
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
                II  ++ G+ Y+HK    +++HRDLK  N+LL+ +    N +I DFG++  F   
Sbjct: 150 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 203
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           E        +GT  Y++PE V++G    K DV+S GV++  ++S     GC
Sbjct: 204 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 248

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 119
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVA 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 120
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVA 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
           D  + G  LG+G FG V         K K  +   +A+K L   + +     +V      
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66  KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
           K+I K  H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E
Sbjct: 95  KMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
            + +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +   NT        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 117
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVA 204

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 16/228 (7%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQ 72
           +++  F    +LG G +  VYKG     G  +A+K +   S +G       E  L+ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPN---KSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQ 128
           H N+VRL      + +  LV+E++ N   K +D     ++ + L L+  K F     ++Q
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQ 119
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT-NRIVGTHG 187
           GL + H+    +++HRDLK  N+L++ +   K+ DFG+AR FG   +  NT +  V T  
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVVTLW 173
Query: 188 YMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
           Y +P+ +M     S   D++S G ++ E+I+ K      + E  L L+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 118
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVA 205

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 124
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVA 211

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 143
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 139
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 143
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 139
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVA 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 59/309 (19%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V +      G+E     +A+K L  ++     E   +E K+++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI--------------------FDSS 109
           L QH N+V LLG     G  L++ EY     L  F+                     D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 110 KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
               L+ +   +    + QG+ +L   +    IHRD+ A N+LL +    KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 170 FGMNELEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--N 222
             MN+    +N IV  +      +M+PE + + + +++SDV+S+G+L+ EI S   N   
Sbjct: 208 I-MND----SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 262
Query: 223 GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP 282
           G     +   LV   +Q+                + +P  +   +     C   + T RP
Sbjct: 263 GILVNSKFYKLVKDGYQM-------------AQPAFAPKNIYSIMQA---CWALEPTHRP 306
Query: 283 TMSDVASML 291
           T   + S L
Sbjct: 307 TFQQICSFL 315

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 145
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVA 232

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHT 74
           NF    ++G+G F  VY+   LLDG  +A+K++        +   +   E  L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYL 133
           N+++     ++  E  +V E      L   I    K K L+  +  +     +   L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H  SR RV+HRD+K +N+ +      K+ D G+ R F      A++  +VGT  YMSPE 
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     + KSD++S G L+ E+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++GQG  G VY    +  GQE+AI++++           NE  ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V EYL   SL   + ++     +D  +   +    +Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ NILL    + K++DFG        + + +T  +VGT  +M+PE V       K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 197
Query: 204 DVYSFGVLVLEIISSK 219
           D++S G++ +E+I  +
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18  DNFSPGNRLGQGGFGP-VYKGKLLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F   V   +L   +E AIK L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74  TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
              V+L   + Q  E+L     Y  N  L  +I     FD +         RF   E IV
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y+SPE +        SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D  + G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKT 136
Query: 118 -----KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 165
                K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
           +AR    +              +M+PE + + + +++SDV+SFGVL+ EI S        
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------- 245
Query: 226 DTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTM 284
                L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT 
Sbjct: 246 -----LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 285 SDVASMLTN 293
           S++   L N
Sbjct: 299 SELVEHLGN 307

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
           +F P   LG+GGFG V++ K  +D    AIKR+   + +   E    E K +AKL+H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---------KKR---FNIIE 124
           VR     L+K     +    P   L   +    K+ L DW         ++R    +I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNIL--LDDQMNPKISDFGMARTFGMNELE------ 176
            I + + +LH      ++HRDLK SNI   +DD +  K+ DFG+      +E E      
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVV--KVGDFGLVTAMDQDEEEQTVLTP 180
Query: 177 ----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
               A     VGT  YMSPE +     S K D++S G+++ E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G+L L G+    +AIK L    + +   +F  EA ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    ++V E++ N +LD F+     +  +   +   ++ GI  G+ YL   + + 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYL---ADMG 165
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
            +HRDL A NIL++  +  K+SDFG++R      +E +   +  T G      + +PE +
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                +  SDV+S+G+++ E++S
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS 243

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +G G +G   K      GK+L  +E+    ++++  Q +V   +E  L+ +L+H N+VR 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 80  LGCSLQKGERLL--VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKY 136
               + +    L  V EY     L   I   +K ++ LD +    ++  +   L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 137 SR--LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           S     V+HRDLK +N+ LD + N K+ DFG+AR   +N  E      VGT  YMSPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQM 188
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                + KSD++S G L+ E+ +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++GQG  G VY    +  GQE+AI++++           NE  ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V EYL   SL   + ++     +D  +   +    +Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ NILL    + K++DFG      +   ++  + +VGT  +M+PE V       K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 204 DVYSFGVLVLEIISSK 219
           D++S G++ +E+I  +
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 37/305 (12%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D  + G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 61  FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY----------EYLPNKSLDFFIFDSS 109
             +E K++  +  H N+V LLG   + G  L+V            YL +K  +F  +   
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 110 KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
            K+ L  +        + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR 
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARD 193
Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER 229
              +              +M+PE + + + +++SDV+SFGVL+ EI S            
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------------ 241
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVA 288
            L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT S++ 
Sbjct: 242 -LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298
Query: 289 SMLTN 293
             L N
Sbjct: 299 EHLGN 303

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 37/305 (12%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D  + G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 61  FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY----------EYLPNKSLDFFIFDSS 109
             +E K++  +  H N+V LLG   + G  L+V            YL +K  +F  +   
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 110 KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
            K+ L  +        + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR 
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARD 193
Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER 229
              +              +M+PE + + + +++SDV+SFGVL+ EI S            
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------------ 241
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVA 288
            L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT S++ 
Sbjct: 242 -LGASPYPGVKIDEEFXRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298
Query: 289 SMLTN 293
             L N
Sbjct: 299 EHLGN 303

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 112/211 (53%), Gaps = 30/211 (14%)
Query: 27  GQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNLVRLLGCSL 84
            +G FG V+K +LL+ + +A+K       Q    ++NE ++  +  ++H N+++ +G   
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAE- 87
Query: 85  QKGERL-----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK---- 135
           ++G  +     L+  +    SL  F+    K  ++ W +  +I E + +GL YLH+    
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 136 ---YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
                +  + HRD+K+ N+LL + +   I+DFG+A  F   +   +T+  VGT  YM+PE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 193 YVMNGIVS------MKSDVYSFGVLVLEIIS 217
            V+ G ++      ++ D+Y+ G+++ E+ S
Sbjct: 204 -VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 136/308 (44%), Gaps = 41/308 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKP 137
Query: 118 ----KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 166
               K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DFG+
Sbjct: 138 EDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGL 194
Query: 167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD 226
           AR    +              +M+PE + + + +++SDV+SFGVL+ EI S         
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 245
Query: 227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMS 285
               L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT S
Sbjct: 246 ----LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 286 DVASMLTN 293
           ++   L N
Sbjct: 300 ELVEHLGN 307

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 23  GNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNLVR 78
           G+ LG G FG V  GK  L G ++A+K L++   +    + + + E + +   +H ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
           L        +  +V EY+    L  +I  + +   LD K+   + + I+ G+ Y H++  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM- 136
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
             V+HRDLK  N+LLD  MN KI+DFG++      E    +    G+  Y +PE +   +
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRL 191
Query: 199 VS-MKSDVYSFGVLVLEII 216
            +  + D++S GV++  ++
Sbjct: 192 YAGPEVDIWSSGVILYALL 210

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V K K    +++AIK++   S +    F  E + ++++ H N+V+L G  L 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
                LV EY    SL   +  +            +      QG+ YLH      +IHRD
Sbjct: 74  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 146 LKASNILL-DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
           LK  N+LL       KI DFG A      +++ +     G+  +M+PE       S K D
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 205 VYSFGVLVLEIISSKK 220
           V+S+G+++ E+I+ +K
Sbjct: 187 VFSWGIILWEVITRRK 202

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 10/215 (4%)
Query: 6   KIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNE 64
           K+    ++      ++   ++GQG  G VY    +  GQE+AI++++           NE
Sbjct: 9   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 68
Query: 65  AKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
             ++ + ++ N+V  L   L   E  +V EYL   SL   + ++     +D  +   +  
Sbjct: 69  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCR 124
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
             +Q L +LH     +VIHRD+K+ NILL    + K++DFG      +   ++  + +VG
Sbjct: 125 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           T  +M+PE V       K D++S G++ +E+I  +
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 34/227 (14%)
Query: 11  QTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---EAK 66
            + A  +D +     LG+G FG V   K  + GQE A+K +SK   +   + ++   E +
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN----- 121
           L+ +L H N+ +L      KG   LV E      L    FD    E++  +KRF+     
Sbjct: 79  LLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSEVDAA 129
Query: 122 -IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEA 177
            II  ++ G+ Y HK    +++HRDLK  N+LL+ +    N +I DFG++  F   E   
Sbjct: 130 RIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASK 183
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
                +GT  Y++PE V++G    K DV+S GV++  ++S     GC
Sbjct: 184 KXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 224

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++GQG  G VY    +  GQE+AI++++           NE  ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V EYL   SL   + ++     +D  +   +    +Q L +LH     +VIH
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ NILL    + K++DFG      +   ++  + +VGT  +M+PE V       K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 204 DVYSFGVLVLEIISSK 219
           D++S G++ +E+I  +
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +G G +G   K      GK+L  +E+    ++++  Q +V   +E  L+ +L+H N+VR 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 80  LGCSLQKGERLL--VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKY 136
               + +    L  V EY     L   I   +K ++ LD +    ++  +   L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 137 SR--LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           S     V+HRDLK +N+ LD + N K+ DFG+AR    +   A T   VGT  YMSPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQM 188
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                + KSD++S G L+ E+ +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V K K    +++AIK++   S +    F  E + ++++ H N+V+L G  L 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 86  KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
                LV EY    SL   +  +            +      QG+ YLH      +IHRD
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 146 LKASNILL-DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
           LK  N+LL       KI DFG A      +++ +     G+  +M+PE       S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 205 VYSFGVLVLEIISSKK 220
           V+S+G+++ E+I+ +K
Sbjct: 186 VFSWGIILWEVITRRK 201

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 26  LGQGGFGPVYKGKL-----LDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V   +        G+++A+K L  +S G  I + K E +++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 80  LG-CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G C+   G  + L+ E+LP+ SL  ++  +  K  ++ K++      I +G+ YL    
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE--LEANTNRIVGTHGYMSPEYVM 195
             + +HRDL A N+L++ +   KI DFG+ +    ++       +R      Y +PE +M
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
                + SDV+SFGV + E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 26  LGQGGFGPVYKGKLLD-----GQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+G FG V   +        G+++A+K L  +S G  I + K E +++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 80  LG-CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            G C+   G  + L+ E+LP+ SL  ++  +  K  ++ K++      I +G+ YL    
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYL---G 143
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE--LEANTNRIVGTHGYMSPEYVM 195
             + +HRDL A N+L++ +   KI DFG+ +    ++       +R      Y +PE +M
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
                + SDV+SFGV + E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 126
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
                 K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           G+AR    +              +M+PE + + + +++SDV+SFGVL+ EI S       
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 236
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
                 L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT
Sbjct: 237 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 284 MSDVASMLTN 293
            S++   L N
Sbjct: 289 FSELVEHLGN 298

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 135
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
                 K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           G+AR    +              +M+PE + + + +++SDV+SFGVL+ EI S       
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 245
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
                 L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT
Sbjct: 246 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 284 MSDVASMLTN 293
            S++   L N
Sbjct: 298 FSELVEHLGN 307

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +  + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 237 LISRLLKHNPSQRPMLR 253

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
           D  + G  LG+G FG V         K K  +   +A+K L   + +     +V      
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66  KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
           K+I K  H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E
Sbjct: 95  KMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
            + +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +    T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKL 67
            A   N+     LG+G FG V        GQ++A+K      L+KS  QG +E   E   
Sbjct: 10  GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISY 67
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  L+H ++++L      K E ++V EY  N+  D+ +    +++ +  ++     + I+
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQII 123
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             + Y H++   +++HRDLK  N+LLD+ +N KI+DFG++           +    G+  
Sbjct: 124 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPN 177
Query: 188 YMSPEYVMNGIVS-MKSDVYSFGVLV 212
           Y +PE +   + +  + DV+S GV++
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 43/300 (14%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 70
           D    G  LG+G FG V +       K    + +A+K L + +         +E K++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 71  L-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK-------KRFN 121
           +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K       K F 
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFL 136
Query: 122 IIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    + 
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
                        +M+PE + + + +++SDV+SFGVL+ EI S             L   
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGAS 240
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
            Y     +E     L + T     +PD  T  ++  +L C   + + RPT S++   L N
Sbjct: 241 PYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
           D  + G  LG+G FG V         K K  +   +A+K L   + +     +V      
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66  KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
           K+I K  H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E
Sbjct: 95  KMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
            + +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +    T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
           F+   ++G+G FG V+KG  +D +    +AIK +  + +   I + + E  ++++     
Sbjct: 9   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           + +  G  L+  +  ++ EYL   S      D  +   LD  +   I+  I++GL YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE + 
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 177
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
                 K+D++S G+  +E+
Sbjct: 178 QSAYDSKADIWSLGITAIEL 197

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLI 68
           A   N+     LG+G FG V        GQ++A+K      L+KS  QG +E   E   +
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 58
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
             L+H ++++L      K E ++V EY  N+  D+ +      E     +RF   + I+ 
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIIS 114
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
            + Y H++   +++HRDLK  N+LLD+ +N KI+DFG++           +    G+  Y
Sbjct: 115 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 168
Query: 189 MSPEYVMNGIVS-MKSDVYSFGVLV 212
            +PE +   + +  + DV+S GV++
Sbjct: 169 AAPEVISGKLYAGPEVDVWSCGVIL 193

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKL 67
            A   N+     LG+G FG V        GQ++A+K      L+KS  QG +E   E   
Sbjct: 9   GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISY 66
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  L+H ++++L      K E ++V EY  N+  D+ +    +++ +  ++     + I+
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQII 122
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             + Y H++   +++HRDLK  N+LLD+ +N KI+DFG++           +    G+  
Sbjct: 123 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPN 176
Query: 188 YMSPEYVMNGIVS-MKSDVYSFGVLV 212
           Y +PE +   + +  + DV+S GV++
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
           D  + G  LG+G FG V         K K  +   +A+K L   + +     +V      
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66  KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
           K+I K  H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E
Sbjct: 95  KMIGK--HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
            + +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +    T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
           F+   ++G+G FG V+KG  +D +    +AIK +  + +   I + + E  ++++     
Sbjct: 29  FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           + +  G  L+  +  ++ EYL   S      D  +   LD  +   I+  I++GL YLH 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE + 
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 197
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
                 K+D++S G+  +E+
Sbjct: 198 QSAYDSKADIWSLGITAIEL 217

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +  + + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     +VIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   DT + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 236 LISRLLKHNPSQRPMLREV 254

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G FG VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 131
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 190
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKL 67
            A   N+     LG+G FG V        GQ++A+K      L+KS  QG +E   E   
Sbjct: 4   GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISY 61
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  L+H ++++L      K E ++V EY  N+  D+ +    +++ +  ++     + I+
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQII 117
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             + Y H++   +++HRDLK  N+LLD+ +N KI+DFG++           +    G+  
Sbjct: 118 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPN 171
Query: 188 YMSPEYVMNGIVS-MKSDVYSFGVLV 212
           Y +PE +   + +  + DV+S GV++
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVIL 197

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +  + + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 262 LISRLLKHNPSQRPMLREV 280

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 135
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
                 K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           G+AR    +              +M+PE + + + +++SDV+SFGVL+ EI S       
Sbjct: 193 GLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 245
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
                 L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT
Sbjct: 246 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 284 MSDVASMLTN 293
            S++   L N
Sbjct: 298 FSELVEHLGN 307

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 22/248 (8%)
Query: 8   FDFQTIAA---ATDNF---SPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVE 60
           FD + + A   A ++F   S    LG G FG V+K  +   G ++A K +     +   E
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 61  FKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKR 119
            KNE  ++ +L H NL++L      K + +LV EY+    L D  I +S     LD    
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---T 189
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL--DDQMNPKISDFGMARTFGMNE-LE 176
              ++ I +G+ ++H   ++ ++H DLK  NIL    D    KI DFG+AR +   E L+
Sbjct: 190 ILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERHLNLVG 235
            N     GT  +++PE V    VS  +D++S GV+   ++S      G  D E   N++ 
Sbjct: 247 VN----FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 236 YAWQLWNE 243
             W L +E
Sbjct: 303 CRWDLEDE 310

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 241 LISRLLKHNPSQRPMLR 257

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 239 LISRLLKHNPSQRPMLR 255

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +G+G FG V  G    G ++A+K + + ++ Q    F  EA ++ +L+H+NLV+LLG  +
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 85  Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + KG   +V EY+   SL  ++    +  L  D   +F++   + + + YL   +    +
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 130
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
           HRDL A N+L+ +    K+SDFG+ +       EA++ +  G     + +PE +     S
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 201 MKSDVYSFGVLVLEIIS 217
            KSDV+SFG+L+ EI S
Sbjct: 184 TKSDVWSFGILLWEIYS 200

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 234
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 235 LISRLLKHNPSQRPMLR 251

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 134/312 (42%), Gaps = 47/312 (15%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 61  FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY----------EYLPNKSLDFFIFDSS 109
             +E K++  +  H N+V LLG   + G  L+V            YL +K  +F  +  +
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 110 KKELLDWKKRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS 162
            ++L    K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI 
Sbjct: 139 PEDLY---KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 192
Query: 163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN 222
           DFG+AR    +              +M+PE + + + +++SDV+SFGVL+ EI S     
Sbjct: 193 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----- 247
Query: 223 GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDR 281
                   L    Y     +E     L + T     +PD  T  ++  +L C   + + R
Sbjct: 248 --------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQR 297
Query: 282 PTMSDVASMLTN 293
           PT S++   L N
Sbjct: 298 PTFSELVEHLGN 309

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +  + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKV 126
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
                 K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           G+AR    +              +M+PE + + + +++SDV+SFGVL+ EI S       
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 236
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
                 L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT
Sbjct: 237 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 284 MSDVASMLTN 293
            S++   L N
Sbjct: 289 FSELVEHLGN 298

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           E +   +   K D++S GVL  E +  K
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 237 LISRLLKHNPSQRPMLR 253

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +G G +G   K      GK+L  +E+    ++++  Q +V   +E  L+ +L+H N+VR 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 80  LGCSLQKGERLL--VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKY 136
               + +    L  V EY     L   I   +K ++ LD +    ++  +   L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 137 SR--LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           S     V+HRDLK +N+ LD + N K+ DFG+AR   +N   +     VGT  YMSPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQM 188
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                + KSD++S G L+ E+ +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++GQG  G VY    +  GQE+AI++++           NE  ++ + ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  +V EYL   SL   + ++     +D  +   +    +Q L +LH     +VIH
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           R++K+ NILL    + K++DFG        + + +T  +VGT  +M+PE V       K 
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 198
Query: 204 DVYSFGVLVLEIISSK 219
           D++S G++ +E+I  +
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   +   +   SK    D ++    I  +   L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 241 LISRLLKHNPSQRPMLR 257

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 23  GNR--LGQGGFGPVYKGKLLDGQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           G+R  LG+G +G VY G+ L  Q  IAIK + +   +       E  L   L+H N+V+ 
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQGLLYLHKYSR 138
           LG   + G   +  E +P  SL   +  S    L D ++      + I++GL YLH    
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 139 LRVIHRDLKASNILLDDQMNP-KISDFGMA-RTFGMNELEANTNRIVGTHGYMSPEYVMN 196
            +++HRD+K  N+L++      KISDFG + R  G+N     T    GT  YM+PE +  
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDK 197
Query: 197 GI--VSMKSDVYSFGVLVLEIISSK 219
           G       +D++S G  ++E+ + K
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 241 LISRLLKHNPSQRPMLR 257

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 238 LISRLLKHNPSQRPMLR 254

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 239
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 240 LISRLLKHNPSQRPMLREV 258

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 131/269 (48%), Gaps = 30/269 (11%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 131
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-WTAPESLAYNKFSIK 190
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH----ESC 258
           SDV++FGVL+ EI +       Y    +  +        +  +  EL++        E C
Sbjct: 191 SDVWAFGVLLWEIAT-------YGMSPYPGI--------DPSQVYELLEKDYRMERPEGC 235
Query: 259 SPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
            P++V   +     C Q   +DRP+ +++
Sbjct: 236 -PEKVYELMRA---CWQWNPSDRPSFAEI 260

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 26  LGQGGFGPVYKGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +G G FG V  G L L G+    +AIK L S  + +   +F +EA ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   +    +++ E++ N SLD F+  +  +  +   +   ++ GI  G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNG 197
            +HR L A NIL++  +  K+SDFG++R    +  +      +G      + +PE +   
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 198 IVSMKSDVYSFGVLVLEIIS 217
             +  SDV+S+G+++ E++S
Sbjct: 190 KFTSASDVWSYGIVMWEVMS 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 262 LISRLLKHNPSQRPMLREV 280

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 135
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
                 K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           G+AR    +              +M+PE + + + +++SDV+SFGVL+ EI S       
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 245
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
                 L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT
Sbjct: 246 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 284 MSDVASMLTN 293
            S++   L N
Sbjct: 298 FSELVEHLGN 307

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 43/300 (14%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 70
           D    G  LG+G FG V +       K    + +A+K L + +         +E K++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 71  L-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK-------KRFN 121
           +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K       K F 
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFL 136
Query: 122 IIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    + 
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
                        +M+PE + + + +++SDV+SFGVL+ EI S             L   
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGAS 240
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
            Y     +E     L + T     +PD  T  ++  +L C   + + RPT S++   L N
Sbjct: 241 PYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 26  LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
           LG+G FG        P   G    G+ +A+K L +  G  +   ++ E +++  L H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 77  VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           V+  GC   +GE+   LV EY+P  SL     D   +  +   +     + I +G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                  IHR L A N+LLD+    KI DFG+A+       E +    V   G     + 
Sbjct: 129 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 181
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +        SDV+SFGV + E+++   +N    T +   L+G+      +G+   L
Sbjct: 182 APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHT-KFTELIGH-----TQGQMTVL 235
Query: 250 IDTTLHESCS----PDEVTRC----IHVGLLCVQDKATDRPTMSDVASML 291
             T L E       PD   RC     H+   C + +A+ RPT  ++  +L
Sbjct: 236 RLTELLERGERLPRPD---RCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 196
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
           +D        D    G  LG+G FG V +       K    + +A+K L + +       
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 61  FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
             +E K++  +  H N+V LLG C+   G  +++ E+    +L  ++  S + E + +K 
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 172
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
                 K F  +E ++       +G+ +L   +  + IHRDL A NILL ++   KI DF
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 229
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           G+AR    +              +M+PE + + + +++SDV+SFGVL+ EI S       
Sbjct: 230 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 282
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
                 L    Y     +E     L + T     +PD  T  ++  +L C   + + RPT
Sbjct: 283 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 334
Query: 284 MSDVASMLTN 293
            S++   L N
Sbjct: 335 FSELVEHLGN 344

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 236 LISRLLKHNPSQRPMLREV 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 41/287 (14%)
Query: 26  LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
           LG+G FG        P   G    G+ +A+K L    G Q    +K E  ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 77  VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           ++  GC   +GE+   LV EY+P  SL     D   +  +   +     + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                  IHR+L A N+LLD+    KI DFG+A+       E +    V   G     + 
Sbjct: 135 A---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 187
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +        SDV+SFGV + E+++   ++    T + L L+G A     +G+   L
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT-KFLELIGIA-----QGQMTVL 241
Query: 250 IDTTLHESCS----PDEV-TRCIHVGLLCVQDKATDRPTMSDVASML 291
             T L E       PD+      H+   C + +A+ RPT  ++  +L
Sbjct: 242 RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 41/287 (14%)
Query: 26  LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
           LG+G FG        P   G    G+ +A+K L    G Q    +K E  ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 77  VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           ++  GC   +GE+   LV EY+P  SL     D   +  +   +     + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                  IHR+L A N+LLD+    KI DFG+A+       E +    V   G     + 
Sbjct: 135 S---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 187
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +        SDV+SFGV + E+++   ++    T + L L+G A     +G+   L
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT-KFLELIGIA-----QGQMTVL 241
Query: 250 IDTTLHESCS----PDEV-TRCIHVGLLCVQDKATDRPTMSDVASML 291
             T L E       PD+      H+   C + +A+ RPT  ++  +L
Sbjct: 242 RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 26  LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
           LG+G FG        P   G    G+ +A+K L +  G  +   ++ E +++  L H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 77  VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           V+  GC   +GE+   LV EY+P  SL     D   +  +   +     + I +G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                  IHR L A N+LLD+    KI DFG+A+       E +    V   G     + 
Sbjct: 130 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 182
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +        SDV+SFGV + E+++   +N    T +   L+G+      +G+   L
Sbjct: 183 APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHT-KFTELIGH-----TQGQMTVL 236
Query: 250 IDTTLHESCS----PDEVTRC----IHVGLLCVQDKATDRPTMSDVASML 291
             T L E       PD   RC     H+   C + +A+ RPT  ++  +L
Sbjct: 237 RLTELLERGERLPRPD---RCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   +   +   SK    D ++    I  +   L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 241 LISRLLKHNPSQRPMLREV 259

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 37/209 (17%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           ++G+G +G VYK +   G+  A+K++  +   +GI      E  ++ +L+H+N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-------------IVQG 129
              K   +LV+E+L          D   K+LLD      + EG             ++ G
Sbjct: 69  IHTKKRLVLVFEHL----------DQDLKKLLD------VCEGGLESVTAKSFLLQLLNG 112
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           + Y H     RV+HRDLK  N+L++ +   KI+DFG+AR FG+  +   T+ IV T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYR 167
Query: 190 SPEYVMNG-IVSMKSDVYSFGVLVLEIIS 217
           +P+ +M     S   D++S G +  E+++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 194
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 239 LISRLLKHNPSQRPMLR 255

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
           F+   ++G+G FG V+KG  +D +    +AIK +  + +   I + + E  ++++     
Sbjct: 9   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           + +  G  L+  +  ++ EYL   S      D  +   LD  +   I+  I++GL YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +   IHRD+KA+N+LL +    K++DFG+A    + + +   N  VGT  +M+PE + 
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIK 177
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
                 K+D++S G+  +E+
Sbjct: 178 QSAYDSKADIWSLGITAIEL 197

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 130/269 (48%), Gaps = 30/269 (11%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+        +   I   + YL K +    I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN---FI 131
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 190
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH----ESC 258
           SDV++FGVL+ EI +       Y    +  +        +  +  EL++        E C
Sbjct: 191 SDVWAFGVLLWEIAT-------YGMSPYPGI--------DPSQVYELLEKDYRMERPEGC 235
Query: 259 SPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
            P++V   +     C Q   +DRP+ +++
Sbjct: 236 -PEKVYELMRA---CWQWNPSDRPSFAEI 260

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 23  GNR--LGQGGFGPVYKGKLLDGQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           G+R  LG+G +G VY G+ L  Q  IAIK + +   +       E  L   L+H N+V+ 
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQGLLYLHKYSR 138
           LG   + G   +  E +P  SL   +  S    L D ++      + I++GL YLH    
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 139 LRVIHRDLKASNILLDDQMNP-KISDFGMA-RTFGMNELEANTNRIVGTHGYMSPEYVMN 196
            +++HRD+K  N+L++      KISDFG + R  G+N     T    GT  YM+PE +  
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDK 183
Query: 197 GI--VSMKSDVYSFGVLVLEIISSK 219
           G       +D++S G  ++E+ + K
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPAFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 193
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 194
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    +I+DFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 146
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 205
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 232
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 233 LISRLLKHNPSQRPMLR 249

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E +
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
           F+   ++G+G FG V+KG  +D +    +AIK +  + +   I + + E  ++++     
Sbjct: 24  FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           + +  G  L+  +  ++ EYL   S      D  +   LD  +   I+  I++GL YLH 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +   IHRD+KA+N+LL +    K++DFG+A    + + +   N  VGT  +M+PE + 
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIK 192
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
                 K+D++S G+  +E+
Sbjct: 193 QSAYDSKADIWSLGITAIEL 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           F+ S   +E L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 45/236 (19%)
Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
           DF+ IA           LGQG FG V K +  LD +  AIK++ + + + +    +E  L
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 68  IAKLQHTNLVRLLGCSLQ-------------KGERLLVYEYLPNKSLDFFIFDSSKKELL 114
           +A L H  +VR     L+             K    +  EY  N++L   I   +  +  
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTF 170
           D  + + +   I++ L Y+H      +IHRDLK  NI +D+  N KI DFG+A    R+ 
Sbjct: 116 D--EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 171 GMNELEA--------NTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEII 216
            + +L++        N    +GT  Y++ E V++G    + K D+YS G++  E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           +D ++  +E +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           E +       K D++S GVL  E +  K
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 37/209 (17%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           ++G+G +G VYK +   G+  A+K++  +   +GI      E  ++ +L+H+N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-------------IVQG 129
              K   +LV+E+L          D   K+LLD      + EG             ++ G
Sbjct: 69  IHTKKRLVLVFEHL----------DQDLKKLLD------VCEGGLESVTAKSFLLQLLNG 112
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           + Y H     RV+HRDLK  N+L++ +   KI+DFG+AR FG+  +   T+ +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYR 167
Query: 190 SPEYVMNG-IVSMKSDVYSFGVLVLEIIS 217
           +P+ +M     S   D++S G +  E+++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +G+G FG V  G    G ++A+K + + ++ Q    F  EA ++ +L+H+NLV+LLG  +
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 85  Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + KG   +V EY+   SL  ++    +  L  D   +F++   + + + YL   +    +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 311
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
           HRDL A N+L+ +    K+SDFG+ +       EA++ +  G     + +PE +     S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 201 MKSDVYSFGVLVLEIIS 217
            KSDV+SFG+L+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 37/209 (17%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           ++G+G +G VYK +   G+  A+K++  +   +GI      E  ++ +L+H+N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-------------IVQG 129
              K   +LV+E+L          D   K+LLD      + EG             ++ G
Sbjct: 69  IHTKKRLVLVFEHL----------DQDLKKLLD------VCEGGLESVTAKSFLLQLLNG 112
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           + Y H     RV+HRDLK  N+L++ +   KI+DFG+AR FG+  +   T+ +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYR 167
Query: 190 SPEYVMNG-IVSMKSDVYSFGVLVLEIIS 217
           +P+ +M     S   D++S G +  E+++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A          + +PE +     S+K
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-WTAPESLAYNKFSIK 193
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 237 LISRLLKHNPSQRPMLREV 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +G+G FG V  G    G ++A+K + + ++ Q    F  EA ++ +L+H+NLV+LLG  +
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 85  Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + KG   +V EY+   SL  ++    +  L  D   +F++   + + + YL   +    +
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 124
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
           HRDL A N+L+ +    K+SDFG+ +       EA++ +  G     + +PE +     S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 201 MKSDVYSFGVLVLEIIS 217
            KSDV+SFG+L+ EI S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL A N L+ +    K++DFG++R    +   A          + +PE +     S+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-WTAPESLAYNKFSIK 194
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNLVRLLGC 82
           +G+G +G V K +  D G+ +AIK+  +S    +V+     E KL+ +L+H NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 83  SLQKGERLLVYEYLPNKSLD-FFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
             +K    LV+E++ +  LD   +F +     +  K  F II GI  G  + H      +
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFCHSHN-----I 145
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNRIVGTHGYMSPEYVMNGIVS 200
           IHRD+K  NIL+      K+ DFG ART     E+  +    V T  Y +PE ++  +  
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAPELLVGDVKY 202
Query: 201 MKS-DVYSFGVLVLEII 216
            K+ DV++ G LV E+ 
Sbjct: 203 GKAVDVWAIGCLVTEMF 219

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKLQ 72
           AT  + P   +G G +G VYK +    G  +A+K +   +G+ G+ +    E  L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 73  ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
              H N+VRL+  C+  + +R     LV+E++ ++ L  ++ D +    L  +   +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
             ++GL +LH      ++HRDLK  NIL+      K++DFG+AR +     +   + +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           T  Y +PE ++    +   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 126
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 178
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           +G+G FG V  G    G ++A+K + + ++ Q    F  EA ++ +L+H+NLV+LLG  +
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 85  Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
           + KG   +V EY+   SL  ++    +  L  D   +F++   + + + YL   +    +
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 139
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
           HRDL A N+L+ +    K+SDFG+ +       EA++ +  G     + +PE +     S
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 201 MKSDVYSFGVLVLEIIS 217
            KSDV+SFG+L+ EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAK- 70
           I    ++F     LG+G FG V+  +     Q  AIK L K     +++   E  ++ K 
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKR 70
Query: 71  -----LQHTNLVRLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
                 +H  L  +  C+ Q  E L  V EYL    L + I    K +L   +  F   E
Sbjct: 71  VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAE 127
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I+ GL +LH      +++RDLK  NILLD   + KI+DFGM +   +   +A TN   G
Sbjct: 128 -IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNEFCG 181
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           T  Y++PE ++    +   D +SFGVL+ E++
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI++FG    + ++   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
           LI   L  + S   + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
           A ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N++RL G         L+ EY P   L     +  K    D ++    I  +   L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H     RVIHRD+K  N+LL      KI++FG    + ++   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           E +   +   K D++S GVL  E +  K   + N   +T + ++ V + +  +    A +
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 249 LIDTTLHESCSPDEVTR 265
           LI   L  + S   + R
Sbjct: 238 LISRLLKHNPSQRPMLR 254

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 126
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 178
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 26  LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
           LG+G FG        P   G    G+ +A+K L   +G Q    +K E  ++  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 77  VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           ++  GC    G     LV EY+P  SL     D   +  +   +     + I +G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                  IHRDL A N+LLD+    KI DFG+A+       E +    V   G     + 
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEXYRVREDGDSPVFWY 204
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +        SDV+SFGV + E+++   ++    T + L L+G A     +G+   L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT-KFLELIGIA-----QGQMTVL 258
Query: 250 IDTTLHESCS----PDEV-TRCIHVGLLCVQDKATDRPTMSDVASML 291
             T L E       PD+      H+   C + +A+ RPT  ++  +L
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
           +D +  G  LG GG   V+  + L D +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73  HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           H  +V +      +        +V EY+   +L   +        +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
            L + H+     +IHRD+K +NIL+      K+ DFG+AR           T  ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y+SPE      V  +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKLQH 73
           ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G         L+ EY P   L     +  K    D ++    I  +   L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H     RVIHRD+K  N+LL      KI+DFG    + ++   +  + + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 194 VMNGIVSMKSDVYSFGVLVLEII 216
           +   +   K D++S GVL  E +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKLQ 72
           AT  + P   +G G +G VYK +    G  +A+K +   +G+ G+ +    E  L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 73  ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
              H N+VRL+  C+  + +R     LV+E++ ++ L  ++ D +    L  +   +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
             ++GL +LH      ++HRDLK  NIL+      K++DFG+AR +      A    +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           T  Y +PE ++    +   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D  + G  LG+G FG V         K K  +   +A+K L   ++ + + +  +E +++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
             + +H N++ LLG   Q G   ++  Y    +L  ++           +D ++  +E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
            +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFK 62
           R L   D   +      F     +G G +G VYKG+ +   ++A  ++   +G    E K
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 63  NEAKLIAKL-QHTNLVRLLGCSLQKG------ERLLVYEYLPNKSLDFFIFDSSKKELLD 115
            E  ++ K   H N+    G  ++K       +  LV E+    S+   I  ++K   L 
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLK 127
Query: 116 WKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTFG 171
            +    I   I++GL +LH++   +VIHRD+K  N+LL +    K+ DFG++    RT G
Sbjct: 128 EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 172 MNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
                   N  +GT  +M+PE +      +     KSD++S G+  +E+
Sbjct: 185 ------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKLQH 73
           ++F  G  LG+G FG VY  +    + I A+K L K+  +  G+  + + E ++ + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G         L+ EY P   L     +  K    D ++    I  +   L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H     RVIHRD+K  N+LL      KI+DFG    + ++   +    + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 194 VMNGIVSMKSDVYSFGVLVLEII 216
           +   +   K D++S GVL  E +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 91/329 (27%), Positives = 139/329 (42%), Gaps = 53/329 (16%)
Query: 25  RLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNLV 77
           +LG G FG V +G+     G+   +A+K L     S  + + +F  E   +  L H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           RL G  L    ++ V E  P  SL   +       LL    R+ +   + +G+ YL    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSPE 192
             R IHRDL A N+LL  +   KI DFG+ R    N    + + ++  H      + +PE
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAPE 188
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT 252
            +     S  SD + FGV + E+ +       Y  E  + L        N  + L  ID 
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKIDK 233
Query: 253 TLHESCSPDEVTRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINIS 311
                  P++  + I+ V + C   K  DRPT   +   L     A PT       +   
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE---AQPTD------MRAL 284
Query: 312 SDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
            D+EEP+   I++     NDV I+ +E R
Sbjct: 285 QDFEEPDKLHIQM-----NDV-ITVIEGR 307

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 137 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 25/219 (11%)
Query: 12  TIAAATD------NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFK 62
           +I +ATD      N+     +G+G F  V   + +L G+E+A+K + K+  +   + +  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFN 121
            E +++  L H N+V+L      +    LV EY    +  D+ +     KE  + + +F 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR 121
Query: 122 IIEGIVQGLLYLH-KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANT 179
            I   VQ   Y H KY    ++HRDLKA N+LLD  MN KI+DFG +  F + N+L+   
Sbjct: 122 QIVSAVQ---YCHQKY----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-- 172
Query: 180 NRIVGTHGYMSPE-YVMNGIVSMKSDVYSFGVLVLEIIS 217
               G+  Y +PE +        + DV+S GV++  ++S
Sbjct: 173 --FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 141 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 45/236 (19%)
Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
           DF+ IA           LGQG FG V K +  LD +  AIK++ + + + +    +E  L
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 68  IAKLQHTNLVRLLGCSLQ-------------KGERLLVYEYLPNKSLDFFIFDSSKKELL 114
           +A L H  +VR     L+             K    +  EY  N +L   I   +  +  
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTF 170
           D  + + +   I++ L Y+H      +IHRDLK  NI +D+  N KI DFG+A    R+ 
Sbjct: 116 D--EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 171 GMNELEA--------NTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEII 216
            + +L++        N    +GT  Y++ E V++G    + K D+YS G++  E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
           +D +  G  LG GG   V+  + L D +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73  HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           H  +V +      +        +V EY+   +L   +        +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
            L + H+     +IHRD+K +NI++      K+ DFG+AR           T  ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y+SPE      V  +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 140 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
           +D +  G  LG GG   V+  + L D +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73  HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           H  +V +      +        +V EY+   +L   +        +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
            L + H+     +IHRD+K +NI++      K+ DFG+AR           T  ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y+SPE      V  +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 26  LGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQ---GIVEFKNEAKL--IAKLQHTNLVR 78
           +G+G +G V+K + L   G+ +A+KR+   +G+    +   +  A L  +   +H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 79  LLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           L   C++ + +R     LV+E++ ++ L  ++ D   +  +  +   +++  +++GL +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H +   RV+HRDLK  NIL+      K++DFG+AR +     +     +V T  Y +PE 
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
           ++    +   D++S G +  E+   K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR +KSS +G+   + + E  ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+   ++KE L  ++    ++ I+ G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
            YLH    L++ H DLK  NI+L D+  PK    I DFG+A    FG NE +     I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  TIAAATD------NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFK 62
           +IA+  D      N+     +G+G F  V   + +L G+E+AIK + K+  +   + +  
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFN 121
            E +++  L H N+V+L      +    L+ EY    +  D+ +     KE    K+  +
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE----KEARS 118
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
               IV  + Y H+    R++HRDLKA N+LLD  MN KI+DFG +  F +       + 
Sbjct: 119 KFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDA 172
Query: 182 IVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIIS 217
             G   Y +PE          + DV+S GV++  ++S
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAK- 70
           I    ++F     LG+G FG V+  +     Q  AIK L K     +++   E  ++ K 
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKR 69
Query: 71  -----LQHTNLVRLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
                 +H  L  +  C+ Q  E L  V EYL    L + I    K +L   +  F   E
Sbjct: 70  VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAE 126
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I+ GL +LH      +++RDLK  NILLD   + KI+DFGM +   +   +A TN   G
Sbjct: 127 -IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNXFCG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           T  Y++PE ++    +   D +SFGVL+ E++
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
           D  + G  LG+G FG V         K K  +   +A+K L   + +     +V      
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66  KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
           K+I K  H N++ LLG   Q G   ++  Y    +L  ++           +D ++  +E
Sbjct: 95  KMIGK--HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
            + +K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR    
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +    T        +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 45/236 (19%)
Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
           DF+ IA           LGQG FG V K +  LD +  AIK++ + + + +    +E  L
Sbjct: 7   DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXL 55
Query: 68  IAKLQHTNLVRLLGCSLQ-------------KGERLLVYEYLPNKSLDFFIFDSSKKELL 114
           +A L H  +VR     L+             K    +  EY  N++L   I   +  +  
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTF 170
           D  + + +   I++ L Y+H      +IHR+LK  NI +D+  N KI DFG+A    R+ 
Sbjct: 116 D--EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 171 GMNELEA--------NTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEII 216
            + +L++        N    +GT  Y++ E V++G    + K D YS G++  E I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 75
           N+     +G+G F  V   + +L G+E+AIK + K+  +   + +   E +++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 76  LVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           +V+L      +    L+ EY    +  D+ +     KE    K+  +    IV  + Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE----KEARSKFRQIVSAVQYCH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           +    R++HRDLKA N+LLD  MN KI+DFG +  F +       +   G+  Y +PE  
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGSPPYAAPELF 182
Query: 195 MNGIV-SMKSDVYSFGVLVLEIIS 217
                   + DV+S GV++  ++S
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVS 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIV-EFKNE 64
           D  T     D+F  G  LG+G FG VY  +      I A+K L KS    +G+  + + E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 65  AKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
            ++ A L H N++RL      +    L+ EY P   L     +  K    D ++   I+E
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL---YKELQKSCTFDEQRTATIME 130
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            +   L+Y H     +VIHRD+K  N+LL  +   KI+DFG    + ++        + G
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCG 183
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           T  Y+ PE +   + + K D++  GVL  E++
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELL 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 26  LGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQ---GIVEFKNEAKL--IAKLQHTNLVR 78
           +G+G +G V+K + L   G+ +A+KR+   +G+    +   +  A L  +   +H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 79  LLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           L   C++ + +R     LV+E++ ++ L  ++ D   +  +  +   +++  +++GL +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H +   RV+HRDLK  NIL+      K++DFG+AR +     +     +V T  Y +PE 
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
           ++    +   D++S G +  E+   K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 26  LGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQ---GIVEFKNEAKL--IAKLQHTNLVR 78
           +G+G +G V+K + L   G+ +A+KR+   +G+    +   +  A L  +   +H N+VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 79  LLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           L   C++ + +R     LV+E++ ++ L  ++ D   +  +  +   +++  +++GL +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H +   RV+HRDLK  NIL+      K++DFG+AR +     +     +V T  Y +PE 
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
           ++    +   D++S G +  E+   K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26  LGQGGFGPVYKGKLLDG----QEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
           LGQG FG V+  K + G    Q  A+K L K++   +  V  K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 +G+  L+ ++L  +  D F   S +    +   +F + E +   L +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 145
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +I+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE V     
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 200 SMKSDVYSFGVLVLEIIS 217
           +  +D +SFGVL+ E+++
Sbjct: 204 TQSADWWSFGVLMFEMLT 221

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E+      +   + I   + YL K +    I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 340
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HR+L A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 399
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKLQ 72
           AT  + P   +G G +G VYK +    G  +A+K +   +G+ G+ +    E  L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 73  ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
              H N+VRL+  C+  + +R     LV+E++ ++ L  ++ D +    L  +   +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
             ++GL +LH      ++HRDLK  NIL+      K++DFG+AR +     +     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           T  Y +PE ++    +   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18  DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V         K K     ++A+K L S ++ + + +  +E +++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++           ++ S   +E L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               T        +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26  LGQGGFGPVYKGKLL----DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
           LGQG FG V+  + +     G   A+K L K++   +  V  K E  ++A + H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 +G+  L+ ++L  +  D F   S +    +   +F + E +  GL +LH    L
Sbjct: 96  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLDHLHS---L 149
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +I+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE V     
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQGH 207
Query: 200 SMKSDVYSFGVLVLEIIS 217
           S  +D +S+GVL+ E+++
Sbjct: 208 SHSADWWSYGVLMFEMLT 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   +++  KR+ K  G+ +    NE +++ K+    +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K    LV   +    L F I+   +    + +  F   E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           R+++RDLK  NILLDD  + +ISD G+A    + E +    R VGT GYM+PE V N   
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERY 362
Query: 200 SMKSDVYSFGVLVLEIISSK 219
           +   D ++ G L+ E+I+ +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24  NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NLV+LLG 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   +L  ++ + +++E ++      +   I   + YL K +    I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HR+L A N L+ +    K++DFG++R    +   A+         + +PE +     S+K
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 438
Query: 203 SDVYSFGVLVLEIIS 217
           SDV++FGVL+ EI +
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 107/198 (54%), Gaps = 15/198 (7%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLS----KSSGQGIVEFK-NEAKLIAKLQHTNLVRL 79
           LG+G F  VYK +  +  Q +AIK++       +  GI      E KL+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           L     K    LV++++    L+  I D+S        K + ++   +QGL YLH++   
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-I 198
            ++HRDLK +N+LLD+    K++DFG+A++FG     A  +++V T  Y +PE +    +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYXHQVV-TRWYRAPELLFGARM 189
Query: 199 VSMKSDVYSFGVLVLEII 216
             +  D+++ G ++ E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHT 74
           ++  G+ LG G FG V  G+  L G ++A+K L++    S   + + K E + +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           ++++L        +  +V EY+    L  +I    + E ++ ++ F   + I+  + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           ++    V+HRDLK  N+LLD  MN KI+DFG++      E   ++    G+  Y +PE +
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVI 182
Query: 195 MNGIVS-MKSDVYSFGVLVLEII 216
              + +  + D++S GV++  ++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALL 205

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           LG+GGFG V        GK+   +++  KR+ K  G+ +    NE +++ K+    +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 K    LV   +    L F I+   +    + +  F   E I  GL  LH   R 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           R+++RDLK  NILLDD  + +ISD G+A    + E +    R VGT GYM+PE V N   
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERY 362
Query: 200 SMKSDVYSFGVLVLEIISSK 219
           +   D ++ G L+ E+I+ +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
           ++G+G  G V   +    G+++A+K +     Q      NE  ++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
           L   E  ++ E+L   +L     D   +  L+ ++   + E ++Q L YLH      VIH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
           RD+K+ +ILL      K+SDFG       +        +VGT  +M+PE +   + + + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 204 DVYSFGVLVLEII 216
           D++S G++V+E++
Sbjct: 223 DIWSLGIMVIEMV 235

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G F  V   + +L G+E+A+K + K+  +   + +   E +++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83  SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +    LV EY    +  D+ +     KE  + + +F  I   VQ   Y H+     +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           +HRDLKA N+LLD  MN KI+DFG +   TFG N+L+A      G   Y +PE       
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDA----FCGAPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
              + DV+S GV++  ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26  LGQGGFGPVYKGKLLDG----QEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
           LGQG FG V+  K + G    Q  A+K L K++   +  V  K E  ++ ++ H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 +G+  L+ ++L  +  D F   S +    +   +F + E +   L +LH    L
Sbjct: 93  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 146
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +I+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE V     
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 204
Query: 200 SMKSDVYSFGVLVLEIIS 217
           +  +D +SFGVL+ E+++
Sbjct: 205 TQSADWWSFGVLMFEMLT 222

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
           +DN+     LG+G F  V +      G E A K ++  K S +   + + EA++  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N+VRL     ++    LV++ +    L     D   +E        + I+ I++ + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
           H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA  +   GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 174
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
           PE +     S   D+++ GV++
Sbjct: 175 PEVLKKDPYSKPVDIWACGVIL 196

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26  LGQGGFGPVYKGKLLDG----QEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
           LGQG FG V+  K + G    Q  A+K L K++   +  V  K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                 +G+  L+ ++L  +  D F   S +    +   +F + E +   L +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 145
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +I+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE V     
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 200 SMKSDVYSFGVLVLEIIS 217
           +  +D +SFGVL+ E+++
Sbjct: 204 TQSADWWSFGVLMFEMLT 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHT 74
           ++  G+ LG G FG V  G+  L G ++A+K L++   +    + + K E + +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           ++++L        +  +V EY+    L  +I    + E ++ ++ F   + I+  + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           ++    V+HRDLK  N+LLD  MN KI+DFG++      E    +    G+  Y +PE +
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVI 182
Query: 195 MNGIVS-MKSDVYSFGVLVLEII 216
              + +  + D++S GV++  ++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALL 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
           +DN+     LG+G F  V +      G E A K ++  K S +   + + EA++  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N+VRL     ++    LV++ +    L     D   +E        + I+ I++ + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
           H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA  +   GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
           PE +     S   D+++ GV++
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 27  GQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLVRLLGCSL 84
            +G FG V+K +L++   +A+K       Q    +++E ++ +   ++H NL++ +    
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIAAE- 78
Query: 85  QKGERLLVYEYLPNKSLD-FFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-------- 135
           ++G  L V  +L     D   + D  K  ++ W +  ++ E + +GL YLH+        
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +  + HRD K+ N+LL   +   ++DFG+A  F   +   +T+  VGT  YM+PE V+
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VL 197
Query: 196 NGIVS------MKSDVYSFGVLVLEIISSKK 220
            G ++      ++ D+Y+ G+++ E++S  K
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCK 228

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 25  RLGQGGFGPVYKGKLLDGQ-EIAIKRLSKSS---------GQGIVEFK----NEAKLIAK 70
           +LG G +G V   K  +G  E AIK + KS           + I +F     NE  L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           L H N+++L      K    LV E+     L   I +  K +  D     NI++ I+ G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGI 159
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            YLHK++   ++HRD+K  NILL+++   +N KI DFG++  F     +      +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAY 213
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
           Y++PE V+    + K DV+S GV++
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIM 237

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
           +DN+     LG+G F  V +      G E A K ++  K S +   + + EA++  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N+VRL     ++    LV++ +    L     D   +E        + I+ I++ + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
           H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA  +   GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
           PE +     S   D+++ GV++
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNR--------LGQGGFGPVYKGKLLDGQE----IAIKRL 50
           RDL   D   +A   D   P  R        +G+G FG VY G+ +D  +     AIK L
Sbjct: 1   RDL---DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL 57
Query: 51  SK-SSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ-KGERLLVYEYLPNKSLDFFIFDS 108
           S+ +  Q +  F  E  L+  L H N++ L+G  L  +G   ++  Y+ +  L  FI   
Sbjct: 58  SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
Query: 109 SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
            +   +     F +   + +G+ YL   +  + +HRDL A N +LD+    K++DFG+AR
Sbjct: 118 QRNPTVKDLISFGL--QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
Query: 169 TFGMNELEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                E  +        H      + + E +     + KSDV+SFGVL+ E+++
Sbjct: 173 DILDREYYSVQQH---RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 112/219 (51%), Gaps = 23/219 (10%)
Query: 11  QTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAK 66
           +TI    + +   + +G G +G V     +  G +IA+K+LS+   Q I+  K    E +
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP-FQSIIHAKRTYRELR 102
Query: 67  LIAKLQHTNLVRLL-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           L+  ++H N++ LL       SL++   + +  +L    L+  +     ++L D   +F 
Sbjct: 103 LLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF- 158
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           +I  I++GL Y+H      +IHRDLK SN+ +++    KI DFG+AR       +     
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 210
Query: 182 IVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
            V T  Y +PE ++N +  +M  D++S G ++ E+++ +
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLV--RLL 80
           RLG GGFG V +    D G+++AIK+  +  S +    +  E +++ KL H N+V  R +
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL--------Y 132
              LQK    L    LP  ++++      +K L  ++    + EG ++ LL        Y
Sbjct: 82  PDGLQK----LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 133 LHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           LH+    R+IHRDLK  NI+L     ++  KI D G A+     EL       VGT  Y+
Sbjct: 138 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYL 191
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +PE +     ++  D +SFG L  E I+
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 24/257 (9%)
Query: 43  QEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKS- 100
           +++AIKR++    Q  + E   E + +++  H N+V      + K E  LV + L   S 
Sbjct: 36  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 101 LDFFIFDSSKKE----LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
           LD      +K E    +LD      I+  +++GL YLHK  +   IHRD+KA NILL + 
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 152
Query: 157 MNPKISDFGMARTFGM-NELEANTNR--IVGTHGYMSPEYVMNGI--VSMKSDVYSFGVL 211
            + +I+DFG++       ++  N  R   VGT  +M+PE VM  +     K+D++SFG+ 
Sbjct: 153 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFGIT 211
Query: 212 VLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGL 271
            +E+ +       Y   + L L      L N+  +LE   T + +     +  +     +
Sbjct: 212 AIELATGAAPYHKYPPMKVLMLT-----LQNDPPSLE---TGVQDKEMLKKYGKSFRKMI 263
Query: 272 -LCVQDKATDRPTMSDV 287
            LC+Q     RPT +++
Sbjct: 264 SLCLQKDPEKRPTAAEL 280

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLV--RLL 80
           RLG GGFG V +    D G+++AIK+  +  S +    +  E +++ KL H N+V  R +
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL--------Y 132
              LQK    L    LP  ++++      +K L  ++    + EG ++ LL        Y
Sbjct: 81  PDGLQK----LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 133 LHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           LH+    R+IHRDLK  NI+L     ++  KI D G A+     EL       VGT  Y+
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYL 190
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +PE +     ++  D +SFG L  E I+
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 131/283 (46%), Gaps = 25/283 (8%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTN 75
           D++     +G G    V        +E +AIKR++    Q  + E   E + +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKS-LDFFIFDSSKKE----LLDWKKRFNIIEGIVQGL 130
           +V      + K E  LV + L   S LD      +K E    +LD      I+  +++GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNR--IVGTHG 187
            YLHK  +   IHRD+KA NILL +  + +I+DFG++       ++  N  R   VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 188 YMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
           +M+PE VM  +     K+D++SFG+  +E+ +       Y   + L L      L N+  
Sbjct: 192 WMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-----LQNDPP 245
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGL-LCVQDKATDRPTMSDV 287
           +LE   T + +     +  +     + LC+Q     RPT +++
Sbjct: 246 SLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 45/235 (19%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V         K     ++A+K L + +     E   +E K++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE-------------LLDW 116
           L  H N+V LLG     G   L++EY      D   +  SK+E              L+ 
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYG--DLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 117 KKRFNIIE---------GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 167
           ++  N++           + +G+ +L   S    +HRDL A N+L+      KI DFG+A
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 168 RTFGMNELEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           R     ++ +++N +V  +      +M+PE +  GI ++KSDV+S+G+L+ EI S
Sbjct: 220 R-----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 24  NRLGQGGFGPVYKGKLL-DGQEIAIKRL--SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
            ++G+G FG     K   DG++  IK +  S+ S +   E + E  ++A ++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
               + G   +V +Y   +  D F   +++K +L  + +  I++  VQ  L L      +
Sbjct: 90  ESFEENGSLYIVMDYC--EGGDLFKRINAQKGVLFQEDQ--ILDWFVQICLALKHVHDRK 145
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           ++HRD+K+ NI L      ++ DFG+AR   +N         +GT  Y+SPE   N   +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 201 MKSDVYSFGVLVLEIISSK 219
            KSD+++ G ++ E+ + K
Sbjct: 204 NKSDIWALGCVLYELCTLK 222

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G F  V   + +L G+E+A+K + K+  +   + +   E +++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83  SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +    LV EY    +  D+ +     KE  + + +F  I   VQ   Y H+     +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           +HRDLKA N+LLD  MN KI+DFG +   TFG N+L+       G+  Y +PE       
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
              + DV+S GV++  ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G F  V   + +L G+E+A+K + K+  +   + +   E +++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83  SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +    LV EY    +  D+ +     KE  + + +F  I   VQ   Y H+     +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           +HRDLKA N+LLD  MN KI+DFG +   TFG N+L+       G+  Y +PE       
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
              + DV+S GV++  ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
           +DN+     LG+G F  V +      G E A K ++  K S +   + + EA++  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N+VRL     ++    LV++ +    L     D   +E        + I+ I++ + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
           H      ++HR+LK  N+LL  +      K++DFG+A    +N+ EA  +   GT GY+S
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 198
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
           PE +     S   D+++ GV++
Sbjct: 199 PEVLKKDPYSKPVDIWACGVIL 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
           +D +  G  LG GG   V+  + L   +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73  HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           H  +V +      +        +V EY+   +L   +        +  K+   +I    Q
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
            L + H+     +IHRD+K +NI++      K+ DFG+AR           T  ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y+SPE      V  +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  + A L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 230
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 231 ATDYTSSIDVWSAGCVLAELL 251

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G F  V   + +L G+E+A++ + K+  +   + +   E +++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83  SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +    LV EY    +  D+ +     KE  + + +F  I   VQ   Y H+     +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           +HRDLKA N+LLD  MN KI+DFG +   TFG N+L+       G+  Y +PE       
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
              + DV+S GV++  ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 75
           N+     +G+G F  V   + +L G+E+A+K + K+  +   + +   E +++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 76  LVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           +V+L      +    LV EY    +  D+ +     KE  + + +F  I   VQ   Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK-EARAKFRQIVSAVQ---YCH 123
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPE 192
           +     ++HRDLKA N+LLD  MN KI+DFG +   TFG N+L+       G+  Y +PE
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPE 175
Query: 193 YVMNGIV-SMKSDVYSFGVLVLEIIS 217
                     + DV+S GV++  ++S
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVS 201

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEF 61
           RDL   DF  I            LG G FG VYK +  +   +A  K +   S + + ++
Sbjct: 31  RDLNPEDFWEIIG---------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 62  KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
             E  ++A   H N+V+LL     +    ++ E+    ++D  + +  +   L   +   
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQV 139
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEA 177
           + +  +  L YLH     ++IHRDLKA NIL     + K++DFG++    RT        
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------Q 190
Query: 178 NTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
             +  +GT  +M+PE VM     +     K+DV+S G+ ++E+
Sbjct: 191 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           LG+G F  V +  K+L GQE A K ++  K S +   + + EA++   L+H N+VRL   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++G   L+++ +    L     D   +E        + I+ I++ +L+ H+   + V+
Sbjct: 90  ISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVV 143
Query: 143 HRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMN 196
           HRDLK  N+LL  ++     K++DFG+A      E+E          GT GY+SPE +  
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 197 GIVSMKSDVYSFGVLV 212
                  D+++ GV++
Sbjct: 199 DPYGKPVDLWACGVIL 214

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 162 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 215
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 216 ATDYTSSIDVWSAGCVLAELL 236

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 171 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 224
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 225 ATDYTSSIDVWSAGCVLAELL 245

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 208
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 209 ATDYTSSIDVWSAGCVLAELL 229

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 151 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 204
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 205 ATDYTSSIDVWSAGCVLAELL 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 147 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 200
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 201 ATDYTSSIDVWSAGCVLAELL 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 144 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 197
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 198 ATDYTSSIDVWSAGCVLAELL 218

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 230
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 231 ATDYTSSIDVWSAGCVLAELL 251

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 148 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 201
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 202 ATDYTSSIDVWSAGCVLAELL 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
           +D +  G  LG GG   V+  + L   +++A+K L     +     + F+ EA+  A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73  HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           H  +V +      +        +V EY+   +L   +        +  K+   +I    Q
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
            L + H+     +IHRD+K +NI++      K+ DFG+AR           T  ++GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y+SPE      V  +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL 71
             DNF     LG+G FG V   ++ + G   A+K L K        +     E ++++  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 72  QHTNLVRLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           ++   +  L C  Q  +RL  V E++    L F I  S + +  + + RF   E I+  L
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAE-IISAL 137
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
           ++LH      +I+RDLK  N+LLD + + K++DFGM +    N +   T    GT  Y++
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIA 192
Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEII 216
           PE +   +     D ++ GVL+ E++
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEML 218

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 156 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 209
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 210 ATDYTSSIDVWSAGCVLAELL 230

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G F  V   + +L G+E+A++ + K+  +   + +   E +++  L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83  SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +    LV EY    +  D+ +     KE  + + +F  I   VQ   Y H+     +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           +HRDLKA N+LLD  MN KI+DFG +   TFG N+L    +   G+  Y +PE       
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKL----DEFCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
              + DV+S GV++  ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 179 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 232
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 233 ATDYTSSIDVWSAGCVLAELL 253

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 208
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 209 ATDYTSSIDVWSAGCVLAELL 229

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEF 61
           RDL   DF  I            LG G FG VYK +  +   +A  K +   S + + ++
Sbjct: 31  RDLNPEDFWEIIG---------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 62  KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
             E  ++A   H N+V+LL     +    ++ E+    ++D  + +  +   L   +   
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQV 139
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           + +  +  L YLH     ++IHRDLKA NIL     + K++DFG++          NT  
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------NTRX 188
Query: 182 I------VGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
           I      +GT  +M+PE VM     +     K+DV+S G+ ++E+
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG V+KG  +   E     + IK +   SG Q      +    I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 80  LGCSLQKGERL-LVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
           LG  L  G  L LV +YLP  SL   +         + LL+W  +      I +G+ YL 
Sbjct: 99  LG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLE 150
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           ++    ++HR+L A N+LL      +++DFG+A     ++ +   +       +M+ E +
Sbjct: 151 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
             G  + +SDV+S+GV V E+++
Sbjct: 208 HFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEF 61
           RDL   DF  I            LG G FG VYK +  +   +A  K +   S + + ++
Sbjct: 31  RDLNPEDFWEIIG---------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 62  KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
             E  ++A   H N+V+LL     +    ++ E+    ++D  + +  +   L   +   
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQV 139
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           + +  +  L YLH     ++IHRDLKA NIL     + K++DFG++          NT  
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------NTRX 188
Query: 182 I------VGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
           I      +GT  +M+PE VM     +     K+DV+S G+ ++E+
Sbjct: 189 IQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 222 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 275
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 276 ATDYTSSIDVWSAGCVLAELL 296

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 18  DNFSPGNRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIA 69
           D++  G  LG G F  V K      GK    + I  +RLS SS +G+   E + E  ++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           +++H N++ L      K + +L+ E +    L  F+   ++KE L   +    ++ I+ G
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDG 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKIS--DFGMARTFGMNELEANTN--RIV 183
           + YLH     R+ H DLK  NI+L D+   NP+I   DFG+A     +++EA      I 
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKNIF 179
Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           GT  +++PE V    + +++D++S GV+   ++S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
           +D +  G  LG GG   V+  + L   +++A+K L     +     + F+ EA+  A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 73  HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           H  +V +      +        +V EY+   +L   +        +  K+   +I    Q
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 144
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
            L + H+     +IHRD+K +NI++      K+ DFG+AR           T  ++GT  
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y+SPE      V  +SDVYS G ++ E+++ +
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 181 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 234
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 235 ATDYTSSIDVWSAGCVLAELL 255

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LG+GGFG V+       GKL   +++  KRL K  G QG +    E K++AK+    +V 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           L      K +  LV   +    + + I+  D       + +  F   + IV GL +LH+ 
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
           +   +I+RDLK  N+LLDD  N +ISD G+A    +   +  T    GT G+M+PE ++ 
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
                  D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
           +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84  LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              GE+       LV +Y+P          S  K+ L        +  + + L Y+H + 
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
              + HRD+K  N+LLD D    K+ DFG A+       E N + I   + Y +PE +  
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
                 S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LG+GGFG V+       GKL   +++  KRL K  G QG +    E K++AK+    +V 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           L      K +  LV   +    + + I+  D       + +  F   + IV GL +LH+ 
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
           +   +I+RDLK  N+LLDD  N +ISD G+A    +   +  T    GT G+M+PE ++ 
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
                  D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 18  DNFSPGNRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIA 69
           D++  G  LG G F  V K      GK    + I  +RLS SS +G+   E + E  ++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 63
Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           +++H N++ L      K + +L+ E +    L  F+   ++KE L   +    ++ I+ G
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDG 120
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKIS--DFGMARTFGMNELEANT--NRIV 183
           + YLH     R+ H DLK  NI+L D+   NP+I   DFG+A     +++EA      I 
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKNIF 172
Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           GT  +++PE V    + +++D++S GV+   ++S
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LG+GGFG V+       GKL   +++  KRL K  G QG +    E K++AK+    +V 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           L      K +  LV   +    + + I+  D       + +  F   + IV GL +LH+ 
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
           +   +I+RDLK  N+LLDD  N +ISD G+A    +   +  T    GT G+M+PE ++ 
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
                  D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
           LG G FG V+KG  +   E     + IK +   SG Q      +    I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 80  LGCSLQKGERL-LVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
           LG  L  G  L LV +YLP  SL   +         + LL+W  +      I +G+ YL 
Sbjct: 81  LG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLE 132
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           ++    ++HR+L A N+LL      +++DFG+A     ++ +   +       +M+ E +
Sbjct: 133 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
             G  + +SDV+S+GV V E+++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGI-----VEFKNEAKLIA 69
           AT  + P   +G G +G VYK +    G  +A+K +   +G G      +    E  L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 70  KLQ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           +L+   H N+VRL+  C+  + +R     LV+E++ ++ L  ++ D +    L  +   +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           ++   ++GL +LH      ++HRDLK  NIL+      K++DFG+AR +     +     
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           +V T  Y +PE ++    +   D++S G +  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26  LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
           LG+GGFG V+       GKL   +++  KRL K  G QG +    E K++AK+    +V 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           L      K +  LV   +    + + I+  D       + +  F   + IV GL +LH+ 
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
           +   +I+RDLK  N+LLDD  N +ISD G+A    +   +  T    GT G+M+PE ++ 
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
                  D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +  S G  LG G FG V +       K      +A+K L  S+     E   +E K+++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
           L  H N+V LLG     G  L++ EY     L        D FI   +   +++  +   
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                 +    + +G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 210
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           ++ ++N +V  +      +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
           TD +     +G+G F  V +  KL  G E A K ++  K S +   + + EA++   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           +N+VRL     ++G   LV++ +    L     D   +E        + I+ I++ +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHG 187
           H+   + V+HRDLK  N+LL  +      K++DFG+A      E++ +        GT G
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
           Y+SPE +         D+++ GV++
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
           I    ++FS    +G+GGFG VY  +  D G+  A+K L K      QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 69  AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
             L  T     + C   +    ++L  + + +    L + +  S      +   RF   E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I+ GL ++H  +R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
           THGYM+PE +  G+     +D +S G ++ +++
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
           I    ++FS    +G+GGFG VY  +  D G+  A+K L K      QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 69  AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
             L  T     + C   +    ++L  + + +    L + +  S      +   RF   E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I+ GL ++H  +R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
           THGYM+PE +  G+     +D +S G ++ +++
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
           I    ++FS    +G+GGFG VY  +  D G+  A+K L K      QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 69  AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
             L  T     + C   +    ++L  + + +    L + +  S      +   RF   E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I+ GL ++H  +R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
           THGYM+PE +  G+     +D +S G ++ +++
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13  IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
           I    ++FS    +G+GGFG VY  +  D G+  A+K L K      QG     NE +++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 241
Query: 69  AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
             L  T     + C   +    ++L  + + +    L + +  S      +   RF   E
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 299
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            I+ GL ++H  +R  V++RDLK +NILLD+  + +ISD G+A  F   +  A+    VG
Sbjct: 300 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 351
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
           THGYM+PE +  G+     +D +S G ++ +++
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 26  LGQGGFGPVYKG--KLLDGQ-EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLLG 81
           LG G FG V +G  ++   Q ++AIK L + + +    E   EA+++ +L +  +VRL+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              Q    +LV E      L  F+    K+E +       ++  +  G+ YL + +    
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---F 131
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIV 199
           +HRDL A N+LL ++   KISDFG+++  G ++    T R  G     + +PE +     
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKF 190
Query: 200 SMKSDVYSFGVLVLEIIS 217
           S +SDV+S+GV + E +S
Sbjct: 191 SSRSDVWSYGVTMWEALS 208

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +  S G  LG G FG V +       K      +A+K L  S+     E   +E K+++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
           L  H N+V LLG     G  L++ EY     L        D FI   +   +++  +   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                 +    + +G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           ++ ++N +V  +      +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
           G  LG+GGF   Y+   +D +E+ A K + KS         +   E  +   L + ++V 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
             G         +V E    +SL        +K + + + R+  +   +QG+ YLH    
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 161
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
            RVIHRDLK  N+ L+D M+ KI DFG+A     +     T  + GT  Y++PE +    
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKG 218
Query: 199 VSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
            S + D++S G ++  ++  K      C            Y   RH+N V  A
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 271

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G F  V   + +L G+E+A+K + K+  +   + +   E ++   L H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 83  SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +    LV EY    +  D+ +     KE  + + +F  I   VQ   Y H+     +
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNRIVGTHGYMSPE-YVMNGIV 199
           +HRDLKA N+LLD   N KI+DFG +  F   N+L+A      G   Y +PE +      
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYD 190
Query: 200 SMKSDVYSFGVLVLEIIS 217
             + DV+S GV++  ++S
Sbjct: 191 GPEVDVWSLGVILYTLVS 208

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +  S G  LG G FG V +       K      +A+K L  S+     E   +E K+++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
           L  H N+V LLG     G  L++ EY     L        D FI   +   +++  +   
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                 +    + +G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 217
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           ++ ++N +V  +      +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +  S G  LG G FG V +       K      +A+K L  S+     E   +E K+++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
           L  H N+V LLG     G  L++ EY     L        D FI   +   +++  +   
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                 +    + +G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 212
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           ++ ++N +V  +      +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIA--IKRLSKSSGQGIVEFKNEAKLI 68
           T    T+ +     LG+G F  V +  K+L GQE A  I    K S +   + + EA++ 
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
             L+H N+VRL     ++G   L+++ +    L     D   +E        + I+ I++
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 121
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---I 182
            +L+ H+   + V+HR+LK  N+LL  ++     K++DFG+A      E+E         
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQAWFGF 173
Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
            GT GY+SPE +         D+++ GV++
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 23  GNRLGQGGFGPVYKGKLL--DGQ--EIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           G  LG+G FG V +G L   DG   ++A+K  +L  SS + I EF +EA  +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 77  VRLLGCSLQKGER-----LLVYEYLPNKSLDFFIFDS---SKKELLDWKKRFNIIEGIVQ 128
           +RLLG  ++   +     +++  ++    L  ++  S   +  + +  +     +  I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           G+ YL   S    +HRDL A N +L D M   ++DFG+++     +             +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           ++ E + + + + KSDV++FGV + EI +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24  NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
            +LG G FG V +G+     G+   +A+K L     S  + + +F  E   +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +RL G  L    ++ V E  P  SL   +       LL    R+ +   + +G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
              R IHRDL A N+LL  +   KI DFG+ R    N    + + ++  H      + +P
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHXVMQEHRKVPFAWCAP 193
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +     S  SD + FGV + E+ +       Y  E  + L        N  + L  ID
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 238
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
                   P++  + I+ V + C   K  DRPT
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24  NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
            +LG G FG V +G+     G+   +A+K L     S  + + +F  E   +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +RL G  L    ++ V E  P  SL   +       LL    R+ +   + +G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
              R IHRDL A N+LL  +   KI DFG+ R    N    + + ++  H      + +P
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHXVMQEHRKVPFAWCAP 183
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +     S  SD + FGV + E+ +       Y  E  + L        N  + L  ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 228
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
                   P++  + I+ V + C   K  DRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +  S G  LG G FG V +       K      +A+K L  S+     E   +E K+++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
           L  H N+V LLG     G  L++ EY     L        D FI   +   +++  +   
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                 +    + +G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----H 217
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           ++ ++N +V  +      +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 122
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24  NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
            +LG G FG V +G+     G+   +A+K L     S  + + +F  E   +  L H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +RL G  L    ++ V E  P  SL   +       LL    R+ +   + +G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
              R IHRDL A N+LL  +   KI DFG+ R    N    + + ++  H      + +P
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 187
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +     S  SD + FGV + E+ +       Y  E  + L        N  + L  ID
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 232
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
                   P++  + I+ V + C   K  DRPT
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24  NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
            +LG G FG V +G+     G+   +A+K L     S  + + +F  E   +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +RL G  L    ++ V E  P  SL   +       LL    R+ +   + +G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
              R IHRDL A N+LL  +   KI DFG+ R    N    + + ++  H      + +P
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 193
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +     S  SD + FGV + E+ +       Y  E  + L        N  + L  ID
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 238
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
                   P++  + I+ V + C   K  DRPT
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
           G  LG+GGF   Y+   +D +E+ A K + KS         +   E  +   L + ++V 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
             G         +V E    +SL        +K + + + R+  +   +QG+ YLH    
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 161
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVM 195
            RVIHRDLK  N+ L+D M+ KI DFG+A      ++E +  R   + GT  Y++PE + 
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLC 215
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
               S + D++S G ++  ++  K      C            Y   RH+N V  A
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 271

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 26/221 (11%)
Query: 10  FQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSK----SSGQGIV--EFK 62
           FQ++    D++  G  LG G F  V K +    G+E A K + K    SS +G+   E +
Sbjct: 20  FQSMVE--DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
            E  ++ +++H N++ L      K + +L+ E +    L  F+   ++KE L   +    
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQF 134
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM--NPKIS--DFGMARTFGMNELEAN 178
           ++ I+ G+ YLH     R+ H DLK  NI+L D+   NP+I   DFG+A     +++EA 
Sbjct: 135 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAG 186
Query: 179 T--NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                I GT  +++PE V    + +++D++S GV+   ++S
Sbjct: 187 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
           G  LG+GGF   Y+   +D +E+ A K + KS         +   E  +   L + ++V 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
             G         +V E    +SL        +K + + + R+  +   +QG+ YLH    
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 161
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVM 195
            RVIHRDLK  N+ L+D M+ KI DFG+A      ++E +  R   + GT  Y++PE + 
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCGTPNYIAPEVLC 215
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
               S + D++S G ++  ++  K      C            Y   RH+N V  A
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 271

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIV-EFKNEAKLIAKLQH 73
           D+F  G  LG+G FG VY  +    + I A+K L KS    +G+  + + E ++ + L+H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++R+      +    L+ E+ P   L     +  K    D ++    +E +   L Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H+    +VIHRD+K  N+L+  +   KI+DFG    + ++        + GT  Y+ PE 
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 184
Query: 194 VMNGIVSMKSDVYSFGVLVLE-IISSKKNNGCYDTERHLNLV 234
           +       K D++  GVL  E ++     +    TE H  +V
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 226

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24  NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
            +LG G FG V +G+     G+   +A+K L     S  + + +F  E   +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +RL G  L    ++ V E  P  SL   +       LL    R+ +   + +G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
              R IHRDL A N+LL  +   KI DFG+ R    N    + + ++  H      + +P
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 183
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +     S  SD + FGV + E+ +       Y  E  + L        N  + L  ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 228
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
                   P++  + I+ V + C   K  DRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24  NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
            +LG G FG V +G+     G+   +A+K L     S  + + +F  E   +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +RL G  L    ++ V E  P  SL   +       LL    R+ +   + +G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
              R IHRDL A N+LL  +   KI DFG+ R    N    + + ++  H      + +P
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 183
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +     S  SD + FGV + E+ +       Y  E  + L        N  + L  ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 228
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
                   P++  + I+ V + C   K  DRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
           G  LG+GGF   Y+   +D +E+ A K + KS         +   E  +   L + ++V 
Sbjct: 31  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
             G         +V E    +SL        +K + + + R+  +   +QG+ YLH    
Sbjct: 91  FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 145
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVM 195
            RVIHRDLK  N+ L+D M+ KI DFG+A      ++E +  R   + GT  Y++PE + 
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLC 199
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
               S + D++S G ++  ++  K      C            Y   RH+N V  A
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 255

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 26  LGQGGFGPVYKG--KLLDGQ-EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLLG 81
           LG G FG V +G  ++   Q ++AIK L + + +    E   EA+++ +L +  +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              Q    +LV E      L  F+    K+E +       ++  +  G+ YL + +    
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---F 457
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNGIV 199
           +HR+L A N+LL ++   KISDFG+++  G ++    T R  G     + +PE +     
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKF 516
Query: 200 SMKSDVYSFGVLVLEIIS 217
           S +SDV+S+GV + E +S
Sbjct: 517 SSRSDVWSYGVTMWEALS 534

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 25/197 (12%)
Query: 26  LGQGGFGPV-----YKGKLLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLV 77
           LG+G FG V     YK +    Q++A+K +S+         +  + E   +  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L        + ++V EY   +  D+ +    K+   D  +RF   + I+  + Y H++ 
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRF--FQQIICAIEYCHRH- 127
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
             +++HRDLK  N+LLDD +N KI+DFG++           +    G+  Y +PE V+NG
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE-VING 181
Query: 198 --IVSMKSDVYSFGVLV 212
                 + DV+S G+++
Sbjct: 182 KLYAGPEVDVWSCGIVL 198

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
           +G+G F  V +      GQ+ A+K     + + S G    + K EA +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGLLYLHKYSR 138
           L      G   +V+E++    L F I   +    +  +    + +  I++ L Y H  + 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 139 LRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             +IHRD+K  N+LL  + N    K+ DFG+A   G + L A     VGT  +M+PE V 
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNNGC---YDTERHL 231
                   DV+  GV++  ++S     GC   Y T+  L
Sbjct: 207 REPYGKPVDVWGCGVILFILLS-----GCLPFYGTKERL 240

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
            ++G+G +G V+ GK   G+++A+K    +        + E      ++H N++  +   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIAAD 100
Query: 84  LQKG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK---- 135
           ++      +  L+ +Y  N SL    +D  K   LD K    +    V GL +LH     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 136 -YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF--GMNELEANTNRIVGTHGYMSPE 192
              +  + HRDLK+ NIL+       I+D G+A  F    NE++   N  VGT  YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 193 YVMNGI------VSMKSDVYSFGVLVLEI 215
            +   +        + +D+YSFG+++ E+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 46  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 157
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 209
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 24  NRLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           ++LG+G +  VYKGK  L    +A+K  RL    G      + E  L+  L+H N+V L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 66
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
                +    LV+EYL +K L  ++ D      +   K F  +  +++GL Y H   R +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCH---RQK 120
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI-V 199
           V+HRDLK  N+L++++   K++DFG+AR   +   +   N +V T  Y  P+ ++     
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDILLGSTDY 178
Query: 200 SMKSDVYSFGVLVLEIISSK 219
           S + D++  G +  E+ + +
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 45  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 100
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 156
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 208
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 15/226 (6%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSG--QGIVEF 61
           LK   F       D +     +G G +G V   +  L GQ++AIK++  +          
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 101
Query: 62  KNEAKLIAKLQHTNLVRL---LGCSLQKGERLLVYEYLPNKSLDFF-IFDSSKKELLDWK 117
             E K++   +H N++ +   L  ++  GE   VY  L     D   I  SS+   L+  
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 161
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
           + F  +  +++GL Y+H     +VIHRDLK SN+L+++    KI DFGMAR    +  E 
Sbjct: 162 RYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 178 N--TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKK 220
                  V T  Y +PE +++    +   D++S G +  E+++ ++
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LSK   Q I+  K    E +L+  ++H 
Sbjct: 38  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 46  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 157
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGXVATRWYR 209
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 17/227 (7%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKN 63
           LK   F       D +     +G G +G V   +  L GQ++AIK++  ++   +   K 
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKR 99
Query: 64  ---EAKLIAKLQHTNLVRL---LGCSLQKGERLLVYEYLPNKSLDFF-IFDSSKKELLDW 116
              E K++   +H N++ +   L  ++  GE   VY  L     D   I  SS+   L+ 
Sbjct: 100 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 159
Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
            + F  +  +++GL Y+H     +VIHRDLK SN+L+++    KI DFGMAR    +  E
Sbjct: 160 VRYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214
Query: 177 AN--TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKK 220
                   V T  Y +PE +++    +   D++S G +  E+++ ++
Sbjct: 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +      +L D   +F +I  I++G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCAKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR S++S +G+   E + E  ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           + H N++ L      + + +L+ E +    L  F+   ++KE L  ++  + I+ I+ G+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
            YLH     ++ H DLK  NI+L D+  P    K+ DFG+A     +E+E       I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 31/190 (16%)
Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           ++GQG FG V+K +    GQ++A+K++   ++  G  I   + E K++  L+H N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL------------LDWKKRFNIIEGIVQ 128
                K        Y   K+  + +FD  + +L            L   KR  +++ ++ 
Sbjct: 84  EICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGT 185
           GL Y+H   R +++HRD+KA+N+L+      K++DFG+AR F +   ++     NR+V T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 186 HGYMSPEYVM 195
             Y  PE ++
Sbjct: 193 LWYRPPELLL 202

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGXVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G  G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
            +   + L  EY     L    FD  + ++     D ++ F+    ++ G++YLH    +
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +     
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             +  DV+S G+++  +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 20/234 (8%)
Query: 19  NFSPGNRLGQGGFGPVYKGKLL--DGQ--EIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ 72
            F+ G  LG+G FG V + +L   DG   ++A+K L     +   I EF  EA  + +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 73  HTNLVRLLGCSLQKGER------LLVYEYLPNKSLDFFIFDSSKKEL---LDWKKRFNII 123
           H ++ +L+G SL+   +      +++  ++ +  L  F+  S   E    L  +     +
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             I  G+ YL   S    IHRDL A N +L + M   ++DFG++R     +         
Sbjct: 144 VDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTERHLNLVG 235
               +++ E + + + ++ SDV++FGV + EI++  +    G  + E +  L+G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N +P   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 36  NLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 91
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 147
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 199
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLLG 81
           G ++G+G +G VYK K  DG++     L +  G GI +    E  L+ +L+H N++ L  
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 85
Query: 82  CSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY-----LH 134
             L   +R   L+++Y  +       F  + K     KK   +  G+V+ LLY     +H
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 142
Query: 135 KYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTFG--MNELEANTNRIVGTHGY 188
                 V+HRDLK +NIL+     ++   KI+D G AR F   +  L A+ + +V T  Y
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTFWY 201
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGC 224
            +PE ++      K+ D+++ G +  E+++S+    C
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           ++GQG FG V+K +    GQ++A+K++   ++  G  I   + E K++  L+H N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 81  G-CSLQ-------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
             C  +       KG   LV+++  +  L   + +   K  L   KR  +++ ++ GL Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGTHGYM 189
           +H   R +++HRD+KA+N+L+      K++DFG+AR F +   ++     NR+V T  Y 
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYR 196
Query: 190 SPEYVM 195
            PE ++
Sbjct: 197 PPELLL 202

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 37/213 (17%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE---FKNEAKLIAKLQ 72
           +D +    +LG G +G V   K  L G E AIK + KSS           +E  ++ +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLD---WKKRFN------I 122
           H N+++L             YE+  +K   + + +  +  EL D    +++F+      I
Sbjct: 63  HPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 109
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANT 179
           ++ ++ G  YLHK++   ++HRDLK  N+LL+ +      KI DFG++  F   E+    
Sbjct: 110 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKM 163
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
              +GT  Y++PE V+      K DV+S GV++
Sbjct: 164 KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 22  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 25  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 80
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 136
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 137 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 188
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 31  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 37  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 92
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 148
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 200
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 23  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 78
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 134
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 186
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 24  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 79
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 135
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 136 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 187
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 38  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR    +E+       V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTG----YVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 38  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 37  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 92
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 148
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 200
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 23  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 78
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 134
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 186
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           ++GQG FG V+K +    GQ++A+K++   ++  G  I   + E K++  L+H N+V L+
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 82
Query: 81  G-CSLQ-------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
             C  +       KG   LV+++  +  L   + +   K  L   KR  +++ ++ GL Y
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 139
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGTHGYM 189
           +H   R +++HRD+KA+N+L+      K++DFG+AR F +   ++     NR+V T  Y 
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYR 195
Query: 190 SPEYVM 195
            PE ++
Sbjct: 196 PPELLL 201

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR    +E+       V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTG----YVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 33  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR    +E+       V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTG----YVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 46  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 157
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 209
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 45  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 100
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 156
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 208
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 49  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 104
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 160
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 212
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 12/200 (6%)
Query: 25  RLGQGGFGPVYKGKLLDGQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLG 81
           ++G+G +G V+K K  +  EI A+KR+      +G+      E  L+ +L+H N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                 +  LV+E+  ++ L  + FDS   +L D +   + +  +++GL + H  +   V
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVS 200
           +HRDLK  N+L++     K++DFG+AR FG+  +   +  +V T  Y  P+ +    + S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 201 MKSDVYSFGVLVLEIISSKK 220
              D++S G +  E+ ++ +
Sbjct: 181 TSIDMWSAGCIFAELANAAR 200

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 37/213 (17%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE---FKNEAKLIAKLQ 72
           +D +    +LG G +G V   K  L G E AIK + KSS           +E  ++ +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLD---WKKRFN------I 122
           H N+++L             YE+  +K   + + +  +  EL D    +++F+      I
Sbjct: 80  HPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 126
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANT 179
           ++ ++ G  YLHK++   ++HRDLK  N+LL+ +      KI DFG++  F   E+    
Sbjct: 127 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKM 180
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
              +GT  Y++PE V+      K DV+S GV++
Sbjct: 181 KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVIL 212

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNLVRLLG 81
           ++G+G +G V+K +  D GQ +AIK+  +S    +++     E +++ +L+H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +K    LV+EY  +  L     D  ++ + +   + +I    +Q + + HK++    
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLVK-SITWQTLQAVNFCHKHN---C 123
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGI-V 199
           IHRD+K  NIL+      K+ DFG AR   G ++   +    V T  Y SPE ++     
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE---VATRWYRSPELLVGDTQY 180
Query: 200 SMKSDVYSFGVLVLEIIS 217
               DV++ G +  E++S
Sbjct: 181 GPPVDVWAIGCVFAELLS 198

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 28  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     +G G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY+P    D F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   K++DFG A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     +G G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY+P    D F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   K++DFG A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 32  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 25  RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           ++GQG FG V+K +    GQ++A+K++   ++  G  I   + E K++  L+H N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 81  G-CSLQ-------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
             C  +       KG   LV+++  +  L   + +   K  L   KR  +++ ++ GL Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGTHGYM 189
           +H   R +++HRD+KA+N+L+      K++DFG+AR F +   ++     NR+V T  Y 
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYR 196
Query: 190 SPEYVM 195
            PE ++
Sbjct: 197 PPELLL 202

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 49  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 104
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 160
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+AR       +      V T  Y 
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGYVATRWYR 212
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 33/210 (15%)
Query: 26  LGQGGFGPVYKGKLLDGQ--------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           +G+G F  VYKG  LD +        E+  ++L+KS  Q    FK EA+ +  LQH N+V
Sbjct: 34  IGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 78  RLLGC--SLQKGER--LLVYEYLPNKSLDFFI--FDSSK-KELLDWKKRFNIIEGIVQGL 130
           R      S  KG++  +LV E   + +L  ++  F   K K L  W ++      I++GL
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGL 142
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYM 189
            +LH  +   +IHRDLK  NI +       KI D G+A     +  +A    ++GT  + 
Sbjct: 143 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFX 197
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           +PE           DVY+FG   LE  +S+
Sbjct: 198 APEXYEEK-YDESVDVYAFGXCXLEXATSE 226

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 110/271 (40%), Gaps = 76/271 (28%)
Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
           +F P   +G+GGFG V++ K  +D    AIKR+   + +   E    E K +AKL+H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 77  VRLLGCSLQ----KGERLLVYEYLPNKSLDFFIFDSS----------------------- 109
           VR     L+    K +  +   +L ++S D+ +   S                       
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 110 ------------------KKELLDWKKR------------FNIIEGIVQGLLYLHKYSRL 139
                             K+ L DW  R             +I   I + + +LH     
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 140 RVIHRDLKASNIL--LDDQMNPKISDFGMARTFGMNELE----------ANTNRIVGTHG 187
            ++HRDLK SNI   +DD +  K+ DFG+      +E E          A     VGT  
Sbjct: 185 -LMHRDLKPSNIFFTMDDVV--KVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKL 241
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISS 218
           YMSPE +     S K D++S G+++ E++ S
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KSQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DFG+ R       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIV-EFKNEAKLIAKLQH 73
           D+F     LG+G FG VY  +    + I A+K L KS    +G+  + + E ++ + L+H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++R+      +    L+ E+ P   L     +  K    D ++    +E +   L Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H+    +VIHRD+K  N+L+  +   KI+DFG    + ++        + GT  Y+ PE 
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 183
Query: 194 VMNGIVSMKSDVYSFGVLVLE-IISSKKNNGCYDTERHLNLV 234
           +       K D++  GVL  E ++     +    TE H  +V
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR S++S +G+   E + E  ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           + H N++ L      + + +L+ E +    L  F+   ++KE L  ++  + I+ I+ G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
            YLH     ++ H DLK  NI+L D+  P    K+ DFG+A     +E+E       I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI D+G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAK 70
           A + D +    +LG+G +G VYK    +  + +AIKR+  +   +G+      E  L+ +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           LQH N++ L           L++EY  N    +   D +    +   K F  +  ++ G+
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKY--MDKNPDVSMRVIKSF--LYQLINGV 145
Query: 131 LYLHKYSRLRVIHRDLKASNILL---DDQMNP--KISDFGMARTFGMNELEANTNRIVGT 185
            + H  SR R +HRDLK  N+LL   D    P  KI DFG+AR FG+  +   T+ I+ T
Sbjct: 146 NFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-T 200
Query: 186 HGYMSPEYVMNG-IVSMKSDVYSFGVLVLEII 216
             Y  PE ++     S   D++S   +  E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR S++S +G+   E + E  ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           + H N++ L      + + +L+ E +    L  F+   ++KE L  ++  + I+ I+ G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
            YLH     ++ H DLK  NI+L D+  P    K+ DFG+A     +E+E       I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR S++S +G+   E + E  ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           + H N++ L      + + +L+ E +    L  F+   ++KE L  ++  + I+ I+ G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
            YLH     ++ H DLK  NI+L D+  P    K+ DFG+A     +E+E       I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR S++S +G+   E + E  ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           + H N++ L      + + +L+ E +    L  F+   ++KE L  ++  + I+ I+ G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
            YLH     ++ H DLK  NI+L D+  P    K+ DFG+A     +E+E       I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
           +G+G +G V++G    G+ +A+K  S    +     + E      L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 85  ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
                 +  L+  Y    SL    +D  +   LD      I+  I  GL +LH       
Sbjct: 74  SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
            +  + HRDLK+ NIL+       I+D G+A   +   N+L+   N  VGT  YM+PE V
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 195 MNGIVSM-------KSDVYSFGVLVLEIISSKKNNG 223
           ++  + +       + D+++FG+++ E+     +NG
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
           +G+G +G V++G    G+ +A+K  S    +     + E      L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 85  ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
                 +  L+  Y    SL    +D  +   LD      I+  I  GL +LH       
Sbjct: 74  SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
            +  + HRDLK+ NIL+       I+D G+A   +   N+L+   N  VGT  YM+PE V
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 195 MNGIVSM-------KSDVYSFGVLVLEIISSKKNNG 223
           ++  + +       + D+++FG+++ E+     +NG
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
           +G+G +G V++G    G+ +A+K  S    +     + E      L+H N++  +   + 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 102
Query: 85  ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
                 +  L+  Y    SL    +D  +   LD      I+  I  GL +LH       
Sbjct: 103 SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
            +  + HRDLK+ NIL+       I+D G+A   +   N+L+   N  VGT  YM+PE V
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 217
Query: 195 MNGIVSM-------KSDVYSFGVLVLEIISSKKNNG 223
           ++  + +       + D+++FG+++ E+     +NG
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 253

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18  DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
           D +  G  LG G F  V K +     L    +   KR S++S +G+   E + E  ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           + H N++ L      + + +L+ E +    L  F+   ++KE L  ++  + I+ I+ G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
            YLH     ++ H DLK  NI+L D+  P    K+ DFG+A     +E+E       I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  +++PE V    + +++D++S GV+   ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 11  QTIAAATDNFSPGN---------RLGQGGFGPV-YKGKLLDGQEIAIKRLSKSSGQGIVE 60
           Q  AA     SPG+         ++G+G  G V    +   G+++A+K++     Q    
Sbjct: 29  QFRAALQLVVSPGDPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL 88
Query: 61  FKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
             NE  ++    H N+V +    L   E  +V E+L   +L   +  +   E    ++  
Sbjct: 89  LFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIA 144
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +   +++ L YLH      VIHRD+K+ +ILL      K+SDFG      +++      
Sbjct: 145 TVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRK 199
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
            +VGT  +M+PE +       + D++S G++V+E+I
Sbjct: 200 XLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V    +   G+ +A+K++     Q      NE  ++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   ++Q L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 135
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               VIHRD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +  
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 190
Query: 197 GIVSMKSDVYSFGVLVLEII 216
                + D++S G++V+E++
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V    +   G+ +A+K++     Q      NE  ++   QH N+
Sbjct: 27  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   ++Q L  LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 139
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               VIHRD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +  
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 194
Query: 197 GIVSMKSDVYSFGVLVLEII 216
                + D++S G++V+E++
Sbjct: 195 LPYGPEVDIWSLGIMVIEMV 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 10  FQTIAAAT---DNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKN 63
           FQ +A  T   D++     LG+G F  V +  K    QE A K ++  K S +   + + 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           EA++   L+H N+VRL     ++G   LV++ +    L     D   +E        + I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCI 136
Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTN 180
             I++ + ++H++    ++HRDLK  N+LL  +      K++DFG+A      E +A   
Sbjct: 137 HQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGEQQAWFG 192
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
              GT GY+SPE +         D+++ GV++
Sbjct: 193 -FAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V    +   G+ +A+K++     Q      NE  ++   QH N+
Sbjct: 34  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   ++Q L  LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 146
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               VIHRD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +  
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 201
Query: 197 GIVSMKSDVYSFGVLVLEII 216
                + D++S G++V+E++
Sbjct: 202 LPYGPEVDIWSLGIMVIEMV 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 112/222 (50%), Gaps = 34/222 (15%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK 70
           ++    D+  P   LG+G +G V K + +  GQ +A+KR+     +  V  + + +L+  
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLMD 55
Query: 71  LQHTN-------LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF--- 120
           L  +         V   G   ++G+  +  E + + SLD F      K+++D  +     
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPED 109
Query: 121 ---NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
               I   IV+ L +LH  S+L VIHRD+K SN+L++     K+ DFG++  + ++++  
Sbjct: 110 ILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAK 166
Query: 178 NTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEI 215
           + +   G   YM+PE +   +     S+KSD++S G+ ++E+
Sbjct: 167 DID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
            A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE +
Sbjct: 23  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKR 79
Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
           ++  +    LV+L           +V EY+P   +    F   ++     +   RF   +
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 135
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + G
Sbjct: 136 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 186
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 219

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 34/223 (15%)
Query: 11  QTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIA 69
           Q      D+  P   LG+G +G V K + +  GQ +A+KR+     +  V  + + +L+ 
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLM 98
Query: 70  KLQHTN-------LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF-- 120
            L  +         V   G   ++G+  +  E + + SLD F      K+++D  +    
Sbjct: 99  DLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPE 152
Query: 121 ----NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
                I   IV+ L +LH  S+L VIHRD+K SN+L++     K+ DFG++  + ++ + 
Sbjct: 153 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVA 209
Query: 177 ANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEI 215
              +   G   YM+PE +   +     S+KSD++S G+ ++E+
Sbjct: 210 KTID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V    +   G+ +A+K++     Q      NE  ++   QH N+
Sbjct: 32  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   ++Q L  LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 144
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               VIHRD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +  
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 199
Query: 197 GIVSMKSDVYSFGVLVLEII 216
                + D++S G++V+E++
Sbjct: 200 LPYGPEVDIWSLGIMVIEMV 219

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     +G G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   K++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI DF +AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKEIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY P   +  F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+++D Q   K++DFG+A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY P   +  F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+++D Q   K++DFG A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V   G     GE  +  E++   SLD  +  + +   +  +    +   +++GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE + 
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQ 176
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
               S++SD++S G+ ++E+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEM 196

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V    +   G+ +A+K++     Q      NE  ++   QH N+
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   ++Q L  LH  
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 266
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               VIHRD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +  
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 321
Query: 197 GIVSMKSDVYSFGVLVLEII 216
                + D++S G++V+E++
Sbjct: 322 LPYGPEVDIWSLGIMVIEMV 341

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 182
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 236
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEM 258

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V        +E+ AIK L K        +     E +++A L     +  L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
              Q  +RL  V EY+    L + I    K    + +  F   E I  GL +LHK     
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAE-ISIGLFFLHKRG--- 140
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           +I+RDLK  N++LD + + KI+DFGM +   M+ +   T    GT  Y++PE +      
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYIAPEIIAYQPYG 198
Query: 201 MKSDVYSFGVLVLEIISSK 219
              D +++GVL+ E+++ +
Sbjct: 199 KSVDWWAYGVLLYEMLAGQ 217

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY P   +  F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+++D Q   K++DFG A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 107/200 (53%), Gaps = 12/200 (6%)
Query: 25  RLGQGGFGPVYKGKLLDGQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLG 81
           ++G+G +G V+K K  +  EI A+KR+      +G+      E  L+ +L+H N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                 +  LV+E+  ++ L  + FDS   +L D +   + +  +++GL + H  +   V
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVS 200
           +HRDLK  N+L++     K+++FG+AR FG+  +   +  +V T  Y  P+ +    + S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 201 MKSDVYSFGVLVLEIISSKK 220
              D++S G +  E+ ++ +
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 201
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEM 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           DNF    ++G+G  G V    +   G+ +A+K++     Q      NE  ++   QH N+
Sbjct: 77  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V +    L   E  +V E+L   +L   +  +   E    ++   +   ++Q L  LH  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 189
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               VIHRD+K+ +ILL      K+SDFG      +++       +VGT  +M+PE +  
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 244
Query: 197 GIVSMKSDVYSFGVLVLEII 216
                + D++S G++V+E++
Sbjct: 245 LPYGPEVDIWSLGIMVIEMV 264

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI  FG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 26  LGQGGFGPV---YKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
           +G G +G V   Y  +L   Q++A+K+LS+   Q ++  +    E +L+  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 80  L-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           L       S++    + +   L    L+  +     + L D   +F ++  +++GL Y+H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KSQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                 +IHRDLK SN+ +++    +I DFG+AR     + +      V T  Y +PE +
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 200
Query: 195 MNGI-VSMKSDVYSFGVLVLEIISSK 219
           +N +  +   D++S G ++ E++  K
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 49/219 (22%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLV------ 77
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++      
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 78  ---------------RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
                           L+G  L K   LL  ++L N  + +F++                
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQ--------------- 152
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNR 181
              I++GL Y+H  +   V+HRDLK SN+LL+   + KI DFG+AR    +         
Sbjct: 153 ---ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 206
Query: 182 IVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
            V T  Y +PE ++N     KS D++S G ++ E++S++
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           + +G+ +L   S  + IHRDL A NILL +    KI DFG+AR    N            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +M+PE + + I S KSDV+S+GVL+ EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 123
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       ++   N  VGT  YMSPE 
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDEMANEFVGTRSYMSPER 177
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEM 199

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K        +  ++L     +  +  +   E +++ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  +  + +  +++L       +   +++GL YL
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 139
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YMSPE 
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 193
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 194 LQGTHYSVQSDIWSMGLSLVEM 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI D G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKEIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY P   +  F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+++D Q   +++DFG+A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
            A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE +
Sbjct: 30  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKR 86
Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
           ++  +    LV+L           +V EY+P   +    F   ++     +   RF   +
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ 142
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + G
Sbjct: 143 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
           +G+G +G V++G L  G+ +A+K  S    Q     + E      L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 85  ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
                 +  L+  Y  + SL    +D  +++ L+      +      GL +LH       
Sbjct: 74  SRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
            +  + HRD K+ N+L+   +   I+D G+A   + G + L+   N  VGT  YM+PE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 195 MNGIVS------MKSDVYSFGVLVLEIISSKKNNGCYDTER 229
              I +        +D+++FG+++ EI      NG  +  R
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYR 230

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
           D+F   + LG G  G V K +      I  ++L     +  +  +   E +++ +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
           +V   G     GE  +  E++   SLD  + ++ +  +E+L       +   +++GL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
            +  + +++HRD+K SNIL++ +   K+ DFG++       +++  N  VGT  YM+PE 
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMAPER 184
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
           +     S++SD++S G+ ++E+
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVEL 206

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY+P   +  F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI D G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 26  LGQGGFGPV---YKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
           +G G +G V   Y  +L   Q++A+K+LS+   Q ++  +    E +L+  L+H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 80  L-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           L       S++    + +   L    L+  +     + L D   +F ++  +++GL Y+H
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQF-LVYQLLRGLKYIH 140
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                 +IHRDLK SN+ +++    +I DFG+AR     + +      V T  Y +PE +
Sbjct: 141 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 192
Query: 195 MNGI-VSMKSDVYSFGVLVLEIISSK 219
           +N +  +   D++S G ++ E++  K
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 6   KIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGI-VEFKN 63
           KIF+F+              LG G F  V   +    G+  A+K + K + +G     +N
Sbjct: 22  KIFEFKET------------LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN 69
Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNI 122
           E  ++ K++H N+V L           LV + +    L    FD   +K     K    +
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTL 125
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANT 179
           I  ++  + YLH   R+ ++HRDLK  N+L    D++    ISDFG+++  G  ++ +  
Sbjct: 126 IRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
               GT GY++PE +     S   D +S GV+ 
Sbjct: 183 ---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 212

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    L +L           +V EY P   +  F          +   RF   + IV
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+++D Q   K++DFG A+      ++  T  + GT  
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 26  LGQGGFGPVYKGKLLDGQE----IAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNLV 77
           LG+GG+G V++ + + G       A+K L K+    + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            L+      G+  L+ EYL    L  F+    +   ++    F + E I   L +LH+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQKG 141
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
              +I+RDLK  NI+L+ Q + K++DFG+ +    +     T+   GT  YM+PE +M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHXFCGTIEYMAPEILMRS 196
Query: 198 IVSMKSDVYSFGVLVLEIISS 218
             +   D +S G L+ ++++ 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY P   +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+++D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
           N SP   +G G +G V        G  +A+K+LS+   Q I+  K    E +L+  ++H 
Sbjct: 26  NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75  NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           N++ LL       SL++   + +  +L    L+  +     ++L D   +F +I  I++G
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L Y+H      +IHRDLK SN+ +++    KI D G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE ++N +  +   D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 26  LGQGGFGPVYKGKLLDGQE----IAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNLV 77
           LG+GG+G V++ + + G       A+K L K+    + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            L+      G+  L+ EYL    L  F+    +   ++    F + E I   L +LH+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQKG 141
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
              +I+RDLK  NI+L+ Q + K++DFG+ +    +    +T    GT  YM+PE +M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 198 IVSMKSDVYSFGVLVLEIISS 218
             +   D +S G L+ ++++ 
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
            A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE +
Sbjct: 30  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKR 86
Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
           ++  +    LV+L           +V EY+P   +    F   ++     +   RF   +
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 142
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + G
Sbjct: 143 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 26  LGQGGFGPV---YKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
           +G G +G V   Y  +L   Q++A+K+LS+   Q ++  +    E +L+  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 80  L-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           L       S++    + +   L    L+  +     + L D   +F ++  +++GL Y+H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                 +IHRDLK SN+ +++    +I DFG+AR     + +      V T  Y +PE +
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 200
Query: 195 MNGI-VSMKSDVYSFGVLVLEIISSK 219
           +N +  +   D++S G ++ E++  K
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 18  DNFSPGNRLGQGGFGPVY-KGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 75
           D F    +LG G FG V+   +   G E  IK ++K   Q  +E  + E +++  L H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           ++++           +V E      L +  +   ++ + L       +++ ++  L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 135 KYSRLRVIHRDLKASNILLDDQ--MNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
                 V+H+DLK  NIL  D    +P KI DFG+A  F  +E   N     GT  YM+P
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAP 195
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
           E V    V+ K D++S GV++  +++     GC
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLT-----GC 222

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+P   +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 18/211 (8%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI----AIKRLSKSS----GQGIVEFKNEAKLIA 69
           +NF     LG G +G V+  + + G +     A+K L K++     +     + E +++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 70  KLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
            ++ +  +  L  + Q   +L L+ +Y+    L  F   S ++   + + +  + E IV 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVL 170
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
            L +LHK   L +I+RD+K  NILLD   +  ++DFG+++ F  +E E   +   GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 189 MSPEYVMNGIVSMKS--DVYSFGVLVLEIIS 217
           M+P+ V  G        D +S GVL+ E+++
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGI--VEFKNEAKLIAKL-QHTNLVRLLG 81
           LG G FG V+  +   +G+  A+K L K     +  VE  N+ +L+  +  H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                 +  ++ +Y+    L  F      +   +   +F   E +   L YLH      +
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYLHSKD---I 127
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           I+RDLK  NILLD   + KI+DFG A+      +   T  + GT  Y++PE V     + 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 202 KSDVYSFGVLVLEIIS 217
             D +SFG+L+ E+++
Sbjct: 183 SIDWWSFGILIYEMLA 198

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    L +L           +V EY P   +  F          +   RF   + IV
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+++D Q   K++DFG A+      ++  T  + GT  
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    L +L           +V EY P   +  F          +   RF   + IV
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+++D Q   K++DFG A+      ++  T  + GT  
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
           TD +     LG+G F  V +  K+  GQE A K ++  K S +   + + EA++   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N+VRL     ++G   LV++ +    L     D   +E        + I+ I++ + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHG 187
           H      ++HRDLK  N+LL  +      K++DFG+A      E++ +        GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
           Y+SPE +         D+++ GV++
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGF   ++    D +E+   ++   S         +   E  +   L H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                    +V E    +SL        +K L + + R+  +  IV G  YLH   R RV
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           IHRDLK  N+ L++ +  KI DFG+A     +     T  + GT  Y++PE +     S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 202 KSDVYSFGVLVLEIISSK 219
           + DV+S G ++  ++  K
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 60  EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL-----DFFIFDSSKKELL 114
           +FKNE ++I  +++   +   G      E  ++YEY+ N S+      FF+ D +    +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             +    II+ ++    Y+H  +   + HRD+K SNIL+D     K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 175 LEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLV 212
           ++ +     GT+ +M PE+  N       K D++S G+ +
Sbjct: 207 IKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 26  LGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG G F  V+  K  L G+  A+K + KS        +NE  ++ K++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 85  QKGERLLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                 LV + +    L    FD   ++ +   K    +I+ ++  + YLH+     ++H
Sbjct: 77  STTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 144 RDLKASNIL-LDDQMNPKISDFGMARTFGMNELEAN--TNRIVGTHGYMSPEYVMNGIVS 200
           RDLK  N+L L  + N KI    M   FG++++E N   +   GT GY++PE +     S
Sbjct: 130 RDLKPENLLYLTPEENSKI----MITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 201 MKSDVYSFGVL 211
              D +S GV+
Sbjct: 186 KAVDCWSIGVI 196

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 95  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 147
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 201
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 95  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 147
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 201
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGF   ++    D +E+   ++   S         +   E  +   L H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                    +V E    +SL        +K L + + R+  +  IV G  YLH   R RV
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           IHRDLK  N+ L++ +  KI DFG+A     +     T  + GT  Y++PE +     S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 202 KSDVYSFGVLVLEIISSK 219
           + DV+S G ++  ++  K
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY+P   +  F          +   RF   + IV
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 172
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT  
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 224
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGF   ++    D +E+   ++   S         +   E  +   L H ++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                    +V E    +SL        +K L + + R+  +  IV G  YLH   R RV
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 142
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           IHRDLK  N+ L++ +  KI DFG+A     +     T  + GT  Y++PE +     S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 202 KSDVYSFGVLVLEIISSK 219
           + DV+S G ++  ++  K
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
           TD +     LG+G F  V +  K+  GQE A K ++  K S +   + + EA++   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N+VRL     ++G   LV++ +    L     D   +E        + I+ I++ + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHG 187
           H      ++HRDLK  N+LL  +      K++DFG+A      E++ +        GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
           Y+SPE +         D+++ GV++
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 214 SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 205 SIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY P   +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+++D Q   K++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGF   ++    D +E+   ++   S         +   E  +   L H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                    +V E    +SL        +K L + + R+  +  IV G  YLH   R RV
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 136
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMNGI 198
           IHRDLK  N+ L++ +  KI DFG+A      ++E +  R   + GT  Y++PE +    
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 199 VSMKSDVYSFGVLVLEIISSK 219
            S + DV+S G ++  ++  K
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 129 SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    +            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
             +M+PE + + + +++SDV+SFGVL+ EI S             L    Y     +E  
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 310
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
              L + T     +PD  T  ++  +L C   + + RPT S++   L N
Sbjct: 311 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 357

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    +            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
             +M+PE + + + +++SDV+SFGVL+ EI S             L    Y     +E  
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 312
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
              L + T     +PD  T  ++  +L C   + + RPT S++   L N
Sbjct: 313 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 359

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGF   ++    D +E+   ++   S         +   E  +   L H ++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                    +V E    +SL        +K L + + R+  +  IV G  YLH   R RV
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 160
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMNGI 198
           IHRDLK  N+ L++ +  KI DFG+A      ++E +  R   + GT  Y++PE +    
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 215
Query: 199 VSMKSDVYSFGVLVLEIISSK 219
            S + DV+S G ++  ++  K
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGF   ++    D +E+   ++   S         +   E  +   L H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
                    +V E    +SL        +K L + + R+  +  IV G  YLH   R RV
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 162
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMNGI 198
           IHRDLK  N+ L++ +  KI DFG+A      ++E +  R   + GT  Y++PE +    
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 199 VSMKSDVYSFGVLVLEIISSK 219
            S + DV+S G ++  ++  K
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 93  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 145
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 199
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 79  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENXYKAQTHGKWPVKWYAPEC 185
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    +            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
             +M+PE + + + +++SDV+SFGVL+ EI S             L    Y     +E  
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 305
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
              L + T     +PD  T  ++  +L C   + + RPT S++   L N
Sbjct: 306 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 63  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 121
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 122 SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM---M 175
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 85  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 137
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 191
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    +            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
             +M+PE + + + +++SDV+SFGVL+ EI S             L    Y     +E  
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 303
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
              L + T     +PD  T  ++  +L C   + + RPT S++   L N
Sbjct: 304 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 350

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 75  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 127
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 181
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 73  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 125
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 179
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            D+  P   LG+G +G V K + +  GQ  A+KR+     +  V  + + +L+  L  + 
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-----RATVNSQEQKRLLXDLDISX 87
Query: 76  -------LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF------NI 122
                   V   G   ++G+  +  E L + SLD F      K+++D  +         I
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFY-----KQVIDKGQTIPEDILGKI 141
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
              IV+ L +LH  S+L VIHRD+K SN+L++     K  DFG++  + ++++  + +  
Sbjct: 142 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDID-- 196
Query: 183 VGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEI 215
            G   Y +PE +   +     S+KSD++S G+  +E+
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V++GK   G+E+A+K  S    +     + E      L+H N++  +    +
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 69
Query: 86  KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
                 +  LV +Y  + SL             D+  R+ + +EG+++       GL +L
Sbjct: 70  DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 117
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
           H        +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT 
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
            YM+PE V++  ++MK       +D+Y+ G++  EI
Sbjct: 178 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 79  GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 185
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 42  GQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL 96
           GQ+ A+K     + + S G    + K EA +   L+H ++V LL      G   +V+E++
Sbjct: 51  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 110
Query: 97  PNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD 155
               L F I   +    +  +    + +  I++ L Y H  +   +IHRD+K   +LL  
Sbjct: 111 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLAS 167
Query: 156 QMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
           + N    K+  FG+A   G + L A     VGT  +M+PE V         DV+  GV++
Sbjct: 168 KENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 225
Query: 213 LEIISSKKNNGC---YDTERHL 231
             ++S     GC   Y T+  L
Sbjct: 226 FILLS-----GCLPFYGTKERL 242

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 42  GQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL 96
           GQ+ A+K     + + S G    + K EA +   L+H ++V LL      G   +V+E++
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 97  PNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD 155
               L F I   +    +  +    + +  I++ L Y H  +   +IHRD+K   +LL  
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLAS 165
Query: 156 QMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
           + N    K+  FG+A   G + L A     VGT  +M+PE V         DV+  GV++
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
Query: 213 LEIIS 217
             ++S
Sbjct: 224 FILLS 228

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V++GK   G+E+A+K  S    +     + E      L+H N++  +    +
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 68
Query: 86  KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
                 +  LV +Y  + SL             D+  R+ + +EG+++       GL +L
Sbjct: 69  DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
           H        +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
            YM+PE V++  ++MK       +D+Y+ G++  EI
Sbjct: 177 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      L+   +AI+++S    Q   +    E K++ + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V++GK   G+E+A+K  S    +     + E      L+H N++  +    +
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 107
Query: 86  KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
                 +  LV +Y  + SL             D+  R+ + +EG+++       GL +L
Sbjct: 108 DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 155
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
           H        +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
            YM+PE V++  ++MK       +D+Y+ G++  EI
Sbjct: 216 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V++GK   G+E+A+K  S    +     + E      L+H N++  +    +
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 71
Query: 86  KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
                 +  LV +Y  + SL             D+  R+ + +EG+++       GL +L
Sbjct: 72  DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 119
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
           H        +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT 
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
            YM+PE V++  ++MK       +D+Y+ G++  EI
Sbjct: 180 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V++GK   G+E+A+K  S    +     + E      L+H N++  +    +
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 94
Query: 86  KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
                 +  LV +Y  + SL             D+  R+ + +EG+++       GL +L
Sbjct: 95  DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 142
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
           H        +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT 
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
            YM+PE V++  ++MK       +D+Y+ G++  EI
Sbjct: 203 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           +G+G FG V++GK   G+E+A+K  S    +     + E      L+H N++  +    +
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 74
Query: 86  KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
                 +  LV +Y  + SL             D+  R+ + +EG+++       GL +L
Sbjct: 75  DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 122
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
           H        +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT 
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
            YM+PE V++  ++MK       +D+Y+ G++  EI
Sbjct: 183 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 437 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 489
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 543
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26  LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
           LG G FG V KG  ++    +    ++ K+         E   EA ++ +L +  +VR++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L+ ++     + + D K    ++  +  G+ YL + +  
Sbjct: 438 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 490
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
             +HRDL A N+LL  Q   KISDFG+++      L A+ N     THG     + +PE 
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 544
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
           +     S KSDV+SFGVL+ E  S
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEI--AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           N +G+G +G V K  +  G  I  A K++ K   + +  FK E +++  L H N++RL  
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
                 +  LV E      L    F+    K +        I++ ++  + Y HK   L 
Sbjct: 74  TFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCHK---LN 126
Query: 141 VIHRDLKASNILL--DDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
           V HRDLK  N L   D   +P K+ DFG+A  F   ++       VGT  Y+SP+ V+ G
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-VLEG 182
Query: 198 IVSMKSDVYSFGVLV 212
           +   + D +S GV++
Sbjct: 183 LYGPECDEWSAGVMM 197

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
              +    LV+L           +V EY P   +  F          +   RF   + IV
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   K++DFG A+      ++  T  + GT  
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 216 SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K ++ G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 107
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 108 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 220
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 71  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 129
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 24  NRLGQGGFGPVYKGKLLDGQEI--AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           N +G+G +G V K  +  G  I  A K++ K   + +  FK E +++  L H N++RL  
Sbjct: 32  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
                 +  LV E      L    F+    K +        I++ ++  + Y HK   L 
Sbjct: 91  TFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCHK---LN 143
Query: 141 VIHRDLKASNILL--DDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
           V HRDLK  N L   D   +P K+ DFG+A  F   ++       VGT  Y+SP+ V+ G
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-VLEG 199
Query: 198 IVSMKSDVYSFGVLV 212
           +   + D +S GV++
Sbjct: 200 LYGPECDEWSAGVMM 214

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 62
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 63  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 122 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 175
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 63
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 64  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 176
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 63
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 64  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 176
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 71  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 129
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 20  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 69  AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 127
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 128 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 181
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 182 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG---MNELE 176
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G   M E E
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE 185
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
                 V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 186 ------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVEFKNEAKLIAKLQH 73
           A +D F   + LG+G    VY+ K    Q+  A+K L K+  + IV  + E  ++ +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSH 107
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLY 132
            N+++L        E  LV E +    L    FD   +K     +   + ++ I++ + Y
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYM 189
           LH+     ++HRDLK  N+L          KI+DFG+++   + E +     + GT GY 
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYC 217
Query: 190 SPEYVMNGIVSMKSDVYSFGVL 211
           +PE +       + D++S G++
Sbjct: 218 APEILRGCAYGPEVDMWSVGII 239

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 107
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P K+L+ F        + D++  ++    LD ++ 
Sbjct: 108 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 220
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
              V T  Y +PE ++        D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 42/212 (19%)
Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           +LG G +G V   +  +   E AIK      +S SS   ++E   E  ++  L H N+++
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMK 100
Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLD---WKKRFN------IIEGIVQ 128
           L             Y++  +K   + + +  K  EL D    + +FN      II+ ++ 
Sbjct: 101 L-------------YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGT 185
           G+ YLHK++   ++HRDLK  N+LL+ +      KI DFG++  F   E +      +GT
Sbjct: 148 GVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE V+      K DV+S GV++  +++
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 26  LGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRLLGCS 83
           LG G F  V   +    Q+ +AIK ++K + +G     +NE  ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
              G   L+ + +    L    FD   +K     +    +I  ++  + YLH    L ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 143 HRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           HRDLK  N+L   LD+     ISDFG+++   M +  +  +   GT GY++PE +     
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 200 SMKSDVYSFGVLV 212
           S   D +S GV+ 
Sbjct: 196 SKAVDCWSIGVIA 208

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
            A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE +
Sbjct: 24  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKR 80
Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
           ++  +    LV+L           +V EY+    +    F   ++     +   RF   +
Sbjct: 81  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ 136
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            IV    YLH    L +I+RDLK  N+L+D+Q   +++DFG A+      ++  T  + G
Sbjct: 137 -IVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCG 187
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 220

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
              V T  Y +PE ++        D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 26/232 (11%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEF 61
           RD  +    +     +N+ P   LG+G    V +       +E A+K +  + G      
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 62  KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLDW---- 116
           + +    A L+  +++R +       +    YE     +  F +FD  KK EL D+    
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYE---TNTFFFLVFDLMKKGELFDYLTEK 118
Query: 117 -----KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG 171
                K+   I+  +++ +  LHK   L ++HRDLK  NILLDD MN K++DFG +    
Sbjct: 119 VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 172 MNELEANTNRIVGTHGYMSPEYVMNGI------VSMKSDVYSFGVLVLEIIS 217
             E       + GT  Y++PE +   +         + D++S GV++  +++
Sbjct: 176 PGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 63
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 64  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 122
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 176
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L   L 
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 76
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 77  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 130
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 55/283 (19%)
Query: 23  GNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQ--- 72
           G  LG+GGFG V+ G +L D  ++AIK + ++   G     +      E  L+ K+    
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 73  -HTNLVRLLGC-SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR--FNIIEGIVQ 128
            H  ++RLL     Q+G  L++   LP +  D F + + K  L +   R  F  +   +Q
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQ--DLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMN-PKISDFGMARTFGMNELEANTNRIVGTHG 187
                H +SR  V+HRD+K  NIL+D +    K+ DFG      +   E  T+   GT  
Sbjct: 154 -----HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG---ALLHDEPYTD-FDGTRV 203
Query: 188 YMSPEYV-MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA 246
           Y  PE++  +   ++ + V+S G+L+ +++       C D                  + 
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMV-------CGDIPFE--------------RD 242
Query: 247 LELIDTTLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
            E+++  LH     SPD    C  +   C+  K + RP++ ++
Sbjct: 243 QEILEAELHFPAHVSPD----CCALIRRCLAPKPSSRPSLEEI 281

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 26  LGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRLLGCS 83
           LG G F  V   +    Q+ +AIK ++K + +G     +NE  ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
              G   L+ + +    L    FD   +K     +    +I  ++  + YLH    L ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 143 HRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           HRDLK  N+L   LD+     ISDFG+++   M +  +  +   GT GY++PE +     
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 200 SMKSDVYSFGVLV 212
           S   D +S GV+ 
Sbjct: 196 SKAVDCWSIGVIA 208

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 22/131 (16%)
Query: 103 FFIFDSSKK-ELLDW---------KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL 152
           F +FD  KK EL D+         K+   I+  +++ +  LHK   L ++HRDLK  NIL
Sbjct: 87  FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENIL 143
Query: 153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI------VSMKSDVY 206
           LDD MN K++DFG +      E       + GT  Y++PE +   +         + D++
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 200
Query: 207 SFGVLVLEIIS 217
           S GV++  +++
Sbjct: 201 STGVIMYTLLA 211

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 26/232 (11%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEF 61
           RD  +    +     +N+ P   LG+G    V +       +E A+K +  + G      
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 62  KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLDW---- 116
           + +    A L+  +++R +       +    YE     +  F +FD  KK EL D+    
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYE---TNTFFFLVFDLMKKGELFDYLTEK 118
Query: 117 -----KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG 171
                K+   I+  +++ +  LHK   L ++HRDLK  NILLDD MN K++DFG +    
Sbjct: 119 VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 172 MNELEANTNRIVGTHGYMSPEYVMNGI------VSMKSDVYSFGVLVLEIIS 217
             E       + GT  Y++PE +   +         + D++S GV++  +++
Sbjct: 176 PGE---KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/281 (21%), Positives = 120/281 (42%), Gaps = 33/281 (11%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           G  +G+G FG VY G+      I +  + + +   +  FK E     + +H N+V  +G 
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
            +      ++      ++L   + D+  K +LD  K   I + IV+G+ YLH      ++
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY---MSPEYVMN--- 196
           H+DLK+ N+  D+     I+DFG+    G+ +     +++   +G+   ++PE +     
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 197 ------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
                    S  SDV++ G +  E+         + T+    ++      W  G  ++  
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYEL---HAREWPFKTQPAEAII------WQMGTGMK-- 260
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
              L +     E++  +   L C   +  +RPT + +  ML
Sbjct: 261 -PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML 297

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 26  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 74
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 75  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 133
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 134 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 187
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
              V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 188 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 26  LGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRLLGCS 83
           LG G F  V   +    Q+ +AIK ++K + +G     +NE  ++ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
              G   L+ + +    L    FD   +K     +    +I  ++  + YLH    L ++
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 143 HRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
           HRDLK  N+L   LD+     ISDFG+++   M +  +  +   GT GY++PE +     
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 200 SMKSDVYSFGVLV 212
           S   D +S GV+ 
Sbjct: 196 SKAVDCWSIGVIA 208

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L   L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L   L 
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 74
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 75  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 128
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 14  AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
            A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE +
Sbjct: 32  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKR 88
Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
           ++  +    LV+L           +V EY+    +    F   ++     +   RF   +
Sbjct: 89  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ 144
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + G
Sbjct: 145 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 195
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T  Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 228

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
              V T  Y +PE ++        D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 70
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 71  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 129
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
              V T  Y +PE ++        D++S G ++ E+I
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG---MNELE 176
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G   M E E
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE 185
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
                 V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 186 ------VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 7   IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNE 64
           I+DF+ +            LG G F  V   +    Q+ +AIK ++K + +G     +NE
Sbjct: 19  IYDFRDV------------LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 65  AKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNII 123
             ++ K++H N+V L       G   L+ + +    L    FD   +K     +    +I
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLI 122
Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTN 180
             ++  + YLH    L ++HRDLK  N+L   LD+     ISDFG+++   M +  +  +
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
              GT GY++PE +     S   D +S GV+ 
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L   L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L   L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
           LG+G FG VY+G   +  G++I  A+K   K       E F +EA ++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G  +++    ++ E  P   L  ++ + +K  L    K   ++   +Q    +     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLESIN 129
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +HRD+   NIL+      K+ DFG++R     +  +A+  R+     +MSPE +     
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 200 SMKSDVYSFGVLVLEIISSKKN 221
           +  SDV+ F V + EI+S  K 
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQ 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L   L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   +    G+  A+K L K    +   +     E++++   +H  L   L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +    
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D ER   L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY+    +  F          +   RF   + IV
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQ-IV 172
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT  
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 224
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 23  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 71
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 72  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 130
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 131 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP- 186
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
              V T  Y +PE ++        D++S G ++ E+I
Sbjct: 187 --FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +    
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
              V T  Y +PE ++        D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+    AK 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
            +  LV L+ C   K    L+  + P KSL+ F        + D++  ++    LD ++ 
Sbjct: 70  AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +   T
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MT 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
             +V T  Y +PE ++        D++S G ++ E+I
Sbjct: 184 PEVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
           LG+G FG VY+G   +  G++I  A+K   K       E F +EA ++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G  +++    ++ E  P   L  ++ + +K  L    K   ++   +Q    +     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLESIN 133
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +HRD+   NIL+      K+ DFG++R     +  +A+  R+     +MSPE +     
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 200 SMKSDVYSFGVLVLEIISSKKN 221
           +  SDV+ F V + EI+S  K 
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQ 213

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 26  LGQGGFGPVYKGKLLDGQ---EIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLL 80
           +G G +G V     +DG+   ++AIK+L +     +   +   E +L+  ++H N++ LL
Sbjct: 33  VGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 81  GCSLQKGERLLVYEYLPNKSLDFF-------------IFDSSKKELLDWKKRFNIIEGIV 127
                         + P+++LD F             +    K E L   +   ++  ++
Sbjct: 91  DV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +GL Y+H      +IHRDLK  N+ +++    KI DFG+AR     + ++     V T  
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRW 190
Query: 188 YMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
           Y +PE ++N +   ++ D++S G ++ E+I+ K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 7/198 (3%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
           +G+G +G V      ++   +AIK++S    Q   +    E K++   +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  +   Y+    ++  ++   K + L        +  I++GL Y+H  +   V+H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
           RDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE ++N     K
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 203 S-DVYSFGVLVLEIISSK 219
           S D++S G ++ E++S++
Sbjct: 210 SIDIWSVGCILAEMLSNR 227

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   K    G+  A+K L K    +   +     E +++   +H  L   L 
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 76
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH  S   
Sbjct: 77  YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 131
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + +    
Sbjct: 132 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLEDNDYG 189
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D E+   L+
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 26  LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
           LG+G FG VY+G   +  G++I  A+K   K       E F +EA ++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G  +++    ++ E  P   L  ++ + +K  L    K   ++   +Q    +     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLESIN 145
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGIV 199
            +HRD+   NIL+      K+ DFG++R     +  +A+  R+     +MSPE +     
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 200 SMKSDVYSFGVLVLEIISSKKN 221
           +  SDV+ F V + EI+S  K 
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQ 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 40/234 (17%)
Query: 10  FQTIAAATDNFSPGNR------LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK 62
           F ++  A   F+   R      +G G  G V      + G  +A+K+LS+        F+
Sbjct: 10  FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQ 62
Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
           N+    AK  +  LV LL C   K    L+  + P K+L+ F        + D++  ++ 
Sbjct: 63  NQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
              LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART 
Sbjct: 120 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
             N +       V T  Y +PE ++    +   D++S G ++ E++      GC
Sbjct: 177 CTNFM---MTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV-----KGC 222

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY+    +  F          +   RF   + IV
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT  
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   K    G+  A+K L K    +   +     E +++   +H  L   L 
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 75
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH  S   
Sbjct: 76  YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 130
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + +    
Sbjct: 131 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D E+   L+
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 39  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 129/313 (41%), Gaps = 70/313 (22%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
           LG G  G V       G+ +A+KR+       +++F + A +  KL      H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 93
Query: 81  GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
            CS      L +   L N +L D     +   E L  +K +N   ++  I  G+ +LH  
Sbjct: 94  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
             L++IHRDLK  NIL+        D Q   +     ISDFG+ +    G      N N 
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 182 IVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW 238
             GT G+ +PE +       ++   D++S G +   I+S  K+       R  N++   +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL 298
            L                    DE+ +C+H   L  +  ATD      ++ M+ +D +  
Sbjct: 270 SL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHDPLKR 301
Query: 299 PTP----RQPAFF 307
           PT     R P F+
Sbjct: 302 PTAMKVLRHPLFW 314

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   K    G+  A+K L K    +   +     E +++   +H  L   L 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 214
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH  S   
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 269
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + +    
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D E+   L+
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   K    G+  A+K L K    +   +     E +++   +H  L   L 
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 74
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH  S   
Sbjct: 75  YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 129
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + +    
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLEDNDYG 187
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D E+   L+
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 129/313 (41%), Gaps = 70/313 (22%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
           LG G  G V       G+ +A+KR+       +++F + A +  KL      H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 93
Query: 81  GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
            CS      L +   L N +L D     +   E L  +K +N   ++  I  G+ +LH  
Sbjct: 94  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
             L++IHRDLK  NIL+        D Q   +     ISDFG+ +    G      N N 
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 182 IVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW 238
             GT G+ +PE +       ++   D++S G +   I+S  K+       R  N++   +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL 298
            L                    DE+ +C+H   L  +  ATD      ++ M+ +D +  
Sbjct: 270 SL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHDPLKR 301
Query: 299 PTP----RQPAFF 307
           PT     R P F+
Sbjct: 302 PTAMKVLRHPLFW 314

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V   K    G+  A+K L K    +   +     E +++   +H  L   L 
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 217
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH  S   
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 272
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           V++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + +    
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
              D +  GV++ E++  +      D E+   L+
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLV---RLL 80
           +G+G +G V      +    +AIK++S    Q   +    E +++ + +H N++    +L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
             S  +  R +   Y+    ++  ++   K + L        +  I++GL Y+H  +   
Sbjct: 111 RASTLEAMRDV---YIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNRIVGTHGYMSPEYVMNGIV 199
           V+HRDLK SN+L++   + KI DFG+AR     ++        V T  Y +PE ++N   
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
             KS D++S G ++ E++S++
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H  LV L  C   +     V EY+    L F +    +++L +   RF   E I   L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 168
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH+     +I+RDLK  N+LLD + + K++D+GM +  G+   +  T+   GT  Y++PE
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPE 223
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +         D ++ GVL+ E+++ +
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H  LV L  C   +     V EY+    L F +    +++L +   RF   E I   L Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 136
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH+     +I+RDLK  N+LLD + + K++D+GM +  G+   +  T+   GT  Y++PE
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 191
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +         D ++ GVL+ E+++ +
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 24  NRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLL 80
             +G G +G V        G+++AIK+LS+     I   +   E  L+  +QH N++ LL
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 81  GCSLQKGERLLVYEYLPNKSL----DFFI----FDSSKKELLDWK----KRFNIIEGIVQ 128
                         + P  SL    DF++      +  ++++  K    K   ++  +++
Sbjct: 90  DV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK 137
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           GL Y+H      V+HRDLK  N+ +++    KI DFG+AR       +A     V T  Y
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 189
Query: 189 MSPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
            +PE +++ +  +   D++S G ++ E+++ K
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 24  NRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLL 80
             +G G +G V        G+++AIK+LS+     I   +   E  L+  +QH N++ LL
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSK---KELLDWKKRFNIIEGIVQGLLYLHKYS 137
                       Y++     + F   D  K    E  + K ++ ++  +++GL Y+H   
Sbjct: 108 DVFTPASSLRNFYDFY--LVMPFMQTDLQKIMGMEFSEEKIQY-LVYQMLKGLKYIHSAG 164
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
              V+HRDLK  N+ +++    KI DFG+AR       +A     V T  Y +PE +++ 
Sbjct: 165 ---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSW 216
Query: 198 I-VSMKSDVYSFGVLVLEIISSK 219
           +  +   D++S G ++ E+++ K
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+       
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67  ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
               L+  + H N++ LL              + P K+L+ F        + D++  ++ 
Sbjct: 72  RELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
              LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART 
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           G + +       V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H  LV L  C   +     V EY+    L F +    +++L +   RF   E I   L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 125
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH+     +I+RDLK  N+LLD + + K++D+GM +  G+   +  T+   GT  Y++PE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 180
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +         D ++ GVL+ E+++ +
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
           +  +    LV+L           +V EY+    +  F          +   RF   + IV
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 172
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
               YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT  
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPE 224
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 36/169 (21%)
Query: 58  IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL--PNKSLDFFIFD-------- 107
           I +   E  ++ KL H N+V+L+             E L  PN+   + +F+        
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLV-------------EVLDDPNEDHLYMVFELVNQGPVM 126
Query: 108 --SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 165
              + K L + + RF   + +++G+ YLH     ++IHRD+K SN+L+ +  + KI+DFG
Sbjct: 127 EVPTLKPLSEDQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 166 MARTF-GMNELEANTNRIVGTHGYMSPEYV--MNGIVSMKS-DVYSFGV 210
           ++  F G + L +NT   VGT  +M+PE +     I S K+ DV++ GV
Sbjct: 183 VSNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 34/221 (15%)
Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           +LG+G +G V+K      G+ +A+K++    ++S      F+    L     H N+V LL
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 81  GCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
                  +R   LV++Y+        +    +  +L+   +  ++  +++ + YLH    
Sbjct: 76  NVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTF------------GMNELEANTN------ 180
             ++HRD+K SNILL+ + + K++DFG++R+F             +NE   N +      
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 181 -RIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
              V T  Y +PE ++      K  D++S G ++ EI+  K
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H  LV L  C   +     V EY+    L F +    +++L +   RF   E I   L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 121
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH+     +I+RDLK  N+LLD + + K++D+GM +  G+   +  T+   GT  Y++PE
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 176
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
            +         D ++ GVL+ E+++ +
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 132/317 (41%), Gaps = 74/317 (23%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
           LG G  G V       G+ +A+KR+       +++F + A +  KL      H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 81  GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
            CS      L +   L N +L D     +   E L  +K +N   ++  I  G+ +LH  
Sbjct: 76  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
             L++IHRDLK  NIL+        D Q   +     ISDFG+ +    G +    N N 
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 182 IVGTHGYMSPEYV--MNGIVSMKS-----DVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
             GT G+ +PE +   N + + +      D++S G +   I+S  K+       R  N++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
              + L                    DE+ +C+H   L  +  ATD      ++ M+ +D
Sbjct: 252 RGIFSL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHD 283
Query: 295 TMALPTP----RQPAFF 307
            +  PT     R P F+
Sbjct: 284 PLKRPTAMKVLRHPLFW 300

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 10  FQTIAAATDNFSPGNR------LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK 62
           F ++  A   F+   R      +G G  G V      + G  +A+K+LS+        F+
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQ 60
Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
           N+    AK  +  LV LL C   K    L+  + P K+L+ F        + D++  ++ 
Sbjct: 61  NQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 117
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
              LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART 
Sbjct: 118 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 174
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
             N +       V T  Y +PE ++        D++S G ++ E++
Sbjct: 175 STNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+       
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67  ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
               L+  + H N++ LL              + P KSL+ F        + D++  ++ 
Sbjct: 72  RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
              LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART 
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           G + +       V T  Y +PE ++        D++S GV++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 107/244 (43%), Gaps = 37/244 (15%)
Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN 63
           LKI   Q      ++      +G+G +G V K      GQ +A+KR+     +  V+ K 
Sbjct: 9   LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-----RSTVDEKE 63
Query: 64  EAKLIAKLQ-------HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF------DSSK 110
           + +L+  L           +V+  G   ++G+  +  E +      F+ +      D   
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123
Query: 111 KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
           +E+L       I    V+ L +L +   L++IHRD+K SNILLD   N K+ DFG++   
Sbjct: 124 EEILG-----KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS--- 173
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEIISSK----KNN 222
           G         R  G   YM+PE +          ++SDV+S G+ + E+ + +    K N
Sbjct: 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233
Query: 223 GCYD 226
             +D
Sbjct: 234 SVFD 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+++D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIIISKGYNKAVDWWALGVLIYEMAA 233

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLI 68
           T+     N  P     QG     Y   L   + +AIK+LS+   Q     K    E  L+
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLM 77
Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDW 116
             + H N++ LL              + P K+L+ F        + D++  ++    LD 
Sbjct: 78  KXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 125
Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
           ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + + 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM- 181
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
                 V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 182 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +++   +   D ++ GVL+ ++ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYQMAA 233

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+       
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67  ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
               L+  + H N++ LL              + P KSL+ F        + D++  ++ 
Sbjct: 72  RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
              LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART 
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           G + +       V T  Y +PE ++        D++S GV++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G FG V   +    Q++ A+K LSK     +    F  E + I    ++  V  L C
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 83  SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           + Q  + L +V EY+P   L   +  +D  +K    W K +       + +L L     +
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHSM 193
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
            +IHRD+K  N+LLD   + K++DFG         +  + +  VGT  Y+SPE +     
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VHCDTAVGTPDYISPEVLKSQGG 252
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
           +G    + D +S GV + E++
Sbjct: 253 DGYYGRECDWWSVGVFLFEML 273

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG G FG V++  +   G+    K ++          KNE  ++ +L H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 85  QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK----KRFNIIEGIVQGLLYLHKYSRLR 140
            K E +L+ E+L    L    FD    E  D+K    +  N +    +GL ++H++S   
Sbjct: 119 DKYEMVLILEFLSGGEL----FDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 141 VIHRDLKASNILLDDQM--NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
           ++H D+K  NI+ + +   + KI DFG+A     +E+   T     T  + +PE V    
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREP 226
Query: 199 VSMKSDVYSFGVLVLEIIS 217
           V   +D+++ GVL   ++S
Sbjct: 227 VGFYTDMWAIGVLGYVLLS 245

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQH 73
           D+F     +G+G FG V   +  D +++ A+K ++K       E +N   E +++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSS--KKELLDWKKRFNIIEGIVQGLL 131
             LV L      + +  +V + L    L + +  +   K+E +   K F  I  +V  L 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV---KLF--ICELVMALD 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL      R+IHRD+K  NILLD+  +  I+DF +A    M   E     + GT  YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA---AMLPRETQITTMAGTKPYMAP 183
Query: 192 EYVMN---GIVSMKSDVYSFGVLVLEIISSKK 220
           E   +      S   D +S GV   E++  ++
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCSL 84
           +G G FG V++ KL++  E+AIK++ +        FKN E +++  ++H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 85  QKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
             G++       LV EY+P          +  K+ +        +  +++ L Y+H    
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--- 159
Query: 139 LRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
           + + HRD+K  N+LLD      K+ DFG A+       E N + I   + Y +PE +   
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSXICSRY-YRAPELIFGA 216
Query: 198 I-VSMKSDVYSFGVLVLEIISSK 219
              +   D++S G ++ E++  +
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLI 68
           T+     N  P     QG     Y   L   + +AIK+LS+   Q     K    E  L+
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLM 77
Query: 69  AKLQHTNLVRLLGC-SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
             + H N++ LL   + QK        YL  + +D  +    + EL D ++   ++  ++
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-DHERMSYLLYQML 136
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +       V T  
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM---MTPYVVTRY 190
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           Y +PE ++        D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 70/136 (51%), Gaps = 22/136 (16%)
Query: 98  NKSLDFFIFDSSKK-ELLDW---------KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK 147
           + S  F +FD  +K EL D+         K+  +I+  +++ + +LH  +   ++HRDLK
Sbjct: 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLK 227
Query: 148 ASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI------VSM 201
             NILLDD M  ++SDFG +      E       + GT GY++PE +   +         
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 202 KSDVYSFGVLVLEIIS 217
           + D+++ GV++  +++
Sbjct: 285 EVDLWACGVILFTLLA 300

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKL 71
           +D +     +G G FG     +L+  ++    +A+K + +  G+ I E  K E      L
Sbjct: 17  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSL 71
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N+VR     L      +V EY     L   I ++ +    + + RF   + ++ G+ 
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 128
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
           Y H    ++V HRDLK  N LLD    P  KI DFG +++   + L +     VGT  Y+
Sbjct: 129 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYI 182
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
           +PE ++      K +DV+S GV
Sbjct: 183 APEVLLKKEYDGKVADVWSCGV 204

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 25  RLGQGGFGPVYKGKLLDGQ---EIAIKRLSKSSGQGIVEFKNEAKL-IAKLQHTNLVRLL 80
           RLG+G FG V++  + D Q   + A+K++       +  F+ E  +  A L    +V L 
Sbjct: 100 RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 81  GCSLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G ++++G  + ++ E L   SL   +    ++  L   +    +   ++GL YLH  SR 
Sbjct: 152 G-AVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR- 204
Query: 140 RVIHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVM 195
           R++H D+KA N+LL  D  +  + DFG A      G+ +     + I GT  +M+PE V+
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
                 K DV+S   ++L ++     NGC+
Sbjct: 265 GRSCDAKVDVWSSCCMMLHML-----NGCH 289

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 26  LGQGGFGPVYKGKLLDGQEI--AIKRLSKSSGQGIVEFKNEAKLIAK-------LQHTNL 76
           +G+G FG V   +    +E+  A+K L K   + I++ K E  ++++       ++H  L
Sbjct: 46  IGKGSFGKVLLARH-KAEEVFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           V L   S Q  ++L  V +Y+    L  F     ++  L+ + RF   E I   L YLH 
Sbjct: 102 VGL-HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS 157
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              L +++RDLK  NILLD Q +  ++DFG+ +     E  + T+   GT  Y++PE + 
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
                   D +  G ++ E++
Sbjct: 213 KQPYDRTVDWWCLGAVLYEML 233

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           RLG+G FG V++ K    G + A+K++       +  F+  E    A L    +V L G 
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG- 131
Query: 83  SLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           ++++G  + ++ E L   SL   I    +   L   +    +   ++GL YLH     R+
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 185
Query: 142 IHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVMNG 197
           +H D+KA N+LL  D     + DFG A      G+ +     + I GT  +M+PE VM  
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCY 225
               K D++S   ++L ++     NGC+
Sbjct: 246 PCDAKVDIWSSCCMMLHML-----NGCH 268

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++P  +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEYLAPAIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 74
           +D +     +G G FG     +     E +A+K + +  G+ I E  K E      L+H 
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDENVKREIINHRSLRHP 75
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+VR     L      +V EY     L   I ++ +    + + RF   + ++ G+ Y H
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVSYAH 132
Query: 135 KYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
               ++V HRDLK  N LLD    P  KI+DFG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA---SVLHSQPKSAVGTPAYIAPE 186
Query: 193 YVMNGIVSMK-SDVYSFGV 210
            ++      K +DV+S GV
Sbjct: 187 VLLKKEYDGKVADVWSCGV 205

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 131/317 (41%), Gaps = 74/317 (23%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
           LG G  G V       G+ +A+KR+       +++F + A +  KL      H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 81  GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
            CS      L +   L N +L D     +   E L  +K +N   ++  I  G+ +LH  
Sbjct: 76  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
             L++IHRDLK  NIL+        D Q   +     ISDFG+ +    G      N N 
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 182 IVGTHGYMSPEYV--MNGIVSMKS-----DVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
             GT G+ +PE +   N + + +      D++S G +   I+S  K+       R  N++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
              + L                    DE+ +C+H   L  +  ATD      ++ M+ +D
Sbjct: 252 RGIFSL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHD 283
Query: 295 TMALPTP----RQPAFF 307
            +  PT     R P F+
Sbjct: 284 PLKRPTAMKVLRHPLFW 300

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
             R +HRD+ A N+L+      K+ DFG++R +  +      ++      +M+PE +   
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFR 187
Query: 198 IVSMKSDVYSFGVLVLEII 216
             +  SDV+ FGV + EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIV-EFKNEAKLIAKL 71
           +D +     +G G FG     +L+  ++    +A+K + +  G+ I    K E      L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIAANVKREIINHRSL 72
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N+VR     L      +V EY     L   I ++ +    + + RF   + ++ G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
           Y H    ++V HRDLK  N LLD    P  KI DFG +++   + L +     VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYI 183
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
           +PE ++      K +DV+S GV
Sbjct: 184 APEVLLKKEYDGKVADVWSCGV 205

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 25  RLGQGGFGPVYKGKLLDGQ---EIAIKRLSKSSGQGIVEFKNEAKL-IAKLQHTNLVRLL 80
           RLG+G FG V++  + D Q   + A+K++       +  F+ E  +  A L    +V L 
Sbjct: 81  RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 81  GCSLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G ++++G  + ++ E L   SL   +    ++  L   +    +   ++GL YLH  SR 
Sbjct: 133 G-AVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR- 185
Query: 140 RVIHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVM 195
           R++H D+KA N+LL  D  +  + DFG A      G+ +     + I GT  +M+PE V+
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
                 K DV+S   ++L ++     NGC+
Sbjct: 246 GRSCDAKVDVWSSCCMMLHML-----NGCH 270

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 48/226 (21%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+       
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67  ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
               L+  + H N++ LL              + P KSL+ F        + D++  ++ 
Sbjct: 72  RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
              LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART 
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           G + +       V T  Y +PE ++        D++S G ++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 77  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 132
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 133 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 188
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 72  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 127
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 183
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 186
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 186
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 103 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 158
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 159 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 214
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           R+G+G FG V++ K    G + A+K++       +  F+  E    A L    +V L G 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG- 117
Query: 83  SLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           ++++G  + ++ E L   SL   I    +   L   +    +   ++GL YLH     R+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 142 IHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVMNG 197
           +H D+KA N+LL  D     + DFG A      G+ +     + I GT  +M+PE VM  
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCY 225
               K D++S   ++L ++     NGC+
Sbjct: 232 PCDAKVDIWSSCCMMLHML-----NGCH 254

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 48/226 (21%)
Query: 12  TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
           T+     N  P     QG     Y   L   + +AIK+LS+        F+N+       
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67  ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
               L+  + H N++ LL              + P KSL+ F        + D++  ++ 
Sbjct: 72  RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
              LD ++   ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           G + +       V T  Y +PE ++        D++S G ++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 80  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 191
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
           R+G+G FG V++ K    G + A+K++       +  F+  E    A L    +V L G 
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG- 133
Query: 83  SLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
           ++++G  + ++ E L   SL   I    +   L   +    +   ++GL YLH     R+
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 187
Query: 142 IHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVMNG 197
           +H D+KA N+LL  D     + DFG A      G+ +     + I GT  +M+PE VM  
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCY 225
               K D++S   ++L ++     NGC+
Sbjct: 248 PCDAKVDIWSSCCMMLHML-----NGCH 270

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 78  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 133
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 134 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 189
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 15  AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
           A  D F     LG G FG V   K  + G   A+K L K   Q +V+ K      NE ++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
           +  +    LV+L           +V EY+    +    F   ++     +   RF   + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           IV    YLH    L +I+RDLK  N+L+D Q   +++DFG A+      ++  T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
              ++PE +++   +   D ++ GVL+ E+ +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
           LG+G FG V++      ++  + +  K  G   V  K E  ++   +H N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 86  KGERLLVYEYLPNKSLDFF------IFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
             E ++++E++    LD F       F+ +++E++ +      +  + + L +LH ++  
Sbjct: 73  MEELVMIFEFISG--LDIFERINTSAFELNEREIVSY------VHQVCEALQFLHSHN-- 122
Query: 140 RVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
            + H D++  NI+   + +   KI +FG AR     +   N   +     Y +PE   + 
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD 178
Query: 198 IVSMKSDVYSFGVLVLEIIS 217
           +VS  +D++S G LV  ++S
Sbjct: 179 VVSTATDMWSLGTLVYVLLS 198

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 131 --RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 186
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 455 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 566
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 17  TDNFSPGNRLGQGGFG--PVYKGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQH 73
           +D +     +G G FG   + + KL   + +A+K + +  G  I E  + E      L+H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIER--GAAIDENVQREIINHRSLRH 75
Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N+VR     L      ++ EY     L   I ++ +    + + RF   + ++ G+ Y 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARF-FFQQLLSGVSYC 132
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           H    +++ HRDLK  N LLD    P  KI DFG +++   + L +     VGT  Y++P
Sbjct: 133 HS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAP 186
Query: 192 EYVMNGIVSMK-SDVYSFGV 210
           E ++      K +DV+S GV
Sbjct: 187 EVLLRQEYDGKIADVWSCGV 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +     +AIK     +   + E F  EA  + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L+G  + +    ++ E      L  F+    +K  LD          +   L YL    
Sbjct: 455 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
             R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE +  
Sbjct: 511 --RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 566
Query: 197 GIVSMKSDVYSFGVLVLEII 216
              +  SDV+ FGV + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKL 71
           +D +     +G G FG     +L+  ++    +A+K + +  G+ I E  K E      L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSL 72
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N+VR     L      +V EY     L   I ++ +    + + RF   + ++ G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
           Y H    ++V HRDLK  N LLD    P  KI  FG +++   + L +     VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS---SVLHSQPKSTVGTPAYI 183
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
           +PE ++      K +DV+S GV
Sbjct: 184 APEVLLKKEYDGKVADVWSCGV 205

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 24  NRLGQGGFGPV-YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG- 81
            +LG+GGF  V     L DG   A+KR+     Q   E + EA +     H N++RL+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE---------GIVQGLLY 132
           C  ++G +   +  LP     FF   +   E+   K + N +          GI +GL  
Sbjct: 95  CLRERGAKHEAWLLLP-----FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV--------G 184
           +H        HRDLK +NILL D+  P + D G      ++ +E +   +          
Sbjct: 150 IHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH-VEGSRQALTLQDWAAQRC 205
Query: 185 THGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD 226
           T  Y +PE      + ++  ++DV+S G ++  ++  +   G YD
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE---GPYD 247

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 19  NFSPGNRLGQGGFGP-VYKGKLLDGQEIAIKRLSKSSGQGIVEFKN-EAKLIAKL-QHTN 75
           +F P + LG G  G  VY+G + D +++A+KR+          F + E +L+ +  +H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPN 79
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           ++R   C+ +  +   +   L   +L  ++       L    +   +++    GL +LH 
Sbjct: 80  VIRYF-CTEKDRQFQYIAIELCAATLQEYVEQKDFAHL--GLEPITLLQQTTSGLAHLHS 136
Query: 136 YSRLRVIHRDLKASNILLD-----DQMNPKISDFGMARTFGMNELE-ANTNRIVGTHGYM 189
              L ++HRDLK  NIL+       ++   ISDFG+ +   +     +  + + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 190 SPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
           +PE +        +   D++S G +   +IS   +      +R  N++
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKL 71
           +D +     +G G FG     +L+  ++    +A+K + +  G+ I E  K E      L
Sbjct: 18  SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSL 72
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           +H N+VR     L      +V EY     L   I ++ +    + + RF   + ++ G+ 
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
           Y H    ++V HRDLK  N LLD    P  KI  FG +++   + L +     VGT  Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS---SVLHSQPKDTVGTPAYI 183
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
           +PE ++      K +DV+S GV
Sbjct: 184 APEVLLKKEYDGKVADVWSCGV 205

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 25  RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSS-GQGI-VEFKNEAKLIAKLQHT-NLVRLL 80
            LG+G F  V +      GQE A K L K   GQ    E  +E  ++   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
                  E +L+ EY     + F +      E++       +I+ I++G+ YLH+ +   
Sbjct: 96  EVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--- 151
Query: 141 VIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
           ++H DLK  NILL   + P    KI DFGM+R  G          I+GT  Y++PE +  
Sbjct: 152 IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEILNY 207
Query: 197 GIVSMKSDVYSFGVLVLEIIS 217
             ++  +D+++ G++   +++
Sbjct: 208 DPITTATDMWNIGIIAYMLLT 228

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS-------GQGIVEFKNEAKLIAKLQHTN 75
           G+ LG+G +G V   ++LD + +  + +             G    K E +L+ +L+H N
Sbjct: 10  GDLLGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 76  LVRLLGC--SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW--KKRFNIIEG------ 125
           +++L+    + +K +  +V EY               +E+LD   +KRF + +       
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYC----------VCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           ++ GL YLH      ++H+D+K  N+LL      KIS  G+A        +       G+
Sbjct: 118 LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 186 HGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISS 218
             +  PE + NG+      K D++S GV +  I + 
Sbjct: 175 PAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           I  GL +L       +I+RDLK  N++LD + + KI+DFGM +    + +   T    GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 505
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
             Y++PE +         D ++FGVL+ E+++ +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 122
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 222
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S    + C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 223 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 10  FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKL 67
           FQ+++     +S   ++G GG   V++      Q  AIK   L ++  Q +  ++NE   
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 68  IAKLQ-HTN-LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG 125
           + KLQ H++ ++RL    +       +Y  +   ++D   +   KK +  W+++ +  + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKN 135
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           +++ +  +H++    ++H DLK +N L+ D M  K+ DFG+A     +      +  VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 186 HGYMSPEYV 194
             YM PE +
Sbjct: 192 VNYMPPEAI 200

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            IV+ L YL +  +  VIHRD+K SNILLD++   K+ DFG++   G    +   +R  G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAG 186
Query: 185 THGYMSPEYV-----MNGIVSMKSDVYSFGVLVLEIISSK 219
              YM+PE +           +++DV+S G+ ++E+ + +
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 10  FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKL 67
           FQ+++     +S   ++G GG   V++      Q  AIK   L ++  Q +  ++NE   
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 68  IAKLQ-HTN-LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG 125
           + KLQ H++ ++RL    +       +Y  +   ++D   +   KK +  W+++ +  + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKN 135
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           +++ +  +H++    ++H DLK +N L+ D M  K+ DFG+A     +      +  VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGT 191
Query: 186 HGYMSPEYV 194
             YM PE +
Sbjct: 192 VNYMPPEAI 200

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 32/205 (15%)
Query: 24  NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-------QHTN 75
           +RLG G +G V+K +   DG+  A+KR S S  +G    K+ A+ +A++       QH  
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGP---KDRARKLAEVGSHEKVGQHPC 118
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            VRL   + ++G  L +   L   SL      + +S  E   W      +   +  L +L
Sbjct: 119 CVRLEQ-AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHL 173
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGM---ARTFGMNELEANTNRIVGTHGYMS 190
           H      ++H D+K +NI L  +   K+ DFG+     T G  E++    R      YM+
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR------YMA 224
Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEI 215
           PE ++ G     +DV+S G+ +LE+
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEV 248

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 254
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S    + C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 255 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           I  GL +L       +I+RDLK  N++LD + + KI+DFGM +    + +   T    GT
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 184
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
             Y++PE +         D ++FGVL+ E+++ +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S    + C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 256 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S    + C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 256 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 254
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S    + C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 255 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 26  LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
           LG GG G V+     D  + +AIK++  +  Q +     E K+I +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 85  QKGERL--------------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
             G +L              +V EY+     +       +  LL+   R  + + +++GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARLFMYQ-LLRGL 133
Query: 131 LYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMN-ELEANTNRIVGTHGY 188
            Y+H  +   V+HRDLK +N+ ++ + +  KI DFG+AR    +   + + +  + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
            SP  +++     K+ D+++ G +  E+++ K
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S      C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 256 ------FRQRVS----XECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEF 61
           RD   F  QT+            L +GGF  VY+ + +  G+E A+KRL  +  +     
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 62  KNEAKLIAKLQ-HTNLVRLLGCS--------LQKGERLLVYEYLPNKSLDFFIFDSSKKE 112
             E   + KL  H N+V+    +          + E LL+ E    + ++F     S+  
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
           L        I     + + ++H+  +  +IHRDLK  N+LL +Q   K+ DFG A T   
Sbjct: 133 L-SCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190
Query: 173 ---------------NELEANTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLV 212
                           E+  NT     T  Y +PE +    N  +  K D+++ G ++
Sbjct: 191 YPDYSWSAQRRALVEEEITRNT-----TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 254
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S      C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 255 ------FRQRVS----XECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 30/244 (12%)
Query: 26  LGQGGFGPVYKG--------KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           LGQG F  ++KG          L   E+ +K L K+       F   A +++KL H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              G  +   E +LV E++   SLD ++  +     + WK     +E   Q    +H   
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAAAMHFLE 130
Query: 138 RLRVIHRDLKASNILL---DDQM--NP---KISDFGMARTFGMNELEANTNRIVGTHGYM 189
              +IH ++ A NILL   +D+   NP   K+SD G++ T    ++     RI     ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERI----PWV 184
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
            PE + N   +++ +D +SFG  + EI S   K     D++R L       QL    KA 
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL-PAPKAA 243
Query: 248 ELID 251
           EL +
Sbjct: 244 ELAN 247

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++      G    E    ++G        G+  
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S      C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 256 ------FRQRVS----XECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 26  LGQGGFGPVYKG--------KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           LGQG F  ++KG          L   E+ +K L K+       F   A +++KL H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
              G      E +LV E++   SLD ++  +     + WK     +E   Q    +H   
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAWAMHFLE 130
Query: 138 RLRVIHRDLKASNILL---DDQM--NP---KISDFGMARTFGMNELEANTNRIVGTHGYM 189
              +IH ++ A NILL   +D+   NP   K+SD G++ T    ++     RI     ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERI----PWV 184
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNL 233
            PE + N   +++ +D +SFG  + EI S   K     D++R L  
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLI----AKLQ 72
           D F      GQG FG V  GK    G  +AIK++ +        F+N    I    A L 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLH 77
Query: 73  HTNLVRLLGCSLQKGER-------LLVYEYLPNK----SLDFFIFDSSKKELLDWKKRFN 121
           H N+V+L       GER        +V EY+P+       +++    +   +L     F 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTN 180
           +I  I  G L+L     + V HRD+K  N+L+++     K+ DFG A+   ++  E N  
Sbjct: 138 LIRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK--LSPSEPNVA 190
Query: 181 RIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEII 216
            I   + Y +PE +  N   +   D++S G +  E++
Sbjct: 191 YICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 122
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 123 VRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 141
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 142 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 194
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           D++     LG G FG V++  +   G   A K +           + E + ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V L        E +++YE++    L   + D   K   D  +    +  + +GL ++H+ 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 274
Query: 137 SRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           +    +H DLK  NI+   + +   K+ DFG+       + + +     GT  + +PE  
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 328
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
               V   +D++S GVL   ++S
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLS 351

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 141
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 142 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 194
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 72  Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 125
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 126 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 178
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 122
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72  Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 126
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 127 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 179
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 195
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 195
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 180
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 180
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 18  DNFSPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           D++     LG G FG V++  +   G   A K +           + E + ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V L        E +++YE++    L   + D   K   D  +    +  + +GL ++H+ 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 137 SRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           +    +H DLK  NI+   + +   K+ DFG+       + + +     GT  + +PE  
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 222
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
               V   +D++S GVL   ++S
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLS 245

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 195
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 169
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 170 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 222
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 174
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 175 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 227
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 228 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 169
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 170 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 222
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 161
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 214
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 43/292 (14%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 180
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
             PE++       +S  V+S G+L+ +++       C D              +   + +
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMV-------CGDIP------------FEHDEEI 221
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
                   +  S    + C H+   C+  + +DRPT  ++ +      + LP
Sbjct: 222 IRGQVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV-----------EFKNEAKLIAKLQHT 74
           +  G +G V  G   +G  +AIKR+  +   G                 E +L+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSL--DFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           N++ L    +   E  +   YL  + +  D       ++ ++  +     +  I+ GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH+     V+HRDL   NILL D  +  I DF +AR    +  +AN    V    Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVTHRWYRAPE 203
Query: 193 YVMN--GIVSMKSDVYSFGVLVLEIISSK 219
            VM   G   +  D++S G ++ E+ + K
Sbjct: 204 LVMQFKGFTKL-VDMWSAGCVMAEMFNRK 231

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 72  Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E  P    D F F + +  L +   R +    +++ 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 150 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 202
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV-----------EFKNEAKLIAKLQHT 74
           +  G +G V  G   +G  +AIKR+  +   G                 E +L+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSL--DFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           N++ L    +   E  +   YL  + +  D       ++ ++  +     +  I+ GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH+     V+HRDL   NILL D  +  I DF +AR    +  +AN    V    Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVTHRWYRAPE 203
Query: 193 YVMN--GIVSMKSDVYSFGVLVLEIISSK 219
            VM   G   +  D++S G ++ E+ + K
Sbjct: 204 LVMQFKGFTKL-VDMWSAGCVMAEMFNRK 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
           +S   ++G GG   V++      Q  AIK   L ++  Q +  ++NE   + KLQ H++ 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           ++RL    +       +Y  +   ++D   +   KK +  W+++ +  + +++ +  +H+
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
           +    ++H DLK +N L+ D M  K+ DFG+A     +      +  VGT  YM PE + 
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 196 NGIVSMKS-----------DVYSFGVLV 212
           +   S ++           DV+S G ++
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G FG V   +    +++ A+K LSK     +    F  E + I    ++  V  L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 83  SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           + Q    L +V EY+P   L   +  +D  +K    W  RF   E +V  L  +H    +
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTAE-VVLALDAIHS---M 187
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
             IHRD+K  N+LLD   + K++DFG        E     +  VGT  Y+SPE +     
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
           +G    + D +S GV + E++
Sbjct: 247 DGYYGRECDWWSVGVFLYEML 267

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G FG V   +    +++ A+K LSK     +    F  E + I    ++  V  L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 83  SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           + Q    L +V EY+P   L   +  +D  +K    W  RF   E +V  L  +H    +
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTAE-VVLALDAIHS---M 192
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
             IHRD+K  N+LLD   + K++DFG        E     +  VGT  Y+SPE +     
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
           +G    + D +S GV + E++
Sbjct: 252 DGYYGRECDWWSVGVFLYEML 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G FG V   +    +++ A+K LSK     +    F  E + I    ++  V  L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 83  SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           + Q    L +V EY+P   L   +  +D  +K    W  RF   E +V  L  +H    +
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTAE-VVLALDAIHS---M 192
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
             IHRD+K  N+LLD   + K++DFG        E     +  VGT  Y+SPE +     
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
           +G    + D +S GV + E++
Sbjct: 252 DGYYGRECDWWSVGVFLYEML 272

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
           +S   ++G GG   V++      Q  AIK   L ++  Q +  ++NE   + KLQ H++ 
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           ++RL    +       +Y  +   ++D   +   KK +  W+++ +  + +++ +  +H+
Sbjct: 74  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 129
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           +    ++H DLK +N L+ D M  K+ DFG+A     +      +  VGT  YM PE +
Sbjct: 130 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCS 83
           LG+G +  V     L +G+E A+K + K +G        E + + + Q + N++ L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
                  LV+E L   S+   I    K++  + ++   ++  +   L +LH      + H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 144 RDLKASNILLD--DQMNP-KISDFGMARTFGMNE-----LEANTNRIVGTHGYMSPEYV- 194
           RDLK  NIL +  ++++P KI DF +     +N               G+  YM+PE V 
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 195 ----MNGIVSMKSDVYSFGVLVLEIIS 217
                      + D++S GV++  ++S
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLS 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 18/182 (9%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
           +S   ++G GG   V++      Q  AIK   L ++  Q +  ++NE   + KLQ H++ 
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF---NIIEGIVQGLLY 132
           ++RL    +       +Y  +   ++D   +   KK +  W+++    N++E +      
Sbjct: 70  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 120
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H   +  ++H DLK +N L+ D M  K+ DFG+A     +      +  VGT  YM PE
Sbjct: 121 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 193 YV 194
            +
Sbjct: 179 AI 180

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 20  FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
           +S   ++G GG   V++      Q  AIK   L ++  Q +  ++NE   + KLQ H++ 
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           ++RL    +       +Y  +   ++D   +   KK +  W+++ +  + +++ +  +H+
Sbjct: 71  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 126
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           +    ++H DLK +N L+ D M  K+ DFG+A     +      +  VGT  YM PE +
Sbjct: 127 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN-LVRLL 80
           ++G GG   V++      Q  AIK   L ++  Q +  ++NE   + KLQ H++ ++RL 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
              +       +Y  +   ++D   +   KK +  W+++ +  + +++ +  +H++    
Sbjct: 123 DYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           ++H DLK +N L+ D M  K+ DFG+A     +      +  VGT  YM PE + +   S
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 201 MKS-----------DVYSFGVLV 212
            ++           DV+S G ++
Sbjct: 235 RENGKSKSKISPKSDVWSLGCIL 257

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19  NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
            +  G  LG GGFG VY G ++ D   +AIK + K       E  N      E  L+ K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72  Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
               + ++RLL    +    +L+ E +     D F F + +  L +   R +    +++ 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELAR-SFFWQVLEA 126
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           + + H      V+HRD+K  NIL+D ++   K+ DFG          +       GT  Y
Sbjct: 127 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 179
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
             PE++       +S  V+S G+L+ +++
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCS 83
           LG+G    V     L+  QE A+K + K  G        E +++ + Q H N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            ++    LV+E +   S+   I    K+   +  +   +++ +   L +LH      + H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 144 RDLKASNILLD--DQMNP-KISDFGMARTFGMNELEANTNRI--------VGTHGYMSPE 192
           RDLK  NIL +  +Q++P KI DFG+     +N    + + I         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLN---GDCSPISTPELLTPCGSAEYMAPE 191
Query: 193 YV-----MNGIVSMKSDVYSFGVLVLEIIS 217
            V        I   + D++S GV++  ++S
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 6   KIFDFQTIAAA----TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS------- 53
           K  + + +AA     +  +S  + LG G FG V+     +  +E+ +K + K        
Sbjct: 8   KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 54  -SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE 112
                + +   E  ++++++H N++++L     +G   LV E      LD F F   +  
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK-HGSGLDLFAF-IDRHP 125
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLR-VIHRDLKASNILLDDQMNPKISDFGMARTFG 171
            LD      I   +V  + YL    RL+ +IHRD+K  NI++ +    K+ DFG A    
Sbjct: 126 RLDEPLASYIFRQLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
Query: 172 MNELEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEII 216
             +L        GT  Y +PE +M N     + +++S GV +  ++
Sbjct: 182 RGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 118/244 (48%), Gaps = 48/244 (19%)
Query: 10  FQTI--AAATDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVEFKN--- 63
           FQ I      DN+   + +G+G +G VY     + ++ +AIK++++   + +++ K    
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILR 74
Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           E  ++ +L+   ++RL    +   + LL ++ L    +   I DS  K+L  +K    + 
Sbjct: 75  EITILNRLKSDYIIRLYDLII--PDDLLKFDEL---YIVLEIADSDLKKL--FKTPIFLT 127
Query: 124 EGIVQGLLY--------LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG---- 171
           E  ++ +LY        +H+     +IHRDLK +N LL+   + K+ DFG+ART      
Sbjct: 128 EEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 172 ---MNELEAN--------------TNRIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVL 213
              +N+LE N              T+ +V T  Y +PE ++      KS D++S G +  
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 214 EIIS 217
           E+++
Sbjct: 244 ELLN 247

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH 73
           + +F   + LG+G +G V        G+ +AIK++ +   + +   +   E K++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68
Query: 74  TNLVRLLGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
            N++ +       S +    + + + L    L   I   S + L D   ++ I + + + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RA 124
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL--------EANTNR 181
           +  LH  +   VIHRDLK SN+L++   + K+ DFG+AR    +          ++    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 182 IVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEI 215
            V T  Y +PE ++     S   DV+S G ++ E+
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH 73
           + +F   + LG+G +G V        G+ +AIK++ +   + +   +   E K++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68
Query: 74  TNLVRLLGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
            N++ +       S +    + + + L    L   I   S + L D   ++ I + + + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RA 124
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL--------EANTNR 181
           +  LH  +   VIHRDLK SN+L++   + K+ DFG+AR    +          ++    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 182 IVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEI 215
            V T  Y +PE ++     S   DV+S G ++ E+
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH 73
           + +F   + LG+G +G V        G+ +AIK++ +   + +   +   E K++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68
Query: 74  TNLVRLLGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
            N++ +       S +    + + + L    L   I   S + L D   ++ I + + + 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RA 124
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN--------- 180
           +  LH  +   VIHRDLK SN+L++   + K+ DFG+AR   ++E  A+ +         
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGM 179
Query: 181 -RIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEI 215
              V T  Y +PE ++     S   DV+S G ++ E+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE---FKNEAKLIAKLQHTNLVRLLG 81
           +G+G FG V   KL +  ++ A+K L+K       E   F+ E  ++     +  +  L 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLH 140
Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + Q    L LV +Y     L   +    +  L +   RF + E ++     +    +L 
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIA----IDSVHQLH 195
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM----- 195
            +HRD+K  NIL+D   + +++DFG      M +    ++  VGT  Y+SPE +      
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
            G    + D +S GV + E++
Sbjct: 255 KGRYGPECDWWSLGVCMYEML 275

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 25  RLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN-LVRLL 80
           ++G GG   V++      Q  AIK   L ++  Q +  ++NE   + KLQ H++ ++RL 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
              +       +Y  +   ++D   +   KK +  W+++ +  + +++ +  +H++    
Sbjct: 123 DYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           ++H DLK +N L+ D M  K+ DFG+A     +      +  VG   YM PE + +   S
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 201 MKS-----------DVYSFGVLV 212
            ++           DV+S G ++
Sbjct: 235 RENGKSKSKISPKSDVWSLGCIL 257

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 108/244 (44%), Gaps = 37/244 (15%)
Query: 18  DNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQH 73
           D +   + +G G +G V +    L+ + +AIK++ +   + +++ K    E  ++ +L H
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNH 111
Query: 74  TNLVRLLGCSLQKGERLL--VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            ++V++L   + K       +Y  L     DF     +   L +   +  ++  ++ G+ 
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLLYNLLVGVK 170
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE----------LEANTNR 181
           Y+H      ++HRDLK +N L++   + K+ DFG+ART    E           E + N 
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 182 I---------------VGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
           +               V T  Y +PE + +    +   DV+S G +  E+++  K N  Y
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 226 DTER 229
             +R
Sbjct: 288 HADR 291

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 99/240 (41%), Gaps = 60/240 (25%)
Query: 26  LGQGGFGPVYKGKLLDGQEIAIK--------RLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           +GQG +G V     ++ Q  AI+        ++ + + + +   K E +L+ KL H N+ 
Sbjct: 34  IGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 78  RLLGCSLQKGERLLVYE-----YLPNKSLDFFIFDSSKK--------------------- 111
           RL      +    LV E     +L +K L+ FI DS+ K                     
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 112 --------ELLDWKKR----FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL--DDQM 157
                   E LD+ +R     NI+  I   L YLH      + HRD+K  N L   +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSF 207
Query: 158 NPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYV--MNGIVSMKSDVYSFGVLV 212
             K+ DFG+++ F      E    T +  GT  +++PE +   N     K D +S GVL+
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCS 83
           LG+G    V     L+  QE A+K + K  G        E +++ + Q H N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
            ++    LV+E +   S+   I    K+   +  +   +++ +   L +LH      + H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 144 RDLKASNILLD--DQMNP-KISDFGMARTFGMNELEANTNRI--------VGTHGYMSPE 192
           RDLK  NIL +  +Q++P KI DF +     +N    + + I         G+  YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLN---GDCSPISTPELLTPCGSAEYMAPE 191
Query: 193 YV-----MNGIVSMKSDVYSFGVLVLEIIS 217
            V        I   + D++S GV++  ++S
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
           T  F    ++G G FG V+K  K LDG   AIKR SK    G V+ +N  + +       
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
           QH+++VR      +    L+  EY    SL   I  S    ++ + K   + + ++Q   
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 124
Query: 129 GLLYLHKYSRLRVIHRDLKASNILL 153
           GL Y+H  S   ++H D+K SNI +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
           T  F    ++G G FG V+K  K LDG   AIKR SK    G V+ +N  + +       
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
           QH+++VR      +    L+  EY    SL   I  S    ++ + K   + + ++Q   
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 122
Query: 129 GLLYLHKYSRLRVIHRDLKASNILL 153
           GL Y+H  S   ++H D+K SNI +
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
           T  F    ++G G FG V+K  K LDG   AIKR SK    G V+ +N  + +       
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
           QH+++VR      +    L+  EY    SL   I  S    ++ + K   + + ++Q   
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 124
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP 159
           GL Y+H  S   ++H D+K SNI +     P
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 152

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
           T  F    ++G G FG V+K  K LDG   AIKR SK    G V+ +N  + +       
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
           QH+++VR      +    L+  EY    SL   I  S    ++ + K   + + ++Q   
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 126
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP 159
           GL Y+H  S   ++H D+K SNI +     P
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 154

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 22/138 (15%)
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGY 188
           YLH+     +IHRDLK  N+LL  Q      KI+DFG ++  G   L      + GT  Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTY 182
Query: 189 MSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL---------NLVGY 236
           ++PE +++      +   D +S GV++   +S       + T+  L         N +  
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 237 AWQLWNEGKALELIDTTL 254
            W   +E KAL+L+   L
Sbjct: 243 VWAEVSE-KALDLVKKLL 259

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 22/138 (15%)
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGY 188
           YLH+     +IHRDLK  N+LL  Q      KI+DFG ++  G   L      + GT  Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTY 181
Query: 189 MSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL---------NLVGY 236
           ++PE +++      +   D +S GV++   +S       + T+  L         N +  
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 241
Query: 237 AWQLWNEGKALELIDTTL 254
            W   +E KAL+L+   L
Sbjct: 242 VWAEVSE-KALDLVKKLL 258
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	340
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-143
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-137
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-120
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-89
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-78
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-47
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-42
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-41
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-41
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-40
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-38
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-38
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-38
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-37
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-26
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	8e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  405 bits (1043), Expect = e-143
 Identities = 107/306 (34%), Positives = 156/306 (50%), Gaps = 21/306 (6%)

Query: 4   DLKIFDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----S 53
               F F  +   T+NF        GN++G+GGFG VYKG  ++   +A+K+L+     +
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDIT 69

Query: 54  SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL 113
           + +   +F  E K++AK QH NLV LLG S    +  LVY Y+PN SL   +        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 114 LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN 173
           L W  R  I +G   G+ +LH+      IHRD+K++NILLD+    KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER-HLN 232
                T+RIVGT  YM+PE  + G ++ KSD+YSFGV++LEII+        D  R    
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA---VDEHREPQL 242

Query: 233 LVGYAWQLWNEGKALE-LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           L+    ++ +E K +E  ID  +        V     V   C+ +K   RP +  V  +L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

Query: 292 TNDTMA 297
              T +
Sbjct: 302 QEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  391 bits (1008), Expect = e-137
 Identities = 114/297 (38%), Positives = 173/297 (58%), Gaps = 5/297 (1%)

Query: 5   LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGI-VEFKN 63
           LK F  + +  A+DNFS  N LG+GGFG VYKG+L DG  +A+KRL +   QG  ++F+ 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 64  EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNI 122
           E ++I+   H NL+RL G  +   ERLLVY Y+ N S+   + +  + +  LDW KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
             G  +GL YLH +   ++IHRD+KA+NILLD++    + DFG+A+     +    T  +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AV 195

Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTERHLNLVGYAWQL 240
            GT G+++PEY+  G  S K+DV+ +GV++LE+I+ ++         +  + L+ +   L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA 297
             E K   L+D  L  +   +EV + I V LLC Q    +RP MS+V  ML  D +A
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  347 bits (892), Expect = e-120
 Identities = 96/292 (32%), Positives = 163/292 (55%), Gaps = 4/292 (1%)

Query: 1   MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE 60
           +  +        +  AT+NF     +G G FG VYKG L DG ++A+KR +  S QGI E
Sbjct: 22  VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81

Query: 61  FKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKR 119
           F+ E + ++  +H +LV L+G   ++ E +L+Y+Y+ N +L   ++ S    + + W++R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141

Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             I  G  +GL YLH  +   +IHRD+K+ NILLD+   PKI+DFG+++     +    +
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ 239
             + GT GY+ PEY + G ++ KSDVYSFGV++ E++ ++           +NL  +A +
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258

Query: 240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
             N G+  +++D  L +   P+ + +     + C+   + DRP+M DV   L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  269 bits (689), Expect = 4e-89
 Identities = 63/308 (20%), Positives = 121/308 (39%), Gaps = 28/308 (9%)

Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
              + +   +          +G FG V+K +L   + +A+K       Q   + + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 68  IAKLQHTNLVRLLGCSLQ----KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           +  ++H N+++ +G   +      +  L+  +    SL  F+    K  ++ W +  +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 124 EGIVQGLLYLH-------KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
           E + +GL YLH          +  + HRD+K+ N+LL + +   I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 177 ANTNRIVGTHGYMSPEYVMNGI-----VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL 231
            +T+  VGT  YM+PE +   I       ++ D+Y+ G+++ E+ S          E  L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 232 NLVGYAWQLWNEGKALELIDT-----TLHESCSPDEVTRCI-HVGLLCVQDKATDRPTMS 285
                  Q  +     E++        L +          +      C    A  R +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 286 DVASMLTN 293
            V   +T 
Sbjct: 308 CVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  242 bits (619), Expect = 2e-78
 Identities = 70/338 (20%), Positives = 125/338 (36%), Gaps = 45/338 (13%)

Query: 8   FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK- 66
                 +   DN      +G+G +G VYKG L D + +A+K  S ++ Q    F NE   
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 67  -LIAKLQHTNLVRLLGCSL-----QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
             +  ++H N+ R +          + E LLV EY PN SL  ++         DW    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 121 NIIEGIVQGLLYLH------KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN- 173
            +   + +GL YLH       + +  + HRDL + N+L+ +     ISDFG++     N 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 174 -----ELEANTNRIVGTHGYMSPEYVMNGI-------VSMKSDVYSFGVLVLEIISSKKN 221
                E +      VGT  YM+PE +   +          + D+Y+ G++  EI     +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 222 NGCYDTERHLNLVGYAWQLWNEGKALELIDT--------TLHESCSPDEVTRCIHVGLL- 272
               ++     +  +  ++ N     ++              E+   + +        + 
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 273 -CVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFIN 309
            C    A  R T       +    M     +  +   +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (504), Expect = 2e-61
 Identities = 74/287 (25%), Positives = 138/287 (48%), Gaps = 22/287 (7%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
             ++G G FG V++ +   G ++A+K L +     + + EF  E  ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G   Q     +V EYL   SL   +  S  +E LD ++R ++   + +G+ YLH      
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           ++HR+LK+ N+L+D +   K+ DFG++R         ++    GT  +M+PE + +   +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSP 260
            KSDVYSFGV++ E+ + ++    +    +LN       +  + K LE+           
Sbjct: 218 EKSDVYSFGVILWELATLQQP---WG---NLNPAQVVAAVGFKCKRLEIPRNL------N 265

Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN-DTMALPTPRQPAF 306
            +V   I     C  ++   RP+ + +  +L      A+P P +   
Sbjct: 266 PQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  194 bits (494), Expect = 5e-60
 Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 25/291 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
              +G+G FG V K K    +++AIK++   S      F  E + ++++ H N+V+L G 
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
            L      LV EY    SL   +  +            +      QG+ YLH      +I
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 143 HRDLKASNILLDDQMN-PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           HRDLK  N+LL       KI DFG A      +++ +     G+  +M+PE       S 
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182

Query: 202 KSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPD 261
           K DV+S+G+++ E+I+ +K    +D E         W + + G    LI         P 
Sbjct: 183 KCDVFSWGIILWEVITRRK---PFD-EIGGPAFRIMWAV-HNGTRPPLIKNL------PK 231

Query: 262 EVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISS 312
            +   +     C     + RP+M ++  ++T+     P   +P  +    S
Sbjct: 232 PIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (464), Expect = 5e-56
 Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 36/283 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNLVR 78
              +G GGFG VY+     G E+A+K           Q I   + EAKL A L+H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
           L G  L++    LV E+     L+  +      + +      N    I +G+ YLH  + 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 139 LRVIHRDLKASNILLDDQMNP--------KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
           + +IHRDLK+SNIL+  ++          KI+DFG+AR +      +      G + +M+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMA 182

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           PE +   + S  SDV+S+GVL+ E+++ +     +     ++ +  A+ +     AL + 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP---FR---GIDGLAVAYGVAMNKLALPIP 236

Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
            T       P+   + +     C       RP+ +++   LT 
Sbjct: 237 STC------PEPFAKLME---DCWNPDPHSRPSFTNILDQLTT 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  182 bits (465), Expect = 7e-56
 Identities = 66/287 (22%), Positives = 125/287 (43%), Gaps = 40/287 (13%)

Query: 23  GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHT 74
             ++G+GGFG V+KG+L+ D   +AIK L     +G         EF+ E  +++ L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+L G         +V E++P   L   +    K   + W  +  ++  I  G+ Y+ 
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 135 KYSRLRVIHRDLKASNILLDDQ-----MNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
                 ++HRDL++ NI L        +  K++DFG+++     +   + + ++G   +M
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193

Query: 190 SPEYVMNG---IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA 246
           +PE  +       + K+D YSF +++  I++ +     +D E     + +   +  EG  
Sbjct: 194 APE-TIGAEEESYTEKADTYSFAMILYTILTGEGP---FD-EYSYGKIKFINMIREEGLR 248

Query: 247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
             + +        P  +   I    LC       RP  S +   L+ 
Sbjct: 249 PTIPEDC------PPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  177 bits (451), Expect = 5e-54
 Identities = 47/277 (16%), Positives = 109/277 (39%), Gaps = 34/277 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
             +L +   G ++KG+   G +I +K L     S +   +F  E   +    H N++ +L
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 81  GCSLQKGERLL--VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
           G            +  ++P  SL   + + +   + D  +       + +G+ +LH    
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEP 132

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG- 197
           L +    L + ++++D+ M  +IS   +  +F            +    +++PE  +   
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAPE-ALQKK 183

Query: 198 ---IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                   +D++SF VL+ E+++ +     +     L+ +    ++  EG    +     
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVP---FA---DLSNMEIGMKVALEGLRPTIP---- 233

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
               SP  V++ +    +C+ +    RP    +  +L
Sbjct: 234 -PGISP-HVSKLMK---ICMNEDPAKRPKFDMIVPIL 265

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  178 bits (454), Expect = 5e-54
 Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 44/302 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           G  LG+G FG   K    + G+ + +K L +   +    F  E K++  L+H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +      + EY+   +L   I     +    W +R +  + I  G+ YLH    + +
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR------------IVGTHGYM 189
           IHRDL + N L+ +  N  ++DFG+AR     + +    R            +VG   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +       K DV+SFG+++ EII                    A   +        
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLPRTMDFG 233

Query: 250 IDTTLH------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
           ++           +C P          + C       RP+   +   L    M L     
Sbjct: 234 LNVRGFLDRYCPPNC-PPSFFPIT---VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289

Query: 304 PA 305
             
Sbjct: 290 LG 291

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  172 bits (439), Expect = 4e-52
 Identities = 72/274 (26%), Positives = 133/274 (48%), Gaps = 24/274 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           G R+G G FG VYKGK     ++A+K L+ +  + Q +  FKNE  ++ K +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G S    +  +V ++    SL   +  S  K   + KK  +I     +G+ YLH      
Sbjct: 87  GYST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH---AKS 140

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN---G 197
           +IHRDLK++NI L +    KI DFG+A             ++ G+  +M+PE +      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             S +SDVY+FG+++ E+++ +     Y    + + +     +     + +L  + +  +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQI--IEMVGRGSLSPDL--SKVRSN 253

Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           C P  + R +     C++ K  +RP+   + + +
Sbjct: 254 C-PKRMKRLM---AECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  170 bits (433), Expect = 9e-51
 Identities = 62/285 (21%), Positives = 118/285 (41%), Gaps = 37/285 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
           G  +G+G FG VY G+     E+AI+ +     +   +  FK E     + +H N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G  +      ++      ++L   +     K +LD  K   I + IV+G+ YLH      
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI---VGTHGYMSPEYVMNG 197
           ++H+DLK+ N+  D+     I+DFG+    G+ +     +++    G   +++PE +   
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 198 IV---------SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE 248
                      S  SDV++ G +  E+ + +     +   +        WQ+   G    
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---F---KTQPAEAIIWQM-GTGMKPN 262

Query: 249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           L    +       E++  +   L C   +  +RPT + +  ML  
Sbjct: 263 LSQIGM-----GKEISDIL---LFCWAFEQEERPTFTKLMDMLEK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  164 bits (418), Expect = 2e-48
 Identities = 67/303 (22%), Positives = 117/303 (38%), Gaps = 48/303 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK--LIAKLQHTNLVRLL 80
             ++G+G +G V+ GK   G+++A+K            +  E +      ++H N++  +
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97

Query: 81  GCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-- 134
              ++         L+ +Y  N SL    +D  K   LD K    +    V GL +LH  
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 135 ---KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF--GMNELEANTNRIVGTHGYM 189
                 +  + HRDLK+ NIL+       I+D G+A  F    NE++   N  VGT  YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 190 SPEYVMNGIVSM-------KSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVGYAWQL 240
            PE V++  ++         +D+YSFG+++ E+     + G  +  +  + +LV      
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 241 W-------NEGKALELIDTTLHESCSP---DEVTRCIHVGLLCVQDKATDRPTMSDVASM 290
                    +       +    + C       +T C              R T   V   
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA-------HNPASRLTALRVKKT 325

Query: 291 LTN 293
           L  
Sbjct: 326 LAK 328

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  160 bits (408), Expect = 2e-47
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNLVRLL 80
              +G+G +G V++G    G+ +A+K  S    +    +  E +L     L+H N++  +
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68

Query: 81  GCSL----QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-- 134
              +       +  L+  Y    SL    +D  +   LD      I+  I  GL +LH  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 135 ---KYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYM 189
                 +  + HRDLK+ NIL+       I+D G+A   +   N+L+   N  VGT  YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 190 SPEYVMNGIVSM-------KSDVYSFGVLVLEIISSKKNNGCYD 226
           +PE V++  + +       + D+++FG+++ E+     +NG  +
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  161 bits (408), Expect = 6e-47
 Identities = 64/300 (21%), Positives = 122/300 (40%), Gaps = 42/300 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK--LIAKLQHTNLVRLL 80
              +G+G FG V++GK   G+E+A+K  S    +    +  EA+      L+H N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102

Query: 81  GCSLQKG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-- 134
               +      +  LV +Y  + SL    FD   +  +  +    +      GL +LH  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 135 ---KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF--GMNELEANTNRIVGTHGYM 189
                 +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 190 SPEYVMNGIVSM-------KSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN 242
           +PE V++  ++M       ++D+Y+ G++  EI       G ++  +    + Y   + +
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----LPYYDLVPS 273

Query: 243 EGKALELIDTTLHESCSP---DEVTRCIHVGLL------CVQDKATDRPTMSDVASMLTN 293
           +    E+      +   P   +    C  + ++      C       R T   +   L+ 
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  149 bits (379), Expect = 4e-43
 Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 29/287 (10%)

Query: 23  GNRLGQGGFGPVYKGKLL-----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
             +LG+G FG V   +        G+ +A+K+L  S+ + + +F+ E +++  LQH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 78  RLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +  G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 130

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMS 190
               R IHRDL   NIL++++   KI DFG+ +    ++        V   G     + +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           PE +     S+ SDV+SFGV++ E+ +  + +     E    +             +EL+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 251 DT--TLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
                L   + C PDE+   +     C  +    RP+  D+A  +  
Sbjct: 246 KNNGRLPRPDGC-PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 288

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (380), Expect = 6e-43
 Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 29/287 (10%)

Query: 23  GNRLGQGGFGPVYKGKLL-----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
             +LG+G FG V   +        G+ +A+K+L  S+ + + +F+ E +++  LQH N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 78  RLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +  G     G R   L+ EYLP  SL  ++     KE +D  K       I +G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 161

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMS 190
               R IHRDL   NIL++++   KI DFG+ +    ++        V   G     + +
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYA 216

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           PE +     S+ SDV+SFGV++ E+ +  + +     E    +             +EL+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 251 DT--TLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
                L   + C PDE+   +     C  +    RP+  D+A  +  
Sbjct: 277 KNNGRLPRPDGC-PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 319

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (380), Expect = 2e-42
 Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 40/287 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTN 75
           ++   G ++G+G FG V+ G+L  D   +A+K            +F  EA+++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +VRL+G   QK    +V E +       F+   ++   L  K    ++     G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY----MSP 191
                 IHRDL A N L+ ++   KISDFGM+R     E +       G         +P
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAP 284

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA-WQLWNEGKALELI 250
           E +  G  S +SDV+SFG+L+ E  S                 G + +   +  +  E +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSL----------------GASPYPNLSNQQTREFV 328

Query: 251 DT----TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           +        E C PD V R +     C   +   RP+ S +   L +
Sbjct: 329 EKGGRLPCPELC-PDAVFRLM---EQCWAYEPGQRPSFSTIYQELQS 371

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (371), Expect = 6e-42
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 27/223 (12%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTN 75
            +F P   LG+GGFG V++ K  +D    AIKR+          +   E K +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 76  LVRLLGC---------SLQKGERLLVY---EYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
           +VR                   ++ +Y   +    ++L  ++      E  +     +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT---- 179
             I + + +LH      ++HRDLK SNI        K+ DFG+      +E E       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 180 ------NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
                    VGT  YMSPE +     S K D++S G+++ E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  147 bits (372), Expect = 8e-42
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 35/289 (12%)

Query: 23  GNRLGQGGFGPVYKGKLL---DGQEI--AIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
              LG+G FG V         DG     A+K L   +G Q    +K E  ++  L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 77  VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           ++  GC    G     LV EY+P  SL  ++     +  +   +     + I +G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                  IHRDL A N+LLD+    KI DFG+A+              V   G     + 
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWY 204

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALE 248
           +PE +        SDV+SFGV + E+++    +         L  +    Q+    +  E
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVL-RLTE 262

Query: 249 LIDT--TLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           L++    L   + C P EV   +     C + +A+ RPT  ++  +L  
Sbjct: 263 LLERGERLPRPDKC-PAEVYHLM---KNCWETEASFRPTFENLIPILKT 307

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  145 bits (369), Expect = 2e-41
 Identities = 67/289 (23%), Positives = 127/289 (43%), Gaps = 37/289 (12%)

Query: 23  GNRLGQGGFGPVYKGKLL-----DGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL 76
              LG+G FG V   +        G+++A+K L  +S G  I + K E +++  L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 77  VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           V+  G   + G     L+ E+LP+ SL  ++     K  ++ K++      I +G+ YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL- 142

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
                + +HRDL A N+L++ +   KI DFG+ +    ++        V         + 
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWY 196

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +M     + SDV+SFGV + E+++   ++          +     Q+        L
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT----RL 252

Query: 250 IDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           ++T           +C PDEV + +     C + + ++R +  ++    
Sbjct: 253 VNTLKEGKRLPCPPNC-PDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (371), Expect = 2e-41
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 30/210 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE-----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNL 76
              LG G FG VYKG  +   E     +AIK L + +S +   E  +EA ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLY 132
            RLLG  L      L+ + +P   L  ++ +       + LL+W         I +G+ Y
Sbjct: 80  CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 132

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG----- 187
           L      R++HRDL A N+L+    + KI+DFG+A+  G  E E +        G     
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIK 184

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +M+ E +++ I + +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  144 bits (365), Expect = 3e-41
 Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 28/220 (12%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
            +F     +G GGFG V+K K  +DG+   IKR+  ++     + + E K +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 77  VRLLGC---------------SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
           V   GC               S  K + L +  E+    +L+ +I +  + E LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            + E I +G+ Y+H     ++I+RDLK SNI L D    KI DFG+  +   N+ +    
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR- 180

Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK 220
              GT  YMSPE + +     + D+Y+ G+++ E++    
Sbjct: 181 -SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  143 bits (364), Expect = 8e-41
 Identities = 76/310 (24%), Positives = 126/310 (40%), Gaps = 63/310 (20%)

Query: 23  GNRLGQGGFGPVYKGKLLDG------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
              LG+G FG V+  +  +         +A+K L   +     +F+ EA+L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFF-------------IFDSSKKELLDWKKRFNII 123
           V+  G        ++V+EY+ +  L+ F                   K  L   +  +I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             I  G++YL   +    +HRDL   N L+   +  KI DFGM+R    +    +  R V
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-V 191

Query: 184 GTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW 238
           G H      +M PE +M    + +SDV+SFGV++ EI +                  + +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT-------------YGKQPW-F 237

Query: 239 QLWNEGKALELIDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           QL N     E+I+             C P EV   +   L C Q +   R  + ++  +L
Sbjct: 238 QLSNT----EVIECITQGRVLERPRVC-PKEVYDVM---LGCWQREPQQRLNIKEIYKIL 289

Query: 292 TNDTMALPTP 301
               +   TP
Sbjct: 290 --HALGKATP 297

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  144 bits (366), Expect = 8e-41
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 31/218 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE------IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
              LG+G FG V+  +  +         +A+K L ++S     +F+ EA+L+  LQH ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFF------------IFDSSKKELLDWKKRFNIIE 124
           VR  G   +    L+V+EY+ +  L+ F              +      L   +   +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            +  G++YL   + L  +HRDL   N L+   +  KI DFGM+R    +    +  R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217

Query: 185 THG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                   +M PE ++    + +SDV+SFGV++ EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  144 bits (366), Expect = 8e-41
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 33/303 (10%)

Query: 23  GNRLGQGGFGPVYKGKLL-----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
            ++LG+G FG V   +        G  +A+K+L  S      +F+ E +++  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 78  RLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +  G S   G +   LV EYLP+  L  F+     +  LD  +       I +G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 143

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMS 190
               R +HRDL A NIL++ + + KI+DFG+A+   +++       +V   G     + +
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           PE + + I S +SDV+SFGV++ E+ +    + C  +   L ++G    +    + LEL+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-CSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 251 DT--TLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN---DTMALPTPRQ 303
           +    L    +C P EV   +    LC      DRP+ S +   L      +    T   
Sbjct: 258 EEGQRLPAPPAC-PAEVHELM---KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313

Query: 304 PAF 306
            A 
Sbjct: 314 TAH 316

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (363), Expect = 2e-40
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQH 73
            NF    ++G+G F  VY+   LLDG  +A+K++        +   +   E  L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF------NIIEGIV 127
            N+++     ++  E  +V E      L   I     K     K+             + 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L ++H     RV+HRD+K +N+ +      K+ D G+ R F      A++  +VGT  
Sbjct: 147 SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 201

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           YMSPE +     + KSD++S G L+ E+ + +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  142 bits (361), Expect = 2e-40
 Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 33/220 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLDG------QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN 75
              LG+  FG VYKG L         Q +AIK L   + G    EF++EA L A+LQH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFF-------------IFDSSKKELLDWKKRFNI 122
           +V LLG   +     +++ Y  +  L  F               D + K  L+     ++
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
           +  I  G+ YL   S   V+H+DL   N+L+ D++N KISD G+ R     E+ A     
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYK 185

Query: 183 VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +  +      +M+PE +M G  S+ SD++S+GV++ E+ S
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (362), Expect = 4e-40
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 9/205 (4%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHT 74
           + +    ++G+G FG     K   DG++  IK   +S+ S +   E + E  ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+      + G   +V +Y     L   I ++ K  L    +  +    I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                +++HRD+K+ NI L      ++ DFG+AR        A     +GT  Y+SPE  
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSK 219
            N   + KSD+++ G ++ E+ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (356), Expect = 5e-40
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
              +G G FG V+ G  L+  ++AIK + +       +F  EA+++ KL H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
            L++    LV E++ +  L  ++   +++ L   +    +   + +G+ YL       VI
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN-----RIVGTHGYMSPEYVMNG 197
           HRDL A N L+ +    K+SDFGM R    ++  ++T      +      + SPE     
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVFSFS 180

Query: 198 IVSMKSDVYSFGVLVLEIIS 217
             S KSDV+SFGVL+ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  141 bits (357), Expect = 2e-39
 Identities = 79/319 (24%), Positives = 136/319 (42%), Gaps = 52/319 (16%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE------IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN 75
              LGQG FG VY+G      +      +AIK +++ +S +  +EF NEA ++ +    +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFF-------IFDSSKKELLDWKKRFNIIEGIVQ 128
           +VRLLG   Q    L++ E +    L  +       + ++         K   +   I  
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           G+ YL   +  + +HRDL A N ++ +    KI DFGM R     ++        G  G 
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGL 201

Query: 189 -----MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
                MSPE + +G+ +  SDV+SFGV++ EI +               L    +Q  + 
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSN 246

Query: 244 GKALELIDT--TLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
            + L  +     L   ++C PD +   +    +C Q     RP+  ++ S +       P
Sbjct: 247 EQVLRFVMEGGLLDKPDNC-PDMLFELM---RMCWQYNPKMRPSFLEIISSI--KEEMEP 300

Query: 300 TPRQPAFFINISSDYEEPE 318
             R+ +F+ +  +   EPE
Sbjct: 301 GFREVSFYYSEENKLPEPE 319

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (355), Expect = 3e-39
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 29/210 (13%)

Query: 23  GNRLGQGGFGPVYKGKLL--DGQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLV 77
              +G G  G V  G+L     +++  AIK L +  + +   +F +EA ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK----ELLDWKKRFNIIEGIVQGLLYL 133
           RL G   +    ++V EY+ N SLD F+     +    +L+        + G+  G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM------LRGVGAGMRYL 167

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
              S L  +HRDL A N+L+D  +  K+SDFG++R      LE + +    T G      
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-----VLEDDPDAAYTTTGGKIPIR 219

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +PE +     S  SDV+SFGV++ E+++
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  139 bits (352), Expect = 3e-39
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
            + +    LG G FG V  GK     ++AIK + K       EF  EAK++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L G   ++    ++ EY+ N  L  ++     +     ++   + + + + + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN-----RIVGTHGYMSPE 192
             + +HRDL A N L++DQ   K+SDFG++R    +E  ++       R      +  PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPE 191

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIIS 217
            +M    S KSD+++FGVL+ EI S
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  140 bits (354), Expect = 4e-39
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 30/210 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE-----IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNL 76
              LG G FG VYKG  +   E     +AIK L   +S +   E  +EA ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLY 132
            RLLG  L      L+ + +P   L  ++ +       + LL+W         I +G+ Y
Sbjct: 80  CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 132

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG----- 187
           L      R++HRDL A N+L+    + KI+DFG+A+  G  E E +        G     
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIK 184

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +M+ E +++ I + +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  139 bits (353), Expect = 5e-39
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 30/210 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
              LG G FG V+KG  +   E     + IK +   SG Q      +    I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLY 132
           VRLLG         LV +YLP  SL   +         + LL+W         I +G+ Y
Sbjct: 78  VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYY 130

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG----- 187
           L       ++HR+L A N+LL      +++DFG+A     ++ +        +       
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-----SEAKTPIK 182

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +M+ E +  G  + +SDV+S+GV V E+++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  139 bits (353), Expect = 5e-39
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQE-----IAIKRLSK-SSGQGIVEFKNEAKLIAKL 71
              +    +G G FG VYKG L          +AIK L    + +  V+F  EA ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N++RL G   +    +++ EY+ N +LD F+    K       +   ++ GI  G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG---- 187
           YL   + +  +HRDL A NIL++  +  K+SDFG++R      LE +      T G    
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----VLEDDPEATYTTSGGKIP 213

Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             + +PE +     +  SDV+SFG+++ E+++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (351), Expect = 5e-39
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLV 77
              +G+G FG VY G+ +D  +     AIK LS+ +  Q +  F  E  L+  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 78  RLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
            L+G     +G   ++  Y+ +  L  FI    +      K   +    + +G+ YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL--- 140

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSP 191
           +  + +HRDL A N +LD+    K++DFG+AR   + + E  + +    H      + + 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQ-QHRHARLPVKWTAL 197

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E +     + KSDV+SFGVL+ E+++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (351), Expect = 6e-39
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 31/224 (13%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
             +F     LGQG FG V K +  LD +  AIK++  +  + +    +E  L+A L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFD-SSKKELLDW---KKRF-------NIIE 124
           +VR     L++   +     +  KS  F   +      L D    +           +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF------------GM 172
            I++ L Y+H      +IHRDLK  NI +D+  N KI DFG+A+               +
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVS--MKSDVYSFGVLVLE 214
                N    +GT  Y++ E V++G      K D+YS G++  E
Sbjct: 181 PGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFE 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (351), Expect = 6e-39
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 23  GNRLGQGGFGPVYKGKLLDG----QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLV 77
              +G+G FG VY G LLD        A+K L++ +    + +F  E  ++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 78  RLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
            LLG C   +G  L+V  Y+ +  L  FI + +       K        + +G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 144

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMS 190
           +  + +HRDL A N +LD++   K++DFG+AR    +  +     +    G      +M+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            E +     + KSDV+SFGVL+ E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  139 bits (353), Expect = 6e-39
 Identities = 69/214 (32%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDG------QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN 75
              LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFI----FDSSKKELLDWKKRFNIIEGIVQGLL 131
           +VR +G SLQ   R ++ E +    L  F+       S+   L      ++   I  G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 132 YLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           YL        IHRD+ A N LL         KI DFGMAR     ++   +    G    
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAM 206

Query: 189 -----MSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                M PE  M GI + K+D +SFGVL+ EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 8e-39
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           +  +    LG G FG V  GK     ++A+K + K       EF  EA+ + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +  G   ++    +V EY+ N  L  ++   S  + L+  +   +   + +G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
             + IHRDL A N L+D  +  K+SDFGM R    ++  +       + G      + +P
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-------SVGTKFPVKWSAP 174

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E       S KSDV++FG+L+ E+ S
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFS 200

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  139 bits (352), Expect = 2e-38
 Identities = 69/214 (32%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDG------QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTN 75
              LG G FG VY+G++          ++A+K L +  S Q  ++F  EA +I+K  H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFI----FDSSKKELLDWKKRFNIIEGIVQGLL 131
           +VR +G SLQ   R ++ E +    L  F+       S+   L      ++   I  G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 132 YLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           YL        IHRD+ A N LL         KI DFGMAR     ++        G    
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAM 247

Query: 189 -----MSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                M PE  M GI + K+D +SFGVL+ EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (356), Expect = 2e-38
 Identities = 76/301 (25%), Positives = 136/301 (45%), Gaps = 48/301 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
             +LG G FG V+        ++A+K + K     +  F  EA ++  LQH  LV+L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    ++ E++   SL  F+  S +       K  +    I +G+ ++    +   I
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG---YMSPEYVMNGIV 199
           HRDL+A+NIL+   +  KI+DFG+AR    NE  A      G      + +PE +  G  
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362

Query: 200 SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH---- 255
           ++KSDV+SFG+L++EI++                + Y   + N  + +  ++        
Sbjct: 363 TIKSDVWSFGILLMEIVT-------------YGRIPY-PGMSNP-EVIRALERGYRMPRP 407

Query: 256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYE 315
           E+C P+E+   +   + C +++  +RPT   + S+L +            F+    S YE
Sbjct: 408 ENC-PEELYNIM---MRCWKNRPEERPTFEYIQSVLDD------------FYTATESQYE 451

Query: 316 E 316
           E
Sbjct: 452 E 452

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (351), Expect = 3e-38
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 23  GNRLGQGGFGPVYKGKLL--DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLV 77
              +G G FG V  G+L     +EI  AIK L    + +   +F  EA ++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           RL G   +    ++V EY+ N SLD F+            +   ++ GI  G+ YL   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
            +  +HRDL A NIL++  +  K+SDFG+ R      LE +      T G      + SP
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E +     +  SDV+S+G+++ E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  136 bits (346), Expect = 3e-38
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 25  RLGQGGFGPVYKGKLLDGQE---IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
            LG G FG V +G     ++   +AIK L + +      E   EA+++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 81  G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
           G C  +    +LV E      L  F+    K+E +       ++  +  G+ YL      
Sbjct: 77  GVCQAEA--LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEK 129

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSPEYV 194
             +HRDL A N+LL ++   KISDFG+++  G ++          + G     + +PE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPECI 185

Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
                S +SDV+S+GV + E +S
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  136 bits (345), Expect = 3e-38
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 23/201 (11%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG- 81
              +G+G FG V  G    G ++A+K +   +      F  EA ++ +L+H+NLV+LLG 
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGV 82

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +KG   +V EY+   SL  ++  S  + +L           + + + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN-----RIVGTHGYMSPEYVMN 196
           +HRDL A N+L+ +    K+SDFG+ +                 +      + +PE +  
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK------WTAPEALRE 188

Query: 197 GIVSMKSDVYSFGVLVLEIIS 217
              S KSDV+SFG+L+ EI S
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  141 bits (357), Expect = 4e-38
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 42/300 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
             +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    +V EY+   SL  F       + L   +  ++   I  G+ Y+    R+  +
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIK 444

Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH----ESC 258
           SDV+SFG+L+ E+ +                V Y   +  E   L+ ++          C
Sbjct: 445 SDVWSFGILLTELTT-------------KGRVPYPGMVNRE--VLDQVERGYRMPCPPEC 489

Query: 259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYEEPE 318
            P+ +   +     C + +  +RPT   + + L +            +F +    Y+  E
Sbjct: 490 -PESLHDLM---CQCWRKEPEERPTFEYLQAFLED------------YFTSTEPQYQPGE 533

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  136 bits (345), Expect = 4e-38
 Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 23  GNRLGQGGFGPVYKGKLLDG-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
            ++LG G +G VY+G        +A+K L K     + EF  EA ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              ++    ++ E++   +L  ++     ++ +       +   I   + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN-----RIVGTHGYMSPEYVMN 196
           IHRDL A N L+ +    K++DFG++R    +   A+       +      + +PE +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186

Query: 197 GIVSMKSDVYSFGVLVLEIIS 217
              S+KSDV++FGVL+ EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  137 bits (348), Expect = 4e-38
 Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 23  GNRLGQGGFGPVYKGKLLD--------GQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-Q 72
           G  LG+G FG V   + +            +A+K L   ++ + + +  +E +++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG------- 125
           H N++ LLG   Q G   ++ EY    +L  ++       +        + E        
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 126 ------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
                 + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     ++    
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 211

Query: 180 NRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                T+G     +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (344), Expect = 5e-38
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 40/218 (18%)

Query: 23  GNRLGQGGFGPVYKGKL--------LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT 74
              LGQG F  ++KG          L   E+ +K L K+       F   A +++KL H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           +LV   G  +   E +LV E++   SLD ++     K  ++   +  + + +   + +L 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL- 129

Query: 135 KYSRLRVIHRDLKASNILLDDQMNP--------KISDFGMARTFGMNELEANTNRIVGTH 186
                 +IH ++ A NILL  + +         K+SD G++ T            ++   
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKD 175

Query: 187 GY------MSPEYVMNGIV-SMKSDVYSFGVLVLEIIS 217
                   + PE + N    ++ +D +SFG  + EI S
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  136 bits (344), Expect = 6e-38
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)

Query: 25  RLGQGGFGPVYKGKLLDG---QEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
            LG G FG V KG        + +A+K L    +      E   EA ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 80  LG-CSLQKGERLLVYEYLPNKSLDFFIFDSSK---KELLDWKKRFNIIEGIVQGLLYLHK 135
           +G C  +    +LV E      L+ ++  +     K +++       +  +  G+ YL  
Sbjct: 84  IGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL-- 133

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMS 190
                 +HRDL A N+LL  Q   KISDFG+++    +E          THG     + +
Sbjct: 134 -EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYA 188

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           PE +     S KSDV+SFGVL+ E  S
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  137 bits (348), Expect = 7e-38
 Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 23  GNRLGQGGFGPVYKGKLLD--------GQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-Q 72
           G  LG+G FG V   + +            +A+K L   ++ + + +  +E +++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG------- 125
           H N++ LLG   Q G   ++ EY    +L  ++       +        + E        
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 126 ------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
                 + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     ++    
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 257

Query: 180 NRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                T+G     +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (354), Expect = 7e-38
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 7/196 (3%)

Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
            ++LG G +G VY+G        +A+K L K     + EF  EA ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              ++    ++ E++   +L  ++     ++ +       +   I   + YL    +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 339

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
           IHR+L A N L+ +    K++DFG++R    +   A+         + +PE +     S+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSI 398

Query: 202 KSDVYSFGVLVLEIIS 217
           KSDV++FGVL+ EI +
Sbjct: 399 KSDVWAFGVLLWEIAT 414

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (343), Expect = 7e-38
 Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 34/213 (15%)

Query: 23  GNRLGQGGFGPVYKGKLL--DGQEI--AIKRL---SKSSGQGIVEFKNEAKLIAKLQHTN 75
             +LG G FG V +G+     G+ +  A+K L     S  + + +F  E   +  L H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 76  LVRLLG-CSLQKGERL-LVYEYLPNKSLDFFIFDSSKK----ELLDWKKRFNIIEGIVQG 129
           L+RL G         + +V E  P  SL   +           L  +         + +G
Sbjct: 83  LIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEG 133

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-- 187
           + YL      R IHRDL A N+LL  +   KI DFG+ R    N+           H   
Sbjct: 134 MGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ----EHRKV 186

Query: 188 ---YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
              + +PE +     S  SD + FGV + E+ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 8e-38
 Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 42/300 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
             +LGQG FG V+ G       +AIK L K        F  EA+++ KL+H  LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
             ++    +V EY+   SL  F       + L   +  ++   I  G+ Y+    R+  +
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
           HRDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G  ++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIK 361

Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH----ESC 258
           SDV+SFG+L+ E+ +  +                 +      + L+ ++          C
Sbjct: 362 SDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPPEC 406

Query: 259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINISSDYEEPE 318
            P+ +   +     C + +  +RPT   + + L +            +F +    Y+  E
Sbjct: 407 -PESLHDLM---CQCWRKEPEERPTFEYLQAFLED------------YFTSTEPQYQPGE 450

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  137 bits (346), Expect = 8e-38
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 41/228 (17%)

Query: 23  GNRLGQGGFGPVYKGKLLDG------QEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTN 75
              +G+G FG V++ +            +A+K L  ++S     +F+ EA L+A+  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG---------- 125
           +V+LLG         L++EY+    L+ F+   S   +                      
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 126 -----------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                      +  G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R    N 
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224

Query: 175 LEANTNRIVGTHGY-----MSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             A+  +    +       M PE +     + +SDV+++GV++ EI S
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (343), Expect = 1e-37
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 27/214 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL 76
           G  LG+G FG V +G L         +A+K +    SS + I EF +EA  +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 77  VRLLGCSLQKG-----ERLLVYEYLPNKSLDFFIFDS---SKKELLDWKKRFNIIEGIVQ 128
           +RLLG  ++       + +++  ++    L  ++  S   +  + +  +     +  I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG- 187
           G+ YL   S    +HRDL A N +L D M   ++DFG+++         +  R  G    
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYR-QGRIAK 210

Query: 188 ----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               +++ E + + + + KSDV++FGV + EI +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (347), Expect = 1e-37
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 23  GNRLGQGGFGPVYKGKLLDG----QEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLV 77
              +G+G FG VY G LLD        A+K L++ +    + +F  E  ++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 78  RLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
            LLG C   +G  L+V  Y+ +  L  FI + +       K        + +G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL--- 208

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMS 190
           +  + +HRDL A N +LD++   K++DFG+AR       +   + +    G      +M+
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKWMA 264

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            E +     + KSDV+SFGVL+ E+++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  136 bits (344), Expect = 1e-37
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHTNLV 77
            + +G+G FG V K ++         AIKR+   +S     +F  E +++ KL  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG------------ 125
            LLG    +G   L  EY P+ +L  F+  S   E        N                
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 126 -IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            + +G+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R                
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYV-KK 198

Query: 185 THG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           T G     +M+ E +   + +  SDV+S+GVL+ EI+S
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (341), Expect = 1e-37
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
              +G+G F  VYKG       E+A    +  K +      FK EA+++  LQH N+VR 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 80  LGC---SLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
                 +++  + +++  E + + +L  ++    + +++  K   +    I++GL +LH 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 136 YSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                +IHRDLK  NI +     + KI D G+A         A    ++GT  +M+PE  
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA--VIGTPEFMAPEMY 202

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSK 219
                    DVY+FG+ +LE+ +S+
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSE 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  135 bits (342), Expect = 2e-37
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 36/223 (16%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE------IAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHT 74
           G  LG G FG V +       +      +A+K L  S          +E K+++ L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG--------- 125
           N+V LLG     G  L++ EY     L  F+       +        + +          
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 126 ------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
                 + +G+ +L   +    IHRDL A NILL      KI DFG+AR     +++ ++
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDS 199

Query: 180 NRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           N +V  +      +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (342), Expect = 2e-37
 Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 23  GNRLGQGGFGPVYKGKLLDG----QEIAIKRLSK--SSGQGIVEFKNEAKLIAKLQHTNL 76
           G  LG+G FG V + +L        ++A+K L     +   I EF  EA  + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 77  VRLLGCSLQKGER------LLVYEYLPNKSLDFFIFDSSKKE---LLDWKKRFNIIEGIV 127
            +L+G SL+   +      +++  ++ +  L  F+  S   E    L  +     +  I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            G+ YL   S    IHRDL A N +L + M   ++DFG++R     ++ +      G   
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCAS 199

Query: 188 -----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                +++ E + + + ++ SDV++FGV + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  138 bits (349), Expect = 2e-37
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 25/202 (12%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG- 81
              +G+G FG V  G    G ++A+K +   +      F  EA ++ +L+H+NLV+LLG 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGV 254

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
              +KG   +V EY+   SL  ++  S  + +L           + + + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYVM 195
           +HRDL A N+L+ +    K+SDFG+ +                         + +PE + 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 359

Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
               S KSDV+SFG+L+ EI S
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  134 bits (339), Expect = 2e-37
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 17/205 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           +      RLG G FG V+ G      ++A+K L K        F  EA L+ +LQH  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           RL     Q+    ++ EY+ N SL  F+  +     L   K  ++   I +G+ ++    
Sbjct: 72  RLYAVVTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN-----RIVGTHGYMSPE 192
               IHRDL+A+NIL+ D ++ KI+DFG+AR    NE  A        +      + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPE 180

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIIS 217
            +  G  ++KSDV+SFG+L+ EI++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  135 bits (343), Expect = 2e-37
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 32/219 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE------IAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHT 74
           G  LG G FG V +       +      +A+K L S +         +E K+++ L QH 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSL-----------DFFIFDSSKKELLDWKKRFNII 123
           N+V LLG     G  L++ EY     L           +     +        +   +  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             + QG+ +L   +    IHRD+ A N+LL +    KI DFG+AR     ++  ++N IV
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 222

Query: 184 GTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             +      +M+PE + + + +++SDV+S+G+L+ EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (340), Expect = 4e-37
 Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 31/223 (13%)

Query: 11  QTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIA 69
             +     ++    +LG+GGF  V   + L DG   A+KR+     Q   E + EA +  
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 70  KLQHTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRF----- 120
              H N++RL+   L++        L+  +    +L   I     + L D          
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQI 136

Query: 121 -NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF--------G 171
             ++ GI +GL  +H        HRDLK +NILL D+  P + D G              
Sbjct: 137 LWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193

Query: 172 MNELEANTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVL 211
              L+    +   T  Y +PE      + ++  ++DV+S G +
Sbjct: 194 ALTLQDWAAQ-RCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  133 bits (337), Expect = 4e-37
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 10/208 (4%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 74
           +++     +G G +G   K +   DG+ +  K L     +        +E  L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 75  NLVRLLGCSLQKGERLL--VYEYLPNKSLDFFIFDSSKK-ELLDWKKRFNIIEGIVQGLL 131
           N+VR     + +    L  V EY     L   I   +K+ + LD +    ++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 132 YLH--KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
             H        V+HRDLK +N+ LD + N K+ DFG+AR    +   A T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           SPE +     + KSD++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  134 bits (339), Expect = 4e-37
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 41/228 (17%)

Query: 23  GNRLGQGGFGPVYKGKLLDG------QEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTN 75
           G  LG+G FG V K              +A+K L   +S   + +  +E  ++ ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSL-DF--------------------FIFDSSKKELL 114
           +++L G   Q G  LL+ EY    SL  F                       D   +  L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                 +    I QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R     +
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----D 199

Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +    + +  + G     +M+ E + + I + +SDV+SFGVL+ EI++
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  135 bits (341), Expect = 8e-37
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 36/223 (16%)

Query: 23  GNRLGQGGFGPVYKGKLLD--------GQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-Q 72
           G  LG+G FG V   + +           ++A+K L S ++ + + +  +E +++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG------- 125
           H N++ LLG   Q G   ++ EY    +L  ++       L       +  E        
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 126 ------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
                 + +G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR     ++    
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 245

Query: 180 NRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                T+G     +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  132 bits (334), Expect = 1e-36
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 24/206 (11%)

Query: 23  GNRLGQGGFGPVYKGKLL--DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLV 77
              LG+G FG VY+G      G++I  A+K   K  +     +F +EA ++  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 78  RLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +L+G     +    ++ E  P   L  ++     K  L           I + + YL   
Sbjct: 77  KLIGIIE--EEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL--- 129

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSP 191
             +  +HRD+   NIL+      K+ DFG++R         + +    +       +MSP
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSR------YIEDEDYYKASVTRLPIKWMSP 183

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E +     +  SDV+ F V + EI+S
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (348), Expect = 1e-36
 Identities = 71/314 (22%), Positives = 124/314 (39%), Gaps = 60/314 (19%)

Query: 25  RLGQGGFGPVYKGKL-LDGQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
            LG G FG V +G   +  ++I  AIK L   +      E   EA+++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
           G    +   +LV E      L  F+    K+E +       ++  +  G+ YL       
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSPEYVM 195
            +HR+L A N+LL ++   KISDFG+++  G ++          + G     + +PE + 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPECIN 512

Query: 196 NGIVSMKSDVYSFGVLVLEIIS------SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
               S +SDV+S+GV + E +S       K      +    +           +GK +E 
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI----------EQGKRME- 559

Query: 250 IDTTLHESCSPDEVTRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFI 308
                     P E    ++ +   C   K  DRP    V   +               + 
Sbjct: 560 ---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA------------CYY 598

Query: 309 NISSDYEEPEVTEI 322
           +++S  E     E+
Sbjct: 599 SLASKVEGGSALEV 612

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (334), Expect = 2e-36
 Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 35/222 (15%)

Query: 23  GNRLGQGGFGPVYKGKLLD------GQEIAIKRL-SKSSGQGIVEFKNEAKLIAKL-QHT 74
           G  LG+G FG V +            + +A+K L   ++        +E K++  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 75  NLVRLLGCSLQKGE-RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-------- 125
           N+V LLG   + G   +++ E+    +L  ++     + +       ++ +         
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 126 -----IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
                + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR     ++  + +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPD 203

Query: 181 RIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
            +          +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (331), Expect = 4e-36
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 27/205 (13%)

Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
              LG+G +G VY G+ L     IAIK + +   +       E  L   L+H N+V+ LG
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86

Query: 82  CSLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG--------IVQGLLY 132
               +   + ++ E +P  SL           L          E         I++GL Y
Sbjct: 87  SF-SENGFIKIFMEQVPGGSL--------SALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 133 LHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           LH     +++HRD+K  N+L++      KISDFG ++   +  +   T    GT  YM+P
Sbjct: 138 LH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 192

Query: 192 EYVMNGIV--SMKSDVYSFGVLVLE 214
           E +  G       +D++S G  ++E
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIE 217

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  131 bits (332), Expect = 5e-36
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 23/225 (10%)

Query: 10  FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKL 67
           FQ+++     +S   ++G GG   V++      Q  AIK ++      Q +  ++NE   
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 68  IAKLQHTNL--VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG 125
           + KLQ  +   +RL    +      +V E   N  L+ ++    KK+ +D  +R +  + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKN 135

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           +++ +  +H++    ++H DLK +N L+ D    K+ DFG+A     +      +  VGT
Sbjct: 136 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 186 HGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIISSK 219
             YM PE + +             +S KSDV+S G ++  +   K
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (330), Expect = 5e-36
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 24/206 (11%)

Query: 23  GNRLGQGGFGPVYKGKLL--DGQEI--AIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLV 77
           G  +G+G FG V++G  +  +   +  AIK     +S     +F  EA  + +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 78  RLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +L+G  +       ++ E      L  F+    +K  LD          +   L YL   
Sbjct: 80  KLIGVITENP--VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL--- 132

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YMSP 191
              R +HRD+ A N+L+      K+ DFG++R         ++     + G     +M+P
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAP 186

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
           E +     +  SDV+ FGV + EI+ 
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM 212

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  131 bits (331), Expect = 7e-36
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 16/208 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QH 73
            +F   +RLG G +G V+K     DG+  A+KR        +       E     K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 74  TNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
              VRL   + ++G  L L  E     SL       +    L   + +  +   +  L +
Sbjct: 117 PCCVRLEQ-AWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH      ++H D+K +NI L  +   K+ DFG+    G            G   YM+PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE 226

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSKK 220
            ++ G     +DV+S G+ +LE+  + +
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME 253

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (330), Expect = 2e-35
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 23/216 (10%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL 76
            +S   ++G GG   V++      Q  AIK ++      Q +  ++NE   + KLQ  + 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 77  --VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
             +RL    +      +V E   N  L+ ++    KK+ +D  +R +  + +++ +  +H
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           ++    ++H DLK +N L+ D    K+ DFG+A     +      +  VGT  YM PE +
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 195 MN-----------GIVSMKSDVYSFGVLVLEIISSK 219
            +             +S KSDV+S G ++  +   K
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  131 bits (331), Expect = 3e-35
 Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNL 76
            +S   ++G GG   V++      Q  AIK ++      Q +  ++NE   + KLQ  + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 77  --VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
             +RL    +      +V E   N  L+ ++    KK+ +D  +R +  + +++ +  +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
           ++    ++H DLK +N L+ D    K+ DFG+A     +      +  VG   YM PE +
Sbjct: 173 QH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 195 MN-----------GIVSMKSDVYSFGVLVLEIISSK 219
            +             +S KSDV+S G ++  +   K
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (328), Expect = 3e-35
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 41/228 (17%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQE------IAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHT 74
           G  LG G FG V         +      +A+K L +           +E K++ +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG--------- 125
           N+V LLG     G   L++EY     L  ++    +K   D  +  N             
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 126 -----------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
                      + +G+ +L        +HRDL A N+L+      KI DFG+AR     +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----D 221

Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           + +++N +V  +      +M+PE +  GI ++KSDV+S+G+L+ EI S
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (327), Expect = 4e-35
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 30/209 (14%)

Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
             R+G+G FG V++ K    G + A+K++     +       E    A L    +V L G
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 117

Query: 82  CSLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRF------NIIEGIVQGLLYLH 134
               +G  + ++ E L   SL          +L+              +   ++GL YLH
Sbjct: 118 AVR-EGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEGLEYLH 167

Query: 135 KYSRLRVIHRDLKASNILLDDQMNP-KISDFGMAR---TFGMNELEANTNRIVGTHGYMS 190
                R++H D+KA N+LL    +   + DFG A      G+ +     + I GT  +M+
Sbjct: 168 ---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           PE VM      K D++S   ++L +++  
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (337), Expect = 5e-35
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 22/210 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKG--KLLDGQEI--AIKRL-SKSSGQGIVEFKNEAKLIAKLQ 72
           +    G  +G+G FG V++G     +   +  AIK   + +S     +F  EA  + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H ++V+L+G   +     ++ E      L  F+    +K  LD          +   L Y
Sbjct: 450 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG----- 187
           L      R +HRD+ A N+L+      K+ DFG++R         ++     + G     
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIK 557

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           +M+PE +     +  SDV+ FGV + EI+ 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILM 587

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (320), Expect = 2e-34
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 11/196 (5%)

Query: 25  RLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
           +LG GG   VY  +  +   ++AIK   +     +  ++ F+ E    ++L H N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
               +     LV EY+   +L  +I        L      N    I+ G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           ++HRD+K  NIL+D     KI DFG+A+      L   TN ++GT  Y SPE        
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190

Query: 201 MKSDVYSFGVLVLEII 216
             +D+YS G+++ E++
Sbjct: 191 ECTDIYSIGIVLYEML 206

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (327), Expect = 2e-33
 Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 24/200 (12%)

Query: 25  RLGQGGFGPVYKGK--LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL- 80
            +  GG G +Y      ++G+ + +K L  S           E + +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 81  -GCSLQKGERLLVY---EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
                 +    + Y   EY+  +SL          + L   +    +  I+  L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
             + +++ DLK  NI+L ++   K+ D G                + GT G+ +PE V  
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251

Query: 197 GIVSMKSDVYSFGVLVLEII 216
           G  ++ +D+Y+ G  +  + 
Sbjct: 252 G-PTVATDIYTVGRTLAALT 270

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (310), Expect = 6e-33
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVE-FKNEAKLIAKLQHTNLVR 78
           G  LG GG   V+  + L D +++A+K  R   +        F+ EA+  A L H  +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 79  LL--GCSLQKGERL--LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           +   G +      L  +V EY+   +L   +     +  +  K+   +I    Q L + H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE-ANTNRIVGTHGYMSPEY 193
              +  +IHRD+K +NI++      K+ DFG+AR    +      T  ++GT  Y+SPE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 194 VMNGIVSMKSDVYSFGVLVLEII 216
                V  +SDVYS G ++ E++
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVL 213

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 7e-33
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQH 73
           ++F  GN LG+G F  VY+ + +  G E+AIK + K +    G+V+  +NE K+  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            +++ L           LV E   N  +      +  K   + + R   +  I+ G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARH-FMHQIITGMLYL 128

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMS 190
           H      ++HRDL  SN+LL   MN KI+DFG+A      +L+    +   + GT  Y+S
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYIS 180

Query: 191 PEYVMNGIVSMKSDVYSFGVL 211
           PE        ++SDV+S G +
Sbjct: 181 PEIATRSAHGLESDVWSLGCM 201

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  125 bits (316), Expect = 7e-33
 Identities = 46/209 (22%), Positives = 91/209 (43%), Gaps = 19/209 (9%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLV 77
           +F P + LG G  G +    + D +++A+KR+             E +L+ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           R       +  + +  E     +L  ++    K       +   +++    GL +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 138 RLRVIHRDLKASNILLDDQ-----MNPKISDFGMARTFGMNELE-ANTNRIVGTHGYMSP 191
            L ++HRDLK  NIL+        +   ISDFG+ +   +     +  + + GT G+++P
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 192 EYV---MNGIVSMKSDVYSFGVLVLEIIS 217
           E +        +   D++S G +   +IS
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 1e-32
 Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 22/216 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 75
             +   + LGQG    V++G+    G   AIK  +  S    V+    E +++ KL H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 76  LVRLLGC--SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           +V+L           ++L+ E+ P  SL   + + S    L   +   ++  +V G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 134 HKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
            +     ++HR++K  NI+     D Q   K++DFG AR    +E    +  + GT  Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEYL 182

Query: 190 SPEYVMNGIVSM--------KSDVYSFGVLVLEIIS 217
            P+     ++            D++S GV      +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  122 bits (308), Expect = 1e-32
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQH 73
             +  G  LG+GGF   ++    D  +  A K + KS        E    E  +   L H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIV 127
            ++V   G         +V E    +SL     +  K+     +K          +  IV
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 125

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVG 184
            G  YLH   R RVIHRDLK  N+ L++ +  KI DFG+A      ++E +  R   + G
Sbjct: 126 LGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCG 177

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVL 211
           T  Y++PE +     S + DV+S G +
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCI 204

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (310), Expect = 1e-32
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQH 73
             +  G  LG+GGF   ++    D  +  A K + KS        E    E  +   L H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIV 127
            ++V   G         +V E    +SL     +  K+     +K          +  IV
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 151

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVG 184
            G  YLH   R RVIHRDLK  N+ L++ +  KI DFG+A      ++E +  R   + G
Sbjct: 152 LGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCG 203

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVL 211
           T  Y++PE +     S + DV+S G +
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCI 230

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  123 bits (309), Expect = 1e-32
 Identities = 62/268 (23%), Positives = 91/268 (33%), Gaps = 72/268 (26%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 75
            +F P   +G+GGFG V++ K  +D    AIKR+   + +   E    E K +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE----------------------- 112
           +VR     L+        E       D                                 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 113 ----------------------LLDWKKRFN------------IIEGIVQGLLYLHKYSR 138
                                 L DW  R              I   I + + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN----------RIVGTHGY 188
             ++HRDLK SNI        K+ DFG+      +E E                VGT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           MSPE +     S K D++S G+++ E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (308), Expect = 5e-32
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 75
             +   + LGQG    V++G+    G   AIK  +  S    V+    E +++ KL H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 76  LVRLLGC--SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           +V+L           ++L+ E+ P  SL   + + S    L   +   ++  +V G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 134 HKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
            +     ++HR++K  NI+     D Q   K++DFG AR    +E    +  + GT  Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEYL 182

Query: 190 SPEYVMNGIVSM--------KSDVYSFGVLV 212
            P+     ++            D++S GV  
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  120 bits (302), Expect = 1e-31
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 25/209 (11%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCS 83
           L +GGF  VY+ + +  G+E A+KRL  +  +       E   + KL  H N+V+    +
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 84  LQKGER-------LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
               E         L+   L    L  F+     +  L       I     + + ++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTF-----------GMNELEANTNRIVGT 185
            +  +IHRDLK  N+LL +Q   K+ DFG A T                +E    R   T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR-NTT 213

Query: 186 HGYMSPEYV---MNGIVSMKSDVYSFGVL 211
             Y +PE +    N  +  K D+++ G +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCI 242

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (299), Expect = 2e-31
 Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 11/202 (5%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHT 74
            + F+   ++G+G FG V+KG      + +AIK +  + +   I + + E  ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
            + +  G  L+  +  ++ EYL   S      D  +   LD  +   I+  I++GL YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                + IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE +
Sbjct: 137 S---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191

Query: 195 MNGIVSMKSDVYSFGVLVLEII 216
                  K+D++S G+  +E+ 
Sbjct: 192 KQSAYDSKADIWSLGITAIELA 213

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (298), Expect = 3e-31
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 13/195 (6%)

Query: 25  RLGQGGFGPVYKGK--LLDGQEIAIKRLSK--SSGQGIVE-FKNEAKLIAKLQHTNLVRL 79
            +G+GG G VY+ +  + + + +A+K +S+  SS        + EA+   +LQ  ++V +
Sbjct: 41  LVGRGGMGDVYEAEDTVRE-RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
                  G+  +    +    L   +        L   +   I+  I   L   H     
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH---AA 153

Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
              HRD+K  NIL+       + DFG+A      +L       VGT  YM+PE       
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHA 212

Query: 200 SMKSDVYSFGVLVLE 214
           + ++D+Y+   ++ E
Sbjct: 213 TYRADIYALTCVLYE 227

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (297), Expect = 4e-31
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 10/201 (4%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
              ++   ++GQG  G VY    +  GQE+AI++++           NE  ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V  L   L   E  +V EYL   SL     D   +  +D  +   +    +Q L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               +VIHRD+K+ NILL    + K++DFG        + + +T  +VGT  +M+PE V 
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 196 NGIVSMKSDVYSFGVLVLEII 216
                 K D++S G++ +E+I
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMI 210

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (295), Expect = 7e-31
 Identities = 54/222 (24%), Positives = 109/222 (49%), Gaps = 13/222 (5%)

Query: 1   MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIV 59
           M++  +    +      + +     LG G FG VYK K    G   A K +   S + + 
Sbjct: 2   MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61

Query: 60  EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR 119
           ++  E +++A   H  +V+LLG     G+  ++ E+ P  ++D  + +  +   L   + 
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQI 119

Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
             +   +++ L +LH     R+IHRDLKA N+L+  + + +++DFG++        + ++
Sbjct: 120 QVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176

Query: 180 NRIVGTHGYMSPEYVMNGIVS-----MKSDVYSFGVLVLEII 216
              +GT  +M+PE VM   +       K+D++S G+ ++E+ 
Sbjct: 177 --FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (296), Expect = 1e-30
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 29/209 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEF-KNEAKLIAKLQHTN 75
           D+F   + LG G  G V+K      G  +A K +       I      E +++ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQG 129
           +V   G     GE  +  E++   SLD         ++L    R        +   +++G
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE---ANTNRIVGTH 186
           L YL    + +++HRD+K SNIL++ +   K+ DFG++      +L    AN+   VGT 
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----QLIDSMANSF--VGTR 194

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
            YMSPE +     S++SD++S G+ ++E+
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (294), Expect = 2e-30
 Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 10/201 (4%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
                   ++G+G  G V   +    G+++A+K +     Q      NE  ++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V +    L   E  ++ E+L   +L     D   +  L+ ++   + E ++Q L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
                VIHRD+K+ +ILL      K+SDFG       +  +  +  +VGT  +M+PE + 
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214

Query: 196 NGIVSMKSDVYSFGVLVLEII 216
             + + + D++S G++V+E++
Sbjct: 215 RSLYATEVDIWSLGIMVIEMV 235

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (290), Expect = 3e-30
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 34/213 (15%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQH 73
           ++F  G  LG+G FG VY  +       +A+K L K+     G+    + E ++ + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 74  TNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGI 126
            N++RL G       R+ L+ EY P  ++    +   +K       +F+       I  +
Sbjct: 69  PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITEL 118

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IV 183
              L Y H     RVIHRD+K  N+LL      KI+DFG +       + A ++R   + 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLC 168

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
           GT  Y+ PE +   +   K D++S GVL  E +
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (302), Expect = 3e-30
 Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 17/212 (8%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 74
              +    RLG GGFG V +      G+++AIK+  +       E +  E +++ KL H 
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72

Query: 75  NLVRLL------GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           N+V                  LL  EY     L  ++        L       ++  I  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGT 185
            L YLH+    R+IHRDLK  NI+L     ++  KI D G A+     EL       VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE--FVGT 186

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
             Y++PE +     ++  D +SFG L  E I+
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (289), Expect = 4e-30
 Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 34/228 (14%)

Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKL-Q 72
           T  F    ++G G FG V+K  K LDG   AIKR     +          E    A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLDWKKRFNIIEGIVQGLL 131
           H+++VR      +    L+  EY    SL   I ++ +        +  +++  + +GL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP-------------------KISDFGMARTFGM 172
           Y+H    + ++H D+K SNI +     P                   KI D G       
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185

Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSK 219
                +     G   +++ E +        K+D+++  + V+    ++
Sbjct: 186 -----SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (286), Expect = 2e-29
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 10/201 (4%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            + F    +LG+G +G VYK      GQ +AIK++       + E   E  ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V+  G   +  +  +V EY    S+   I    + + L   +   I++  ++GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              +R IHRD+KA NILL+ + + K++DFG+A        + NT  ++GT  +M+PE + 
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198

Query: 196 NGIVSMKSDVYSFGVLVLEII 216
               +  +D++S G+  +E+ 
Sbjct: 199 EIGYNCVADIWSLGITAIEMA 219

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (283), Expect = 3e-29
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE-FKNEAK-LIAKLQHT 74
           D+  P   LG+G +G V K + +  GQ +A+KR+  +      +    +    +  +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQ 128
             V   G   ++G+  +  E + + SLD F      K+++D  +         I   IV+
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
            L +LH  S+L VIHRD+K SN+L++     K+ DFG++    ++++  + +   G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCKPY 175

Query: 189 MSPEYVMNGIV----SMKSDVYSFGVLVLEI 215
           M+PE +   +     S+KSD++S G+ ++E+
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (283), Expect = 6e-29
 Identities = 56/235 (23%), Positives = 95/235 (40%), Gaps = 39/235 (16%)

Query: 2   KRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE 60
              LKI   Q      ++      +G+G +G V K      GQ +A+KR+  +  +   +
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65

Query: 61  -FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK 118
               +  ++ +      +V+  G   ++G+  +  E + + S D F     K        
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDD 120

Query: 119 RFN------IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG------- 165
                    I    V+ L +L     L++IHRD+K SNILLD   N K+ DFG       
Sbjct: 121 VIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178

Query: 166 -MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV----SMKSDVYSFGVLVLEI 215
            +A+T              G   YM+PE +          ++SDV+S G+ + E+
Sbjct: 179 SIAKTR-----------DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (283), Expect = 8e-29
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 31/227 (13%)

Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS---KSSGQGI 58
           +D  + +          FS    +G G FG VY  + + + + +AIK++S   K S +  
Sbjct: 39  KDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 98

Query: 59  VEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK 118
            +   E + + KL+H N ++  GC L++    LV EY    + D          L   KK
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL---------LEVHKK 149

Query: 119 RFN------IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
                    +  G +QGL YLH      +IHRD+KA NILL +    K+ DFG A     
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA- 205

Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVS---MKSDVYSFGVLVLEII 216
               AN+   VGT  +M+PE ++         K DV+S G+  +E+ 
Sbjct: 206 ---PANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  111 bits (281), Expect = 1e-28
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFK------NEAKLIAK 70
           ++F  G  LG+G F  V   + L      AIK L K     I++         E  ++++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH---IIKENKVPYVTRERDVMSR 86

Query: 71  LQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           L H   V+L   + Q  E+L     Y  N  L  +I         +   RF   E IV  
Sbjct: 87  LDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAE-IVSA 142

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L YLH      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
           SPE +        SD+++ G ++ ++++
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (284), Expect = 1e-28
 Identities = 39/213 (18%), Positives = 82/213 (38%), Gaps = 18/213 (8%)

Query: 17  TDNFSPGNRLGQG--GFGPVYKGK-LLDGQEIAIKR--LSKSSGQGIVEFKNEAKLIAKL 71
              +     +G+G      V   +    G+ + ++R  L   S + +   + E  +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
            H N+V      +   E  +V  ++   S  D  +  +   + ++      I++G+++ L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKAL 141

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT-----NRIVGT 185
            Y+H    +  +HR +KAS+IL+       +S      +   +              V  
Sbjct: 142 DYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 186 HGYMSPEYVMNGIV--SMKSDVYSFGVLVLEII 216
             ++SPE +   +     KSD+YS G+   E+ 
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (281), Expect = 2e-28
 Identities = 30/222 (13%), Positives = 71/222 (31%), Gaps = 22/222 (9%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSSGQGIVEFKNEAKLIAK 70
           +      + LG+G F  VY+    D       Q+  +K    ++           + +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQ 128
                 ++     L +   +LV E     +L   I  + ++ ++++      +    ++ 
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP-----------KISDFGMARTFGMNELEA 177
            +  +H      +IH D+K  N +L +                + D G +    +     
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
                  T G+   E + N   + + D +     V  ++   
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (278), Expect = 2e-28
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 18/212 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
           D++     +G G    V         +++AIKR++ +     + E   E + +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 76  LVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQ 128
           +V     S    + L LV + L   S+   I      +        +      I+  +++
Sbjct: 75  IVSYY-TSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA---RTFGMNELEANTNRIVGT 185
           GL YLHK      IHRD+KA NILL +  + +I+DFG++    T G           VGT
Sbjct: 133 GLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 186 HGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
             +M+PE +        K+D++SFG+  +E+ 
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  111 bits (279), Expect = 3e-28
 Identities = 19/233 (8%), Positives = 49/233 (21%), Gaps = 43/233 (18%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHT 74
                  L  G    V+  + ++  ++ A+K  +     S   +          A+L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 75  NLVRLLGC--------------------------SLQKGERLLVYEYLP---NKSLDFFI 105
           +                                        LL+                
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 106 FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 165
           F    +          +   +++    L       ++H      N+ +       + D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 166 MARTFGMNELEANTNRIVGTHGYMSPEYVM--NGIVSMKSDVYSFGVLVLEII 216
                G                Y   E++       +   + +  G+ +  + 
Sbjct: 240 ALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 4e-28
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 22/229 (9%)

Query: 2   KRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE 60
            R L   D   +      F     +G G +G VYKG+ +  GQ  AIK +   +G    E
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEE 66

Query: 61  FKNEAKLIAKL-QHTNLVRLLGCSLQKGERL------LVYEYLPNKSL-DFFIFDSSKKE 112
            K E  ++ K   H N+    G  ++K          LV E+    S+ D  +  ++K  
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGN 124

Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
            L  +    I   I++GL +LH+    +VIHRD+K  N+LL +    K+ DFG++     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181

Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVS-----MKSDVYSFGVLVLEII 216
                NT   +GT  +M+PE +            KSD++S G+  +E+ 
Sbjct: 182 TVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 5e-28
 Identities = 43/313 (13%), Positives = 82/313 (26%), Gaps = 81/313 (25%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ------ 72
           G  LGQ       +      G+   +     +       I + K E   +  L+      
Sbjct: 78  GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137

Query: 73  -------------------HTNLVRLLGC--SLQKGERLLVYEYLPNKSLDFF--IFD-S 108
                                 ++R+      +    R  +Y  + +    F   +   S
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197

Query: 109 SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
           S  + L    R  +   +++ L  LH      ++H  L+  +I+LD +    ++ F    
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 169 TFGMNELEANTNRIVGTHGYMSPEYVM-----------NGIVSMKSDVYSFGVLVLEIIS 217
             G             + G+  PE                +++   D ++ G+++  I  
Sbjct: 255 RDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI-- 306

Query: 218 SKKNNGCYDTERHLNLVGYA-WQLWNEGKALELIDTTLHESCS--PDEVTRCIHVGLLCV 274
                                          E I      SC   P  V   +  G L  
Sbjct: 307 ---------------WCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLE-GFLRY 346

Query: 275 QDKATDRPTMSDV 287
                DR      
Sbjct: 347 P--KEDRLLPLQA 357

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 8e-28
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 34/209 (16%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
            + ++    LG+G FG V K K  +  QE A+K ++K+    +       E +L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFN------IIE 124
            N+++L           +V E              +  EL D    +KRF+      II+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELY------------TGGELFDEIIKRKRFSEHDAARIIK 128

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNR 181
            +  G+ Y+HK     ++HRDLK  NILL   +   + KI DFG++  F  N        
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGV 210
            +GT  Y++PE V+ G    K DV+S GV
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 9e-28
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 13/200 (6%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 74
            D F    +LG G FG V+  +    G E  IK ++K   Q  +E  + E +++  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           N++++           +V E      L +  +   ++ + L       +++ ++  L Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 134 HKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
           H      V+H+DLK  NIL          KI DFG+A  F  +E    +    GT  YM+
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMA 194

Query: 191 PEYVMNGIVSMKSDVYSFGV 210
           PE V    V+ K D++S GV
Sbjct: 195 PE-VFKRDVTFKCDIWSAGV 213

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 1e-27
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVE-FKNEAKLIAKLQH 73
           D+F  G  LG+G FG VY  +       +A+K L KS    +G+    + E ++ + L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 74  TNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGI 126
            N++R+        +R+ L+ E+ P   L    +   +K       RF+       +E +
Sbjct: 74  PNILRMYN-YFHDRKRIYLMLEFAPRGEL----YKELQKH-----GRFDEQRSATFMEEL 123

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IV 183
              L Y H     +VIHRD+K  N+L+  +   KI+DFG +       + A + R   + 
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMC 173

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
           GT  Y+ PE +       K D++  GVL  E
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  112 bits (281), Expect = 1e-27
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 15/201 (7%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            D++     LG G FG V++      G   A K +           + E + ++ L+H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFD--SSKKELLDWKKRFNIIEGIVQGLLYL 133
           LV L        E +++YE++    L    F+  + +   +   +    +  + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           H+      +H DLK  NI+   + +   K+ DFG+       +   +     GT  + +P
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325

Query: 192 EYVMNGIVSMKSDVYSFGVLV 212
           E      V   +D++S GVL 
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (271), Expect = 1e-27
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 32/207 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
              ++  N +G+G +G V            A K++ K   + +  FK E +++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFN------IIEGI 126
           ++RL        +  LV E              +  EL +    K+ F       I++ +
Sbjct: 68  IIRLYETFEDNTDIYLVMELC------------TGGELFERVVHKRVFRESDAARIMKDV 115

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIV 183
           +  + Y HK   L V HRDLK  N L          K+ DFG+A  F   ++       V
Sbjct: 116 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKV 169

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGV 210
           GT  Y+SP+ V+ G+   + D +S GV
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGV 195

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (274), Expect = 2e-27
 Identities = 48/220 (21%), Positives = 93/220 (42%), Gaps = 35/220 (15%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEF---------------- 61
           +++     L QG F  +   +  D +  A+K+  KS  +   +F                
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 62  -KNEAKLIAKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKR 119
            KNE ++I  +++   +   G  +   + + ++YEY+ N S+     +       ++   
Sbjct: 90  FKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSI-LKFDEYFFVLDKNYTCF 147

Query: 120 F------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN 173
                   II+ ++    Y+H  +   + HRD+K SNIL+D     K+SDFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 174 ELEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVL 211
           +++       GT+ +M PE+  N       K D++S G+ 
Sbjct: 206 KIK--G--SRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (275), Expect = 2e-27
 Identities = 31/232 (13%), Positives = 68/232 (29%), Gaps = 43/232 (18%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ------ 72
           G  LGQ       +      G+   +     +       I + K E   +  L+      
Sbjct: 83  GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 73  -------------------HTNLVRLLGCSLQKG--ERLLVYEYLPNKSLDFFIF---DS 108
                                 ++R+           R  +Y  + +    F       S
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 109 SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
           S  + L    R  +   +++ L  LH      ++H  L+  +I+LD +    ++ F    
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 169 TFGMNELEANTNRIVGTHGYMSPEYV-----MNGIVSMKSDVYSFGVLVLEI 215
             G + +     R        +   +        +++   D ++ G+ +  I
Sbjct: 260 RDGASAVSP-IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (278), Expect = 2e-27
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 34/210 (16%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
           ++ +    +LG G +G V   +  +   E AIK + K+  S     +   E  ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFN------IIE 124
            N+++L      K    LV E                 EL D    + +FN      II+
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECY------------KGGELFDEIIHRMKFNEVDAAVIIK 143

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNR 181
            ++ G+ YLHK     ++HRDLK  N+LL   +     KI DFG++  F   +       
Sbjct: 144 QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKE 197

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 211
            +GT  Y++PE V+      K DV+S GV+
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (277), Expect = 3e-27
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 35/211 (16%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQ 72
           +D +     LG+G FG V   K  + GQE A+K +SK              E +L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFN------II 123
           H N+++L      KG   LV E              +  EL D    +KRF+      II
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVY------------TGGELFDEIISRKRFSEVDAARII 132

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTN 180
             ++ G+ Y+HK    +++HRDLK  N+LL       N +I DFG++  F  ++      
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMK 186

Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 211
             +GT  Y++PE V++G    K DV+S GV+
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (276), Expect = 4e-27
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 34/209 (16%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
            + ++    LG+G FG V K K  +  QE A+K ++K+    +       E +L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFN------IIE 124
            N+++L           +V E              +  EL D    +KRF+      II+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELY------------TGGELFDEIIKRKRFSEHDAARIIK 128

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNR 181
            +  G+ Y+HK     ++HRDLK  NILL   +   + KI DFG++  F  N        
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKD 182

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGV 210
            +GT  Y++PE V+ G    K DV+S GV
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  109 bits (273), Expect = 6e-27
 Identities = 51/228 (22%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNL 76
           +       LG G  G V       G+ +A+KR+             E KL+ +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 71

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFI----FDSSKKELLDWKKRFNIIEGIVQGLLY 132
           +R            +  E   N +L   +          +L       +++  I  G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 133 LHKYSRLRVIHRDLKASNILLD-------------DQMNPKISDFGMARTF--GMNELEA 177
           LH    L++IHRDLK  NIL+              + +   ISDFG+ +    G +    
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 178 NTNRIVGTHGYMSPEYVMNGIVSM-------KSDVYSFGVLVLEIISS 218
           N N   GT G+ +PE +                D++S G +   I+S 
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  108 bits (271), Expect = 8e-27
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 15/200 (7%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            D +     LG G FG V++      G+    K ++          KNE  ++ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFD--SSKKELLDWKKRFNIIEGIVQGLLYL 133
           L+ L      K E +L+ E+L    L    FD  +++   +   +  N +    +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           H+     ++H D+K  NI+ + +     KI DFG+A     +E          T  + +P
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219

Query: 192 EYVMNGIVSMKSDVYSFGVL 211
           E V    V   +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVL 239

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  106 bits (266), Expect = 1e-26
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 34/190 (17%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 70
           +NF    ++G+G +G VYK +  L G+ +A+K++   +  +G+          E  L+ +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAIREISLLKE 58

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV--- 127
           L H N+V+LL     + +  LV+E+L              K+ +D      I   ++   
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL----------HQDLKKFMDASALTGIPLPLIKSY 108

Query: 128 -----QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
                QGL + H +   RV+HRDLK  N+L++ +   K++DFG+AR FG   +   T+ +
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEV 164

Query: 183 VGTHGYMSPE 192
           V T  Y +PE
Sbjct: 165 V-TLWYRAPE 173

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  106 bits (266), Expect = 2e-26
 Identities = 49/189 (25%), Positives = 96/189 (50%), Gaps = 34/189 (17%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAKL 71
           + +    ++G+G +G VYK K   G+ +A+KR+   +  +GI          E  L+ +L
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI----PSTAIREISLLKEL 76

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV---- 127
            H N+V L+     +    LV+E++          +   K++LD + +  + +  +    
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM----------EKDLKKVLD-ENKTGLQDSQIKIYL 125

Query: 128 ----QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
               +G+ + H++   R++HRDLK  N+L++     K++DFG+AR FG   + + T+ +V
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV 181

Query: 184 GTHGYMSPE 192
            T  Y +P+
Sbjct: 182 -TLWYRAPD 189

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  105 bits (265), Expect = 2e-26
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 37/196 (18%)

Query: 15  AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-----EAKLI 68
           +++  F    +LG G +  VYKG     G  +A+K +   S +G           E  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57

Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG--- 125
            +L+H N+VRL      + +  LV+E++          D+  K+ +D +   N   G   
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFM----------DNDLKKYMDSRTVGNTPRGLEL 107

Query: 126 ---------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
                    ++QGL + H+    +++HRDLK  N+L++ +   K+ DFG+AR FG   + 
Sbjct: 108 NLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVN 163

Query: 177 ANTNRIVGTHGYMSPE 192
             ++ +V T  Y +P+
Sbjct: 164 TFSSEVV-TLWYRAPD 178

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  106 bits (267), Expect = 2e-26
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 15/198 (7%)

Query: 19  NFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
             S    LG G FG V+K +    G ++A K +     +   E KNE  ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDS--SKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +L      K + +LV EY+    L    FD    +   L        ++ I +G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 136 YSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
              + ++H DLK  NIL  ++     KI DFG+AR +   E         GT  +++PE 
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259

Query: 194 VMNGIVSMKSDVYSFGVL 211
           V    VS  +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVI 277

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  108 bits (271), Expect = 3e-26
 Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 13/196 (6%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGFG V   ++    ++ A K+L K      +G     NE +++ K+    +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
            + +  + L LV   +    L F I+   +    + +  F   E I  GL  LH+    R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ER 306

Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
           +++RDLK  NILLDD  + +ISD G+A      +        VGT GYM+PE V N   +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYT 363

Query: 201 MKSDVYSFGVLVLEII 216
              D ++ G L+ E+I
Sbjct: 364 FSPDWWALGCLLYEMI 379

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (261), Expect = 6e-26
 Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 35/190 (18%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 70
             +    ++G+G +G V+K K     + +A+KR+      +G+          E  L+ +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKE 57

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV--- 127
           L+H N+VRL        +  LV+E+           D   K+  D     ++   IV   
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFC----------DQDLKKYFD-SCNGDLDPEIVKSF 106

Query: 128 -----QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
                +GL + H      V+HRDLK  N+L++     K+++FG+AR FG   +   +  +
Sbjct: 107 LFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEV 162

Query: 183 VGTHGYMSPE 192
           V T  Y  P+
Sbjct: 163 V-TLWYRPPD 171

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (260), Expect = 6e-26
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 33/209 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
           +DN+     LG+G F  V +      G E A K ++    S +   + + EA++  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRF------NIIE 124
            N+VRL     ++    LV++ +            +  EL +    ++ +      + I+
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLV------------TGGELFEDIVAREFYSEADASHCIQ 112

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR 181
            I++ + Y H      ++HR+LK  N+LL  +      K++DFG+A     +E     + 
Sbjct: 113 QILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHG 166

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGV 210
             GT GY+SPE +     S   D+++ GV
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGV 195

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (263), Expect = 7e-26
 Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 36/192 (18%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN--------EAKLI 68
             +   + LG+G F  VYK +     Q +AIK++         E K+        E KL+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLL 66

Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV- 127
            +L H N++ LL     K    LV++++          ++  + ++       +    + 
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFM----------ETDLEVIIK-DNSLVLTPSHIK 115

Query: 128 -------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
                  QGL YLH++    ++HRDLK +N+LLD+    K++DFG+A++FG +   A T+
Sbjct: 116 AYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTH 171

Query: 181 RIVGTHGYMSPE 192
           ++V T  Y +PE
Sbjct: 172 QVV-TRWYRAPE 182

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (261), Expect = 7e-26
 Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 11/178 (6%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHT 74
           + +    ++G+G +G V+K +    GQ +AIK+  +S    +++     E +++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           NLV LL    +K    LV+EY  + ++   +    +       K        +Q + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI--TWQTLQAVNFCH 119

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           K+     IHRD+K  NIL+      K+ DFG AR       +   + +  T  Y SPE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPE 172

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (261), Expect = 8e-26
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 20/215 (9%)

Query: 11  QTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE-FKNEAKLI 68
           Q   A  ++      +G G  G V+K +    G  IA+K++ +S  +   +    +  ++
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
            K      +V+  G  +   +  +  E +     +        +  +  +    +   IV
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVAIV 134

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT--NRIVGT 185
           + L YL    +  VIHRD+K SNILLD++   K+ DFG++       L  +   +R  G 
Sbjct: 135 KALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG-----RLVDDKAKDRSAGC 187

Query: 186 HGYMSPEYVMNGIV-----SMKSDVYSFGVLVLEI 215
             YM+PE +           +++DV+S G+ ++E+
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  106 bits (266), Expect = 1e-25
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 45/221 (20%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIV-------------EFK 62
            +++    +LG G +G V   K      E AIK + KS                   E  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 63  NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKR 119
           NE  L+  L H N+++L      K    LV E+                EL +    + +
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY------------EGGELFEQIINRHK 142

Query: 120 FN------IIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTF 170
           F+      I++ I+ G+ YLHK     ++HRD+K  NILL   +  +N KI DFG++  F
Sbjct: 143 FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 211
             +         +GT  Y++PE V+    + K DV+S GV+
Sbjct: 200 SKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (260), Expect = 2e-25
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 15/205 (7%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLIAK 70
            D +     +G+G F  V +      GQ+ A+K     + + S G    + K EA +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           L+H ++V LL      G   +V+E++    L    +  +    +       + +  I++ 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTH 186
           L Y H      +IHRD+K   +LL  + N    K+  FG+A   G + L A     VGT 
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVL 211
            +M+PE V         DV+  GV+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  105 bits (264), Expect = 2e-25
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 14/198 (7%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+GGFG V+  ++    ++ A K+L+K      +G      E K++AK+    +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 82  CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKE--LLDWKKRFNIIEGIVQGLLYLHKYSR 138
            + +    L LV   +    + + I++  +      + +  F   + IV GL +LH+   
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQ--- 307

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
             +I+RDLK  N+LLDD  N +ISD G+A      + +       GT G+M+PE ++   
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEE 365

Query: 199 VSMKSDVYSFGVLVLEII 216
                D ++ GV + E+I
Sbjct: 366 YDFSVDYFALGVTLYEMI 383

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  103 bits (258), Expect = 2e-25
 Identities = 53/185 (28%), Positives = 84/185 (45%), Gaps = 26/185 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTN 75
           + +   ++LG+G +  VYKGK  L    +A+K +     +G       E  L+  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV-------- 127
           +V L      +    LV+EYL          D   K+ LD      I    V        
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYL----------DKDLKQYLD-DCGNIINMHNVKLFLFQLL 110

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
           +GL Y H+    +V+HRDLK  N+L++++   K++DFG+AR       +   N +V T  
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLW 165

Query: 188 YMSPE 192
           Y  P+
Sbjct: 166 YRPPD 170

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  102 bits (256), Expect = 3e-25
 Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 34/189 (17%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAKL 71
           + +    ++G+G +G VYK +   G+  A+K++  +   +GI          E  ++ +L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKEL 57

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV---- 127
           +H+N+V+L      K   +LV+E+L          D   K+LLD      +         
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHL----------DQDLKKLLD-VCEGGLESVTAKSFL 106

Query: 128 ----QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
                G+ Y H     RV+HRDLK  N+L++ +   KI+DFG+AR FG   +   T+ IV
Sbjct: 107 LQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV 162

Query: 184 GTHGYMSPE 192
            T  Y +P+
Sbjct: 163 -TLWYRAPD 170

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (259), Expect = 3e-25
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSS------GQGIVEFKNEAKLIA 69
            D +  G  LG G F  V K +    G E A K + K        G    E + E  ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           ++ H N++ L      + + +L+ E +    L DF     S  E    ++  + I+ I+ 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILD 126

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELEANTNRIVG 184
           G+ YLH     ++ H DLK  NI+L D+  P    K+ DFG+A              I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVL 211
           T  +++PE V    + +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  102 bits (257), Expect = 3e-25
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIA 69
            D +  G  LG G F  V K +    G E A K + K        G    E + E  ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           ++ H N++ L      + + +L+ E +    L DF     S  E    ++  + I+ I+ 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILD 126

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELEANTNRIVG 184
           G+ YLH     ++ H DLK  NI+L D+  P    K+ DFG+A              I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVL 211
           T  +++PE V    + +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (258), Expect = 4e-25
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 33/209 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
           +DN+     LG+G F  V +      G E A K ++    S +   + + EA++  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRF------NIIE 124
            N+VRL     ++    LV++ +            +  EL +    ++ +      + I+
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLV------------TGGELFEDIVAREFYSEADASHCIQ 135

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR 181
            I++ + Y H      ++HR+LK  N+LL  +      K++DFG+A     +E     + 
Sbjct: 136 QILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHG 189

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGV 210
             GT GY+SPE +     S   D+++ GV
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (255), Expect = 4e-25
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 32/207 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
              F     LG G F  V+  K  L G+  A+K + KS        +NE  ++ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRF------NIIEGI 126
           +V L           LV + +            S  EL D    +  +       +I+ +
Sbjct: 68  IVTLEDIYESTTHYYLVMQLV------------SGGELFDRILERGVYTEKDASLVIQQV 115

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIV 183
           +  + YLH+     ++HRDLK  N+L    ++     I+DFG+++      +    +   
Sbjct: 116 LSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STAC 168

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGV 210
           GT GY++PE +     S   D +S GV
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  102 bits (256), Expect = 4e-25
 Identities = 41/208 (19%), Positives = 82/208 (39%), Gaps = 32/208 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            + +     LG+G FG V++       +    K +    G   V  K E  ++   +H N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW--KKRF--------NIIEG 125
           ++ L        E ++++E++            S  ++ +      F        + +  
Sbjct: 63  ILHLHESFESMEELVMIFEFI------------SGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIV 183
           + + L +LH      + H D++  NI+   + +   KI +FG AR     +   N   + 
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLF 164

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVL 211
               Y +PE   + +VS  +D++S G L
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTL 192

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  102 bits (256), Expect = 4e-25
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 17/181 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQHT 74
           + +     +G+G +G V K +    G+ +AIK+  +S    +V+     E KL+ +L+H 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 75  NLVRLLGCSLQKGERLLVYEYLPN---KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
           NLV LL    +K    LV+E++ +     L+           LD++     +  I+ G+ 
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTILDDLE------LFPNGLDYQVVQKYLFQIINGIG 138

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           + H +    +IHRD+K  NIL+      K+ DFG ART      E   + +  T  Y +P
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRAP 193

Query: 192 E 192
           E
Sbjct: 194 E 194

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (258), Expect = 5e-25
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 38/229 (16%)

Query: 9   DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN-EAKL 67
           D +T       ++    +G G FG V++ KL++  E+AIK++ +        FKN E ++
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQI 85

Query: 68  IAKLQHTNLVRLLGCSLQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           +  ++H N+V L       G++       LV EY+P         ++  +    + K   
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---------ETVYRASRHYAKLKQ 136

Query: 122 IIEG---------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFG 171
            +           +++ L Y+H    + + HRD+K  N+LLD      K+ DFG A+   
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL- 192

Query: 172 MNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSK 219
               E N + I  +  Y +PE +      +   D++S G ++ E++  +
Sbjct: 193 -IAGEPNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  101 bits (255), Expect = 7e-25
 Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 37/193 (19%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFKN-----EAKLIAK 70
           D +    +LG+G +G VYK    +  + +AIKR+  +   +G+          E  L+ +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV----PGTAIREVSLLKE 89

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG----- 125
           LQH N++ L           L++EY           ++  K+ +D     ++        
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFLY 139

Query: 126 -IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-----KISDFGMARTFGMNELEANT 179
            ++ G+ + H     R +HRDLK  N+LL           KI DFG+AR FG+  +   T
Sbjct: 140 QLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFT 195

Query: 180 NRIVGTHGYMSPE 192
           + I+ T  Y  PE
Sbjct: 196 HEII-TLWYRPPE 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (255), Expect = 9e-25
 Identities = 49/236 (20%), Positives = 98/236 (41%), Gaps = 45/236 (19%)

Query: 1   MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIV 59
           M  + ++ D+         + P + +G+G    V +      G E A+K +  ++ +   
Sbjct: 77  MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136

Query: 60  E--------FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK 110
           E         + E  ++ ++  H +++ L+          LV++ +              
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----------- 185

Query: 111 KELLDW---KKRF------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 161
            EL D+   K         +I+  +++ + +LH      ++HRDLK  NILLDD M  ++
Sbjct: 186 -ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL 241

Query: 162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-------SMKSDVYSFGV 210
           SDFG +      E       + GT GY++PE ++   +         + D+++ GV
Sbjct: 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGV 293

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =   99 bits (250), Expect = 2e-24
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 38/215 (17%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIA 69
            D++  G  LG G F  V K +    G+E A K + K        G    E + E  ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRF------ 120
           +++H N++ L      K + +L+ E +            S  EL D+   K+        
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELV------------SGGELFDFLAEKESLTEDEAT 111

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE 176
             ++ I+ G+ YLH     R+ H DLK  NI+L D+  P    K+ DFG+A         
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-- 166

Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 211
                I GT  +++PE V    + +++D++S GV+
Sbjct: 167 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 99.6 bits (249), Expect = 2e-24
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 21/194 (10%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG------IVQGLLYLHKYS 137
            +   + L  EY     L    FD      ++        +       ++ G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVVYLH--- 122

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN- 196
            + + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 197 GIVSMKSDVYSFGV 210
              +   DV+S G+
Sbjct: 183 EFHAEPVDVWSCGI 196

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (250), Expect = 2e-24
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 44/234 (18%)

Query: 3   RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE- 60
           RD  +    +     +N+ P   LG+G    V +       +E A+K +  + G      
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61

Query: 61  --------FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK 111
                      E  ++ K+  H N+++L           LV++ +               
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG------------ 109

Query: 112 ELLDW---KKRF------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS 162
           EL D+   K          I+  +++ +  LHK   L ++HRDLK  NILLDD MN K++
Sbjct: 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT 166

Query: 163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS------DVYSFGV 210
           DFG +      E       + GT  Y++PE +   +           D++S GV
Sbjct: 167 DFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (251), Expect = 2e-24
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS------SGQGIVEFKNEAKLIA 69
            D +  G  LG G F  V K +    G + A K + K        G    + + E  ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQ 128
           ++QH N++ L      K + +L+ E +    L    FD  ++KE L  ++    ++ I+ 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILN 125

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELEANTNRIVG 184
           G+ YLH    L++ H DLK  NI+L D+  P    KI DFG+A              I G
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVL 211
           T  +++PE V    + +++D++S GV+
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (257), Expect = 2e-24
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 26/203 (12%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEA---------KLIAKLQHTN 75
           +G+GGFG VY  +  D  ++ A+K L K     I   + E           L++      
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 76  LVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           +V +   +    ++L  + + +    L + +  S      +   RF   E I+ GL ++H
Sbjct: 254 IVCM-SYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE-IILGLEHMH 309

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                 V++RDLK +NILLD+  + +ISD G+A  F     +   +  VGTHGYM+PE +
Sbjct: 310 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVL 362

Query: 195 MNGIVSMKS-DVYSFGVLVLEII 216
             G+    S D +S G ++ +++
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLL 385

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  100 bits (250), Expect = 3e-24
 Identities = 50/244 (20%), Positives = 77/244 (31%), Gaps = 54/244 (22%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLIAK 70
              +     +GQG +G V            AIK     ++ + + + +   K E +L+ K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF---------- 120
           L H N+ RL      +    LV E      L   +                         
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 121 ---------------------------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL 153
                                      NI+  I   L YLH      + HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 154 --DDQMNPKISDFGMARTFGMNELEANT--NRIVGTHGYMSPEYVMNGIV---SMKSDVY 206
             +     K+ DFG+++ F               GT  +++PE V+N        K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAW 260

Query: 207 SFGV 210
           S GV
Sbjct: 261 SAGV 264

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 38/209 (18%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLV 77
           G+ LG+G +G V +          A+K L K        G    K E +L+ +L+H N++
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLD--FFIF---DSSKKELLDW--KKRFNIIEG----- 125
           +L              + L N+     + +        +E+LD   +KRF + +      
Sbjct: 70  QL-------------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116

Query: 126 -IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
            ++ GL YLH      ++H+D+K  N+LL      KIS  G+A        +       G
Sbjct: 117 QLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173

Query: 185 THGYMSPEYVMNGIVS---MKSDVYSFGV 210
           +  +  PE + NG+ +    K D++S GV
Sbjct: 174 SPAFQPPE-IANGLDTFSGFKVDIWSAGV 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 38/199 (19%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFKN----EAKLIA 69
           AT  + P   +G G +G VYK +    G  +A+K +   + G G          E  L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 70  KLQ---HTNLVRLL----GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           +L+   H N+VRL+         +  ++ LV+E++          D   +  LD      
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYLDKAPPPG 116

Query: 122 IIEGIV--------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN 173
           +    +        +GL +LH      ++HRDLK  NIL+      K++DFG+AR +   
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173

Query: 174 ELEANTNRIVGTHGYMSPE 192
              A T  +V T  Y +PE
Sbjct: 174 --MALTPVVV-TLWYRAPE 189

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 7e-24
 Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 59/229 (25%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS-------------------SGQGIVEFK 62
            + +G+G +G V       D    A+K LSK                    +  G ++ +
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 63  NEAKLIA-------KLQHTNLVRLLGCSLQKGERLLVYEYL--PNKSLDFFIFD-SSKKE 112
              + +        KL H N+V+L              E L  PN+   + +F+  ++  
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQGP 124

Query: 113 LLD--WKKRFNIIEG------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
           +++    K  +  +       +++G+ YLH     ++IHRD+K SN+L+ +  + KI+DF
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGV 210
           G++  F  ++   +    VGT  +M+PE +            DV++ GV
Sbjct: 182 GVSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 21/194 (10%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
           LG+G +G V      +  + +A+K +         E  K E  +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 84  LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG------IVQGLLYLHKYS 137
            +   + L  EY     L    FD      ++        +       ++ G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVVYLH--- 122

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN- 196
            + + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE +   
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 197 GIVSMKSDVYSFGV 210
              +   DV+S G+
Sbjct: 183 EFHAEPVDVWSCGI 196

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.9 bits (249), Expect = 9e-24
 Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 36/193 (18%)

Query: 23  GNRLGQGGFGPVYKGKLLD---GQEIAIKRLSK----SSGQGIVEFKNEAKLIAKLQHTN 75
           G ++G+G +G VYK K  D    ++ A+K++       S         E  L+ +L+H N
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPN 79

Query: 76  LVRLLGCSLQKGERL--LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV------ 127
           ++ L    L   +R   L+++Y      D +      +     KK   +  G+V      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 128 --QGLLYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFG--MNELEANT 179
              G+ YLH      V+HRDLK +NIL+  +       KI+D G AR F   +  L    
Sbjct: 137 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 180 NRIVGTHGYMSPE 192
             +V T  Y +PE
Sbjct: 194 PVVV-TFWYRAPE 205

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.5 bits (246), Expect = 9e-24
 Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 45/219 (20%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE--------FKNEAKL 67
            D +     LG G  G V         +++AIK +SK                 + E ++
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRF---- 120
           + KL H  ++++        +  +V E +               EL D     KR     
Sbjct: 69  LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGG------------ELFDKVVGNKRLKEAT 115

Query: 121 --NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNEL 175
                  ++  + YLH      +IHRDLK  N+LL   ++    KI+DFG ++  G   L
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 176 EANTNRIVGTHGYMSPEYVMNGIV----SMKSDVYSFGV 210
                 + GT  Y++PE V+  +     +   D +S GV
Sbjct: 173 ---MRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGV 207

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 38/214 (17%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAK 70
             +  G  LG GGFG VY G  + D   +AIK + K       E  N      E  L+ K
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 71  LQHT--NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFNIIEG 125
           +      ++RLL    +    +L+ E                ++L D+   +        
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERP-----------EPVQDLFDFITERGALQEELA 151

Query: 126 ------IVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEAN 178
                 +++ + + H      V+HRD+K  NIL+D ++   K+ DFG             
Sbjct: 152 RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-- 206

Query: 179 TNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVL 211
                GT  Y  PE++         + V+S G+L
Sbjct: 207 --DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 32/209 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
           T+ +     LG+G F  V +   +L GQE A   ++    S +   + + EA++   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRF------NIIE 124
            N+VRL     ++G   L+++ +            +  EL +    ++ +      + I+
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLV------------TGGELFEDIVAREYYSEADASHCIQ 117

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNR 181
            I++ +L+ H+   + V+HR+LK  N+LL         K++DFG+A      +       
Sbjct: 118 QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGV 210
             GT GY+SPE +         D+++ GV
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGV 201

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 55/206 (26%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEA----------- 65
             +    ++GQG FG V+K +    GQ++A+K+         V  +NE            
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK---------VLMENEKEGFPITALREI 67

Query: 66  KLIAKLQHTNLVRLLGCSLQKGERL--------LVYEYLPNKSLDFFIFDSSKKELLDWK 117
           K++  L+H N+V L+     K            LV+++           +     LL   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLLS-N 116

Query: 118 KRFNIIEGIV--------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
                    +         GL Y+H+    +++HRD+KA+N+L+      K++DFG+AR 
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173

Query: 170 FGMNELEAN---TNRIVGTHGYMSPE 192
           F + +       TNR+V T  Y  PE
Sbjct: 174 FSLAKNSQPNRYTNRVV-TLWYRPPE 198

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 27/216 (12%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHT 74
             +++    +G G FG VY+ KL D G+ +AIK++ +        FKN E +++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107

Query: 75  NLVRLLGCSLQKGERL------LVYEYLPNKSLDFFI--FDSSKKEL-LDWKKRFNIIEG 125
           N+VRL       GE+       LV +Y+P +++      +  +K+ L + + K +  +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLY--MYQ 164

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVG 184
           + + L Y+H      + HRD+K  N+LLD      K+ DFG A+       E N + I  
Sbjct: 165 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC- 218

Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSK 219
           +  Y +PE +      +   DV+S G ++ E++  +
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.8 bits (244), Expect = 4e-23
 Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 45/221 (20%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--------SGQGIVEFKNEAKL 67
            D +     LG G  G V         +++AI+ +SK              +  + E ++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 68  IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFN--- 121
           + KL H  ++++        +  +V E +               EL D     KR     
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGG------------ELFDKVVGNKRLKEAT 240

Query: 122 ---IIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNEL 175
                  ++  + YLH+     +IHRDLK  N+LL   ++    KI+DFG ++  G   L
Sbjct: 241 CKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297

Query: 176 EANTNRIVGTHGYMSPEYVMNGIV----SMKSDVYSFGVLV 212
                 + GT  Y++PE V+  +     +   D +S GV++
Sbjct: 298 ---MRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVIL 334

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 42/227 (18%)

Query: 15  AATDNFSP---------GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNE 64
            +TD+FS           + LG+G    V     L+  QE A+K + K  G        E
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60

Query: 65  AKLIAKLQ-HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN-- 121
            +++ + Q H N++ L+    ++    LV+E +   S+         K     ++ FN  
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHK-----RRHFNEL 111

Query: 122 ----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNE 174
               +++ +   L +LH      + HRDLK  NIL +        KI DF +     +N 
Sbjct: 112 EASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

Query: 175 LEANTNR-----IVGTHGYMSPEYVMNGIVSMKS-----DVYSFGVL 211
             +  +        G+  YM+PE V              D++S GV+
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.9 bits (239), Expect = 9e-23
 Identities = 44/214 (20%), Positives = 83/214 (38%), Gaps = 40/214 (18%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKL------IA 69
            +S  + LG G FG V+        +E+ +K + K        +E     K+      ++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 70  KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI--FDSSKKELLDW---KKRFNIIE 124
           +++H N++++              +   N+     +     S  +L  +     R +   
Sbjct: 85  RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131

Query: 125 G------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN 178
                  +V  + YL       +IHRD+K  NI++ +    K+ DFG A      +L   
Sbjct: 132 ASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL--- 185

Query: 179 TNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVL 211
                GT  Y +PE +M N     + +++S GV 
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVT 219

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 54/204 (26%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK--LLDGQEIAIKRLSKSSGQGIVEFKNEA---------- 65
             +     +G+G +G V+K +     G+ +A+KR         V  +             
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR---------VRVQTGEEGMPLSTIRE 61

Query: 66  ----KLIAKLQHTNLVRLL----GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDW 116
               + +   +H N+VRL          +  +L LV+E++          D      LD 
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDK 111

Query: 117 KKRFNIIEGIV--------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
                +    +        +GL +LH +   RV+HRDLK  NIL+      K++DFG+AR
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 169 TFGMNELEANTNRIVGTHGYMSPE 192
            +      A T+ +V T  Y +PE
Sbjct: 169 IYSFQ--MALTSVVV-TLWYRAPE 189

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 20/200 (10%)

Query: 22  PGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT-NLV 77
               LG+G F  V +      GQE A K L K         E  +E  ++   +    ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFD---SSKKELLDWKKRFNIIEGIVQGLLYLH 134
            L        E +L+ EY     +    F        E++       +I+ I++G+ YLH
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 135 KYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           +     ++H DLK  NILL       + KI DFGM+R  G          I+GT  Y++P
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAP 202

Query: 192 EYVMNGIVSMKSDVYSFGVL 211
           E +    ++  +D+++ G++
Sbjct: 203 EILNYDPITTATDMWNIGII 222

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 33/207 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
           +D F   + LG+G    VY+ K     +  A+K L K+  + IV  + E  ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPN 109

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRF------NIIEGI 126
           +++L        E  LV E +            +  EL D    K  +      + ++ I
Sbjct: 110 IIKLKEIFETPTEISLVLELV------------TGGELFDRIVEKGYYSERDAADAVKQI 157

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIV 183
           ++ + YLH+     ++HRDLK  N+L          KI+DFG+++      L      + 
Sbjct: 158 LEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVC 211

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGV 210
           GT GY +PE +       + D++S G+
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGI 238

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 3e-22
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 34/204 (16%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSS--GQGIVE-FKNEAKLIAKLQHTNLVR 78
           G+ LG G FG V  G+  L G ++A+K L++       +V   K E + +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFD-SSKKELLDW---KKRFNIIEG------IVQ 128
           L             Y+ +   +  F + +  S  EL D+     R   +E       I+ 
Sbjct: 76  L-------------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
            + Y H   R  V+HRDLK  N+LLD  MN KI+DFG++      E    T+   G+  Y
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNY 176

Query: 189 MSPEYVMN-GIVSMKSDVYSFGVL 211
            +PE +        + D++S GV+
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVI 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 35/201 (17%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
           +G+G F  V   + +L G+E+AIK + K+  +   + +   E +++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79

Query: 83  SLQKGERLLVYEYLPNKSLDFFIFD-SSKKELLDW---KKRFNIIEG------IVQGLLY 132
                     +E +  +   + I + +S  E+ D+     R    E       IV  + Y
Sbjct: 80  ----------FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H   + R++HRDLKA N+LLD  MN KI+DFG +  F +       +   G   Y +PE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPE 183

Query: 193 YVMNGI--VSMKSDVYSFGVL 211
            +  G      + DV+S GV+
Sbjct: 184 -LFQGKKYDGPEVDVWSLGVI 203

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 22/199 (11%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL-----IAKL-----QHT 74
           LG+GGFG V+ G  L D  ++AIK + ++   G     +         +         H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
            ++RLL     +   +LV E  P  + D F + + K  L +   R      +V  + + H
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

Query: 135 KYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
                 V+HRD+K  NIL+D +    K+ DFG                  GT  Y  PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTRVYSPPEW 209

Query: 194 VMNGI-VSMKSDVYSFGVL 211
           +      ++ + V+S G+L
Sbjct: 210 ISRHQYHALPATVWSLGIL 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 33/221 (14%)

Query: 2   KRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE 60
           +   ++  F  I            LG G FG V   K  +     A+K L K     +V+
Sbjct: 35  QNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKILDKQK---VVK 81

Query: 61  FK------NEAKLIAKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKEL 113
            K      NE +++  +    LV+L   S +    L +V EY+    + F       +  
Sbjct: 82  LKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR-F 138

Query: 114 LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN 173
            +   RF   + IV    YLH      +I+RDLK  N+L+D Q   +++DFG A+     
Sbjct: 139 SEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK----- 189

Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
            ++  T  + GT   ++PE +++   +   D ++ GVL+ E
Sbjct: 190 RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 35/228 (15%)

Query: 2   KRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE 60
           +  L+  DF+ +            +G+G F  V   K+    ++ A+K ++K     +++
Sbjct: 55  EVRLQRDDFEILKV----------IGRGAFSEVAVVKMKQTGQVYAMKIMNKWD---MLK 101

Query: 61  ------FKNEAKLIAKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKEL 113
                 F+ E  ++       + +L   + Q    L LV EY     L   +     + +
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERI 159

Query: 114 LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN 173
                RF + E IV  +  +H+   L  +HRD+K  NILLD   + +++DFG       +
Sbjct: 160 PAEMARFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215

Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVY-------SFGVLVLE 214
                +   VGT  Y+SPE +        +  Y       + GV   E
Sbjct: 216 G-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 33/200 (16%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG+G FG V         Q++A+K +S+         +  + E   +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFNIIEG------IVQGLLY 132
                      Y+ +   +    + + +  EL D+   KKR    EG      I+  + Y
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
            H   R +++HRDLK  N+LLDD +N KI+DFG++           T+   G+  Y +PE
Sbjct: 124 CH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPE 177

Query: 193 YVMN-GIVSMKSDVYSFGVL 211
            +        + DV+S G++
Sbjct: 178 VINGKLYAGPEVDVWSCGIV 197

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 36/210 (17%)

Query: 17  TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHT 74
           TD +     +G G +    +        E A+K + KS      +   E +++ +  QH 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHP 76

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFN------IIEG 125
           N++ L           +V E +               ELLD    +K F+      ++  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGG------------ELLDKILRQKFFSEREASAVLFT 124

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTFGMNELEANTNR 181
           I + + YLH      V+HRDLK SNIL      +  + +I DFG A+          T  
Sbjct: 125 ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-- 179

Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVL 211
              T  +++PE +         D++S GVL
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 23/210 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE------FKNEAKLIAK 70
           ++F     +G+G FG V   KL +  ++ A+K L+K     +++      F+ E  ++  
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE---MLKRAETACFREERDVLVN 130

Query: 71  LQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
                +  L   + Q    L LV +Y     L   +    +  L +   RF + E +V  
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIA 187

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           +  +H+   L  +HRD+K  NIL+D   + +++DFG      M +    ++  VGT  Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYI 243

Query: 190 SPEYVMNGIVSMKS-----DVYSFGVLVLE 214
           SPE +              D +S GV + E
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 31/237 (13%)

Query: 1   MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKR-LSKSSGQGI 58
           M  +      +      D F      GQG FG V  GK    G  +AIK+ +        
Sbjct: 6   MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---- 61

Query: 59  VEFKN----EAKLIAKLQHTNLVRLLGCSLQKGER-------LLVYEYLPNKSLDFFI-- 105
             F+N      + +A L H N+V+L       GER        +V EY+P  +L      
Sbjct: 62  --FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRN 118

Query: 106 FDSSKKEL-LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISD 163
           +   +        K F  +  +++ +  LH  S + V HRD+K  N+L+++     K+ D
Sbjct: 119 YYRRQVAPPPILIKVF--LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCD 175

Query: 164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSK 219
           FG A+    +  E N   I  +  Y +PE +      +   D++S G +  E++  +
Sbjct: 176 FGSAKKL--SPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 5e-21
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE------FKNEAKLIAK 70
           +++     +G+G FG V   +    +++ A+K LSK     +++      F  E  ++A 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE---MIKRSDSAFFWEERDIMAF 125

Query: 71  LQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
                +V+L   + Q    L +V EY+P   L   +   S  ++ +   RF   E +V  
Sbjct: 126 ANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-VNLM--SNYDVPEKWARFYTAE-VVLA 180

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L  +H    +  IHRD+K  N+LLD   + K++DFG         +    +  VGT  Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYI 236

Query: 190 SPEYVMNGIVSMK----SDVYSFGVLVLE 214
           SPE + +           D +S GV + E
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYE 265

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 34/226 (15%)

Query: 2   KRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE 60
             D+    F+ + A          +G+G FG V   +  D +++ A+K ++K      VE
Sbjct: 9   NEDVNFDHFEILRA----------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQK---CVE 55

Query: 61  FK------NEAKLIAKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKEL 113
                    E +++  L+H  LV L   S Q  E + +V + L    L + +        
Sbjct: 56  RNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHF 112

Query: 114 LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN 173
            +   +  I E +V  L YL      R+IHRD+K  NILLD+  +  I+DF +A      
Sbjct: 113 KEETVKLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168

Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIV---SMKSDVYSFGVLVLEII 216
                   + GT  YM+PE   +      S   D +S GV   E++
Sbjct: 169 TQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 90.3 bits (225), Expect = 8e-21
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFK------NEAKLIAK 70
            +F     LG G FG V+  +        A+K L K     +V  K      +E  +++ 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI---VVRLKQVEHTNDERLMLSI 62

Query: 71  LQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
           + H  ++R+   + Q  +++ ++ +Y+    L F +   S++   +   +F   E +   
Sbjct: 63  VTHPFIIRMW-GTFQDAQQIFMIMDYIEGGEL-FSLLRKSQR-FPNPVAKFYAAE-VCLA 118

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L YLH      +I+RDLK  NILLD   + KI+DFG A+      +   T  + GT  Y+
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYI 170

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLE 214
           +PE V     +   D +SFG+L+ E
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYE 195

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.8 bits (228), Expect = 9e-21
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 34/201 (16%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
           LG G FG V  GK  L G ++A+K L++    S   + + + E + +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 82  CSLQKGERLLVYEYLPNKSLDFFIFD-SSKKELLDW---KKRFNIIEG------IVQGLL 131
                      Y+ +   S  F + +  S  EL D+     R +  E       I+ G+ 
Sbjct: 82  -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           Y H   R  V+HRDLK  N+LLD  MN KI+DFG++      E    T+   G+  Y +P
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAP 184

Query: 192 EYVMN-GIVSMKSDVYSFGVL 211
           E +        + D++S GV+
Sbjct: 185 EVISGRLYAGPEVDIWSSGVI 205

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 34/205 (16%)

Query: 21  SPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVR 78
                LG+G F    K       Q  A+K +SK         + E   +   + H N+V+
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVK 70

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD---WKKRFN------IIEGIVQG 129
           L      +    LV E L            +  EL +    KK F+      I+  +V  
Sbjct: 71  LHEVFHDQLHTFLVMELL------------NGGELFERIKKKKHFSETEASYIMRKLVSA 118

Query: 130 LLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
           + ++H    + V+HRDLK  N+L    +D +  KI DFG AR    +     T     T 
Sbjct: 119 VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTL 173

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVL 211
            Y +PE +         D++S GV+
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVI 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 19/199 (9%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE------FKNEAKLIAKLQHTNLVR 78
           LG+G FG V   K        A+K L K     IV          E +++   +H  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEV---IVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 79  LLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           L   S Q  +RL  V EY     L F +  S ++   + + RF   E IV  L YLH  S
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--S 266

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
              V++RDLK  N++LD   + KI+DFG+ +  G+ +  A      GT  Y++PE + + 
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLEDN 324

Query: 198 IVSMKSDVYSFGVLVLEII 216
                 D +  GV++ E++
Sbjct: 325 DYGRAVDWWGLGVVMYEMM 343

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 45/206 (21%), Positives = 74/206 (35%), Gaps = 44/206 (21%)

Query: 26  LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLG-- 81
           LG G  G V +      GQ+ A+K L  S      + + E     +     ++V +L   
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVY 91

Query: 82  --CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD-----WKKRFN------IIEGIVQ 128
                 K   L++ E +               EL         + F       I+  I  
Sbjct: 92  ENMHHGKRCLLIIMECM------------EGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 129 GLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
            + +LH      + HRD+K  N+L    +     K++DFG A+    N L         T
Sbjct: 140 AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYT 192

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVL 211
             Y++PE +         D++S GV+
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 34/202 (16%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
              +G G FG     +  L  + +A+K + +  G  I E  + E      L+H N+VR  
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFK 82

Query: 81  GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---KKRFNIIEG------IVQGLL 131
              L      ++ EY                EL +      RF+  E       ++ G+ 
Sbjct: 83  EVILTPTHLAIIMEYASGG------------ELYERICNAGRFSEDEARFFFQQLLSGVS 130

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQ--MNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           Y H    +++ HRDLK  N LLD       KI DFG +++  ++    +T   VGT  Y+
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYI 184

Query: 190 SPEYVMN-GIVSMKSDVYSFGV 210
           +PE ++        +DV+S GV
Sbjct: 185 APEVLLRQEYDGKIADVWSCGV 206

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 85.7 bits (213), Expect = 4e-19
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 16/196 (8%)

Query: 26  LGQGGFGPVY---KGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
           LGQG FG V+   K    D +++ A+K L K++   +  V  K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 80  LGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
              + Q   +L L+ ++L    L F           +   +F + E +   L +LH    
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHS--- 144

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
           L +I+RDLK  NILLD++ + K++DFG+++   ++  E       GT  YM+PE V    
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRRG 202

Query: 199 VSMKSDVYSFGVLVLE 214
            +  +D +SFGVL+ E
Sbjct: 203 HTQSADWWSFGVLMFE 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 22/200 (11%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE------FKNEAKLIAKLQHTNLVR 78
           LG+G FG V   +        A+K L K     I+          E++++   +H  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEV---IIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 79  LLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGLLYLHKY 136
           L   + Q  +RL  V EY     L F +   S++ +   ++ RF   E IV  L YLH  
Sbjct: 70  LK-YAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAE-IVSALEYLHS- 123

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
               V++RD+K  N++LD   + KI+DFG+ +  G+++  A      GT  Y++PE + +
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLED 179

Query: 197 GIVSMKSDVYSFGVLVLEII 216
                  D +  GV++ E++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMM 199

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 43/209 (20%)

Query: 23  GNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLL 80
              LG G  G V +       ++ A+K L         + + E +L  +     ++VR++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIV 121

Query: 81  G----CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD-----WKKRF------NIIEG 125
                    +   L+V E L               EL         + F       I++ 
Sbjct: 122 DVYENLYAGRKCLLIVMECL------------DGGELFSRIQDRGDQAFTEREASEIMKS 169

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRI 182
           I + + YLH    + + HRD+K  N+L          K++DFG A+    +    +    
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTP 223

Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVL 211
             T  Y++PE +         D++S GV+
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 46/210 (21%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HT 74
            D++    +LG+G +  V++   + + +++ +K L     +   + K E K++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 75  NLVRLLGC--SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           N++ L             LV+E++ N            + L D+  RF + E I++ L Y
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145

Query: 133 LHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
            H  S   ++HRD+K  N+++D +    ++ D+G+A  +  +  +    R V +  +  P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR-VASRYFKGP 199

Query: 192 EYVMNGIVSMKS-DVYSFGVLVLEIISSKK 220
           E +++  +   S D++S G ++  +I  K+
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 35/205 (17%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           +G+G FG V   +    +   A+K L K +   I++ K E K        L+  ++H  L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKA---ILK-KKEEKHIMSERNVLLKNVKHPFL 101

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFF------IFDSSKKELLDWKKRFNIIEGIVQG 129
           V L   S Q  ++L  V +Y+    L F+       F   +        RF   E I   
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRA-------RFYAAE-IASA 151

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L YLH    L +++RDLK  NILLD Q +  ++DFG+ +   +    + T+   GT  Y+
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEH-NSTTSTFCGTPEYL 206

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLE 214
           +PE +         D +  G ++ E
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYE 231

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 36/207 (17%)

Query: 26  LGQGGFGPVY---KGKLLDGQEI-AIKRLSKSSGQGIVEFKNEA-------KLIAKLQHT 74
           LG+GG+G V+   K    +  +I A+K L K+    IV    +         ++ +++H 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81

Query: 75  NLVRLLGCSLQKGERL-LVYEYLPNKSLDFF------IFDSSKKELLDWKKRFNIIEGIV 127
            +V L+  + Q G +L L+ EYL    L F       IF             F + E I 
Sbjct: 82  FIVDLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTA-------CFYLAE-IS 131

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
             L +LH+     +I+RDLK  NI+L+ Q + K++DFG+ +   +++    T+   GT  
Sbjct: 132 MALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHD-GTVTHTFCGTIE 186

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLE 214
           YM+PE +M    +   D +S G L+ +
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYD 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LI 68
            +F+    LG+G FG V   +     E+ A+K L K     +++  ++ +        L 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLA 396

Query: 69  AKLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
              +   L +L  C  Q  +RL  V EY+    L + I         +    F   E I 
Sbjct: 397 LPGKPPFLTQLHSCF-QTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAE-IA 452

Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            GL +L       +I+RDLK  N++LD + + KI+DFGM +   + +    T    GT  
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWD-GVTTKTFCGTPD 507

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLE 214
           Y++PE +         D ++FGVL+ E
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYE 534

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           LG+G FG V   ++ +  ++ A+K L K     I++  ++ +        L     H  L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDV---ILQ-DDDVECTMTEKRILSLARNHPFL 86

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
            +L  C  Q  +RL  V E++    L  F    S++       RF   E I+  L++LH 
Sbjct: 87  TQLF-CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARA-RFYAAE-IISALMFLHD 142

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
                +I+RDLK  N+LLD + + K++DFGM +  G+      T    GT  Y++PE + 
Sbjct: 143 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICN-GVTTATFCGTPDYIAPEILQ 197

Query: 196 NGIVSMKSDVYSFGVLVLE 214
             +     D ++ GVL+ E
Sbjct: 198 EMLYGPAVDWWAMGVLLYE 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 35/205 (17%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           LG+G FG V   +     E+ A+K L K     +++  ++ +        L    +   L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFL 83

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFF------IFDSSKKELLDWKKRFNIIEGIVQG 129
            +L     Q  +RL  V EY+    L  +       F             F   E I  G
Sbjct: 84  TQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-------VFYAAE-IAIG 133

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
           L +L       +I+RDLK  N++LD + + KI+DFGM +   + +    T    GT  Y+
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWD-GVTTKTFCGTPDYI 188

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLE 214
           +PE +         D ++FGVL+ E
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYE 213

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 26/204 (12%)

Query: 26  LGQGGFGPVY---KGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQH 73
           LG G +G V+   K    D  ++ A+K L K++   IV+     +        L    Q 
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT---IVQKAKTTEHTRTERQVLEHIRQS 118

Query: 74  TNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
             LV L   + Q   +L L+ +Y+    L F      ++       +  + E IV  L +
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEV-QIYVGE-IVLALEH 174

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LHK   L +I+RD+K  NILLD   +  ++DFG+++   + +         GT  YM+P+
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPD 230

Query: 193 YVMNGIVSMKSDV--YSFGVLVLE 214
            V  G       V  +S GVL+ E
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYE 254

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           LG+G FG V+  +     +  AIK L K     ++   ++ +        L    +H  L
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDV---VLM-DDDVECTMVEKRVLSLAWEHPFL 80

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
             +  C+ Q  E L  V EYL    L + I   S  +    +  F   E I+ GL +LH 
Sbjct: 81  THMF-CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAE-IILGLQFLHS 136

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
                +++RDLK  NILLD   + KI+DFGM +   M   +A TN   GT  Y++PE ++
Sbjct: 137 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLG-DAKTNTFCGTPDYIAPEILL 191

Query: 196 NGIVSMKSDVYSFGVLVLE 214
               +   D +SFGVL+ E
Sbjct: 192 GQKYNHSVDWWSFGVLLYE 210

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 23/199 (11%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           +G+G +  V   +L     I A+K + K     + +   +                H  L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKEL---VND-DEDIDWVQTEKHVFEQASNHPFL 72

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           V L     Q   RL  V EY+    L F +    +++L +   RF   E I   L YLH+
Sbjct: 73  VGLH-SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHE 128

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
                +I+RDLK  N+LLD + + K++D+GM +  G+      T+   GT  Y++PE + 
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRP-GDTTSTFCGTPNYIAPEILR 183

Query: 196 NGIVSMKSDVYSFGVLVLE 214
                   D ++ GVL+ E
Sbjct: 184 GEDYGFSVDWWALGVLMFE 202

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 43/195 (22%), Positives = 87/195 (44%), Gaps = 29/195 (14%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
            D +   + +G G +G V +    L+ + +AIK++ +        F++         E  
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 67  LIAKLQHTNLVRLL----GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           ++ +L H ++V++L       ++K + L +V E       DF     +   L +   +  
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKT- 160

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           ++  ++ G+ Y+H  S   ++HRDLK +N L++   + K+ DFG+ART    E   +   
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 182 IVGTHGYMSPEYVMN 196
           I      M+     +
Sbjct: 218 ISPREDDMNLVTFPH 232

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 23/199 (11%)

Query: 26  LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKNEAK--------LIAKLQHTNL 76
           +G+G +  V   +L     I A++ + K     + +   +                H  L
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKEL---VND-DEDIDWVQTEKHVFEQASNHPFL 115

Query: 77  VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           V L     Q   RL  V EY+    L F +    +++L +   RF   E I   L YLH+
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHE 171

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
                +I+RDLK  N+LLD + + K++D+GM +  G+      T+   GT  Y++PE + 
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRP-GDTTSTFCGTPNYIAPEILR 226

Query: 196 NGIVSMKSDVYSFGVLVLE 214
                   D ++ GVL+ E
Sbjct: 227 GEDYGFSVDWWALGVLMFE 245

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
              +     +G G  G V      +  + +AIK+LS+        F+N         E  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 67  LIAKLQHTNLVRLL-----GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
           L+  + H N++ LL       SL++ + + +V E +   +L   I    + EL   +  +
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY 131

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            ++  ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +     
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 186

Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
             V T  Y +PE ++        D++S G ++ E+I   
Sbjct: 187 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 79.2 bits (195), Expect = 8e-17
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 13/97 (13%)

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           + +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR     ++  + + +   
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253

Query: 186 HG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
                  +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 33/166 (19%), Positives = 61/166 (36%), Gaps = 19/166 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 70
           D    G  LG+G FG V +            + +A+K L + +         +E K++  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 71  L-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           +  H N+V LLG C+   G  +++ E+    +L  ++            KR   +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
           G  +      +  I  DLK     +    +   S F   ++    E
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 28/221 (12%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE--FKN---------EA 65
              ++    +  G +G V  G   +G  +AIKR+  +   G       +         E 
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 66  KLIAKLQHTNLVRLLGCSLQKGERL-----LVYEYLPNKSLDFF-IFDSSKKELLDWKKR 119
           +L+    H N++ L    +   E       LV E +     D   +    +  +     +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQ 137

Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
           +  +  I+ GL  LH+     V+HRDL   NILL D  +  I DF +AR    +    N 
Sbjct: 138 Y-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NK 190

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
              V    Y +PE VM      K  D++S G ++ E+ + K
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 47/245 (19%), Positives = 94/245 (38%), Gaps = 53/245 (21%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHT 74
           +  +S G  LG G FG V +   ++ G+  A+K++ +        +KN E  ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--------------------ELL 114
           N+++L+      G+        P+        ++                       E +
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 115 D----------WKKRFNIIEGIVQ--------GLLYLHKYSRLRVIHRDLKASNILLDDQ 156
                       +   +I   ++          + ++H    L + HRD+K  N+L++ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177

Query: 157 MNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLE 214
            N  K+ DFG A+       E +   I  +  Y +PE ++     +   D++S G +  E
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 215 IISSK 219
           +I  K
Sbjct: 235 LILGK 239

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
              +     +G G  G V      +  + +AIK+LS+        F+N         E  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 67  LIAKLQHTNLVRLL-----GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
           L+  + H N++ LL       +L++ + + LV E +    L   I    + EL   +  +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY 168

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            + + ++ G+ +LH      +IHRDLK SNI++      KI DFG+ART G +     T 
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTP 222

Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
             V T  Y +PE ++        D++S G ++ E++  K
Sbjct: 223 Y-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 38/220 (17%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
              +     +G G +G V        G+++AIK+LS+        F++         E  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 67  LIAKLQHTNLVRLLG--CSLQKGERL----LVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
           L+  +QH N++ LL                LV  ++    L   +      +  + K ++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY 130

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            ++  +++GL Y+H      V+HRDLK  N+ +++    KI DFG+AR            
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---- 182

Query: 181 RIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
             V T  Y +PE +++ +   ++ D++S G ++ E+++ K
Sbjct: 183 -YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 23/196 (11%), Positives = 53/196 (27%), Gaps = 51/196 (26%)

Query: 25  RLGQGGFGPVYKGK--LLDGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKLQHTNLVRL 79
             G       ++     LD +++A+  +          + E  +    ++++    + R+
Sbjct: 38  FHGGVPPLQFWQALDTALD-RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 80  LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD----WKKRFNIIEGIVQGLLYLHK 135
           L     +   L+V E++   SL         +E+ D           ++ +       H 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSL---------QEVADTSPSPVGAIRAMQSLAAAADAAH- 146

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
             R  V       S +         +S  G                 +     M      
Sbjct: 147 --RAGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPD---- 178

Query: 196 NGIVSMKSDVYSFGVL 211
               + + D+   G  
Sbjct: 179 ---ANPQDDIRGIGAS 191

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 49/227 (21%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
              +     LG GG G V+        + +AIK++            +         E K
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 67  LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF----DS------SKKELLDW 116
           +I +L H N+V++       G +L        +    +I     ++       +  LL+ 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNEL 175
             R   +  +++GL Y+H  +   V+HRDLK +N+ ++ + +  KI DFG+AR    +  
Sbjct: 121 HARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 176 EAN--TNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSK 219
                +  +V T  Y SP  +++    +   D+++ G +  E+++ K
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 35/221 (15%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
              ++  + +G+G +G V      L+   +AIK++S         F++         E K
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 67  LIAKLQHTNLVRLLGCSLQKGERL-----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           ++ + +H N++ +                +V + +    L   +     + L +    + 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL---KTQHLSNDHICY- 132

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN--T 179
            +  I++GL Y+H  S   V+HRDLK SN+LL+   + KI DFG+AR    +       T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
              V T  Y +PE ++N     KS D++S G ++ E++S++
Sbjct: 190 EY-VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 41/222 (18%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
              +     +G G +G V        G ++AIK+L +        F++         E +
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 67  LIAKLQHTNLVRLL-----GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
           L+  ++H N++ LL       +L       LV  ++    L   +     ++L + + +F
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF 132

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG--MNELEAN 178
            ++  +++GL Y+H      +IHRDLK  N+ +++    KI DFG+AR     M      
Sbjct: 133 -LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--- 185

Query: 179 TNRIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
               V T  Y +PE ++N +   ++ D++S G ++ E+I+ K
Sbjct: 186 ----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 40/202 (19%), Positives = 79/202 (39%), Gaps = 38/202 (18%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
            DN+   + +G+G +G VY        + +AIK++++        F++         E  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77

Query: 67  LIAKLQHTNLVRLLGCSLQKGERL-----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           ++ +L+   ++RL    +           +V E   +   D      +   L +   +  
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKTPIFLTEEHIKT- 133

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
           I+  ++ G  ++H      +IHRDLK +N LL+   + K+ DFG+ART    +     N 
Sbjct: 134 ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 182 IVGTHGYMSP---------EYV 194
           +                   +V
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHV 212

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 36/165 (21%), Positives = 61/165 (36%), Gaps = 40/165 (24%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
              LG G  G V +       ++ A+K L         + + E +L  +  Q  ++VR++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIV 77

Query: 81  G----CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD-----WKKRF------NIIEG 125
                    +   L+V E L               EL         + F       I++ 
Sbjct: 78  DVYENLYAGRKCLLIVMECL------------DGGELFSRIQDRGDQAFTEREASEIMKS 125

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMA 167
           I + + YLH    + + HRD+K  N+L          K++DFG A
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 34/193 (17%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
           + +F   + LG+G +G V        G+ +AIK++          F           E K
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 67  LIAKLQHTNLVRLLGCSLQKGERL-----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
           ++   +H N++ +                ++ E +    L   I   S + L D   ++ 
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQY- 116

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
            I   ++ +  LH  +   VIHRDLK SN+L++   + K+ DFG+AR    +E  A+ + 
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSE 171

Query: 182 IVGTHGYMSPEYV 194
             G    M  E+V
Sbjct: 172 PTGQQSGMV-EFV 183

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 37/220 (16%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
            + +   + +G G +G V        G  +A+K+LS+        F++         E +
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 67  LIAKLQHTNLVRLL-----GCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
           L+  ++H N++ LL       SL++   + LV   +    L+  +     ++L D   +F
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV---KCQKLTDDHVQF 136

Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
            +I  I++GL Y+H      +IHRDLK SN+ +++    KI DFG+AR            
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189

Query: 181 RIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
             V T  Y +PE ++N    +   D++S G ++ E+++ +
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.4 bits (166), Expect = 4e-13
 Identities = 32/216 (14%), Positives = 63/216 (29%), Gaps = 57/216 (26%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRL--------SKSSGQGIVEFKNEAKL 67
            T+      ++G+G FG V++    D   +AIK +        + S  +   E   E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 68  IAKLQ---------HTNLVRLLGCSLQKGER----LLVYEYLPNKSLD------------ 102
             +L              + L      +G      L  +++  +                
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 103 -FFIF---------DSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL 152
            F +          +  + +L       +I+  +   L        LR  HRDL   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           L      K+      ++             + + G 
Sbjct: 195 LKKTSLKKLHYTLNGKSST-----------IPSCGL 219

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFK-----NEAKLIAKLQ--HT 74
           LG G F  V+  K +++   +A+K +      +     E K     N+A    +      
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86

Query: 75  NLVRLLGCSLQKGERL----LVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQG 129
           ++++LL     KG       +V+E L  ++L   I     + + L + K+    + ++ G
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI--SKQLLLG 143

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNP------KISDFGMARTFGMNELEANTNRIV 183
           L Y+H+  R  +IH D+K  N+L++   +P      KI+D G A  +        TN I 
Sbjct: 144 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY---TNSIQ 197

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
               Y SPE ++       +D++S   L+ E+I+
Sbjct: 198 TRE-YRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 30/175 (17%), Positives = 64/175 (36%), Gaps = 29/175 (16%)

Query: 19  NFSPGNRLGQGGFGPVYKGK---------LLDGQEIAIKRLSKSSGQGIVEFK------- 62
            +   +   +   G +Y+               Q+ ++K L    G+   E         
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101

Query: 63  ----NEAKLIAKLQHTNLVRLLGCSLQKGE-RLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
               N+ K +       +   +G  + + + R LV   L  +SL     D S K +L  +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159

Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI--SDFGMARTF 170
               +   ++  L +LH+      +H ++ A NI +D +   ++  + +G A  +
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 45/204 (22%), Positives = 93/204 (45%), Gaps = 46/204 (22%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---------EAK 66
              +    +LG+G +G V+K      G+ +A+K++  +       F+N         E  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 67  LIAKLQ-HTNLVRLLGCSLQKGERL----LVYEYLP---NKSLDFFIFDSSKKELLDWKK 118
           ++ +L  H N+V LL  ++ + +      LV++Y+    +      +  +    L    K
Sbjct: 61  ILTELSGHENIVNLL--NVLRADNDRDVYLVFDYMETDLHA-----VIRA--NILEPVHK 111

Query: 119 RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN 178
           ++ ++  +++ + YLH  S   ++HRD+K SNILL+ + + K++DFG++R+F       N
Sbjct: 112 QY-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 179 TNRIVGTHGYMSP--------EYV 194
              +       +         +YV
Sbjct: 168 NIPLSINENTENFDDDQPILTDYV 191

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 43/187 (22%), Positives = 82/187 (43%), Gaps = 26/187 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           + F  G ++G G FG +Y G  +   +E+AIK  +  +    + +  E+K+   LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64

Query: 77  V-RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +  +    ++    +LV + L   SL+      S+K  L  K    + + ++  + ++H 
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHS 121

Query: 136 YSRLRVIHRDLKASNILLDDQMNPK---ISDFGMARTFGMNELEANTNR---------IV 183
            S    +HRD+K  N L+          I DFG+A+ +     + +T++         + 
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNLT 174

Query: 184 GTHGYMS 190
           GT  Y S
Sbjct: 175 GTARYAS 181

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 26/187 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           + +  G ++G G FG +Y G  +  G+E+AIK     +    +    E+K+   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66

Query: 77  V-RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +  +  C  +    ++V E L   SL+      S+K     K    + + ++  + Y+H 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123

Query: 136 YSRLRVIHRDLKASNILLDDQMNPK---ISDFGMARTFGMNELEANTNR---------IV 183
            +    IHRD+K  N L+          I DFG+A+ +     +A T++         + 
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY----RDARTHQHIPYRENKNLT 176

Query: 184 GTHGYMS 190
           GT  Y S
Sbjct: 177 GTARYAS 183

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 46/212 (21%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQHT------N 75
           +G+G FG V K    ++ + +AIK          Q     + E +L+  +          
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN-----------IIE 124
           +V L    + +    LV+E L   S + +       +LL   +  N             +
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML---SYNLY-------DLL---RNTNFRGVSLNLTRKFAQ 164

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRI 182
            +   LL+L     L +IH DLK  NILL +      KI DFG +       +     + 
Sbjct: 165 QMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI----YQY 218

Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
           + +  Y SPE ++     +  D++S G +++E
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 40/189 (21%), Positives = 79/189 (41%), Gaps = 28/189 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
            ++  G R+G+G FG +++G  LL+ Q++AIK   + S    +    E +    L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTG 67

Query: 77  V-RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +  +     +    +LV + L   SL+  +    +K     K      + ++  +  +H+
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE 124

Query: 136 YSRLRVIHRDLKASNILLDDQMNPK-----ISDFGMARTFGMNELEANTNR--------- 181
            S   +++RD+K  N L+    +       + DFGM + +     +  T +         
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY----RDPVTKQHIPYREKKN 177

Query: 182 IVGTHGYMS 190
           + GT  YMS
Sbjct: 178 LSGTARYMS 186

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 44/195 (22%), Positives = 75/195 (38%), Gaps = 42/195 (21%)

Query: 19  NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           NF  G ++G G FG +  GK L   + +AIK     S    +    E +   +L   + +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGI 67

Query: 78  -RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR-------FNIIEGIVQG 129
            ++           +V E L   SL+         +L D   R         I   ++  
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLE---------DLFDLCDRTFSLKTVLMIAIQLISR 117

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPK-----ISDFGMARTFGMNELEANTNR--- 181
           + Y+H  +   +I+RD+K  N L+    N       I DF +A+ +    ++  T +   
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHIP 170

Query: 182 ------IVGTHGYMS 190
                 + GT  YMS
Sbjct: 171 YREHKSLTGTARYMS 185

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 9e-10
 Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 29/171 (16%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEI------AIKRLSKSSGQGIVEFK-----NEAKLIAKL 71
           G  +GQGGFG +Y   +   + +       +K     +G    E K      + + I K 
Sbjct: 40  GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99

Query: 72  QHTNLVRLLG---------CSLQKGE-RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
             T  ++ LG                 R ++ +      L      ++K+     K    
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR--FSRKTVLQ 156

Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI--SDFGMARTF 170
           +   I+  L Y+H++     +H D+KASN+LL+ +   ++   D+G+A  +
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 38/208 (18%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQH------TN 75
           +G+G FG V K       Q +A+K +    +   Q   E     +++  L+        N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQG 129
           ++ +L     +    + +E L + +L    ++  KK      + F+          I+Q 
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNL----YELIKKNKF---QGFSLPLVRKFAHSILQC 212

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHG 187
           L  LHK    R+IH DLK  NILL  Q     K+ DFG +  +    +       + +  
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRV----YTYIQSRF 264

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEI 215
           Y +PE ++     M  D++S G ++ E+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAEL 292

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 31/166 (18%), Positives = 64/166 (38%), Gaps = 22/166 (13%)

Query: 23  GNRLGQGGFGPVYKGK-LLDGQEIA---IKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           G ++G GGFG +Y        ++ A   +K   + +G    E K   + +AK        
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFY-QRVAKKDCIKKWI 100

Query: 79  LLGCSLQKGERLLVY---EYLPNKSLDFFIFD---SSKKELLDWKKRFN------IIEGI 126
                   G  L           +S  F + +      +++      F       +   +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRM 160

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI--SDFGMARTF 170
           +  L Y+H+      +H D+KA+N+LL  +   ++  +D+G++  +
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 35/185 (18%), Positives = 60/185 (32%), Gaps = 73/185 (39%)

Query: 113 LLDWKKRFN-----------IIEGIVQGLLYLHKYSRLRVIHRDLKASNILL-------- 153
           LL W  + N           II+ ++QGL YLH  ++ R+IH D+K  NILL        
Sbjct: 131 LLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIR 188

Query: 154 -----------------------------------------DDQMNPKISDFGMARTFGM 172
                                                     +++  KI+D G A     
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--- 245

Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK------KNNGCYD 226
             +  +    + T  Y S E ++    +  +D++S   +  E+ +               
Sbjct: 246 --VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303

Query: 227 TERHL 231
            E H+
Sbjct: 304 DEDHI 308

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 62/230 (26%)

Query: 26  LGQGGFGPVYKGK-LLDGQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQH-----TNL 76
           +G G FG V   + + + +  A+K    + K +    +E    A ++ K+Q+      N+
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNNI 98

Query: 77  VRLLGCSLQKGERLLVYEYL-PNKSLDFFIFDSSKKELLDWKKRFN-----------IIE 124
           V+  G  +      L++E L P+              L +   R N              
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGPS--------------LYEIITRNNYNGFHIEDIKLYCI 144

Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR--- 181
            I++ L YL K   + + H DLK  NILLDD    K        T G       T     
Sbjct: 145 EILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 182 -----------------IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
                            I+ T  Y +PE ++N    + SD++SFG ++ E
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 4e-06
 Identities = 31/243 (12%), Positives = 65/243 (26%), Gaps = 60/243 (24%)

Query: 2   KRDLKIFDFQ-TIAAATDNFSPGNRLGQGGFGPVYKGKLLDG--QEIAIKRLSKSSGQGI 58
            +    F+    I   T      + L       +           +     L K      
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315

Query: 59  VEFKNEAKLIAKLQHTNLVRLLGCSLQKG-ERLLVYEYLPNKSL---------------- 101
            +   E            + ++  S++ G      ++++    L                
Sbjct: 316 QDLPREVLTTNPR----RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371

Query: 102 -----DFFIFDSSKK------ELLDW-KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKAS 149
                   +F  S         L+ W     + +  +V     LHKYS   ++ +  K S
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLSLI-WFDVIKSDVMVVVNK---LHKYS---LVEKQPKES 424

Query: 150 NILLDD---QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE-YVMNGIVSMKSDV 205
            I +     ++  K+ +           L      IV    Y  P+ +  + ++    D 
Sbjct: 425 TISIPSIYLELKVKLEN--------EYALH---RSIVDH--YNIPKTFDSDDLIPPYLDQ 471

Query: 206 YSF 208
           Y +
Sbjct: 472 YFY 474

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 6e-06
 Identities = 49/342 (14%), Positives = 94/342 (27%), Gaps = 126/342 (36%)

Query: 62  KNEAKLIAKLQH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDF---FIFDSSKKELLDW 116
           K E   I   +   +  +RL    L K E   + +    + L     F+           
Sbjct: 48  KEEIDHIIMSKDAVSGTLRLFWTLLSKQEE--MVQKFVEEVLRINYKFLMSP-------I 98

Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL- 175
           K        + +  +Y+ +  RL   + D            N   + + ++R     +L 
Sbjct: 99  KTEQRQPSMMTR--MYIEQRDRL---YND------------NQVFAKYNVSRLQPYLKLR 141

Query: 176 ----EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK----------- 220
               E    + V   G       + G  S K+       + L++  S K           
Sbjct: 142 QALLELRPAKNVLIDG-------VLG--SGKT------WVALDVCLSYKVQCKMDFKIFW 186

Query: 221 -NNGCYDTERHL-----NLVGYAWQLWNEG----------------KALELIDTTLHESC 258
            N    ++   +      L+      W                   +   L+ +  +E+C
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 259 --------SPDEVT----RC-IHVGLLCVQDKA-TD--------RPTMSDVASMLTND-T 295
                   +          C I   LL  + K  TD          ++   +  LT D  
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKI---LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303

Query: 296 MALPTPRQPAF--FINISSDYEEPEVTEIKLEVCSVNDVTIS 335
            +L          +++     + P       EV + N   +S
Sbjct: 304 KSL-------LLKYLDCRPQ-DLPR------EVLTTNPRRLS 331

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 46/343 (13%), Positives = 107/343 (31%), Gaps = 65/343 (18%)

Query: 35  YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL---LGCSLQKGERLL 91
            + +L +  ++  K  + S  Q  ++ +       +L+    V +   LG     G+  +
Sbjct: 115 QRDRLYNDNQVFAKY-NVSRLQPYLKLRQALL---ELRPAKNVLIDGVLGS----GKTWV 166

Query: 92  VYEYLPNKSL----DFFIF------DSSKKELL------------DWKKRFNIIEGIVQG 129
             +   +  +    DF IF       +S + +L            +W  R +    I   
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226

Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD-FGM-ARTFGMNELEANTNRIVGTHG 187
           +  +    R  +  +  +   ++L +  N K  + F +  +       +  T+ +     
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVL--VLEIISSK-KNNGCYDTERHLNLVGYA------- 237
                  ++      +      +L   L+               R L+++  +       
Sbjct: 287 T---HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343

Query: 238 WQLW---NEGKALELIDTTLHESCSPDEVTRC------------IHVGLLCVQDKATDRP 282
           W  W   N  K   +I+++L     P E  +             I   LL +      + 
Sbjct: 344 WDNWKHVNCDKLTTIIESSL-NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402

Query: 283 TMSDVASMLTNDTMALPTPRQPAFFI-NISSDYEEPEVTEIKL 324
            +  V + L   ++    P++    I +I  + +     E  L
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 45/231 (19%), Positives = 80/231 (34%), Gaps = 68/231 (29%)

Query: 26  LGQGGFGPVYKG--KLLDGQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQHT------ 74
           LG+G FG V +         ++A+K    + K      +E      ++ K++        
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENKF 82

Query: 75  NLVRLLGCSLQKGERLLVYEYL-PNKSLDFFIFDSSKKELLDWKKRFN-----------I 122
             V +       G   + +E L  N                ++ K  N           +
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGKN--------------TFEFLKENNFQPYPLPHVRHM 128

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-------------------KISD 163
              +   L +LH+    ++ H DLK  NIL  +                       +++D
Sbjct: 129 AYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
           FG A TF   + E +T  +   H Y  PE ++    +   DV+S G ++ E
Sbjct: 186 FGSA-TF---DHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFE 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.4 bits (103), Expect = 6e-05
 Identities = 47/231 (20%), Positives = 82/231 (35%), Gaps = 68/231 (29%)

Query: 26  LGQGGFGPVYKGK--LLDGQEIAIK---RLSKSSGQGIVEFKNEAKLIAKLQH------T 74
           LG+G FG V +       G+ +A+K    + +       E     +++  L         
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNSTF 77

Query: 75  NLVRLLGCSLQKGERLLVYEYL-PNKSLDFFIFDSSKKELLDWKKRFN-----------I 122
             V++L      G   +V+E L  +                D+ K              +
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGLS--------------TYDFIKENGFLPFRLDHIRKM 123

Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-------------------KISD 163
              I + + +LH     ++ H DLK  NIL                          K+ D
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
           FG A T+  +E   + + +V T  Y +PE ++    S   DV+S G +++E
Sbjct: 181 FGSA-TY-DDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 39/220 (17%), Positives = 83/220 (37%), Gaps = 29/220 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-------FKNEAKLIAK 70
               P + +G+G    + +   LD   I  +R+ K      ++          EA+ +A 
Sbjct: 336 KRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLAL 395

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           ++   +       +    + ++  Y+  K           K++++     +I   I + +
Sbjct: 396 VKDFGIPAPYIFDVDLDNKRIMMSYINGKLA---------KDVIE--DNLDIAYKIGEIV 444

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGT 185
             LH   +  VIH DL  SN + D  +   I DFG+ +   ++E     L      ++ T
Sbjct: 445 GKLH---KNDVIHNDLTTSNFIFDKDL--YIIDFGLGKISNLDEDKAVDLIVFKKAVLST 499

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
           H +   + +    +     VY    ++LE++   +    Y
Sbjct: 500 H-HEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	340
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.21
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.88
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.65
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.44
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.06
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.06
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.99
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.78
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.75
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.74
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.65
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.63
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.59
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.33
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.07
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.57
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.69
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.86
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.73
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.36

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.9e-61  Score=419.59  Aligned_cols=261  Identities=25%  Similarity=0.416  Sum_probs=218.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|.+.+.||+|+||.||+|++.      ++..||||+++.......+.|.+|+.++++++|||||++++++.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999864      367899999987776677889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccC----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           92 VYEYLPNKSLDFFIFDSS----------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      |||||++|+|.+++....          ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          2345999999999999999999999999   999999999999999999999


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      +|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |+.||...+..+....+      
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i------  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI------  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence            99999987654443334445678999999999999999999999999999999998 89999765443321111      


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                       ..+.         ....|..++.++.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus       244 -~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 -TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence             1111         1223445567899999999999999999999999999876443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.7e-60  Score=418.85  Aligned_cols=261  Identities=25%  Similarity=0.400  Sum_probs=210.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|.+.++||+|+||.||+|++.      +++.||||+++.......+.|.+|+.++++++|||||++++++.+...+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677788999999999999864      367899999987776777889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCc------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCe
Q 041345           92 VYEYLPNKSLDFFIFDSSK------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP  159 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~  159 (340)
                      |||||++|+|.+++.....            ..++++..++.++.|++.||+|||+++   |+||||||+|||++.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999965322            245899999999999999999999999   9999999999999999999


Q ss_pred             eEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 041345          160 KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  238 (340)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+    
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i----  273 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI----  273 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence            9999999987654443344445678999999999999999999999999999999999 89999765443321111    


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                         ..+         .+...|..++.++.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus       274 ---~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          274 ---TQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ---HHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---HcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence               111         12233445567899999999999999999999999999886543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-59  Score=412.05  Aligned_cols=258  Identities=29%  Similarity=0.444  Sum_probs=214.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .++++.++||+|+||.||+|++.      +++.||||+++.. .....+.|.+|+.++++++|||||+++|++.+.+.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45667889999999999999863      3678999999654 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           91 LVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      +|||||++|+|.+++.....             ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999964321             245899999999999999999999999   99999999999999999


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHH
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~  236 (340)
                      .+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |..||......+....   
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~---  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM---  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH---
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence            999999999987654444444455678999999999999999999999999999999998 8899976554332111   


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          ...+         ...+.|..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       260 ----i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 ----IRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----HHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                1111         12234455677899999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-59  Score=407.54  Aligned_cols=264  Identities=24%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      +++++.++||+|+||+||+|++.  ..||||+++..  .....+.|.+|+.++++++|||||++++++.+ +.++|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            57788899999999999999874  36999998643  34456789999999999999999999998764 568999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      |++|+|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999999643  345999999999999999999999998   99999999999999999999999999987654333


Q ss_pred             ccccccccccCCCCChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ........||+.|+|||++.+   +.|+.++|||||||++|||+||+.||...+.....      ......+...     
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~~~~-----  256 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRGYAS-----  256 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTTCCC-----
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCCC-----
Confidence            333445689999999999864   46899999999999999999999999754433211      1111111100     


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT  300 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  300 (340)
                      ......+..++..+.+|+.+||+.||++|||+.+|++.|+.+..++|.
T Consensus       257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            001123345567899999999999999999999999999877666654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-58  Score=409.58  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=204.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++++.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.++++++|||||++++++.+.+.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999875 4899999998654  34456778999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ||++|+|.+++... ....+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++.+... 
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            99999999999643 3345799999999999999999999999   999999999999999999999999999876422 


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....      ... +..        
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i~~-~~~--------  242 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK------IIS-GSF--------  242 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHH-TCC--------
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH------HHc-CCC--------
Confidence             1223346799999999999999999999999999999999999999976544332211      111 111        


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ...+...+.++.+||.+||+.||++|||+.|+++
T Consensus       243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1122344567899999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.6e-59  Score=405.02  Aligned_cols=248  Identities=25%  Similarity=0.330  Sum_probs=210.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++++.||+|+||+||+|++. +++.||+|++.+.   .......+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999865 4899999999643   2334667899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |||++|+|.+++..   .+.+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999954   345999999999999999999999999   999999999999999999999999999987544


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .........+||+.|+|||++.+..|+.++||||+||++|+|++|..||...+..+....+      .. ..        
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~~-~~--------  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI------IK-LE--------  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-TC--------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-CC--------
Confidence            4444455678999999999999999999999999999999999999999765443322111      11 11        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVA  288 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  288 (340)
                        ...+...+.++.+|+.+||+.||++|||+.|++
T Consensus       251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence              112233456788999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-58  Score=406.63  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=209.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+++.++|||||++++++.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999875 48999999996554444556889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++.+....  
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            99999999853    34999999999999999999999999   9999999999999999999999999998764322  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+       ......       ..
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~~~~-------~~  290 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP-------RL  290 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSSCC-------CC
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcCCCC-------CC
Confidence            2234568999999999999999999999999999999999999999765443322111       111100       11


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            122344577899999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8e-58  Score=403.19  Aligned_cols=252  Identities=22%  Similarity=0.252  Sum_probs=206.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +.|++.++||+|+||.||+|++. +|+.||||+++....     ..+|+.+++.++|||||++++++.+++.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777889999999999999875 489999999965432     246999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEecccccccccCccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFGMNEL  175 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~~~~~~  175 (340)
                      ++|+|.+++..   .+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++ ++||+|||+++.+.....
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999954   345999999999999999999999999   99999999999999887 699999999987654322


Q ss_pred             c---cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          176 E---ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       176 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .   ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+.      .....      
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~~------  274 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPPP------  274 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCCG------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCCC------
Confidence            1   12234579999999999999999999999999999999999999997655544322221      11100      


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                        ....++..+..+.+++.+||+.||++|||+.|+++.|...
T Consensus       275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence              0122344567789999999999999999999999888653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.4e-57  Score=408.04  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=209.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999875 48999999997655555567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++..+....  
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--  301 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  301 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence            99999999843    34999999999999999999999999   9999999999999999999999999998764322  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+      . .....       ..
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~-~~~~~-------~~  367 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------R-DNLPP-------RL  367 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-HSCCC-------CC
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-cCCCC-------CC
Confidence            2234568999999999999999999999999999999999999999765443322111      1 11100       01


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            112334567899999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.7e-57  Score=387.18  Aligned_cols=245  Identities=21%  Similarity=0.347  Sum_probs=191.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||+||+|++. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999864 5899999998654   2334567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||| +|+|.+++..   .+.+++..+..++.||+.||+|||++|   |+||||||+|||++.++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6788888854   345999999999999999999999999   999999999999999999999999999875432


Q ss_pred             ccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .   ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+       ..+.       
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i-------~~~~-------  228 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-------SNGV-------  228 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTC-------
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCC-------
Confidence            2   2334679999999999988776 57999999999999999999999754433221111       1111       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       229 ---~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 ---YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               1122334567889999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5e-57  Score=402.60  Aligned_cols=261  Identities=25%  Similarity=0.401  Sum_probs=213.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCC-CceeeeeeEEeeC-
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQH-TNLVRLLGCSLQK-   86 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-   86 (340)
                      -.++|++.+.||+|+||.||+|++.+      ++.||||.+.... ......+.+|+.++.++.| ||||+++++|... 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            34789999999999999999998643      3579999996553 3345678999999999965 8999999998664 


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ..+++|||||++|+|.+++.....             ...+++..+..++.||+.||+|||+++   |+||||||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence            568999999999999999965322             245899999999999999999999999   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      ++++.+||+|||+|+.+.............||+.|+|||++.+..|+.++|||||||++|||+| |..||......... 
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~-  297 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-  297 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence            9999999999999987654443334455678999999999999999999999999999999998 89999765433211 


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                           ......         ..+...|..++.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       298 -----~~~i~~---------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          298 -----CRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             -----HHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHc---------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                 111111         122333445567899999999999999999999999999865

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-56  Score=386.97  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=196.5

Q ss_pred             CCCCcccccCCeeEEEEEECC-CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee----CCeeEEEE
Q 041345           21 SPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGERLLVY   93 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~iv~   93 (340)
                      ++.++||+|+||.||+|.+.. +..||+|.+...  .....+.+.+|+.++++++|||||++++++.+    ...+++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            667789999999999998754 889999998543  34456678999999999999999999999865    34589999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~~~~  172 (340)
                      |||++|+|.+++..   ...+++..+..++.||+.||+|||+++ .+|+||||||+|||+++ ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   345999999999999999999999874 35999999999999984 78999999999986432


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                          ......+||+.|+|||++.+ .|+.++|||||||++|+|+||..||........      .......+.....   
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~~---  250 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPAS---  250 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGG---
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCCC---
Confidence                22344679999999998865 699999999999999999999999964333221      1111111111110   


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                           .+...++++.+|+.+||+.||++|||+.|+++
T Consensus       251 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11122356889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.1e-57  Score=394.03  Aligned_cols=247  Identities=24%  Similarity=0.321  Sum_probs=198.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|++.+.||+|+||+||+|+..    .++.||+|++....  ......+.+|+.++++++||||+++++++.+.+.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999763    36789999986542  2233467889999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |||||++|+|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+|||++.++++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   345999999999999999999999999   9999999999999999999999999998653


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ...  ......+||+.|+|||++.+..|+.++||||+||++|+|++|..||...+..+....+      .. ..      
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~-~~------  242 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LK-AK------  242 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CC------
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------Hc-CC------
Confidence            322  2234467999999999999999999999999999999999999999765544322211      11 11      


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM-----SDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  289 (340)
                          ...|...+.++.+|+.+||+.||++|||+     +|+++
T Consensus       243 ----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 ----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                11233445678999999999999999995     56664

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.3e-56  Score=392.34  Aligned_cols=264  Identities=22%  Similarity=0.286  Sum_probs=200.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC----eeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG----ERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~iv   92 (340)
                      .++|.+.++||+|+||.||+|++ +|+.||||++...... ......|+..+.+++||||+++++++...+    .+++|
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            45788889999999999999988 6899999999654322 223345666667789999999999987653    57999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS-----RLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ||||++|+|.+++..    ..+++..+.+++.|++.||+|||++.     ..+|+||||||+|||++.++++||+|||++
T Consensus        80 ~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999953    34899999999999999999999871     123999999999999999999999999999


Q ss_pred             ccccCcccc--cccccccccCCCCChhhhccC------CCCccCceehhhHHHHHHHhCCCCCCCCCcccccc-------
Q 041345          168 RTFGMNELE--ANTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-------  232 (340)
Q Consensus       168 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~-------  232 (340)
                      +........  .......||+.|+|||++.+.      .++.++|||||||++|||+||..||+.....+...       
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            876543222  122345799999999998654      36789999999999999999988875544332110       


Q ss_pred             -hhHHHHHHhhcCcccccccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          233 -LVGYAWQLWNEGKALELIDTTLHESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                       ..........        ...++...     +.+....+.+|+.+||+.||++|||+.||++.|+++
T Consensus       236 ~~~~~~~~~~~--------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          236 PSVEEMRKVVC--------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHT--------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHh--------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence             0111111111        11111222     235667899999999999999999999999999865

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.8e-55  Score=381.75  Aligned_cols=251  Identities=25%  Similarity=0.338  Sum_probs=190.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC--------
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG--------   87 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------   87 (340)
                      ++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999875 58999999986543 334567899999999999999999999987544        


Q ss_pred             ----eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEec
Q 041345           88 ----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD  163 (340)
Q Consensus        88 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~D  163 (340)
                          .+|+|||||++|+|.+++.........+...+..++.|++.||+|||++|   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976544445677788999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCcccc----------cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccch
Q 041345          164 FGMARTFGMNELE----------ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNL  233 (340)
Q Consensus       164 fg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~  233 (340)
                      ||+|+.+......          ...+..+||+.|+|||++.+..|+.++|||||||++|||++   ||....  +   .
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~---~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E---R  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H---H
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H---H
Confidence            9999876543221          11234579999999999999999999999999999999996   664211  0   0


Q ss_pred             hHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ... ..........         .......+.+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~-~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VRT-LTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH-HHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH-HHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000 0111111111         011233456778999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-53  Score=382.01  Aligned_cols=266  Identities=20%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee------CC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ------KG   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   87 (340)
                      .++|++++.||+|+||+||+|++. +|+.||||++...  .......+.+|+.+|+.++||||+++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999875 5899999999654  23345678899999999999999999998764      35


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .+|+|||||+ |+|.+++.   ..+.+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            6899999996 67888884   3456999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCccc--ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          168 RTFGMNEL--EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       168 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      +.+.....  .......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+..........
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            87643322  2233456899999999998775 56999999999999999999999998766554433332111000000


Q ss_pred             cccc--------ccccc-ccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALE--------LIDTT-LHESCS-----PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~--------~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+..        .+... .....+     +..+.++.+|+.+||+.||++|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000        00000 000011     123467889999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-51  Score=365.91  Aligned_cols=285  Identities=34%  Similarity=0.594  Sum_probs=243.3

Q ss_pred             cccHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC
Q 041345            7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK   86 (340)
Q Consensus         7 ~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (340)
                      .+++.++....++|++.+.||+|+||.||+|++.+++.||+|.+..........+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34555666678999999999999999999999888999999998776666677899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      +..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999854322 235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ++................|++.|+|||.+.+..++.++||||||+++|+|++|+.||.............+.......+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            99865433322333445689999999999999999999999999999999999999987766665555555555555566


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ....++.......++..+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            6666666666777888999999999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.3e-52  Score=372.41  Aligned_cols=204  Identities=21%  Similarity=0.380  Sum_probs=173.2

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEe
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSL   84 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   84 (340)
                      |+.+....++|++.+.||+|+||+||+|+..    .++.||+|.+....  ....+.+|+.+++.+ .||||+++++++.
T Consensus        13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            4556667899999999999999999999753    36789999885543  344678899999988 6999999999999


Q ss_pred             eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEec
Q 041345           85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISD  163 (340)
Q Consensus        85 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~D  163 (340)
                      +.+.+|+|||||++++|.+++.      .+++..+..++.|++.||+|||++|   |+||||||+|||++.+ +.+||+|
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            9999999999999999999982      3899999999999999999999999   9999999999999876 7899999


Q ss_pred             ccccccccCcccc--------------------------cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHH
Q 041345          164 FGMARTFGMNELE--------------------------ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEII  216 (340)
Q Consensus       164 fg~~~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~ell  216 (340)
                      ||+|+........                          ......+||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            9999765432111                          111234699999999999775 5899999999999999999


Q ss_pred             hCCCCCCC
Q 041345          217 SSKKNNGC  224 (340)
Q Consensus       217 tg~~p~~~  224 (340)
                      +|+.||..
T Consensus       242 ~G~~Pf~~  249 (361)
T 4f9c_A          242 SGRYPFYK  249 (361)
T ss_dssp             HTCSSSSC
T ss_pred             HCCCCCCC
Confidence            99999943

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.2e-51  Score=385.87  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=210.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+..........+.+|+.+|+.++||||+++++++.+...+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            478999999999999999999875 4899999999776666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC--CCeeEecccccccccCc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKISDFGMARTFGMN  173 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~--~~~~l~Dfg~~~~~~~~  173 (340)
                      |++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999999988532  345899999999999999999999999   9999999999999854  78999999999876533


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .   .....+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+..+....+      . ....      .
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~-~~~~------~  374 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------K-SCDW------N  374 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-TTCC------C
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-hCCC------C
Confidence            2   223457999999999999999999999999999999999999999765544322211      1 1100      0


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      +........+..+.+||.+||+.||.+|||+.|+++
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001111233567889999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-50  Score=358.96  Aligned_cols=287  Identities=39%  Similarity=0.670  Sum_probs=238.2

Q ss_pred             ccccccHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeE
Q 041345            4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGC   82 (340)
Q Consensus         4 ~~~~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~   82 (340)
                      +++.|++.++....++|++.+.||+|+||.||+|+..+++.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            5678999999999999999999999999999999887899999999865432 223368899999999999999999999


Q ss_pred             EeeCCeeEEEEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCCCCCeEeCCCCC
Q 041345           83 SLQKGERLLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKY---SRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        83 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                      +......++||||+++++|.+++.... ....+++..+..++.|++.||+|||++   +   ++|+||||+||+++.++.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence            999999999999999999999997643 234589999999999999999999999   7   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcc--cccchhHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE--RHLNLVGY  236 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~--~~~~~~~~  236 (340)
                      ++|+|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......  .......+
T Consensus       173 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             EEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             EEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999987643322 2233345899999999998889999999999999999999999999532211  11122223


Q ss_pred             HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          237 AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..............+.......+...+..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            3333334455555666666777888999999999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-50  Score=382.77  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=200.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHH---HHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEF---KNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ++|++++.||+|+||.||+|+.. +|+.||+|++.+..   .......   ..++.+++.++||||+++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999875 48999999985431   1122223   33456677789999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|||||+||+|.+++..   .+.+++..+..++.||+.||+|||++|   |+||||||+|||++.+|++||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999954   345999999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ...    .....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|..||.............   .....      
T Consensus       343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~------  409 (689)
T 3v5w_A          343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTM------  409 (689)
T ss_dssp             SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHC------
T ss_pred             CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCC------
Confidence            432    2334689999999999964 579999999999999999999999996544433221111   11111      


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                           ....+...+.++.+||.+||+.||.+|++     +++|++
T Consensus       410 -----~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -----CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                 11223445677899999999999999998     577764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-49  Score=349.79  Aligned_cols=265  Identities=25%  Similarity=0.420  Sum_probs=207.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.+.||+|+||.||+|+. .++.||+|++....  ......+.+|+.++++++||||+++++++.+....++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            347899999999999999999987 68899999986543  344567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++........+++..++.++.|++.||+|||++| .+++||||||+||+++.++.++|+|||++......
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999976544455999999999999999999999974 34999999999999999999999999999754322


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                        ........||+.|+|||.+.+..++.++||||||+++|+|++|..||......+.....      ....         
T Consensus       193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~------~~~~---------  255 (309)
T 3p86_A          193 --FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV------GFKC---------  255 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------HHSC---------
T ss_pred             --ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcC---------
Confidence              12233456899999999999999999999999999999999999999765433221111      0011         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                      .....+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            1122334455678999999999999999999999999998765443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.8e-48  Score=339.51  Aligned_cols=285  Identities=35%  Similarity=0.551  Sum_probs=231.7

Q ss_pred             ccccccHHHHHHHhcCCCCC------CcccccCCeeEEEEEECCCCEEEEEEccCC----ChhcHHHHHHHHHHHHcCCC
Q 041345            4 DLKIFDFQTIAAATDNFSPG------NRLGQGGFGPVYKGKLLDGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQH   73 (340)
Q Consensus         4 ~~~~~~~~~i~~~~~~y~~~------~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h   73 (340)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||+|++...    .......+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            46789999999999998877      8999999999999987 6889999998543    23345678899999999999


Q ss_pred             CceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        74 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      |||+++++++.+....++||||+++++|.+++........+++..+..++.|++.||.|||++|   ++|+||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999998999999999999999999876545556999999999999999999999999   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccch
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNL  233 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~  233 (340)
                      +.++.++|+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            9999999999999987654332223334568999999998764 588999999999999999999999976655443322


Q ss_pred             hHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      +..... .........++..+ ...+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       246 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIE-DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHH-TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhh-hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            211100 01112222222222 3456778889999999999999999999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.2e-48  Score=341.82  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=208.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            47899999999999999999986 45889999998665555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++..    ..+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999853    24899999999999999999999999   99999999999999999999999999887543222


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                        ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+.......      ......        ..
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~~--------~~  235 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT--------PE  235 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHCS--------CC
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC--------CC
Confidence              23345689999999999999999999999999999999999999965443321111      111110        01


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1122345567899999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=344.67  Aligned_cols=262  Identities=24%  Similarity=0.422  Sum_probs=214.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            468899999999999999999875 4889999998777777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++........
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999653  345899999999999999999999999   99999999999999999999999999987643322


Q ss_pred             cc------------ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 041345          176 EA------------NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       176 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      ..            ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..............       
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-------  236 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-------  236 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-------
Confidence            11            11135689999999999999999999999999999999999999865444322111100       


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                             ........+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       237 -------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          237 -------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             -------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                   00011112233445688999999999999999999999999876443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-48  Score=353.06  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=213.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC--------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      .++|++.+.||+|+||.||+|++.        ++..||+|++.... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367899999999999999999752        24569999996553 34466789999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ...++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+++   |+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999965431             234889999999999999999999999   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      +.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987654433333344556788999999999999999999999999999999 999997654433211


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .       ...+         .....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       317 ~-------~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          317 L-------LKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             H-------HHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-------HhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1       1111         11223344567799999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.4e-48  Score=344.89  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++...  .......+.+|+.+++.++||||+++++++......++
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            3457899999999999999999987 46899999998543  34456678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...   +.+++..+..++.|++.||+|||++|   ++||||||+||+++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999998543   45899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccCCCCChhhhccCCCC-ccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVS-MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ...   ......||+.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+      . .+.     
T Consensus       166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~-~~~-----  230 (328)
T 3fe3_A          166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------L-RGK-----  230 (328)
T ss_dssp             SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HCC-----
T ss_pred             CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCC-----
Confidence            322   23445789999999999887765 7999999999999999999999765433321111      1 110     


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           ...+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       231 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 -----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 11223345678899999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.6e-49  Score=348.06  Aligned_cols=266  Identities=22%  Similarity=0.326  Sum_probs=208.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC----eeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG----ERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|++ .++.||||++.... .......+|+.++++++||||+++++++....    .+++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            46899999999999999999987 47899999996543 33445567888899999999999999988754    37999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC----------CCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY----------SRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                      |||+++++|.+++..    ..+++..+..++.|++.||+|||+.          +   ++||||||+||+++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999953    3489999999999999999999998          8   9999999999999999999999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccC-----CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH-
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-----IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY-  236 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~-  236 (340)
                      |||++................||+.|+|||++.+.     .++.++|||||||++|+|++|..||.............. 
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876544433334446789999999998763     566789999999999999999999976544332221110 


Q ss_pred             --------HHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          237 --------AWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       237 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                              .............+..   .......+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    0111111110000000   001234567799999999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-48  Score=354.06  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=210.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999886 58899999986543 3334567899999999999999999999998889999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......
T Consensus       193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999998642  335899999999999999999999999   9999999999999999999999999998654332


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .........++..|+|||.+.++.++.++||||||+++|+|++ |..||......+..       .....         .
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~---------~  331 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEK---------G  331 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHT---------T
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHc---------C
Confidence            2222222345778999999998999999999999999999998 89998765433211       11111         1


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .+...+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            12223344556789999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.9e-47  Score=338.28  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=215.5

Q ss_pred             ccccHHHHHHHhcC----------CCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCC
Q 041345            6 KIFDFQTIAAATDN----------FSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT   74 (340)
Q Consensus         6 ~~~~~~~i~~~~~~----------y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~   74 (340)
                      ..|+++++..+.+.          |...+.||+|+||.||+|+.. +|+.||||++..........+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            57889999988865          777789999999999999876 5899999999766656677889999999999999


Q ss_pred             ceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC
Q 041345           75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        75 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~  154 (340)
                      ||+++++++...+..++||||+++++|.+++..    ..+++..+..++.|++.||.|||++|   ++||||||+||+++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999999842    34899999999999999999999999   99999999999999


Q ss_pred             CCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchh
Q 041345          155 DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV  234 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~  234 (340)
                      .++.++|+|||++.......  .......||+.|+|||.+.+..++.++||||||+++|+|++|..||..........  
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~--  251 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK--  251 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--
T ss_pred             CCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence            99999999999988754321  12234568999999999999999999999999999999999999996543322111  


Q ss_pred             HHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          . ........       ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       252 ----~-~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          252 ----R-LRDSPPPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ----H-HHHSSCCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----H-HhcCCCCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1 11111000       0111234567889999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-48  Score=351.76  Aligned_cols=265  Identities=25%  Similarity=0.391  Sum_probs=216.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC--------CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL--------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      .++|.+.+.||+|+||.||+|++.        .+..||+|++... .......+.+|+.+++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467899999999999999999752        2357999998655 334457788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      +..++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+++   |+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999965432             235899999999999999999999999   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      +.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......+.. 
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~-  303 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-  303 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence            9999999999999987654433333444567889999999999999999999999999999999 99998654433211 


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT  300 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  300 (340)
                            .....+         .....+...+..+.+++.+||+.||++|||+.+|++.|+.+....+.
T Consensus       304 ------~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          304 ------KLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             ------HHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             ------HHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                  111111         11222334456789999999999999999999999999886544433

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=344.06  Aligned_cols=258  Identities=25%  Similarity=0.378  Sum_probs=209.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|++.+.||+|+||.||+|++.    .+..||||.+... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56888999999999999999874    2445999999654 344556789999999999999999999999998899999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++.....
T Consensus       129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999998543  335899999999999999999999999   99999999999999999999999999987654


Q ss_pred             cccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          173 NELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       173 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+       ..       
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~-------  269 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-------EE-------  269 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HT-------
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------Hc-------
Confidence            3221 12223345778999999998999999999999999999999 99999654433221111       11       


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                        ......+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       270 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          270 --GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              11122334456779999999999999999999999999987644

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-47  Score=331.28  Aligned_cols=257  Identities=25%  Similarity=0.340  Sum_probs=212.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||+|+||.||+|++.++..||+|++.... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            57899999999999999999999888899999996543 33567899999999999999999999999988999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998643  335899999999999999999999999   999999999999999999999999999876543222


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........       ...+.         .
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~---------~  223 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-------VSQGH---------R  223 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTTC---------C
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-------HHcCC---------C
Confidence             2223445678999999998899999999999999999999 9999965443322111       11111         1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      ...+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            11122334678899999999999999999999999998654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.5e-48  Score=332.99  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=211.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++.... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            36789999999999999999999888999999996543 33467899999999999999999999999998999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++...  ...+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            999999998543  345899999999999999999999999   99999999999999999999999999987543221 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...........       ....         ..
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~-------~~~~---------~~  225 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------ISTG---------FR  225 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTT---------CC
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------HhcC---------cc
Confidence            22233456778999999998999999999999999999999 8999975443321111       1111         11


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            122233456789999999999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.1e-48  Score=343.37  Aligned_cols=265  Identities=28%  Similarity=0.414  Sum_probs=216.5

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEE
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCS   83 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (340)
                      ..+....++|.+.+.||+|+||.||+|..      .+++.||+|.+... .......+.+|+.+++.++||||+++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            33444568899999999999999999975      23578999999654 344567789999999999999999999999


Q ss_pred             eeCCeeEEEEeccCCCChhhHhhccCc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 041345           84 LQKGERLLVYEYLPNKSLDFFIFDSSK---------------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI  142 (340)
Q Consensus        84 ~~~~~~~iv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~  142 (340)
                      .+....++||||+++++|.+++.....                     ...+++..++.++.|++.||.|||+++   ++
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv  172 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV  172 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence            999999999999999999999975432                     234899999999999999999999999   99


Q ss_pred             ecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCC
Q 041345          143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKN  221 (340)
Q Consensus       143 H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p  221 (340)
                      |+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987654333333344556788999999999999999999999999999999 9999


Q ss_pred             CCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          222 NGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      |...........+       ..+.         ....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       253 ~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          253 YPGIPPERLFNLL-------KTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             STTCCGGGHHHHH-------HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHh-------hcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            9765543322111       1111         1122334557789999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-47  Score=340.57  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999875 588999999854432 234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++.   ....+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999984   3345999999999999999999999999   9999999999999999999999999998765433


Q ss_pred             cccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........      ...+....        
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~--------  225 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKK--------  225 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTC--------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhccc--------
Confidence            3333445678999999999987765 78999999999999999999999654433211      01111110        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0011113345678899999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.9e-49  Score=345.11  Aligned_cols=269  Identities=25%  Similarity=0.379  Sum_probs=209.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--Ce
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   88 (340)
                      ..++|++.+.||+|+||.||+|+.     .+++.||+|++..........+.+|+.+++.++||||+++++++...  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            357899999999999999999974     24788999999877766677899999999999999999999988543  45


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            89999999999999999653  234899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC---
Q 041345          169 TFGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG---  244 (340)
Q Consensus       169 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  244 (340)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+.......        .......   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~  234 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--------MRMIGNDKQG  234 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--------HHHHCTTCCT
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH--------HhhhcCcccc
Confidence            76433221 12223446778999999999999999999999999999999999885422110        0000000   


Q ss_pred             -----cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          245 -----KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       245 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                           ...+.+........+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                 00011111222333455567899999999999999999999999999876443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=332.76  Aligned_cols=273  Identities=21%  Similarity=0.245  Sum_probs=215.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC--eeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG--ERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            4789999999999999999998765 8899999986543 234567789999999999999999999987665  67999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe----CCCCCeeEecccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMAR  168 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv----~~~~~~~l~Dfg~~~  168 (340)
                      |||+++++|.+++........+++..+..++.|++.||+|||+++   |+||||||+||++    +.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976544445999999999999999999999999   9999999999999    777789999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhc--------cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccc-hhHHHHH
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVM--------NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-LVGYAWQ  239 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~-~~~~~~~  239 (340)
                      ......   ......|++.|+|||++.        +..++.++|||||||++|+|++|..||.......... .......
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            764332   222356899999999886        5778999999999999999999999996554433222 1111111


Q ss_pred             HhhcCcccccc-----------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          240 LWNEGKALELI-----------DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       240 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ......+....           ........+......+.+++.+||+.||++|||+.|+++..++..
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            11111110000           001112345778889999999999999999999999999988643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-47  Score=343.11  Aligned_cols=266  Identities=24%  Similarity=0.392  Sum_probs=215.2

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK   86 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (340)
                      ....++|++.+.||+|+||.||+|+..+      ++.||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3445889999999999999999998743      4789999997553 34456789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK---------------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD  145 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d  145 (340)
                      ...++||||+++++|.+++.....                     ...+++..++.++.|++.||.|||+++   ++|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            999999999999999999965321                     146899999999999999999999999   99999


Q ss_pred             CCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCC
Q 041345          146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGC  224 (340)
Q Consensus       146 lk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~  224 (340)
                      |||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987654333333334567889999999998999999999999999999999 9999965


Q ss_pred             CCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 041345          225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL  298 (340)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  298 (340)
                      .......       .....+..         ...+...+..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus       280 ~~~~~~~-------~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          280 MAHEEVI-------YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             SCHHHHH-------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CChHHHH-------HHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            4432211       11111111         1223344567899999999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.6e-47  Score=333.62  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=207.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|++. +++.||+|.+...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            478999999999999999999865 5889999988443   334456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++..   ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999854   345899999999999999999999999   99999999999999999999999999987643


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||........      ...... ......   
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~-~~~~~~---  232 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQ-DSVPNV---  232 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHS-SCCCCH---
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhh-ccCCCc---
Confidence            221 223345689999999999999999999999999999999999999965433221      111111 111100   


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhcCCCC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRP-TMSDVASMLTNDTMA  297 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~  297 (340)
                        ....+...+..+.+++.+||+.||++|| +++++.+.|+.....
T Consensus       233 --~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          233 --TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             --HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             --chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence              0111233456789999999999999998 999999999876543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.6e-47  Score=355.42  Aligned_cols=263  Identities=24%  Similarity=0.401  Sum_probs=215.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ...++|++.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+.+++.++||||+++++++. ....++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3456788899999999999999999888899999996543 45678999999999999999999999886 567899999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++|+|.+++... ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......
T Consensus       263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999999643 2235889999999999999999999999   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      . .......++..|+|||.+.++.++.++||||||+++|+|++ |..||......+....+                ...
T Consensus       339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----------------~~~  401 (454)
T 1qcf_A          339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----------------ERG  401 (454)
T ss_dssp             H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----------------HHT
T ss_pred             e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------HcC
Confidence            1 11223345778999999998999999999999999999999 99999754433221111                111


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT  300 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  300 (340)
                      .+...+..++..+.++|.+||+.||++|||+.+|++.|+++..+..+
T Consensus       402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~  448 (454)
T 1qcf_A          402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES  448 (454)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence            12223344567899999999999999999999999999998665443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-47  Score=341.80  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CC----EEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .++|++.+.||+|+||.||+|++.. ++    +||+|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            4679999999999999999998643 44    3588887543 3345677899999999999999999999998764 78


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|++++.+++|.+++...  ...+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            899999999999998653  345899999999999999999999999   999999999999999999999999999877


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+               
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---------------  232 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------------  232 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------------
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH---------------
Confidence            54443333344556889999999999999999999999999999999 99999765444322111               


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                       ........+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       233 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          233 -EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             -HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             111122233445667899999999999999999999999997643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=342.83  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=201.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|+... ++.||+|++...   .......+.+|..++..+ .||||+++++++.+....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            4789999999999999999998754 889999998643   223456678899999988 79999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|..++..   ...+++..+..++.||+.||+|||++|   |+||||||+||+++.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999854   345999999999999999999999999   9999999999999999999999999997543


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+      .. ..      
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~~------  240 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LN-DE------  240 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CC------
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-CC------
Confidence            22  12233467899999999999888999999999999999999999999765443322111      11 10      


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM------SDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~  289 (340)
                          ...+...+..+.+++.+||+.||++||++      .++++
T Consensus       241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                11223345678899999999999999999      66665

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.7e-47  Score=338.50  Aligned_cols=249  Identities=22%  Similarity=0.283  Sum_probs=206.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999875 4889999998543   223456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|..++..   ...+++..+..++.||+.||+|||++|   |+||||||+||+++.++.++|+|||++.....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999998853   345899999999999999999999999   99999999999999999999999999976432


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..  .......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+      .. ..       
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~-~~-------  221 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LM-EE-------  221 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CC-------
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH------Hc-CC-------
Confidence            21  2233467899999999999999999999999999999999999999654433211111      11 10       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~  290 (340)
                         ...+...+..+.+++.+||+.||++||     ++.++++.
T Consensus       222 ---~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               112233456789999999999999999     89998763

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=346.56  Aligned_cols=258  Identities=29%  Similarity=0.417  Sum_probs=209.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ++|++.+.||+|+||.||+|++.      +++.||||.+... .......+.+|+.++++++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            67889999999999999999843      3568999998654 3444567889999999999999999999999988999


Q ss_pred             EEEeccCCCChhhHhhccCc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC---CeeEec
Q 041345           91 LVYEYLPNKSLDFFIFDSSK----KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKISD  163 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~---~~~l~D  163 (340)
                      +||||+++++|.+++.....    ...+++..++.++.|++.||+|||++|   |+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999965421    235899999999999999999999999   99999999999999554   599999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhh
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      ||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........       ..
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-------i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-------VT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------HH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HH
Confidence            999986543333333344567889999999999999999999999999999998 9999975543322111       11


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .+.         ....+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus       301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111         1222334456789999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.2e-48  Score=347.43  Aligned_cols=270  Identities=25%  Similarity=0.396  Sum_probs=216.1

Q ss_pred             cccHHHHHHHhcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceee
Q 041345            7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVR   78 (340)
Q Consensus         7 ~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~   78 (340)
                      .+....+....++|++.+.||+|+||.||+|++      .+++.||+|++.... ......+.+|+.++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345566666779999999999999999999974      235789999996643 33456789999999999 7999999


Q ss_pred             eeeEEeeCCe-eEEEEeccCCCChhhHhhccCc-----------------------------------------------
Q 041345           79 LLGCSLQKGE-RLLVYEYLPNKSLDFFIFDSSK-----------------------------------------------  110 (340)
Q Consensus        79 ~~~~~~~~~~-~~iv~e~~~~~~L~~~l~~~~~-----------------------------------------------  110 (340)
                      +++++.+... .++||||+++++|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999887544 8999999999999999965432                                               


Q ss_pred             ----------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345          111 ----------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus       111 ----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                                      ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++.++|+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            122889999999999999999999999   9999999999999999999999999998764433


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........      ......+         
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~---------  312 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEG---------  312 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHT---------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcC---------
Confidence            3333444567889999999999999999999999999999998 99999654433211      1111111         


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11122333456789999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.9e-47  Score=338.60  Aligned_cols=262  Identities=23%  Similarity=0.398  Sum_probs=196.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCC----EEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQ----EIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      ..++|++.+.||+|+||.||+|++....    .||+|++...  .......+.+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            4578999999999999999999865432    7999998654  334567789999999999999999999998876554


Q ss_pred             ------EEEEeccCCCChhhHhhccCc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCee
Q 041345           90 ------LLVYEYLPNKSLDFFIFDSSK---KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK  160 (340)
Q Consensus        90 ------~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~  160 (340)
                            ++||||+++++|.+++.....   ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  999999999999999854322   125899999999999999999999999   99999999999999999999


Q ss_pred             EecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHH
Q 041345          161 ISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      |+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+     
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-----  252 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-----  252 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-----
Confidence            999999987654433333344556788999999999999999999999999999999 89999765544322111     


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                        ..+.         ....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       253 --~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          253 --IGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             --HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --hcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              1111         112233445678999999999999999999999999987543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-47  Score=341.44  Aligned_cols=252  Identities=23%  Similarity=0.313  Sum_probs=205.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh------hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++.....      .....+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4678999999999999999999875 488999999865422      135678999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC----CeeEecc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDF  164 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~----~~~l~Df  164 (340)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||++|   |+||||||+||+++.++    .++|+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999843   345999999999999999999999999   99999999999998776    7999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+       ...
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i-------~~~  233 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-------TAV  233 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HTT
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hhc
Confidence            9998764321   223456899999999999889999999999999999999999999765433321111       111


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ... + ...    .....+..+.+++.+||..||.+|||+.++++
T Consensus       234 ~~~-~-~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SYD-F-DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCC-C-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCC-C-Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000 0 000    00123456889999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.7e-47  Score=331.69  Aligned_cols=256  Identities=27%  Similarity=0.397  Sum_probs=208.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..++|++.+.||+|+||.||+|++.++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            346788899999999999999999888899999996543 2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++........
T Consensus       101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999998642  345899999999999999999999999   99999999999999999999999999987643321


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+       ...         .
T Consensus       176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------~~~---------~  238 (283)
T 3gen_A          176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQG---------L  238 (283)
T ss_dssp             -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HTT---------C
T ss_pred             -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-------hcc---------c
Confidence             12223446778999999998899999999999999999998 99999765443221111       111         1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ....+...+..+.+++.+||+.||++|||+.++++.|.++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1122233356788999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.4e-47  Score=335.69  Aligned_cols=266  Identities=23%  Similarity=0.298  Sum_probs=203.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.+.||+|+||.||+|++.+++.||+|++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999999889999999986442  223457889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++ +|.+.+...  ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||++......
T Consensus        99 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99975 677766432  345899999999999999999999999   999999999999999999999999999876432


Q ss_pred             ccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc--
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI--  250 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  250 (340)
                      .  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+....  
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            1  22233467999999999876 568999999999999999999999997766554332221111000001111000  


Q ss_pred             -----------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 -----------DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 -----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                 .........+..+.++.+|+.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                       000000001223457889999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-47  Score=343.04  Aligned_cols=265  Identities=25%  Similarity=0.396  Sum_probs=211.1

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   87 (340)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++++ .||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3478999999999999999999852      35579999986542 33456788999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCcc--------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKK--------------------ELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK  147 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk  147 (340)
                      ..++||||+++++|.+++......                    ..+++..++.++.|++.||+|||++|   ++|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999654321                    34789999999999999999999999   9999999


Q ss_pred             CCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCC
Q 041345          148 ASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYD  226 (340)
Q Consensus       148 ~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~  226 (340)
                      |+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654333333334557889999999999999999999999999999998 999996654


Q ss_pred             cccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 041345          227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL  298 (340)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  298 (340)
                      .....      ......+         .....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       280 ~~~~~------~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDANF------YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSHHH------HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHHHH------HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            33211      1111111         112223344677999999999999999999999999999865543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.5e-47  Score=353.88  Aligned_cols=266  Identities=26%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..++|++.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            346788899999999999999999888889999996543 345678999999999999999999999876 668999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++... ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999542 2234899999999999999999999999   99999999999999999999999999987643221


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       .......++..|+|||.+.++.++.++||||||+++|+|++ |..||......+...       ...         ...
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~---------~~~  398 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVE---------RGY  398 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHH---------TTC
T ss_pred             -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHH---------cCC
Confidence             12223446788999999999999999999999999999999 899986544332111       111         112


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP  304 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  304 (340)
                      +...+..++..+.+++.+||+.||++|||+.++++.|+.+....+++..+
T Consensus       399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~  448 (452)
T 1fmk_A          399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  448 (452)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence            22334556678999999999999999999999999999987766555443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.6e-47  Score=343.53  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=198.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|++.+.||+|+||.||+|+..    ++..||+|.+... .......+.+|+.++++++||||+++++++......++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999864    4677999999654 334456789999999999999999999999998899999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus       125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999643  335899999999999999999999999   99999999999999999999999999987653


Q ss_pred             ccccc-ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          173 NELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       173 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........       ..         
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~-------~i---------  263 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK-------AV---------  263 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH-------HH---------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HH---------
Confidence            32211 1222345678999999999999999999999999999998 999996544322111       11         


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ........+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       264 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            11112223344567799999999999999999999999999765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-46  Score=330.96  Aligned_cols=269  Identities=17%  Similarity=0.202  Sum_probs=213.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+|+..++.+ +|++++++++++......++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            357899999999999999999986 4588999999854432  23567899999999 7999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC-----eeEecccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-----PKISDFGMAR  168 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~-----~~l~Dfg~~~  168 (340)
                      ||+ +++|.+++...  ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.     ++|+|||++.
T Consensus        86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 99999999643  234899999999999999999999999   999999999999987765     9999999998


Q ss_pred             cccCcccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 041345          169 TFGMNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       169 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      ........     .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            76543221     1233456899999999999999999999999999999999999999775544332222221111111


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTP  301 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~  301 (340)
                      .....     .    ....+..+.+++.+||+.||++|||+.+|++.|+++...+...
T Consensus       240 ~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          240 TPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             SCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ccHHH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            11000     0    1123467899999999999999999999999999875554443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.7e-47  Score=327.89  Aligned_cols=254  Identities=28%  Similarity=0.403  Sum_probs=198.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC----hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|.+ .++.||+|++....    ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46899999999999999999987 58899999986542    23356788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC--------CCCeeEecc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD--------QMNPKISDF  164 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~--------~~~~~l~Df  164 (340)
                      |||+++++|.+++.    ...+++..+..++.|++.|++|||+++..+++|+||||+||+++.        ++.++|+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    335899999999999999999999987445889999999999985        678999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      |++.......    .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.........      ...... 
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~-  229 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGVAMN-  229 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHHTS-
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HhhhcC-
Confidence            9998654321    22346899999999999999999999999999999999999999654332211      111111 


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                              ......+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 --------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                    111222344456799999999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.2e-47  Score=339.18  Aligned_cols=271  Identities=25%  Similarity=0.397  Sum_probs=218.6

Q ss_pred             cccHHHHHHHhcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeee
Q 041345            7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRL   79 (340)
Q Consensus         7 ~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~   79 (340)
                      ++..+++....++|++.+.||+|+||.||+|.+.      .++.||+|.+.... ......+.+|+.+++.++||||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            4444555667789999999999999999999754      36789999986543 3345568899999999999999999


Q ss_pred             eeEEeeCCeeEEEEeccCCCChhhHhhccCc-------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeE
Q 041345           80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSK-------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL  152 (340)
Q Consensus        80 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nil  152 (340)
                      ++++.+....++||||+++++|.+++.....       ...+++..++.++.|++.||.|||++|   ++||||||+||+
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence            9999998899999999999999999864321       134789999999999999999999999   999999999999


Q ss_pred             eCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccccc
Q 041345          153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHL  231 (340)
Q Consensus       153 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~  231 (340)
                      ++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence            99999999999999987654333333334456888999999999999999999999999999999 88888654332211


Q ss_pred             chhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          232 NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                             .....+..         ...+...+..+.+++.+||+.||.+|||+.++++.|++...
T Consensus       251 -------~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 -------RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                   11111111         11223445678999999999999999999999999998644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-46  Score=336.14  Aligned_cols=261  Identities=18%  Similarity=0.191  Sum_probs=208.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.....  ...+.+|+.+++.+ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            57899999999999999999986 4588999999865432  23578899999999 89999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC-----eeEeccccccc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-----PKISDFGMART  169 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~-----~~l~Dfg~~~~  169 (340)
                      |+ +++|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.     ++|+|||++..
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998653  345999999999999999999999999   999999999999998876     99999999987


Q ss_pred             ccCccccc-----ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          170 FGMNELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       170 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      +.......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            64332211     1234678999999999999999999999999999999999999998765444332222211110000


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ..     ....    ...+ .+.+++.+||+.||.+||++.+|++.|+++.
T Consensus       240 ~~-----~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          240 PI-----EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             CH-----HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CH-----HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            00     0000    1122 7999999999999999999999999997643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=334.84  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=205.1

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh------hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.....      .....+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4567999999999999999999875 488999999854321      235678999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC----CeeEecc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDF  164 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~----~~~l~Df  164 (340)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++    .++|+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999999843   345899999999999999999999999   99999999999999877    7999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+      .. .
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------~~-~  232 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------SA-V  232 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HH-T
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------Hh-c
Confidence            9998764322   223356899999999999889999999999999999999999999654433211111      00 0


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .. .. ...    .....+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~-~~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          233 NY-EF-EDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CC-CC-CHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC-Cc-Ccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00 00 000    00123456889999999999999999999997

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.2e-47  Score=353.64  Aligned_cols=258  Identities=23%  Similarity=0.374  Sum_probs=214.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|.+.. +..||||.+.... .....+.+|+.++++++||||+++++++......++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4668888999999999999998765 7889999996543 3467899999999999999999999999998899999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++........
T Consensus       298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999996532 345899999999999999999999999   99999999999999999999999999987643222


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+                ....
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~----------------~~~~  436 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----------------EKDY  436 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----------------HTTC
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------HcCC
Confidence             12223445778999999998999999999999999999999 88998765443321111                1112


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      +...+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            223344556789999999999999999999999999998643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-46  Score=329.40  Aligned_cols=261  Identities=21%  Similarity=0.287  Sum_probs=200.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999875 48899999986442  3335678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |++++.+ +.+..  ....+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++...... 
T Consensus        82 ~~~~~l~-~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  154 (292)
T 3o0g_A           82 FCDQDLK-KYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-  154 (292)
T ss_dssp             CCSEEHH-HHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred             cCCCCHH-HHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence            9976544 44432  2345999999999999999999999999   999999999999999999999999999876432 


Q ss_pred             cccccccccccCCCCChhhhccCC-CCccCceehhhHHHHHHHhCCCCC-CCCCcccccchhHHHHHHhhcC---ccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSKKNN-GCYDTERHLNLVGYAWQLWNEG---KALEL  249 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~  249 (340)
                       ........+|+.|+|||++.+.. ++.++|||||||++|+|++|+.|| ...+....   ...........   .+...
T Consensus       155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTTTCTTG
T ss_pred             -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhhhhhh
Confidence             12233456799999999987765 899999999999999999988885 33222221   11111111111   11100


Q ss_pred             cc------------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 ID------------TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..            ........+..+..+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00            00001122345677889999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-46  Score=348.13  Aligned_cols=250  Identities=25%  Similarity=0.370  Sum_probs=207.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-eeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-ERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|.+ .++.||||++....  ....+.+|+.++++++||||+++++++.... ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            46788999999999999999988 47899999996543  4567899999999999999999999987665 78999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++.... ...++...+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++......  
T Consensus       269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            99999999996532 234789999999999999999999999   999999999999999999999999998754321  


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+       .         ...
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~---------~~~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------E---------KGY  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-------H---------TTC
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------H---------cCC
Confidence               122356789999999999999999999999999999998 99999765444321111       1         111


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      +...+..++..+.++|.+||+.||++|||+.++++.|+.+
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2233445567899999999999999999999999999865

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8e-47  Score=334.16  Aligned_cols=262  Identities=24%  Similarity=0.385  Sum_probs=213.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   87 (340)
                      ..++|++.+.||+|+||.||+|.+      .+++.||+|.+.... ......+.+|+.+++++ +||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            457899999999999999999974      236789999996553 33456789999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCc---------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeE
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSK---------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL  152 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nil  152 (340)
                      ..++||||+++++|.+++.....               ...+++..++.++.|++.||+|||+++   ++|+||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999865432               124899999999999999999999999   999999999999


Q ss_pred             eCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccccc
Q 041345          153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHL  231 (340)
Q Consensus       153 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~  231 (340)
                      ++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999999987654433333334556788999999999999999999999999999998 99998655433211


Q ss_pred             chhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          232 NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                            ......         ......+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       258 ------~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          258 ------YKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             ------HHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                  111111         1111222344567899999999999999999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=334.11  Aligned_cols=252  Identities=19%  Similarity=0.260  Sum_probs=205.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..++|++.+.||+|+||.||+|.... ++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            35789999999999999999998754 7889999986543 345668899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC--CCCeeEecccccccccC
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD--QMNPKISDFGMARTFGM  172 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~--~~~~~l~Dfg~~~~~~~  172 (340)
                      |+++++|.+++...  ...+++..+..++.|++.||.|||++|   ++||||||+||+++.  ++.++|+|||++..+..
T Consensus        82 ~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999998532  235899999999999999999999999   999999999999987  78999999999987643


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..   ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+      .. .... . ..
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~-~~~~-~-~~  224 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MN-AEYT-F-DE  224 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-TCCC-C-CH
T ss_pred             CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------Hc-CCCC-C-Ch
Confidence            22   223456899999999998888999999999999999999999999764433221111      11 1000 0 00


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .    ..+..+..+.+++.+||+.||.+|||+.++++
T Consensus       225 ~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 E----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             H----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0    00123567889999999999999999999997

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=345.19  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=206.1

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ....++|++.+.||+|+||.||+|... +++.+|+|++....  ......+.+|+.+++.++||||+++++++.+....+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            346788999999999999999999764 58889999986543  334567889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC---CCCCeeEeccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMA  167 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~---~~~~~~l~Dfg~~  167 (340)
                      +||||+++++|.+.+..   ...+++..+..++.|++.||.|||++|   |+||||||+||+++   .++.+||+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            99999999999998854   345999999999999999999999999   99999999999998   5678999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      .......  .......||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......+       ..+...
T Consensus       161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~~~  231 (444)
T 3soa_A          161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-------KAGAYD  231 (444)
T ss_dssp             BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHTCCC
T ss_pred             EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HhCCCC
Confidence            8764322  1223457899999999999889999999999999999999999999654433221111       111100


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                            .........+..+.+++.+||+.||++|||+.++++
T Consensus       232 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 ------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  001111234567889999999999999999999987

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-46  Score=338.41  Aligned_cols=254  Identities=23%  Similarity=0.264  Sum_probs=208.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            3478999999999999999999875 488999999977665556678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC--CCCCeeEecccccccccC
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD--DQMNPKISDFGMARTFGM  172 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~--~~~~~~l~Dfg~~~~~~~  172 (340)
                      |+++++|.+++...  ...+++..+..++.|++.||+|||++|   |+||||||+||+++  .++.++|+|||++.....
T Consensus       129 ~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          129 FLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999998532  235899999999999999999999999   99999999999997  456799999999987643


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+      . ....      
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i------~-~~~~------  267 (387)
T 1kob_A          204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------K-RCDW------  267 (387)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-HCCC------
T ss_pred             Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCCC------
Confidence            22   122346899999999999989999999999999999999999999765433211111      0 1100      


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..........+..+.+++.+||+.||++|||+.++++.
T Consensus       268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            01111223345678999999999999999999999873

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-46  Score=336.28  Aligned_cols=261  Identities=25%  Similarity=0.416  Sum_probs=212.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC--------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEee
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL--------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQ   85 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   85 (340)
                      ..++|++.+.||+|+||.||+|++.        ++..||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4578999999999999999999863        46789999996543 34566788999999999 89999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeE
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL  152 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nil  152 (340)
                      ....++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+++   ++|+||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999965432             234899999999999999999999999   999999999999


Q ss_pred             eCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCccccc
Q 041345          153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHL  231 (340)
Q Consensus       153 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~  231 (340)
                      ++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            99999999999999987654433333344456788999999988899999999999999999999 99998654433211


Q ss_pred             chhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          232 NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      .       ....+.         ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       270 ~-------~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          270 K-------LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             H-------HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H-------HHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1       111111         11223344567899999999999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.7e-47  Score=336.47  Aligned_cols=246  Identities=20%  Similarity=0.309  Sum_probs=202.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            37899999999999999999986 458899999985431   12245688999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+ +|+|.+++..   ...+++..+..++.|++.||.|||++|   ++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6788888754   345899999999999999999999999   99999999999999999999999999986543


Q ss_pred             cccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+                .
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----------------~  221 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----------------N  221 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------C
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------H
Confidence            22   2234568999999999987776 68999999999999999999999654333322111                0


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      . .....+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       222 ~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 S-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             S-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             c-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0 011223344567899999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.6e-47  Score=336.43  Aligned_cols=258  Identities=26%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCE----EEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQE----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .++|++.+.||+|+||.||+|++.. ++.    |++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            4789999999999999999998643 443    577777443 3345678899999999999999999999988764 78


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|++++.+++|.+++...  ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998653  335899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+               
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---------------  232 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------------  232 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------------
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---------------
Confidence            54433333334456788999999999999999999999999999999 99999765544322111               


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                       ........+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       233 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          233 -EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             1111122234455678999999999999999999999999987643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=329.68  Aligned_cols=267  Identities=25%  Similarity=0.393  Sum_probs=206.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||+|+||.||+|++ .++.||+|.+...  .....+.+|+.++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            36789999999999999999988 5788999998644  335678899999999999999999998763  479999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC-eeEecccccccccCccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-PKISDFGMARTFGMNEL  175 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~-~~l~Dfg~~~~~~~~~~  175 (340)
                      ++++|.+++........++...++.++.|++.||+|||+.+..+++||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976554455889999999999999999999932223999999999999998877 799999998764321  


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                         .....|++.|+|||.+.+..++.++||||||+++|+|++|..||........    ...+.. ..+..         
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~-~~~~~---------  222 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAV-HNGTR---------  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHH-HTTCC---------
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHH-hcCCC---------
Confidence               2234589999999999998999999999999999999999999965433211    111111 11111         


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCcee
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFF  307 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~  307 (340)
                      ...+...+..+.+++.+||+.||++|||+.++++.|+.+...++....|..+
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~  274 (307)
T 2eva_A          223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY  274 (307)
T ss_dssp             CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred             CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence            1112234467889999999999999999999999999877666655554433

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.4e-46  Score=336.52  Aligned_cols=254  Identities=24%  Similarity=0.317  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ...++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++.++||||+++++++.+....++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45678999999999999999999875 4889999998644  33455678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC---CCeeEecccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMAR  168 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~---~~~~l~Dfg~~~  168 (340)
                      ||||+++++|.+.+..   ...+++..+..++.|++.||.|||+++   |+||||||+||+++.+   +.+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999998843   345899999999999999999999999   9999999999999864   459999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......       ...+... 
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~~~~-  248 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ-------IKAGAYD-  248 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCCC-
T ss_pred             EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhCCCC-
Confidence            764322   22345689999999999988999999999999999999999999965443221111       1111100 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           .........+..+.+++.+||+.||++|||+.++++.
T Consensus       249 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 0001112345678999999999999999999998863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-46  Score=327.67  Aligned_cols=261  Identities=22%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||+|+||.||+|+..+++.||+|++.....  .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999987799999999865432  2346778999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++ +|.+++...  ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            975 888887542  245899999999999999999999999   9999999999999999999999999998654321 


Q ss_pred             ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC---cccccc-
Q 041345          176 EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG---KALELI-  250 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  250 (340)
                       .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+   .......   .+.... 
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGG
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHHCCCChhhchhhhc
Confidence             122334679999999998764 5899999999999999999999999765443322111   1111110   000000 


Q ss_pred             ----cccc-------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 ----DTTL-------HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ----~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          +...       ........+..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                0000       00111234567889999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-46  Score=330.72  Aligned_cols=245  Identities=23%  Similarity=0.304  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|..+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999875 58899999985432   23456778899999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||++|   |+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999954   335899999999999999999999999   99999999999999999999999999986532


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                           ......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+......      ..... .       
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~-~-------  219 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNA-E-------  219 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHC-C-------
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-C-------
Confidence                 2234578999999999999999999999999999999999999996544322111      11111 0       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                         ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       220 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 ---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               112233456789999999999999999     8898884

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.1e-47  Score=336.47  Aligned_cols=258  Identities=25%  Similarity=0.338  Sum_probs=204.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCE----EEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQE----IAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      .++|++.+.||+|+||.||+|.+.. ++.    ||+|.+.... ......+.+|+.+++.++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            3678999999999999999998644 443    7888774432 233345678999999999999999999886 45689


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+++++|.+++...  ...+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999998643  345899999999999999999999999   999999999999999999999999999887


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+       ...     
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~-----  233 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKG-----  233 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTT-----
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcC-----
Confidence            54443333445567889999999999999999999999999999999 99999765443321111       111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                          .....+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       234 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          234 ----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ----CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ----CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                1112223344568889999999999999999999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.3e-47  Score=337.51  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=204.0

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      ......++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|..++..+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            34456689999999999999999999875 48889999986431   23455677888888876 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      ...++||||+++|+|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||+
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence            999999999999999999854   345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      +.......  .......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+      . ... 
T Consensus       165 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~-~~~-  234 (345)
T 1xjd_A          165 CKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------R-MDN-  234 (345)
T ss_dssp             CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HCC-
T ss_pred             hhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------H-hCC-
Confidence            97543221  2234467899999999999999999999999999999999999999765433221111      1 110 


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMS-DVA  288 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl  288 (340)
                               ...+...+..+.+++.+||+.||++||++. +++
T Consensus       235 ---------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ---------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                     112233456788999999999999999997 665

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=338.39  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=205.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|+... ++.||+|++...   .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            3789999999999999999998754 788999998543   223456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+.+++|..++..   ...+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999853   345999999999999999999999999   99999999999999999999999999987543


Q ss_pred             cccccccccccccCCCCChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .   .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||................    ..     
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~-----  235 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TT-----  235 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HC-----
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hc-----
Confidence            2   22344678999999999863   458999999999999999999999997554443222221111    00     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-MSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~  289 (340)
                           ....+...+..+.+|+.+||+.||.+||+ +.++++
T Consensus       236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 11223344577899999999999999999 677664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-46  Score=333.76  Aligned_cols=253  Identities=26%  Similarity=0.336  Sum_probs=200.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC------
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG------   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------   87 (340)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999876 68999999986543 334567899999999999999999999886543      


Q ss_pred             ---------------------------------------------------eeEEEEeccCCCChhhHhhccCccccCCH
Q 041345           88 ---------------------------------------------------ERLLVYEYLPNKSLDFFIFDSSKKELLDW  116 (340)
Q Consensus        88 ---------------------------------------------------~~~iv~e~~~~~~L~~~l~~~~~~~~~~~  116 (340)
                                                                         ..++|||||++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27999999999999999977655556777


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc----------cccccccccC
Q 041345          117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE----------ANTNRIVGTH  186 (340)
Q Consensus       117 ~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~~  186 (340)
                      ..++.++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++.........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            789999999999999999999   999999999999999999999999999876543211          1223356899


Q ss_pred             CCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHH
Q 041345          187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRC  266 (340)
Q Consensus       187 ~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (340)
                      .|+|||.+.+..++.++||||||+++|+|++|..|+..        ... ..........         ..........+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~---------~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKF---------PLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCC---------CHHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCC---------CcccccCChhH
Confidence            99999999999999999999999999999998766410        000 0010111110         11113445677


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHH
Q 041345          267 IHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       267 ~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+++.+||+.||++|||+.++++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            89999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.5e-46  Score=335.86  Aligned_cols=276  Identities=23%  Similarity=0.272  Sum_probs=213.3

Q ss_pred             cccccccHHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-----CCce
Q 041345            3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTNL   76 (340)
Q Consensus         3 ~~~~~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i   76 (340)
                      ++...|+++......++|++.++||+|+||.||+|++. +++.||+|++... ......+..|+.+++.+.     ||||
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            45667777777788899999999999999999999874 5889999999643 344556778999999886     9999


Q ss_pred             eeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-
Q 041345           77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-  155 (340)
Q Consensus        77 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-  155 (340)
                      +++++++......++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++|   |+||||||+||+++. 
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP  173 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence            99999999999999999999 8999999865432 34899999999999999999999999   999999999999975 


Q ss_pred             ------------------------CCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHH
Q 041345          156 ------------------------QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVL  211 (340)
Q Consensus       156 ------------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~v  211 (340)
                                              ++.++|+|||++.....     ......||+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    78899999999986432     1234568999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCcccccchhHHHH--------HHhhcCcccccccc-ccc----CCC-------------C---HHH
Q 041345          212 VLEIISSKKNNGCYDTERHLNLVGYAW--------QLWNEGKALELIDT-TLH----ESC-------------S---PDE  262 (340)
Q Consensus       212 l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~----~~~-------------~---~~~  262 (340)
                      +|+|++|..||......+....+....        .............. ...    ...             +   ...
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            999999999997655443222211100        00000000000000 000    000             0   001


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          263 VTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       263 ~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+.+|+.+||+.||++|||+.|+++
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            256789999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=324.17  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=210.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            36789999999999999999998888899999996543 23467899999999999999999999999988999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++...  ...+++..+..++.|++.||.+||+++   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            999999998643  235899999999999999999999999   99999999999999999999999999987543221 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........       .....+         ..
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~i~~~---------~~  223 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTG---------FR  223 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTT---------CC
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH-------HHHhcC---------Cc
Confidence            12223456778999999998899999999999999999999 88998654332211       111111         11


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            112233456789999999999999999999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-46  Score=326.76  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=200.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHc--CCCCceeeeeeEEeeC----Cee
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLVRLLGCSLQK----GER   89 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~   89 (340)
                      ..++|++.+.||+|+||.||+|+. +++.||+|++....   ...+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            467899999999999999999988 78999999985442   3345566666665  7899999999986542    458


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH--------KYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      ++||||+++++|.+++.    ...+++..+..++.|++.||+|||        +++   ++||||||+||+++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999993    235899999999999999999999        777   999999999999999999999


Q ss_pred             ecccccccccCcccc--cccccccccCCCCChhhhccC------CCCccCceehhhHHHHHHHhC----------CCCCC
Q 041345          162 SDFGMARTFGMNELE--ANTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIISS----------KKNNG  223 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg----------~~p~~  223 (340)
                      +|||++.........  .......||+.|+|||.+.+.      .++.++||||||+++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999765432221  112334689999999999776      456799999999999999999          77775


Q ss_pred             CCCcccccchhHHHHHHh-hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          224 CYDTERHLNLVGYAWQLW-NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .........  ....... ........    .....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       235 ~~~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPSF--EDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCCH--HHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcch--hhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            433322111  1111111 11111111    00112245678899999999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.3e-47  Score=330.59  Aligned_cols=260  Identities=30%  Similarity=0.438  Sum_probs=211.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..++|++.+.||+|+||.||+|...+++.||+|.+.... .....+.+|+.+++.++||||+++++++.. +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            457899999999999999999998888899999986543 345678999999999999999999998764 468999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++... ....+++..+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||++........
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            9999999998532 1225899999999999999999999999   99999999999999999999999999987653322


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       .......++..|+|||.+.++.++.++||||||+++|+|++ |..||......+..       .....+         .
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~  227 (279)
T 1qpc_A          165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------QNLERG---------Y  227 (279)
T ss_dssp             -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT---------C
T ss_pred             -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-------HHHhcc---------c
Confidence             12223446788999999988899999999999999999999 88998654332211       111111         1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL  298 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  298 (340)
                      ....+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            11222344567899999999999999999999999998765443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.3e-46  Score=337.74  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=199.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|+... ++.||+|++.+..   ......+.+|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            3689999999999999999998764 7789999986442   22334577888988877 89999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++|+|..++..   ...+++..+..++.||+.||+|||++|   |+||||||+||+++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999854   345999999999999999999999999   9999999999999999999999999997532


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc--chhHHHHHHhhcCccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL--NLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  249 (340)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.........  .............     
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-----  277 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-----  277 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence            21  12234467999999999999999999999999999999999999999654332211  1111111111111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                           ....+...+..+.+|+.+||+.||++||++
T Consensus       278 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 -----QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -----ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                 112233455678999999999999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=328.35  Aligned_cols=249  Identities=21%  Similarity=0.284  Sum_probs=195.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--------------------------hcHHHHHHHHHHHH
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--------------------------QGIVEFKNEAKLIA   69 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~   69 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....                          .....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            378999999999999999999865 478899999854421                          11346789999999


Q ss_pred             cCCCCceeeeeeEEee--CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 041345           70 KLQHTNLVRLLGCSLQ--KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK  147 (340)
Q Consensus        70 ~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk  147 (340)
                      .++||||+++++++.+  ....++||||+++++|.+++    ....+++..+..++.|++.||+|||+++   ++|+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999886  56789999999999998865    2345999999999999999999999999   9999999


Q ss_pred             CCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCC---CCccCceehhhHHHHHHHhCCCCCCC
Q 041345          148 ASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGC  224 (340)
Q Consensus       148 ~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~p~~~  224 (340)
                      |+||+++.++.++|+|||++........  ......||+.|+|||.+.+..   ++.++||||||+++|+|++|..||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987643221  123356899999999987654   47889999999999999999999965


Q ss_pred             CCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .......      ... ....        .........+..+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~------~~~-~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMCLH------SKI-KSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHHHH------HHH-HHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHHHH------HHH-hccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            4322111      111 1110        001111234467899999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-47  Score=338.33  Aligned_cols=274  Identities=25%  Similarity=0.330  Sum_probs=210.5

Q ss_pred             hcCC-CCCCcccccCCeeEEEEEEC-----CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--C
Q 041345           17 TDNF-SPGNRLGQGGFGPVYKGKLL-----DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--G   87 (340)
Q Consensus        17 ~~~y-~~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   87 (340)
                      .++| ++.+.||+|+||.||++.+.     +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.  .
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            3455 99999999999999988642     57889999996553 34466789999999999999999999999874  6


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..++||||+++++|.+++..    ..+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             eEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence            78999999999999999843    23899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          168 RTFGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       168 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..............
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRL  260 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHH
Confidence            876543221 2233345778899999999989999999999999999999999998532211000 00000000000001


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL  298 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  298 (340)
                      .+.+........+...+..+.+++.+||+.||++|||+.++++.|+.+...+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            1112222223334555678999999999999999999999999998765444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.7e-47  Score=337.92  Aligned_cols=275  Identities=25%  Similarity=0.353  Sum_probs=213.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEe--eCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL--QKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~   89 (340)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++..........+.+|+.++++++||||+++++++.  .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36899999999999999999984     357889999998777666778999999999999999999999876  45668


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999998643  235899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||............ .............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  255 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLE  255 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHH
Confidence            6533221 2223345788899999999999999999999999999999999998532221000000 0000000000011


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                      .+........+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            1112222333455667899999999999999999999999999986543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.3e-46  Score=329.16  Aligned_cols=268  Identities=24%  Similarity=0.321  Sum_probs=190.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            4578999999999999999999865 48899999986543 223457789999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccC---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           94 EYLPNKSLDFFIFDSS---KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ||++ ++|.+++....   ....+++..+..++.|++.||.|||++|   |+||||||+||+++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 58888875431   1234899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ....  .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...........+...
T Consensus       159 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            4321  122334679999999998764 6899999999999999999999999766554332221110000000000000


Q ss_pred             -----------------ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 -----------------IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 -----------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                       +...+....+...+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                             0000000111123457899999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-46  Score=333.53  Aligned_cols=269  Identities=25%  Similarity=0.403  Sum_probs=215.0

Q ss_pred             ccHHHHHHHhcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeee
Q 041345            8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRL   79 (340)
Q Consensus         8 ~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~   79 (340)
                      +....+....++|++.+.||+|+||.||+|++      .+++.||+|++.... ......+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44455666678999999999999999999974      246789999986543 33456788999999999 79999999


Q ss_pred             eeEEeeCC-eeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 041345           80 LGCSLQKG-ERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD  145 (340)
Q Consensus        80 ~~~~~~~~-~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d  145 (340)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..+..++.|++.||.|||+++   ++|+|
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987654 48999999999999999965432             123789999999999999999999999   99999


Q ss_pred             CCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCC
Q 041345          146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGC  224 (340)
Q Consensus       146 lk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~  224 (340)
                      |||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654333333344567889999999999999999999999999999998 9999965


Q ss_pred             CCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .......      ......+.         ....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       254 ~~~~~~~------~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDEEF------CRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSHHH------HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHHH------HHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            4433211      11111111         1112233456789999999999999999999999999865

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=330.45  Aligned_cols=269  Identities=23%  Similarity=0.271  Sum_probs=208.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee----CCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+++. .+++.||+|++..........+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999987 4689999999876666667788999999999999999999999863    346899


Q ss_pred             EEeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           92 VYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ||||+++++|.+++... .....+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999988652 12356899999999999999999999999   999999999999999999999999998765


Q ss_pred             cCccccc-------ccccccccCCCCChhhhccCC---CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          171 GMNELEA-------NTNRIVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       171 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      .......       ......|++.|+|||.+.+..   ++.++||||||+++|+|++|..||......... ..    ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~----~~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA----LA  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH----HH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh----HH
Confidence            3211100       112245689999999986553   688999999999999999999998421111100 00    00


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPR  302 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~  302 (340)
                               +........+...+..+.+++.+||+.||.+|||+.++++.|+.+....|.+.
T Consensus       260 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~  312 (317)
T 2buj_A          260 ---------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH  312 (317)
T ss_dssp             ---------HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred             ---------hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence                     00111112223445679999999999999999999999999998766555543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-46  Score=331.59  Aligned_cols=266  Identities=23%  Similarity=0.392  Sum_probs=201.1

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-   87 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   87 (340)
                      ...++|++.+.||+|+||.||+|....    +..||+|.+...  .......+.+|+.++++++||||+++++++.... 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345678888999999999999997543    447999998644  3344567889999999999999999999987654 


Q ss_pred             ----eeEEEEeccCCCChhhHhhcc---CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCee
Q 041345           88 ----ERLLVYEYLPNKSLDFFIFDS---SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK  160 (340)
Q Consensus        88 ----~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~  160 (340)
                          ..++||||+++++|.+++...   .....+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence                359999999999999998532   23356999999999999999999999999   99999999999999999999


Q ss_pred             EecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHH
Q 041345          161 ISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      |+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||............     
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-----  262 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-----  262 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-----
Confidence            999999987654333333344556888999999999999999999999999999999 88888655443321111     


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                        ..+.         ....+...+..+.+++.+||+.||.+|||+.++++.|+++...+|
T Consensus       263 --~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          263 --LHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             --HTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --HcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence              1111         112223345678999999999999999999999999988655444

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.3e-46  Score=334.10  Aligned_cols=244  Identities=23%  Similarity=0.255  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67999999999999999999875 58899999985432   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++......
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999998542   35899999999999999999999999   999999999999999999999999999875422


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......       ...+.        
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------i~~~~--------  254 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK-------IVSGK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCC--------
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH-------HHcCC--------
Confidence                 2345789999999999999999999999999999999999999975443321111       11111        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                        ...+...+..+.+++.+||+.||.+||+     +.++++
T Consensus       255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence              1122334567899999999999999998     888875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.4e-46  Score=326.35  Aligned_cols=258  Identities=23%  Similarity=0.380  Sum_probs=214.1

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ...++|++.+.||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            356789999999999999999998765 7889999986543 34667899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++... ....+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999999653 2345899999999999999999999999   999999999999999999999999999876533


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+........                ..
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----------------~~  227 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----------------EK  227 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----------------HT
T ss_pred             cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------hc
Confidence            22 22233456788999999999999999999999999999999 88998765443322111                11


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ......+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            111222344457789999999999999999999999999764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-45  Score=336.92  Aligned_cols=271  Identities=17%  Similarity=0.197  Sum_probs=206.3

Q ss_pred             HhcCCCCCCccccc--CCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           16 ATDNFSPGNRLGQG--GFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G--~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ..++|++.+.||+|  +||.||+|+.. +++.||+|++...  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45789999999999  99999999876 5899999998544  2344567888999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+++++|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||.+...
T Consensus       103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999986542 234899999999999999999999999   999999999999999999999999988654


Q ss_pred             cCccc-----ccccccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH-HHHHh-
Q 041345          171 GMNEL-----EANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY-AWQLW-  241 (340)
Q Consensus       171 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~-~~~~~-  241 (340)
                      .....     ........|++.|+|||++.+  ..++.++|||||||++|+|++|..||.............. ..... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            32211     111223468889999999987  5789999999999999999999999976554432211100 00000 


Q ss_pred             hc-----C-------------cccccc---------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          242 NE-----G-------------KALELI---------DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       242 ~~-----~-------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..     .             .....+         ........+...+..+.+|+.+||+.||++|||+.++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            00     0             000000         0000011223345678999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=355.10  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=215.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            346788889999999999999999888889999996543 345678999999999999999999999866 678999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            9999999999542 2234899999999999999999999999   99999999999999999999999999987643221


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                       .......++..|+|||.+.++.++.++||||||+++|+|++ |..||......+....       ...         ..
T Consensus       419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-------i~~---------~~  481 (535)
T 2h8h_A          419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VER---------GY  481 (535)
T ss_dssp             -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-------HHT---------TC
T ss_pred             -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHc---------CC
Confidence             11223346778999999999999999999999999999999 8999865443321111       111         11


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ  303 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~  303 (340)
                      +...+..++..+.+||.+||+.||++|||+.+|++.|+.+.....+...
T Consensus       482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~  530 (535)
T 2h8h_A          482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  530 (535)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence            2233445567899999999999999999999999999998766555443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-46  Score=336.08  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=194.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3578999999999999999999876 588999999965432 23567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC--eeEecccccccccC
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--PKISDFGMARTFGM  172 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~--~~l~Dfg~~~~~~~  172 (340)
                      |+++++|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.  +||+|||++.....
T Consensus        97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999854   335899999999999999999999999   999999999999987665  99999999874322


Q ss_pred             cccccccccccccCCCCChhhhccCCCCcc-CceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMK-SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                         ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||............  .......        
T Consensus       171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~--------  237 (361)
T 3uc3_A          171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSV--------  237 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTT--------
T ss_pred             ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcC--------
Confidence               122234568999999999988777655 89999999999999999999765443322111  1111110        


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                       ..........+..+.+|+.+||+.||++|||+.++++.
T Consensus       238 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          238 -KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             00111111234678899999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.3e-46  Score=338.30  Aligned_cols=282  Identities=16%  Similarity=0.211  Sum_probs=208.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCCChhcHH-----------HHHHHHHHHHcCCCCceeee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSSGQGIV-----------EFKNEAKLIAKLQHTNLVRL   79 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~i~~~   79 (340)
                      .++|++.+.||+|+||.||+|.+..      ++.||+|++.........           ....|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998755      368999998655422111           12345556677789999999


Q ss_pred             eeEEeeC----CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-
Q 041345           80 LGCSLQK----GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-  154 (340)
Q Consensus        80 ~~~~~~~----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-  154 (340)
                      ++++...    ...++||||+ +++|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9998764    4589999999 99999998653  345999999999999999999999999   99999999999998 


Q ss_pred             -CCCCeeEecccccccccCccccc-----ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcc
Q 041345          155 -DQMNPKISDFGMARTFGMNELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE  228 (340)
Q Consensus       155 -~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~  228 (340)
                       .++.++|+|||++..+.......     ......||+.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998765332211     112345899999999999999999999999999999999999999743322


Q ss_pred             cccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCceee
Q 041345          229 RHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFI  308 (340)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~  308 (340)
                      ...  ........ ......+++..+..   ...+..+.+++..||+.+|++|||+.+|++.|+++......+....+.|
T Consensus       268 ~~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          268 PKY--VRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             HHH--HHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             HHH--HHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            211  11111111 11112222222111   1234678899999999999999999999999988666555544444444


Q ss_pred             ec
Q 041345          309 NI  310 (340)
Q Consensus       309 ~~  310 (340)
                      ..
T Consensus       342 ~~  343 (364)
T 3op5_A          342 SV  343 (364)
T ss_dssp             --
T ss_pred             Ee
Confidence            43

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3e-46  Score=325.62  Aligned_cols=256  Identities=22%  Similarity=0.323  Sum_probs=197.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|.+... .......+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            35789999999999999999998643    446999998654 3344567889999999999999999999874 45689


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999998643  235899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+       ....    
T Consensus       167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-------~~~~----  234 (281)
T 1mp8_A          167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGE----  234 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTC----
T ss_pred             Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-------HcCC----
Confidence            43221 12223446778999999998899999999999999999996 88999765443321111       1111    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                           ....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          235 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 1122344557789999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-46  Score=328.83  Aligned_cols=252  Identities=23%  Similarity=0.381  Sum_probs=203.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-C-------CEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-G-------QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      .++|++.+.||+|+||.||+|.+.. +       ..||+|.+..........+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4689999999999999999997643 3       4699999977666667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC--------ee
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--------PK  160 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~--------~~  160 (340)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.        ++
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999653  334899999999999999999999999   999999999999988876        99


Q ss_pred             EecccccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCC-CCCCcccccchhHHHH
Q 041345          161 ISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNN-GCYDTERHLNLVGYAW  238 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~-~~~~~~~~~~~~~~~~  238 (340)
                      |+|||++.....      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|+ .........       
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-------  228 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-------  228 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-------
Confidence            999999875432      123457889999999987 67899999999999999999966554 332221110       


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                      ......           ...+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       229 ~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          229 QFYEDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHhhcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            111110           011112234588999999999999999999999999987653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.2e-46  Score=330.56  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE----CCCCEEEEEEccCCC----hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|++....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            47899999999999999999986    468899999986542    2334567889999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999854   345899999999999999999999999   9999999999999999999999999987


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+......      .....     
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~~~-----  236 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID------KILKC-----  236 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHT-----
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhC-----
Confidence            543221  12234568999999999998899999999999999999999999997544332111      11110     


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                            ....+...+..+.+++.+||+.||++||     ++.++++
T Consensus       237 ------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 ------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                  0112334456789999999999999999     7778775

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.3e-46  Score=323.87  Aligned_cols=262  Identities=26%  Similarity=0.454  Sum_probs=197.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.++||+|+||.||+|+..  ..+|+|++...  .......+.+|+.+++.++||||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3578999999999999999999763  35999998644  334556789999999999999999999965 455689999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            999999999998543  345899999999999999999999999   999999999999999999999999999865432


Q ss_pred             ccccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ..........|++.|+|||.+.   +..++.++||||||+++|+|++|..||.........      ......+..... 
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~~~~-  246 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGSLSPD-  246 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH------HHHHHHTSCCCC-
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH------HHHhcccccCcc-
Confidence            2223333456899999999986   567889999999999999999999999654433211      111111111110 


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                          ........+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       247 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          247 ----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                011123345679999999999999999999999999998653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-45  Score=329.97  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=200.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|+... ++.||+|++...   .......+.+|..++.++ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            3679999999999999999998754 788999998644   334456678899999887 89999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.+++++|+|||++....
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999854   345899999999999999999999999   9999999999999999999999999997533


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc--chhHHHHHHhhcCccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL--NLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  249 (340)
                      ..  ........||+.|+|||++.+..++.++|+|||||++|+|++|..||.........  ..............    
T Consensus       162 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          162 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             CC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            21  12234467899999999999999999999999999999999999999653322111  01111111111111    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM  284 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  284 (340)
                            ...+...+..+.+++.+||+.||.+||++
T Consensus       236 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                  11233445678999999999999999996

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-46  Score=336.22  Aligned_cols=255  Identities=23%  Similarity=0.304  Sum_probs=203.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-----ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...     .......+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3467999999999999999999875 4899999998432     122456789999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC---eeEeccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFG  165 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~---~~l~Dfg  165 (340)
                      ++||||+++++|.+.+.... ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.   ++|+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988775432 2335899999999999999999999999   999999999999986554   9999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......    .    ......+.
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~----~~~i~~~~  248 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----L----FEGIIKGK  248 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----H----HHHHHHTC
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----H----HHHHHcCC
Confidence            9987653221  223456899999999999889999999999999999999999999653211    1    11111111


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...  ....    ....+..+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~--~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          249 YKM--NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC--Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000  0000    0123467889999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-46  Score=335.53  Aligned_cols=262  Identities=26%  Similarity=0.414  Sum_probs=210.7

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC-C-----CEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD-G-----QEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      ...++|++.+.||+|+||.||+|.... +     ..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345789999999999999999998643 2     479999986553 34456788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc-----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK-----------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD  155 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~  155 (340)
                      ...++||||+++++|.+++.....           ...+++..++.++.|++.||+|||+++   ++|+||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence            999999999999999999864321           235799999999999999999999999   999999999999999


Q ss_pred             CCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchh
Q 041345          156 QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLV  234 (340)
Q Consensus       156 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~  234 (340)
                      ++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........   
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---  276 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---  276 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---
Confidence            99999999999987644332223334456788999999999999999999999999999998 88898654433211   


Q ss_pred             HHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                         .......         .....+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       277 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 ---YKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ---HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence               1111111         11112233456789999999999999999999999999764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=335.92  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=197.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCC--CceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH--TNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||++...+++.||+|++...  .......+.+|+.++..++|  +||+++++++......++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            45789999999999999999999888999999998544  33445678899999999976  999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||| +.+++|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+||+++ ++.++|+|||++....
T Consensus        87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 568899999854   345899999999999999999999999   99999999999997 5689999999998765


Q ss_pred             CcccccccccccccCCCCChhhhcc-----------CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      ............||+.|+|||++.+           ..++.++|||||||++|+|++|..||......     .......
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~  233 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI  233 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHH
Confidence            4333333345678999999999865           67899999999999999999999999643221     1111111


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..         .......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       234 ~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          234 ID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            11         111122223334678899999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.8e-46  Score=321.31  Aligned_cols=254  Identities=18%  Similarity=0.331  Sum_probs=206.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--CeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|++ .++.||+|++...  .......+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            36899999999999999999998 5889999998654  334456789999999999999999999999876  678999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++.... ...+++..+..++.|++.||+|||+++ .+++|+||||+||+++.++.++|+|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            99999999999996532 235899999999999999999999864 359999999999999999999999988865422 


Q ss_pred             cccccccccccccCCCCChhhhccCCCCc---cCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSM---KSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                            .....+|+.|+|||.+.+..++.   ++||||||+++|+|++|..||.........      .......     
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~-----  227 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEG-----  227 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSC-----
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcC-----
Confidence                  12345789999999998765544   799999999999999999999654433211      1111111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                          .....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          228 ----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                112233445667999999999999999999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.7e-46  Score=322.34  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=202.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||+|.... +..||+|++....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34789999999999999999998754 6789999985432   2235568899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...   ..+++..+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999998543   34899999999999999999999999   9999999999999999999999999986543


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..    ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+       ..        
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~--------  221 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SR--------  221 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HH--------
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH-------Hh--------
Confidence            22    223456899999999999999999999999999999999999999754433221111       00        


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        .....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0112223345678899999999999999999999973

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.5e-46  Score=344.50  Aligned_cols=248  Identities=23%  Similarity=0.276  Sum_probs=195.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999864 4889999998543   233445677899999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |||+++++|.+++..   ...+++..+..++.|++.||+|||+ +|   |+||||||+||+++.++.++|+|||++....
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999854   3458999999999999999999998 88   9999999999999999999999999997643


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+      ....       
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~-------  365 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE-------  365 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC-------
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC-------
Confidence            221  2233467899999999999999999999999999999999999999654443322111      1110       


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                          ...+...+..+.+|+.+||+.||.+||     |+.++++
T Consensus       366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                112233456789999999999999999     9999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-45  Score=340.86  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=205.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999875 58999999985432   22356788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999843   445999999999999999999999999   99999999999999999999999999987643


Q ss_pred             cccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........       ....+.      
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-------~i~~~~------  232 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-------KICDGI------  232 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH-------HHHTTC------
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH-------HHhcCC------
Confidence            22   2234578999999999988765 789999999999999999999997544332111       111111      


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ...+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 ----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                1112234467889999999999999999999997

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.8e-45  Score=320.43  Aligned_cols=255  Identities=26%  Similarity=0.467  Sum_probs=203.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhc-------HHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.......       ...+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            478999999999999999999874 58899999985443211       157889999999999999999999986654 


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC-----eeEec
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-----PKISD  163 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~-----~~l~D  163 (340)
                       ++||||+++++|.+++...  ...+++..+..++.|++.|++|||+++ .+++|+||||+||+++.++.     ++|+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999998888543  345899999999999999999999975 34999999999999987776     99999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhh--ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYV--MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      ||++.....     ......|++.|+|||.+  ....++.++||||||+++|+|++|..||..........    .....
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF----INMIR  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH----HHHHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH----HHHHh
Confidence            999875432     22335689999999998  34567899999999999999999999997554433211    11111


Q ss_pred             hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..         ......+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       244 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11         112223344567799999999999999999999999999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7e-47  Score=332.90  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=207.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC--Ce
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK--GE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   88 (340)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++.... ......+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35689999999999999999983     357899999986443 34567789999999999999999999998876  56


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            89999999999999998543  234899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcc--------cccchhHHHHH
Q 041345          169 TFGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE--------RHLNLVGYAWQ  239 (340)
Q Consensus       169 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~--------~~~~~~~~~~~  239 (340)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+......        ...........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76543221 2233455788899999999999999999999999999999999886321100        00000000011


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                               .+........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       255 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          255 ---------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             ---------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence                     1111122233445567899999999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=335.89  Aligned_cols=274  Identities=20%  Similarity=0.242  Sum_probs=214.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC--eeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG--ERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            5789999999999999999998765 8899999986543 234567789999999999999999999988755  67999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe----CCCCCeeEecccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMAR  168 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv----~~~~~~~l~Dfg~~~  168 (340)
                      |||+++++|.+++........+++..++.++.|++.||+|||++|   |+||||||+||++    +.++.+||+|||++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999966544444999999999999999999999999   9999999999999    777789999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhcc--------CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccc-hhHHHHH
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMN--------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-LVGYAWQ  239 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~-~~~~~~~  239 (340)
                      ......   ......|++.|+|||++.+        ..++.++|||||||++|+|++|..||.......... .......
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            764322   2233568999999999865        567889999999999999999999996544432221 1111111


Q ss_pred             HhhcCccccc----------c-cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          240 LWNEGKALEL----------I-DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       240 ~~~~~~~~~~----------~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      ......+...          . ........+......+.+++.+||+.||++|||+.++++.+.++..
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            1111000000          0 0011123447788899999999999999999999999999977543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.1e-46  Score=332.42  Aligned_cols=249  Identities=22%  Similarity=0.299  Sum_probs=203.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   90 (340)
                      ..++|++.+.||+|+||.||+|+... ++.||+|++...   .......+..|..++..+ .||+|+++++++.+....+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34789999999999999999998765 788999998643   223456778899999888 7999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+++|+|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||++...
T Consensus        98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999854   235899999999999999999999999   999999999999999999999999999864


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ....  .......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+      .. ..     
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~~-----  237 (353)
T 2i0e_A          172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------ME-HN-----  237 (353)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CC-----
T ss_pred             ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH------Hh-CC-----
Confidence            3221  2233467899999999999999999999999999999999999999765433221111      11 11     


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                           ...+...+..+.+++.+||+.||++||+     +.++++
T Consensus       238 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 1123344567899999999999999996     466664

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.7e-45  Score=318.89  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=205.1

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+.++|++.+.||+|+||.||+|.... +..+|+|.+..........+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            356789999999999999999998755 6789999987665556778999999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe---CCCCCeeEecccccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTF  170 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv---~~~~~~~l~Dfg~~~~~  170 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++|+||||+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999998854   345899999999999999999999999   9999999999999   78889999999999875


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ....   ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+       ..+.     
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~-----  223 (277)
T 3f3z_A          160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------REGT-----  223 (277)
T ss_dssp             CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC-----
T ss_pred             cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhCC-----
Confidence            4322   2233568999999998865 4899999999999999999999999764433211111       1110     


Q ss_pred             cccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSP----DEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                           ...+.    ..+..+.+++.+||+.||++|||+.++++
T Consensus       224 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 -----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 01111    23567889999999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=324.04  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC-----hhcHHHHHHHHHHHHcC---CCCceeeeeeEEee
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS-----GQGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQ   85 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~   85 (340)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++....     ......+.+|+.+++.+   .||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3468999999999999999999986 458899999985321     11223556777777666   59999999999887


Q ss_pred             CC-----eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCee
Q 041345           86 KG-----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK  160 (340)
Q Consensus        86 ~~-----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~  160 (340)
                      ..     ..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     5799999996 59999886533 234899999999999999999999999   99999999999999999999


Q ss_pred             EecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          161 ISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      |+|||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......
T Consensus       161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999865432   2233456899999999999999999999999999999999999999765544332222111100


Q ss_pred             hhcCccccccc---ccccCC-------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          241 WNEGKALELID---TTLHES-------CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       241 ~~~~~~~~~~~---~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .....+.....   ......       ..+..+..+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11111111000   000000       01234567889999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-45  Score=320.26  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=206.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999875 58899999985432 334567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||.+......
T Consensus        85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999884   3345899999999999999999999999   999999999999999999999999999876433


Q ss_pred             ccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..........|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.........      ...+.....      
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~------  226 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKT------  226 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCT------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhccc------
Confidence            32233344568999999999977665 78999999999999999999999654433211      111111110      


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ........+..+.+++.+||+.||++|||+.++++
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              01111234567889999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.6e-46  Score=332.15  Aligned_cols=268  Identities=17%  Similarity=0.176  Sum_probs=199.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCCChhc-----------HHHHHHHHHHHHcCCCCceeeeee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKSSGQG-----------IVEFKNEAKLIAKLQHTNLVRLLG   81 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~   81 (340)
                      .++|++.+.||+|+||.||+|.+.    .+..+|+|++.......           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999875    46789999986543211           123557788889999999999999


Q ss_pred             EEee----CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           82 CSLQ----KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        82 ~~~~----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9887    67799999999 9999999853   336999999999999999999999999   99999999999998777


Q ss_pred             --CeeEecccccccccCcccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          158 --NPKISDFGMARTFGMNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       158 --~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                        .++|+|||++..+......     .......|++.|+|||.+.+..++.++|||||||++|+|++|..||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211     111345689999999999999999999999999999999999999953222111


Q ss_pred             cchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                      .  .......... .....+.....   ....+..+.+++.+||+.||++|||+.+|++.|++....
T Consensus       269 ~--~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          269 A--VQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             H--HHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             H--HHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            1  1111111110 01111100000   013345789999999999999999999999999986553

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=325.22  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=209.6

Q ss_pred             hcCCCCCC-cccccCCeeEEEEEEC---CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGN-RLGQGGFGPVYKGKLL---DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~-~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||+|++... .......+.+|+.+++.++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35677776 9999999999999753   4778999999764 334567789999999999999999999998 4566899


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++..  ....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999853  2345899999999999999999999999   9999999999999999999999999998764


Q ss_pred             Ccccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          172 MNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       172 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+...       ....+.    
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~i~~~~----  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQGK----  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-------HHHTTC----
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHhcCC----
Confidence            33221 12223446788999999988889999999999999999998 999996554332111       111111    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                           ....+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       231 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          231 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                 1223345567899999999999999999999999999875443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.8e-46  Score=340.39  Aligned_cols=258  Identities=21%  Similarity=0.237  Sum_probs=206.9

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG   87 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (340)
                      ++....++|++.+.||+|+||.||+|+... ++.||+|++....   ......+.+|+.+++.++||||+++++++.+..
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            344456889999999999999999998764 7889999985421   112334778999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..++||||+++|+|.+++..    ..+++..+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999853    24899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCC----CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE  243 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  243 (340)
                      ........ .......||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+......   
T Consensus       216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---  291 (410)
T 3v8s_A          216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---  291 (410)
T ss_dssp             EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence            87653321 1233467999999999997654    889999999999999999999999765443322222110000   


Q ss_pred             CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041345          244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATD--RPTMSDVASM  290 (340)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  290 (340)
                                +........+..+.+|+.+||+.+|.+  ||++.+|++.
T Consensus       292 ----------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          292 ----------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ----------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ----------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                      001111234567889999999999998  9999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-45  Score=323.91  Aligned_cols=264  Identities=27%  Similarity=0.369  Sum_probs=205.7

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECCC----CEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEe-eCCe
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLDG----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL-QKGE   88 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   88 (340)
                      ....+|++.+.||+|+||.||+|...++    ..+|+|.+... .......+.+|+.++++++||||+++++++. ....
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3456789999999999999999986432    25899988654 3345677899999999999999999999864 4557


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence            89999999999999999642  345889999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccc--cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          169 TFGMNELE--ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       169 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ........  .......+++.|+|||.+.+..++.++||||||+++|+|++| ..||............       ..+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-------~~~~  249 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGR  249 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-------HTTC
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hcCC
Confidence            76543221  122334567889999999999999999999999999999995 4555544333211111       0110


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                               ....+...+..+.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                     111123344678999999999999999999999999988655443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=326.93  Aligned_cols=266  Identities=24%  Similarity=0.290  Sum_probs=201.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      -++|++.+.||+|+||.||+|++.. ++.||+|++....  ......+.+|+.++++++||||+++++++......++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3689999999999999999998754 8899999885543  233456789999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|..++..   ...+++..+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999988743   344899999999999999999999999   999999999999999999999999999875422


Q ss_pred             ccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhcC
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWNEG  244 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~  244 (340)
                      .  .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...        ...+...
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 S--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             c--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            1  12233467899999999876 57899999999999999999999999776554433222110        1111111


Q ss_pred             cccccccccccCCC------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          245 KALELIDTTLHESC------SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       245 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..............      .+..+..+.+++.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            11100000000000      02345568899999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.3e-45  Score=321.20  Aligned_cols=268  Identities=18%  Similarity=0.224  Sum_probs=208.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEE-eeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS-LQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~iv~   93 (340)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++......  ..+.+|+.+++.+.|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999986 46889999998654322  3578999999999988766655554 5667789999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC---CCCCeeEecccccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTF  170 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~---~~~~~~l~Dfg~~~~~  170 (340)
                      ||+ +++|.+++...  ...+++..+..++.|++.||+|||+++   ++|+||||+||+++   .++.++|+|||++...
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 99999998532  235899999999999999999999999   99999999999994   7889999999999876


Q ss_pred             cCccccc-----ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          171 GMNELEA-----NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       171 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      .......     ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            5432211     12345689999999999999999999999999999999999999976554433332222111110000


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT  300 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~  300 (340)
                      ..     ..    +...+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus       239 ~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          239 IE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hH-----HH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            00     00    112346789999999999999999999999999876544433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-46  Score=337.76  Aligned_cols=265  Identities=22%  Similarity=0.321  Sum_probs=194.5

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCC--e
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKG--E   88 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~   88 (340)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            45689999999999999999999864 5889999998543  3445667789999999996 999999999987544  6


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .|+||||++ ++|..++..    ..++...+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 588888743    35899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcc-------------------cccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcc
Q 041345          169 TFGMNE-------------------LEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE  228 (340)
Q Consensus       169 ~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~  228 (340)
                      .+....                   .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            653211                   0111233578999999999876 67899999999999999999999999776554


Q ss_pred             cccchhHHHHHHhhcCcc-----------------------------ccccc----ccccCCCCHHHHHHHHHHHHhccC
Q 041345          229 RHLNLVGYAWQLWNEGKA-----------------------------LELID----TTLHESCSPDEVTRCIHVGLLCVQ  275 (340)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~----~~~~~~~~~~~~~~l~~li~~cl~  275 (340)
                      .....+..   .......                             .....    .......+...+..+.+|+.+||+
T Consensus       238 ~~~~~i~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQLERIIG---VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHHHHHH---HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHHHHHH---hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            43322211   0000000                             00000    000000011234578899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 041345          276 DKATDRPTMSDVASM  290 (340)
Q Consensus       276 ~~p~~RPt~~evl~~  290 (340)
                      .||++|||+.|+++.
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-45  Score=322.66  Aligned_cols=267  Identities=18%  Similarity=0.227  Sum_probs=204.5

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEE-eeCCeeEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS-LQKGERLLV   92 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~iv   92 (340)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++......  ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            4568999999999999999999986 45889999987544322  2467899999999887766666554 667788999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe---CCCCCeeEeccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMART  169 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv---~~~~~~~l~Dfg~~~~  169 (340)
                      |||+ +++|.+++...  ...+++..+..++.|++.||.|||+++   ++||||||+||++   +.++.++|+|||++..
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 99999998643  234899999999999999999999999   9999999999999   7888999999999987


Q ss_pred             ccCcccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          170 FGMNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       170 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      .......     .......|++.|+|||.+.+..++.++|||||||++|+|++|..||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6543221     12234568999999999999999999999999999999999999997765554433332221111111


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCC
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL  298 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~  298 (340)
                      ...     ...    ...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       238 ~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          238 PIE-----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             CHH-----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhh-----hhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            000     000    112467899999999999999999999999998765433

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.7e-46  Score=327.76  Aligned_cols=257  Identities=21%  Similarity=0.253  Sum_probs=199.1

Q ss_pred             hcCCCCC-CcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEE
Q 041345           17 TDNFSPG-NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        17 ~~~y~~~-~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .++|++. +.||+|+||.||+|... +++.||+|++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678885 78999999999999864 5889999999766555677889999999885 7999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC---eeEecccccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGMARTF  170 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~---~~l~Dfg~~~~~  170 (340)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.   ++|+|||++...
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999998543   45899999999999999999999999   999999999999998766   999999998765


Q ss_pred             cCccc-----ccccccccccCCCCChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccch-------
Q 041345          171 GMNEL-----EANTNRIVGTHGYMSPEYVMN-----GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNL-------  233 (340)
Q Consensus       171 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~-------  233 (340)
                      .....     ........|++.|+|||++.+     ..++.++|||||||++|+|++|..||...........       
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211     111223458999999999865     5688999999999999999999999976544321100       


Q ss_pred             -hHHHHHHhhcCcccccccccccCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          234 -VGYAWQLWNEGKALELIDTTLHESCSP----DEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ..........+.          ...+.    ..+..+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGK----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCC----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccC----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             000111111111          01111    23467899999999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-45  Score=331.17  Aligned_cols=262  Identities=21%  Similarity=0.210  Sum_probs=203.3

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-----ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-----SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ   85 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (340)
                      ++..+.++|++.+.||+|+||.||+|... +++.||+|++...     .......+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            35567889999999999999999999874 4788999988533     23445678999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhccC-------------------------------------ccccCCHHHHHHHHHHHHH
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSS-------------------------------------KKELLDWKKRFNIIEGIVQ  128 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~qi~~  128 (340)
                      ....++||||+++++|.+++....                                     ....+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999884210                                     0122467788899999999


Q ss_pred             HHHHHHhCCCCceeecCCCCCCeEeCCCC--CeeEecccccccccCccc--ccccccccccCCCCChhhhcc--CCCCcc
Q 041345          129 GLLYLHKYSRLRVIHRDLKASNILLDDQM--NPKISDFGMARTFGMNEL--EANTNRIVGTHGYMSPEYVMN--GIVSMK  202 (340)
Q Consensus       129 ~l~~LH~~~~~~i~H~dlk~~Nilv~~~~--~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~  202 (340)
                      ||+|||+++   ++|+||||+||+++.++  .++|+|||++..+.....  ........|++.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999999   99999999999998766  899999999986543211  112334568999999999865  678999


Q ss_pred             CceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 041345          203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP  282 (340)
Q Consensus       203 ~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  282 (340)
                      +||||||+++|+|++|..||......+..      ...........       .......+..+.+++.+||+.||.+||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCC
Confidence            99999999999999999999755443221      11111111000       011122456789999999999999999


Q ss_pred             CHHHHHH
Q 041345          283 TMSDVAS  289 (340)
Q Consensus       283 t~~evl~  289 (340)
                      |+.++++
T Consensus       324 s~~~~l~  330 (345)
T 3hko_A          324 DAMRALQ  330 (345)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999987

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=330.25  Aligned_cols=251  Identities=20%  Similarity=0.266  Sum_probs=190.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..++|++.+.||+|+||.||+|+... ++.||+|++....  ....+.+|+.++++++||||+++++++......++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            45779999999999999999998764 7889999986543  23467889999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCeeEeccccccccc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMARTFG  171 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~~l~Dfg~~~~~~  171 (340)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.   ++.++|+|||++....
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999843   345899999999999999999999999   999999999999975   8899999999998654


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........      ...........    
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~----  269 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYY----  269 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCC----
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCc----
Confidence            321   22345689999999999998999999999999999999999999965433221      11111111100    


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        .........+..+.+|+.+||+.||++|||+.++++
T Consensus       270 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 --FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              011112334567899999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.5e-46  Score=332.30  Aligned_cols=259  Identities=29%  Similarity=0.418  Sum_probs=205.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE------CCCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|++.+.||+|+||.||+|++      .+++.||+|.+... .......+.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            47899999999999999999973      24678999999654 334556788999999999999999999999998899


Q ss_pred             EEEEeccCCCChhhHhhccCc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCeeEe
Q 041345           90 LLVYEYLPNKSLDFFIFDSSK----KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKIS  162 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~~l~  162 (340)
                      ++||||+++++|.+++.....    ...+++..++.++.|++.||.|||++|   ++|+||||+||+++.   +..++|+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432    134899999999999999999999999   999999999999984   4469999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHh
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      |||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........       ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------EFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH-------HHH
Confidence            9999986544333333344567889999999999999999999999999999998 88998654332211       111


Q ss_pred             hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..+.         ....+...+..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       259 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1111         1122234456789999999999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-46  Score=343.08  Aligned_cols=263  Identities=18%  Similarity=0.215  Sum_probs=208.7

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEee
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ   85 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (340)
                      +.++....++|++.+.||+|+||.||+|+... ++.||+|++.+..   ......+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34444556899999999999999999998765 7789999985421   1122347889999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ....++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            99999999999999999999642  345999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      ++........ .......||+.|+|||++.     ++.++.++|||||||++|+|++|..||...+..+....+......
T Consensus       221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  299 (437)
T 4aw2_A          221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER  299 (437)
T ss_dssp             TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence            9976543222 2233457999999999986     467899999999999999999999999765544332222110000


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATD--RPTMSDVASM  290 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~  290 (340)
                         ...         .......+..+.+|+.+||..+|++  ||+++++++.
T Consensus       300 ---~~~---------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          300 ---FQF---------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ---CCC---------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ---ccC---------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence               000         0111224567889999999998888  9999999873

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.9e-46  Score=337.80  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=196.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCC--CCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ--HTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|...+++.||||++...  .......+.+|+.+++.+.  ||||+++++++......++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            459999999999999999999878999999998543  3445677899999999996  599999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      | +.+++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+||+++ ++.+||+|||++..+...
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 5688999998643   35889999999999999999999999   99999999999996 578999999999876543


Q ss_pred             ccccccccccccCCCCChhhhcc-----------CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      ..........||+.|+|||++.+           ..++.++|||||||++|+|++|..||......     .........
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~  282 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIID  282 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhC
Confidence            32223344578999999999865           36889999999999999999999999643221     111111111


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .         ......+...+..+.+|+.+||+.||++|||+.++++.
T Consensus       283 ~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 P---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             T---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             c---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1         11111222224678899999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-46  Score=325.96  Aligned_cols=261  Identities=26%  Similarity=0.330  Sum_probs=206.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CC---EEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee-EE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQ---EIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER-LL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~i   91 (340)
                      ..|.+.+.||+|+||.||+|.+.+ ++   .+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            346667899999999999997533 22   69999986543 34567788999999999999999999999876655 99


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+.+++|.+++...  ...+++..+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||++....
T Consensus       101 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999999642  345889999999999999999999999   9999999999999999999999999998664


Q ss_pred             Ccccc--cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCC-CCCCcccccchhHHHHHHhhcCcccc
Q 041345          172 MNELE--ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       172 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      .....  .......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+ ...+.....   ..    ....    
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~----~~~~----  244 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HF----LAQG----  244 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HH----HHTT----
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HH----hhcC----
Confidence            43221  2223456788999999999999999999999999999999966554 333222211   11    1111    


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                           .....+...+..+.+++.+||+.||.+|||+.++++.|+++...+.
T Consensus       245 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          245 -----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                 1112223345678999999999999999999999999988655443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-45  Score=318.81  Aligned_cols=252  Identities=24%  Similarity=0.326  Sum_probs=205.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ..++|++.+.||+|+||.||+|.... ++.||+|++...  .......+.+|+.++++++||||+++++++......++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            46899999999999999999998754 889999998543  334456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC---eeEeccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGMART  169 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~---~~l~Dfg~~~~  169 (340)
                      |||+++++|.+.+..   ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.   ++|+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999888854   345899999999999999999999999   999999999999986655   99999999976


Q ss_pred             ccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .....   ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+       ..+...  
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~~--  225 (284)
T 3kk8_A          158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGAYD--  225 (284)
T ss_dssp             CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCC--
T ss_pred             cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-------Hhcccc--
Confidence            54322   123356899999999999999999999999999999999999999654433211111       111100  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          .........+..+.+++.+||+.||++|||+.++++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                001111234567889999999999999999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.9e-45  Score=326.67  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=205.1

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh------hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+.....      .....+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            4578999999999999999999875 488999999854321      135678999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC----CeeEecc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDF  164 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~----~~~l~Df  164 (340)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||+|||++|   ++|+||||+||+++.++    .++|+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999854   345899999999999999999999999   99999999999999887    7999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      |++.......   ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........       ....
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------i~~~  233 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------ITSV  233 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHTT
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhc
Confidence            9998764321   12335689999999999989999999999999999999999999965443321111       1111


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .. . .....    ....+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~-~-~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          234 SY-D-FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CC-C-CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cc-c-cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00 0 00000    0123456889999999999999999999997

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.9e-46  Score=328.08  Aligned_cols=260  Identities=24%  Similarity=0.337  Sum_probs=196.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe---
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE---   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   88 (340)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++....   ......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            457899999999999999999986 458899999996542   3345578899999999999999999999876543   


Q ss_pred             -eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           89 -RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        89 -~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                       .++||||+++++|.+++..   ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             4999999999999999854   345899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          168 RTFGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       168 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ......... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||........      ..........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCC
Confidence            876433221 223345689999999999999999999999999999999999999965443321      1111111110


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHhhcC
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVA-SMLTND  294 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl-~~L~~~  294 (340)
                      ..   ..    .....+..+.+++.+||+.||++||++.+++ ..|...
T Consensus       238 ~~---~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 PP---SA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CH---HH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             Cc---cc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            00   00    0112346788999999999999999766554 445443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.5e-45  Score=329.34  Aligned_cols=246  Identities=26%  Similarity=0.317  Sum_probs=196.7

Q ss_pred             CCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           23 GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      .+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            457999999999999864 5889999999776656677899999999999999999999999999999999999999999


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe--CCCCCeeEecccccccccCccccccc
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL--DDQMNPKISDFGMARTFGMNELEANT  179 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv--~~~~~~~l~Dfg~~~~~~~~~~~~~~  179 (340)
                      .+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||++  +.++.++|+|||++..+....   ..
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            9888542  335899999999999999999999999   9999999999999  567789999999998764322   12


Q ss_pred             ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCC
Q 041345          180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCS  259 (340)
Q Consensus       180 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (340)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+      ... .+.      ......
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~-~~~------~~~~~~  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI------LAC-RWD------LEDEEF  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHT-CCC------SCSGGG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hhc-cCC------CChhhh
Confidence            2346899999999999889999999999999999999999999765443221111      111 000      000011


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          260 PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       260 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            223567899999999999999999999997

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-45  Score=326.84  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=200.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-----CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ++|++.+.||+|+||.||+|....     +..||+|.+.... ......+.+|+.+++.++||||+++++++......++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456778899999999999997643     2359999986543 3345578899999999999999999999999889999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++....
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999998643  245899999999999999999999999   9999999999999999999999999998765


Q ss_pred             Cccccc-ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          172 MNELEA-NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       172 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........       .....+     
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~-----  266 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-------KAINDG-----  266 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTT-----
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHCC-----
Confidence            332111 1222345778999999998999999999999999999998 99999654332211       111111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                          .....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                111223345567899999999999999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5e-46  Score=325.89  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=207.4

Q ss_pred             cHHHHHHHhcCCCCCC-cccccCCeeEEEEEEC---CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeE
Q 041345            9 DFQTIAAATDNFSPGN-RLGQGGFGPVYKGKLL---DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC   82 (340)
Q Consensus         9 ~~~~i~~~~~~y~~~~-~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~   82 (340)
                      ...++....++|++.+ .||+|+||.||+|.+.   .++.||+|++....  ......+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A            7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3344445567888888 9999999999999542   36789999986543  2335678999999999999999999999


Q ss_pred             EeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        83 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                      + ..+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEc
Confidence            8 56678999999999999999954   334899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 041345          163 DFGMARTFGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       163 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      |||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........       ..
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~  232 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AM  232 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HH
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HH
Confidence            99999876433221 11222345788999999988889999999999999999999 99999754433211       11


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ...+.         ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       233 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          233 LEKGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111         12233445677999999999999999999999999998753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=323.80  Aligned_cols=270  Identities=22%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC--CCCceeeeeeEEeeC--
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL--QHTNLVRLLGCSLQK--   86 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~--   86 (340)
                      ..-....++|++.+.||+|+||.||+|+. .++.||+|++....   ...+..|.+++...  +||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34445568999999999999999999988 48999999985432   23444555655554  899999999999887  


Q ss_pred             --CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC--------CCCceeecCCCCCCeEeCCC
Q 041345           87 --GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY--------SRLRVIHRDLKASNILLDDQ  156 (340)
Q Consensus        87 --~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~~~i~H~dlk~~Nilv~~~  156 (340)
                        ...++||||+++++|.+++..    ..+++..++.++.|++.||+|||++        +   ++||||||+||+++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN  178 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred             CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence              689999999999999999943    2489999999999999999999998        7   9999999999999999


Q ss_pred             CCeeEecccccccccCccccc--ccccccccCCCCChhhhccCCCCcc------CceehhhHHHHHHHhC----------
Q 041345          157 MNPKISDFGMARTFGMNELEA--NTNRIVGTHGYMSPEYVMNGIVSMK------SDVYSFGVLVLEIISS----------  218 (340)
Q Consensus       157 ~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~vl~elltg----------  218 (340)
                      +.+||+|||++..+.......  ......||+.|+|||++.+...+.+      +|||||||++|+|++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999997664322211  1224568999999999987766655      9999999999999999          


Q ss_pred             CCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          219 KKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      ..||..........  ................   .....+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       259 ~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          259 QLPYHDLVPSDPSY--EDMREIVCIKKLRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             CCTTTTTSCSSCCH--HHHHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccHhhhcCCCCch--hhhHHHHhhhccCccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            55554332222111  1111111111000000   0001123677889999999999999999999999999987543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-45  Score=327.21  Aligned_cols=250  Identities=22%  Similarity=0.223  Sum_probs=179.1

Q ss_pred             CCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEeccCCCC
Q 041345           23 GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~  100 (340)
                      .+.||+|+||.||+|.+. +++.||+|++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999875 4889999998543   3456778999999996 9999999999999999999999999999


Q ss_pred             hhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC---CeeEecccccccccCccccc
Q 041345          101 LDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKISDFGMARTFGMNELEA  177 (340)
Q Consensus       101 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~---~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      |.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++   .++|+|||++.......  .
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            9999954   345999999999999999999999999   99999999999997665   79999999998654322  1


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES  257 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (340)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....................+...      ....
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~  238 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE  238 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence            2234567999999999999999999999999999999999999997654432221111111111111110      0000


Q ss_pred             CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       258 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .....+..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            01224567899999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.5e-45  Score=328.22  Aligned_cols=252  Identities=21%  Similarity=0.252  Sum_probs=200.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ..++|++.+.||+|+||.||+|... +++.||+|++......    ..+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4678999999999999999999875 4888999999655432    24677778777 7999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC----CCeeEeccccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ----MNPKISDFGMART  169 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~----~~~~l~Dfg~~~~  169 (340)
                      ||+++++|.+.+..   ...+++..+..++.|++.||+|||++|   |+||||||+||++.+.    +.++|+|||++..
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999854   345899999999999999999999999   9999999999998543    2499999999987


Q ss_pred             ccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||..............    ...+...  
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~--  241 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFS--  241 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCC--
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCcc--
Confidence            54322  122345689999999999888899999999999999999999999975433222111111    1111110  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          .....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                111122345567899999999999999999999886

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=317.12  Aligned_cols=253  Identities=20%  Similarity=0.259  Sum_probs=198.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC----hhcHHHHHHHHHHHHcCCCCceeeeeeEEe--eCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLGCSL--QKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   88 (340)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....    ......+.+|+.+++.++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4589999999999999999999875 47899999985432    234567899999999999999999999984  4457


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||++++ +.+++... ....+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999877 66666443 2345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccCC--CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ...............|++.|+|||.+.+..  ++.++||||||+++|+|++|..||..........       ....+. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~i~~~~-  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE-------NIGKGS-  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHCC-
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH-------HHhcCC-
Confidence            764322222333456899999999987643  4789999999999999999999997543322111       111111 


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                               ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       230 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ---------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                     11223345678899999999999999999999963

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-45  Score=323.83  Aligned_cols=264  Identities=19%  Similarity=0.227  Sum_probs=200.4

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++...+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            344588999999999999999999875 57889999986542   23346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EEEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            999999999999999854   345899999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......       ......... .. 
T Consensus       184 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~-  253 (309)
T 2h34_A          184 TTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAI-PR-  253 (309)
T ss_dssp             --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCC-CC-
T ss_pred             cccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCC-CC-
Confidence            543221 12233468899999999998899999999999999999999999996533221       011111110 00 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhcCCCCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-TMSDVASMLTNDTMAL  298 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~~  298 (340)
                           ....++..+..+.+++.+||+.||++|| |++++++.|+......
T Consensus       254 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 -----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             -----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             -----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                 0111233456788999999999999999 9999999999865543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=334.01  Aligned_cols=260  Identities=27%  Similarity=0.395  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCCeeEEEEEECC--C--CEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee-CCeeEEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLD--G--QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ-KGERLLV   92 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv   92 (340)
                      .|++.+.||+|+||.||+|...+  +  ..||+|.+... .......+.+|+.++++++||||+++++++.. ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46677899999999999997532  2  35899998654 33456788999999999999999999998654 4578999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus       170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999999543  334789999999999999999999999   99999999999999999999999999986643


Q ss_pred             ccccc--ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          173 NELEA--NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       173 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .....  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+       ..+.    
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-------~~~~----  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGR----  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-------HTTC----
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-------HcCC----
Confidence            32211  1233456788999999999999999999999999999999 56777654443321111       1111    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                           ....+...+..+.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus       314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                 111223345678999999999999999999999999998655544

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-45  Score=320.69  Aligned_cols=250  Identities=25%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-CeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-GERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|+. .++.||+|.+....  ..+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            47899999999999999999987 58899999986543  456788999999999999999999987554 468999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++++|.+++... ....+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++......  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999998543 2234889999999999999999999999   999999999999999999999999998764322  


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........       ....+         .
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-------~~~~~---------~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKG---------Y  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-------HHTTT---------C
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhcC---------C
Confidence               122356788999999998999999999999999999998 999997554332111       11111         1


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            1222344557789999999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-45  Score=325.52  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=209.3

Q ss_pred             ccHHHHHHHhcCCCCC-CcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcC-CCCceeeeeeE
Q 041345            8 FDFQTIAAATDNFSPG-NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL-QHTNLVRLLGC   82 (340)
Q Consensus         8 ~~~~~i~~~~~~y~~~-~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   82 (340)
                      ..|+....+.++|.+. +.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.+ .||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3456677788899988 89999999999999875 48999999986542  33466788999999998 57999999999


Q ss_pred             EeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCe
Q 041345           83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNP  159 (340)
Q Consensus        83 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~  159 (340)
                      +.+....++||||+++++|.+++... ....+++..+..++.|++.||+|||++|   ++||||||+||+++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999998543 2345899999999999999999999999   999999999999987   7899


Q ss_pred             eEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 041345          160 KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      +|+|||++.......   ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.    
T Consensus       174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----  246 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS----  246 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----
T ss_pred             EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH----
Confidence            999999998764321   1233568999999999999999999999999999999999999996654433211110    


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        ...       ...........+..+.+++.+||+.||++|||+.++++.
T Consensus       247 --~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          247 --QVN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             --HTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             --hcc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence              000       011111223345678899999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=333.19  Aligned_cols=265  Identities=25%  Similarity=0.400  Sum_probs=208.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-----CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC--ee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-----LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG--ER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~   89 (340)
                      .++|++.+.||+|+||.||+|+.     .+++.||+|.+..........+.+|+.+++.++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            36699999999999999999983     358889999997766666778999999999999999999999886543  68


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||++||+++   ++|+||||+||+++.++.++|+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999653  234899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC----
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG----  244 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  244 (340)
                      ....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......-        .......    
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~--------~~~~~~~~~~~  266 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--------MRMIGNDKQGQ  266 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH--------HHHHCTTCCTH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH--------HHhhccccchh
Confidence            6543221 11223456778999999998889999999999999999999998875321000        0000000    


Q ss_pred             ----cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          245 ----KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       245 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          ...+.+........+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                00011111112223344567899999999999999999999999999865

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.8e-45  Score=318.65  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=203.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ..++|++.+.||+|+||.||+|.+.+    +..||+|.+... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            35789999999999999999997543    235999998655 334567789999999999999999999997654 568


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+++++|.+++...  ...++...+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            999999999999998643  234899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+   .    ...    
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~----~~~----  231 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---E----KGD----  231 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---H----HTC----
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---h----cCC----
Confidence            43221 11223446788999999998999999999999999999998 99999654443321111   0    110    


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                           ....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          232 -----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                 1112233456789999999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.3e-45  Score=321.89  Aligned_cols=252  Identities=22%  Similarity=0.291  Sum_probs=203.9

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            35678999999999999999999875 58899999997655444567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe---CCCCCeeEecccccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTF  170 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv---~~~~~~~l~Dfg~~~~~  170 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||++|   ++|+||||+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           86 QLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999998854   335899999999999999999999999   9999999999999   77889999999998754


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ...    ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..........       ....+..    
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~i~~~~~----  224 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE-------KIKEGYY----  224 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHCCC----
T ss_pred             CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHcCCC----
Confidence            321    2233468999999999998899999999999999999999999996543322111       1111110    


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ..........+..+.+++.+||+.||++|||+.++++
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 --EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0011122334567899999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=329.02  Aligned_cols=243  Identities=21%  Similarity=0.272  Sum_probs=200.6

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--------hcHHHHHHHHHHHHcCCCCceeeeeeEEeeC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK   86 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (340)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.....        .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999864 588899999865421        1233567899999999999999999999999


Q ss_pred             CeeEEEEeccCCC-ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           87 GERLLVYEYLPNK-SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        87 ~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ...++||||+.+| +|.+++..   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99988853   335899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ++.......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......               
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------  237 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------  237 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence            998764322   2233568999999999988776 889999999999999999999995421110               


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            ...  ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       238 ------~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ------EAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------TTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------hhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  000  01112234678999999999999999999999984

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-45  Score=319.03  Aligned_cols=253  Identities=23%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +.++|.+.+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            4578999999999999999999875 48899999985543 334678899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe---CCCCCeeEeccccccc
Q 041345           94 EYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMART  169 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv---~~~~~~~l~Dfg~~~~  169 (340)
                      ||+++++|.+++.... ....+++..+..++.|++.||+|||++|   ++|+||||+||++   +.++.++|+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999999885432 2345999999999999999999999999   9999999999999   4567899999999976


Q ss_pred             ccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      .....   ......|++.|+|||.+. +.++.++||||||+++|+|++|..||............     ........  
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~~~--  245 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-----TYKEPNYA--  245 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCCCCC--
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-----ccCCcccc--
Confidence            54321   223456899999999875 56899999999999999999999999764433211111     01011000  


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                            . .....+..+.+++.+||+.||++|||+.++++
T Consensus       246 ------~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 ------V-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------C---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ------c-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0 00112456889999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=335.16  Aligned_cols=262  Identities=19%  Similarity=0.218  Sum_probs=206.7

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEee
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ   85 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (340)
                      +.++....++|++.+.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455689999999999999999999875 58999999985432   1223357889999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      .+..|+||||+++|+|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++++||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            99999999999999999999643  235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhc-------cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVM-------NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~  238 (340)
                      ++........ .......||+.|+|||++.       +..++.++|||||||++|+|++|..||...+..+....+....
T Consensus       208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  286 (412)
T 2vd5_A          208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK  286 (412)
T ss_dssp             TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            9987643221 1223457899999999986       3568999999999999999999999997655443222221100


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDR---PTMSDVASM  290 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~~  290 (340)
                      ...   ..         ...+...+.++.+||.+||. +|.+|   |+++++++.
T Consensus       287 ~~~---~~---------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          287 EHL---SL---------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHC---CC---------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             cCc---CC---------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            000   00         00112345678999999999 99998   589998763

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=317.38  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=185.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            3478999999999999999999874 68899999985432   2234678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++...  ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            99999999999998642  345899999999999999999999999   9999999999999999999999999998754


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ....  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||............               ..
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------------~~  226 (278)
T 3cok_A          164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---------------VL  226 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------CS
T ss_pred             CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------hh
Confidence            3221  122356889999999998888999999999999999999999999754433211100               00


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .  ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       227 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          227 A--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             S--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0  01122334567889999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-45  Score=321.43  Aligned_cols=253  Identities=28%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--------
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--------   85 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   85 (340)
                      ...++|++.+.||+|+||.||+|++. +++.||+|.+.....    .+.+|+.+++.++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            45678999999999999999999876 589999999865542    45789999999999999999998754        


Q ss_pred             --------CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC
Q 041345           86 --------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM  157 (340)
Q Consensus        86 --------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~  157 (340)
                              ....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                    345799999999999999996532 345899999999999999999999999   99999999999999999


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~  237 (340)
                      .++|+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...         ...
T Consensus       160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~  227 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKF  227 (284)
T ss_dssp             EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH
T ss_pred             CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH
Confidence            99999999988764322   223346899999999999989999999999999999999999886210         001


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                      ........            .+...+..+.+++.+||+.||++|||+.++++.|..+.....
T Consensus       228 ~~~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          228 FTDLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            11111111            122234568899999999999999999999999987655443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-45  Score=338.51  Aligned_cols=262  Identities=23%  Similarity=0.250  Sum_probs=196.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC------C
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK------G   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   87 (340)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999865 4888999998654  344566788999999999999999999998654      3


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..++||||++++ +.+.+.     ..+++..+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999765 555552     13889999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH----------
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA----------  237 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~----------  237 (340)
                      ......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...          
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            875432   2233467899999999999999999999999999999999999999876654432221110          


Q ss_pred             ------HHHhhcC-c-----ccccccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 ------WQLWNEG-K-----ALELIDTTLHESC---SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 ------~~~~~~~-~-----~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            ....... .     .............   ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  0000000 0     0000000000000   01225678999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.2e-45  Score=325.32  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CCE--EEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQE--IAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|++.+.||+|+||.||+|+... +..  +++|.+... .......+.+|+.+++++ +||||+++++++.+....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            679999999999999999998644 554  489988643 233455788999999999 899999999999999999999


Q ss_pred             EeccCCCChhhHhhccC-------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCe
Q 041345           93 YEYLPNKSLDFFIFDSS-------------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP  159 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~  159 (340)
                      |||+++++|.+++....             ....+++..++.++.|++.||.|||++|   ++||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999986532             2245899999999999999999999999   9999999999999999999


Q ss_pred             eEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 041345          160 KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  238 (340)
                      +|+|||++.....   ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........       
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------  251 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------  251 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH-------
Confidence            9999999874321   122233456788999999988889999999999999999998 99999654432211       


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      .....+         .....+...+..+.+++.+||+.||.+|||+.++++.|..+..
T Consensus       252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111111         1122233445778999999999999999999999999987543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-45  Score=332.19  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=192.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHH-HHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKL-IAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|+... ++.||+|++.+..   ......+.+|..+ ++.++||||+++++++.+....|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4679999999999999999998754 7889999986542   2233445566665 566799999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++..   ...+++..+..++.||+.||+|||++|   |+||||||+||+++.++++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999854   345899999999999999999999999   9999999999999999999999999998643


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..  ........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+...      ......       
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~~-------  255 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NILNKP-------  255 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH------HHHHSC-------
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHhcc-------
Confidence            22  122345678999999999999999999999999999999999999996544332211      111110       


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV  287 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  287 (340)
                          ...++..+..+.+|+.+||+.||.+||++.+.
T Consensus       256 ----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          256 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             ----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             ----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence                11223345678899999999999999998543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=330.98  Aligned_cols=261  Identities=22%  Similarity=0.262  Sum_probs=191.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEe--------e
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSL--------Q   85 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~   85 (340)
                      ...+|++.+.||+|+||.||+|++. +++.||+|++..........+.+|+.+++++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4568999999999999999999875 58899999986666666778899999999995 999999999984        3


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ...++++|||+. |+|.+++........+++..++.++.|++.||+|||+++ .+++|+||||+||+++.++.++|+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            345799999995 688888765444556999999999999999999999874 349999999999999999999999999


Q ss_pred             ccccccCccccc----------ccccccccCCCCChhhh---ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccc
Q 041345          166 MARTFGMNELEA----------NTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN  232 (340)
Q Consensus       166 ~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~  232 (340)
                      ++..........          ......+++.|+|||++   .+..++.++||||||+++|+|++|..||........  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--  261 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--  261 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence            998765322111          11134588999999988   566789999999999999999999999964322211  


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                                       +............+..+.+++.+||+.||.+|||+.++++.|..+...
T Consensus       262 -----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          262 -----------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                             011111111122234578899999999999999999999999876443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=328.47  Aligned_cols=264  Identities=23%  Similarity=0.343  Sum_probs=196.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhc-HHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999875 58899999986443221 11345799999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      ++ ++|.+++...  ...+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 5787877543  335899999999999999999999999   9999999999999999999999999997654221 


Q ss_pred             ccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc-
Q 041345          176 EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT-  253 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  253 (340)
                       .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...........+....... 
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             12233467999999999876 568999999999999999999999997765544322221111111111111111000 


Q ss_pred             --------cc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 --------LH----ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 --------~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                              ..    ....+..+..+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                    00    0001223567889999999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=324.08  Aligned_cols=244  Identities=23%  Similarity=0.295  Sum_probs=191.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.++||+|+||.||+|++. +++.||||++...  ..........|+..+..+ .||||+++++++.+....++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999876 5899999988543  223333445555555555 8999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+ +++|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 66888887543  335999999999999999999999999   999999999999999999999999998875432


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....          +.....+...    ..
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~----~~  272 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLP----PE  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCC----HH
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCC----cc
Confidence            2   2234568999999998875 789999999999999999999776632111          1111111100    00


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          .+...+..+.+++.+||+.||++|||+.++++
T Consensus       273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                11223467899999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.7e-45  Score=330.84  Aligned_cols=263  Identities=22%  Similarity=0.281  Sum_probs=204.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.+++.++||||+++++++......++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367999999999999999999875 4889999998655 34445678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||++ +   ++|+||||+||+++.++.++|+|||++..... 
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            99999999998543   3589999999999999999999996 7   99999999999999999999999999876432 


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH-------------
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL-------------  240 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-------------  240 (340)
                         .......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..............             
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               1223456899999999999999999999999999999999999999765443321111000000             


Q ss_pred             ----------hhcCcccccccc----cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          241 ----------WNEGKALELIDT----TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       241 ----------~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                .......+.++.    ..........+..+.+|+.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      000000000000    0001111223567899999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.2e-45  Score=327.36  Aligned_cols=267  Identities=21%  Similarity=0.276  Sum_probs=194.4

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ....++|++.+.||+|+||.||+|++. +++.||+|++.....  .....+.+|+.+++.++||||+++++++.+....+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            344578999999999999999999864 588899999965432  23446778999999999999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-----CCCCeeEeccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-----DQMNPKISDFG  165 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-----~~~~~~l~Dfg  165 (340)
                      +||||+++ +|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+||+++     .++.++|+|||
T Consensus       110 lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999974 888888543   34899999999999999999999999   99999999999994     44559999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ++.......  .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..........
T Consensus       183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            998764321  222334679999999999774 58999999999999999999999997655433221111100000000


Q ss_pred             ccccc---------cc----ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALEL---------ID----TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~---------~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+...         ..    ..+....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000         00    00000001113467889999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-45  Score=327.39  Aligned_cols=265  Identities=25%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .++|++.+.||+|+||.||+|+... ++.||+|++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3679999999999999999998754 8899999885443  233456789999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++......
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999888643   334899999999999999999999999   999999999999999999999999999765432


Q ss_pred             ccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH--------HHHHhhcC
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY--------AWQLWNEG  244 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~  244 (340)
                      .  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+..        ....+...
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  122334689999999998775 789999999999999999999999976654432211110        00011111


Q ss_pred             cccc-cccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALE-LIDTTLHESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .... ..........     .+..+..+.+|+.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000 0000000111     1234567999999999999999999999886

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.4e-45  Score=328.22  Aligned_cols=246  Identities=30%  Similarity=0.413  Sum_probs=198.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +.|++.+.||+|+||.||+|+. .+++.||+|++....   ......+.+|+.+++.++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            5588999999999999999986 458899999986432   233467889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+. |++.+++...  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..... 
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            9997 5777776432  345899999999999999999999999   99999999999999999999999999976532 


Q ss_pred             ccccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                           .....||+.|+|||++.   ++.++.++|||||||++|+|++|..||.........      ....... ..   
T Consensus       207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~-~~---  271 (348)
T 1u5q_A          207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE-SP---  271 (348)
T ss_dssp             -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-CC---
T ss_pred             -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-CC---
Confidence                 22356899999999884   567899999999999999999999999654332211      1111111 01   


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       272 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 01112334668899999999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.2e-45  Score=328.41  Aligned_cols=261  Identities=21%  Similarity=0.319  Sum_probs=208.1

Q ss_pred             cccHHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh--------hcHHHHHHHHHHHHcC-CCCce
Q 041345            7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG--------QGIVEFKNEAKLIAKL-QHTNL   76 (340)
Q Consensus         7 ~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i   76 (340)
                      ...+.....+.++|++.+.||+|+||.||+|... +|+.||||++.....        .....+.+|+.+++++ .||||
T Consensus        83 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i  162 (365)
T 2y7j_A           83 LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI  162 (365)
T ss_dssp             BCHHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             cccchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence            3445666777889999999999999999999875 589999999854421        1244577899999998 79999


Q ss_pred             eeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC
Q 041345           77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ  156 (340)
Q Consensus        77 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~  156 (340)
                      +++++++......++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.|   ++|+||||+||+++.+
T Consensus       163 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN  236 (365)
T ss_dssp             CCEEEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred             eEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence            9999999999999999999999999999853   345899999999999999999999999   9999999999999999


Q ss_pred             CCeeEecccccccccCcccccccccccccCCCCChhhhcc------CCCCccCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          157 MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       157 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                      +.++|+|||++..+....   ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||........
T Consensus       237 ~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  313 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM  313 (365)
T ss_dssp             CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999988764322   2234568999999998863      3588899999999999999999999965433221


Q ss_pred             cchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...       ...+..... . ..    ....+..+.+++.+||+.||++|||+.++++
T Consensus       314 ~~~-------i~~~~~~~~-~-~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 LRM-------IMEGQYQFS-S-PE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH-------HHHTCCCCC-H-HH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHH-------HHhCCCCCC-C-cc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111       111110000 0 00    0122456889999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.6e-45  Score=318.08  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=204.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|+... ++.||+|++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            3789999999999999999998754 6789999985431   22345788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999998543   35899999999999999999999999   99999999999999999999999999876532


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .    ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..........      ... ..        
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~-~~--------  227 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIV-NV--------  227 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-TT--------
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHh-cc--------
Confidence            2    1233568999999999999899999999999999999999999997544332111      111 11        


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              01122334567889999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.5e-45  Score=324.27  Aligned_cols=264  Identities=22%  Similarity=0.340  Sum_probs=200.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+...   .......+.+|+.+++.++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3467999999999999999999864 5899999998643   34456678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ||||+++++|.+++.... ....++...++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999985421 2345899999999999999999999999   999999999999999999999999998765


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ....  .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......    ... ..........   
T Consensus       187 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~-~~~~~~~~~~---  256 (310)
T 2wqm_A          187 SSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSL-CKKIEQCDYP---  256 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHH-HHHHHTTCSC---
T ss_pred             cCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHH-HHHhhcccCC---
Confidence            4322  12233468899999999999999999999999999999999999986432211    111 1111111111   


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                           ...+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       257 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          257 -----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             -----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                 111123456789999999999999999999999999886443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-45  Score=325.88  Aligned_cols=268  Identities=22%  Similarity=0.311  Sum_probs=198.1

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChh-----cHHHHHHHHHHHHcCCCCceeeeeeEEee
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQ-----GIVEFKNEAKLIAKLQHTNLVRLLGCSLQ   85 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (340)
                      ++....++|++.+.||+|+||.||+|++. +++.||+|++......     ....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            34566789999999999999999999875 4889999998643211     12357789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ....++||||+++ +|..++..  ....+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             CCceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence            9999999999976 78777743  2345888999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc-
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE-  243 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  243 (340)
                      ++.......  .......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||...........+   ...... 
T Consensus       158 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i---~~~~~~~  232 (346)
T 1ua2_A          158 LAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTP  232 (346)
T ss_dssp             GGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCC
T ss_pred             cceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHcCCC
Confidence            998764322  222345689999999998664 5899999999999999999999998765543322111   111111 


Q ss_pred             --Cccccccc------ccccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          244 --GKALELID------TTLHESCS-----PDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       244 --~~~~~~~~------~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                        ..+.....      .......+     ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              11111000      00001111     2234679999999999999999999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.4e-45  Score=318.20  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=206.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||+|+... ++.+|+|++...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            35789999999999999999998764 788999988543   23445678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++..   ...+++..+..++.|++.||+|||++|   ++|+||||+||+++.++.++|+|||++....
T Consensus        93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999998853   345899999999999999999999999   9999999999999999999999999998754


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ...  .......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+..       .......      
T Consensus       167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~------  231 (294)
T 2rku_A          167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNE------  231 (294)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC------
T ss_pred             cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhhcc------
Confidence            322  1223356899999999998888999999999999999999999999754432211       1111111      


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                11223344678899999999999999999999973

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.8e-45  Score=324.28  Aligned_cols=248  Identities=24%  Similarity=0.327  Sum_probs=205.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|.+.+.||+|+||.||++++.. ++.+|+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4679999999999999999998755 788999998543   334456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998854   345899999999999999999999999   99999999999999999999999999987543


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..  .......|+..|+|||.+.+..++.++||||||+++|+|++|..||..........      .. ....       
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~-~~~~-------  257 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RI-KKNE-------  257 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH-HHTC-------
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HH-hcCC-------
Confidence            22  12234568999999999998889999999999999999999999996544322111      11 0110       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       258 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1112233467889999999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=315.09  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=200.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      ++|.....||+|+||.||+|.+. +++.||+|.+..........+.+|+.+++.++||||+++++++......++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34455559999999999999864 47899999997666566678899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEecccccccccCccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      ++++|.+++........+++..+..++.|++.||.|||++|   ++|+||||+||+++. ++.++|+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999976544445788999999999999999999999   999999999999987 8899999999998754321 


Q ss_pred             ccccccccccCCCCChhhhccCC--CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                       .......|++.|+|||.+.+..  ++.++||||||+++|+|++|..||.........     .......         .
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~---------~  242 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----MFKVGMF---------K  242 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-----HHHHHHH---------C
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-----HHhhccc---------c
Confidence             1223456889999999987654  789999999999999999999999543222110     0000000         1


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .....+...+..+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            112223344567899999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=327.01  Aligned_cols=270  Identities=26%  Similarity=0.353  Sum_probs=198.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHH--HHcCCCCceeeeeeEEee-----CCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNLVRLLGCSLQ-----KGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~~   89 (340)
                      .++|++.+.||+|+||.||+|+. +++.||+|++....   ...+..|.++  +..++||||+++++.+..     ...+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            47899999999999999999987 78999999986443   2233444444  445799999999975532     2357


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC---------CCCceeecCCCCCCeEeCCCCCee
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY---------SRLRVIHRDLKASNILLDDQMNPK  160 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~~~~i~H~dlk~~Nilv~~~~~~~  160 (340)
                      ++||||+++++|.+++...    ..++..+..++.|++.||+|||++         +   |+||||||+||+++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            8999999999999999432    358889999999999999999999         8   99999999999999999999


Q ss_pred             EecccccccccCccc------ccccccccccCCCCChhhhcc-------CCCCccCceehhhHHHHHHHhCCCCCCCCCc
Q 041345          161 ISDFGMARTFGMNEL------EANTNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDT  227 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~vl~elltg~~p~~~~~~  227 (340)
                      |+|||++..+.....      ........||+.|+|||++.+       ..++.++|||||||++|+|++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987643221      112223468999999999876       3567899999999999999999877633322


Q ss_pred             ccc-cchhHH----------HHHHhh-cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          228 ERH-LNLVGY----------AWQLWN-EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       228 ~~~-~~~~~~----------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ... ......          ...... ......+ .  .........+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF-P--EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC-C--TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCC-C--cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            221 111100          000000 0000000 0  001112346778999999999999999999999999999876


Q ss_pred             CCCCC
Q 041345          296 MALPT  300 (340)
Q Consensus       296 ~~~~~  300 (340)
                      ..+..
T Consensus       318 ~~~~~  322 (336)
T 3g2f_A          318 MIWER  322 (336)
T ss_dssp             HCCCC
T ss_pred             HHHHh
Confidence            65544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-44  Score=325.90  Aligned_cols=267  Identities=20%  Similarity=0.303  Sum_probs=200.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEee--------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--------   85 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   85 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            478999999999999999999874 58899999985442  2234567899999999999999999999877        


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ....++||||+++ +|...+...  ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            3468999999976 666665432  234899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCccc--ccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          166 MARTFGMNEL--EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       166 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      ++..+.....  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987643221  122234567999999998876 4689999999999999999999999976655443322221111111


Q ss_pred             cCccccccc--------ccccCCCC-HH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 EGKALELID--------TTLHESCS-PD------EVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 ~~~~~~~~~--------~~~~~~~~-~~------~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+...-.        ........ ..      .+..+.+|+.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111111000        00000000 00      1356889999999999999999999997

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-44  Score=318.13  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467999999999999999999864 58899999986543 3456788999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++.......
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999842    45899999999999999999999999   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........      . ....         
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~-~~~~---------  235 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------I-PKNN---------  235 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------H-HHSC---------
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH------h-hcCC---------
Confidence              122345688999999999999999999999999999999999999965433221111      0 0111         


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111122334668999999999999999999999873

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.4e-45  Score=317.91  Aligned_cols=246  Identities=22%  Similarity=0.295  Sum_probs=199.0

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999876 5899999998653  233456778899999998 89999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC--------------
Q 041345           92 VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ--------------  156 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~--------------  156 (340)
                      ||||+++++|.+++..... ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999865322 245899999999999999999999999   9999999999999844              


Q ss_pred             -----CCeeEecccccccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          157 -----MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       157 -----~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                           ..++|+|||.+......      ....|++.|+|||.+.+. .++.++||||||+++|+|++|..++.....   
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                 47999999998875432      223488999999999766 667899999999999999999877642211   


Q ss_pred             cchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                             ......+..         ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       237 -------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -------WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   111111111         1122334567899999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1e-44  Score=341.36  Aligned_cols=253  Identities=26%  Similarity=0.339  Sum_probs=206.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+....++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999875 5899999998543   123455678999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++|+|.+++.... ...+++..+..++.||+.||.|||++|   |+||||||+||+++.++.+||+|||++.....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986532 334899999999999999999999999   99999999999999999999999999987643


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.   ......        
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---~~i~~~--------  404 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEV--------  404 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---HHHHHC--------
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---HHhhcc--------
Confidence            22   1233478999999999999899999999999999999999999997654332211111   111100        


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                        ....+...+..+.+|+.+||+.||.+||     ++.++++
T Consensus       405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              1122234456789999999999999999     7788875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=328.75  Aligned_cols=267  Identities=15%  Similarity=0.140  Sum_probs=205.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC---------CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceee---------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD---------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR---------   78 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------   78 (340)
                      .++|++.+.||+|+||.||+|+...         ++.||+|.+...     ..+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999998764         788999998644     25678999999999999887         


Q ss_pred             ------eeeEEee-CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCe
Q 041345           79 ------LLGCSLQ-KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNI  151 (340)
Q Consensus        79 ------~~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  151 (340)
                            +++++.. ....++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5667765 67889999999 99999999653 2356999999999999999999999999   99999999999


Q ss_pred             EeCCCC--CeeEecccccccccCcccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCC
Q 041345          152 LLDDQM--NPKISDFGMARTFGMNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC  224 (340)
Q Consensus       152 lv~~~~--~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~  224 (340)
                      +++.++  .++|+|||++..+......     .......|++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999988  8999999999876533211     112334789999999999998999999999999999999999999975


Q ss_pred             CCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                      ......  .+......+.. ....+.....   .....+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       271 ~~~~~~--~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          271 CLPNTE--DIMKQKQKFVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GTTCHH--HHHHHHHHHHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCcCHH--HHHHHHHhccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            432211  11111111111 1111111000   001234678999999999999999999999999987654443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=348.45  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=199.8

Q ss_pred             cccccCCeeEEEEEEC---CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCCCC
Q 041345           25 RLGQGGFGPVYKGKLL---DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        25 ~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~  100 (340)
                      .||+|+||.||+|.+.   ++..||||++.... ......+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999763   35679999996643 3456789999999999999999999999876 56899999999999


Q ss_pred             hhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc-ccc
Q 041345          101 LDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE-ANT  179 (340)
Q Consensus       101 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~  179 (340)
                      |.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......... ...
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            99998543  345899999999999999999999999   999999999999999999999999999876432211 112


Q ss_pred             ccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCC
Q 041345          180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESC  258 (340)
Q Consensus       180 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (340)
                      ....+++.|+|||++.+..++.++|||||||++|||++ |..||......+....       ...         ..+...
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~---------~~~~~~  560 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQ---------GKRMEC  560 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-------HHT---------TCCCCC
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHc---------CCCCCC
Confidence            22345688999999999999999999999999999998 9999976544332111       111         112233


Q ss_pred             CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          259 SPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       259 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      +..++..+.++|.+||+.||++|||+.+|++.|+.+
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            455667899999999999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.7e-45  Score=316.90  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh------hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+.....      .....+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999876 488999998854321      2366789999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC----CeeEeccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDFG  165 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~----~~~l~Dfg  165 (340)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++    .++|+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999854   345899999999999999999999999   99999999999998776    79999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........       .....
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~  227 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN-------ISAVN  227 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHTTC
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH-------hHhcc
Confidence            998754322   12234588999999999988999999999999999999999999975443321111       11110


Q ss_pred             ccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..  .....    ....+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 YD--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00  00000    0123456889999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.5e-44  Score=326.81  Aligned_cols=253  Identities=19%  Similarity=0.200  Sum_probs=191.7

Q ss_pred             hcCCCCC-CcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHH-cCCCCceeeeeeEEee----CCee
Q 041345           17 TDNFSPG-NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIA-KLQHTNLVRLLGCSLQ----KGER   89 (340)
Q Consensus        17 ~~~y~~~-~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~   89 (340)
                      .++|.+. +.||.|+||.||+|.+. +++.||||++...     ..+.+|+.++. ..+||||+++++++..    ...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3566666 68999999999999875 4889999998532     24567888764 4589999999998875    5568


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCeeEecccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGM  166 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~~l~Dfg~  166 (340)
                      ++||||+++|+|.+++... ....+++..+..++.|++.||.|||++|   |+||||||+||+++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999999653 2345899999999999999999999999   999999999999997   78899999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      +......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||..............   ....+..
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~i~~~~~  284 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIRMGQY  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---HHHHTCC
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---HHHcCcc
Confidence            9865422   122345689999999999889999999999999999999999999976554332211110   0001100


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .      .........+..+.+|+.+||+.||++|||+.++++.
T Consensus       285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0      0011112345678999999999999999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-44  Score=334.92  Aligned_cols=195  Identities=24%  Similarity=0.391  Sum_probs=153.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----Ce
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----GE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   88 (340)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999865 5889999998553  334556788999999999999999999998543     46


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .|+||||+ +++|.+++..   ...+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5688888843   345999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccc-------------------------cccccccccCCCCChhhh-ccCCCCccCceehhhHHHHHHHhC
Q 041345          169 TFGMNELE-------------------------ANTNRIVGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIISS  218 (340)
Q Consensus       169 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg  218 (340)
                      ........                         .......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76422110                         122345689999999976 556799999999999999999993

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-44  Score=337.19  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=206.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            77999999999999999999875 48999999985432   234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           94 EYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||+++++|..++..... ...+++..+..++.||+.||.|||++|   |+||||||+||+++.++.+||+|||++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999865332 345999999999999999999999999   99999999999999999999999999987643


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........  .........         
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~~---------  408 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLEQ---------  408 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHHC---------
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhhc---------
Confidence            22  12234578999999999999999999999999999999999999997654322111  111111111         


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTM-----SDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  289 (340)
                        ....+...+..+.+++.+||+.||++||++     .++++
T Consensus       409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence              112233455778999999999999999975     56653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-45  Score=335.63  Aligned_cols=242  Identities=14%  Similarity=0.163  Sum_probs=187.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCC---ChhcHHHHHHHHHH---HHcCCCCceeeee-------eE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKS---SGQGIVEFKNEAKL---IAKLQHTNLVRLL-------GC   82 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~---l~~l~h~~i~~~~-------~~   82 (340)
                      .++|++.+.||+|+||.||+|++ .+++.||||++...   .......+.+|+.+   ++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999986 45899999998632   33456778899954   4555799999988       55


Q ss_pred             EeeCC-----------------eeEEEEeccCCCChhhHhhccCc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 041345           83 SLQKG-----------------ERLLVYEYLPNKSLDFFIFDSSK----KELLDWKKRFNIIEGIVQGLLYLHKYSRLRV  141 (340)
Q Consensus        83 ~~~~~-----------------~~~iv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  141 (340)
                      +.+.+                 ..++||||+ +|+|.+++.....    ...+++..++.++.|++.||+|||++|   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 6799999864311    112335888899999999999999999   9


Q ss_pred             eecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccC-----------CCCccCceehhhH
Q 041345          142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-----------IVSMKSDVYSFGV  210 (340)
Q Consensus       142 ~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~  210 (340)
                      +||||||+||+++.++.+||+|||++...+.     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2233456 999999999877           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          211 LVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       211 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ++|+|++|..||...........+               ..      .....+..+.+++.+||+.||++|||+.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~---------------~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI---------------FR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG---------------GS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchhhh---------------hh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999999654433322111               00      01223467889999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-44  Score=338.82  Aligned_cols=253  Identities=25%  Similarity=0.312  Sum_probs=203.6

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .+.++|++.+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            45678999999999999999999875 5889999998532  22345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC---CCCCeeEecccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMAR  168 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~---~~~~~~l~Dfg~~~  168 (340)
                      |||||.+++|.+.+...   ..+++..+..++.|++.||.|||++|   |+||||||+||+++   .++.++|+|||++.
T Consensus        99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999999888543   45899999999999999999999999   99999999999995   45679999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      .+....   ......||+.|+|||++.+ .++.++||||+||++|+|++|..||...........+       ..+....
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~~  241 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------ETGKYAF  241 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCCS
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCCC
Confidence            654321   2233568999999998865 5899999999999999999999999765443321111       1111000


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            ........+..+.+++.+||+.||.+|||+.++++.
T Consensus       242 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  001112345678899999999999999999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.8e-44  Score=331.62  Aligned_cols=199  Identities=24%  Similarity=0.387  Sum_probs=165.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----Ce
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----GE   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   88 (340)
                      .++|++.+.||+|+||.||+|++.. ++.||||++...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            5789999999999999999998754 788999999653  334456788999999999999999999998766     56


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .|+||||++ ++|.+++..   ...+++..+..++.||+.||.|||++|   |+||||||+||+++.++.+||+|||++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 589888843   345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccc--------------------cccccccccCCCCChhhh-ccCCCCccCceehhhHHHHHHHhCCCCC
Q 041345          169 TFGMNELE--------------------ANTNRIVGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       169 ~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~vl~elltg~~p~  222 (340)
                      ........                    .......||+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76432211                    122456789999999986 5567999999999999999999865554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-45  Score=328.33  Aligned_cols=259  Identities=23%  Similarity=0.299  Sum_probs=196.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG------   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------   87 (340)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            478999999999999999999874 5899999998543  3334567889999999999999999999987653      


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .+++||||+ +++|.+++..    ..+++..+..++.|++.||.|||++|   ++||||||+||+++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 8899999853    35899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH-----Hh
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ-----LW  241 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~  241 (340)
                      ......     .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.....     .+
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            875421     234567999999999877 6799999999999999999999999976655433222111000     00


Q ss_pred             h---cC-------cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          242 N---EG-------KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       242 ~---~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .   ..       ......... .....+..+..+.+|+.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhhhHHHHHHHHhCCCCCCCC-HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            0   00       000000000 01112334567899999999999999999999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.8e-45  Score=339.96  Aligned_cols=251  Identities=26%  Similarity=0.340  Sum_probs=205.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4578999999999999999999875 58999999985432   3456788999999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe---CCCCCeeEecccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMAR  168 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv---~~~~~~~l~Dfg~~~  168 (340)
                      ||||+.+++|.+.+..   ...+++..+..++.|++.||+|||++|   |+||||||+||++   +.++.++|+|||++.
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999998854   345899999999999999999999999   9999999999999   467889999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      .+....   ......||+.|+|||++.+ .++.++||||+||++|+|++|..||...+.......+       ..+... 
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~-  245 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------EKGKYT-  245 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCC-
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCC-
Confidence            764322   2234568999999998865 6899999999999999999999999765443322111       111100 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                           .........+..+.+++.+||+.||.+|||+.++++
T Consensus       246 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 -----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                 000111234567899999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.3e-44  Score=319.10  Aligned_cols=271  Identities=23%  Similarity=0.285  Sum_probs=208.5

Q ss_pred             cHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHc--CCCCceeeeeeEEeeC
Q 041345            9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLVRLLGCSLQK   86 (340)
Q Consensus         9 ~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~   86 (340)
                      ++..-..+.++|++.+.||+|+||.||+|+. +++.||+|++...   ....+.+|.+++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3444556678999999999999999999988 6899999998543   24466788888887  6899999999998877


Q ss_pred             C----eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCCeEeC
Q 041345           87 G----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH--------KYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        87 ~----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~dlk~~Nilv~  154 (340)
                      .    ..++||||+++++|.+++..    ..+++..++.++.|++.||+|||        +++   ++|+||||+||+++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK  181 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence            5    78999999999999999953    34899999999999999999999        777   99999999999999


Q ss_pred             CCCCeeEecccccccccCccccc--ccccccccCCCCChhhhccC------CCCccCceehhhHHHHHHHhC--------
Q 041345          155 DQMNPKISDFGMARTFGMNELEA--NTNRIVGTHGYMSPEYVMNG------IVSMKSDVYSFGVLVLEIISS--------  218 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~vl~elltg--------  218 (340)
                      .++.++|+|||++..........  ......|++.|+|||.+.+.      .++.++||||||+++|+|++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998765332211  22345689999999998765      234789999999999999999        


Q ss_pred             --CCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          219 --KKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       219 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                        ..||.........  ................+..   ..........+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       262 ~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPS--VEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccCccccCcCccc--HHHHHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence              6677543332211  1111111111111000000   0012466778999999999999999999999999998753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.2e-44  Score=332.47  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=205.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCC-CceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH-TNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++......  ..+.+|+.+++.+.| +++..+..++......++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            57899999999999999999986 45889999987544322  246789999999976 566666667777888999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe---CCCCCeeEeccccccccc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFG  171 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv---~~~~~~~l~Dfg~~~~~~  171 (340)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||+   +.++.++|+|||++..+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998642  335999999999999999999999999   9999999999999   578899999999998765


Q ss_pred             Ccccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          172 MNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       172 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      .....     .......||..|+|||.+.+..++.++|||||||++|+|++|..||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            43221     1122467899999999999999999999999999999999999999766554433322221111111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..+     .    ...+.++.+++..||+.+|++||++.+|++.|+++
T Consensus       238 ~~l-----~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          238 EAL-----C----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHH-----H----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHH-----h----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            000     0    11245789999999999999999999999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-44  Score=339.46  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=198.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      +.++|++.+.||+|+||.||+|+.. ++..||+|++....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999875 58899999986542  23356788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC---CCeeEeccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMART  169 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~---~~~~l~Dfg~~~~  169 (340)
                      ||||++++|.+.+...   ..+++..+..++.|++.||+|||++|   |+||||||+||+++..   +.+||+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999888543   45899999999999999999999999   9999999999999764   4599999999987


Q ss_pred             ccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      +....   ......||+.|+|||++. +.++.++||||+||++|+|++|..||...........+       ..+.... 
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~~-  256 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------EKGKYTF-  256 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCCC-
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCCC-
Confidence            65322   223456899999999875 56899999999999999999999999765543322111       1111000 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                           ........+..+.+++.+||+.||.+|||+.++++
T Consensus       257 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          257 -----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                 00001223467889999999999999999999885

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-44  Score=318.66  Aligned_cols=253  Identities=22%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..++|++.+.||+|+||.||+|++.. ++.||+|++..........+.+|+.+++.++||||+++++++......++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            45789999999999999999998764 88999999976666667889999999999999999999999999989999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++...  ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++...... 
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999988542  234899999999999999999999999   999999999999999999999999987643211 


Q ss_pred             cccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                       ........|++.|+|||.+.     +..++.++||||||+++|+|++|..||...+.....      ..... ..... 
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~~-  241 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAK-SDPPT-  241 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCCCC-
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhc-cCCcc-
Confidence             11122346889999999883     567899999999999999999999999755433211      11111 11110 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                            ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       242 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 ------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  1112334567899999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.7e-45  Score=318.28  Aligned_cols=259  Identities=24%  Similarity=0.336  Sum_probs=204.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCeeE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   90 (340)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+...  .......+.+|+.++++++||||+++++++..  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4578999999999999999999875 5889999998643  33455678899999999999999999998754  56799


Q ss_pred             EEEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYS--RLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      +||||+++++|.+++.... ....+++..++.++.|++.||+|||+++  ..+++|+||||+||+++.++.++|+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999986532 2334899999999999999999999976  234999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ........  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.........       .....+.. 
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~~-  233 (279)
T 2w5a_A          164 RILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------GKIREGKF-  233 (279)
T ss_dssp             HHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC-
T ss_pred             eeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH-------HHHhhccc-
Confidence            87543211  122346899999999999889999999999999999999999999765432211       11111111 


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                              ...+...+..+.+++.+||+.||++|||+.++++.+.
T Consensus       234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                    1122344567899999999999999999999998654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-45  Score=326.55  Aligned_cols=254  Identities=22%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEE----CCCCEEEEEEccCCC----hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKL----LDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   88 (340)
                      ++|++.+.||+|+||.||+|+.    .+++.||+|++....    ......+.+|+.+++.+ .||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6899999999999999999987    368899999985432    12334567789999999 69999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999854   335899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      .+..... .......||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+.  ......   
T Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~---  281 (355)
T 1vzo_A          208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS---  281 (355)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC---
T ss_pred             ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHhcc---
Confidence            6543221 223345689999999999753  47899999999999999999999996544333221111  111110   


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVASML  291 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~L  291 (340)
                              ....+...+..+.+|+.+||+.||.+||     |+.++++..
T Consensus       282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                    1122344456788999999999999999     999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=325.08  Aligned_cols=264  Identities=25%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             ccccccHHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeee
Q 041345            4 DLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLG   81 (340)
Q Consensus         4 ~~~~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~   81 (340)
                      +++.+++..+....++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++++ +||||+++++
T Consensus        10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeee
Confidence            4455666777778899999999999999999999874 58899999986543 2345788999999998 7999999999


Q ss_pred             EEee------CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC
Q 041345           82 CSLQ------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD  155 (340)
Q Consensus        82 ~~~~------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~  155 (340)
                      ++..      ....++||||+++++|.+++... ....+++..+..++.|++.||.|||++|   ++|+||||+||+++.
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~  164 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTE  164 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECT
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcC
Confidence            9877      46789999999999999998653 2345899999999999999999999999   999999999999999


Q ss_pred             CCCeeEecccccccccCcccccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          156 QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       156 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                      ++.++|+|||++.......  .......|++.|+|||.+.     +..++.++||||||+++|+|++|..||........
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  242 (326)
T 2x7f_A          165 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  242 (326)
T ss_dssp             TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             CCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence            9999999999987654221  1223356899999999986     56789999999999999999999999965433221


Q ss_pred             cchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .      ....... ...        ..+...+..+.+++.+||..||.+|||+.++++
T Consensus       243 ~------~~~~~~~-~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 L------FLIPRNP-APR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             H------HHHHHSC-CCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H------HHhhcCc-ccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1      1111111 110        111223467889999999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-44  Score=326.84  Aligned_cols=269  Identities=22%  Similarity=0.285  Sum_probs=200.3

Q ss_pred             cHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC-----------hhcHHHHHHHHHHHHcCCCCcee
Q 041345            9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS-----------GQGIVEFKNEAKLIAKLQHTNLV   77 (340)
Q Consensus         9 ~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~   77 (340)
                      ...++....++|++.+.||+|+||.||+|...+++.||+|++....           ......+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3567888899999999999999999999998889999999884421           12236789999999999999999


Q ss_pred             eeeeEEee-----CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeE
Q 041345           78 RLLGCSLQ-----KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL  152 (340)
Q Consensus        78 ~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nil  152 (340)
                      ++++++..     ....++||||++ ++|.+.+..  ....+++..+..++.|++.||.|||++|   ++|+||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            99999854     236899999997 577777653  3345899999999999999999999999   999999999999


Q ss_pred             eCCCCCeeEecccccccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCccccc
Q 041345          153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL  231 (340)
Q Consensus       153 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~  231 (340)
                      ++.++.++|+|||++......   .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999754322   22234567899999999876 67899999999999999999999999765443322


Q ss_pred             chhHHHHHHhhcCccc-----------ccccccc-------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          232 NLVGYAWQLWNEGKAL-----------ELIDTTL-------HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       232 ~~~~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+   ..........           ..+....       .....+..+..+.+|+.+||+.||++|||+.++++
T Consensus       244 ~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          244 NKI---VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHH---HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH---HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            111   1100000000           0000000       00011223567889999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.7e-45  Score=319.88  Aligned_cols=266  Identities=24%  Similarity=0.344  Sum_probs=188.4

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ....++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            345689999999999999999999754 58899999985443 2345567889999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhcc-----CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           92 VYEYLPNKSLDFFIFDS-----SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                      ||||+++++|.+++...     .....+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999998541     12345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCccc---ccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          167 ARTFGMNEL---EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       167 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      +........   ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||..........      ... 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~-  240 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTL-  240 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHH-
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHh-
Confidence            876543211   111233568999999999865 568999999999999999999999997655433211      111 


Q ss_pred             cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....................+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111110000111112233467889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=325.55  Aligned_cols=252  Identities=14%  Similarity=0.150  Sum_probs=201.6

Q ss_pred             HhcCCCCCCcccccCCeeEEEEE------ECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC---CCceeeeeeEEeeC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGK------LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ---HTNLVRLLGCSLQK   86 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   86 (340)
                      ..++|++.+.||+|+||.||+|.      ...++.||+|++....   ...+..|+.+++.+.   |+|++++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34678899999999999999993      4458899999996554   335677777777775   99999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccC--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---------
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSS--KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---------  155 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---------  155 (340)
                      +..++||||+++|+|.+++....  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999996421  2345999999999999999999999999   999999999999988         


Q ss_pred             --CCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccch
Q 041345          156 --QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNL  233 (340)
Q Consensus       156 --~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~  233 (340)
                        ++.+||+|||++..+.............||+.|+|||++.+..++.++|||||||++|+|++|..||.........  
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--  294 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--  294 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence              8999999999997654322233344567899999999999999999999999999999999999998432221100  


Q ss_pred             hHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhhcC
Q 041345          234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDR-PTMSDVASMLTND  294 (340)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~~  294 (340)
                                      +...+...   .....+.+++..|++.+|.+| |++.++.+.|++.
T Consensus       295 ----------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          295 ----------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ----------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ----------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                            01111111   124567788899999999999 7788888888764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=316.42  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=200.1

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ..++|++.+.||+|+||.||+|.... ++.||+|.+....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45789999999999999999998754 8899999986543  34578899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+++++|.+++...  ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++.......
T Consensus       105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999998532  345899999999999999999999999   9999999999999999999999999997654321


Q ss_pred             cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.........      ...... ...       
T Consensus       180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-~~~-------  243 (314)
T 3com_A          180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTN-PPP-------  243 (314)
T ss_dssp             --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-CCC-------
T ss_pred             --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcC-CCc-------
Confidence              1223456889999999999889999999999999999999999999654332211      111011 000       


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            01112334567899999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-44  Score=312.93  Aligned_cols=248  Identities=22%  Similarity=0.349  Sum_probs=196.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999875 58999999985432   23456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998543   35899999999999999999999999   99999999999999999999999999987543


Q ss_pred             cccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ..   ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.........       .....+.      
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~------  227 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF-------KKIRGGV------  227 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC------
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-------HHhhcCc------
Confidence            22   1223467899999999887665 68999999999999999999999654332211       1111110      


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                          ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       228 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 ----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                11122334678899999999999999999999973

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.6e-45  Score=318.16  Aligned_cols=258  Identities=26%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC--CCC--EEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL--DGQ--EIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|++.+.||+|+||.||+|++.  +++  .||+|++...   .......+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            468999999999999999999753  233  5899988644   2344667889999999999999999999987765 8


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++|+||+++++|.+++...  ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            9999999999999998643  345899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........      .......   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~---  241 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEG---  241 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSC---
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHccC---
Confidence            6433221 12233456778999999988889999999999999999999 99999655433211      1111111   


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                            .....+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus       242 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          242 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                  111122344577999999999999999999999999998753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.3e-45  Score=331.56  Aligned_cols=264  Identities=21%  Similarity=0.279  Sum_probs=197.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC------eeE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG------ERL   90 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~   90 (340)
                      ..+|++.+.||+|+||.||+|+...+..+|+|++......    ..+|+.+++.++||||+++++++....      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3569999999999999999999877777999987543322    236999999999999999999986543      278


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCCeeEeccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMART  169 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~~~l~Dfg~~~~  169 (340)
                      +||||++++.+............+++..+..++.|++.||+|||++|   |+||||||+||+++ .++.+||+|||++..
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655544432233456999999999999999999999999   99999999999998 789999999999987


Q ss_pred             ccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HHH
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQL  240 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~  240 (340)
                      .....   ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...        ...
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54322   12235678999999998765 5899999999999999999999999776554332211110        000


Q ss_pred             hh----cCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          241 WN----EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       241 ~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..    ................+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00    000000000000011112245679999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-44  Score=338.47  Aligned_cols=252  Identities=27%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCCh-------------hcHHHHHHHHHHHHcCCCCceeeee
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSG-------------QGIVEFKNEAKLIAKLQHTNLVRLL   80 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~   80 (340)
                      .+.++|++.+.||+|+||.||+|+... ++.||+|++.....             .....+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            356889999999999999999998754 78899999854321             2356788999999999999999999


Q ss_pred             eEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC---
Q 041345           81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM---  157 (340)
Q Consensus        81 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~---  157 (340)
                      +++.+....++|||||++++|.+.+..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++   
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999998854   345899999999999999999999999   99999999999998775   


Q ss_pred             CeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH
Q 041345          158 NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       158 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~  237 (340)
                      .++|+|||++.......   ......||+.|+|||++. +.++.++||||+||++|+|++|..||...........+   
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---  259 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---  259 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence            69999999998764321   223456899999999886 56899999999999999999999999765543322111   


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ..+....  ...    .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       260 ----~~~~~~~--~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          260 ----EKGKYYF--DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ----HHCCCCC--CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HcCCCCC--Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                1111000  000    00123467899999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.7e-44  Score=328.70  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=192.2

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--------hhcHHHHHHHHHHHHcCCCCceeeeeeEEe
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQHTNLVRLLGCSL   84 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (340)
                      ....++|.+.+.||+|+||.||+|.... ++.||+|++....        ......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3456899999999999999999998654 7899999985431        112234788999999999999999999875


Q ss_pred             eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC---CeeE
Q 041345           85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKI  161 (340)
Q Consensus        85 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~---~~~l  161 (340)
                       ....++||||+++++|.+++.   ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++   .+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence             456899999999999999884   3445999999999999999999999999   99999999999997544   5999


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~  238 (340)
                      +|||++......   .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.........  ..   
T Consensus       284 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~---  355 (419)
T 3i6u_A          284 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KD---  355 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HH---
T ss_pred             eecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HH---
Confidence            999999876432   22234568999999998853   57889999999999999999999999654333211  10   


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       ....+... ....     .....+..+.+++.+||+.||++|||+.++++
T Consensus       356 -~i~~~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          356 -QITSGKYN-FIPE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -HHHTTCCC-CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHhcCCCC-CCch-----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             11111100 0000     00123467889999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=323.67  Aligned_cols=272  Identities=24%  Similarity=0.378  Sum_probs=199.7

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ...++|++.+.||+|+||.||+|++.+  .+|+|++....  ......+.+|+.++++++||||+++++++.+....++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345789999999999999999998743  49999985432  22334567899999999999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||++|   ++|+||||+||+++ ++.++|+|||++.....
T Consensus       108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            9999999999998542  335899999999999999999999999   99999999999998 67999999999876532


Q ss_pred             ccc---ccccccccccCCCCChhhhcc---------CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 041345          173 NEL---EANTNRIVGTHGYMSPEYVMN---------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL  240 (340)
Q Consensus       173 ~~~---~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  240 (340)
                      ...   ........|++.|+|||.+.+         ..++.++||||||+++|+|++|..||.........      .. 
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~-  254 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------WQ-  254 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH------HH-
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-
Confidence            111   112233458899999999864         35788999999999999999999999654433211      11 


Q ss_pred             hhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCceeee
Q 041345          241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFIN  309 (340)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~  309 (340)
                      ...+.....        .+...+..+.+++.+||+.||++|||+.++++.|+.+.........|..+|.
T Consensus       255 ~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~  315 (319)
T 2y4i_B          255 MGTGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK  315 (319)
T ss_dssp             HHTTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred             hccCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence            111111111        0112335688999999999999999999999999998777666555555554

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-44  Score=346.58  Aligned_cols=248  Identities=26%  Similarity=0.361  Sum_probs=198.9

Q ss_pred             CcccccCCeeEEEEEEC---CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLL---DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      +.||+|+||.||+|.+.   .++.||||++....  ......+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            36999999999999642   35789999986542  3346789999999999999999999999864 458899999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc-cc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL-EA  177 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~  177 (340)
                      ++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||++..+..... ..
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999953   345899999999999999999999999   99999999999999999999999999987653322 12


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+       ..         ....
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~---------~~~~  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EK---------GERM  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HT---------TCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------Hc---------CCCC
Confidence            2233446788999999999999999999999999999998 99999765443321111       11         1122


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..+..++..+.++|.+||+.||++|||+.+|++.|+++
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            33445567899999999999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3e-45  Score=324.27  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=200.6

Q ss_pred             ccccHHHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCC--CCceeeeee
Q 041345            6 KIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ--HTNLVRLLG   81 (340)
Q Consensus         6 ~~~~~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~   81 (340)
                      +.+.++.+....++|++.+.||+|+||.||++...+++.||+|++...  .......+.+|+.++.+++  |+||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            345556666677899999999999999999999888999999998543  3445677889999999996  599999999


Q ss_pred             EEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        82 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      ++......++||| +.+++|.+++...   ..++...+..++.|++.||.|||+++   ++|+||||+||++++ +.++|
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence            9999999999999 5688999998543   35899999999999999999999999   999999999999965 78999


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhcc-----------CCCCccCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN-----------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                      +|||++................|++.|+|||.+.+           ..++.++||||||+++|+|++|..||....... 
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-  246 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence            99999987654332223334568999999999865           468889999999999999999999996432211 


Q ss_pred             cchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          .........         ......+...+..+.+++.+||+.||++|||+.++++
T Consensus       247 ----~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          247 ----SKLHAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ----HHHHHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHHhc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                111111111         1111122223467889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.8e-44  Score=313.24  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=203.7

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---------hhcHHHHHHHHHHHHcCC-CCceee
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---------GQGIVEFKNEAKLIAKLQ-HTNLVR   78 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~   78 (340)
                      ........++|++.+.||+|+||.||+|... +++.||+|++....         ......+.+|+.+++++. ||||++
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A            9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             ------CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             ccCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            3445566789999999999999999999875 47889999985442         122456788999999995 999999


Q ss_pred             eeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC
Q 041345           79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN  158 (340)
Q Consensus        79 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~  158 (340)
                      +++++......++||||+++++|.+++..   ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  162 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN  162 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence            99999999999999999999999999854   345899999999999999999999999   999999999999999999


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhc------cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccc
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM------NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN  232 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~  232 (340)
                      ++|+|||++.......   ......+++.|+|||.+.      ...++.++||||||+++|+|++|..||..........
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  239 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR  239 (298)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence            9999999998754322   223356889999999885      4568899999999999999999999996544322111


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .       ...+...      .........+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~-------~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 M-------IMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H-------HHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H-------HhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1       1111100      001111334567899999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-43  Score=323.30  Aligned_cols=262  Identities=21%  Similarity=0.218  Sum_probs=201.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC--------CCceeeeeeEEe---
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ--------HTNLVRLLGCSL---   84 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---   84 (340)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++... ......+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999864 4788999999644 344567889999999885        788999999887   


Q ss_pred             -eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCC-----
Q 041345           85 -QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQM-----  157 (340)
Q Consensus        85 -~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~-----  157 (340)
                       .....++||||+. +++.+.+... ....+++..+..++.||+.||.|||++ |   |+||||||+||+++.++     
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             4557899999994 5555555432 224589999999999999999999998 8   99999999999998775     


Q ss_pred             --------------------------------------------CeeEecccccccccCcccccccccccccCCCCChhh
Q 041345          158 --------------------------------------------NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY  193 (340)
Q Consensus       158 --------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  193 (340)
                                                                  .++|+|||++......     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999875422     233468999999999


Q ss_pred             hccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH---hhc--------Cccc-ccccc---------
Q 041345          194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL---WNE--------GKAL-ELIDT---------  252 (340)
Q Consensus       194 ~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~--------~~~~-~~~~~---------  252 (340)
                      +.+..++.++|||||||++|+|++|..||..................   ...        +... .....         
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999999766654432211111110   000        0000 00000         


Q ss_pred             ----------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 ----------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                ......+...+..+.+|+.+||+.||++|||+.++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                      0011345677888999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-43  Score=320.81  Aligned_cols=262  Identities=23%  Similarity=0.244  Sum_probs=193.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG------   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------   87 (340)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999865 4888999998643  3344567889999999999999999999987654      


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..++||||+++ +|.+.+.     ..+++..+..++.|++.||+|||++|   ++||||||+||+++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            68999999975 6777763     23889999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH-----------
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY-----------  236 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~-----------  236 (340)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..           
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8654221   22335689999999999998999999999999999999999999976554322111100           


Q ss_pred             -----HHHHhhc-Cccc-----ccccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          237 -----AWQLWNE-GKAL-----ELIDTTLHESC---SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       237 -----~~~~~~~-~~~~-----~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                           ....... ....     ...........   +...+..+.+|+.+||+.||++|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                 0000000 0000     00000000000   12346789999999999999999999999873

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-44  Score=328.33  Aligned_cols=266  Identities=18%  Similarity=0.241  Sum_probs=196.4

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----   86 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   86 (340)
                      +....++|++.+.||+|+||.||+|++ .+++.||+|++......    ..+|+.+++.++||||+++++++...     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345678999999999999999999986 45899999988554322    24799999999999999999998442     


Q ss_pred             ---------------------------------CeeEEEEeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHH
Q 041345           87 ---------------------------------GERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLY  132 (340)
Q Consensus        87 ---------------------------------~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~  132 (340)
                                                       ...++||||++ ++|.+.+... .....+++..+..++.|++.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             34889999997 4777666431 233469999999999999999999


Q ss_pred             HHhCCCCceeecCCCCCCeEeC-CCCCeeEecccccccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhH
Q 041345          133 LHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGV  210 (340)
Q Consensus       133 LH~~~~~~i~H~dlk~~Nilv~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~  210 (340)
                      ||++|   |+||||||+||+++ .++.++|+|||++.......   ......+++.|+|||.+.+. .++.++||||+||
T Consensus       157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            99999   99999999999997 68899999999998754322   22334678999999998765 4899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcccccchhHHH--------HHHhh----cCcccccccccccCCCCHHHHHHHHHHHHhccCCCC
Q 041345          211 LVLEIISSKKNNGCYDTERHLNLVGYA--------WQLWN----EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKA  278 (340)
Q Consensus       211 vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  278 (340)
                      ++|+|++|..||......+....+...        .....    ................+...+..+.+|+.+||+.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            999999999999776554432221110        00000    000000000001111223345678999999999999


Q ss_pred             CCCCCHHHHHH
Q 041345          279 TDRPTMSDVAS  289 (340)
Q Consensus       279 ~~RPt~~evl~  289 (340)
                      ++|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.1e-44  Score=345.74  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=204.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCC---ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|+... ++.||||++...   .......+..|..++..+ .||+|+++++++.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            4679999999999999999998754 788999998643   223345677899999887 79999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++|+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999998543   45999999999999999999999999   9999999999999999999999999998643


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|..||...+..+....+      . ..       
T Consensus       494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~-~~-------  557 (674)
T 3pfq_A          494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------M-EH-------  557 (674)
T ss_dssp             CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-SS-------
T ss_pred             cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------H-hC-------
Confidence            221  2234567999999999999999999999999999999999999999765443322111      1 11       


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM-----SDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~  289 (340)
                         ....+...+.++.+|+.+||+.||++||++     .+|++
T Consensus       558 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 ---NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               112234456778999999999999999998     66664

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.4e-44  Score=311.53  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=196.8

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee----CCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~   90 (340)
                      +.|++.+.||+|+||.||+|.+. ++..||+|.+...  .......+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            44788889999999999999875 4778999988543  34456678899999999999999999998865    34589


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCCeeEeccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMART  169 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~~~l~Dfg~~~~  169 (340)
                      +||||+++++|.+++..   ...+++..+..++.|++.||.|||+++ .+++|+||||+||+++ .++.++|+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999954   245899999999999999999999874 3499999999999998 788999999999975


Q ss_pred             ccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ....    ......|++.|+|||.+. +.++.++||||||+++|+|++|..||.........      ......+.... 
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~-  249 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPA-  249 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCG-
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH------HHHHhccCCcc-
Confidence            4322    223356899999999876 45899999999999999999999999654332211      11111111111 


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                             ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus       250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   011122356899999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=328.79  Aligned_cols=270  Identities=23%  Similarity=0.341  Sum_probs=184.0

Q ss_pred             HHhcCCCC-CCcccccCCeeEEEEEEC---CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCe
Q 041345           15 AATDNFSP-GNRLGQGGFGPVYKGKLL---DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGE   88 (340)
Q Consensus        15 ~~~~~y~~-~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   88 (340)
                      ...+.|++ +++||+|+||.||+|+..   +++.||+|++.....  ...+.+|+.+++.++||||+++++++..  ...
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            33456777 558999999999999865   478899999965432  2367899999999999999999999954  678


Q ss_pred             eEEEEeccCCCChhhHhhccC------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe----CCCCC
Q 041345           89 RLLVYEYLPNKSLDFFIFDSS------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL----DDQMN  158 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv----~~~~~  158 (340)
                      .++||||+.+ +|.+++....      ....+++..+..++.||+.||+|||+++   |+||||||+||++    +.++.
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence            9999999965 6666664221      1224899999999999999999999999   9999999999999    67789


Q ss_pred             eeEecccccccccCccc-ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCccccc-----
Q 041345          159 PKISDFGMARTFGMNEL-EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL-----  231 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~-----  231 (340)
                      ++|+|||++..+..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.........     
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            99999999987653211 1223346789999999998774 5899999999999999999999999655432100     


Q ss_pred             -chhHHHHHHhhcC---cccccc------------cccccCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041345          232 -NLVGYAWQLWNEG---KALELI------------DTTLHESCS---------PDEVTRCIHVGLLCVQDKATDRPTMSD  286 (340)
Q Consensus       232 -~~~~~~~~~~~~~---~~~~~~------------~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~e  286 (340)
                       ..+..........   .+..+.            .......+.         ...+..+.+|+.+||+.||.+|||+.|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence             1111111111100   000000            000000000         011456889999999999999999999


Q ss_pred             HHHH
Q 041345          287 VASM  290 (340)
Q Consensus       287 vl~~  290 (340)
                      +++.
T Consensus       331 ~L~h  334 (405)
T 3rgf_A          331 AMQD  334 (405)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9973

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-44  Score=327.09  Aligned_cols=261  Identities=22%  Similarity=0.292  Sum_probs=185.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC------C
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK------G   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   87 (340)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999864 4889999998653  334456788999999999999999999998654      4


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..++|++++ +++|.+++..    ..+++..+..++.|++.||.|||++|   ++||||||+||+++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999998 7889888743    35899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH-----h
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL-----W  241 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----~  241 (340)
                      .....     ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......     +
T Consensus       180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            86432     1234568999999999877 67899999999999999999999999776654333222110000     0


Q ss_pred             hc---Cccccccccccc-CCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          242 NE---GKALELIDTTLH-ESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       242 ~~---~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..   ......+..... ...     .+..+..+.+|+.+||+.||++|||+.++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00   000000000000 000     01234678899999999999999999999873

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-43  Score=315.92  Aligned_cols=258  Identities=17%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEE-CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEee--CCeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQ--KGERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~iv   92 (340)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....   ...+.+|+.+++.+. ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999986 458899999986443   457889999999996 9999999999987  5678999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEeccccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFG  171 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~~  171 (340)
                      |||+++++|.+++.      .++...+..++.|++.||+|||++|   ++||||||+||+++.++ .++|+|||++....
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998873      2889999999999999999999999   99999999999999766 79999999998654


Q ss_pred             CcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcc-cccchhHH------HHHHhhc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE-RHLNLVGY------AWQLWNE  243 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~-~~~~~~~~------~~~~~~~  243 (340)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... .....+..      .......
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            322   2233467889999999877 67899999999999999999999998433221 11100000      0000000


Q ss_pred             --------------CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          244 --------------GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       244 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                    ...............+...+..+.+|+.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                          0000001111112222334678999999999999999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-44  Score=325.25  Aligned_cols=253  Identities=9%  Similarity=0.037  Sum_probs=180.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh---hcHHHHHHHHHHHHcC--CCCceeeee-------eEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAKL--QHTNLVRLL-------GCSL   84 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~   84 (340)
                      .+|++.+.||+|+||.||+|++. +++.||+|++.....   .....+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            34889999999999999999875 588999999966432   3345567775444444  699988755       4443


Q ss_pred             eC-----------------CeeEEEEeccCCCChhhHhhccCccccCCHHHH------HHHHHHHHHHHHHHHhCCCCce
Q 041345           85 QK-----------------GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR------FNIIEGIVQGLLYLHKYSRLRV  141 (340)
Q Consensus        85 ~~-----------------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~~~i  141 (340)
                      ..                 ...++||||++ ++|.+++...  ...+....+      ..++.|++.||+|||++|   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            32                 33799999998 8999999653  223455555      678899999999999999   9


Q ss_pred             eecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCC
Q 041345          142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSK  219 (340)
Q Consensus       142 ~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~  219 (340)
                      +||||||+||+++.++.+||+|||++...+..     .....+++.|+|||++.+  ..++.++|||||||++|+|++|.
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999875422     113456699999999987  67999999999999999999999


Q ss_pred             CCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          220 KNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .||............        ....................+..+.+|+.+||+.||++|||+.++++
T Consensus       291 ~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999765332211000        00000000111111122345678999999999999999999999974

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.8e-44  Score=324.60  Aligned_cols=263  Identities=20%  Similarity=0.264  Sum_probs=202.6

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----Ce
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----GE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   88 (340)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            4578999999999999999999865 47789999986543 33456788999999999999999999998654     36


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+. ++|.+++..    ..+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++.
T Consensus       105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            899999997 588888743    34899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccc-cccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          169 TFGMNELE-ANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       169 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...   ......
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~  253 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI---LGSPSQ  253 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH---HCSCCH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH---hCCCCH
Confidence            76432221 11234578999999998754 45899999999999999999999999776655433222110   000000


Q ss_pred             c-----------ccccccc-cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 L-----------ELIDTTL-HESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~-----------~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .           ....... ....     .+..+..+.+|+.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0           0000000 0000     1223467899999999999999999999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.8e-43  Score=324.36  Aligned_cols=202  Identities=23%  Similarity=0.280  Sum_probs=171.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcC------CCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKL------QHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~   89 (340)
                      ..+|++.+.||+|+||.||+|.+.. ++.||||++... ......+.+|+.+++.+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            4579999999999999999998754 788999999654 33345677788887776      577999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC--eeEeccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--PKISDFGMA  167 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~--~~l~Dfg~~  167 (340)
                      ++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 68888876533 234899999999999999999999999   999999999999998887  999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccc
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER  229 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~  229 (340)
                      .....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            76432     1223568999999999999999999999999999999999999997765543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3e-44  Score=322.45  Aligned_cols=258  Identities=22%  Similarity=0.275  Sum_probs=203.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChh-----------------cHHHHHHHHHHHHcCCCCceeee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQ-----------------GIVEFKNEAKLIAKLQHTNLVRL   79 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~i~~~   79 (340)
                      .++|++.+.||+|+||.||+|.. +++.||+|.+......                 ....+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 8999999998543211                 11678999999999999999999


Q ss_pred             eeEEeeCCeeEEEEeccCCCChhhH------hhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeE
Q 041345           80 LGCSLQKGERLLVYEYLPNKSLDFF------IFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNIL  152 (340)
Q Consensus        80 ~~~~~~~~~~~iv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nil  152 (340)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.|++.||.|||+ +|   ++|+||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      532 124569999999999999999999999 88   999999999999


Q ss_pred             eCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccC-CCCc-cCceehhhHHHHHHHhCCCCCCCCCcccc
Q 041345          153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSM-KSDVYSFGVLVLEIISSKKNNGCYDTERH  230 (340)
Q Consensus       153 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~vl~elltg~~p~~~~~~~~~  230 (340)
                      ++.++.++|+|||.+......    ......++..|+|||.+.+. .++. ++||||||+++|+|++|..||........
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999875432    23345688999999999877 6666 99999999999999999999976544210


Q ss_pred             cchhHHHHHHhhcCccccc------ccc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          231 LNLVGYAWQLWNEGKALEL------IDT---TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~------~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        .    ......+...-.      ...   ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       261 --~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 --L----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --H----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --H----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              0    111111110000      000   0000011334567899999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-44  Score=315.76  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=186.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hh-cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.... .. ....+.++...++.++||||+++++++.+....++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999874 58899999986542 22 223344555567788999999999999999999999


Q ss_pred             EeccCCCChhhHhhcc-CccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           93 YEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      |||+++ +|.+++... .....+++..+..++.|++.||+|||++ |   ++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 777766431 2334699999999999999999999998 8   999999999999999999999999999875


Q ss_pred             cCcccccccccccccCCCCChhhh----ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYV----MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ....   ......|++.|+|||.+    .+..++.++||||+|+++|+|++|..||.......     ........... 
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-  231 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPS-  231 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCC-
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCC-
Confidence            4321   22234689999999996    45678999999999999999999999996433221     11111111111 


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                              ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 --------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                    11111234567899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.6e-43  Score=316.21  Aligned_cols=263  Identities=21%  Similarity=0.255  Sum_probs=203.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEE--CCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCC------ceeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKL--LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT------NLVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~   87 (340)
                      ..++|++.+.||+|+||.||+|.+  .+++.||+|++... ......+.+|+.+++.+.|+      +++++++++....
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            357899999999999999999986  35788999998644 34456778899998888654      5999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC------------
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD------------  155 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~------------  155 (340)
                      ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++|   ++||||||+||+++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 889999886532 235889999999999999999999999   999999999999987            


Q ss_pred             -------CCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcc
Q 041345          156 -------QMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE  228 (340)
Q Consensus       156 -------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~  228 (340)
                             ++.++|+|||++.....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   66899999999976432     123356899999999999989999999999999999999999999766554


Q ss_pred             cccchhHHHHH-----HhhcCccccc---------------------ccc-cccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 041345          229 RHLNLVGYAWQ-----LWNEGKALEL---------------------IDT-TLHESCSPDEVTRCIHVGLLCVQDKATDR  281 (340)
Q Consensus       229 ~~~~~~~~~~~-----~~~~~~~~~~---------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~R  281 (340)
                      .....+.....     .+........                     ... ......+...+..+.+|+.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            32222211100     0000000000                     000 00011234567889999999999999999


Q ss_pred             CCHHHHHH
Q 041345          282 PTMSDVAS  289 (340)
Q Consensus       282 Pt~~evl~  289 (340)
                      ||+.|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.4e-44  Score=315.90  Aligned_cols=253  Identities=22%  Similarity=0.291  Sum_probs=196.2

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC--------hhcHHHHHHHHHHHHcCCCCceeeeeeEEee
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ   85 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (340)
                      ...++|++.+.||+|+||.||+|.... ++.||+|++....        ......+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            355789999999999999999998754 7889999985432        1223357889999999999999999999876


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC---eeEe
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKIS  162 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~---~~l~  162 (340)
                      .. .++||||+++++|.+++.   ....+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.   ++|+
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             Cc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            54 899999999999999884   3445899999999999999999999999   999999999999987654   9999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      |||++.......   ......|++.|+|||++.   +..++.++||||||+++|+|++|..||.........  ....  
T Consensus       160 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~--  232 (322)
T 2ycf_A          160 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQI--  232 (322)
T ss_dssp             CCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHH--
T ss_pred             cCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHH--
Confidence            999998754321   122356899999999874   467899999999999999999999999654433211  1110  


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ..+... ... .    .....+..+.+++.+||+.||++|||+.++++
T Consensus       233 --~~~~~~-~~~-~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 --TSGKYN-FIP-E----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --HHTCCC-CCH-H----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --HhCccc-cCc-h----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence              011100 000 0    00123467889999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=318.85  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=195.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEe-----------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL-----------   84 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----------   84 (340)
                      .++|++.+.||+|+||.||+|.... ++.||+|.+..........+.+|+.+++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            5789999999999999999998765 8899999997776666778899999999999999999998873           


Q ss_pred             ---eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCCee
Q 041345           85 ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPK  160 (340)
Q Consensus        85 ---~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~~~  160 (340)
                         .....++||||++ ++|.+++.    ...+++..+..++.|++.||+|||++|   ++|+||||+||+++ .++.++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999997 68998884    245899999999999999999999999   99999999999997 567899


Q ss_pred             EecccccccccCccc-ccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH-
Q 041345          161 ISDFGMARTFGMNEL-EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA-  237 (340)
Q Consensus       161 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-  237 (340)
                      |+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+... 
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999987543211 112233457889999998865 67899999999999999999999999765543322111100 


Q ss_pred             -------HHHhhcCccccccccccc-CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          238 -------WQLWNEGKALELIDTTLH-ES-----CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       238 -------~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                             ..... ......+..... ..     ..+..+..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                   00000 000000000000 00     01224567899999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.4e-44  Score=322.20  Aligned_cols=273  Identities=20%  Similarity=0.244  Sum_probs=192.2

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe-
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE-   88 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   88 (340)
                      .......++|++.+.||+|+||.||+|+.. +++.||||++.... .......+++..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            456677799999999999999999999875 48899999885442 223355677888888999999999999865433 


Q ss_pred             ------eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCCCCCeEeCC-CCCe
Q 041345           89 ------RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH--KYSRLRVIHRDLKASNILLDD-QMNP  159 (340)
Q Consensus        89 ------~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~i~H~dlk~~Nilv~~-~~~~  159 (340)
                            .++||||++++.+..+.........++...+..++.|++.|+.|||  ++|   |+||||||+||+++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987544333322234456899999999999999999999  888   999999999999996 8899


Q ss_pred             eEecccccccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH-
Q 041345          160 KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA-  237 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-  237 (340)
                      +|+|||++.......   ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... 
T Consensus       172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            999999998764322   22334679999999998665 4899999999999999999999999765544332221110 


Q ss_pred             -------HHHhhcC-ccccccc------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 -------WQLWNEG-KALELID------TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 -------~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                             ....... .......      .......+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   0000000 0000000      000111122356789999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-43  Score=314.88  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=200.1

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEE--CCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcC---CCCceeeeeeEEe---
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKL--LDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKL---QHTNLVRLLGCSL---   84 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---   84 (340)
                      ...++|++.+.||+|+||.||+|++  .+++.||+|++....  ......+.+|+.+++.+   .||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4568999999999999999999987  357889999885332  11122455677666665   8999999999987   


Q ss_pred             --eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           85 --QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        85 --~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                        .....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999997 69999886533 234899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      |||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+........
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999998654221   22345689999999999988999999999999999999999999976554332211110000000


Q ss_pred             cCccccccc----------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 EGKALELID----------TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 ~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...+.....          ...........+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000000          00001112334567889999999999999999999995

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.9e-44  Score=329.34  Aligned_cols=260  Identities=23%  Similarity=0.291  Sum_probs=192.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC------CeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK------GERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~   90 (340)
                      .+|++.+.||+|+||.||+|++. +++.||||++.....    ...+|+.+++.++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            36899999999999999999875 489999999854432    224799999999999999999987542      2367


Q ss_pred             EEEeccCCCChhhHhhc-cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-CCeeEecccccc
Q 041345           91 LVYEYLPNKSLDFFIFD-SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMAR  168 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-~~~~l~Dfg~~~  168 (340)
                      +||||+++ ++.+.+.. ......+++..+..++.||+.||+|||++|   |+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 55554432 123456999999999999999999999999   9999999999999955 568999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH--------HH
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA--------WQ  239 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~  239 (340)
                      .+....   ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+...        ..
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            754322   12235689999999998765 7899999999999999999999999776544322211110        00


Q ss_pred             HhhcCcccccccccccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          240 LWNEGKALELIDTTLHE-----SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .. ..............     ..++..+..+.+|+.+||+.||.+|||+.|+++
T Consensus       283 ~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00 01111100000000     011233567899999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.6e-43  Score=315.47  Aligned_cols=262  Identities=21%  Similarity=0.272  Sum_probs=198.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-----------CCceeeeeeEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----------HTNLVRLLGCSL   84 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~   84 (340)
                      .++|++.+.||+|+||.||+|++. +++.||+|++... ......+.+|+.+++++.           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999999864 5889999999643 334566788999888875           899999999987


Q ss_pred             eCC----eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeC-----
Q 041345           85 QKG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLD-----  154 (340)
Q Consensus        85 ~~~----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~-----  154 (340)
                      ...    ..++|||++ +++|.+++.... ...+++..+..++.|++.||+|||++ |   |+||||||+||+++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    689999999 889999986533 33489999999999999999999998 8   99999999999994     


Q ss_pred             -CCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccch
Q 041345          155 -DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNL  233 (340)
Q Consensus       155 -~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~  233 (340)
                       ..+.++|+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4447999999999865422     2334689999999999999999999999999999999999999976543322111


Q ss_pred             hHHHHHH---h------------------hcCcccccccc----------cccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 041345          234 VGYAWQL---W------------------NEGKALELIDT----------TLHESCSPDEVTRCIHVGLLCVQDKATDRP  282 (340)
Q Consensus       234 ~~~~~~~---~------------------~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  282 (340)
                      .......   .                  ........+..          ......+...+..+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            1111000   0                  00000000000          011234567888999999999999999999


Q ss_pred             CHHHHHH
Q 041345          283 TMSDVAS  289 (340)
Q Consensus       283 t~~evl~  289 (340)
                      |+.++++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1e-43  Score=319.49  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=199.9

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----Ce
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----GE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   88 (340)
                      +.++|++.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4688999999999999999999875 48889999986543 33456778999999999999999999987654     56


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .++||||+. ++|.+++..    ..+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999996 588888743    35899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCccccc--------ccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 041345          169 TFGMNELEA--------NTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       169 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      .........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            764322111        1123467999999998764 6789999999999999999999999976554322211110000


Q ss_pred             HhhcCcccc---------ccccccc-CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          240 LWNEGKALE---------LIDTTLH-ES-----CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       240 ~~~~~~~~~---------~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .........         .+..... ..     ..+..+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000         0000000 00     01234567889999999999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.4e-43  Score=307.26  Aligned_cols=254  Identities=25%  Similarity=0.299  Sum_probs=203.4

Q ss_pred             HHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           13 IAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        13 i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .....++|++.+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.++++++||||+++++++......
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            3456689999999999999999999875 5889999998543  234567889999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC---CCeeEecccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGM  166 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~---~~~~l~Dfg~  166 (340)
                      ++||||+++++|.+.+...   ..+++..+..++.|++.||.+||++|   ++|+||||+||+++.+   +.++|+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            9999999999998888542   35899999999999999999999999   9999999999999754   4699999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      +.......   ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.........       .....+..
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~  239 (287)
T 2wei_A          171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-------KRVETGKY  239 (287)
T ss_dssp             GGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC
T ss_pred             ceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC
Confidence            88654321   1223457889999998865 4899999999999999999999999764433211       11111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...      .......+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          240 AFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCC------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            000      0001223467889999999999999999999997

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.7e-43  Score=308.26  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=193.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee---------
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ---------   85 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   85 (340)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+... ......+.+|+.+++.++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4678999999999999999999874 5889999998543 3445678899999999999999999998765         


Q ss_pred             ----CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           86 ----KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        86 ----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                          ....++||||+++++|.+++...  ...++...++.++.|++.||+|||+++   ++|+||||+||+++.++.++|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                34679999999999999999643  234788999999999999999999999   999999999999999999999


Q ss_pred             ecccccccccCccc------------ccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcc
Q 041345          162 SDFGMARTFGMNEL------------EANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTE  228 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~  228 (340)
                      +|||++........            ........|++.|+|||.+.+. .++.++||||||+++|+|++   ||....  
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence            99999986542210            1122345688999999998764 68999999999999999998   442110  


Q ss_pred             cccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          229 RHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .   .... .......      ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       233 ~---~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 E---RVNI-LKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H---HHHH-HHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h---HHHH-HHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0   0000 1111111      011122233445567899999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-42  Score=314.04  Aligned_cols=260  Identities=22%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee----
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER----   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----   89 (340)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            478999999999999999999865 4889999998654  333456788999999999999999999999876654    


Q ss_pred             --EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           90 --LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        90 --~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                        ++||||+. ++|.+.+.     ..+++..+..++.|++.||+|||++|   |+||||||+||+++.++.++|+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 57777762     23899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH----Hhh
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ----LWN  242 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----~~~  242 (340)
                      .....     ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.....    .+.
T Consensus       192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            86532     2233567999999999877 6789999999999999999999999976554332211110000    000


Q ss_pred             cC----cccccccccccC------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          243 EG----KALELIDTTLHE------SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       243 ~~----~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      ..    .....+......      ...+..+..+.+|+.+||+.||++|||+.++++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00    000000000000      0012235678999999999999999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.4e-43  Score=340.07  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=203.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|.+.... ......+.+|+.++++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34678889999999999999998643    4569999986543 344567899999999999999999999985 45689


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||++...
T Consensus       467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999998643  234899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+       ..+     
T Consensus       542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-------~~~-----  608 (656)
T 2j0j_A          542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENG-----  608 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HHT-----
T ss_pred             CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcC-----
Confidence            43322 12223456788999999998899999999999999999997 88999754433211111       111     


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          .....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       609 ----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          609 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                11223344557789999999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.7e-42  Score=312.01  Aligned_cols=264  Identities=20%  Similarity=0.254  Sum_probs=200.3

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CC-----ceeeeeeEEeeCC
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HT-----NLVRLLGCSLQKG   87 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~   87 (340)
                      ...++|++.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.+. |+     +++++++++....
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999875 4788999999644 334556777888888774 44     4999999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCCCCCeEeC--CCCCeeEec
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK--YSRLRVIHRDLKASNILLD--DQMNPKISD  163 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~~i~H~dlk~~Nilv~--~~~~~~l~D  163 (340)
                      ..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+  .+   |+||||||+||+++  .++.+||+|
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence            9999999996 58988886543 2348999999999999999999995  56   99999999999995  477899999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH----
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ----  239 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----  239 (340)
                      ||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....    
T Consensus       205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999875422     2335688999999999999999999999999999999999999987655443222211000    


Q ss_pred             -Hhhc-Cccccccccc-----------------------------------------ccCCCCHHHHHHHHHHHHhccCC
Q 041345          240 -LWNE-GKALELIDTT-----------------------------------------LHESCSPDEVTRCIHVGLLCVQD  276 (340)
Q Consensus       240 -~~~~-~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~cl~~  276 (340)
                       .+.. ......+...                                         ........+...+.+|+.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence             0000 0000000000                                         00011234456899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 041345          277 KATDRPTMSDVAS  289 (340)
Q Consensus       277 ~p~~RPt~~evl~  289 (340)
                      ||++|||+.|+++
T Consensus       360 dP~~Rpta~e~L~  372 (382)
T 2vx3_A          360 DPKTRIQPYYALQ  372 (382)
T ss_dssp             CTTTSCCHHHHTT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.4e-43  Score=314.46  Aligned_cols=256  Identities=22%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe-----
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE-----   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   88 (340)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|.+...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            478999999999999999999875 4889999998654  23345678899999999999999999999876643     


Q ss_pred             -eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           89 -RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        89 -~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                       .++||||+. ++|.+++.     ..+++..+..++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 57877762     23899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC--
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--  244 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  244 (340)
                      ......     .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.   ......  
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~---~~~~~~~~  245 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL---KVTGVPGT  245 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH---HHHCBCCH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCCH
Confidence            764321     233567999999999876 678999999999999999999999997655432211110   000000  


Q ss_pred             ----cc--------ccccccc---ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 ----KA--------LELIDTT---LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ----~~--------~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ..        ...+...   ......+..+..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                00        0000000   001122345678999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.5e-43  Score=311.84  Aligned_cols=253  Identities=19%  Similarity=0.215  Sum_probs=173.6

Q ss_pred             HhcCCCCCC-cccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEee----CCee
Q 041345           16 ATDNFSPGN-RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGER   89 (340)
Q Consensus        16 ~~~~y~~~~-~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~   89 (340)
                      ..++|.+.+ .||+|+||.||+|.+. +++.||+|++.... .   ...+....++.+.||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            457899865 6999999999999876 58999999985432 1   12223334566799999999999876    4458


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCeeEecccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGM  166 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~~l~Dfg~  166 (340)
                      ++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|   ++||||||+||+++.   ++.++|+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999996532 345899999999999999999999999   999999999999986   44599999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      +......    ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.............   ......  
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~--  248 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLG--  248 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhcc--
Confidence            9765422    2233567999999999988889999999999999999999999996544332111000   000000  


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ............+..+.+++.+||+.||.+|||+.++++
T Consensus       249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                000111111234567899999999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-42  Score=309.79  Aligned_cols=255  Identities=22%  Similarity=0.333  Sum_probs=178.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHH-HHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAK-LIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999875 58899999986543 333445555655 667779999999999999999999999


Q ss_pred             eccCCCChhhHhhcc--CccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           94 EYLPNKSLDFFIFDS--SKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ||+++ +|.+++...  .....+++..+..++.|++.||.|||++ +   ++|+||||+||+++.++.++|+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 777766421  1245689999999999999999999998 8   999999999999999999999999999765


Q ss_pred             cCcccccccccccccCCCCChhhh----ccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYV----MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ....   ......|++.|+|||.+    .+..++.++||||||+++|+|++|..||.........         .  ...
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~--~~~  242 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L--TQV  242 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H--HHH
Confidence            4321   12234689999999998    4567899999999999999999999999654321100         0  000


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .......+........+..+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000001111111234567899999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-42  Score=311.54  Aligned_cols=263  Identities=18%  Similarity=0.231  Sum_probs=199.7

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-C-CEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc------eeeeeeEEeeCC
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-G-QEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN------LVRLLGCSLQKG   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~   87 (340)
                      ..++|++.+.||+|+||.||+|.... + +.||+|++... ......+.+|+.+++.+.|++      ++.+++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            35789999999999999999998743 4 68999999644 344567788999999886554      899999999999


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe--------------
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL--------------  153 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv--------------  153 (340)
                      ..++||||+ ++++.+.+... ....+++..+..++.|++.||+|||++|   |+||||||+||++              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            999999999 55666665443 2235899999999999999999999999   9999999999999              


Q ss_pred             -----CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcc
Q 041345          154 -----DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE  228 (340)
Q Consensus       154 -----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~  228 (340)
                           +.++.++|+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 56788999999999764321     23356899999999999999999999999999999999999999765544


Q ss_pred             cccchhHHHHH-----HhhcCcccccc-c--------------------c-cccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 041345          229 RHLNLVGYAWQ-----LWNEGKALELI-D--------------------T-TLHESCSPDEVTRCIHVGLLCVQDKATDR  281 (340)
Q Consensus       229 ~~~~~~~~~~~-----~~~~~~~~~~~-~--------------------~-~~~~~~~~~~~~~l~~li~~cl~~~p~~R  281 (340)
                      .....+.....     .+......... .                    . ..........+..+.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            32221111100     00000000000 0                    0 00011223456789999999999999999


Q ss_pred             CCHHHHHH
Q 041345          282 PTMSDVAS  289 (340)
Q Consensus       282 Pt~~evl~  289 (340)
                      ||+.++++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=311.48  Aligned_cols=245  Identities=25%  Similarity=0.385  Sum_probs=189.9

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChh------cHHHHHHHHHHHHcC----CCCceeeee
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQ------GIVEFKNEAKLIAKL----QHTNLVRLL   80 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~~   80 (340)
                      +.....++|++.+.||+|+||.||+|+.. +++.||+|++......      ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            44556789999999999999999999864 5889999999654321      222345788888888    899999999


Q ss_pred             eEEeeCCeeEEEEec-cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCC
Q 041345           81 GCSLQKGERLLVYEY-LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMN  158 (340)
Q Consensus        81 ~~~~~~~~~~iv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~  158 (340)
                      +++...+..++|+|+ +.+++|.+++..   ...+++..+..++.|++.||.|||+++   ++|+||||+||+++ .++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence            999988899999999 789999999854   335899999999999999999999999   99999999999998 7889


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~  237 (340)
                      ++|+|||++.......    .....|+..|+|||++.+..+ +.++||||||+++|+|++|..||.....          
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------  244 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------  244 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence            9999999998765322    233558999999999877665 4589999999999999999999953210          


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ... .          ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       245 --~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 --ILE-A----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --HHH-T----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --Hhh-h----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000 0          01122334567889999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-43  Score=314.87  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=197.1

Q ss_pred             HHHHHHHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChh------cHHHHHHHHHHHHcCC--CCceeeee
Q 041345           10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQ------GIVEFKNEAKLIAKLQ--HTNLVRLL   80 (340)
Q Consensus        10 ~~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~   80 (340)
                      ........++|++.+.||+|+||.||+|... +++.||+|.+......      ....+.+|+.+++.+.  |+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            3455556789999999999999999999864 5888999998543211      1234567899999985  69999999


Q ss_pred             eEEeeCCeeEEEEeccCC-CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCC
Q 041345           81 GCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMN  158 (340)
Q Consensus        81 ~~~~~~~~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~  158 (340)
                      +++...+..++|+|++.+ ++|.+++..   ...+++..+..++.|++.||+|||+++   ++||||||+||+++ +++.
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCC
Confidence            999999999999999976 899999854   345899999999999999999999999   99999999999998 7789


Q ss_pred             eeEecccccccccCcccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH
Q 041345          159 PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA  237 (340)
Q Consensus       159 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~  237 (340)
                      ++|+|||++......    ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.....          
T Consensus       189 ~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------  254 (320)
T 3a99_A          189 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------  254 (320)
T ss_dssp             EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred             EEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence            999999999876432    1223468999999999877665 7889999999999999999999953211          


Q ss_pred             HHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        .....           ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       255 --~~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 --IIRGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --HHHCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --hhccc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00000           0011223467889999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.3e-42  Score=317.87  Aligned_cols=253  Identities=22%  Similarity=0.289  Sum_probs=187.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....   ...+.+|+.+++++ +||||+++++++.+....++|||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4455568899999999987777789999999885432   34567899999876 8999999999999999999999999


Q ss_pred             CCCChhhHhhccCccc----cCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCC-------------CCe
Q 041345           97 PNKSLDFFIFDSSKKE----LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ-------------MNP  159 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~-------------~~~  159 (340)
                      . ++|.+++.......    ..++..++.++.|++.||+|||+++   |+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999986532211    1123345789999999999999999   9999999999999654             479


Q ss_pred             eEecccccccccCccccc--ccccccccCCCCChhhhcc-------CCCCccCceehhhHHHHHHHh-CCCCCCCCCccc
Q 041345          160 KISDFGMARTFGMNELEA--NTNRIVGTHGYMSPEYVMN-------GIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTER  229 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~  229 (340)
                      +|+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998765432211  2234578999999999865       568999999999999999999 899996433221


Q ss_pred             ccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .        .........    ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       248 ~--------~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S--------NIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H--------HHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--------HHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            0        000110000    01111224567788999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=314.88  Aligned_cols=249  Identities=20%  Similarity=0.315  Sum_probs=186.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .+|.+.+.||+|+||.||.....+++.||||++......   .+.+|+.+++.+ +||||+++++++.+....++|||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            468888999999999977665668999999998654322   346799999998 7999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-----CCCeeEeccccccccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-----QMNPKISDFGMARTFG  171 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-----~~~~~l~Dfg~~~~~~  171 (340)
                      . ++|.+++....  .......+..++.|++.||.|||+++   |+||||||+||+++.     ...++|+|||++....
T Consensus       101 ~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            6 58998886432  22445566789999999999999999   999999999999953     2357899999998765


Q ss_pred             Cccc-ccccccccccCCCCChhhhc---cCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          172 MNEL-EANTNRIVGTHGYMSPEYVM---NGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       172 ~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      .... ........||+.|+|||++.   +..++.++|||||||++|+|++ |..||+.......       .... ....
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~-~~~~  246 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILL-GACS  246 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHT-TCCC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHh-ccCC
Confidence            3321 12233457899999999987   4567889999999999999999 8888854322211       0000 1100


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..      ...........+.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 LD------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CT------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00      01112345667889999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=301.28  Aligned_cols=252  Identities=20%  Similarity=0.303  Sum_probs=179.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-hc-HHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-QG-IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++..... .. ...+.++..+++.++||||+++++++......++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3477899999999999999999875 588999999865432 22 23344455567788999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |||+ ++++..+....  ...+++..+..++.|++.||.|||++ |   ++|+||||+||+++.++.++|+|||++....
T Consensus       103 ~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 55565555322  34589999999999999999999995 8   9999999999999999999999999987654


Q ss_pred             CcccccccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ...   ......+++.|+|||.+.     +..++.++||||||+++|+|++|..||.......     ......... ..
T Consensus       177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~-~~  247 (318)
T 2dyl_A          177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQE-EP  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHS-CC
T ss_pred             CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhcc-CC
Confidence            321   122346899999999984     4568899999999999999999999996533221     111111111 10


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..       .......+..+.+++.+||+.||.+|||+.++++
T Consensus       248 ~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 PL-------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC-------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC-------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00       0011123467889999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-42  Score=328.11  Aligned_cols=266  Identities=23%  Similarity=0.241  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee------C
Q 041345           15 AATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ------K   86 (340)
Q Consensus        15 ~~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   86 (340)
                      ...++|++.+.||.|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++..      .
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            34489999999999999999999864 4889999998654 34456678999999999999999999998755      5


Q ss_pred             CeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCC---eeEec
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISD  163 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~---~~l~D  163 (340)
                      ...++||||+++++|.+++........+++..+..++.|++.||+|||++|   ++||||||+||+++.++.   ++|+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence            668999999999999999976555556899999999999999999999999   999999999999997765   89999


Q ss_pred             ccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCccccc-chhH-HHHHH-
Q 041345          164 FGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL-NLVG-YAWQL-  240 (340)
Q Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~-~~~~-~~~~~-  240 (340)
                      ||++.......   ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......... .... ..... 
T Consensus       168 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          168 LGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             ccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            99998764332   223456899999999999999999999999999999999999999643211100 0000 00000 


Q ss_pred             hhcCccc---cccc-ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 041345          241 WNEGKAL---ELID-TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSD  286 (340)
Q Consensus       241 ~~~~~~~---~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  286 (340)
                      .......   .+.. .......+...+..+.+++.+||+.||++|||+.+
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000000   0000 01112234567888999999999999999999966

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-40  Score=323.64  Aligned_cols=238  Identities=19%  Similarity=0.301  Sum_probs=191.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC--CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe-----
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL--DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE-----   88 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----   88 (340)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++... .......+.+|+.++.+++||||+++++++.....     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999875  5789999998644 33445678899999999999999999999987655     


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .|+||||+++++|.+++..     .+++..++.++.|++.||.|||++|   |+||||||+||+++.+ .+||+|||++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999887632     5899999999999999999999999   9999999999999986 99999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      .....      ....||+.|+|||++.++. +.++|||||||++|+|++|..||.........                 
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-----------------  285 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-----------------  285 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence            75422      3456899999999987664 88999999999999999998887532111100                 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhhc
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-MSDVASMLTN  293 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L~~  293 (340)
                            ........+..+.+++.+||+.||++||+ ++++...|..
T Consensus       286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                  00011223467889999999999999995 5556555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.7e-40  Score=286.99  Aligned_cols=230  Identities=11%  Similarity=0.040  Sum_probs=184.1

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      ..++|++.+.||+|+||.||+|++.. ++.||+|++....   ......+.+|+..+.+++||||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            34789999999999999999998755 8899999996543   3345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++++|.+++..    + .....+..++.|++.||.|||++|   |+||||||+||+++.++.++|++++      
T Consensus       109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999842    2 355678899999999999999999   9999999999999999999998543      


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                                      |++       .++.++|||||||++|+|++|..||...+.........            ..+.
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------~~~~  219 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------RDTA  219 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------BCTT
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------HHhc
Confidence                            223       36889999999999999999999997655433210000            0000


Q ss_pred             cccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          252 TTLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       252 ~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ....  .......+..+.+++.+||+.||++| |+.++++.|....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            0000  00112345678999999999999999 9999999998743

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.4e-40  Score=289.24  Aligned_cols=228  Identities=20%  Similarity=0.223  Sum_probs=177.9

Q ss_pred             HhcCCCCC-CcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHH-HcCCCCceeeeeeEEee----CCe
Q 041345           16 ATDNFSPG-NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLI-AKLQHTNLVRLLGCSLQ----KGE   88 (340)
Q Consensus        16 ~~~~y~~~-~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~   88 (340)
                      ..++|.+. +.||+|+||.||+|... +++.||+|++...     ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            34677777 77999999999999874 5889999998542     2456788877 55689999999999876    667


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCeeEeccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFG  165 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~~l~Dfg  165 (340)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.   ++.++|+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            899999999999999996532 335899999999999999999999999   999999999999997   7889999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCc
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK  245 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (340)
                      ++....                        +..++.++|||||||++|+|++|..||...........            
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~------------  209 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------------  209 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC------------
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH------------
Confidence            986432                        24567899999999999999999999965433221100            


Q ss_pred             ccccccccccCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          246 ALELIDTTLHESCS----PDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       246 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ....+... ....+    ...+..+.+++.+||+.||.+|||+.++++
T Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          210 MKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SCCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00000000 01111    123567899999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-40  Score=303.31  Aligned_cols=240  Identities=17%  Similarity=0.183  Sum_probs=178.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCC-Ccee---------eee---
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQH-TNLV---------RLL---   80 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~---------~~~---   80 (340)
                      .+|...+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.+++.+.| ++..         ...   
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            44777889999999999999864 58999999986332   2235678899999999876 2211         111   


Q ss_pred             ---------eEEee-----CCeeEEEEeccCCCChhhHhhc----cCccccCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 041345           81 ---------GCSLQ-----KGERLLVYEYLPNKSLDFFIFD----SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI  142 (340)
Q Consensus        81 ---------~~~~~-----~~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~  142 (340)
                               .++..     ...++++|+++ +++|.+++..    ......+++..++.++.|++.||+|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                     11111     12357778865 6789888842    122445788899999999999999999999   99


Q ss_pred             ecCCCCCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhh----------ccCCCCccCceehhhHHH
Q 041345          143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV----------MNGIVSMKSDVYSFGVLV  212 (340)
Q Consensus       143 H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~vl  212 (340)
                      ||||||+|||++.++.+||+|||++...+..     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998865422     333456 999999998          455688899999999999


Q ss_pred             HHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 041345          213 LEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVA  288 (340)
Q Consensus       213 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl  288 (340)
                      |+|++|..||...........+               +..  .    ...+..+.+|+.+||+.||++|||+.+++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~~~---------------~~~--~----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSEWI---------------FRS--C----KNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSGGG---------------GSS--C----CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhhHHHH---------------Hhh--c----ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999755443322111               000  0    12236789999999999999999976654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.5e-40  Score=293.88  Aligned_cols=242  Identities=15%  Similarity=0.128  Sum_probs=182.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC--------hhcHHHHHHHHHHHHcCC---------CCceeee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--------GQGIVEFKNEAKLIAKLQ---------HTNLVRL   79 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~~   79 (340)
                      .++|++.+.||+|+||.||+|++ +++.||||++....        ......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            47899999999999999999988 78999999986442        223467888999888875         6666666


Q ss_pred             eeEE-----------------ee-------------CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHH
Q 041345           80 LGCS-----------------LQ-------------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG  129 (340)
Q Consensus        80 ~~~~-----------------~~-------------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~  129 (340)
                      .+++                 .+             ....++||||+++|++.+.+..    ..+++..+..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            6553                 22             6789999999999976666522    458999999999999999


Q ss_pred             HHHHH-hCCCCceeecCCCCCCeEeCCCC--------------------CeeEecccccccccCcccccccccccccCCC
Q 041345          130 LLYLH-KYSRLRVIHRDLKASNILLDDQM--------------------NPKISDFGMARTFGMNELEANTNRIVGTHGY  188 (340)
Q Consensus       130 l~~LH-~~~~~~i~H~dlk~~Nilv~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y  188 (340)
                      |+||| +++   |+||||||+|||++.++                    .+||+|||+++....       ....||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 898   99999999999999876                    899999999987542       134689999


Q ss_pred             CChhhhccCCCCccCceehhhHH-HHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHH
Q 041345          189 MSPEYVMNGIVSMKSDVYSFGVL-VLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCI  267 (340)
Q Consensus       189 ~aPE~~~~~~~~~~~DvwslG~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (340)
                      +|||++.+.. +.++||||+|++ .+++++|..||....      ...............   ........+...+.++.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~  313 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTF---KTKCNTPAMKQIKRKIQ  313 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCC---SSCCCSHHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhcc---CcccchhhhhhcCHHHH
Confidence            9999998766 889999998777 777888988873100      000010110000000   00011112346788899


Q ss_pred             HHHHhccCCCCCCCCCHHHHH
Q 041345          268 HVGLLCVQDKATDRPTMSDVA  288 (340)
Q Consensus       268 ~li~~cl~~~p~~RPt~~evl  288 (340)
                      +|+.+||+.|     |+.|++
T Consensus       314 dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          314 EFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHhccC-----CHHHHH
Confidence            9999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.2e-31  Score=254.08  Aligned_cols=184  Identities=18%  Similarity=0.178  Sum_probs=127.3

Q ss_pred             ccccCCeeEEEEE-ECCCCEEEEEEccCCC----------hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEEE
Q 041345           26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKSS----------GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        26 Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+.|+.|.+..++ .--|+.+++|++....          ....+.+.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4455555555443 2247889999985431          12345689999999999 6999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||++|++|.+++..   .++++..   +++.||+.||+|+|++|   |+||||||+|||++.+|++||+|||+++.....
T Consensus       322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999954   3446654   47899999999999999   999999999999999999999999999875432


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCC
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN  221 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p  221 (340)
                      .  .......||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 C--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             C--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2  22334679999999998865 467789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.4e-28  Score=232.01  Aligned_cols=185  Identities=19%  Similarity=0.220  Sum_probs=143.4

Q ss_pred             CCCCcccccCCeeEEEEEECCCCEEEEEEccCCC---h-----hcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           21 SPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS---G-----QGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ...+.||+|+||.||+|.. .++.+++|......   .     ...+.+.+|+.++++++||||+++..++......++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4466899999999999954 67888999763321   1     1134578999999999999999666666677778999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      |||+++++|.+++..           +..++.|++.||.|||+++   |+||||||+||+++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5689999999999999999   999999999999998  999999999998754


Q ss_pred             ccccc-----ccccccccCCCCChhhhcc--CCCCccCceehhhHHHHHHHhCCCCC
Q 041345          173 NELEA-----NTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       173 ~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~vl~elltg~~p~  222 (340)
                      .....     ......||+.|+|||++.+  ..|+..+|+||..+-..+-+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32211     1234678999999999976  56888899999999888887766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1e-25  Score=195.40  Aligned_cols=152  Identities=16%  Similarity=0.138  Sum_probs=120.3

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCCh------------------hcHHHHHHHHHHHHcCC
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG------------------QGIVEFKNEAKLIAKLQ   72 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~   72 (340)
                      ..+......|.+++.||+|+||.||+|.+.+|+.||+|.++....                  .....+.+|+.+++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344445566777799999999999999987789999999854321                  13456889999999998


Q ss_pred             CCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeE
Q 041345           73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL  152 (340)
Q Consensus        73 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nil  152 (340)
                        | +++.+++.. +..++||||+++++|.+ +..         .....++.|++.|+.+||++|   |+||||||+||+
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence              4 566665443 45699999999999988 411         124469999999999999999   999999999999


Q ss_pred             eCCCCCeeEecccccccccCcccccccccccccCCCCChhhhc
Q 041345          153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM  195 (340)
Q Consensus       153 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  195 (340)
                      ++ ++.++|+|||++..               +..+.|||.+.
T Consensus       226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            99 99999999999864               34468899774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.8e-21  Score=164.68  Aligned_cols=136  Identities=18%  Similarity=0.239  Sum_probs=104.6

Q ss_pred             CCCCCcccccCCeeEEEEEE-CCCCE--EEEEEccCCChh------------------------cHHHHHHHHHHHHcCC
Q 041345           20 FSPGNRLGQGGFGPVYKGKL-LDGQE--IAIKRLSKSSGQ------------------------GIVEFKNEAKLIAKLQ   72 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~   72 (340)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999987 67888  999987443111                        1135788999999998


Q ss_pred             CCce--eeeeeEEeeCCeeEEEEeccCC-C----ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHH-hCCCCceeec
Q 041345           73 HTNL--VRLLGCSLQKGERLLVYEYLPN-K----SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-KYSRLRVIHR  144 (340)
Q Consensus        73 h~~i--~~~~~~~~~~~~~~iv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~  144 (340)
                      |+++  ..++++    ...++||||+.+ |    +|.+....      .+...+..++.|++.|+.+|| +.|   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            7754  333332    246899999942 3    56555421      224467789999999999999 888   9999


Q ss_pred             CCCCCCeEeCCCCCeeEecccccccc
Q 041345          145 DLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus       145 dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.5e-19  Score=159.70  Aligned_cols=137  Identities=17%  Similarity=0.199  Sum_probs=98.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCCh--------------hcHH--------HHHHHHHHHHcCCCCc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG--------------QGIV--------EFKNEAKLIAKLQHTN   75 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~~   75 (340)
                      .-|++++.||.|++|.||+|...+|+.||||+++....              ....        ...+|...+.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34999999999999999999988899999998743210              0000        1234555666654333


Q ss_pred             ee--eeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           76 LV--RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        76 i~--~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      +.  ..+++  .  ..++||||+++++|..+..         ......++.|++.++.+||++|   |+||||||.|||+
T Consensus       175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl  238 (397)
T 4gyi_A          175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILI  238 (397)
T ss_dssp             CSCCCEEEE--E--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             CCCCeeeec--c--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence            32  22221  1  2379999999988765531         1123568899999999999999   9999999999999


Q ss_pred             CCCCC----------eeEecccccccc
Q 041345          154 DDQMN----------PKISDFGMARTF  170 (340)
Q Consensus       154 ~~~~~----------~~l~Dfg~~~~~  170 (340)
                      ++++.          +.|+||+.+...
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             eCCCCcccccccccceEEEEeCCcccC
Confidence            87763          789999977653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=4.6e-14  Score=120.82  Aligned_cols=148  Identities=16%  Similarity=0.119  Sum_probs=113.6

Q ss_pred             HHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeE
Q 041345           12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        12 ~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   90 (340)
                      .+....+.|++...++.|+.+.||++.. +++.+++|............+.+|+.+++.+. +..+.++++++......+
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3455567898888999999999999975 46899999986422122335788999998884 667888999888888899


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS---------------------------------  137 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------  137 (340)
                      +|||+++|.++.+.+.        +......++.+++.+++.||+..                                 
T Consensus        87 lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999999877631        11223467889999999999811                                 


Q ss_pred             -----------------------CCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345          138 -----------------------RLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus       138 -----------------------~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                                             ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   1349999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=2.1e-12  Score=110.13  Aligned_cols=142  Identities=16%  Similarity=0.161  Sum_probs=100.9

Q ss_pred             HHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc--eeeeeeEEeeCCeeEE
Q 041345           14 AAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN--LVRLLGCSLQKGERLL   91 (340)
Q Consensus        14 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~i   91 (340)
                      ......|.+....+.|..+.||++...+|+.+++|......   ...+.+|+.+++.+.+.+  +.+++++...++..++
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            33344555544444666799999987667889999875442   235678888888885334  5568888777777899


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS----------------------------------  137 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------  137 (340)
                      |||+++|.++.  . ..     .+   ...++.+++..++.||+..                                  
T Consensus        93 v~e~i~G~~l~--~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           93 LLGEVPGQDLL--S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEECCSSEETT--T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEEecCCcccC--c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            99999998884  2 11     11   1256777888888888743                                  


Q ss_pred             ---------------------CCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          138 ---------------------RLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       138 ---------------------~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                                           ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 11299999999999998775567999998653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.21  E-value=5.4e-11  Score=106.44  Aligned_cols=142  Identities=13%  Similarity=0.219  Sum_probs=104.1

Q ss_pred             CCCcccccCCeeEEEEEECCCCEEEEEEcc--CCC-hhcHHHHHHHHHHHHcCC--CCceeeeeeEEeeC---CeeEEEE
Q 041345           22 PGNRLGQGGFGPVYKGKLLDGQEIAIKRLS--KSS-GQGIVEFKNEAKLIAKLQ--HTNLVRLLGCSLQK---GERLLVY   93 (340)
Q Consensus        22 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~iv~   93 (340)
                      ..+.|+.|.++.||++... +..+++|...  ... ......+.+|+.+++.+.  +..+.+++.++.+.   ...++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3557899999999999764 5688889875  322 122346788999999886  44577888877665   3478999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS------------------------------------  137 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------  137 (340)
                      |+++|..+.+...     ..++......++.+++.+|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999987754221     12677788889999999999999731                                    


Q ss_pred             -------------------CCceeecCCCCCCeEeCCCCC--eeEeccccccc
Q 041345          138 -------------------RLRVIHRDLKASNILLDDQMN--PKISDFGMART  169 (340)
Q Consensus       138 -------------------~~~i~H~dlk~~Nilv~~~~~--~~l~Dfg~~~~  169 (340)
                                         ...++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               135999999999999997653  58999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=2.3e-10  Score=99.96  Aligned_cols=183  Identities=16%  Similarity=0.187  Sum_probs=119.8

Q ss_pred             CCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcC-CCCc--eeeeeeEEeeCC---eeEEEEecc
Q 041345           23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-QHTN--LVRLLGCSLQKG---ERLLVYEYL   96 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~iv~e~~   96 (340)
                      .+.++.|..+.||++.    +.+++|.....  .....+.+|..+++.+ .+..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999873    56888986432  3456788999999887 3332  334444433322   247899999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS---------------------------------------  137 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------  137 (340)
                      +|.++.....     ..++..+...++.+++..++.||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988875442     22677778888889999888888621                                       


Q ss_pred             ----------------CCceeecCCCCCCeEeCC--CCCeeEecccccccccCcccccccccccccCCC---CChhhhcc
Q 041345          138 ----------------RLRVIHRDLKASNILLDD--QMNPKISDFGMARTFGMNELEANTNRIVGTHGY---MSPEYVMN  196 (340)
Q Consensus       138 ----------------~~~i~H~dlk~~Nilv~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~  196 (340)
                                      ...++|+|++|.||++++  +..+.|+||+.+..... ...     ......+   ..|+....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~D-----l~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DND-----FISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THH-----HHTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHH-----HHHHHhhccccCHHHHHH
Confidence                            134899999999999997  45578999998765221 000     0000111   23332210


Q ss_pred             -----CCC---------CccCceehhhHHHHHHHhCCCCC
Q 041345          197 -----GIV---------SMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       197 -----~~~---------~~~~DvwslG~vl~elltg~~p~  222 (340)
                           +..         ....+.|++|.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 010         12257899999999999998664

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=2.2e-07  Score=81.02  Aligned_cols=135  Identities=21%  Similarity=0.196  Sum_probs=93.2

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCC---ceeeeeeEEe-eCCeeEEEEeccCCC
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHT---NLVRLLGCSL-QKGERLLVYEYLPNK   99 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~iv~e~~~~~   99 (340)
                      +.++.|....||+.    ++.+++|...  .......+.+|..+++.+.+.   .+.+.+.+.. .....++||++++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            46788888899988    5678888742  233456788999999998642   2455555553 334568999999998


Q ss_pred             ChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 041345          100 SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS------------------------------------------  137 (340)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  137 (340)
                      .+......     .++......++.+++..++.||+..                                          
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88764321     1344555556666666666666432                                          


Q ss_pred             ---------------CCceeecCCCCCCeEeCC---CCCe-eEeccccccc
Q 041345          138 ---------------RLRVIHRDLKASNILLDD---QMNP-KISDFGMART  169 (340)
Q Consensus       138 ---------------~~~i~H~dlk~~Nilv~~---~~~~-~l~Dfg~~~~  169 (340)
                                     ...++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           124699999999999987   4554 7999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.65  E-value=1.9e-07  Score=79.72  Aligned_cols=135  Identities=19%  Similarity=0.151  Sum_probs=96.0

Q ss_pred             cccccCCe-eEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           25 RLGQGGFG-PVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        25 ~Lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|...++.+. +--+.++++++.+.+..++||+++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34456555 68987654 4667999986432   3446778888888773 33466788888888899999999999888


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS--------------------------------------------  137 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------  137 (340)
                      .+.....       ......++.+++..++.||+..                                            
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            7765321       1223356677777778887521                                            


Q ss_pred             -----------CCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          138 -----------RLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       138 -----------~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                                 ...++|+|+.+.||++++++.+-|.||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       11379999999999999876667999988753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.44  E-value=3.2e-07  Score=81.67  Aligned_cols=80  Identities=8%  Similarity=0.005  Sum_probs=52.7

Q ss_pred             Ccc-cccCCeeEEEEEEC-------CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCC-C--CceeeeeeEEeeC---
Q 041345           24 NRL-GQGGFGPVYKGKLL-------DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQ-H--TNLVRLLGCSLQK---   86 (340)
Q Consensus        24 ~~L-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---   86 (340)
                      +.| +.|..+.+|+....       +++.+++|......   ......+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 88889999998753       26678999864322   001234567888877773 2  3456677766554   


Q ss_pred             CeeEEEEeccCCCChhh
Q 041345           87 GERLLVYEYLPNKSLDF  103 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~  103 (340)
                      ...++|||+++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            24689999998877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.27  E-value=5.9e-06  Score=72.82  Aligned_cols=30  Identities=20%  Similarity=0.285  Sum_probs=26.7

Q ss_pred             CceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345          139 LRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      ..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            359999999999999888889999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=5.9e-06  Score=74.63  Aligned_cols=75  Identities=16%  Similarity=0.181  Sum_probs=47.8

Q ss_pred             CCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh-------hcHHHHHHHHHHHHcCC-C-Cc-eeeeeeEEeeCCeeEE
Q 041345           23 GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG-------QGIVEFKNEAKLIAKLQ-H-TN-LVRLLGCSLQKGERLL   91 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~-h-~~-i~~~~~~~~~~~~~~i   91 (340)
                      .+.||.|..+.||++... +++.+++|.......       .....+..|..+++.+. + +. +.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999653 468899997643211       12334567888888763 2 33 3345443  3445689


Q ss_pred             EEeccCCC
Q 041345           92 VYEYLPNK   99 (340)
Q Consensus        92 v~e~~~~~   99 (340)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.06  E-value=2.2e-05  Score=67.58  Aligned_cols=79  Identities=19%  Similarity=0.228  Sum_probs=55.6

Q ss_pred             CCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-C-C-ceeeeeeEEeeCCeeEEEEec
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-H-T-NLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ...-.+.+|.|..+.||+.+..+|+.+++|+...........+..|+..|+.+. . + -+.+++++  .  .-++|||+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence            344456789999999999999899999999876554444446778888888773 2 1 23344443  2  23789999


Q ss_pred             cCCCCh
Q 041345           96 LPNKSL  101 (340)
Q Consensus        96 ~~~~~L  101 (340)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            877654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.06  E-value=4.8e-05  Score=66.12  Aligned_cols=74  Identities=22%  Similarity=0.242  Sum_probs=57.9

Q ss_pred             CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC---CCceeeeeeEEeeCCeeEEEEeccCCCC
Q 041345           24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ---HTNLVRLLGCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~iv~e~~~~~~  100 (340)
                      +.|+.|..+.+|+... +++.+++|.....   ....+..|+..++.+.   ...+.+++.+.......++|||++++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            4689999999999976 5778899987533   3556788888888773   3567778888777778999999999876


Q ss_pred             h
Q 041345          101 L  101 (340)
Q Consensus       101 L  101 (340)
                      +
T Consensus       118 ~  118 (312)
T 3jr1_A          118 N  118 (312)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.99  E-value=4.5e-05  Score=69.37  Aligned_cols=73  Identities=15%  Similarity=0.162  Sum_probs=44.1

Q ss_pred             CCcccccCCeeEEEEEECCCCEEEEEEccCC----C---h--hcHHHHHHHHHHHHc-CCCCceeeeeeEEeeCCeeEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS----S---G--QGIVEFKNEAKLIAK-LQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~----~---~--~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      .+.||.|..+.||++.. +++.++||.....    .   .  .....+..|+..+.. .....+.+++.+.  ....++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45789999999999965 5678999943211    0   0  122334444433322 1223455666554  4567999


Q ss_pred             Eecc-CC
Q 041345           93 YEYL-PN   98 (340)
Q Consensus        93 ~e~~-~~   98 (340)
                      ||++ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.78  E-value=0.00011  Score=65.70  Aligned_cols=142  Identities=17%  Similarity=0.167  Sum_probs=82.8

Q ss_pred             CCcccccCCeeEEEEEECC--------CCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+.|..|-...+|++...+        ++.+++|+.... ........+|..+++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            3567779999999998642        478999986332 234556678989888773 3333556665543    3899


Q ss_pred             eccCCCChhhHh-----------------hccC--ccccCC--HHHHHHHHHHHHH-------------------HHHH-
Q 041345           94 EYLPNKSLDFFI-----------------FDSS--KKELLD--WKKRFNIIEGIVQ-------------------GLLY-  132 (340)
Q Consensus        94 e~~~~~~L~~~l-----------------~~~~--~~~~~~--~~~~~~i~~qi~~-------------------~l~~-  132 (340)
                      ||++|.++..--                 +...  ......  +.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999886653210                 1100  011112  3455555544422                   1222 


Q ss_pred             ---HHhCC-CCceeecCCCCCCeEeCCC----CCeeEeccccccc
Q 041345          133 ---LHKYS-RLRVIHRDLKASNILLDDQ----MNPKISDFGMART  169 (340)
Q Consensus       133 ---LH~~~-~~~i~H~dlk~~Nilv~~~----~~~~l~Dfg~~~~  169 (340)
                         |...+ ...++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               22222 2359999999999999876    6899999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.75  E-value=0.0002  Score=62.45  Aligned_cols=160  Identities=17%  Similarity=0.157  Sum_probs=86.9

Q ss_pred             cccHHHHHHHhcCCCCCC-----cccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-----CCce
Q 041345            7 IFDFQTIAAATDNFSPGN-----RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTNL   76 (340)
Q Consensus         7 ~~~~~~i~~~~~~y~~~~-----~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i   76 (340)
                      .++.+++.....+|.+..     .|+.|....+|++...++ .+++|.......  ...+..|..+++.+.     -|.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcc
Confidence            466788888888887743     355688899999987555 688898865211  123445666666552     2333


Q ss_pred             eeee-e--EEeeCCeeEEEEeccCCCChhh--------------HhhccCc----c--ccCC---HHHHHH---------
Q 041345           77 VRLL-G--CSLQKGERLLVYEYLPNKSLDF--------------FIFDSSK----K--ELLD---WKKRFN---------  121 (340)
Q Consensus        77 ~~~~-~--~~~~~~~~~iv~e~~~~~~L~~--------------~l~~~~~----~--~~~~---~~~~~~---------  121 (340)
                      +... +  +....+..++++++++|..+..              .++....    .  ....   +.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            3211 1  1123456789999998865421              0111000    0  0001   111000         


Q ss_pred             ---HHHHHHHHHHHHHhC----CCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          122 ---IIEGIVQGLLYLHKY----SRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       122 ---i~~qi~~~l~~LH~~----~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                         +...+...+..++..    ....++|+|+.+.||++++++.+.|.||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               001133344455421    123599999999999998875567999987653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.74  E-value=0.00084  Score=58.58  Aligned_cols=95  Identities=13%  Similarity=0.081  Sum_probs=58.9

Q ss_pred             cccccHHHHHHHhcCCCCC-----CcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-C-Ccee
Q 041345            5 LKIFDFQTIAAATDNFSPG-----NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-H-TNLV   77 (340)
Q Consensus         5 ~~~~~~~~i~~~~~~y~~~-----~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~~i~   77 (340)
                      +...+.+.+......|.+.     ..|+ |....||++...+|+.+++|...... .....+..|..+++.+. + -.++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            4455667777776666542     2466 88889999877667789999985332 12345566777777663 1 1133


Q ss_pred             eeeeE-----EeeCCeeEEEEeccCCCCh
Q 041345           78 RLLGC-----SLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        78 ~~~~~-----~~~~~~~~iv~e~~~~~~L  101 (340)
                      +++..     ....+..+++|++++|..+
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~  114 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQF  114 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence            33332     1234556889999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.65  E-value=0.00015  Score=58.62  Aligned_cols=102  Identities=10%  Similarity=0.043  Sum_probs=65.6

Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      -+|.+.|...  +.++++.+++.++.|.+.+|.-+-. +.   -..+=+.|..|++..+|.|.+.+ +.+.         
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc---------
Confidence            4788888643  4579999999999999998877622 11   11223456889999998888764 1110         


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN  221 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p  221 (340)
                           .....+.|||... ...+.+.-|||||+++|..+-.+.|
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 1123466888652 3456788899999999999875544

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.63  E-value=0.00016  Score=62.59  Aligned_cols=71  Identities=13%  Similarity=0.200  Sum_probs=43.6

Q ss_pred             CCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCce-eeeeeEEeeCCeeEEEEecc-CCCC
Q 041345           23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-VRLLGCSLQKGERLLVYEYL-PNKS  100 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~-~~~~  100 (340)
                      .+.|+.|..+.+|++     +.+++|+....... .....+|+.+++.+...++ .+++++  +...-+++++|+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678889999999998     56888987543211 1123457777776632222 345443  333457899999 6655


Q ss_pred             h
Q 041345          101 L  101 (340)
Q Consensus       101 L  101 (340)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.63  E-value=0.00059  Score=59.77  Aligned_cols=31  Identities=29%  Similarity=0.442  Sum_probs=26.6

Q ss_pred             CceeecCCCCCCeEeCCC----CCeeEeccccccc
Q 041345          139 LRVIHRDLKASNILLDDQ----MNPKISDFGMART  169 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~----~~~~l~Dfg~~~~  169 (340)
                      ..++|||+.+.||+++.+    +.+.|.||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            359999999999999874    6789999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.59  E-value=0.00027  Score=64.37  Aligned_cols=73  Identities=16%  Similarity=0.216  Sum_probs=48.0

Q ss_pred             CCcccccCCeeEEEEEECC--------CCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+.|+.|....+|++...+        ++.+++|+......  ...+.+|..+++.+. +.-..++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            3467888899999998653        47899998843221  134557888888774 322355666543  2  3899


Q ss_pred             eccCCCCh
Q 041345           94 EYLPNKSL  101 (340)
Q Consensus        94 e~~~~~~L  101 (340)
                      +|++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99976444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.52  E-value=0.00042  Score=63.53  Aligned_cols=73  Identities=15%  Similarity=0.156  Sum_probs=46.1

Q ss_pred             CcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCce-eeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL-VRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      +.|+.|-...+|++...+ ++.+++|+....... .....+|..+++.+...++ .++++++.  +  .+|++|+++.++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            467788899999998755 478899987443211 1122578888888854334 45666552  2  359999987554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.38  E-value=0.0019  Score=56.80  Aligned_cols=31  Identities=23%  Similarity=0.348  Sum_probs=27.2

Q ss_pred             CceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          139 LRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       139 ~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ..++|+|+.+.||+++.++.+.|.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.33  E-value=0.00052  Score=61.09  Aligned_cols=74  Identities=12%  Similarity=0.133  Sum_probs=43.2

Q ss_pred             CCcccccCCeeEEEEEECC---------CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc-eeeeeeEEeeCCeeEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLD---------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-LVRLLGCSLQKGERLLV   92 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~iv   92 (340)
                      .+.|+.|....+|++...+         ++.+++|+....... ......|..+++.+...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3467788889999997644         268899987543221 112356777777763222 34555443  2  2689


Q ss_pred             EeccCCCCh
Q 041345           93 YEYLPNKSL  101 (340)
Q Consensus        93 ~e~~~~~~L  101 (340)
                      |+|++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.57  E-value=0.0098  Score=53.78  Aligned_cols=73  Identities=11%  Similarity=0.110  Sum_probs=47.2

Q ss_pred             CcccccCCeeEEEEEECC--------CCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEEe
Q 041345           24 NRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +.|..|-...+|++...+        ++.+++++..... .......+|..+++.+. +.-..++++.+  .  -++|++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            457778899999998753        5789999874432 22223457778777773 32234455433  2  278999


Q ss_pred             ccCCCCh
Q 041345           95 YLPNKSL  101 (340)
Q Consensus        95 ~~~~~~L  101 (340)
                      |++|.++
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9988764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.69  E-value=0.025  Score=50.77  Aligned_cols=30  Identities=27%  Similarity=0.398  Sum_probs=25.0

Q ss_pred             ceeecCCCCCCeEe------CCCCCeeEeccccccc
Q 041345          140 RVIHRDLKASNILL------DDQMNPKISDFGMART  169 (340)
Q Consensus       140 ~i~H~dlk~~Nilv------~~~~~~~l~Dfg~~~~  169 (340)
                      .++|+|+.+.||++      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      4566799999988754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.86  E-value=1.5  Score=35.41  Aligned_cols=113  Identities=10%  Similarity=0.087  Sum_probs=74.0

Q ss_pred             CCCceeeeeeEEeeCCeeEEEEeccCCC-ChhhHhhccCccccCCHHHHHHHHHHHHHHHH-HHHhCCCCceeecCCCCC
Q 041345           72 QHTNLVRLLGCSLQKGERLLVYEYLPNK-SLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL-YLHKYSRLRVIHRDLKAS  149 (340)
Q Consensus        72 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~~i~H~dlk~~  149 (340)
                      .||++  --.+..+++.+.+.++.-+++ ++.. +      ..++....++++.+|+.... +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            67887  333446667777777754333 2222 2      23788899999999988666 4543     688899999


Q ss_pred             CeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCC
Q 041345          150 NILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       150 Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~  222 (340)
                      |++++.++.+++.-.|+-..+              +|.=..+|-+          .-++=|++..++.++..|
T Consensus       114 NL~f~~~~~p~i~hRGi~~~l--------------pP~e~~ee~f----------l~qyKali~all~~K~~F  162 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESL--------------PPDEWDDERL----------LREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTB--------------SSCSCCHHHH----------HHHHHHHHHHHTTCSSCH
T ss_pred             eEEEeCCCcEEEEEcCCcccC--------------CCCCCCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence            999999999999877753321              0101223322          225677888888888776

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.73  E-value=0.99  Score=36.30  Aligned_cols=114  Identities=9%  Similarity=0.051  Sum_probs=76.3

Q ss_pred             CCCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCe
Q 041345           72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNI  151 (340)
Q Consensus        72 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Ni  151 (340)
                      .||+.+.. .+..+.+.+.+.++.-+  ....+-    .-...+....++++.+|+....++++     =+|--|.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            68888866 45566666666666433  222222    11237888999999999987755544     57889999999


Q ss_pred             EeCCCCCeeEecccccccccCcccccccccccccCCC-CChhhhccCCCCccCceehhhHHHHHHHhCCCCC
Q 041345          152 LLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY-MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN  222 (340)
Q Consensus       152 lv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~  222 (340)
                      +++.++.+++.-.|+...+               +.| ..+|-+          .-.+=+++..+++++..|
T Consensus       111 ~f~~~~~p~i~~RGik~~l---------------~P~~~~ee~f----------L~qyKAliiall~~K~~F  157 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV---------------DPLPVSEAEF----------LTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECTTSCEEESCCEETTTB---------------SCCCCCHHHH----------HHHHHHHHHHHHCTTCCH
T ss_pred             EEcCCCCEEEEEccCccCC---------------CCCCCCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence            9999999999876653221               011 122222          235678888999998887

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.36  E-value=0.18  Score=46.03  Aligned_cols=61  Identities=8%  Similarity=0.111  Sum_probs=18.1

Q ss_pred             CCCCcccccCCeeEEEEEECC-CCEEEE------EEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEe
Q 041345           21 SPGNRLGQGGFGPVYKGKLLD-GQEIAI------KRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL   84 (340)
Q Consensus        21 ~~~~~Lg~G~~g~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (340)
                      .+.+.||   ||.||+|.+.. ..+||+      |.....  ..+....+.++..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4556776   99999998754 356788      655332  2223345778888888889999999888654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	340
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-71
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-67
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-45
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-25

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 6e-71
 Identities = 68/285 (23%), Positives = 125/285 (43%), Gaps = 20/285 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
              + G R+G G FG VYKGK      + +  ++  + Q +  FKNE  ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
             +G S    +  +V ++    SL   +     K   +  K  +I     QG+ YLH   
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH--- 121

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
              +IHRDLK++NI L + +  KI DFG+A             ++ G+  +M+PE +   
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 196 -NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                S +SDVY+FG+++ E+++ +          ++N       +   G     +   +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLS-KV 234

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
             +C          +   C++ K  +RP    + + +     +LP
Sbjct: 235 RSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 3e-67
 Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 22/274 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           +      RLG G FG V+ G      ++A+K L + S      F  EA L+ +LQH  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           RL      +    ++ EY+ N SL  F+   S  +L    K  ++   I +G+ ++ +  
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
               IHRDL+A+NIL+ D ++ KI+DFG+AR    NE  A          + +PE +  G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             ++KSDV+SFG+L+ EI++  +      T   +       Q    G  +   D     +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPD-----N 234

Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           C  +       +  LC +++  DRPT   + S+L
Sbjct: 235 CPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 1e-66
 Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 22/288 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
           ++     +LGQG FG V+ G       +AIK L   +      F  EA+++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L    + +    +V EY+   SL  F+   + K  L   +  ++   I  G+ Y+ +  
Sbjct: 76  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM- 132

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
               +HRDL+A+NIL+ + +  K++DFG+AR    NE  A          + +PE  + G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             ++KSDV+SFG+L+ E+ +  +                 +      + L+ ++      
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMP 234

Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
           C P+       +   C + +  +RPT   + + L +   +     QP 
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 7e-66
 Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 22/274 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
              +    +G G FG V+ G  L+  ++AIK + + +     +F  EA+++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L G  L++    LV+E++ +  L  ++   +++ L   +    +   + +G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
              VIHRDL A N L+ +    K+SDFGM R    ++   ++        + SPE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             S KSDV+SFGVL+ E+ S  K                 ++  +  + +E I T     
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK---------------IPYENRSNSEVVEDISTGFRLY 222

Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                 T    +   C +++  DRP  S +   L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 2e-65
 Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 22/276 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
            + +    LG G FG V  GK     ++AIK + + S     EF  EAK++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
           +L G   ++    ++ EY+ N  L  ++ +   +     ++   + + + + + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE--- 117

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
             + +HRDL A N L++DQ   K+SDFG++R    +E  ++         +  PE +M  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176

Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             S KSD+++FGVL+ EI S  K                 ++ +   +  E I   L   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221

Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
                  +   +   C  +KA +RPT   + S + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (512), Expect = 2e-63
 Identities = 65/301 (21%), Positives = 120/301 (39%), Gaps = 37/301 (12%)

Query: 8   FDFQTIAAATDNFSP---------GNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS- 53
           F F+    A   F+             +G G FG V  G L         +AIK L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 54  SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL 113
           + +   +F +EA ++ +  H N++ L G   +    +++ E++ N SLD F+  +  +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 114 LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN 173
               +   ++ GI  G+ YL        +HRDL A NIL++  +  K+SDFG++R    +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 174 ELEANTNRIVG---THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH 230
             +      +G      + +PE +     +  SDV+S+G+++ E++S  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 231 LNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM 290
                  +        +  I+         D  +    + L C Q     RP    + + 
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 291 L 291
           L
Sbjct: 287 L 287

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-62
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQH 73
             D+F   + LG G  G V+K      G  +A K +       I      E +++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
             +V   G     GE  +  E++   SLD  +  + +   +  +    +   +++GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
               + +++HRD+K SNIL++ +   K+ DFG++        ++  N  VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPER 174

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
           +     S++SD++S G+ ++E+   +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (506), Expect = 2e-62
 Identities = 61/302 (20%), Positives = 118/302 (39%), Gaps = 46/302 (15%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIV-EFKNEAKLIAK 70
           +N      +G+G FG V++ +            +A+K L + +   +  +F+ EA L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL----------------- 113
             + N+V+LLG         L++EY+    L+ F+   S   +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 114 ----LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
               L   ++  I   +  G+ YL +    + +HRDL   N L+ + M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER 229
               +             +M PE +     + +SDV+++GV++ EI S            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------- 241

Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
                   +      + +  +      +C  +      ++  LC      DRP+   +  
Sbjct: 242 -------PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 290 ML 291
           +L
Sbjct: 295 IL 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (503), Expect = 4e-62
 Identities = 61/275 (22%), Positives = 125/275 (45%), Gaps = 22/275 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
            + +  ++LG G +G VY+G        +A+K L + + + + EF  EA ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V+LLG   ++    ++ E++   +L  ++ + +++E +       +   I   + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
            +   IHRDL A N L+ +    K++DFG++R    +   A+         + +PE +  
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 197 GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE 256
              S+KSDV++FGVL+ EI +   +                +   +  +  EL++     
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEKDYRM 235

Query: 257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                   +   +   C Q   +DRP+ +++    
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 5e-62
 Identities = 59/293 (20%), Positives = 114/293 (38%), Gaps = 28/293 (9%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
              +G+G FG V++GK   G+E+A+K  S    +     + E      L+H N++  +  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAA 65

Query: 83  SLQKG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK--- 135
             +      +  LV +Y  + SL  ++     +  +  +    +      GL +LH    
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 136 --YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF--GMNELEANTNRIVGTHGYMSP 191
               +  + HRDLK+ NIL+       I+D G+A       + ++   N  VGT  YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 192 EYVMNGI------VSMKSDVYSFGVLVLEIISSKKNNGCYDTERH----LNLVGYAWQLW 241
           E + + I         ++D+Y+ G++  EI       G ++  +     L     + +  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 242 NEGKALELIDTTLHESCSPDEVTRCIH-VGLLCVQDKATDRPTMSDVASMLTN 293
            +    + +   +       E  R +  +   C       R T   +   L+ 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 4e-61
 Identities = 67/275 (24%), Positives = 115/275 (41%), Gaps = 28/275 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
                   +G+G FG V  G    G ++A+K +   +      F  EA ++ +L+H+NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLV 63

Query: 78  RLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +LLG  +++   L +V EY+   SL  ++  S  + +L           + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
                +HRDL A N+L+ +    K+SDFG+ +     E  +  +       + +PE +  
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174

Query: 197 GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE 256
              S KSDV+SFG+L+ EI S  +        + +           +G  ++  D     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPD----- 223

Query: 257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
            C P        V   C    A  RP+   +   L
Sbjct: 224 GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-61
 Identities = 72/324 (22%), Positives = 135/324 (41%), Gaps = 41/324 (12%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKL 71
             F     LG G FG VYKG  +   E     +AIK L ++ S +   E  +EA ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            + ++ RLLG         L+ + +P   L  ++ +   K+ +  +   N    I +G+ 
Sbjct: 69  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 125

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
           YL      R++HRDL A N+L+    + KI+DFG+A+  G  E E +         +M+ 
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
           E +++ I + +SDV+S+GV V E+++                    +      +   +++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILE 227

Query: 252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT--------------NDTMA 297
                   P        + + C    A  RP   ++    +              ++ M 
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287

Query: 298 LPTPRQPAFFINISSDYEEPEVTE 321
           LP+P    F+  +  + +  +V +
Sbjct: 288 LPSPTDSNFYRALMDEEDMDDVVD 311

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 9e-61
 Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 27/298 (9%)

Query: 16  ATDNFSPGNR-LGQGGFGPVYKGKLL---DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
             DN    +  LG G FG V +G         ++AIK L + + +   E    EA+++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           L +  +VRL+G   Q    +LV E      L  F+    K+E +       ++  +  G+
Sbjct: 66  LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYM 189
            YL        +HRDL A N+LL ++   KISDFG+++  G ++      +       + 
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +     S +SDV+S+GV + E +S  +                 ++     + +  
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAF 224

Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFF 307
           I+      C P+       +   C   K  DRP    V   +     +L +  +    
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-60
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 27/281 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSGQG-IVEFKNEAKLIAKL 71
              +    +G G FG VYKG L          +AIK L     +   V+F  EA ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 72  QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
            H N++RL G   +    +++ EY+ N +LD F+ +  K       +   ++ GI  G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT-NRIVGTHGYMS 190
           YL     +  +HRDL A NIL++  +  K+SDFG++R    +     T +       + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
           PE +     +  SDV+SFG+++ E+++  +                 +   +  + ++ I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMKAI 226

Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
           +         D  +    + + C Q +   RP  +D+ S+L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 7e-59
 Identities = 64/276 (23%), Positives = 108/276 (39%), Gaps = 28/276 (10%)

Query: 24  NRLGQGGFGPVYKGKLLD---GQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTNLVR 78
             LG G FG V KG        + +A+K L   +    +  E   EA ++ +L +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
           ++G   +    +LV E      L+ ++  +     +  K    ++  +  G+ YL     
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---E 125

Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN-RIVGTHGYMSPEYVMNG 197
              +HRDL A N+LL  Q   KISDFG+++    +E              + +PE +   
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
             S KSDV+SFGVL+ E  S  +                 ++     +   +++      
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMG 230

Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
           C          +  LC      +RP  + V   L N
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 1e-58
 Identities = 66/297 (22%), Positives = 108/297 (36%), Gaps = 40/297 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +  S G  LG G FG V +              +A+K L  S+     E   +E K+++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL---------------L 114
           L  H N+V LLG     G  L++ EY     L  F+       +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
           D +   +    + +G+ +L        IHRDL A NILL      KI DFG+AR    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
                        +M+PE + N + + +SDV+S+G+ + E+ S   +             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                +  + K  ++I                  +   C       RPT   +  ++
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-58
 Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 28/278 (10%)

Query: 23  GNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
              +G+G FG VY G LLD        A+K L++ +  G V  F  E  ++    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 78  RLLGCSLQ-KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
            LLG  L+ +G  L+V  Y+ +  L  FI + +    +     F +          +   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----GMKFL 146

Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR--IVGTHGYMSPEYV 194
           +  + +HRDL A N +LD++   K++DFG+AR     E ++  N+        +M+ E +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                + KSDV+SFGVL+ E+++             +N       L    + L       
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLL------Q 255

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
            E C          V L C   KA  RP+ S++ S ++
Sbjct: 256 PEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-58
 Identities = 69/306 (22%), Positives = 128/306 (41%), Gaps = 34/306 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKL------LDGQEIAIKRLSKS-SGQGIVEFKNEAKLIAK 70
           +  +    LGQG FG VY+G             +AIK ++++ S +  +EF NEA ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNII 123
               ++VRLLG   Q    L++ E +    L  ++        ++         K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
             I  G+ YL+     + +HRDL A N ++ +    KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNE 243
               +MSPE + +G+ +  SDV+SFGV++ EI +  +                 +Q  + 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241

Query: 244 GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQ 303
            + L  +          +       +  +C Q     RP+  ++ S +  +    P  R+
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFRE 299

Query: 304 PAFFIN 309
            +F+ +
Sbjct: 300 VSFYYS 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 6e-58
 Identities = 65/292 (22%), Positives = 121/292 (41%), Gaps = 39/292 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDG---QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-Q 72
           ++    + +G+G FG V K ++       + AIKR+ + +S     +F  E +++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-------------FDSSKKELLDWKKR 119
           H N++ LLG    +G   L  EY P+ +L  F+               +S    L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
            +    + +G+ YL +    + IHRDL A NIL+ +    KI+DFG++R   +       
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ 239
                   +M+ E +   + +  SDV+S+GVL+ EI+S                    + 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYC 228

Query: 240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
                +  E +          +       +   C ++K  +RP+ + +   L
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 9e-58
 Identities = 59/273 (21%), Positives = 108/273 (39%), Gaps = 23/273 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 75
           +++     LG+G +G V         + +A+K +         E  K E  +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V+  G   +   + L  EY     L   I        +           ++ G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH- 120

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
              + + HRD+K  N+LLD++ N KISDFG+A  F  N  E   N++ GT  Y++PE + 
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 196 NG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                +   DV+S G+++  +++ +                  +  W E K        +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKI 232

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
             +     + + +           + R T+ D+
Sbjct: 233 DSAPL-ALLHKILVE-------NPSARITIPDI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-57
 Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 26/278 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHT 74
           +++     +G G +G   K +   DG+ +  K L   S          +E  L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 75  NLVRLLGCSLQKGERLL--VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLL 131
           N+VR     + +    L  V EY     L   I   +K ++ LD +    ++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 132 YLHKYSR--LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
             H+ S     V+HRDLK +N+ LD + N K+ DFG+AR    +   A     VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           SPE +     + KSD++S G L+ E+ +                    +  +++ +    
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM----------------PPFTAFSQKELAGK 225

Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           I                  +    +  K   RP++ ++
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 4e-57
 Identities = 67/302 (22%), Positives = 117/302 (38%), Gaps = 45/302 (14%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
           +N   G  LG G FG V               ++A+K L + +     E   +E K++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 71  L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK------------------ 111
           L  H N+V LLG     G   L++EY     L  ++    +K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 112 --ELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
              +L ++        + +G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER 229
              +              +M+PE +  GI ++KSDV+S+G+L+ EI S   N        
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYP 268

Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
            + +    ++L   G  ++          + +       +   C    +  RP+  ++ S
Sbjct: 269 GIPVDANFYKLIQNGFKMD-----QPFYATEE----IYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 290 ML 291
            L
Sbjct: 320 FL 321

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 77/279 (27%), Positives = 115/279 (41%), Gaps = 36/279 (12%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
              FS    +G G FG VY  + + + + +AIK++S S  Q      +   E + + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H N ++  GC L++    LV EY    + D        K+ L   +   +  G +QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH      +IHRD+KA NILL +    K+ DFG A         A  N  VGT  +M+PE
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 193 YVM---NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
            ++    G    K DV+S G+  +E+   K                      N   AL  
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK----------------PPLFNMNAMSALYH 225

Query: 250 IDTTLHESCSPDEVTR-CIHVGLLCVQDKATDRPTMSDV 287
           I      +      +    +    C+Q    DRPT   +
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 4e-56
 Identities = 73/283 (25%), Positives = 109/283 (38%), Gaps = 28/283 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSK---SSGQGIVEFKNEAKLIAK 70
            +     +LG G FG V +G+          +A+K L     S  + + +F  E   +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           L H NL+RL G         +V E  P  SL   +       LL    R+ +   + +G+
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE-ANTNRIVGTHGYM 189
            YL      R IHRDL A N+LL  +   KI DFG+ R    N+              + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           +PE +     S  SD + FGV + E+ +  +          LN      ++  EG+ L  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPR 236

Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
                 E C  D      +V + C   K  DRPT   +   L 
Sbjct: 237 P-----EDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 7e-56
 Identities = 61/277 (22%), Positives = 114/277 (41%), Gaps = 27/277 (9%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
            D +     LG G FG VYK +  +     A K +   S + + ++  E  ++A   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V+LL     +    ++ E+    ++D  + +  +   L   +   + +  +  L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH- 127

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               ++IHRDLKA NIL     + K++DFG++          ++   +GT  +M+PE VM
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 196 -----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
                +     K+DV+S G+ ++E+   +  +   +  R L  +  +          E  
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------EPP 233

Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
                   S +           C++     R T S +
Sbjct: 234 TLAQPSRWSSN----FKDFLKKCLEKNVDARWTTSQL 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-55
 Identities = 64/277 (23%), Positives = 111/277 (40%), Gaps = 37/277 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G FG VY  +       +A+K L K+         + + E ++ + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
            N++RL G         L+ EY P  ++   +   SK    D ++    I  +   L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H     RVIHRD+K  N+LL      KI+DFG +     +        + GT  Y+ PE 
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI--- 250
           +   +   K D++S GVL  E +  K                  ++     +  + I   
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK----------------PPFEANTYQETYKRISRV 219

Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           + T  +  +         +    ++   + RP + +V
Sbjct: 220 EFTFPDFVTEG----ARDLISRLLKHNPSQRPMLREV 252

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 3e-54
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 31/273 (11%)

Query: 23  GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRL 79
              +G+G F  VYKG   +   E+A   L     +      FK EA+++  LQH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 80  LGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
                     K   +LV E + + +L  ++    + +++  K   +    I++GL +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 136 YSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
            +   +IHRDLK  NI +     + KI D G+A     +        ++GT  +M+PE +
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE-M 184

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                    DVY+FG+ +LE+ +S+           +      ++    G      D   
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPASFD--- 235

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
            +   P+       +   C++    +R ++ D+
Sbjct: 236 -KVAIPE----VKEIIEGCIRQNKDERYSIKDL 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 2e-53
 Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 24/272 (8%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
              ++   ++GQG  G VY    +  GQE+AI++++           NE  ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V  L   L   E  +V EYL   SL   + ++      D  +   +    +Q L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               +VIHRD+K+ NILL    + K++DFG          ++  + +VGT  +M+PE V 
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVT 189

Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH 255
                 K D++S G++ +E+I  +      +  R L L+                +    
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----------ATNGTPELQNP 239

Query: 256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           E  S             C+      R +  ++
Sbjct: 240 EKLSAI----FRDFLNRCLDMDVEKRGSAKEL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-53
 Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 27/281 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQ 72
           +    G  +G+G FG V++G  +        +AIK     +   + E F  EA  + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H ++V+L+G  + +    ++ E      L  F+        LD          +   L Y
Sbjct: 67  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           L      R +HRD+ A N+L+      K+ DFG++R    +      ++      +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPE 179

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT 252
            +     +  SDV+ FGV + EI+              +            G+ L +   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPP- 232

Query: 253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
               +C P        +   C     + RP  +++ + L+ 
Sbjct: 233 ----NCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 4e-53
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 39/298 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 70
           D    G  LG+G FG V +            + +A+K L + +         +E K++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 71  -LQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIF-------------DSSKKELLD 115
              H N+V LLG   + G  L ++ E+    +L  ++              +   K+ L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 116 WKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL 175
            +        + +G+ +L      + IHRDL A NILL ++   KI DFG+AR    +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVG 235
                       +M+PE + + + +++SDV+SFGVL+ EI S             + +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244

Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
              +   EG  +   D       +P+         L C   + + RPT S++   L N
Sbjct: 245 EFCRRLKEGTRMRAPD-----YTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-52
 Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 41/297 (13%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL--------DGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
           D    G  LG+G FG V   + +           ++A+K L   ++ + + +  +E +++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 69  AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKELL 114
             + +H N++ LLG   Q G   ++ EY    +L  ++                + +E L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
             K   +    + +G+ YL      + IHRDL A N+L+ +    KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
               T        +M+PE + + I + +SDV+SFGVL+ EI +   +         L   
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246

Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
              ++L  EG  ++        +C+ +       +   C     + RPT   +   L
Sbjct: 247 ---FKLLKEGHRMDKP-----SNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 58/309 (18%), Positives = 108/309 (34%), Gaps = 31/309 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           D++     LG G FG V++      G   A K +           + E + ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           V L        E +++YE++    L   + D   K  +   +    +  + +GL ++H+ 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE- 142

Query: 137 SRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                +H DLK  NI+   + +   K+ DFG+       +   +     GT  + +PE  
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
               V   +D++S GVL   ++S     G  + +           L N       +D + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---------TLRNVKSCDWNMDDSA 248

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM-------LTNDTMALPTPRQPAFF 307
               S D            +      R T+                    +P+ R     
Sbjct: 249 FSGISED----GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304

Query: 308 INISSDYEE 316
            +I + Y+ 
Sbjct: 305 DSIKTKYDA 313

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 4e-50
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 10/206 (4%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F  G  LG+G F  V   + L   +E AIK L K        +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
              V+L        +      Y  N  L  +I         D          IV  L YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H      +IHRDLK  NILL++ M+ +I+DFG A+       +A  N  VGT  Y+SPE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
           +        SD+++ G ++ ++++  
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (413), Expect = 4e-48
 Identities = 60/273 (21%), Positives = 104/273 (38%), Gaps = 24/273 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           D +     LG G FG V++      G+    K ++          KNE  ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           + L      K E +L+ E+L    L   I  +++   +   +  N +    +GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 137 SRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
               ++H D+K  NI+ + +     KI DFG+A     +E+         T  + +PE V
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
               V   +D+++ GVL   ++S        D             L N  +     D   
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---------TLQNVKRCDWEFDEDA 251

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
             S SP+            +Q +   R T+ D 
Sbjct: 252 FSSVSPE----AKDFIKNLLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (389), Expect = 2e-45
 Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 29/285 (10%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
           +D +  G  LG GG   V+  + L   +++A+K L     +     + F+ EA+  A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 73  HTNLVRLLGCSLQKGERL----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           H  +V +      +        +V EY+   +L   +        +  K+   +I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN-ELEANTNRIVGTHG 187
            L + H   +  +IHRD+K +NI++      K+ DFG+AR    +      T  ++GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
           Y+SPE      V  +SDVYS G ++ E+++ +                     +   +  
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---------VAYQHVRED 230

Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-TMSDVASML 291
            +  +  HE  S D       V L  +     +R  T +++ + L
Sbjct: 231 PIPPSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADL 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (392), Expect = 7e-45
 Identities = 64/275 (23%), Positives = 113/275 (41%), Gaps = 32/275 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNE---AKLIAK 70
           ++FS    +G+GGFG VY  +  D G+  A+K L K      QG     NE     L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
                +V +        +   + + +    L + +   S+  +            I+ GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
            ++H      V++RDLK +NILLD+  + +ISD G+A  F   +     +  VGTHGYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 191 PEYVMNGI-VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
           PE +  G+     +D +S G ++ +++        + T+    +      +  E      
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------ 227

Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTM 284
               L +S SP+       +    +Q     R   
Sbjct: 228 ----LPDSFSPE----LRSLLEGLLQRDVNRRLGC 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-44
 Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 21/289 (7%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 74
              ++  + +G+G +G V      ++   +AIK++S    Q   +    E K++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N++ +           +   YL    +   ++   K + L        +  I++GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT-NRIVGTHGYMSPEY 193
                 V+HRDLK SN+LL+   + KI DFG+AR    +          V T  Y +PE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 194 VMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLV--------------GYAW 238
           ++N     KS D++S G ++ E++S++           LN +                  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           +  N   +L   +        P+  ++ + +    +      R  +   
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
            +F     LG G FG V+  +   +G+  A+K L K      + +    +E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
             ++R+ G      +  ++ +Y+    L   +  S +      K     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
                  +I+RDLK  NILLD   + KI+DFG A+      +   T  + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKK 220
           V     +   D +SFG+L+ E+++   
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 8e-44
 Identities = 51/285 (17%), Positives = 97/285 (34%), Gaps = 25/285 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           + +  G ++G G FG +Y G  +  G+E+AIK     +     +   E+K+   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVG 64

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +  +     +G+  ++   L   SL+      S+K     K    + + ++  + Y+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120

Query: 137 SRLRVIHRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEAN-----TNRIVGTHGY 188
                IHRD+K  N L           I DFG+A+ +       +        + GT  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE 248
            S    +    S + D+ S G +++                               K + 
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-----ERISEKKMS 234

Query: 249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
                L +    +           C   +  D+P  S +  +  N
Sbjct: 235 TPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-43
 Identities = 52/273 (19%), Positives = 107/273 (39%), Gaps = 25/273 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
           + +     LG+G FG V++       +    K + K  G   V  K E  ++   +H N+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           + L        E ++++E++    +   I  S+ +  L+ ++  + +  + + L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH-- 119

Query: 137 SRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
               + H D++  NI+   + +   KI +FG AR     +   N   +     Y +PE  
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
            + +VS  +D++S G LV  ++S          ++          + N   A    D   
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---------IIENIMNAEYTFDEEA 226

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
            +  S +     +      +  +   R T S+ 
Sbjct: 227 FKEISIE----AMDFVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 51/273 (18%), Positives = 96/273 (35%), Gaps = 21/273 (7%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 74
            D +   + LG G F  V   +     + +AIK ++K + +G     +NE  ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V L       G   L+ + +    L   I    +K     +    +I  ++  + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
               +    +        LD+     ISDFG+++      +    +   GT GY++PE +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
                S   D +S GV+   ++         +  +               KA    D+  
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---------LFEQILKAEYEFDSPY 232

Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
            +  S              ++     R T    
Sbjct: 233 WDDISDS----AKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (372), Expect = 8e-43
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 26/219 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE---------FKNEAKL 67
           +N+ P   LG+G    V +       +E A+K +  + G                 E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 68  IAKLQ-HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGI 126
           + K+  H N+++L           LV++ +    L  ++   ++K  L  K+   I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
           ++ +  LH   +L ++HRDLK  NILLDD MN K++DFG +      E       + GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173

Query: 187 GYMSPEYVMNGIV------SMKSDVYSFGVLVLEIISSK 219
            Y++PE +   +         + D++S GV++  +++  
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-42
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG---QGIVEFKNEAKLIAK-LQ 72
           ++F     LG+G FG V+  +     Q  AIK L K        +     E ++++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
           H  L  +      K     V EYL    L + I    K    D  +       I+ GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           LH      +++RDLK  NILLD   + KI+DFGM +   +   +A TN   GT  Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPE 173

Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
            ++    +   D +SFGVL+ E++  +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 19/211 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
            +++    +G G FG VY+ KL D G+ +AIK++ +           E +++ KL H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 77  VRLLGCSLQKGER------LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           VRL       GE+       LV +Y+P          S  K+ L        +  + + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 131 LYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
            Y+H      + HRD+K  N+LLD D    K+ DFG A+     E   +    + +  Y 
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189

Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           +PE +      +   DV+S G ++ E++  +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (355), Expect = 3e-40
 Identities = 46/287 (16%), Positives = 103/287 (35%), Gaps = 27/287 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
            ++  G R+G+G FG +++G  LL+ Q++AIK   + S     + ++E +    L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTG 62

Query: 77  VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
           +  +    Q+G   ++   L   SL+  +    +K     K      + ++  +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIH-- 118

Query: 137 SRLRVIHRDLKASNILLDDQMNP-----KISDFGMARTF-----GMNELEANTNRIVGTH 186
               +++RD+K  N L+    +       + DFGM + +       +        + GT 
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA 246
            YMS    +    S + D+ + G + +  +             +        +    G+ 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------KQKYERIGEK 231

Query: 247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
            +        +  P+E  + +H             P    +  + + 
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-40
 Identities = 64/304 (21%), Positives = 116/304 (38%), Gaps = 34/304 (11%)

Query: 24  NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQHTNLV 77
           + LG+G F  VYK +     Q +AIK++         +        E KL+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 78  RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
            LL     K    LV++++                +L        +   +QGL YLH++ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN- 196
              ++HRDLK +N+LLD+    K++DFG+A++FG           V T  Y +PE +   
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175

Query: 197 GIVSMKSDVYSFGVLVLEIIS--------------SKKNNGCYDTERHLNLVGYAWQLWN 242
            +  +  D+++ G ++ E++               ++                 +   + 
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 243 EGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM--LTNDTMALPT 300
             K+   I      S + D++   I             R T +    M   +N     P 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 301 PRQP 304
            + P
Sbjct: 293 CQLP 296

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-40
 Identities = 58/292 (19%), Positives = 114/292 (39%), Gaps = 26/292 (8%)

Query: 16  ATDNFSPGNRLGQGGFGPVYKGKLL--DGQEIAIKRLSKSSGQG-----IVEFKNEAKLI 68
           A   +     +G+G +G V+K + L   G+ +A+KR+   +G+       +      + +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 69  AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLD---FFIFDSSKKELLDWKKRFNIIEG 125
              +H N+VRL                L  + +D       D   +  +  +   +++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
           +++GL +LH     RV+HRDLK  NIL+      K++DFG+AR +           +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178

Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK----KNNGCYDTERHLNLVGYAWQL- 240
             Y +PE ++    +   D++S G +  E+   K     ++      + L+++G   +  
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 241 WNEGKALELIDTTLHESCSPDEVTRCIHVGLL-----CVQDKATDRPTMSDV 287
           W    AL         +   ++    I          C+      R +    
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 5e-40
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 11/206 (5%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 74
           +NF    ++G+G +G VYK +  L G+ +A+K++     +         E  L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+V+LL     + +  LV+E+L      F   D+S    +      + +  ++QGL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE-Y 193
            +   RV+HRDLK  N+L++ +   K++DFG+AR FG+          V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
           +     S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (350), Expect = 1e-39
 Identities = 61/289 (21%), Positives = 116/289 (40%), Gaps = 31/289 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTN 75
           + +    ++G+G +G VYK +   G+  A+K  RL K           E  ++ +L+H+N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 76  LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
           +V+L      K   +LV+E+L              +  L+     + +  ++ G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
               RV+HRDLK  N+L++ +   KI+DFG+AR FG+   +      + T  Y +P+ +M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 196 N-GIVSMKSDVYSFGVLVLEIISSK----------------KNNGCYDTERHLNLVGYAW 238
                S   D++S G +  E+++                  +  G  +++   N+     
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
              N      L   +  +          I +    ++     R T    
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDES----GIDLLSKMLKLDPNQRITAKQA 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-39
 Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 33/281 (11%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS------GQGIVEFKNEAKLIAK 70
           D +  G  LG G F  V K +    G + A K + K        G    + + E  ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 71  LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
           +QH N++ L      K + +L+ E +    L  F+    +KE L  ++    ++ I+ G 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125

Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELEANTNRIVGTH 186
             ++    L++ H DLK  NI+L D+  P    KI DFG+A              I GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 187 GYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA 246
            +++PE V    + +++D++S GV+   ++S          +  L  V            
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------ 228

Query: 247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
              ++    +    +            +      R T+ D 
Sbjct: 229 -SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-39
 Identities = 57/281 (20%), Positives = 105/281 (37%), Gaps = 43/281 (15%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE------FKNEAKLIAK 70
             +  G  LG GGFG VY G  + D   +AIK + K       E         E  L+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 71  LQ--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           +    + ++RLL    +    +L+ E        F     +++  L  +   +    +++
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
            + + H      V+HRD+K  NIL+D ++   K+ DFG                  GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRV 174

Query: 188 YMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA 246
           Y  PE++         + V+S G+L+ +++                        +   + 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------IPFEHDEE 215

Query: 247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           +        +  S +    C H+   C+  + +DRPT  ++
Sbjct: 216 IIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-37
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 12/221 (5%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           ++F     LG+G FG V   +    G+  A+K L K    +   +     E++++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
             L  L            V EY     L F +   S++ +   ++       IV  L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H      V++RD+K  N++LD   + KI+DFG+ +    +   A      GT  Y++PE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
           + +       D +  GV++ E++  +      D ER   L+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 5e-37
 Identities = 49/216 (22%), Positives = 100/216 (46%), Gaps = 20/216 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHT 74
             +    ++GQG FG V+K +    GQ++A+K++   + +    +    E K++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 75  NLVRLLGC--------SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGI 126
           N+V L+          +  KG   LV+++  +           K       +   +++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126

Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR--IVG 184
           + GL Y+H+    +++HRD+KA+N+L+      K++DFG+AR F + +          V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 185 THGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
           T  Y  PE ++         D++  G ++ E+ +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 8e-37
 Identities = 58/334 (17%), Positives = 121/334 (36%), Gaps = 41/334 (12%)

Query: 1   MKRDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIV 59
           +K++  I D++              LG G  G V +       ++ A+K L         
Sbjct: 4   IKKNAIIDDYKVT---------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----- 49

Query: 60  EFKNEAKLIAKL-QHTNLVRLLGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELL 114
           + + E +L  +  Q  ++VR++         +   L+V E L    L   I D   +   
Sbjct: 50  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF- 108

Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFG 171
             ++   I++ I + + YLH    + + HRD+K  N+L   +      K++DFG A+   
Sbjct: 109 TEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165

Query: 172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL 231
            +    +      T  Y++PE +         D++S GV++  ++        + +   L
Sbjct: 166 SHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGL 219

Query: 232 NLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM- 290
            +          G+             S +       +    ++ + T R T+++  +  
Sbjct: 220 AISPGMKTRIRMGQ--YEFPNPEWSEVSEE----VKMLIRNLLKTEPTQRMTITEFMNHP 273

Query: 291 -LTNDTMALPTPRQPAFFINISSDYEEPEVTEIK 323
            +   T    TP   +  +    +  E    E+ 
Sbjct: 274 WIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT 307

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  128 bits (322), Expect = 6e-35
 Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 15/206 (7%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
           D F     LG G FG V   K    G   A+K L K      + I    NE +++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 74  TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
             LV+L           +V EY+    +   +    +               IV    YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H    L +I+RDLK  N+L+D Q   +++DFG A+          T  + GT   ++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEI 209

Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
           +++   +   D ++ GVL+ E+ +  
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 1e-34
 Identities = 45/206 (21%), Positives = 85/206 (41%), Gaps = 10/206 (4%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 74
             +    ++G+G +G V+K K     + +A+KR+               E  L+ +L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 75  NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
           N+VRL        +  LV+E+       +F   +             +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
                 V+HRDLK  N+L++     K+++FG+AR FG+      +  +V           
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLF 174

Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKK 220
              + S   D++S G +  E+ ++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-33
 Identities = 57/289 (19%), Positives = 111/289 (38%), Gaps = 27/289 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 74
             +     +G G +G V        G ++AIK+L +   S         E +L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 75  NLVRLLGCSLQKGERLLVYE-YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           N++ LL             + YL    +   +    K E L   +   ++  +++GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
           H      +IHRDLK  N+ +++    KI DFG+AR     + ++     V T  Y +PE 
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189

Query: 194 VMNGI-VSMKSDVYSFGVLVLEIIS--------------SKKNNGCYDTERHLNLVGYAW 238
           ++N +  +   D++S G ++ E+I+               +                 + 
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
           +  N  K L  ++     S   +     +++    +   A  R T  + 
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (299), Expect = 8e-32
 Identities = 41/208 (19%), Positives = 93/208 (44%), Gaps = 21/208 (10%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTN 75
           D++    +LG+G +  V++   + + +++ +K L     +   + K E K++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 76  LVRLLGCSLQKGERL--LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
           ++ L         R   LV+E++ N             + L        +  I++ L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 134 HKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           H    + ++HRD+K  N+++D +    ++ D+G+A  +   +     N  V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPE 199

Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
            +++  +     D++S G ++  +I  K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 4e-31
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 18/213 (8%)

Query: 18  DNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKSS----GQGIVEFKNEAKLIA 69
           +NF     LG G +G V+  + +     G+  A+K L K++     +     + E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 70  KLQHT-NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
            ++ +  LV L      + +  L+ +Y+    L   +    +    + +          +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
            +L L    +L +I+RD+K  NILLD   +  ++DFG+++ F  +E E       GT  Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 189 MSPEYVMNGI--VSMKSDVYSFGVLVLEIISSK 219
           M+P+ V  G        D +S GVL+ E+++  
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-30
 Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 21/226 (9%)

Query: 18  DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHT 74
             +     +G G  G V      +  + +AIK+LS+   +         E  L+  + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 75  NLVRLLGCSLQKG------ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
           N++ LL     +       +  LV E +          +       D ++   ++  ++ 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130

Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
           G+ +LH      +IHRDLK SNI++      KI DFG+ART G + +       V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
            +PE ++        D++S G ++ E++  K      D     N V
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-29
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 13/208 (6%)

Query: 17  TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQH 73
            + +   + +G G +G V        G  +A+K+LS+   S         E +L+  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 74  TNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
            N++ LL   +  +        YL    +   + +  K + L       +I  I++GL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
           +H      +IHRDLK SN+ +++    KI DFG+AR              V T  Y +PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPE 188

Query: 193 YVMNGI-VSMKSDVYSFGVLVLEIISSK 219
            ++N +  +   D++S G ++ E+++ +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 9e-27
 Identities = 36/215 (16%), Positives = 81/215 (37%), Gaps = 18/215 (8%)

Query: 20  FSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
           +    +LG G F  V+  K +++   +A+K +           ++E KL+ ++   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTK 73

Query: 79  LLGCSLQKGERLLVYEYLPNKSLDFF-------------IFDSSKKELLDWKKRFNIIEG 125
                     +LL +      +                 +    +   +       I + 
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVG 184
           ++ GL Y+H+  R  +IH D+K  N+L++       +    +A        + +    + 
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
           T  Y SPE ++       +D++S   L+ E+I+  
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 97.5 bits (242), Expect = 6e-25
 Identities = 37/203 (18%), Positives = 71/203 (34%), Gaps = 27/203 (13%)

Query: 23  GNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQ--------GIVEFKNEAKLIAKLQ 72
           G  +G+G    V+        E  +K  ++  +S +        G + F   A   A+ +
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 73  HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
              L +L G ++ K     VY +  N  L   I       +        +++ I++ +  
Sbjct: 65  FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAK 118

Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR-IVGTHGYMSP 191
            +      ++H DL   N+L+ +     I DF  +   G         R +     Y S 
Sbjct: 119 FYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174

Query: 192 EYVMNGIVSMKSDVYSFGVLVLE 214
            Y        + D+ S    +L+
Sbjct: 175 TY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	340
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.95
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.38
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.04
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.62
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.47
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.46
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	82.73

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=390.01  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=205.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999999875 58999999986543 2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ||++|+|.+++.   ....+++..+..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999984   3446999999999999999999999999   9999999999999999999999999998775444


Q ss_pred             cccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..........      .......        
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~--------  223 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKK--------  223 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTC--------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCC--------
Confidence            4444455789999999999988775 678999999999999999999996544332111      0011110        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .........+.++.+|+.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011112234567889999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=391.53  Aligned_cols=264  Identities=26%  Similarity=0.430  Sum_probs=206.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||.||+|+..  ..||||+++..  .......+.+|+.++++++||||+++++++.. +.+++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            478999999999999999999863  36999998644  34456788999999999999999999998754 56899999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ||++|+|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999998643  345899999999999999999999999   9999999999999999999999999998765433


Q ss_pred             cccccccccccCCCCChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      .........||+.|+|||++.+   +.++.++|||||||++|||+||+.||..........      .....+....   
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~~~p---  229 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGYLSP---  229 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTSCCC---
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCCCC---
Confidence            3334445678999999999864   358999999999999999999999997654332211      1111111000   


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCC
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP  299 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~  299 (340)
                        .....+...+..+.+|+.+||+.||++|||+.+|++.|+.+..++|
T Consensus       230 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         230 --DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             --CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence              0011223445679999999999999999999999999998766555

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=388.59  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=209.1

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      ++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+++.++||||+++++++.+.+..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999864 58999999986655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++|+|.+++..    ..+++..+..++.||+.||.|||++|   |+||||||+|||++.++++||+|||++..+....  
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            99999998743    35899999999999999999999999   9999999999999999999999999998764322  


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      .......||+.|+|||++.+..++.++||||+||++|+|++|..||...+......      .......        ...
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~--------~~~  236 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT--------PEL  236 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS--------CCC
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC--------CCC
Confidence            22344579999999999999999999999999999999999999996544333211      1111111        011


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            123345677899999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-57  Score=385.75  Aligned_cols=245  Identities=24%  Similarity=0.358  Sum_probs=206.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++++.||+|+||.||+|++. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999875 4889999998543   2234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |||++|+|.+++..   ...+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++......
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999853   345999999999999999999999999   999999999999999999999999999865432


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+       ....        
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~--------  220 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRVE--------  220 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HTTC--------
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC--------
Confidence                233457999999999999999999999999999999999999999765433322111       1111        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              1123334567899999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=378.26  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=214.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      ++|++.++||+|+||+||+|++++++.||||+++... .....+.+|+.++++++||||+++++++.+.+.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888899999996553 345689999999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +|+|..++...  ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||+++....... .
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~  156 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  156 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence            99999997543  345889999999999999999999999   99999999999999999999999999987653322 2


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......+|..|+|||.+.++.++.++||||||+++|||+| |..||......+....+       ..+         .+.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------~~~---------~~~  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQG---------LRL  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTT---------CCC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-------HhC---------CCC
Confidence            2334568899999999999999999999999999999998 78899766554422111       111         122


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..|...+..+.+|+.+||+.||++|||++++++.|.++
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            23344557899999999999999999999999998753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=384.67  Aligned_cols=254  Identities=27%  Similarity=0.389  Sum_probs=200.9

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccC
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLP   97 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   97 (340)
                      ++|++.+.||+|+||.||+|++.+++.||||+++... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788999999999999999999888899999996543 345679999999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccccc
Q 041345           98 NKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA  177 (340)
Q Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~  177 (340)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++....... .
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            99999998543  345889999999999999999999999   99999999999999999999999999987643322 2


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCC-CCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN-NGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......||+.|+|||++.+..++.++|||||||++|||+|++.| |......+..   ..    ...         ..+.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~---~~----i~~---------~~~~  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---ED----IST---------GFRL  221 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH---HH----HHH---------TCCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH---HH----HHh---------cCCC
Confidence            22345689999999999999999999999999999999996544 4433222211   11    111         1112


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..|..++..+.+++.+||+.||++|||+++|++.|+++
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            22344456789999999999999999999999999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-57  Score=393.16  Aligned_cols=258  Identities=23%  Similarity=0.357  Sum_probs=212.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC-CCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|++.. ++.||||+++... ...+++.+|+.++++++||||+++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4689999999999999999998754 7889999986543 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      |++|+|.+++... ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999998653 3345899999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                       .......|++.|+|||++.++.++.++|||||||++|||++|+.||........      ......         ...+
T Consensus       171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~---------~~~~  234 (287)
T d1opja_         171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLE---------KDYR  234 (287)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH---------TTCC
T ss_pred             -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHh---------cCCC
Confidence             222334578899999999999999999999999999999998777632222111      111111         1122


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ...+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            3334455678999999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-56  Score=389.27  Aligned_cols=269  Identities=24%  Similarity=0.394  Sum_probs=207.2

Q ss_pred             cccccHHHHHHHh---------cCCCCCCcccccCCeeEEEEEECC-CC---EEEEEEccCC-ChhcHHHHHHHHHHHHc
Q 041345            5 LKIFDFQTIAAAT---------DNFSPGNRLGQGGFGPVYKGKLLD-GQ---EIAIKRLSKS-SGQGIVEFKNEAKLIAK   70 (340)
Q Consensus         5 ~~~~~~~~i~~~~---------~~y~~~~~Lg~G~~g~V~~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~   70 (340)
                      +..|+|+++..++         ++|++.+.||+|+||.||+|++.. ++   .||||.+... .......+.+|+.++++
T Consensus         4 ~d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~   83 (299)
T d1jpaa_           4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ   83 (299)
T ss_dssp             CCGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT
T ss_pred             cCCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh
Confidence            3456776666554         456677899999999999998743 22   5889988654 34456679999999999


Q ss_pred             CCCCceeeeeeEEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 041345           71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASN  150 (340)
Q Consensus        71 l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~N  150 (340)
                      ++||||+++++++.+.+..++|||||++|+|.+++...  ...+++..+..++.|++.||+|||+++   ++||||||+|
T Consensus        84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~N  158 (299)
T d1jpaa_          84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARN  158 (299)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccce
Confidence            99999999999999999999999999999999988542  345899999999999999999999999   9999999999


Q ss_pred             eEeCCCCCeeEecccccccccCccccc---ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCC
Q 041345          151 ILLDDQMNPKISDFGMARTFGMNELEA---NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYD  226 (340)
Q Consensus       151 ilv~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~  226 (340)
                      ||++.++.+||+|||+++.+.......   ......||+.|+|||.+.++.++.++|||||||++|||+| |..||....
T Consensus       159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             EEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence            999999999999999998765432221   1223457889999999999999999999999999999998 889997654


Q ss_pred             cccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ..+....+                ....+...+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       239 ~~~~~~~i----------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         239 NQDVINAI----------------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HHHHHHHH----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHH----------------HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            43221111                11122333455667899999999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=384.95  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=208.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +.|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999875 48899999997766666678899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++|+|.+++...  ...+++..+..++.||+.||.|||++|   |+||||||+|||++.++++||+|||++......  .
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence            999999987543  345999999999999999999999999   999999999999999999999999999765322  1


Q ss_pred             cccccccccCCCCChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                      .......||+.|+|||++.     +..++.++|||||||++|+|++|..||...+..+....+      .. ....    
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~~-~~~~----  233 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------AK-SEPP----  233 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------HH-SCCC----
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------Hc-CCCC----
Confidence            2233467899999999983     456899999999999999999999999765544422111      11 1111    


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                         ....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       234 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 ---TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               11122345678899999999999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=386.28  Aligned_cols=255  Identities=29%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||+|+||.||+|++++++.||||++.... .....+.+|+.++++++||||+++++++.+ +..++|||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46889999999999999999999888899999996543 345679999999999999999999998754 5679999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||++++++.+||+|||+++....... 
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999999987543 2335899999999999999999999999   99999999999999999999999999987654322 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCC-CCCCcccccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .......|++.|+|||++.++.++.++|||||||++|||+||+.|+ ......+.   .    .....         ..+
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~---~----~~i~~---------~~~  228 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---I----QNLER---------GYR  228 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H----HHHHT---------TCC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHh---------cCC
Confidence            2233456889999999999999999999999999999999976665 32222111   1    11111         112


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ...+...+.++.+|+.+||+.||++|||+.+|++.|+++
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            223344566789999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=386.98  Aligned_cols=249  Identities=24%  Similarity=0.328  Sum_probs=204.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++++.||+|+||.||+|++. +++.||||++...   .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999874 5889999998543   2234567899999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |||++|+|.+++..   .+.+++..+..++.|++.||+|||++|   |+||||||+||++++++.++|+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998853   345999999999999999999999999   999999999999999999999999999887544


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+       ....        
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i-------~~~~--------  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-------IKLE--------  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HTTC--------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH-------HcCC--------
Confidence            4344444567999999999999999999999999999999999999999765433321111       1111        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence              1122334567899999999999999999998743

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-56  Score=382.59  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=196.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--CCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--KGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~i   91 (340)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.+...  .....+.+.+|+.++++++||||+++++++.+  ...+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999875 5889999998654  33445678899999999999999999998865  456899


Q ss_pred             EEeccCCCChhhHhhccC-ccccCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           92 VYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYS--RLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      |||||++|+|.+++.... ....+++..++.++.|++.||.|||+++  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999985432 2346999999999999999999999865  2359999999999999999999999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      .+....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....       ...+... 
T Consensus       163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~-------i~~~~~~-  232 (269)
T d2java1         163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-------IREGKFR-  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHTCCC-
T ss_pred             ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH-------HHcCCCC-
Confidence            765322  223346789999999999999999999999999999999999999976544332111       1111111 


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                              ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                    122334567899999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=389.93  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-C-----CEEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-G-----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   89 (340)
                      ++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.++.++ +||||+++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            678999999999999999998643 2     25899988544 333455788999999988 899999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCc--------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 041345           90 LLVYEYLPNKSLDFFIFDSSK--------------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKAS  149 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~  149 (340)
                      ++|||||++|+|.+++.....                    ...+++..++.++.|++.||+|||+++   |+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999965422                    235899999999999999999999999   999999999


Q ss_pred             CeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcc
Q 041345          150 NILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTE  228 (340)
Q Consensus       150 Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~  228 (340)
                      ||+++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654433333345668999999999999999999999999999999997 89999765443


Q ss_pred             cccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 041345          229 RHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT  292 (340)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~  292 (340)
                      ....      ....         ...+...+...+..+.+||.+||+.||++|||++||++.|.
T Consensus       274 ~~~~------~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ANFY------KLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHH------HHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH------HHHh---------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3211      1111         11223334455678999999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=380.67  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=211.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      .++|++.+.||+|+||.||+|++.+++.||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++|||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            36899999999999999999999888899999996543 345689999999999999999999999854 5689999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++|+|..++... ....+++..++.++.||+.||+|||+++   ++||||||+|||++.++++||+|||+++....... 
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999999888553 2335899999999999999999999999   99999999999999999999999999987643322 


Q ss_pred             cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcc-cccchhHHHHHHhhcCccccccccccc
Q 041345          177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTE-RHLNLVGYAWQLWNEGKALELIDTTLH  255 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (340)
                      .......||+.|+|||.+.++.++.++|||||||++|||++|+.|+...... +....       .         ....+
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-------i---------~~~~~  232 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------V---------ERGYR  232 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------H---------HTTCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-------H---------HhcCC
Confidence            2233456899999999999999999999999999999999977665432221 11111       1         11122


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCCCCCCCCC
Q 041345          256 ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP  304 (340)
Q Consensus       256 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~  304 (340)
                      ...+...+.++.+++.+||+.||++|||+++|++.|++.....+++..|
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence            3344555678999999999999999999999999999877666655554

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=387.77  Aligned_cols=263  Identities=22%  Similarity=0.284  Sum_probs=204.8

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .++|++.+.||+|+||+||+|++. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+...+++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999875 48899999986543 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||++|+|.+++..   ...+++..+..++.|++.||.|||++ +   |+||||||+|||++.++++||+|||+|..+.. 
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            9999999999954   34599999999999999999999974 7   99999999999999999999999999987542 


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHH----------hh-
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQL----------WN-  242 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~-  242 (340)
                         .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..............          .. 
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               2233467999999999999999999999999999999999999999765443211000000000          00 


Q ss_pred             ------------cCccccccccccc---CCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 ------------EGKALELIDTTLH---ESC-SPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 ------------~~~~~~~~~~~~~---~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                  .....+.......   ... ....+.++.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                        0000000000000   000 0113467889999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=378.20  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=208.1

Q ss_pred             cCCCCCC-cccccCCeeEEEEEEC---CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGN-RLGQGGFGPVYKGKLL---DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~-~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|.+.+ +||+|+||.||+|.+.   ++..||||+++.. .......+.+|+.++++++||||+++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            5566666 4999999999999753   2457999999654 34456789999999999999999999999865 468999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||||++|+|.+++...  +..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999987432  345899999999999999999999999   99999999999999999999999999987754


Q ss_pred             cccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          173 NELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       173 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .... .......||+.|+|||++.++.++.++|||||||++|||+| |..||......+...       ....+      
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-------~i~~~------  228 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQG------  228 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-------HHHTT------
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcC------
Confidence            3322 22334568899999999999999999999999999999998 899997654432211       11111      


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                         .+...|+..+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       229 ---~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         229 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               12233455667899999999999999999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-54  Score=384.77  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=210.3

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      -++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||||+++++++.+.+.+|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999875 5889999999777666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC--CCCCeeEecccccccccCc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD--DQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~--~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |++|+|.+++...  ...+++..+..++.||+.||.|||++|   |+||||||+|||++  .++.+||+|||++..+...
T Consensus       105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999999998532  345999999999999999999999999   99999999999996  4678999999999876432


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+      .. ...      .
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~-~~~------~  243 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KS-CDW------N  243 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-TCC------C
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-CCC------C
Confidence            2   233467899999999999999999999999999999999999999765443322111      11 100      0


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0011112345678999999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-55  Score=380.71  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      +.+.|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3577999999999999999999875 48899999986543 223456789999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC---CCCCeeEecccccccc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTF  170 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~---~~~~~~l~Dfg~~~~~  170 (340)
                      |||++|+|.+++..   ...+++..+..++.||+.||+|||++|   |+||||||+||++.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999953   345999999999999999999999999   99999999999995   5788999999999875


Q ss_pred             cCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....      .. ....    
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~-~~~~----  226 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------IL-KAEY----  226 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HH-TTCC----
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------Hh-ccCC----
Confidence            4322   22345799999999999999999999999999999999999999975443322111      11 1110    


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        ......++..+.++.+|+.+||+.||++|||+.|+++
T Consensus       227 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         227 --EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              1111222345577899999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-55  Score=375.39  Aligned_cols=247  Identities=27%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             CcccccCCeeEEEEEECC---CCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEeccCC
Q 041345           24 NRLGQGGFGPVYKGKLLD---GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN   98 (340)
Q Consensus        24 ~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   98 (340)
                      ++||+|+||.||+|.+.+   ++.||||+++..  +......+.+|+.++++++||||+++++++.. +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999997533   467999998643  23345678999999999999999999999865 457899999999


Q ss_pred             CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc-cc
Q 041345           99 KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL-EA  177 (340)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~  177 (340)
                      |+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+..... ..
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   345999999999999999999999999   99999999999999999999999999987643322 22


Q ss_pred             ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccccC
Q 041345          178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE  256 (340)
Q Consensus       178 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (340)
                      ......||+.|+|||.+.+..++.++|||||||++|||++ |..||...+..+...       ....+         .+.
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-------~i~~~---------~~~  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------MLEKG---------ERM  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTT---------CCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-------HHHcC---------CCC
Confidence            2334568899999999999999999999999999999998 899997654332211       11111         122


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       257 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                      ..+...+.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            3344556789999999999999999999999998875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-55  Score=377.88  Aligned_cols=258  Identities=25%  Similarity=0.409  Sum_probs=201.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCC-----CEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDG-----QEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      +.|++.+.||+|+||.||+|.+..+     ..||||.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688889999999999999976442     369999986543 3345578899999999999999999999999999999


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      |||||.++++.+++...  ...+++..+..++.|++.|++|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999887543  345899999999999999999999999   9999999999999999999999999998765


Q ss_pred             Cccc-ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNEL-EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .... ........||+.|+|||++.++.++.++|||||||++|||++|+.|+.......  ..    ....         
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~----~~~i---------  226 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EV----MKAI---------  226 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH----HHHH---------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HH----HHHH---------
Confidence            4322 222334567899999999999999999999999999999999776653222111  01    1111         


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ....+...+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            112223344456678999999999999999999999999998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-54  Score=382.51  Aligned_cols=253  Identities=23%  Similarity=0.266  Sum_probs=210.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|++. +|+.||||++..........+.+|+.++++++||||+++++++.+...+|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999999999874 5899999999776655667788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC--CCCCeeEecccccccccCc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD--DQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~--~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |++|+|.+.+..  ....+++..+..++.||+.||+|||++|   |+||||||+|||++  .++.+||+|||++..+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999887743  2345999999999999999999999999   99999999999998  6789999999999876532


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+      .. ...      .
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~-~~~------~  246 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KR-CDW------E  246 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HH-CCC------C
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-CCC------C
Confidence            2   233456899999999999999999999999999999999999999765544322111      11 100      1


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .........+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112223455678999999999999999999999873

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-55  Score=381.40  Aligned_cols=244  Identities=30%  Similarity=0.440  Sum_probs=201.0

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      .|++.+.||+|+||.||+|++. +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4999999999999999999865 57889999986543   2345668899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ||++|++..++..   ...+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++.....  
T Consensus        96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            9999999776643   345999999999999999999999999   99999999999999999999999999986432  


Q ss_pred             cccccccccccCCCCChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc
Q 041345          175 LEANTNRIVGTHGYMSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID  251 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (340)
                          .....||+.|+|||++.+   +.++.++|||||||++|+|++|..||......+..      ...... ...    
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~~-~~~----  232 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-ESP----  232 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-CCC----
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhC-CCC----
Confidence                234579999999999854   46899999999999999999999999654333211      111111 111    


Q ss_pred             ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                1112234567899999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-54  Score=368.60  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=196.9

Q ss_pred             cCC-CCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee----CCee
Q 041345           18 DNF-SPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ----KGER   89 (340)
Q Consensus        18 ~~y-~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~   89 (340)
                      ++| ++.+.||+|+||+||+|++. +++.||+|.+...  .....+.+.+|++++++++||||+++++++.+    ...+
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            344 66678999999999999875 4789999998543  34456678999999999999999999999865    3457


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC-CCCCeeEecccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMAR  168 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~-~~~~~~l~Dfg~~~  168 (340)
                      ++|||||++|+|.+++..   ...+++..+..++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+++
T Consensus        88 ~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999999854   345899999999999999999999874 3599999999999996 57899999999997


Q ss_pred             cccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALE  248 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (340)
                      ....    .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........      .......+....
T Consensus       164 ~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~  232 (270)
T d1t4ha_         164 LKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA  232 (270)
T ss_dssp             GCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG
T ss_pred             eccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCc
Confidence            6432    12334679999999998865 599999999999999999999999964433221      111111111111


Q ss_pred             cccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          249 LIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                          ..    +...++++.+|+.+||+.||++|||+.|+++
T Consensus       233 ----~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 ----SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                11    1223456889999999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=373.57  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=206.4

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC------hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS------GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      ..++|++++.||+|+||+||+|++. +|+.||||++....      ....+.+.+|+.++++++||||+++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4578999999999999999999874 58999999985431      2246778999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC----CeeEecc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDF  164 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~----~~~l~Df  164 (340)
                      +++|||||++|+|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++    .+||+||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999854   345999999999999999999999999   99999999999998766    4999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      |++.......   ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+       ...
T Consensus       162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i-------~~~  231 (293)
T d1jksa_         162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------SAV  231 (293)
T ss_dssp             TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HTT
T ss_pred             hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH-------Hhc
Confidence            9998764322   233456899999999999999999999999999999999999999765443321111       111


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ...      .....++..+..+.+|+.+||+.||++|||+.++++
T Consensus       232 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         232 NYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000      000001223467889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-54  Score=374.44  Aligned_cols=261  Identities=24%  Similarity=0.403  Sum_probs=212.8

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGE   88 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (340)
                      -.++|++.+.||+|+||.||+|+..      +++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3578999999999999999999864      24689999986543 3345678999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCc---------------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSK---------------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK  147 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk  147 (340)
                      .+++|||+++|+|.+++.....                     ...+++..++.++.|++.||+|||+++   ++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            9999999999999999864321                     224889999999999999999999999   9999999


Q ss_pred             CCCeEeCCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCC-CCCCCCC
Q 041345          148 ASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK-KNNGCYD  226 (340)
Q Consensus       148 ~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~-~p~~~~~  226 (340)
                      |+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++|. .||...+
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998765444334444566889999999999999999999999999999999986 5676544


Q ss_pred             cccccchhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCC
Q 041345          227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT  295 (340)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~  295 (340)
                      ..+....       ...+.         ....+...+.++.+|+.+||+.+|++|||+.||++.|+++.
T Consensus       248 ~~e~~~~-------v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEEVIYY-------VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHH-------HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHH-------HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            4332111       11221         12233445567899999999999999999999999999763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=374.91  Aligned_cols=247  Identities=22%  Similarity=0.283  Sum_probs=207.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++++.||+|+||.||+|+.. +++.||+|++.+.   ......++.+|+.+++.++||||+++++++.+...+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            67999999999999999999874 5899999998643   2334667889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |||++|+|.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+|||++.+|.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999854   345899999999999999999999999   999999999999999999999999999865432


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                      .  ......+||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......+       ....        
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i-------~~~~--------  221 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-------LMEE--------  221 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC--------
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH-------hcCC--------
Confidence            2  2334467999999999999999999999999999999999999999765543322111       1111        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                        ...|...+.++.+||.+||+.||++||+     ++++++
T Consensus       222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              1223344567889999999999999995     788876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=365.13  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=200.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-CeeEEEEec
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-GERLLVYEY   95 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~   95 (340)
                      .++|++.+.||+|+||.||+|++ .|+.||||+++...  ..+.+.+|+.++++++||||+++++++.+. +.+++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35788899999999999999998 57899999996543  356789999999999999999999988654 568999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +++|+|.+++... ....+++..++.++.||+.|+.|||+++   ++||||||+||+++.++.++|+|||+++....   
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---  155 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---  155 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC---
Confidence            9999999998643 2335899999999999999999999998   99999999999999999999999999986432   


Q ss_pred             ccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          176 EANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                        ......++..|+|||.+.++.++.++|||||||++|||+| |..||......+....+       .         ...
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-------~---------~~~  217 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------E---------KGY  217 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------T---------TTC
T ss_pred             --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------H---------cCC
Confidence              2233457889999999999999999999999999999998 67777654444322111       1         112


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      +...+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            2334445567899999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-53  Score=370.71  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++.+.||+|+||.||+|++. +|+.||||++...   .....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999874 4899999998543   2234667889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      |||++|+|..++..   ...+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998854   344788999999999999999999999   999999999999999999999999999876432


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+      .. +.        
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~-~~--------  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LN-AE--------  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-CC--------
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------Hc-CC--------
Confidence                 23467999999999999999999999999999999999999999765433321111      11 11        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                        ...++..+.++.+++.+||+.||.+||     |++++++
T Consensus       218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              112334456788999999999999996     8999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=372.34  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=204.4

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CC----EEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQ----EIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .+|++.+.||+|+||.||+|.+.. |+    .||+|.+... .......+.+|+.++++++||||+++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999998643 43    5899988644 334567899999999999999999999998865 5678


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      +++++.+++|.+.+...  ...+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            88999999998887653  345899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      ............||+.|+|||.+.++.++.++|||||||++|||+| |..||......+....+                
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i----------------  226 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------------  226 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH----------------
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----------------
Confidence            5444444445568999999999999999999999999999999998 78888765544322211                


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      ....+...+..++..+.+|+.+||+.||++|||+.+|++.|..+
T Consensus       227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            11122233455667899999999999999999999999988754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=366.13  Aligned_cols=255  Identities=22%  Similarity=0.324  Sum_probs=198.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC----CCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD----GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLL   91 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   91 (340)
                      .++|++++.||+|+||.||+|.+..    +..||+|.+... .......+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3689999999999999999998643    346899988654 3344567899999999999999999999986 457899


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG  171 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~  171 (340)
                      ||||+++|++.+++...  ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999987543  345899999999999999999999999   9999999999999999999999999998764


Q ss_pred             CcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCcccccc
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI  250 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (340)
                      .... .......||+.|+|||.+.++.++.++|||||||++|||++ |..||......+....+       ..+.     
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~~-----  226 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGE-----  226 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTC-----
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC-----
Confidence            3222 22334567899999999999999999999999999999998 78888765544322111       1111     


Q ss_pred             cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          ....++..+..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       227 ----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         227 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                1223445567899999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=366.43  Aligned_cols=256  Identities=26%  Similarity=0.344  Sum_probs=199.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--C--CEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--G--QEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|++.+.||+|+||.||+|+...  +  ..||||++...   .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3679999999999999999997532  2  36899988543   23445678999999999999999999999975 467


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ++|||||+++++.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            8999999999999887543  345999999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCcccc-cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcCccc
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKAL  247 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (340)
                      ....... .......|+..|+|||.+.+..++.++||||||+++|||+| |..||...+..+..      ......+   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~------~~i~~~~---  231 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEG---  231 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSC---
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH------HHHHhCC---
Confidence            7543222 22334557889999999999999999999999999999998 89999755444322      1111111   


Q ss_pred             ccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 041345          248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN  293 (340)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~  293 (340)
                            .+...+...+..+.+|+.+||+.||++|||+.+|++.|.+
T Consensus       232 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                  1222334455679999999999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-52  Score=370.76  Aligned_cols=244  Identities=23%  Similarity=0.262  Sum_probs=205.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      ++|++++.||+|+||.||+|++. +|+.||||++...   .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            67999999999999999999875 5899999998543   2234567889999999999999999999999999999999


Q ss_pred             eccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCc
Q 041345           94 EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMN  173 (340)
Q Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~  173 (340)
                      ||+.+|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999854   345999999999999999999999999   999999999999999999999999999876432


Q ss_pred             ccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccccc
Q 041345          174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT  253 (340)
Q Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (340)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+      .. +.        
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~-~~--------  254 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------VS-GK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-CC--------
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH------hc-CC--------
Confidence                 23457899999999999999999999999999999999999999754433221111      11 11        


Q ss_pred             ccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 041345          254 LHESCSPDEVTRCIHVGLLCVQDKATDRP-----TMSDVAS  289 (340)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~  289 (340)
                        ...+...+.++.+++.+||+.||.+|+     |++++++
T Consensus       255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              112233456789999999999999994     8999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=371.62  Aligned_cols=247  Identities=26%  Similarity=0.362  Sum_probs=203.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHH-cCCCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIA-KLQHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|++++.||+|+||+||+|++. +++.||||++++.   .......+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999875 4888999998543   1233455666666654 68999999999999999999999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccC
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM  172 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~  172 (340)
                      ||||++|+|.+++..   ...+++..+..++.||+.||+|||+++   ++||||||+|||++.++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954   345899999999999999999999999   99999999999999999999999999986543


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      .  ........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+      . .+.       
T Consensus       156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~-~~~-------  219 (320)
T d1xjda_         156 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------R-MDN-------  219 (320)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HCC-------
T ss_pred             c--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------H-cCC-------
Confidence            2  22334467899999999999999999999999999999999999999765444322111      1 111       


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMS-DVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~  289 (340)
                         ...+...+.++.+|+.+||+.||++|||+. ++++
T Consensus       220 ---~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               112233456789999999999999999995 6754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-53  Score=367.98  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=209.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC--------CCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK   86 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   86 (340)
                      .++|++++.||+|+||.||+|+..+        +..||||+++... ......+.+|...+.++ +||||+++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4789999999999999999997533        2369999996654 34456788888888888 799999999999999


Q ss_pred             CeeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEe
Q 041345           87 GERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL  153 (340)
Q Consensus        87 ~~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv  153 (340)
                      ...++|||||++|+|.+++.....             ...+++..++.++.|++.||+|||+++   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965431             235899999999999999999999999   9999999999999


Q ss_pred             CCCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCcccccc
Q 041345          154 DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLN  232 (340)
Q Consensus       154 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~ellt-g~~p~~~~~~~~~~~  232 (340)
                      +.++.+||+|||++................+++.|+|||.+.++.++.++||||||+++|||++ |..||......... 
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH-
Confidence            9999999999999988765554445556678999999999999999999999999999999998 67888654433211 


Q ss_pred             hhHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          233 LVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                            .....+         .....+...+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus       248 ------~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         248 ------KLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             ------HHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                  111122         12223344556799999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-53  Score=368.51  Aligned_cols=260  Identities=26%  Similarity=0.411  Sum_probs=200.2

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECC------CCEEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeC-C
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLD------GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQK-G   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~   87 (340)
                      .++|++.+.||+|+||.||+|++..      ++.||||++... .......+.+|...+.++ +|+||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            3789999999999999999997532      457999998654 333455677788877776 689999999987654 4


Q ss_pred             eeEEEEeccCCCChhhHhhccCc-------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSK-------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~  154 (340)
                      .+++|||||++|+|.+++.....             ...+++..+..++.|++.||+|||+++   |+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            68999999999999999965322             235899999999999999999999999   99999999999999


Q ss_pred             CCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCC-CCCCCCCcccccch
Q 041345          155 DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK-KNNGCYDTERHLNL  233 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~-~p~~~~~~~~~~~~  233 (340)
                      .++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++|. .||.........  
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~--  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            99999999999998765444444445567899999999999999999999999999999999875 567544333211  


Q ss_pred             hHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          ......+         .+...+...+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       247 ----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         247 ----CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                1111111         12223344556789999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-52  Score=360.60  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=205.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh---------hcHHHHHHHHHHHHcCC-CCceeeeeeEEee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG---------QGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQ   85 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   85 (340)
                      .++|++.+.||+|+||+||+|++. +++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999874 588999999855421         12345788999999996 9999999999999


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ++..|+|||||++|+|.+++..   ...+++..+..++.||+.||+|||++|   |+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999954   345999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhcc------CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMN------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ  239 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  239 (340)
                      ++.......   ......||+.|.|||.+.+      ..++.++||||+||++|+|++|+.||...+.......+     
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i-----  227 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----  227 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH-----
Confidence            998765322   2334578999999999853      34788999999999999999999999765433321111     


Q ss_pred             HhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       .. +..      ..........++++.+|+.+||+.||++|||+.|+++
T Consensus       228 -~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 -MS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -HH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -Hh-CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             11 110      0111122345678999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-52  Score=362.63  Aligned_cols=260  Identities=24%  Similarity=0.343  Sum_probs=202.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC---ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC----
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG----   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   87 (340)
                      ..++|++.+.||+|+||.||+|++. +++.||||+++..   +......+.+|+.+++.++||||+++++++....    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            3578999999999999999999864 5889999999654   2334567899999999999999999999987653    


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..|+|||||++++|..++..   .+.+++..+..++.||+.||+|||++|   |+||||||+||+++.++.++++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            37899999999999988843   345999999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCcc-cccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          168 RTFGMNE-LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       168 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ....... .........||+.|+|||++.+..++.++||||+||++|+|++|..||...+..+.      ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCC
Confidence            7654322 12233446789999999999999999999999999999999999999976543321      1111111111


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhcC
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP-TMSDVASMLTND  294 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~  294 (340)
                      ..       ....+..+..+.+++.+||+.||++|| |++++++.|..+
T Consensus       233 ~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         233 PP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            10       111123456788999999999999999 899999888653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.2e-52  Score=370.99  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=199.7

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC---hhcHHHH---HHHHHHHHcCCCCceeeeeeEEeeCCeeE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS---GQGIVEF---KNEAKLIAKLQHTNLVRLLGCSLQKGERL   90 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (340)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....   ......+   .+++.+++.++||||+++++++.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999875 48999999985321   1122223   34466777788999999999999999999


Q ss_pred             EEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccc
Q 041345           91 LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF  170 (340)
Q Consensus        91 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~  170 (340)
                      +|||||++|+|.+++..   ...+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++..+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999854   345899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccc
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL  249 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (340)
                      ...    ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............    ....       
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~-------  222 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL-------  222 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSS-------
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhcc-------
Confidence            532    2334579999999999865 56899999999999999999999999765544322111    0000       


Q ss_pred             ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                         ......+...+.++.+||.+||+.||++|||     ++++++
T Consensus       223 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 ---TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               0011222334567899999999999999999     688875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=367.23  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=212.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   89 (340)
                      ++|+++++||+|+||.||+|++.      .++.||||+++... ......+.+|+.++..+ +||||+++++++.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            68899999999999999999752      35689999996543 34456788999999999 699999999999999999


Q ss_pred             EEEEeccCCCChhhHhhccCc---------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC
Q 041345           90 LLVYEYLPNKSLDFFIFDSSK---------------KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD  154 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~  154 (340)
                      ++|||||++|+|.+++.....               ...+++..+..++.||+.|++|||+++   ++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence            999999999999999865431               235899999999999999999999999   99999999999999


Q ss_pred             CCCCeeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCC-CCCCCcccccch
Q 041345          155 DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN-NGCYDTERHLNL  233 (340)
Q Consensus       155 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p-~~~~~~~~~~~~  233 (340)
                      .++.++++|||.++...............||+.|+|||.+.++.++.++|||||||++|||+|++.| |.........  
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~--  257 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--  257 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            9999999999999987654444445557789999999999999999999999999999999995544 5443332211  


Q ss_pred             hHHHHHHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                          ...         +....+...+...+..+.+||.+||+.||++|||+.+|+++|+++
T Consensus       258 ----~~~---------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         258 ----YKM---------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             ----HHH---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHH---------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                111         111222333344567899999999999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=362.49  Aligned_cols=263  Identities=22%  Similarity=0.257  Sum_probs=198.2

Q ss_pred             CCcccccCCeeEEEEEEC-CCCEEEEEEccCCChh-----cHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEecc
Q 041345           23 GNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQ-----GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL   96 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   96 (340)
                      +++||+|+||+||+|++. +|+.||||++......     ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999875 4899999998544221     1235789999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      .++++..+..   ....+++..+..++.||+.||+|||++|   |+||||||+||+++.++.+||+|||++........ 
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            9887776652   3445899999999999999999999999   99999999999999999999999999987653322 


Q ss_pred             cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc---
Q 041345          177 ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT---  252 (340)
Q Consensus       177 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  252 (340)
                       ......||+.|+|||++.+. .++.++||||+||++|+|++|..||......+....+...........+......   
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence             22335689999999988654 6799999999999999999999999766554433222111000000111000000   


Q ss_pred             ---cccCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhhc
Q 041345          253 ---TLHESCS-----PDEVTRCIHVGLLCVQDKATDRPTMSDVAS--MLTN  293 (340)
Q Consensus       253 ---~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~  293 (340)
                         ......+     ...+..+.+|+.+||+.||++|||+.|+++  .|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence               0000111     123467899999999999999999999997  3554

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=368.24  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=206.0

Q ss_pred             cCCCCCCcccccCCeeEEEEEECC-CC--EEEEEEccCC-ChhcHHHHHHHHHHHHcC-CCCceeeeeeEEeeCCeeEEE
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLD-GQ--EIAIKRLSKS-SGQGIVEFKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLV   92 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   92 (340)
                      ++|++.+.||+|+||.||+|.+.+ +.  .||||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            788999999999999999998754 33  4788887543 334556789999999998 799999999999999999999


Q ss_pred             EeccCCCChhhHhhcc-------------CccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCe
Q 041345           93 YEYLPNKSLDFFIFDS-------------SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP  159 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~  159 (340)
                      |||+++|+|.+++...             .....+++..+..++.||+.|+.|||+++   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998653             22356999999999999999999999999   9999999999999999999


Q ss_pred             eEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCC-CCCCCCcccccchhHHHH
Q 041345          160 KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKK-NNGCYDTERHLNLVGYAW  238 (340)
Q Consensus       160 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~-p~~~~~~~~~~~~~~~~~  238 (340)
                      ||+|||+++.....   .......||..|+|||.+.++.++.++|||||||++|||++|.. ||...+..+....     
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-----  238 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-----  238 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-----
Confidence            99999999764322   22234568999999999999999999999999999999999765 5654433322111     


Q ss_pred             HHhhcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                        ...         ..+...+...+..+.+||.+||+.||++|||+.+|++.|+++..
T Consensus       239 --i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         239 --LPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             --GGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              111         11233344556789999999999999999999999999987644

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=363.60  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=214.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC------CCCEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCee
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL------DGQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGER   89 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (340)
                      .++|++.+.||+|+||.||+|.+.      .++.||||+++.. .......+.+|+.++++++||||+++++++......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            378899999999999999999763      2568999999654 334455689999999999999999999999998999


Q ss_pred             EEEEeccCCCChhhHhhccC-------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEe
Q 041345           90 LLVYEYLPNKSLDFFIFDSS-------KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS  162 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~  162 (340)
                      ++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            99999999999999985431       1124788999999999999999999998   9999999999999999999999


Q ss_pred             cccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCC-CCCCCCCcccccchhHHHHHHh
Q 041345          163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK-KNNGCYDTERHLNLVGYAWQLW  241 (340)
Q Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~  241 (340)
                      |||+++...............+++.|+|||.+.++.++.++||||||+++|||+||. .||......+....+       
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i-------  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-------  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------
Confidence            999998776554444455567899999999999999999999999999999999985 666554333322111       


Q ss_pred             hcCcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          242 NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      ..+.         ....+...+..+.+++.+||+.||++|||+.+|++.|++...
T Consensus       249 ~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1111         122334455779999999999999999999999999987643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-52  Score=364.72  Aligned_cols=252  Identities=19%  Similarity=0.253  Sum_probs=205.5

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +.++|++.+.||+|+||+||+|.+. +++.||+|+++.... ....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3578999999999999999999875 478899999976543 34567899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC--CCCeeEecccccccccC
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD--QMNPKISDFGMARTFGM  172 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~--~~~~~l~Dfg~~~~~~~  172 (340)
                      ||++++|.+++...  ...+++..+..++.||+.||.|||++|   |+||||||+||+++.  ...++|+|||++.....
T Consensus        82 ~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999998542  235899999999999999999999999   999999999999984  45799999999987543


Q ss_pred             cccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccc
Q 041345          173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT  252 (340)
Q Consensus       173 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (340)
                      ..   ......+++.|+|||.+.+..++.++||||+||++|+|++|..||...+..+....+      ..... . + ..
T Consensus       157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~~~-~-~-~~  224 (321)
T d1tkia_         157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEY-T-F-DE  224 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCC-C-C-CH
T ss_pred             CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC-C-C-Ch
Confidence            22   223356899999999999999999999999999999999999999765543322111      11100 0 0 00


Q ss_pred             cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          253 TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..    .+..+.++.+|+.+||+.||++|||+.|+++
T Consensus       225 ~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 EA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00    0123456889999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=360.64  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=203.2

Q ss_pred             CCcccccCCeeEEEEEECCC----CEEEEEEccCC-ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-CeeEEEEecc
Q 041345           23 GNRLGQGGFGPVYKGKLLDG----QEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-GERLLVYEYL   96 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~   96 (340)
                      .++||+|+||+||+|++.++    ..||||.++.. .......+.+|+.++++++||||+++++++... ...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999986442    25899998654 445567899999999999999999999998764 5789999999


Q ss_pred             CCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcccc
Q 041345           97 PNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE  176 (340)
Q Consensus        97 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~~  176 (340)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999998643  334778889999999999999999999   999999999999999999999999999876543222


Q ss_pred             c--ccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcccccccccc
Q 041345          177 A--NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL  254 (340)
Q Consensus       177 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (340)
                      .  ......||+.|+|||.+.++.++.++||||||+++|||++|+.||........  .....    ..+.         
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i----~~g~---------  251 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----LQGR---------  251 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC---------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCC---------
Confidence            2  22335688999999999999999999999999999999998888754322211  11111    1111         


Q ss_pred             cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCCC
Q 041345          255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA  297 (340)
Q Consensus       255 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~  297 (340)
                      +...+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1222344456789999999999999999999999999887544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=357.84  Aligned_cols=273  Identities=22%  Similarity=0.287  Sum_probs=204.2

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++.+.||+|+||.||+|++. +++.||||++....  ......+.+|+.++++++||||+++++++.+....|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999874 58999999985442  2335678899999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      |+.++++......  ....+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9976554444322  2345999999999999999999999999   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCCCChhhhccCC-CCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCccccccc--
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID--  251 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  251 (340)
                        .......||+.|+|||.+.... ++.++||||+||++|+|++|..||...+..+....+........+..+.....  
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              2233457899999999876655 57899999999999999999999976544332211110000000000000000  


Q ss_pred             ----c---cccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcCCCC
Q 041345          252 ----T---TLHES---CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM--LTNDTMA  297 (340)
Q Consensus       252 ----~---~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~  297 (340)
                          .   .....   ..+..+.++.+|+.+||+.||++|||+.|+++.  |.++..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                0   00000   011234678899999999999999999999984  6555443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=363.60  Aligned_cols=250  Identities=19%  Similarity=0.205  Sum_probs=197.5

Q ss_pred             hcCCCCCC-cccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHc-CCCCceeeeeeEEee----CCee
Q 041345           17 TDNFSPGN-RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAK-LQHTNLVRLLGCSLQ----KGER   89 (340)
Q Consensus        17 ~~~y~~~~-~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~   89 (340)
                      .++|++.+ .||+|+||+||+|++. +++.||||++...     ..+.+|+.++.+ .+||||+++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            47898875 5999999999999874 5899999998543     346788888655 489999999999875    3568


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC---CCCeeEecccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGM  166 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~---~~~~~l~Dfg~  166 (340)
                      |+|||||++|+|.+++... ....+++..+..++.|++.||+|||++|   |+||||||+||+++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999653 2345999999999999999999999999   999999999999985   45799999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.   .       
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~-------  227 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---T-------  227 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---H-------
Confidence            98765332   2334579999999999999899999999999999999999999996544433221110   0       


Q ss_pred             cccccccccCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          247 LELIDTTLHES--CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                       .+........  .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             0000001111  11345678999999999999999999999988

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-52  Score=360.94  Aligned_cols=268  Identities=22%  Similarity=0.286  Sum_probs=197.9

Q ss_pred             hcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC----eeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG----ERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~iv   92 (340)
                      .++|.+.+.||+|+||.||+|+. +|+.||||+++..... ....+.|+..+..++||||+++++++.+..    .+++|
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            46788889999999999999987 6889999998544321 222334555556779999999999987654    57999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS-----RLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ||||++|+|.+++..    ..+++..++.++.|++.|++|||+..     ..+|+||||||+||||+.++.+||+|||++
T Consensus        80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999954    24899999999999999999999731     124999999999999999999999999999


Q ss_pred             ccccCcccc--cccccccccCCCCChhhhccCC------CCccCceehhhHHHHHHHhCCCCCCCCCcccccc-------
Q 041345          168 RTFGMNELE--ANTNRIVGTHGYMSPEYVMNGI------VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-------  232 (340)
Q Consensus       168 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~-------  232 (340)
                      .........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||+.........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            876543222  2233467899999999986542      6779999999999999999998875433322110       


Q ss_pred             -hhHHHHHHhhcCcccccccccc-cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          233 -LVGYAWQLWNEGKALELIDTTL-HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                       ..............    .+.+ ....+......+.+|+.+||+.||++|||+.||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence             01111111111110    0000 0111234567799999999999999999999999999764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.1e-51  Score=353.50  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=202.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCC--hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEec
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEY   95 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   95 (340)
                      ++|++.++||+|+||+||+|++.+|+.||||++....  ......+.+|+.++++++||||+++++++...+..++++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999889999999986543  23356789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCccc
Q 041345           96 LPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL  175 (340)
Q Consensus        96 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~~  175 (340)
                      +.++++..+..   ....+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+||+|||.+........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            98877766653   3455999999999999999999999999   99999999999999999999999999987653322


Q ss_pred             ccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC---cccccc-
Q 041345          176 EANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG---KALELI-  250 (340)
Q Consensus       176 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  250 (340)
                        ......+++.|.|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+   .......   .+.... 
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGG
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCChhhccchhh
Confidence              2233468899999999865 45799999999999999999999999765443322111   1111110   000000 


Q ss_pred             -----------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 -----------DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 -----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                 ............+..+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       000001112234567889999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=354.93  Aligned_cols=240  Identities=24%  Similarity=0.366  Sum_probs=194.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCCh------hcHHHHHHHHHHHHcCC--CCceeeeeeEEeeCC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSG------QGIVEFKNEAKLIAKLQ--HTNLVRLLGCSLQKG   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~   87 (340)
                      .++|++.+.||+|+||+||+|++. +++.||||++.....      .....+.+|+.+++++.  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999875 589999999854311      11223568999999885  899999999999999


Q ss_pred             eeEEEEeccCC-CChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-CCCeeEeccc
Q 041345           88 ERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFG  165 (340)
Q Consensus        88 ~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-~~~~~l~Dfg  165 (340)
                      ..++||||+.+ +++.+++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 567777643   345999999999999999999999999   999999999999985 4789999999


Q ss_pred             ccccccCcccccccccccccCCCCChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      ++......    ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.            .....
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~~  220 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQ  220 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCC
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhcc
Confidence            99865422    2234578999999999987665 6789999999999999999999964211            00000


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                 ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       221 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 -----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                       0111223467899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=352.96  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=197.6

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-C-CCEEEEEEccCC--ChhcHHHHHHHHHHHHcC---CCCceeeeeeEEee----
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-D-GQEIAIKRLSKS--SGQGIVEFKNEAKLIAKL---QHTNLVRLLGCSLQ----   85 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----   85 (340)
                      .++|++++.||+|+||+||+|++. + ++.||||++...  .......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            579999999999999999999874 3 567899998533  112223455677776655   79999999998853    


Q ss_pred             -CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecc
Q 041345           86 -KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF  164 (340)
Q Consensus        86 -~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Df  164 (340)
                       ....+++||+++++++......  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             2468999999988877655432  3345899999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      |++......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+....+..........
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            998764322   23345678999999999999999999999999999999999999997665444322221110000000


Q ss_pred             cccc---cccc-------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          245 KALE---LIDT-------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       245 ~~~~---~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      .+..   ....       ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000   0000       0001112234567889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-48  Score=340.32  Aligned_cols=263  Identities=17%  Similarity=0.195  Sum_probs=207.1

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCC-CceeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH-TNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      +++|++.+.||+|+||+||+|++. +++.||||+++....  ...+.+|+..++.+.| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            578999999999999999999875 488999998855432  2246778888888864 899999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCC-----CCCeeEeccccccc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD-----QMNPKISDFGMART  169 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~-----~~~~~l~Dfg~~~~  169 (340)
                      |+ +++|.+++...  ...++...+..++.|++.||+|||++|   |+||||||+||+++.     ++.++|+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 68888887543  335899999999999999999999999   999999999999974     56799999999987


Q ss_pred             ccCcccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcC
Q 041345          170 FGMNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG  244 (340)
Q Consensus       170 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (340)
                      +......     .......||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6532211     12334579999999999999999999999999999999999999997665554333222111111111


Q ss_pred             cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcCCC
Q 041345          245 KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTM  296 (340)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~  296 (340)
                      ...+     +...    .+.++.+++..||+.+|++||+++.+.+.|+++..
T Consensus       236 ~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         236 PLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             CHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            1011     1112    23568889999999999999999999998876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-49  Score=345.93  Aligned_cols=268  Identities=19%  Similarity=0.294  Sum_probs=198.4

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee--------
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ--------   85 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   85 (340)
                      -++|++.+.||+|+||+||+|++. +|+.||||++...  .......+.+|+.++++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999874 5899999998544  23345678899999999999999999998754        


Q ss_pred             CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccc
Q 041345           86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG  165 (340)
Q Consensus        86 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg  165 (340)
                      ....++||||+.++++....   .....+++..+..++.|++.||.|||++|   |+||||||+||+++.++.++|+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34579999999887766554   23445899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCcccc--cccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 041345          166 MARTFGMNELE--ANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWN  242 (340)
Q Consensus       166 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  242 (340)
                      ++.........  .......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||...........+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99766532221  122335689999999998765 689999999999999999999999976554443322221111100


Q ss_pred             cCccccc--------ccccccCCCCH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          243 EGKALEL--------IDTTLHESCSP-------DEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       243 ~~~~~~~--------~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .......        +..........       .....+.+|+.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0000000        00000001111       113466789999999999999999999963

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=349.92  Aligned_cols=261  Identities=23%  Similarity=0.289  Sum_probs=196.5

Q ss_pred             CCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC------CeeEE
Q 041345           19 NFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK------GERLL   91 (340)
Q Consensus        19 ~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~i   91 (340)
                      +|+..++||+|+||+||+|++. +++.||||++......    ..+|+.++++++||||+++++++...      ..+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999875 4899999999654322    24799999999999999999998543      34789


Q ss_pred             EEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEecccccccc
Q 041345           92 VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTF  170 (340)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~  170 (340)
                      |||||+++++..+.........+++..+..++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||++..+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755555433334556999999999999999999999999   99999999999999765 8999999999876


Q ss_pred             cCcccccccccccccCCCCChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH--------HHHHh
Q 041345          171 GMNELEANTNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY--------AWQLW  241 (340)
Q Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~  241 (340)
                      ....   ......|++.|+|||.+.+ ..++.++||||+||++|+|++|..||......+....+..        .+...
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            4322   2233568999999998765 4689999999999999999999999976655433222110        00110


Q ss_pred             hc----CcccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          242 NE----GKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       242 ~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                      ..    ................+..+.++.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00    0001100001111112334567899999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-48  Score=340.00  Aligned_cols=261  Identities=19%  Similarity=0.258  Sum_probs=197.5

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCc-eeeeeeEEeeCCeeEEEEe
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN-LVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~iv~e   94 (340)
                      +++|++.+.||+|+||.||+|++. +++.||||++......  ..+..|+++++.++|++ |+.+..++.+....++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            468999999999999999999874 4889999988654322  35678999999998766 4555566677888999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeC---CCCCeeEeccccccccc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFG  171 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~---~~~~~~l~Dfg~~~~~~  171 (340)
                      |+ ++++...+..  ....+++..+..++.|++.||+|||++|   |+||||||+||+++   .+..++|+|||+++.+.
T Consensus        84 ~~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             Ec-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            98 4556555543  2345999999999999999999999999   99999999999986   35579999999999775


Q ss_pred             Ccccc-----cccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          172 MNELE-----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       172 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|+|++|..||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            43221     1233457999999999999999999999999999999999999999766555443332211111100000


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcC
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND  294 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~  294 (340)
                      .     ..    ....+.++.+++..||+.+|++||++.++.+.|+..
T Consensus       238 ~-----~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         238 E-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             H-----HH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             h-----Hh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0     01    122346788999999999999999999999888764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=347.71  Aligned_cols=266  Identities=22%  Similarity=0.283  Sum_probs=198.3

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC-----
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG-----   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   87 (340)
                      ..++|++++.||+|+||+||+|.+. +|+.||||+++..  .......+.+|+.+++.++||||+++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3578999999999999999999875 4899999999653  3344567889999999999999999999987654     


Q ss_pred             -eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccc
Q 041345           88 -ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM  166 (340)
Q Consensus        88 -~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~  166 (340)
                       .+|+||||+ +.+|..+..    ...+++..+..++.|++.||+|||++|   |+||||||+|||++.++.++++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             479999999 567777663    345999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH-----H
Q 041345          167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ-----L  240 (340)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----~  240 (340)
                      +.....     ..+...||+.|+|||.+.+. .++.++||||+||++|+|++|..||...+.............     .
T Consensus       168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            987543     23345689999999998764 578999999999999999999999976654433221111000     0


Q ss_pred             hhcC----------cccccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcCC
Q 041345          241 WNEG----------KALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM--LTNDT  295 (340)
Q Consensus       241 ~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~  295 (340)
                      +...          ...+. ............+..+.+|+.+||+.||++|||+.|+++.  |+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhcchhhhhhhccCCcc-cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0000          00000 0000011122334568899999999999999999999984  55543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=347.18  Aligned_cols=268  Identities=20%  Similarity=0.240  Sum_probs=198.1

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCC-hhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCC----ee
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG----ER   89 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~   89 (340)
                      ++++|++++.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            4578999999999999999999864 68999999996543 344567889999999999999999999986543    23


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      +++++++.+++|.+++..    ..+++..+..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            444556679999999843    34899999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCcccc-cccccccccCCCCChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHh-----h
Q 041345          170 FGMNELE-ANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLW-----N  242 (340)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~  242 (340)
                      ....... .......|++.|+|||++. +..++.++||||+||++|+|++|..||......+............     .
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            6543222 2234566899999999884 4567899999999999999999999997655433221111100000     0


Q ss_pred             cCccccc---c-cccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          243 EGKALEL---I-DTTLHESC-----SPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       243 ~~~~~~~---~-~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                      .......   . ........     .+..+.++.+|+.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000   0 00000000     11234568899999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=342.38  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=203.6

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC----CCCEEEEEEccCC----ChhcHHHHHHHHHHHHcCCC-CceeeeeeEEeeCCe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL----DGQEIAIKRLSKS----SGQGIVEFKNEAKLIAKLQH-TNLVRLLGCSLQKGE   88 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~   88 (340)
                      ++|++++.||+|+||.||+|+..    +|+.||||++...    .......+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999752    3789999998543    12234567899999999966 899999999999999


Q ss_pred             eEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccc
Q 041345           89 RLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR  168 (340)
Q Consensus        89 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~  168 (340)
                      .+++|||+.+++|.+++...   ..+++..+..++.|++.|+.|||+++   ++||||||+||+++.++.++|+|||++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998543   34788999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCcccccccccccccCCCCChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcCcc
Q 041345          169 TFGMNELEANTNRIVGTHGYMSPEYVMNG--IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA  246 (340)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  246 (340)
                      .+..... .......|++.|+|||.+.+.  .++.++|||||||+||+|++|..||...........+.....   ..  
T Consensus       178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~---~~--  251 (322)
T d1vzoa_         178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL---KS--  251 (322)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH---HC--
T ss_pred             hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc---cC--
Confidence            7653322 223346789999999998654  478899999999999999999999976655543332221111   00  


Q ss_pred             cccccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 041345          247 LELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPT-----MSDVAS  289 (340)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~  289 (340)
                              ....+...+.++.+|+.+||++||++|||     ++|+++
T Consensus       252 --------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                    12233455678999999999999999994     788886

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=336.36  Aligned_cols=264  Identities=21%  Similarity=0.261  Sum_probs=203.5

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeCCeeEEEEe
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYE   94 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   94 (340)
                      ++|++++.||+|+||+||+|++. +++.||||+++..  ......++.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999874 5888999998544  23446788999999999999999999999999999999999


Q ss_pred             ccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEecccccccccCcc
Q 041345           95 YLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE  174 (340)
Q Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~~~~~~  174 (340)
                      ++.++++..++..   ...+++..+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||.+.......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999988887743   345899999999999999999999999   9999999999999999999999999998765332


Q ss_pred             cccccccccccCCCCChhhhccCC-CCccCceehhhHHHHHHHhCCCCCCCCCc-ccccchhHHHHHHhhcCcccccc--
Q 041345          175 LEANTNRIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSKKNNGCYDT-ERHLNLVGYAWQLWNEGKALELI--  250 (340)
Q Consensus       175 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--  250 (340)
                      .  ......++..|.|||.+.+.. ++.++||||+||++|+|++|+.||..... .+....+...........+....  
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            2  223345678899999887654 68999999999999999999998643222 22221111111000000100000  


Q ss_pred             ----------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          251 ----------DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       251 ----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                                ............+..+.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      000111122344567889999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.2e-47  Score=335.98  Aligned_cols=258  Identities=17%  Similarity=0.261  Sum_probs=197.0

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeC--CeeEEE
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQK--GERLLV   92 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~iv   92 (340)
                      .++|+++++||+|+||+||+|++. +++.||||+++...   ...+.+|+.+++.+. ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            368999999999999999999874 58889999986543   456789999999995 99999999998744  468999


Q ss_pred             EeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCC-CeeEeccccccccc
Q 041345           93 YEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARTFG  171 (340)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~-~~~l~Dfg~~~~~~  171 (340)
                      ||||++++|..+.      +.+++..+..++.||+.||.|||++|   |+||||||+|||++.++ .++|+|||++....
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999987664      24899999999999999999999999   99999999999998655 58999999998764


Q ss_pred             CcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCccccc-chhHH------HHHHhh-
Q 041345          172 MNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL-NLVGY------AWQLWN-  242 (340)
Q Consensus       172 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~-~~~~~------~~~~~~-  242 (340)
                      ...   ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ..+..      ...... 
T Consensus       182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            322   23345689999999998765 5799999999999999999999999654432211 11100      000000 


Q ss_pred             --cCccccc-----------ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 041345          243 --EGKALEL-----------IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS  289 (340)
Q Consensus       243 --~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~  289 (340)
                        .......           .............+.++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0000000           0011111112334567889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=340.87  Aligned_cols=262  Identities=22%  Similarity=0.238  Sum_probs=192.7

Q ss_pred             hcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEee------CC
Q 041345           17 TDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ------KG   87 (340)
Q Consensus        17 ~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   87 (340)
                      .++|++.++||+|+||+||+|++. +|+.||||++...  .......+.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999875 4899999999644  34445678899999999999999999999863      36


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      .+|+|||||.++++....      ..+++..+..++.|++.||.|||++|   |+||||||+|||++.++.++++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            789999999776554442      24899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHH----------
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYA----------  237 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~----------  237 (340)
                      .....   ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+...          
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            76543   22334456899999999999999999999999999999999999999765543322111100          


Q ss_pred             ------HHHhhcC------cccccccccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 041345          238 ------WQLWNEG------KALELIDTTLHES---CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM  290 (340)
Q Consensus       238 ------~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~  290 (340)
                            .......      .............   .....+.++.+|+.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                  0000000      0000111111111   113456788999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=336.24  Aligned_cols=267  Identities=21%  Similarity=0.269  Sum_probs=198.2

Q ss_pred             HhcCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCC--ChhcHHHHHHHHHHHHcCCCCceeeeeeEEeeC-----C
Q 041345           16 ATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQK-----G   87 (340)
Q Consensus        16 ~~~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   87 (340)
                      +.++|++.+.||+|+||+||+|++. +|+.||||++...  +......+.+|+.+++.++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3678999999999999999999864 5899999999654  334456788999999999999999999998643     2


Q ss_pred             eeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeEeccccc
Q 041345           88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA  167 (340)
Q Consensus        88 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~  167 (340)
                      ..+++++++.+++|.+++..    ..+++..+..++.||+.||+|||++|   |+||||||+||+++.++.++++|||++
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence            34666777889999999842    35999999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCcccccccccccccCCCCChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHHHHH-----Hh
Q 041345          168 RTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQ-----LW  241 (340)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~  241 (340)
                      .....     ......|++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+.....     ..
T Consensus       169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            76432     23345688999999987665 468899999999999999999999976654433222211000     00


Q ss_pred             hcCccc---ccccccccC-C-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhhcC
Q 041345          242 NEGKAL---ELIDTTLHE-S-----CSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS--MLTND  294 (340)
Q Consensus       242 ~~~~~~---~~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~  294 (340)
                      ......   ......... .     .....+..+.+|+.+||+.||.+|||+.|+++  .|.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            000000   000000000 0     01123456889999999999999999999997  35443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.2e-42  Score=306.90  Aligned_cols=264  Identities=19%  Similarity=0.216  Sum_probs=191.3

Q ss_pred             cCCCCCCcccccCCeeEEEEEEC-CCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-----------CCceeeeeeEEee
Q 041345           18 DNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----------HTNLVRLLGCSLQ   85 (340)
Q Consensus        18 ~~y~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~   85 (340)
                      ++|+++++||+|+||+||+|+.. +|+.||||+++... .....+.+|+.+++.+.           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999874 58999999996543 33456778888887764           5789999988754


Q ss_pred             --CCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCeEeCCCCC----
Q 041345           86 --KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-YSRLRVIHRDLKASNILLDDQMN----  158 (340)
Q Consensus        86 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~dlk~~Nilv~~~~~----  158 (340)
                        ....++++.++..+..............+++..+..++.|++.|++|||+ .|   |+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence              34566777766555444443333445568999999999999999999998 77   999999999999986543    


Q ss_pred             --eeEecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCcccccchhHH
Q 041345          159 --PKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY  236 (340)
Q Consensus       159 --~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl~elltg~~p~~~~~~~~~~~~~~~  236 (340)
                        ++++|||.+.....     ......||+.|+|||++.+..++.++|+||+||++++|++|+.||..............
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              89999999876432     22345689999999999999999999999999999999999999965544322211111


Q ss_pred             HHH---H------------------hhcCcccccccc----------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 041345          237 AWQ---L------------------WNEGKALELIDT----------TLHESCSPDEVTRCIHVGLLCVQDKATDRPTMS  285 (340)
Q Consensus       237 ~~~---~------------------~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  285 (340)
                      ...   .                  +........+..          ......+...+..+.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            100   0                  000000000000          011233466788999999999999999999999


Q ss_pred             HHHHH
Q 041345          286 DVASM  290 (340)
Q Consensus       286 evl~~  290 (340)
                      |+++.
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99873

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=7.1e-26  Score=183.34  Aligned_cols=170  Identities=17%  Similarity=0.162  Sum_probs=120.6

Q ss_pred             CCCCCcccccCCeeEEEEEECCCCEEEEEEccCCCh------------------hcHHHHHHHHHHHHcCCCCceeeeee
Q 041345           20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSG------------------QGIVEFKNEAKLIAKLQHTNLVRLLG   81 (340)
Q Consensus        20 y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~   81 (340)
                      +.++++||+|+||+||+|.+.+|+.||||+++....                  .......+|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999988899999998743210                  01123456788889999999988876


Q ss_pred             EEeeCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCeEeCCCCCeeE
Q 041345           82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI  161 (340)
Q Consensus        82 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~dlk~~Nilv~~~~~~~l  161 (340)
                      +.    ..+++|||+++..+..          ++......++.|++.++++||++|   |+||||||+|||++++ .++|
T Consensus        82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            53    2379999998765432          334456689999999999999999   9999999999999866 5899


Q ss_pred             ecccccccccCcccccccccccccCCCCChhhhccCCCCccCceehhhHHH
Q 041345          162 SDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV  212 (340)
Q Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~vl  212 (340)
                      +|||.|.....+...........    .-.+ +....|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~~~l~rd~~----~~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILERDVR----NIIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHHHHHH----HHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHHHHHH----HHHH-HHcCCCCCcccHHHHHHHH
Confidence            99999876543221110000000    0011 2245678899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.95  E-value=1.4e-09  Score=90.69  Aligned_cols=150  Identities=16%  Similarity=0.127  Sum_probs=104.3

Q ss_pred             HHHHHHhcCCCCCCcccccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCee
Q 041345           11 QTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGER   89 (340)
Q Consensus        11 ~~i~~~~~~y~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   89 (340)
                      .++...-..|++.+..+.++.+.||+... +++.+++|............+.+|...++.+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45666778888777766566678999864 67778889875544334445677888877663 33356677777788889


Q ss_pred             EEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 041345           90 LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS--------------------------------  137 (340)
Q Consensus        90 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------  137 (340)
                      ++||+++++.++.......        .....++.+++..++.||+..                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            9999999998876654211        112334556666677777421                                


Q ss_pred             ------------------------CCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          138 ------------------------RLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       138 ------------------------~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                                              ...++|+|+.|.||++++++.+-|.||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                    12379999999999999776667999987653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.38  E-value=1.6e-06  Score=71.07  Aligned_cols=131  Identities=18%  Similarity=0.165  Sum_probs=85.2

Q ss_pred             cccccCC-eeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC--CCceeeeeeEEeeCCeeEEEEeccCCCCh
Q 041345           25 RLGQGGF-GPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ--HTNLVRLLGCSLQKGERLLVYEYLPNKSL  101 (340)
Q Consensus        25 ~Lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~e~~~~~~L  101 (340)
                      .+..|.. +.||+....++..+++|........   .+..|...++.+.  .-.+.+++.+..+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3445554 6789998877888999987554333   3456777776653  22356677777777788999999988765


Q ss_pred             hhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 041345          102 DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS--------------------------------------------  137 (340)
Q Consensus       102 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------  137 (340)
                      ....        .+..   ..+.++...++.||+..                                            
T Consensus        94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            3321        1111   12234444444555310                                            


Q ss_pred             -----------CCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          138 -----------RLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       138 -----------~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                                 ...++|+|+.|.||+++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                       12379999999999999876677999987653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.04  E-value=1.1e-05  Score=70.55  Aligned_cols=77  Identities=16%  Similarity=0.171  Sum_probs=47.6

Q ss_pred             CCcccccCCeeEEEEEECC-CCEEEEEEccCC-------ChhcHHHHHHHHHHHHcC-CC-C-ceeeeeeEEeeCCeeEE
Q 041345           23 GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-------SGQGIVEFKNEAKLIAKL-QH-T-NLVRLLGCSLQKGERLL   91 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l-~h-~-~i~~~~~~~~~~~~~~i   91 (340)
                      .+.||.|....||++...+ ++.+++|.-...       ......+...|.+.++.+ .+ | .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3478999999999997644 678999964321       111233445677777766 22 3 34445543  4556689


Q ss_pred             EEeccCCCCh
Q 041345           92 VYEYLPNKSL  101 (340)
Q Consensus        92 v~e~~~~~~L  101 (340)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.62  E-value=0.00046  Score=57.86  Aligned_cols=159  Identities=13%  Similarity=-0.001  Sum_probs=83.4

Q ss_pred             ccHHHHHHHhcCCCCCCccc-----ccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCC-----CCcee
Q 041345            8 FDFQTIAAATDNFSPGNRLG-----QGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-----HTNLV   77 (340)
Q Consensus         8 ~~~~~i~~~~~~y~~~~~Lg-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~   77 (340)
                      .+.+++..+..+|.+++...     .|--.+.|+....+| .+++|+.......  ..+..+..++..+.     .|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccc
Confidence            46788999999999877654     566678899987655 5899988543222  23344555555542     23222


Q ss_pred             eeee---EEeeCCeeEEEEeccCCCChhhHh--------------hc----cCcc--------------------ccCCH
Q 041345           78 RLLG---CSLQKGERLLVYEYLPNKSLDFFI--------------FD----SSKK--------------------ELLDW  116 (340)
Q Consensus        78 ~~~~---~~~~~~~~~iv~e~~~~~~L~~~l--------------~~----~~~~--------------------~~~~~  116 (340)
                      ...+   +.........++.+..+.......              +.    ....                    .....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2110   112234455666665553221100              00    0000                    00011


Q ss_pred             HHHHHHHHHHHHHHHHHHhCC-CCceeecCCCCCCeEeCCCCCeeEeccccccc
Q 041345          117 KKRFNIIEGIVQGLLYLHKYS-RLRVIHRDLKASNILLDDQMNPKISDFGMART  169 (340)
Q Consensus       117 ~~~~~i~~qi~~~l~~LH~~~-~~~i~H~dlk~~Nilv~~~~~~~l~Dfg~~~~  169 (340)
                      ......+..+...+...+..+ ..+++|+|+.++||+++++...-+.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            111122222223333332211 34599999999999999887678999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.47  E-value=0.00016  Score=63.00  Aligned_cols=73  Identities=15%  Similarity=0.188  Sum_probs=49.4

Q ss_pred             CCcccccCCeeEEEEEECC--------CCEEEEEEccCCChhcHHHHHHHHHHHHcCC-CCceeeeeeEEeeCCeeEEEE
Q 041345           23 GNRLGQGGFGPVYKGKLLD--------GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCSLQKGERLLVY   93 (340)
Q Consensus        23 ~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~   93 (340)
                      .+.|+.|-...+|++...+        .+.|++++....  .......+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3568889999999998643        345777776532  23345678888888874 4434567766542    6889


Q ss_pred             eccCCCCh
Q 041345           94 EYLPNKSL  101 (340)
Q Consensus        94 e~~~~~~L  101 (340)
                      +|+++.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99977544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.46  E-value=0.00089  Score=56.39  Aligned_cols=95  Identities=13%  Similarity=0.043  Sum_probs=55.9

Q ss_pred             cccccHHHHHHHhcCCCC--C-Cccc-ccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCC---C--c
Q 041345            5 LKIFDFQTIAAATDNFSP--G-NRLG-QGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQH---T--N   75 (340)
Q Consensus         5 ~~~~~~~~i~~~~~~y~~--~-~~Lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~--~   75 (340)
                      +..++.+.|..+...+-+  . +.+- .+.-..||+++..+|+.+++|+.+... ....++..|...+..+..   |  .
T Consensus         5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~   83 (325)
T d1zyla1           5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   83 (325)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCC
Confidence            445566666555544321  1 2211 234568999998889999999986542 234567778777776631   1  1


Q ss_pred             eeeee--eEEeeCCeeEEEEeccCCCC
Q 041345           76 LVRLL--GCSLQKGERLLVYEYLPNKS  100 (340)
Q Consensus        76 i~~~~--~~~~~~~~~~iv~e~~~~~~  100 (340)
                      .+..-  ..+......+.++++++|..
T Consensus        84 p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          84 PVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            11111  12344566788999987643

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=82.73  E-value=4.9  Score=32.20  Aligned_cols=133  Identities=13%  Similarity=0.114  Sum_probs=75.7

Q ss_pred             cccCCeeEEEEEECCCCEEEEEEccCCChhcHHHHHHHHHHHHcCCCCceeeeeeEEe----------------------
Q 041345           27 GQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL----------------------   84 (340)
Q Consensus        27 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----------------------   84 (340)
                      ..++.+.|+-+.. ++..+++|.-   .....+.+..++...-.++.|...-+. .+.                      
T Consensus        77 s~~Gs~Gv~FV~~-e~gaiVlK~s---~tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~s  151 (342)
T d1cjaa_          77 SEKGTEGLFFVET-ESGVFIVKRS---TNIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVITT  151 (342)
T ss_dssp             CCSTTSCEEEEEE-SSCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHHH
T ss_pred             eecCCceEEEEEc-CCceEEEecC---CchHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHHHH
Confidence            3445555555644 4667788853   224456677777777777888765443 110                      


Q ss_pred             -eCCeeEEEEeccCCCChhhHhhccCccccCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC-CCCCCeEeCCCC-CeeE
Q 041345           85 -QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD-LKASNILLDDQM-NPKI  161 (340)
Q Consensus        85 -~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~d-lk~~Nilv~~~~-~~~l  161 (340)
                       -....+++|||.+|..+.+.-... ....++.....+ +..|+-.=.+++...+.++.+++ =++.|+++..++ .+..
T Consensus       152 el~~A~~liMeYvpG~~l~e~~~~~-a~~~fs~~~l~~-LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~  229 (342)
T d1cjaa_         152 LANQANILLMELVRGITLNKLTTTS-APEVLTKSTMQQ-LGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVP  229 (342)
T ss_dssp             HTTCSEEEEEECCCEEESTTCCSSS-HHHHSCHHHHHH-HHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEE
T ss_pred             HHhcccceeeeccCCcccccccccc-chhhhcHHHHHH-hhhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEE
Confidence             113467999999988775553111 111233333222 22243334466665555677663 389999998776 5666


Q ss_pred             ecccc
Q 041345          162 SDFGM  166 (340)
Q Consensus       162 ~Dfg~  166 (340)
                      .|=+.
T Consensus       230 IDs~i  234 (342)
T d1cjaa_         230 IDSKI  234 (342)
T ss_dssp             CSCCC
T ss_pred             ecCCc
Confidence            66443